data_6poj_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6poj _Structure_validation_residue.Date_analyzed 2019-09-27 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.63 -5.53 11.15 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.478 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -63.12 -40.26 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.23 -35.75 72.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.119 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.79 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -46.54 62.69 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -33.53 71.66 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.43 -38.32 77.23 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.992 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 75' ' ' LEU . . . -65.6 -46.64 78.58 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 112.899 -1.955 . . . . 0.0 114.865 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -31.32 59.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.506 -177.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -39.05 74.97 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.736 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -44.73 84.01 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -52.5 9.4 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.48 -44.72 94.13 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.604 -177.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.413 ' O ' HG12 ' A' ' 29' ' ' ILE . 63.3 t80 -54.3 -48.97 70.71 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.424 0.631 . . . . 0.0 112.337 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 pt -75.65 -29.54 20.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -36.42 69.18 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.8 mm -60.84 -38.59 79.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.065 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -36.8 64.65 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p -67.01 -41.28 86.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.469 179.579 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.806 0.336 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -49.52 -28.47 5.53 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.4 t -58.77 -42.5 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 O-C-N 121.821 -0.55 . . . . 0.0 112.264 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -65.01 -53.98 37.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.84 -42.17 85.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.225 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.8 m -69.39 -41.23 76.74 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.933 0.771 . . . . 0.0 109.806 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.74 -31.74 72.73 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.49 93.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.508 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -66.15 -46.92 75.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.96 92.2 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.277 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.1 mt -68.28 -43.06 78.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.8 m -57.61 -35.86 71.02 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -60.23 -33.81 54.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.675 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.476 ' N ' HG13 ' A' ' 60' ' ' ILE . . . -60.64 -45.53 93.73 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.51 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -31.52 70.59 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -42.59 72.9 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 104.199 -2.519 . . . . 0.0 104.199 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.98 -44.27 73.21 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.654 174.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -43.57 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -176.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -59.25 -12.26 5.2 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 119.936 1.243 . . . . 0.0 111.856 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 m -119.76 -38.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 154.16 6.34 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -52.94 -22.74 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -70.89 7.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.56 135.71 53.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.11 -159.61 31.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.48 85.99 1.15 Allowed 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 118.574 -1.25 . . . . 0.0 107.776 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -19.54 64.46 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 112.794 -2.003 . . . . 0.0 105.684 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 1.7 pp -84.84 0.18 51.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.398 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.26 128.81 25.53 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 119.371 0.987 . . . . 0.0 113.517 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -83.35 -25.34 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.717 2.278 . . . . 0.0 111.86 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' A' ' 192' ' ' ASN . . . -64.27 -46.16 84.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.23 -36.8 78.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 110.802 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -64.68 -28.62 69.73 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -57.21 -44.47 83.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 110.285 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.24 95.89 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.8 tp -51.41 -41.26 60.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.576 0.227 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 tp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.432 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.854 0.359 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.7 -35.2 78.38 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.701 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 tp -54.78 -38.45 67.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -32.63 64.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.227 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -70.06 -38.65 75.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.287 0.949 . . . . 0.0 111.947 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.77 -41.25 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.49 -37.78 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.414 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.02 83.53 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.008 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.33 -35.89 71.37 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.423 ' O ' HG13 ' A' ' 106' ' ' ILE . 1.2 t -57.91 -36.14 72.03 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.57 -35.33 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.429 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.37 85.22 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 120.781 1.628 . . . . 0.0 113.221 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.8 -35.9 75.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 102' ' ' CYS . 69.5 mt -65.03 -50.36 75.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.98 -37.12 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.434 0.635 . . . . 0.0 109.48 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.45 -49.83 74.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.407 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.71 -37.02 86.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.727 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -44.89 88.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.19 -37.28 76.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.087 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.81 -24.36 66.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.601 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 t -63.3 -44.38 95.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.901 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.25 -36.33 62.16 Favored Glycine 0 CA--C 1.509 -0.299 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -33.16 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.3 -0.95 . . . . 0.0 110.728 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.559 -179.508 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.54 117.2 31.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.281 0.563 . . . . 0.0 111.131 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.85 15.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.665 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.15 90.07 7.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.1 142.8 58.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.317 0.58 . . . . 0.0 111.149 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.96 136.25 47.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.333 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 127.58 16.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.66 -105.05 0.65 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.637 HG12 ' HB2' ' A' ' 137' ' ' GLN . 1.8 t -86.09 124.13 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.445 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 32.1 t30 -71.65 -171.95 0.73 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -62.01 -46.86 87.34 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 114.928 -2.709 . . . . 0.0 110.239 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.53 96.17 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.637 ' HB2' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -53.39 -23.53 9.9 Favored 'General case' 0 C--N 1.248 -3.809 0 CA-C-O 121.261 0.553 . . . . 0.0 110.796 -176.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.53 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -70.33 -1.95 38.53 Favored Glycine 0 C--O 1.187 -2.794 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.98 -50.64 71.26 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.521 -1.576 . . . . 0.0 110.168 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.71 -45.94 56.27 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.53 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -60.88 -42.08 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.184 -1.508 . . . . 0.0 112.084 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 138' ' ' GLY . 8.3 tt0 -68.37 -36.32 79.02 Favored 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 123.687 0.795 . . . . 0.0 112.305 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.4 mt -67.65 -47.68 79.18 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.404 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 26.9 mt -68.33 -46.79 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.059 0.933 . . . . 0.0 111.695 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -60.18 -49.94 73.04 Favored Glycine 0 C--O 1.211 -1.335 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.323 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.1 m -70.58 -38.22 74.03 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.923 0.868 . . . . 0.0 111.13 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 tp -54.98 -40.22 69.83 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.048 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.8 OUTLIER -58.77 -31.06 68.02 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.325 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.8 tp -68.91 -46.69 67.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.353 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.9 t -66.35 -45.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -31.87 72.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.089 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.09 -45.43 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 -48.1 80.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 111.119 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.84 -31.69 72.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.468 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.442 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 119.62 -0.229 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 39.5 Cg_exo -54.31 -44.24 51.24 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.795 1.663 . . . . 0.0 112.019 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 mp -66.1 -38.1 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.26 56.38 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 22.2 pt -60.26 -38.3 76.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.721 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.41 93.53 Favored Glycine 0 C--O 1.2 -1.994 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.681 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mt -55.04 -35.58 64.63 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.161 -2.162 . . . . 0.0 105.161 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -34.54 77.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.31 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.04 -47.24 48.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.907 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.53 -33.61 75.41 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 122.665 1.222 . . . . 0.0 110.027 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.258 0.1 OUTLIER -70.61 -47.49 59.85 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.973 179.375 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.64 -36.84 65.94 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 111.564 -2.562 . . . . 0.0 107.664 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' HIS . . . . . 0.456 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 6.2 m170 -70.46 -34.99 73.06 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.933 -1.633 . . . . 0.0 109.54 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.02 -48.43 81.61 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.359 -177.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -52.07 11.6 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.47 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.66 -51.96 30.04 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 188' ' ' GLY . 5.6 mt -62.11 -49.14 85.29 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.807 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.039 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -35.51 79.64 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 116.119 -2.232 . . . . 0.0 112.818 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.95 -30.4 69.05 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.909 -1.116 . . . . 0.0 111.699 -171.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.295 0.1 OUTLIER -124.31 -26.91 3.86 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.267 1.032 . . . . 0.0 113.182 -178.79 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.61 -5.74 84.51 Favored Glycine 0 CA--C 1.567 3.296 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -170.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 15.4 t -82.68 127.89 33.83 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -44.33 170.35 0.01 OUTLIER Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 111.358 -2.655 . . . . 0.0 113.363 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.424 HG12 ' HB1' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -79.76 -40.14 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 173.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . 0.483 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . 1.2 p-10 -101.32 153.12 38.01 Favored Pre-proline 0 N--CA 1.407 -2.614 0 CA-C-N 111.432 -2.622 . . . . 0.0 108.361 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.46 -14.59 44.75 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 122.879 2.386 . . . . 0.0 111.661 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.11 -34.5 61.72 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.102 0.251 . . . . 0.0 111.094 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.49 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.52 -39.67 73.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.214 0.531 . . . . 0.0 109.928 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -36.49 66.39 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.008 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.464 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 6.1 t80 -72.26 -35.2 68.71 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 126.517 1.927 . . . . 0.0 114.268 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -46.77 91.73 Favored Glycine 0 C--N 1.319 -0.373 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.3 56.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.19 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -63.33 -34.07 76.89 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.514 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 121.031 1.741 . . . . 0.0 110.425 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 CA--C 1.511 -0.545 0 CA-C-O 121.73 0.776 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.53 -36.57 74.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.049 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -84.21 -33.46 24.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.09 -43.97 24.29 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.509 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.12 -44.15 83.6 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.417 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.6 Cg_exo -71.65 -28.72 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.258 . . . . 0.0 113.106 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.03 -32.14 50.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.146 0.498 . . . . 0.0 112.29 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.2 mm -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.255 0 C-N-CA 123.743 0.817 . . . . 0.0 112.164 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.436 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -67.71 -46.6 67.04 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 128.758 3.786 . . . . 0.0 111.731 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.31 -49.03 34.66 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 118.171 -1.966 . . . . 0.0 109.906 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -39.04 68.47 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.649 0.738 . . . . 0.0 109.713 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.86 -31.24 70.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.223 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.68 81.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.17 -49.65 80.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.352 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.84 -39.42 91.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.754 0.788 . . . . 0.0 109.771 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 mt -58.27 -34.72 50.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.069 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--N 1.331 -0.229 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.563 -179.408 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.24 -14.4 11.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.027 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.01 -40.17 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 17.4 m -68.43 -35.81 72.24 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 112.83 -1.986 . . . . 0.0 110.521 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.18 70.07 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -70.81 -46.72 62.29 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -33.83 74.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 11.4 mt -58.63 -38.37 77.93 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.911 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 75' ' ' LEU . . . -65.58 -46.99 77.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.781 -2.009 . . . . 0.0 114.749 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.449 ' HA ' ' HB2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -75.65 -31.53 59.83 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.735 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.79 -36.88 67.69 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.507 -0.745 . . . . 0.0 111.607 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.05 -45.22 82.15 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.18 -47.7 19.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 29' ' ' ILE . 90.2 t -65.28 -49.82 76.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.137 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -54.07 -48.07 71.01 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.5 -29.43 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.616 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -36.17 68.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 25' ' ' VAL . 4.1 mm -60.11 -43.74 93.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.76 63.87 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -67.33 -38.1 84.35 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.605 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 121.08 0.466 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.75 -28.02 5.64 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.403 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.5 m -56.74 -43.85 80.34 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -64.77 -50.46 66.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -67.91 -47.65 78.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.647 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -69.31 -37.18 77.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.43 -32.01 73.46 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.49 93.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.824 -1.534 . . . . 0.0 109.327 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -65.89 -44.27 85.78 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.55 97.93 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.26 -43.92 76.73 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.749 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -36.53 79.82 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -33.89 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.006 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.61 -45.63 71.41 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.857 -1.519 . . . . 0.0 113.016 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 p -67.36 -31.88 72.43 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.35 -41.26 72.28 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.9 -44.14 73.81 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.788 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -38.03 85.96 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.8 m -59.54 -12.13 5.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 119.754 1.161 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.27 -42.91 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.936 0.398 . . . . 0.0 111.133 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 171.77 13.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -65.26 -23.05 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.767 0.318 . . . . 0.0 111.008 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.45 7.11 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.45 135.65 53.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.049 0.452 . . . . 0.0 111.051 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.92 -157.86 16.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.36 86.04 1.11 Allowed 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 122.507 1.146 . . . . 0.0 108.085 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -19.61 62.38 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.498 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 2.4 pp -84.53 4.58 31.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 113.669 -1.605 . . . . 0.0 111.625 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -125.49 126.11 25.05 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.23 -24.02 3.3 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.883 2.389 . . . . 0.0 111.632 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.16 -50.84 62.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -36.67 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.923 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 m -61.21 -32.23 72.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.4 tp -57.27 -44.61 84.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.044 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.25 -45.87 63.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -44.29 66.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 111.008 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.862 0.363 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.91 -35.13 77.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.636 ' O ' HG13 ' A' ' 98' ' ' ILE . 3.1 mm? -54.54 -38.18 66.3 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mtm -73.71 -33.3 64.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.767 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -69.99 -37.84 75.84 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.096 -1.003 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 95' ' ' LEU . 1.8 pp -66.81 -42.55 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.384 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.12 -37.73 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.37 70.27 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -71.96 -35.97 69.72 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.669 0.668 . . . . 0.0 112.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 m -58.1 -35.88 72.07 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.4 -35.36 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.063 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.07 91.59 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 121.152 1.796 . . . . 0.0 112.519 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.433 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.95 -36.1 75.0 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.0 mt -67.99 -42.41 85.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.575 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.4 t -69.93 -37.18 72.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.294 0.569 . . . . 0.0 110.107 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.74 75.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.445 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 35.8 m -65.88 -37.1 85.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.457 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.53 88.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.735 0.303 . . . . 0.0 111.135 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.27 -50.5 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.28 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.85 -24.2 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.537 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -42.63 95.51 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.771 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.26 61.95 Favored Glycine 0 CA--C 1.511 -0.178 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.4 -31.95 44.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.779 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.582 -179.654 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.478 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.56 117.49 32.46 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.125 -0.538 . . . . 0.0 111.778 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 60.23 9.19 1.81 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.02 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -87.68 88.32 7.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.12 143.24 57.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.254 0.55 . . . . 0.0 110.88 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.05 135.7 48.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.679 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -49.64 127.45 15.76 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.6 -105.35 0.67 Allowed Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.645 HG12 ' HB2' ' A' ' 137' ' ' GLN . 1.6 t -85.83 123.93 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.444 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 1.5 m-20 -71.71 -171.85 0.73 Allowed 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -61.92 -46.74 88.05 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 114.807 -2.757 . . . . 0.0 110.409 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.04 -41.24 96.37 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.071 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.645 ' HB2' HG12 ' A' ' 133' ' ' VAL . 4.5 mt-30 -53.53 -23.42 10.48 Favored 'General case' 0 C--N 1.249 -3.789 0 CA-C-O 121.238 0.542 . . . . 0.0 110.237 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.514 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.65 -1.72 24.89 Favored Glycine 0 C--O 1.19 -2.597 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.43 -50.23 66.19 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 118.489 1.144 . . . . 0.0 110.322 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -40.96 75.16 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.514 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.6 OUTLIER -66.17 -38.77 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 113.155 -1.523 . . . . 0.0 112.087 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 32.5 mt-10 -68.46 -36.24 78.71 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 121.948 0.88 . . . . 0.0 111.039 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.6 mt -67.29 -48.47 77.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.627 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.26 -48.47 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 122.088 0.947 . . . . 0.0 111.424 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.25 -51.97 56.02 Favored Glycine 0 C--O 1.211 -1.329 0 CA-C-N 113.466 -1.697 . . . . 0.0 113.138 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.2 m -70.39 -40.42 73.94 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.5 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.64 -40.11 68.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 1.1 pt20 -58.0 -30.82 66.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 tp -68.75 -46.72 68.09 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.426 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 78.9 t -66.26 -41.03 88.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -35.65 81.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.442 0.297 . . . . 0.0 111.463 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -34.47 77.36 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.644 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.01 -38.53 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.847 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.4 mp -65.33 -48.02 74.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.81 0.338 . . . . 0.0 110.971 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.76 72.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.193 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.434 ' N ' ' HD2' ' A' ' 169' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 168' ' ' ALA . 17.9 Cg_endo -61.32 -36.78 77.3 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.007 1.138 . . . . 0.0 111.692 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mp -66.22 -44.95 82.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.87 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.4 -47.43 56.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.2 -37.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.515 0.674 . . . . 0.0 109.446 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.48 93.47 Favored Glycine 0 C--O 1.2 -2.013 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.755 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.92 -35.65 64.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -34.49 77.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.421 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.7 t -73.16 -47.38 47.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.37 -30.73 67.73 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 122.528 1.156 . . . . 0.0 110.195 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.28 2.6 mm? -70.43 -50.88 33.87 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.874 2.274 . . . . 0.0 109.528 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.53 -36.92 65.36 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 110.559 -3.019 . . . . 0.0 107.114 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' HIS . . . . . 0.4 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.4 m-70 -69.08 -35.22 76.28 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.334 -1.433 . . . . 0.0 109.657 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.95 -48.34 81.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.234 -177.498 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.32 -52.07 11.69 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.494 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.79 -52.03 28.75 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.486 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 12.8 mt -60.16 -41.82 88.0 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.602 0 C-N-CA 118.731 -1.188 . . . . 0.0 113.244 -174.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.84 -35.68 59.87 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 115.911 -2.316 . . . . 0.0 112.564 -176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.01 -29.68 68.65 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.385 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.283 0.1 OUTLIER -124.43 -26.8 3.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.063 -178.989 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.74 -5.97 84.15 Favored Glycine 0 CA--C 1.566 3.256 0 N-CA-C 106.046 -2.822 . . . . 0.0 106.046 -170.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.404 ' CB ' ' OG1' ' A' ' 187' ' ' THR . 9.4 t -82.28 127.74 33.5 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -47.83 164.37 0.23 Allowed Glycine 0 N--CA 1.408 -3.226 0 CA-C-N 111.146 -2.752 . . . . 0.0 112.497 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -33.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -109.73 152.44 42.89 Favored Pre-proline 0 N--CA 1.415 -2.217 0 CA-C-N 112.544 -2.116 . . . . 0.0 109.288 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.08 -14.66 45.4 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.618 2.212 . . . . 0.0 111.686 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.39 -35.75 60.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.697 0.285 . . . . 0.0 110.498 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -41.16 72.94 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.336 0.589 . . . . 0.0 109.85 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -32.61 64.71 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.475 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.437 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 2.9 m-85 -72.27 -35.24 68.69 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.464 1.906 . . . . 0.0 113.948 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -44.44 93.9 Favored Glycine 0 C--N 1.318 -0.456 0 N-CA-C 106.971 -2.451 . . . . 0.0 106.971 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.53 -28.21 56.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.088 -1.056 . . . . 0.0 110.842 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.19 75.74 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 121.598 1.999 . . . . 0.0 110.929 -179.813 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.32 0 CA-C-O 121.788 0.804 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -58.92 -37.5 76.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.027 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -84.28 -33.53 23.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.6 p -80.49 -40.06 19.19 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.517 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.0 -48.23 68.52 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.976 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.8 Cg_endo -71.96 -38.97 3.53 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.046 2.497 . . . . 0.0 113.675 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -63.25 -39.79 95.59 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.601 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.9 mm -70.31 -46.55 70.98 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.148 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.67 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -55.18 -45.64 81.71 Favored Glycine 0 C--N 1.364 2.128 0 O-C-N 128.529 3.643 . . . . 0.0 111.339 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.13 -41.41 80.58 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.19 -34.83 61.48 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.7 mt -67.69 -36.92 81.54 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.38 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.06 -39.58 82.53 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.277 -174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 88.4 t -58.38 -49.7 81.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.638 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.61 0.719 . . . . 0.0 110.155 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt -57.14 -34.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.119 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--N 1.329 -0.292 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.437 -179.346 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.449 0.166 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.54 -0.5 13.03 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.814 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.54 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.3 -35.77 72.33 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.762 0 CA-C-N 112.506 -2.134 . . . . 0.0 109.932 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.15 -35.02 69.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -46.72 61.8 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -34.23 73.48 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.05 -38.08 78.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.174 -2.284 . . . . 0.0 108.748 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . . . -64.09 -46.82 82.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.355 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.431 ' HB ' ' N ' ' A' ' 105' ' ' ALA . 0.2 OUTLIER -75.91 -31.51 59.21 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.099 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -38.18 67.05 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.548 -0.72 . . . . 0.0 112.091 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -49.55 15.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 29' ' ' ILE . 97.7 t -65.33 -48.46 83.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.363 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 29' ' ' ILE . 50.1 t80 -53.95 -48.51 70.2 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.6 -29.21 20.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.387 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -36.2 67.41 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 25' ' ' VAL . 2.8 mm -63.06 -41.74 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.311 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.5 -38.83 71.89 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -37.97 84.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -176.819 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -49.87 -28.59 6.76 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.535 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.14 -39.02 64.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -64.7 -54.08 37.26 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.5 t -67.75 -45.65 84.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.724 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 m -69.29 -39.18 78.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.0 -31.68 72.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.38 94.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.231 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -65.88 -43.36 88.51 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.69 -43.02 96.94 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.275 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.2 -43.77 77.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.597 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -36.7 76.26 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.96 -34.13 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 113.228 -1.805 . . . . 0.0 108.13 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.76 85.96 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.174 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 p -70.12 -31.7 69.36 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.28 -40.78 71.44 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.96 -44.25 73.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.218 -1.81 . . . . 0.0 109.828 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -66.8 -39.0 87.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -12.21 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 119.978 1.263 . . . . 0.0 111.329 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.81 -37.12 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.765 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.25 154.52 6.87 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -53.29 -22.91 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.934 0.397 . . . . 0.0 111.065 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 tt -74.34 7.08 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -124.3 135.59 53.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.129 0.49 . . . . 0.0 111.57 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.48 -159.37 24.95 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.57 85.9 1.17 Allowed 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 118.254 -1.378 . . . . 0.0 108.589 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.545 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -82.41 8.44 11.46 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.122 -1.854 . . . . 0.0 112.235 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.95 140.09 30.59 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 119.333 0.97 . . . . 0.0 112.676 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.67 -30.62 0.74 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 123.27 2.647 . . . . 0.0 112.563 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.64 72.9 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.31 -36.69 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -30.89 70.71 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.93 -38.0 75.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.242 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.32 -44.57 93.4 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -21.89 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.643 0.259 . . . . 0.0 111.326 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.01 -179.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 . . . . . 0 N--CA 1.46 0.054 0 CA-C-O 121.064 0.459 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.85 -35.0 77.79 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.212 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.58 -38.49 66.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.5 ttt -70.63 -38.76 73.92 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.542 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -62.59 -37.59 86.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.332 0.969 . . . . 0.0 109.67 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.09 -47.22 87.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.368 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.35 -37.8 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.94 -47.43 77.68 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.529 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -35.18 70.58 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -35.88 71.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.76 -35.41 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.124 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.58 90.74 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 120.815 1.643 . . . . 0.0 113.437 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.431 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.85 -35.98 75.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.37 -42.7 87.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.689 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.86 -37.23 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.311 0.577 . . . . 0.0 109.567 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.38 84.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.105 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -37.03 74.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.394 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.76 -41.19 85.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.012 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.55 -48.22 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.26 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -24.43 61.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.0 t -62.03 -44.28 97.03 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.962 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.31 -36.28 62.4 Favored Glycine 0 CA--C 1.51 -0.234 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -32.39 36.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.366 -0.917 . . . . 0.0 110.742 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.1 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.182 -179.565 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -112.63 122.78 48.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.061 0.458 . . . . 0.0 111.741 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.03 20.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.671 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -108.77 99.66 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.21 147.6 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.441 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.88 139.86 40.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.864 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -50.09 127.57 17.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 130.41 -105.11 0.63 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.68 HG13 ' HB2' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.01 131.0 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.447 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 3.7 t30 -71.74 -171.86 0.73 Allowed 'General case' 0 C--O 1.201 -1.482 0 N-CA-C 103.125 -2.917 . . . . 0.0 103.125 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -46.74 82.9 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 114.648 -2.821 . . . . 0.0 109.788 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.72 -41.51 95.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.976 -175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.68 ' HB2' HG13 ' A' ' 133' ' ' VAL . 1.8 mm100 -53.46 -23.24 9.55 Favored 'General case' 0 C--N 1.247 -3.863 0 CA-C-O 121.375 0.607 . . . . 0.0 110.715 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -68.78 -1.4 24.07 Favored Glycine 0 C--O 1.192 -2.521 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 tp -66.58 -50.04 64.4 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.29 1.045 . . . . 0.0 110.902 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.62 -36.15 75.63 Favored Glycine 0 N--CA 1.455 -0.064 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.473 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.0 OUTLIER -70.52 -36.29 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 113.407 -1.396 . . . . 0.0 111.633 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 138' ' ' GLY . 8.0 mt-10 -68.5 -36.46 78.94 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.06 0.933 . . . . 0.0 110.878 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 40.8 mt -68.82 -52.54 33.9 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 113.977 -1.465 . . . . 0.0 110.743 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.1 tp -68.17 -45.05 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 121.931 0.872 . . . . 0.0 111.472 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -60.7 -52.03 54.99 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.805 -1.543 . . . . 0.0 113.193 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.2 m -70.87 -40.51 72.23 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.93 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -40.01 69.03 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -176.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -57.84 -30.02 65.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.726 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.82 -51.18 43.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.255 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 70.1 t -60.09 -41.03 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.989 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.25 -35.52 80.63 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -34.42 77.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.08 -38.32 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.532 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -41.03 96.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 110.809 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.76 -31.61 72.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.172 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.47 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.429 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 23.2 Cg_exo -54.53 -46.5 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.377 1.385 . . . . 0.0 111.532 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.12 -35.91 74.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -44.12 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.947 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 172' ' ' ILE . 79.4 mt -58.26 -38.09 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.59 -37.45 93.64 Favored Glycine 0 C--O 1.196 -2.229 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.19 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mp -55.05 -35.66 64.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.65 77.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.3 175.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 27.0 t -73.08 -47.54 47.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.89 69.69 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.363 1.078 . . . . 0.0 109.859 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.268 1.8 tt -70.52 -49.73 45.15 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 124.503 2.097 . . . . 0.0 110.56 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.02 65.55 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 111.114 -2.767 . . . . 0.0 107.487 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' HIS . . . . . 0.404 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.6 m-70 -70.18 -35.3 73.87 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.537 -1.831 . . . . 0.0 109.403 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.15 -48.11 81.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.112 -177.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.07 -52.55 10.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.453 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -70.41 -52.24 23.76 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.534 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 9.3 mt -55.34 -40.23 56.09 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.805 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.56 -35.7 52.89 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.194 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -59.91 -30.42 69.03 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.459 -1.296 . . . . 0.0 110.945 -171.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.272 0.1 OUTLIER -124.37 -26.61 3.89 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.083 -178.754 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.9 -6.11 83.94 Favored Glycine 0 CA--C 1.564 3.103 0 N-CA-C 106.208 -2.757 . . . . 0.0 106.208 -170.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 13.1 t -86.63 132.24 33.94 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.0 161.72 7.75 Favored Glycine 1 N--CA 1.392 -4.235 0 CA-C-N 111.285 -2.689 . . . . 0.0 111.031 178.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -72.29 -40.83 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -83.44 134.3 45.58 Favored Pre-proline 0 N--CA 1.416 -2.139 0 CA-C-N 112.693 -2.048 . . . . 0.0 108.038 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -58.37 -14.58 20.88 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.361 2.041 . . . . 0.0 111.642 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.04 -33.81 61.79 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 123.269 0.356 . . . . 0.0 111.653 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.553 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.49 -37.94 74.29 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.471 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -33.48 65.47 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.489 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.442 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 2.1 m-85 -72.4 -35.08 68.32 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 126.41 1.884 . . . . 0.0 114.452 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.79 -44.48 94.2 Favored Glycine 0 C--N 1.318 -0.453 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.1 p -76.44 -28.31 56.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.131 -1.035 . . . . 0.0 110.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.07 75.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 121.268 1.849 . . . . 0.0 110.3 179.699 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 CA--C 1.512 -0.505 0 CA-C-O 121.778 0.799 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.49 -35.29 72.0 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.016 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.35 -48.18 9.96 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.0 -47.87 66.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.321 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' A' ' 216' ' ' PRO . . . -55.68 -48.9 68.45 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 112.709 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 215' ' ' GLY . 49.5 Cg_endo -72.11 -31.1 12.59 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.757 1.638 . . . . 0.0 113.72 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -66.26 -37.37 85.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 0.0 111.29 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.584 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 13.2 mt -70.37 -46.68 70.11 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.084 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.449 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -55.42 -46.93 78.8 Favored Glycine 0 C--N 1.363 2.077 0 O-C-N 128.495 3.622 . . . . 0.0 110.996 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -68.41 -40.77 86.7 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.32 -34.8 61.79 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.4 mt -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.203 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.01 -39.74 82.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.251 -174.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.45 -49.73 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.885 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -39.53 94.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.709 0.766 . . . . 0.0 109.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mt -55.2 -34.69 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.426 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.546 0.213 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.1 1.35 17.28 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.502 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.51 -40.16 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.26 -35.91 73.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.629 0 CA-C-N 112.47 -2.15 . . . . 0.0 110.02 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.04 69.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -46.69 62.63 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -33.88 73.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 mt -58.71 -38.17 77.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.107 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 75' ' ' LEU . . . -65.44 -46.79 78.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 112.97 -1.923 . . . . 0.0 114.755 -176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.66 -31.42 59.77 Favored 'General case' 0 C--O 1.208 -1.128 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.525 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -34.98 72.13 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.995 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -45.34 82.63 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.13 -44.71 29.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 29' ' ' ILE . 76.3 t -65.03 -53.72 37.91 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.46 -175.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -53.7 -48.11 69.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -75.68 -29.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.504 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -36.51 69.11 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.6 mm -58.78 -44.49 90.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 113.661 -1.609 . . . . 0.0 109.223 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -36.76 65.7 Favored Glycine 0 C--O 1.226 -0.369 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -67.4 -44.37 79.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -176.35 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 121.3 0.571 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.72 -28.32 5.92 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.884 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.29 -32.29 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -53.96 37.65 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.6 t -68.15 -37.34 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.451 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 m -68.58 -41.15 80.08 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.985 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -31.43 72.47 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.655 -1.612 . . . . 0.0 106.916 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.86 95.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.458 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 24' ' ' PHE . 3.6 t80 -66.03 -43.22 88.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.52 92.0 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.074 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.5 mp -68.6 -43.81 75.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.525 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 t -59.84 -36.69 77.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -34.37 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.663 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.66 -45.55 93.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.363 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 p -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.79 -42.91 72.35 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.33 72.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.97 -1.923 . . . . 0.0 110.914 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -67.02 -45.97 75.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.5 p -59.14 -12.37 5.01 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.932 1.242 . . . . 0.0 112.387 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.02 -42.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 0.0 111.29 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.24 159.16 8.08 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -57.41 -23.13 47.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.783 0.325 . . . . 0.0 111.43 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.76 7.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.46 135.66 53.41 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.618 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.12 -154.2 24.41 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.52 85.87 1.16 Allowed 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.183 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.97 -19.64 62.52 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.5 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 1.1 pp -80.46 -17.64 51.09 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.42 -1.718 . . . . 0.0 112.497 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -111.05 135.95 20.84 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.58 -22.87 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 123.441 2.761 . . . . 0.0 111.676 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.43 78.11 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -66.22 -36.84 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.753 0.311 . . . . 0.0 111.158 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 m -65.68 -28.63 69.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -43.82 82.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.92 0.39 . . . . 0.0 110.175 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.95 -39.64 97.82 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 tp -53.47 -57.54 10.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.088 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 . . . . . 0 CA--C 1.526 0.026 0 CA-C-O 120.807 0.337 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.14 78.2 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.09 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.69 -38.49 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -40.01 68.05 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.84 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -61.16 -37.63 83.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.357 0.98 . . . . 0.0 109.443 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.29 -44.38 88.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.903 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.3 mt -70.59 -37.78 71.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.2 72.81 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.56 -35.7 70.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -35.96 71.93 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.8 -35.47 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.153 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.68 -44.32 91.36 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 121.102 1.774 . . . . 0.0 113.38 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.74 -36.19 75.61 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.79 -42.59 86.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.821 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.9 -37.41 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.219 0.533 . . . . 0.0 110.068 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.78 75.29 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.318 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -67.75 -37.03 81.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.801 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.73 85.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.659 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.1 tt -69.18 -37.19 75.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.11 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.0 -24.09 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.87 0.367 . . . . 0.0 111.511 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 m -60.43 -44.21 96.01 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.503 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.37 61.26 Favored Glycine 0 CA--C 1.511 -0.215 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.95 32.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.849 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 -179.465 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.62 124.34 52.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.608 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.6 m120 51.85 23.31 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.275 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.3 95.14 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.716 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.45 144.51 57.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.318 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.02 140.03 40.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.649 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -49.63 127.5 15.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.26 -105.48 0.6 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' A' ' 137' ' ' GLN . 1.1 t -85.94 126.82 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.45 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.58 -171.94 0.72 Allowed 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 176.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 m -62.39 -46.76 87.14 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 114.669 -2.812 . . . . 0.0 110.306 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.16 96.47 Favored Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.267 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.641 ' HB2' HG12 ' A' ' 133' ' ' VAL . 4.0 mt-30 -53.24 -23.42 8.73 Favored 'General case' 0 C--N 1.249 -3.778 0 CA-C-N 114.792 -0.704 . . . . 0.0 110.503 -176.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.87 -1.76 13.69 Favored Glycine 0 C--O 1.188 -2.736 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.9 -50.47 64.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 119.123 1.461 . . . . 0.0 110.743 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.87 -40.16 74.97 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.482 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.8 OUTLIER -68.85 -36.34 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 113.209 -1.495 . . . . 0.0 112.267 -177.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 77.1 mt-10 -68.54 -36.21 78.5 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-O 121.736 0.779 . . . . 0.0 110.569 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.3 mt -70.06 -41.9 79.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.437 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.2 mm -68.53 -48.84 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 122.389 1.09 . . . . 0.0 111.198 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.55 -46.9 93.21 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-N 112.841 -1.981 . . . . 0.0 112.966 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.2 m -70.93 -47.64 57.91 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 113.77 -1.215 . . . . 0.0 112.47 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.47 -40.45 68.46 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.252 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.6 pt20 -57.97 -31.28 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.82 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.8 tp -68.89 -52.21 31.92 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.596 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.14 -41.02 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -35.55 81.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 111.349 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -41.11 93.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.851 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 m -72.05 -38.37 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.52 -48.08 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.985 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.68 71.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.464 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.438 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . . . . . . 0 C--O 1.218 -0.571 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 35.3 Cg_exo -54.35 -44.3 50.69 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.738 1.625 . . . . 0.0 112.223 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 mp -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.302 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.33 56.59 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.006 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.5 pt -58.93 -35.96 59.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.61 93.6 Favored Glycine 0 C--O 1.198 -2.107 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.495 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.15 -36.37 65.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 -34.47 77.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.603 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.2 t -72.89 -47.24 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -175.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.82 94.97 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 122.054 0.93 . . . . 0.0 108.727 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.257 3.6 mt -58.29 -47.12 84.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.937 178.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.9 66.19 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.088 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' HIS . . . . . 0.506 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 1.1 t60 -67.84 -34.79 77.39 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 112.926 -1.637 . . . . 0.0 109.789 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -64.66 -47.64 77.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.389 -176.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.96 -51.64 13.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.54 -51.24 37.39 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 188' ' ' GLY . 1.7 mp -66.78 -49.27 75.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.869 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -35.73 81.66 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 115.377 -2.529 . . . . 0.0 112.367 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.88 -31.28 69.64 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.524 -170.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.301 0.1 OUTLIER -124.32 -26.87 3.87 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.387 1.089 . . . . 0.0 113.332 -179.032 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 86.75 -5.78 84.17 Favored Glycine 0 CA--C 1.566 3.264 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 59.9 m -83.64 132.29 34.9 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -54.33 155.59 7.61 Favored Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.869 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -32.99 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 174.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -92.74 139.68 23.54 Favored Pre-proline 0 N--CA 1.42 -1.967 0 CA-C-N 113.321 -1.763 . . . . 0.0 107.234 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -64.47 -14.55 44.91 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.64 1.56 . . . . 0.0 111.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.14 -33.88 61.59 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.248 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.528 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.37 -39.11 78.24 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.0 t -73.18 -34.28 65.91 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.816 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.449 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 3.8 t80 -72.22 -35.4 68.87 Favored 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 126.315 1.846 . . . . 0.0 114.506 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.73 -46.19 92.54 Favored Glycine 0 C--N 1.319 -0.376 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.43 -28.29 56.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.281 -0.959 . . . . 0.0 110.379 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -64.65 -33.89 77.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.607 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 120.939 1.699 . . . . 0.0 110.589 179.518 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 9.5 mm . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -25.09 61.59 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.298 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -84.64 -42.35 15.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.02 -45.47 27.38 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.23 -44.87 84.27 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.531 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.3 Cg_endo -71.49 -28.68 17.46 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.491 2.128 . . . . 0.0 113.084 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -77.2 -31.99 55.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.195 0.521 . . . . 0.0 111.893 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.0 mm -70.7 -46.37 69.52 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.34 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.303 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.416 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -68.11 -46.78 63.25 Favored Glycine 0 C--N 1.357 1.733 0 O-C-N 128.5 3.625 . . . . 0.0 111.838 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.34 -48.91 35.05 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 118.067 -2.016 . . . . 0.0 109.835 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.78 68.45 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.554 0.692 . . . . 0.0 109.562 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -68.13 -30.98 70.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.292 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.8 82.83 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.8 t -58.06 -49.59 80.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.267 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -39.54 93.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.799 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -34.74 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.818 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.419 0.152 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.4 -14.31 5.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.452 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -39.89 87.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 5.9 p -68.66 -36.07 72.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.592 176.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.69 -35.35 70.49 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.95 -46.48 62.34 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -33.79 74.34 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 8.0 mt -58.77 -38.16 77.88 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.884 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 75' ' ' LEU . . . -65.68 -46.51 78.8 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.567 -2.106 . . . . 0.0 114.581 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.81 -31.63 61.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.208 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -38.39 69.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.783 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -45.01 84.21 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -52.52 9.14 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 29' ' ' ILE . 1.5 m -65.64 -40.3 87.54 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 O-C-N 124.031 0.832 . . . . 0.0 112.802 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -54.18 -50.35 67.24 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.539 0.685 . . . . 0.0 111.908 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -29.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.531 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.24 -36.24 68.28 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -175.092 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 25' ' ' VAL . 4.1 mm -59.7 -40.05 81.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.086 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -36.88 64.69 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.8 m -67.5 -38.87 84.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -176.729 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 C--O 1.224 -0.288 0 CA-C-O 121.283 0.563 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -49.73 -28.78 6.57 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.801 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.28 -38.37 61.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.726 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -64.8 -53.56 45.09 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.77 -50.06 68.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.416 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -66.53 -39.07 88.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.358 0.412 . . . . 0.0 110.004 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.85 -31.92 73.03 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.46 94.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.265 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -66.12 -42.44 89.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.42 -43.3 96.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.08 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.33 -43.66 81.03 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.547 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -36.58 74.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.98 -34.1 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.369 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.235 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.7 p -68.96 -31.7 70.75 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -40.58 71.78 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.94 -44.16 73.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.151 -1.841 . . . . 0.0 109.468 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -66.78 -38.47 86.62 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.8 m -59.61 -12.13 6.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 120.058 1.299 . . . . 0.0 111.415 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -42.83 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.697 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.06 168.4 12.83 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -66.0 -23.09 66.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -75.95 7.13 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.79 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 m -124.43 135.64 53.42 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.139 0.495 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -151.84 20.45 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.27 85.89 1.08 Allowed 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.441 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.39 61.91 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.555 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 2.1 pp -87.05 8.53 23.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.375 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.04 129.08 20.88 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.64 -20.49 4.66 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.773 2.315 . . . . 0.0 111.397 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.16 -50.94 62.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -36.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.678 0.275 . . . . 0.0 111.57 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.0 m -64.91 -28.62 69.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -35.4 76.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.376 . . . . 0.0 110.55 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.53 -37.07 84.89 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.671 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -44.41 96.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.456 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.227 -0.087 0 CA-C-O 120.726 0.298 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.14 79.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.451 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.91 -38.53 67.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 ttt -73.27 -35.1 66.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.945 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -64.96 -37.53 87.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 119.523 1.056 . . . . 0.0 109.135 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -46.53 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.656 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.0 mm -67.7 -37.84 79.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.678 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.01 -47.06 86.49 Favored 'General case' 0 C--O 1.206 -1.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -71.24 -36.05 71.68 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.415 ' O ' HG13 ' A' ' 106' ' ' ILE . 3.8 t -57.87 -36.16 71.97 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.38 -35.19 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.645 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.51 -47.78 81.27 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.733 1.606 . . . . 0.0 112.586 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.452 ' HA ' HG23 ' A' ' 25' ' ' VAL . . . -69.88 -36.16 75.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 102' ' ' CYS . 79.3 mt -63.92 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.048 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.14 -37.42 71.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.425 0.631 . . . . 0.0 110.038 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.95 74.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.301 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -70.3 -36.94 74.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.2 -43.75 87.77 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.013 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.2 mm -69.24 -37.33 75.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.243 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.85 -24.49 66.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.512 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.2 t -62.76 -34.96 78.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.248 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.09 -36.16 60.81 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.28 -40.83 76.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.624 -0.788 . . . . 0.0 110.538 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.795 -179.03 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.86 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -112.6 120.11 40.46 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.925 0.393 . . . . 0.0 111.295 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 t30 51.83 23.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.25 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.88 84.7 2.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.419 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.65 144.9 56.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.91 139.65 40.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.136 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.77 127.67 18.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.3 -103.19 0.58 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.649 HG12 ' HB2' ' A' ' 137' ' ' GLN . 2.0 t -86.0 122.38 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.442 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.56 -171.8 0.69 Allowed 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -46.81 88.11 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 114.919 -2.712 . . . . 0.0 110.152 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.83 -41.67 96.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.157 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.649 ' HB2' HG12 ' A' ' 133' ' ' VAL . 24.0 mm100 -53.17 -23.43 8.36 Favored 'General case' 0 C--N 1.252 -3.661 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.232 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.05 -1.69 10.59 Favored Glycine 0 C--O 1.187 -2.796 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -50.5 65.54 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 119.17 1.485 . . . . 0.0 111.004 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.75 -40.13 76.21 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.505 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.7 OUTLIER -67.43 -38.19 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 113.051 -1.575 . . . . 0.0 112.13 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 138' ' ' GLY . 24.0 mt-10 -68.61 -36.53 78.8 Favored 'General case' 0 C--O 1.196 -1.728 0 CA-C-O 121.987 0.899 . . . . 0.0 110.872 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.5 mt -68.35 -43.62 84.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.421 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.154 -174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -68.4 -49.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 122.264 1.031 . . . . 0.0 111.671 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.26 -48.38 86.26 Favored Glycine 0 C--O 1.218 -0.866 0 CA-C-N 113.087 -1.869 . . . . 0.0 113.038 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.8 m -70.79 -45.29 64.93 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 113.97 -1.115 . . . . 0.0 112.175 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.0 tp -54.51 -40.59 68.73 Favored 'General case' 0 CA--C 1.487 -1.464 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.22 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.0 pt20 -59.33 -30.85 68.66 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.1 tp -68.88 -51.22 42.52 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.261 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.4 t -60.83 -41.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.976 . . . . 0.0 113.28 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.18 -35.65 81.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.563 0.22 . . . . 0.0 111.512 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.21 -35.04 78.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.038 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.19 -38.44 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.591 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tt -64.04 -43.57 95.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.78 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.69 -31.54 72.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.561 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.402 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.431 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 23.0 Cg_exo -54.57 -46.48 33.11 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.57 1.514 . . . . 0.0 111.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.9 -36.14 78.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.271 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -45.02 63.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.275 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.26 -38.42 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.52 93.62 Favored Glycine 0 C--O 1.195 -2.293 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.164 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.21 -35.56 65.01 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -34.24 76.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.928 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.6 t -72.59 -47.31 51.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.26 -29.9 66.8 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.577 1.179 . . . . 0.0 110.182 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.267 9.3 mt -70.65 -49.18 50.19 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 124.711 2.196 . . . . 0.0 109.515 178.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.85 66.07 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 110.328 -3.124 . . . . 0.0 107.822 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' HIS . . . . . 0.436 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -70.39 -35.22 73.34 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.041 -1.579 . . . . 0.0 109.727 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.72 -48.21 81.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.139 -177.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.54 -52.25 11.06 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.451 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.97 -51.68 30.56 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 188' ' ' GLY . 7.4 mt -60.58 -49.11 85.71 Favored 'Isoleucine or valine' 0 C--O 1.175 -2.862 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.538 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -35.67 76.59 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 116.741 -1.983 . . . . 0.0 113.502 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.02 -29.16 68.31 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.652 -171.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.285 0.1 OUTLIER -124.32 -26.65 3.91 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.181 0.991 . . . . 0.0 113.076 -179.167 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.56 -5.9 84.26 Favored Glycine 0 CA--C 1.565 3.163 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 -170.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.403 ' SG ' ' CE2' ' A' ' 212' ' ' PHE . 92.1 m -88.08 130.74 34.91 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -56.22 154.71 14.71 Favored Glycine 0 N--CA 1.397 -3.924 0 CA-C-N 111.174 -2.739 . . . . 0.0 112.538 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -27.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.49 135.11 29.79 Favored Pre-proline 0 N--CA 1.414 -2.25 0 CA-C-N 112.74 -2.027 . . . . 0.0 108.25 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -66.09 -17.36 54.86 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.986 1.791 . . . . 0.0 110.587 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.26 -35.37 61.39 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.431 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 29.3 tpt85 -70.62 -40.2 73.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.523 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.3 m -73.23 -38.19 66.13 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.442 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 12.4 t80 -72.25 -34.88 68.58 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 126.945 2.098 . . . . 0.0 114.596 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.62 -47.12 90.61 Favored Glycine 0 C--N 1.315 -0.592 0 N-CA-C 107.069 -2.412 . . . . 0.0 107.069 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -28.21 56.65 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.565 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -64.23 -34.1 77.32 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.412 -0.804 . . . . 0.0 112.843 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.318 -0.785 0 CA-C-N 120.971 1.714 . . . . 0.0 110.803 179.73 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 121.728 0.775 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . 0.444 ' N ' ' CD2' ' A' ' 212' ' ' PHE . 6.3 m-30 -58.27 -41.51 84.46 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.381 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.14 -33.64 24.22 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.8 -47.73 42.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.415 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.15 -48.52 67.76 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.111 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 17.3 Cg_endo -71.61 -28.67 17.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.145 1.896 . . . . 0.0 113.744 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -73.48 -30.65 63.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.304 0.574 . . . . 0.0 111.268 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.556 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 46.3 mt -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.483 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.376 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -66.57 -46.25 78.17 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 128.473 3.608 . . . . 0.0 111.896 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.42 -48.89 34.6 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 118.562 -1.78 . . . . 0.0 110.112 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -39.02 68.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.671 0.748 . . . . 0.0 109.513 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -68.03 -31.07 70.49 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.348 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.51 81.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.11 -49.59 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.962 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.06 -39.44 89.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.693 0.758 . . . . 0.0 109.532 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 mp -57.39 -34.61 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.703 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.77 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.369 0.128 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.72 -8.54 12.64 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.295 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.76 -40.31 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.55 -35.83 72.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 CA-C-N 112.807 -1.997 . . . . 0.0 110.696 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.51 -35.1 69.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -70.82 -46.6 62.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.17 -33.72 70.28 Favored 'General case' 0 C--O 1.212 -0.912 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.73 -38.29 78.03 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 112.284 -2.234 . . . . 0.0 109.461 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -46.63 80.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.232 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.34 -31.14 62.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.61 -177.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -40.82 67.3 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.149 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.94 -45.04 83.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -52.59 9.1 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.66 -43.96 93.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.185 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.432 ' O ' HG12 ' A' ' 29' ' ' ILE . 53.0 t80 -54.13 -50.23 67.39 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.927 0.785 . . . . 0.0 112.135 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -29.16 20.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.705 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.4 -36.33 68.79 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -175.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 25' ' ' VAL . 4.2 mm -58.91 -39.94 79.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.544 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.68 63.74 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -67.35 -38.06 84.22 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.68 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -176.868 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t70 . . . . . 0 C--O 1.225 -0.204 0 CA-C-O 121.126 0.488 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.54 -28.73 14.61 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 p -61.04 -33.45 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -64.94 -54.12 35.68 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.601 1.091 . . . . 0.0 112.978 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.18 -40.56 83.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.599 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.6 m -69.31 -40.51 77.61 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -31.81 72.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.21 -39.52 94.14 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.969 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -66.01 -46.97 76.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.55 -45.84 93.74 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.278 -0.419 . . . . 0.0 114.005 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tp -66.32 -43.83 85.12 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.107 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -58.74 -36.74 74.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -34.0 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.496 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.7 -45.59 82.2 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.506 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -68.94 -32.07 71.42 Favored 'General case' 0 CA--C 1.469 -2.165 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.61 -40.44 72.11 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.87 -44.11 73.98 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.453 173.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -38.31 86.31 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -59.63 -12.29 6.5 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 119.889 1.222 . . . . 0.0 111.579 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -42.87 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 0.0 111.428 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.12 178.9 21.06 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -22.96 62.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.832 0.348 . . . . 0.0 111.133 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -72.69 7.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.306 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.6 m -124.32 135.51 53.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.279 0.561 . . . . 0.0 111.623 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.13 -140.62 8.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.53 85.88 1.16 Allowed 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.368 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -19.63 59.1 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.74 8.35 32.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.089 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -148.26 144.15 18.38 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 121.145 1.793 . . . . 0.0 114.222 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.51 -21.89 4.09 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 124.035 3.157 . . . . 0.0 112.943 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.8 90.16 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.3 m -66.46 -38.16 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.4 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -29.96 70.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mt -60.23 -36.05 76.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.8 -48.92 31.75 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.737 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -14.79 62.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.582 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.855 0.359 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.41 -35.18 80.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.87 -38.73 67.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 tpp -73.33 -31.64 64.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.043 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -65.01 -44.24 89.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 118.777 0.717 . . . . 0.0 111.142 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -41.22 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.5 mt -70.38 -42.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.28 69.07 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -35.81 70.67 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.7 t -57.99 -36.14 72.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.3 -35.25 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.314 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.39 -47.54 82.2 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 120.908 1.685 . . . . 0.0 112.833 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.92 -35.98 74.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 mm -66.05 -50.34 70.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.32 -36.97 77.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.148 0.499 . . . . 0.0 109.757 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.68 75.26 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.556 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -64.68 -37.0 86.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.643 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.65 85.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.124 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.99 -37.33 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.681 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -24.61 67.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.645 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -38.98 88.06 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.423 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.0 -36.17 60.33 Favored Glycine 0 CA--C 1.511 -0.199 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 4.4 mt -54.14 -36.87 33.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.703 -0.749 . . . . 0.0 111.057 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.555 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.604 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -112.6 124.38 52.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.024 0.44 . . . . 0.0 111.337 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 51.97 20.6 1.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.405 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -112.37 92.21 3.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.12 148.42 47.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.057 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.33 138.64 40.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.585 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -49.59 127.6 15.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.71 -105.18 0.66 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.682 HG11 ' HB2' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.16 131.92 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.451 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 -171.98 0.76 Allowed 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 176.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -46.73 81.39 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 114.52 -2.872 . . . . 0.0 109.883 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.93 -41.46 96.28 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.285 -0.96 . . . . 0.0 110.954 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.682 ' HB2' HG11 ' A' ' 133' ' ' VAL . 7.3 mm-40 -53.45 -23.41 9.98 Favored 'General case' 0 C--N 1.248 -3.838 0 CA-C-O 121.443 0.64 . . . . 0.0 110.61 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -69.61 -1.56 30.91 Favored Glycine 0 C--O 1.185 -2.913 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.54 -50.23 63.85 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 118.394 1.097 . . . . 0.0 111.146 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.53 -35.71 75.52 Favored Glycine 0 C--O 1.229 -0.163 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.461 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.1 OUTLIER -71.54 -36.04 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 113.239 -1.48 . . . . 0.0 111.845 -178.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' GLY . 7.9 mt-10 -68.42 -36.38 78.98 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 122.047 0.927 . . . . 0.0 110.863 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 41.2 mt -70.5 -50.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.923 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.25 -43.65 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.062 0.935 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.425 ' O ' ' CG ' ' A' ' 148' ' ' GLN . . . -62.35 -51.7 54.57 Favored Glycine 0 C--O 1.205 -1.663 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.237 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.1 m -70.01 -35.23 74.21 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.796 0.808 . . . . 0.0 110.363 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tp -54.87 -40.15 69.43 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -57.91 -33.35 68.67 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.949 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.477 ' N ' ' HG3' ' A' ' 148' ' ' GLN . 2.3 tp -68.89 -47.08 66.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.972 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.23 -41.02 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.76 -45.63 85.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 21.3 p -64.28 -28.44 69.72 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.704 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.01 -38.54 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.8 mt -65.89 -35.95 82.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.14 80.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.231 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.332 -0.192 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.677 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.438 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 28.0 Cg_exo -54.63 -38.27 90.89 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.557 1.505 . . . . 0.0 111.878 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 62.0 mt -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.035 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.63 -46.95 57.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.087 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.08 -42.05 82.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 121.546 0.688 . . . . 0.0 109.692 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.74 -37.63 93.65 Favored Glycine 0 C--O 1.195 -2.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.131 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.15 -35.53 64.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -34.43 77.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.821 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.5 t -72.01 -47.06 56.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.58 74.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.124 0.964 . . . . 0.0 110.131 -174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.276 4.3 mt -69.16 -52.94 23.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 125.293 2.473 . . . . 0.0 110.918 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.51 62.57 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 110.01 -3.268 . . . . 0.0 106.58 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' HIS . . . . . 0.417 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 2.6 m80 -70.08 -34.88 73.71 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.756 -1.722 . . . . 0.0 110.081 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -56.84 -47.69 79.77 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.369 -178.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.66 -51.56 14.06 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.476 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.38 -52.07 30.56 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 188' ' ' GLY . 1.5 mp -56.65 -49.14 79.21 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.032 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.504 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -35.82 74.45 Favored 'General case' 0 C--N 1.277 -2.564 0 C-N-CA 115.998 -2.281 . . . . 0.0 113.067 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -60.18 -29.47 68.72 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.316 -171.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.276 0.1 OUTLIER -124.27 -26.95 3.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.199 1.0 . . . . 0.0 113.269 -178.744 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 88.48 -5.89 84.2 Favored Glycine 0 CA--C 1.564 3.102 0 N-CA-C 105.981 -2.848 . . . . 0.0 105.981 -170.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 17.4 t -84.45 129.47 34.86 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 123.601 1.667 . . . . 0.0 106.588 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.427 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -50.02 161.84 0.96 Allowed Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 110.659 -2.973 . . . . 0.0 112.465 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -42.71 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -87.05 139.86 32.61 Favored Pre-proline 0 N--CA 1.418 -2.047 0 CA-C-N 111.85 -2.432 . . . . 0.0 107.695 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.01 -14.89 46.52 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.886 1.724 . . . . 0.0 111.674 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.65 60.41 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.589 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.69 -39.61 73.39 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.288 0.566 . . . . 0.0 109.617 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -31.73 64.32 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.85 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.441 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 2.7 m-85 -72.04 -35.0 69.24 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.61 1.964 . . . . 0.0 113.911 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -46.6 91.99 Favored Glycine 0 C--N 1.319 -0.402 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 p -76.35 -28.24 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.688 -0.756 . . . . 0.0 110.297 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -64.81 -34.0 77.32 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.995 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 121.186 1.812 . . . . 0.0 111.019 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 mm . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.62 -36.61 74.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.112 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -84.33 -33.44 23.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 12.3 p -78.61 -47.08 24.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.15 -45.95 80.38 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.313 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 4.1 Cg_exo -71.69 -28.67 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.877 2.385 . . . . 0.0 113.29 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -33.75 58.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.569 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 49.8 mt -70.59 -46.12 71.25 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.295 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.436 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -67.34 -46.81 67.58 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 128.407 3.567 . . . . 0.0 111.886 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.32 -48.96 34.93 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 118.146 -1.978 . . . . 0.0 109.894 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.87 68.19 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.632 0.73 . . . . 0.0 109.789 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.84 -31.24 70.94 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.334 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.63 82.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.21 -49.64 81.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -39.34 91.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.7 0.762 . . . . 0.0 109.719 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -34.59 49.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.765 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--N 1.33 -0.265 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.194 -179.386 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.356 0.122 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.16 -0.18 15.66 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.88 -40.09 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.3 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.775 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.584 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.82 69.42 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -46.74 62.79 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -33.82 73.26 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.3 mt -58.84 -38.35 78.48 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.68 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . . . -65.73 -47.07 76.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.742 -2.026 . . . . 0.0 115.077 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.429 ' HB ' ' N ' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -75.74 -31.5 59.61 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.493 -177.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.72 -39.0 67.28 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.737 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -45.06 83.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -47.2 21.19 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 29' ' ' ILE . 92.5 t -65.25 -50.57 72.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.477 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -53.86 -47.43 71.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -29.17 20.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.594 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -36.23 67.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.2 mm -62.97 -38.61 82.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.88 63.29 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.257 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -63.49 -45.02 92.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.726 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.762 179.801 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.1 t0 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -49.8 -28.04 5.79 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.407 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 t -56.81 -48.24 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -44.12 90.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.2 -47.6 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.548 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.2 m -69.15 -36.49 77.48 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.4 tp -63.41 -31.88 73.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.2 90.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.374 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.401 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 8.4 m-30 -65.92 -43.33 88.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.875 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.56 -43.34 96.67 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.467 -0.396 . . . . 0.0 112.901 -178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.0 mt -66.76 -43.69 83.41 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.301 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -36.54 74.66 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.26 -34.08 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.645 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.39 -45.53 92.73 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.423 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.1 p -67.84 -31.42 71.24 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -41.96 72.1 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.96 -44.07 73.69 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.508 173.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -40.2 87.78 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.51 -12.13 5.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 119.802 1.183 . . . . 0.0 111.702 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -42.85 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.759 0.314 . . . . 0.0 111.395 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.6 170.65 11.91 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -23.08 62.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 pt -76.06 7.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 135.7 53.57 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.377 0.608 . . . . 0.0 111.697 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -149.55 18.45 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.34 85.35 1.09 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -20.01 62.34 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -89.84 3.43 52.97 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 112.26 -2.245 . . . . 0.0 113.636 178.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -126.46 133.85 25.41 Favored Pre-proline 0 N--CA 1.483 1.19 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.68 -32.25 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.171 2.58 . . . . 0.0 112.1 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.89 75.45 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.22 -36.81 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.825 0.345 . . . . 0.0 111.218 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -62.89 -28.63 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.71 -42.05 96.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.874 0.369 . . . . 0.0 110.409 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.68 -39.3 85.95 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -50.23 72.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.615 0.245 . . . . 0.0 111.294 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.837 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.898 0.38 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.13 77.96 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.86 -38.44 67.47 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.4 ttt -71.71 -36.18 70.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.316 -1.765 . . . . 0.0 109.685 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -64.33 -37.52 87.81 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 119.177 0.899 . . . . 0.0 109.236 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.6 -48.12 88.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.532 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.2 pt -70.44 -37.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.22 -47.18 74.7 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.61 -35.84 70.59 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.96 71.74 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.81 -35.39 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.016 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.61 -42.21 90.33 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 121.152 1.797 . . . . 0.0 112.973 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.429 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.91 -36.05 75.08 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.03 -42.22 85.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.825 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.94 -37.23 72.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.269 0.557 . . . . 0.0 109.515 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.67 -44.67 85.92 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.14 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -70.32 -37.17 74.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.709 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -44.83 88.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.707 0.289 . . . . 0.0 111.113 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.8 mt -69.22 -37.51 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.39 . . . . 0.0 110.814 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.47 -24.5 67.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.023 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -36.89 81.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.969 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.95 -36.24 60.16 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.5 mm -55.33 -40.6 57.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.627 -0.787 . . . . 0.0 110.532 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.455 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -112.71 117.47 32.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 111.71 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 52.0 29.44 6.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -108.79 89.61 3.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.01 143.79 57.47 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.055 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.03 139.99 40.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.887 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -49.62 127.63 16.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.28 -104.66 0.59 Allowed Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.662 HG12 ' HB2' ' A' ' 137' ' ' GLN . 1.3 t -86.09 127.76 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.434 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 9.4 t-20 -71.66 -172.03 0.74 Allowed 'General case' 0 C--O 1.203 -1.376 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.8 t -63.54 -46.97 83.56 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 114.499 -2.88 . . . . 0.0 109.893 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -40.13 94.79 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.13 -1.034 . . . . 0.0 111.323 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.662 ' HB2' HG12 ' A' ' 133' ' ' VAL . 2.4 mm100 -53.5 -23.54 10.65 Favored 'General case' 0 C--N 1.253 -3.618 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.676 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.435 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.34 -2.18 13.56 Favored Glycine 0 C--O 1.191 -2.56 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.05 -50.37 73.58 Favored 'General case' 0 C--O 1.206 -1.226 0 O-C-N 120.458 -1.613 . . . . 0.0 108.458 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.77 -46.52 53.12 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.435 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 2.1 mm -59.58 -42.83 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.186 -1.007 . . . . 0.0 111.352 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.19 -36.11 79.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.035 0.934 . . . . 0.0 112.59 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 19.6 mt -67.78 -50.48 59.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 O-C-N 121.718 -0.614 . . . . 0.0 110.474 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.29 -43.59 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.99 0.9 . . . . 0.0 111.948 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 148' ' ' GLN . . . -61.98 -51.05 59.69 Favored Glycine 0 C--O 1.2 -1.993 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.915 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.6 m -70.25 -37.61 74.98 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.838 0.828 . . . . 0.0 110.87 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 tp -55.03 -40.22 69.98 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 149' ' ' LEU . 1.1 pp0? -57.85 -31.42 66.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.778 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.438 ' N ' ' HG3' ' A' ' 148' ' ' GLN . 1.2 tp -68.72 -47.16 67.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.651 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 82.5 t -66.39 -40.98 88.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -45.65 82.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 24.6 p -65.68 -29.02 69.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.94 -39.0 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.167 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -38.21 88.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.554 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.7 72.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.335 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.464 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 10.6 Cg_exo -62.32 -46.76 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.715 1.61 . . . . 0.0 113.842 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.37 -29.97 70.26 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.014 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.35 -45.16 63.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.777 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.16 -37.53 62.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.78 -37.56 93.54 Favored Glycine 0 C--O 1.196 -2.268 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.667 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.26 -35.86 65.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.54 -34.79 77.79 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.173 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.32 -46.92 69.43 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.66 -32.81 72.91 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.516 1.15 . . . . 0.0 110.527 -175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.279 2.7 tp -70.55 -50.64 35.36 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 124.739 2.209 . . . . 0.0 110.212 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.5 -37.12 65.72 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 109.896 -3.32 . . . . 0.0 107.042 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' HIS . . . . . 0.418 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 0.3 OUTLIER -70.33 -35.24 73.49 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.959 -1.62 . . . . 0.0 109.648 178.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -57.16 -47.04 82.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.815 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -74.5 -52.11 12.86 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.494 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.98 -51.94 28.4 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 188' ' ' GLY . 3.7 mt -61.4 -49.21 85.44 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.681 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -35.55 76.29 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 116.226 -2.19 . . . . 0.0 112.645 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.538 -171.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.284 0.1 OUTLIER -124.54 -26.71 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.217 1.008 . . . . 0.0 113.2 -179.501 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.11 -5.67 84.72 Favored Glycine 0 CA--C 1.567 3.327 0 N-CA-C 106.332 -2.707 . . . . 0.0 106.332 -170.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.414 ' CB ' ' OG1' ' A' ' 187' ' ' THR . 37.5 t -84.25 126.04 32.79 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -46.53 162.61 0.17 Allowed Glycine 0 N--CA 1.411 -2.986 0 CA-C-N 111.307 -2.679 . . . . 0.0 112.647 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -41.55 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -94.35 146.31 31.31 Favored Pre-proline 0 N--CA 1.409 -2.488 0 CA-C-N 111.528 -2.578 . . . . 0.0 108.657 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.12 -14.69 45.5 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.524 2.15 . . . . 0.0 111.479 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.24 -34.33 61.41 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.76 0.314 . . . . 0.0 110.574 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.437 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 38.1 tpt85 -70.61 -40.53 73.13 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.906 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.2 -37.53 66.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.43 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 13.3 t80 -72.1 -35.06 69.08 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 126.718 2.007 . . . . 0.0 114.458 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.3 93.34 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 106.7 -2.56 . . . . 0.0 106.7 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 16.2 m -76.6 -28.3 56.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.992 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -67.53 -33.93 76.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 121.152 1.796 . . . . 0.0 111.808 -179.412 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 tp . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -27.13 64.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -84.43 -44.68 13.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.18 -41.11 20.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -175.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.503 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.3 -45.07 84.35 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.434 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 3.4 Cg_exo -71.74 -28.66 16.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.624 2.216 . . . . 0.0 112.95 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -77.4 -31.0 53.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 111.993 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.4 mm -70.77 -46.44 68.81 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.296 0 C-N-CA 123.398 0.679 . . . . 0.0 112.457 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.429 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -68.95 -46.09 60.85 Favored Glycine 0 C--N 1.359 1.84 0 O-C-N 128.659 3.724 . . . . 0.0 111.535 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.27 -49.02 34.93 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.192 -1.956 . . . . 0.0 109.944 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.96 68.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.648 0.737 . . . . 0.0 109.626 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.73 -31.29 71.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.152 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.78 -39.47 81.16 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.5 t -58.15 -49.54 81.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.604 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -39.47 94.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.623 0.725 . . . . 0.0 109.817 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 21.4 mt -58.59 -34.42 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.346 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.2 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.386 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.488 0.185 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.4 1.99 17.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.683 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -40.25 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.36 -36.18 73.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.541 0 CA-C-N 112.605 -2.089 . . . . 0.0 109.833 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.09 70.16 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.18 -46.65 60.92 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -33.96 72.31 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.99 -38.06 78.29 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.508 -2.133 . . . . 0.0 108.912 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . . . -63.18 -46.81 85.39 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.313 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -31.23 59.45 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.699 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -38.16 67.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.781 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -44.92 84.37 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.96 -47.97 19.39 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 29' ' ' ILE . 91.8 t -65.44 -53.76 36.07 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.522 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -53.87 -44.36 70.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.264 0.484 . . . . 0.0 111.96 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.73 -29.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.903 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.0 mm -61.82 -38.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.109 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.35 -36.95 64.08 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -67.14 -38.88 86.29 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.506 179.625 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 C--O 1.226 -0.169 0 CA-C-O 121.037 0.446 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.91 -28.83 53.79 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.659 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.94 -31.92 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -65.05 -54.18 34.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.5 m -68.36 -37.45 77.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.543 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -69.56 -43.19 73.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.9 -31.72 72.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.535 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.68 93.85 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.504 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -66.28 -46.82 75.67 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.67 -41.65 97.62 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.737 -0.268 . . . . 0.0 113.38 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.39 -43.73 76.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.674 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -60.46 -36.48 78.36 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -33.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 113.077 -1.874 . . . . 0.0 107.987 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.08 -45.71 80.32 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.379 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 p -69.42 -31.55 69.97 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.42 -41.01 72.19 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.0 -44.43 72.8 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.155 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -36.74 82.91 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 t -59.68 -12.21 6.49 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 119.98 1.264 . . . . 0.0 111.367 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.59 -42.71 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.883 0.373 . . . . 0.0 110.957 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.14 156.41 6.79 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -23.01 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 tt -74.68 6.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.55 135.64 53.33 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.168 0.509 . . . . 0.0 111.26 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.12 -159.06 21.27 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.47 85.78 1.14 Allowed 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.064 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -19.64 61.08 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 2.1 pp -81.15 -10.26 59.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.856 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -112.73 131.24 22.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.69 -28.97 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.062 2.508 . . . . 0.0 112.557 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.68 74.35 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.39 -36.77 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.778 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.2 m -65.85 -28.52 69.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.78 -35.27 77.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.847 0.356 . . . . 0.0 110.715 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.72 98.27 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mt -58.96 -42.41 89.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 110.975 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.794 0.33 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.36 -35.06 79.83 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.228 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.79 -38.53 67.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtm -73.47 -31.7 63.91 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.738 -1.573 . . . . 0.0 110.132 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -67.66 -40.44 84.52 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 119.032 0.833 . . . . 0.0 111.447 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -41.29 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.48 -42.71 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.33 68.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -71.72 -35.83 70.32 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 t -58.03 -36.19 72.37 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.78 -35.41 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.857 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.7 -44.76 91.37 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 120.897 1.681 . . . . 0.0 113.369 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.1 75.71 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.8 mt -67.26 -41.15 86.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.532 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.9 -37.3 77.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 0.0 109.53 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.99 83.39 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.382 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -67.73 -37.28 81.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.414 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.83 85.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.02 -39.17 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.774 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -24.32 67.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.352 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 m -60.62 -44.37 96.41 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.836 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.07 -36.26 60.87 Favored Glycine 0 CA--C 1.509 -0.297 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.21 -30.72 30.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.441 -0.879 . . . . 0.0 111.016 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.451 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.6 ptt85 -112.59 118.52 35.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.957 0.408 . . . . 0.0 111.884 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 51.82 45.24 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -116.55 110.38 18.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.796 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -82.01 138.07 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.39 148.75 27.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.212 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -49.65 127.66 16.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.39 -97.6 0.87 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' A' ' 137' ' ' GLN . 2.6 t -86.09 119.15 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.44 ' N ' ' HB2' ' A' ' 137' ' ' GLN . 1.6 m-80 -71.8 -172.03 0.77 Allowed 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.78 -46.97 87.26 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 114.525 -2.87 . . . . 0.0 110.793 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.19 -39.35 94.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.519 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.632 ' HB2' HG11 ' A' ' 133' ' ' VAL . 85.4 mm-40 -52.95 -23.33 6.99 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-O 121.342 0.592 . . . . 0.0 110.196 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.532 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -63.5 -1.97 5.21 Favored Glycine 0 C--O 1.187 -2.787 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.23 -50.54 69.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 119.332 1.566 . . . . 0.0 110.951 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.84 -43.94 64.33 Favored Glycine 0 CA--C 1.51 -0.255 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.532 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.8 OUTLIER -63.56 -38.9 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 112.721 -1.739 . . . . 0.0 112.378 -178.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 138' ' ' GLY . 42.2 mt-10 -68.31 -36.3 79.11 Favored 'General case' 0 C--O 1.2 -1.541 0 CA-C-O 122.275 1.036 . . . . 0.0 110.48 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 40.2 mt -65.9 -46.46 88.43 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.645 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.48 -48.99 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 122.073 0.939 . . . . 0.0 111.769 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.77 56.8 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.008 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.8 m -70.65 -43.34 69.37 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.887 -1.156 . . . . 0.0 112.447 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.67 -40.18 68.83 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.705 -176.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt20 -57.86 -30.26 65.65 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.851 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.82 -45.39 71.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.738 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.42 -40.95 87.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.18 -38.38 85.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 5.1 p -73.74 -28.3 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.393 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.98 -45.55 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -41.25 92.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.277 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.02 89.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.423 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.543 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.432 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 23.6 Cg_exo -54.42 -41.08 79.98 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.485 1.456 . . . . 0.0 112.272 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.42 -42.42 91.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 -47.14 57.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.2 -37.11 60.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.44 93.49 Favored Glycine 0 C--O 1.2 -1.977 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.299 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -55.1 -36.23 65.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -34.6 77.41 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.562 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.06 -47.42 47.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.3 -31.75 69.22 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.966 1.365 . . . . 0.0 110.117 -175.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.273 11.3 tp -70.44 -48.67 54.88 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.547 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.72 -37.03 67.09 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 111.075 -2.784 . . . . 0.0 107.817 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' HIS . . . . . 0.488 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 10.2 m-70 -68.59 -35.36 77.26 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.391 -1.405 . . . . 0.0 109.08 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -59.34 -47.73 84.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.672 -177.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -52.52 10.69 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -70.25 -51.96 26.66 Favored 'General case' 0 C--O 1.202 -1.404 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 180' ' ' HIS . 6.0 mt -59.43 -49.21 84.42 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.815 0 C-N-CA 118.984 -1.087 . . . . 0.0 113.14 -174.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -35.71 78.49 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 115.677 -2.409 . . . . 0.0 112.719 -176.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.84 -29.79 68.52 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.673 -171.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.28 0.1 OUTLIER -124.6 -26.85 3.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.292 1.044 . . . . 0.0 113.43 -179.317 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.54 -5.8 84.43 Favored Glycine 0 CA--C 1.566 3.277 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -170.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 11.4 t -84.1 129.0 34.92 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -49.82 159.2 1.31 Allowed Glycine 0 N--CA 1.405 -3.403 0 CA-C-N 111.496 -2.593 . . . . 0.0 112.056 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.433 HD11 HG21 ' A' ' 191' ' ' ILE . 20.3 pt -72.57 -33.07 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -97.69 143.62 26.53 Favored Pre-proline 0 N--CA 1.418 -2.038 0 CA-C-N 113.194 -1.821 . . . . 0.0 108.748 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.05 -14.44 33.31 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.395 2.063 . . . . 0.0 111.596 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.05 -37.38 61.7 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.623 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.533 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.41 -38.62 74.64 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.26 0.552 . . . . 0.0 109.839 -179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -33.74 65.43 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.502 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 2.8 m-85 -72.3 -35.25 68.62 Favored 'General case' 0 N--CA 1.512 2.663 0 C-N-CA 126.532 1.933 . . . . 0.0 114.469 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.69 91.91 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 107.274 -2.331 . . . . 0.0 107.274 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -76.35 -28.41 56.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.605 -0.798 . . . . 0.0 110.349 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -63.8 -34.05 77.05 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.704 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.319 -0.736 0 CA-C-N 121.0 1.727 . . . . 0.0 110.418 179.739 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.519 -0.214 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -58.52 -38.54 77.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.706 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -84.21 -33.61 24.09 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.76 -45.16 28.55 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.477 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.18 -48.15 70.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.435 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 5.2 Cg_endo -72.16 -32.36 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.477 2.118 . . . . 0.0 114.015 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -39.88 75.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.569 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 5.8 mt -70.47 -46.52 70.14 Favored 'Isoleucine or valine' 0 C--O 1.173 -2.929 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.335 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -56.65 -48.46 77.08 Favored Glycine 0 C--N 1.365 2.156 0 O-C-N 128.624 3.703 . . . . 0.0 111.23 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.93 -39.44 89.35 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.47 -34.88 62.34 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 5.5 mt -67.55 -37.18 82.31 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.502 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.8 82.18 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.279 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.6 t -58.46 -49.72 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.08 -39.53 94.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.694 0.759 . . . . 0.0 110.344 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.92 -34.74 38.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.94 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.6 t80 . . . . . 0 C--N 1.331 -0.226 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.589 -179.469 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.23 -12.03 11.23 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.383 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -60.24 -39.75 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -68.34 -35.92 72.85 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.301 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -35.09 69.52 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -70.93 -46.55 62.25 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -34.01 71.83 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -38.18 78.48 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.313 -2.222 . . . . 0.0 109.493 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB1' ' HA ' ' A' ' 75' ' ' LEU . . . -65.73 -46.67 78.01 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.021 -1.899 . . . . 0.0 114.572 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.46 -31.15 60.16 Favored 'General case' 0 C--O 1.204 -1.341 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.66 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.87 -38.05 67.15 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 111.678 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -44.97 84.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.04 -47.21 21.23 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 29' ' ' ILE . 87.8 t -65.41 -52.09 55.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.069 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -53.76 -47.35 70.76 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.094 0.473 . . . . 0.0 112.168 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.63 -29.86 21.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -36.19 69.41 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 25' ' ' VAL . 4.1 mm -59.3 -41.0 82.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.987 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.37 -36.85 64.04 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.9 m -67.38 -39.43 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.615 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 121.044 0.449 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -50.0 -28.52 7.07 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.116 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.2 t -57.15 -40.0 70.57 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -64.8 -53.76 41.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.4 t -67.9 -46.14 82.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.592 -176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.9 m -69.3 -38.67 78.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.77 -31.94 73.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.37 94.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.569 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -65.94 -41.01 91.87 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.54 -41.75 99.11 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.848 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -43.61 80.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.59 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -58.65 -36.57 74.33 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.06 -34.04 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.436 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.66 -45.67 85.74 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.364 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.4 p -66.8 -31.59 72.32 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.7 -43.1 72.24 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.18 -44.41 72.24 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.382 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -66.83 -48.76 67.91 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 m -59.05 -12.13 4.41 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 119.708 1.14 . . . . 0.0 112.086 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.0 m -114.44 -42.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.95 0.405 . . . . 0.0 111.575 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.19 158.91 7.79 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -60.65 -23.02 64.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.642 0.258 . . . . 0.0 111.681 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.14 7.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.62 136.44 53.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.105 0.479 . . . . 0.0 111.599 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.37 -153.46 27.86 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.45 85.8 1.13 Allowed 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 118.439 -1.304 . . . . 0.0 107.802 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -19.65 65.15 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.402 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 1.1 pp -83.78 -11.95 56.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.64 -1.618 . . . . 0.0 113.031 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -115.37 135.7 22.62 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 119.846 1.203 . . . . 0.0 114.06 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.44 -21.6 4.29 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 123.14 2.56 . . . . 0.0 112.004 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.42 -48.67 74.48 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.14 -36.84 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.155 -0.341 . . . . 0.0 111.276 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -28.45 69.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -35.12 69.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.127 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.73 -48.79 47.26 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.76 -30.53 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.86 0.362 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.78 -35.02 77.93 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -38.64 67.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 176.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.93 -37.01 70.1 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.476 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -61.06 -37.69 83.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.923 0.868 . . . . 0.0 109.23 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.17 -48.51 87.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 113.784 -1.553 . . . . 0.0 113.367 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.8 mm -70.42 -38.12 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.31 74.48 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.201 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -35.61 70.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.402 ' O ' HG13 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -58.08 -36.09 72.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.22 -35.33 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.52 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.34 90.03 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 121.041 1.746 . . . . 0.0 113.105 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.02 75.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 102' ' ' CYS . 64.0 mt -65.39 -50.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.9 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.02 -37.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.29 0.567 . . . . 0.0 109.612 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.56 -45.11 85.57 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.619 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.42 -37.13 74.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.819 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -46.7 85.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 pt -67.09 -37.31 79.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.06 -24.4 65.98 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.233 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.3 m -60.89 -44.38 97.18 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.784 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.3 62.01 Favored Glycine 0 CA--C 1.512 -0.136 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.91 -31.62 36.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.258 -0.971 . . . . 0.0 111.009 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.723 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.94 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 117.35 31.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.344 0.592 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 51.97 17.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.048 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.83 91.72 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.17 138.59 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.286 0.565 . . . . 0.0 110.749 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.94 135.61 48.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.405 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -49.81 127.57 16.41 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.05 -104.26 0.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.639 HG13 ' HB2' ' A' ' 137' ' ' GLN . 1.5 t -86.06 125.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.439 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.65 -171.87 0.72 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 102.956 -2.979 . . . . 0.0 102.956 176.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.1 m -62.67 -47.0 85.56 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 114.575 -2.85 . . . . 0.0 110.424 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.25 -39.85 95.12 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.46 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.639 ' HB2' HG13 ' A' ' 133' ' ' VAL . 37.9 mm-40 -53.5 -23.23 9.77 Favored 'General case' 0 C--N 1.25 -3.75 0 CA-C-O 121.29 0.567 . . . . 0.0 110.544 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.524 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.19 -1.65 21.48 Favored Glycine 0 C--O 1.186 -2.901 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -50.46 68.28 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-N 118.709 1.254 . . . . 0.0 110.836 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.48 -41.01 78.45 Favored Glycine 0 CA--C 1.51 -0.249 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.524 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.4 OUTLIER -65.04 -40.67 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 112.775 -1.713 . . . . 0.0 112.063 -178.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 138' ' ' GLY . 15.5 mt-10 -68.43 -36.42 79.03 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.834 0.825 . . . . 0.0 111.697 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 34.6 mt -66.63 -52.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.557 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.22 -44.83 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.935 0.874 . . . . 0.0 111.966 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.53 -51.88 56.44 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 113.542 -1.663 . . . . 0.0 112.036 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.5 m -70.58 -36.95 73.87 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.375 -0.912 . . . . 0.0 111.185 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.0 -40.45 70.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.008 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -58.87 -31.94 69.03 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.126 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.2 tp -68.77 -46.65 68.22 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.457 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.3 t -66.25 -40.98 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.7 -35.55 80.94 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.46 -33.51 74.31 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.05 -45.48 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -48.15 81.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.038 0.447 . . . . 0.0 109.928 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.228 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.43 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 21.1 Cg_exo -54.82 -46.27 34.6 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.17 -37.46 74.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.51 -45.95 61.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.782 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.3 mt -58.3 -39.37 73.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.591 0.71 . . . . 0.0 109.238 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.25 93.29 Favored Glycine 0 C--O 1.2 -2.015 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.929 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 tp -55.09 -35.8 64.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -34.47 76.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.395 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.09 -47.12 48.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.67 -30.85 68.63 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.485 1.135 . . . . 0.0 110.107 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.264 2.1 mp -70.56 -50.5 36.73 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 124.546 2.117 . . . . 0.0 110.323 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.45 -36.91 64.75 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 110.219 -3.173 . . . . 0.0 107.401 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' HIS . . . . . 0.433 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 12.1 m170 -70.18 -35.34 73.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.096 -1.552 . . . . 0.0 109.645 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.88 -47.85 83.47 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.919 -178.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -75.04 -52.64 10.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -70.16 -52.04 26.61 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.497 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 10.8 mt -60.87 -40.67 86.0 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.901 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -35.67 60.47 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 115.742 -2.383 . . . . 0.0 112.266 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.07 -29.94 68.89 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.802 -1.159 . . . . 0.0 111.179 -171.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.281 0.1 OUTLIER -124.44 -26.83 3.83 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.199 -179.109 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.2 -5.87 84.36 Favored Glycine 0 CA--C 1.569 3.423 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.419 ' CB ' ' OG1' ' A' ' 187' ' ' THR . 43.9 t -84.72 129.1 34.87 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -48.4 162.83 0.41 Allowed Glycine 0 N--CA 1.408 -3.187 0 CA-C-N 111.265 -2.698 . . . . 0.0 113.464 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.11 -42.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -92.38 144.73 29.34 Favored Pre-proline 0 N--CA 1.417 -2.096 0 CA-C-N 110.843 -2.889 . . . . 0.0 107.702 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.02 -14.71 45.72 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.907 1.738 . . . . 0.0 111.247 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.83 61.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.989 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.422 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.48 -39.25 74.33 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.376 0.607 . . . . 0.0 109.863 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -36.91 66.79 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.44 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 11.6 t80 -72.22 -35.24 68.82 Favored 'General case' 0 N--CA 1.511 2.575 0 C-N-CA 126.412 1.885 . . . . 0.0 114.442 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.26 93.51 Favored Glycine 0 C--N 1.318 -0.438 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.9 m -76.48 -28.42 56.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.265 -0.968 . . . . 0.0 110.647 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -66.26 -34.06 77.16 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.163 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.318 -0.788 0 CA-C-N 121.013 1.733 . . . . 0.0 111.604 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 CA--C 1.515 -0.369 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -31.82 68.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.178 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -84.56 -33.91 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.79 -46.57 19.93 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.03 -44.73 83.26 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.177 -176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.9 Cg_exo -71.75 -28.6 16.76 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.842 2.362 . . . . 0.0 113.192 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.65 -35.02 60.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.244 0.545 . . . . 0.0 112.147 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.3 mm -70.55 -46.37 70.33 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.158 0 C-N-CA 124.165 0.986 . . . . 0.0 112.685 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -67.91 -46.74 64.76 Favored Glycine 0 C--N 1.359 1.858 0 O-C-N 128.713 3.758 . . . . 0.0 111.768 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.44 -49.04 33.69 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 118.158 -1.972 . . . . 0.0 109.762 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.94 68.6 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.57 0.7 . . . . 0.0 109.715 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.72 -31.2 70.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.274 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.69 82.41 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.129 0.966 . . . . 0.0 108.48 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.34 -49.64 81.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.587 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.84 -39.48 94.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.705 0.765 . . . . 0.0 109.829 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mm -57.84 -34.59 48.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.616 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 t80 . . . . . 0 C--N 1.33 -0.262 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.187 -179.343 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 . . . . . 0 C--O 1.232 0.167 0 N-CA-C 111.289 0.107 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.77 -1.45 12.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.276 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.98 -40.25 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.23 -35.67 72.12 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.641 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.786 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.8 69.33 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.73 -46.78 62.4 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -33.9 71.05 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.87 -38.17 78.19 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 112.293 -2.23 . . . . 0.0 109.482 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 75' ' ' LEU . . . -63.25 -46.59 86.15 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.006 -1.907 . . . . 0.0 113.73 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.454 ' HB ' ' N ' ' A' ' 105' ' ' ALA . 0.1 OUTLIER -75.58 -31.37 59.94 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.96 -177.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.86 -37.95 67.19 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.178 -0.951 . . . . 0.0 111.287 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.92 -45.25 82.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.715 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -77.13 -50.79 12.23 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 29' ' ' ILE . 43.2 t -64.59 -46.31 92.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.384 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.994 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -54.04 -48.67 70.3 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.189 0.519 . . . . 0.0 112.071 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.59 -29.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.519 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -36.19 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 25' ' ' VAL . 2.6 mm -64.02 -40.63 89.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.056 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.54 -41.32 81.05 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -67.57 -45.1 76.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.874 0.368 . . . . 0.0 111.876 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.224 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -49.89 -28.71 6.98 Favored 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.602 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.2 -34.59 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -64.94 -54.09 36.18 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.458 1.027 . . . . 0.0 113.443 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.15 -42.43 84.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.772 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.0 m -69.34 -41.36 76.73 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.52 0.512 . . . . 0.0 109.815 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.82 -31.94 73.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.61 94.46 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.96 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -66.2 -46.83 75.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.44 -40.18 97.52 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.168 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.23 -43.49 77.8 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 p -58.69 -36.53 74.36 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -34.02 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.398 -1.728 . . . . 0.0 108.216 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.54 -45.63 82.68 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.326 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 p -69.08 -31.8 70.8 Favored 'General case' 0 CA--C 1.471 -2.067 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.31 -40.95 71.72 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.0 -44.07 73.55 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.827 173.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 t -59.65 -12.43 6.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 120.115 1.325 . . . . 0.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -32.69 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.809 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 168.58 12.21 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.54 -23.08 66.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 tt -73.62 7.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 p -124.42 135.56 53.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.215 0.531 . . . . 0.0 110.95 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.58 -159.82 22.95 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.41 85.89 1.12 Allowed 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.623 1.202 . . . . 0.0 108.468 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -73.2 -19.65 61.05 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.425 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 1.2 pp -84.87 8.67 16.63 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.787 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -134.55 127.63 18.74 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.33 -28.3 1.52 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.092 2.528 . . . . 0.0 112.275 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.35 -49.03 79.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -36.75 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 m -61.15 -28.62 69.25 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -44.34 96.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.38 . . . . 0.0 110.155 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.79 96.37 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.29 -46.18 65.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.657 0.265 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.586 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 . . . . . 0 N--CA 1.46 0.071 0 CA-C-O 120.816 0.341 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.53 -35.26 78.75 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.681 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.42 67.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 176.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 tpp -73.39 -31.61 63.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.214 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.73 -39.19 76.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 119.267 0.939 . . . . 0.0 111.575 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -41.19 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.695 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -70.65 -38.04 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.42 -47.0 74.63 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -35.71 70.81 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -36.11 72.44 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.35 -35.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.197 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.36 -46.72 86.39 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 120.899 1.681 . . . . 0.0 113.084 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.454 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.89 -36.04 75.13 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 77.6 mt -64.98 -50.31 75.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.305 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 m -65.42 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.27 -43.33 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.973 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -37.05 74.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.75 85.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.454 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt -66.76 -37.33 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.42 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.08 -24.44 65.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.4 p -61.4 -41.71 97.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.813 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.0 61.56 Favored Glycine 0 CA--C 1.51 -0.266 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -29.83 24.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.456 -0.872 . . . . 0.0 111.391 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.627 -179.185 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.501 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.54 117.11 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.2 0.524 . . . . 0.0 111.452 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 58.02 11.01 1.32 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.064 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -87.78 91.85 8.9 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.16 143.1 58.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.302 0.572 . . . . 0.0 111.101 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.95 134.71 49.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.636 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -49.79 127.58 16.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 128.94 -104.38 0.64 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.668 HG13 ' HB2' ' A' ' 137' ' ' GLN . 1.7 t -86.07 124.02 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.439 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 1.4 t30 -71.67 -171.78 0.71 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 102.823 -3.029 . . . . 0.0 102.823 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 p -62.2 -46.8 87.3 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 114.843 -2.743 . . . . 0.0 110.187 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.14 95.94 Favored Glycine 0 CA--C 1.498 -0.992 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.115 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.668 ' HB2' HG13 ' A' ' 133' ' ' VAL . 26.9 mm100 -53.46 -23.59 10.53 Favored 'General case' 0 C--N 1.248 -3.819 0 CA-C-O 121.496 0.665 . . . . 0.0 110.26 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -69.39 -1.54 29.21 Favored Glycine 0 C--O 1.188 -2.728 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.78 -50.32 65.14 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 118.556 1.178 . . . . 0.0 110.902 -176.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -38.23 76.36 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.531 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.7 OUTLIER -68.92 -38.32 78.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.18 -178.274 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 138' ' ' GLY . 20.4 mt-10 -68.54 -36.29 78.61 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-O 121.744 0.783 . . . . 0.0 111.123 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.7 mt -69.65 -45.46 77.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.395 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.496 -174.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.31 -48.78 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.463 1.125 . . . . 0.0 111.27 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.56 58.03 Favored Glycine 0 C--O 1.211 -1.299 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.718 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.8 m -70.62 -40.16 73.32 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.673 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tp -54.8 -40.55 69.59 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.277 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 1.1 pt20 -58.07 -31.1 66.76 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.241 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 tp -68.69 -47.17 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.49 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.33 -40.98 88.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -42.28 96.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 3.8 p -71.0 -27.18 63.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.457 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 t -72.09 -45.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.552 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.59 -41.98 92.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.372 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.56 87.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.519 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.508 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.444 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 24.3 Cg_exo -54.67 -39.39 89.27 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.524 1.483 . . . . 0.0 111.972 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.54 -42.42 96.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.382 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.55 -47.06 57.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.703 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.23 -37.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.62 -37.42 93.58 Favored Glycine 0 C--O 1.198 -2.125 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.306 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -35.98 65.27 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -34.56 77.24 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.52 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.0 t -73.15 -47.6 46.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.72 -34.89 78.85 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.261 1.029 . . . . 0.0 109.667 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.264 8.1 mt -67.06 -50.56 61.45 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 124.454 2.073 . . . . 0.0 110.863 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -36.97 65.38 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.117 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' HIS . . . . . 0.425 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 5.4 m-70 -70.38 -35.12 73.31 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 112.669 -1.766 . . . . 0.0 109.504 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.2 -47.81 83.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.519 -177.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -52.33 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.463 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -70.15 -52.22 25.24 Favored 'General case' 0 C--O 1.206 -1.221 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 188' ' ' GLY . 7.4 mt -56.02 -49.03 77.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.914 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.644 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -69.02 -35.67 76.91 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 115.538 -2.465 . . . . 0.0 112.582 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 133' ' ' VAL . 2.4 m-85 -60.11 -30.35 69.2 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.721 -170.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.288 0.1 OUTLIER -124.54 -26.82 3.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.06 0.933 . . . . 0.0 113.101 -179.401 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 88.35 -5.99 84.09 Favored Glycine 0 CA--C 1.567 3.284 0 N-CA-C 106.165 -2.774 . . . . 0.0 106.165 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 17.1 t -85.36 130.68 34.54 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.47 160.65 10.04 Favored Glycine 0 N--CA 1.402 -3.625 0 CA-C-N 111.497 -2.592 . . . . 0.0 111.752 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.11 -38.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -85.88 139.19 34.99 Favored Pre-proline 0 N--CA 1.413 -2.32 0 CA-C-N 112.657 -2.065 . . . . 0.0 107.997 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -66.03 -14.46 44.53 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.49 2.127 . . . . 0.0 111.58 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.23 -33.23 61.33 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.411 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 15.6 tpt180 -70.74 -38.39 73.54 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.106 0.479 . . . . 0.0 110.158 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.4 t -73.44 -42.22 62.27 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.443 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 1.0 OUTLIER -71.96 -35.2 69.48 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 126.607 1.963 . . . . 0.0 114.777 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.41 93.12 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 m -76.38 -28.35 56.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.322 -0.939 . . . . 0.0 110.669 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -66.31 -34.22 77.49 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.743 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 121.79 2.086 . . . . 0.0 110.526 179.767 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.832 0.825 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -58.8 -36.19 74.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.058 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.27 -33.41 24.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 12.0 p -77.74 -44.99 28.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.496 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.27 -47.73 73.13 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.682 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.1 Cg_endo -71.8 -28.62 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.936 2.424 . . . . 0.0 113.609 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -75.2 -33.81 61.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.051 0.453 . . . . 0.0 111.898 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.558 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 51.8 mt -70.58 -46.25 70.72 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.382 0 C-N-CA 123.892 0.877 . . . . 0.0 112.753 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.445 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -68.29 -45.84 67.61 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 128.343 3.527 . . . . 0.0 111.752 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.39 -48.91 34.71 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 118.306 -1.902 . . . . 0.0 109.532 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.81 68.31 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.601 0.715 . . . . 0.0 109.674 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.0 OUTLIER -67.85 -31.33 71.08 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.225 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.432 ' O ' HG13 ' A' ' 226' ' ' ILE . . . -58.99 -40.03 83.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.51 -50.28 80.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.488 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -39.56 93.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 223' ' ' ALA . 1.1 pp -68.99 -34.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.325 -176.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.3 t80 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.5 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.09 141.07 43.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.553 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -139.76 98.64 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.606 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -135.67 -42.08 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.542 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -110.1 86.93 2.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.545 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -82.37 145.32 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? 72.62 -64.85 0.38 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.68 0.612 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttp 67.19 11.42 8.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.074 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.8 mp 53.48 -179.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.848 0.356 . . . . 0.0 110.864 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -114.93 -44.69 3.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.522 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -141.13 156.38 45.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 -68.56 -0.23 4.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.926 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.63 -5.53 11.15 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.478 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -63.12 -40.26 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.23 -35.75 72.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.119 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.79 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -46.54 62.69 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -33.53 71.66 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.43 -38.32 77.23 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.992 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 75' ' ' LEU . . . -65.6 -46.64 78.58 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 112.899 -1.955 . . . . 0.0 114.865 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -31.32 59.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.506 -177.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.33 -39.05 74.97 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.736 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -44.73 84.01 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.83 -52.5 9.4 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.48 -44.72 94.13 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.604 -177.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.413 ' O ' HG12 ' A' ' 29' ' ' ILE . 63.3 t80 -54.3 -48.97 70.71 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.424 0.631 . . . . 0.0 112.337 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 pt -75.65 -29.54 20.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -36.42 69.18 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.8 mm -60.84 -38.59 79.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.065 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -36.8 64.65 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p -67.01 -41.28 86.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.54 -16.75 63.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.469 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 2.4 mt -83.69 -40.31 19.06 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.55 0.69 . . . . 0.0 110.232 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.64 -34.52 43.77 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.523 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -24.63 60.2 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.77 -9.85 16.28 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.663 176.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 34' ' ' GLY . 35.6 t80 -121.42 121.74 28.34 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 118.753 0.706 . . . . 0.0 110.197 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.95 139.42 52.13 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 119.836 0.977 . . . . 0.0 112.215 0.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.65 151.31 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.866 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.54 154.07 14.06 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.02 103.55 2.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.513 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -124.33 -31.63 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -125.67 -164.86 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.577 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 p -98.61 -24.8 14.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.69 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.7 138.97 58.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.749 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.15 133.46 53.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.184 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -105.95 125.26 50.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.469 . . . . 0.0 111.046 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.12 163.22 15.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.789 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -49.52 -28.47 5.53 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.4 t -58.77 -42.5 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 O-C-N 121.821 -0.55 . . . . 0.0 112.264 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -65.01 -53.98 37.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.84 -42.17 85.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.225 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.8 m -69.39 -41.23 76.74 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.933 0.771 . . . . 0.0 109.806 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.74 -31.74 72.73 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.49 93.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.508 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -66.15 -46.92 75.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.23 -36.96 92.2 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.277 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 27.1 mt -68.28 -43.06 78.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.8 m -57.61 -35.86 71.02 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER -60.23 -33.81 54.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.675 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.476 ' N ' HG13 ' A' ' 60' ' ' ILE . . . -60.64 -45.53 93.73 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.51 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -31.52 70.59 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -42.59 72.9 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 104.199 -2.519 . . . . 0.0 104.199 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.98 -44.27 73.21 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.654 174.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -43.57 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -176.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -59.25 -12.26 5.2 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 119.936 1.243 . . . . 0.0 111.856 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 m -119.76 -38.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 154.16 6.34 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -52.94 -22.74 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -70.89 7.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.56 135.71 53.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.11 -159.61 31.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.48 85.99 1.15 Allowed 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 118.574 -1.25 . . . . 0.0 107.776 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -19.54 64.46 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 112.794 -2.003 . . . . 0.0 105.684 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . 1.7 pp -84.84 0.18 51.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.398 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.26 128.81 25.53 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 119.371 0.987 . . . . 0.0 113.517 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -83.35 -25.34 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.717 2.278 . . . . 0.0 111.86 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB1' ' HA ' ' A' ' 192' ' ' ASN . . . -64.27 -46.16 84.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.23 -36.8 78.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 110.802 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -64.68 -28.62 69.73 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -57.21 -44.47 83.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 110.285 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.24 95.89 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.8 tp -51.41 -41.26 60.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.576 0.227 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 tp -48.33 -51.18 27.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.432 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 70.05 -69.95 0.16 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.156 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 p -176.91 51.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.748 0.309 . . . . 0.0 110.556 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.8 m -135.98 114.24 11.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.645 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -171.71 86.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.656 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.93 -70.17 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.3 m -144.9 91.05 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.55 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.9 mt 65.15 134.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.723 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.41 161.96 38.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.496 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.3 -37.33 64.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.496 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.7 -35.2 78.38 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.701 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 tp -54.78 -38.45 67.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -32.63 64.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.227 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -70.06 -38.65 75.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.287 0.949 . . . . 0.0 111.947 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.77 -41.25 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.49 -37.78 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.414 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.02 83.53 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.008 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.33 -35.89 71.37 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.423 ' O ' HG13 ' A' ' 106' ' ' ILE . 1.2 t -57.91 -36.14 72.03 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.57 -35.33 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.429 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.37 85.22 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 120.781 1.628 . . . . 0.0 113.221 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.8 -35.9 75.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 102' ' ' CYS . 69.5 mt -65.03 -50.36 75.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.98 -37.12 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.434 0.635 . . . . 0.0 109.48 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.45 -49.83 74.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.407 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.71 -37.02 86.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.727 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -44.89 88.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.19 -37.28 76.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.087 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.81 -24.36 66.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.601 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 t -63.3 -44.38 95.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.901 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.25 -36.33 62.16 Favored Glycine 0 CA--C 1.509 -0.299 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -33.16 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.3 -0.95 . . . . 0.0 110.728 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m -80.85 5.35 16.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.559 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.6 t -56.74 -35.02 68.12 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.524 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 t -92.16 -35.35 13.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.41 -177.49 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.43 124.91 48.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.72 78.4 0.26 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.07 -35.35 10.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.687 0.28 . . . . 0.0 111.006 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.49 58.27 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.075 0.464 . . . . 0.0 110.561 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.9 mt -81.74 7.95 11.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.284 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.79 81.85 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.54 117.2 31.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.281 0.563 . . . . 0.0 111.131 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.85 15.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.665 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.15 90.07 7.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.1 142.8 58.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.317 0.58 . . . . 0.0 111.149 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.96 136.25 47.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.333 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 127.58 16.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.66 -105.05 0.65 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.637 HG12 ' HB2' ' A' ' 137' ' ' GLN . 1.8 t -86.09 124.13 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.445 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 32.1 t30 -71.65 -171.95 0.73 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -62.01 -46.86 87.34 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 114.928 -2.709 . . . . 0.0 110.239 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.53 96.17 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.637 ' HB2' HG12 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -53.39 -23.53 9.9 Favored 'General case' 0 C--N 1.248 -3.809 0 CA-C-O 121.261 0.553 . . . . 0.0 110.796 -176.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.53 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -70.33 -1.95 38.53 Favored Glycine 0 C--O 1.187 -2.794 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.98 -50.64 71.26 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.521 -1.576 . . . . 0.0 110.168 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.71 -45.94 56.27 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.53 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.5 OUTLIER -60.88 -42.08 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.184 -1.508 . . . . 0.0 112.084 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 138' ' ' GLY . 8.3 tt0 -68.37 -36.32 79.02 Favored 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 123.687 0.795 . . . . 0.0 112.305 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.4 mt -67.65 -47.68 79.18 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.404 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 26.9 mt -68.33 -46.79 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.059 0.933 . . . . 0.0 111.695 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -60.18 -49.94 73.04 Favored Glycine 0 C--O 1.211 -1.335 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.323 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.1 m -70.58 -38.22 74.03 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.923 0.868 . . . . 0.0 111.13 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 tp -54.98 -40.22 69.83 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.048 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.8 OUTLIER -58.77 -31.06 68.02 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.325 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.8 tp -68.91 -46.69 67.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.353 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.9 t -66.35 -45.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -31.87 72.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.089 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.09 -45.43 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 -48.1 80.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 111.119 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.84 -31.69 72.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -36.96 85.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.468 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.39 -8.83 52.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.358 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 135.69 53.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.785 0.326 . . . . 0.0 110.556 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -26.93 32.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -52.11 174.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.563 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.5 ttp85 -127.74 125.45 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.548 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.44 -58.18 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.59 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.87 107.93 9.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.588 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.16 133.2 38.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.41 83.95 0.11 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.89 -137.35 13.48 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.72 141.57 43.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.59 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.442 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . -52.37 -46.12 94.74 Favored Pre-proline 0 C--O 1.219 -0.505 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.433 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 39.5 Cg_exo -54.31 -44.24 51.24 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.795 1.663 . . . . 0.0 112.019 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 mp -66.1 -38.1 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.26 56.38 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 22.2 pt -60.26 -38.3 76.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.721 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.41 93.53 Favored Glycine 0 C--O 1.2 -1.994 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.681 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mt -55.04 -35.58 64.63 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.161 -2.162 . . . . 0.0 105.161 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -34.54 77.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.31 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.04 -47.24 48.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.907 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.53 -33.61 75.41 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 122.665 1.222 . . . . 0.0 110.027 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.258 0.1 OUTLIER -70.61 -47.49 59.85 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.973 179.375 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.64 -36.84 65.94 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 111.564 -2.562 . . . . 0.0 107.664 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.456 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 6.2 m170 -70.46 -34.99 73.06 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.933 -1.633 . . . . 0.0 109.54 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.02 -48.43 81.61 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.359 -177.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -52.07 11.6 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.47 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.66 -51.96 30.04 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 188' ' ' GLY . 5.6 mt -62.11 -49.14 85.29 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.807 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.039 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.28 -35.51 79.64 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 116.119 -2.232 . . . . 0.0 112.818 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.95 -30.4 69.05 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.909 -1.116 . . . . 0.0 111.699 -171.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.295 0.1 OUTLIER -124.31 -26.91 3.86 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.267 1.032 . . . . 0.0 113.182 -178.79 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.61 -5.74 84.51 Favored Glycine 0 CA--C 1.567 3.296 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -170.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 15.4 t -82.68 127.89 33.83 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -44.33 170.35 0.01 OUTLIER Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 111.358 -2.655 . . . . 0.0 113.363 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.424 HG12 ' HB1' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -79.76 -40.14 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 173.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.483 ' HA ' ' HB1' ' A' ' 78' ' ' ALA . 1.2 p-10 -101.32 153.12 38.01 Favored Pre-proline 0 N--CA 1.407 -2.614 0 CA-C-N 111.432 -2.622 . . . . 0.0 108.361 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.46 -14.59 44.75 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 122.879 2.386 . . . . 0.0 111.661 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.11 -34.5 61.72 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.102 0.251 . . . . 0.0 111.094 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.49 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.52 -39.67 73.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.214 0.531 . . . . 0.0 109.928 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -36.49 66.39 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.008 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.464 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 6.1 t80 -72.26 -35.2 68.71 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 126.517 1.927 . . . . 0.0 114.268 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -46.77 91.73 Favored Glycine 0 C--N 1.319 -0.373 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.3 56.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.19 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -63.33 -34.07 76.89 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.514 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -31.74 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 121.031 1.741 . . . . 0.0 110.425 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.52 -63.22 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.64 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 71.5 m -116.56 110.47 18.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.622 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -79.74 158.64 26.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.454 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -143.88 -166.72 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.715 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -91.36 -143.75 0.19 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.347 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -53.16 -20.61 4.05 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.154 -0.341 . . . . 0.0 111.287 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -55.19 -35.23 64.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.895 0.379 . . . . 0.0 110.302 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -28.64 62.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -70.58 -37.55 73.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.463 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.6 mt -52.64 -35.11 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.73 0.776 . . . . 0.0 109.155 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.53 -36.57 74.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.049 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -84.21 -33.46 24.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.09 -43.97 24.29 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.509 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.12 -44.15 83.6 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.417 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.6 Cg_exo -71.65 -28.72 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.258 . . . . 0.0 113.106 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.03 -32.14 50.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.146 0.498 . . . . 0.0 112.29 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.2 mm -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.255 0 C-N-CA 123.743 0.817 . . . . 0.0 112.164 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.436 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -67.71 -46.6 67.04 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 128.758 3.786 . . . . 0.0 111.731 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.31 -49.03 34.66 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 118.171 -1.966 . . . . 0.0 109.906 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -39.04 68.47 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.649 0.738 . . . . 0.0 109.713 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.86 -31.24 70.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.223 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.68 81.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.17 -49.65 80.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.352 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.84 -39.42 91.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.754 0.788 . . . . 0.0 109.771 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 mt -58.27 -34.72 50.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.069 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -140.95 72.12 1.38 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.563 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -166.35 68.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.635 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -101.42 175.69 5.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.379 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 10.7 mm 58.25 98.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.404 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.94 143.66 26.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.565 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -159.83 68.67 3.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.535 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -47.52 106.39 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.811 2.341 . . . . 0.0 112.094 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 64.79 118.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.565 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.65 106.66 8.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.555 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.31 -28.06 15.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.615 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 38.0 t70 59.33 97.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.3 mt -50.48 -63.33 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.585 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.6 t -162.05 65.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.518 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 62.2 t0 55.13 95.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.58 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 55.64 -176.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.583 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 26.0 m -141.36 26.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.33 159.45 14.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.59 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 1.1 t -132.33 151.26 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.56 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -126.48 -26.71 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.541 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.7 m -151.69 104.79 3.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.544 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 28.0 t -57.82 164.36 2.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.553 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 114.97 -54.94 0.55 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -90.87 151.87 20.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.563 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 92.9 t -125.8 -40.13 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.62 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -97.79 -66.52 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.632 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -173.61 76.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.579 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -114.37 138.13 50.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.549 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.03 -27.63 14.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.568 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.51 172.03 7.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -141.49 54.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.571 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -53.85 173.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.57 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -132.87 38.97 3.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.559 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 56.72 78.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.596 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.63 -50.49 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.556 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -131.26 90.99 2.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.52 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 1.7 m -66.61 112.14 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.609 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -94.42 -58.88 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.545 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 85.1 t -115.36 105.17 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -129.12 -46.8 1.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 8.4 mmm -103.3 111.56 24.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.589 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -46.92 106.55 0.59 Allowed Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.727 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.4 -32.76 15.64 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.877 1.718 . . . . 0.0 112.087 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -174.84 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 64.8 105.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.587 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.5 tt 62.35 101.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.539 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -53.37 159.59 1.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -124.22 -50.9 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.568 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -157.52 -51.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.57 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 64.83 -82.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.818 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 75.36 -6.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.418 0.449 . . . . 0.0 111.838 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.15 138.22 7.67 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.612 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -99.97 173.66 6.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.622 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -60.13 -31.71 70.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.524 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.34 -75.75 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.73 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 49.44 30.02 3.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.337 . . . . 0.0 110.637 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 21.2 t30 63.66 163.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.536 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.8 m -130.03 59.32 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.615 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.16 -37.07 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.597 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.1 91.04 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.521 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -93.98 83.62 4.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.536 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -106.71 -28.65 10.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.552 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -82.41 162.53 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.591 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 13.0 m170 55.97 95.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -134.47 -76.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.591 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 37.6 m80 53.54 48.4 21.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.555 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtp . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.03 33.15 5.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.54 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.7 p -166.24 118.75 1.05 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.564 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.42 25.29 7.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 49.87 35.07 8.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.46 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -91.22 -43.27 9.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.643 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt 53.69 93.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.581 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -106.4 101.5 10.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.66 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.19 -79.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.446 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -141.79 -84.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.368 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 73.74 -54.93 0.68 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.441 0.463 . . . . 0.0 111.36 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.63 1.6 6.44 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.24 -14.4 11.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.027 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.01 -40.17 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 17.4 m -68.43 -35.81 72.24 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 112.83 -1.986 . . . . 0.0 110.521 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.18 70.07 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -70.81 -46.72 62.29 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -33.83 74.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 11.4 mt -58.63 -38.37 77.93 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.911 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 75' ' ' LEU . . . -65.58 -46.99 77.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.781 -2.009 . . . . 0.0 114.749 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.449 ' HA ' ' HB2' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -75.65 -31.53 59.83 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.735 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.79 -36.88 67.69 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.507 -0.745 . . . . 0.0 111.607 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.05 -45.22 82.15 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.18 -47.7 19.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 29' ' ' ILE . 90.2 t -65.28 -49.82 76.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.137 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -54.07 -48.07 71.01 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.5 -29.43 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.616 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -36.17 68.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 25' ' ' VAL . 4.1 mm -60.11 -43.74 93.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.76 63.87 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -67.33 -38.1 84.35 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.605 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.45 -46.48 66.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 pp -85.94 -39.88 16.46 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.81 -35.24 72.83 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.77 -176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.79 -20.04 46.37 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.326 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.71 -9.85 16.32 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.798 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.98 120.1 29.5 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 118.234 0.47 . . . . 0.0 110.312 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.24 141.92 69.09 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 C-N-CA 124.655 -0.977 . . . . 0.0 112.105 -0.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.75 150.97 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.686 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.73 88.73 0.34 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -77.24 155.54 32.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.321 . . . . 0.0 110.625 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -94.64 26.4 3.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.574 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 74.63 -7.89 1.62 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.952 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.56 -31.23 4.95 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.908 0.385 . . . . 0.0 110.488 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.61 143.38 57.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.565 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.55 115.68 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.758 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -100.51 105.9 17.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -114.31 163.08 15.77 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 121.08 0.466 . . . . 0.0 111.683 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.75 -28.02 5.64 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.403 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.5 m -56.74 -43.85 80.34 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -64.77 -50.46 66.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 t -67.91 -47.65 78.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.647 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -69.31 -37.18 77.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.43 -32.01 73.46 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.49 93.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.824 -1.534 . . . . 0.0 109.327 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -65.89 -44.27 85.78 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.55 97.93 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.26 -43.92 76.73 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.749 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -36.53 79.82 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -33.89 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.006 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.61 -45.63 71.41 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.857 -1.519 . . . . 0.0 113.016 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 p -67.36 -31.88 72.43 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.35 -41.26 72.28 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.9 -44.14 73.81 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.788 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -38.03 85.96 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.8 m -59.54 -12.13 5.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 119.754 1.161 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.27 -42.91 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.936 0.398 . . . . 0.0 111.133 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 171.77 13.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -65.26 -23.05 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.767 0.318 . . . . 0.0 111.008 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.45 7.11 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.45 135.65 53.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.049 0.452 . . . . 0.0 111.051 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.92 -157.86 16.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.36 86.04 1.11 Allowed 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 122.507 1.146 . . . . 0.0 108.085 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -19.61 62.38 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.498 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 2.4 pp -84.53 4.58 31.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 113.669 -1.605 . . . . 0.0 111.625 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -125.49 126.11 25.05 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.23 -24.02 3.3 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.883 2.389 . . . . 0.0 111.632 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.16 -50.84 62.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -36.67 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.923 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 m -61.21 -32.23 72.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.4 tp -57.27 -44.61 84.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.044 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.25 -45.87 63.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -44.29 66.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 111.008 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.04 -32.0 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 55.9 57.64 5.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.537 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.92 116.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.6 t -169.65 -59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.442 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -174.74 55.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.516 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.1 tt -176.9 146.77 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.678 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 p -116.12 178.7 4.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.524 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -132.38 -31.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.7 t80 75.22 -53.72 0.66 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.695 0.622 . . . . 0.0 111.132 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -59.03 -36.02 74.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 0.0 110.792 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.91 -35.13 77.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.636 ' O ' HG13 ' A' ' 98' ' ' ILE . 3.1 mm? -54.54 -38.18 66.3 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mtm -73.71 -33.3 64.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.767 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -69.99 -37.84 75.84 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.096 -1.003 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 95' ' ' LEU . 1.8 pp -66.81 -42.55 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.384 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.12 -37.73 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.37 70.27 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -71.96 -35.97 69.72 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.669 0.668 . . . . 0.0 112.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 m -58.1 -35.88 72.07 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.4 -35.36 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.063 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.07 91.59 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 121.152 1.796 . . . . 0.0 112.519 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.433 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.95 -36.1 75.0 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.0 mt -67.99 -42.41 85.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.575 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.4 t -69.93 -37.18 72.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.294 0.569 . . . . 0.0 110.107 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.74 75.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.445 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 35.8 m -65.88 -37.1 85.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.457 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.53 88.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.735 0.303 . . . . 0.0 111.135 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.27 -50.5 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.28 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.85 -24.2 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.537 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -42.63 95.51 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.771 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.26 61.95 Favored Glycine 0 CA--C 1.511 -0.178 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.4 -31.95 44.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.779 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p -85.35 5.57 30.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.582 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 91.9 p -53.65 -26.08 20.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.702 0.286 . . . . 0.0 110.967 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.73 3.61 9.45 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.918 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.8 tp 67.71 20.2 9.55 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.589 0.233 . . . . 0.0 110.789 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 t -118.46 164.14 15.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.343 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 45.74 36.01 6.2 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -71.14 -6.38 38.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.447 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -79.71 76.23 6.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.955 0.407 . . . . 0.0 110.146 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt -85.26 7.93 20.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.479 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.32 31.33 57.27 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.56 117.49 32.46 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.125 -0.538 . . . . 0.0 111.778 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 60.23 9.19 1.81 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.02 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -87.68 88.32 7.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.12 143.24 57.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.254 0.55 . . . . 0.0 110.88 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.05 135.7 48.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.679 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -49.64 127.45 15.76 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.6 -105.35 0.67 Allowed Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.645 HG12 ' HB2' ' A' ' 137' ' ' GLN . 1.6 t -85.83 123.93 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.444 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 1.5 m-20 -71.71 -171.85 0.73 Allowed 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -61.92 -46.74 88.05 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 114.807 -2.757 . . . . 0.0 110.409 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.04 -41.24 96.37 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.071 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.645 ' HB2' HG12 ' A' ' 133' ' ' VAL . 4.5 mt-30 -53.53 -23.42 10.48 Favored 'General case' 0 C--N 1.249 -3.789 0 CA-C-O 121.238 0.542 . . . . 0.0 110.237 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.514 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.65 -1.72 24.89 Favored Glycine 0 C--O 1.19 -2.597 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.43 -50.23 66.19 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 118.489 1.144 . . . . 0.0 110.322 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -40.96 75.16 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.514 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.6 OUTLIER -66.17 -38.77 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 113.155 -1.523 . . . . 0.0 112.087 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 32.5 mt-10 -68.46 -36.24 78.71 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 121.948 0.88 . . . . 0.0 111.039 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.6 mt -67.29 -48.47 77.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.627 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.26 -48.47 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 122.088 0.947 . . . . 0.0 111.424 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.25 -51.97 56.02 Favored Glycine 0 C--O 1.211 -1.329 0 CA-C-N 113.466 -1.697 . . . . 0.0 113.138 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.2 m -70.39 -40.42 73.94 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.5 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.64 -40.11 68.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -176.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 1.1 pt20 -58.0 -30.82 66.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 tp -68.75 -46.72 68.09 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.426 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 78.9 t -66.26 -41.03 88.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -35.65 81.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.442 0.297 . . . . 0.0 111.463 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -34.47 77.36 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.644 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.01 -38.53 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.847 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.4 mp -65.33 -48.02 74.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.81 0.338 . . . . 0.0 110.971 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.76 72.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.53 -37.23 82.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.193 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.4 p -98.85 10.08 42.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -73.17 118.3 15.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.867 0.365 . . . . 0.0 110.568 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.86 -25.95 23.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -54.74 -62.01 1.94 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.659 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -83.78 117.95 23.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -84.6 -174.15 5.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.423 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.54 159.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.598 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.28 123.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.427 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -74.28 119.95 6.43 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.11 -157.22 38.76 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.49 142.24 44.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.087 0.47 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.434 ' N ' ' HD2' ' A' ' 169' ' ' PRO . . . -52.63 -49.42 86.25 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 168' ' ' ALA . 17.9 Cg_endo -61.32 -36.78 77.3 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.007 1.138 . . . . 0.0 111.692 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mp -66.22 -44.95 82.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.87 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.4 -47.43 56.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.2 -37.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.515 0.674 . . . . 0.0 109.446 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.48 93.47 Favored Glycine 0 C--O 1.2 -2.013 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.755 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.92 -35.65 64.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -34.49 77.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.421 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.7 t -73.16 -47.38 47.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.37 -30.73 67.73 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 122.528 1.156 . . . . 0.0 110.195 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.28 2.6 mm? -70.43 -50.88 33.87 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.874 2.274 . . . . 0.0 109.528 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.53 -36.92 65.36 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 110.559 -3.019 . . . . 0.0 107.114 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.4 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.4 m-70 -69.08 -35.22 76.28 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.334 -1.433 . . . . 0.0 109.657 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.95 -48.34 81.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.234 -177.498 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.32 -52.07 11.69 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.494 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.79 -52.03 28.75 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.486 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 12.8 mt -60.16 -41.82 88.0 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.602 0 C-N-CA 118.731 -1.188 . . . . 0.0 113.244 -174.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.84 -35.68 59.87 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 115.911 -2.316 . . . . 0.0 112.564 -176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.01 -29.68 68.65 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.385 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.283 0.1 OUTLIER -124.43 -26.8 3.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.063 -178.989 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.74 -5.97 84.15 Favored Glycine 0 CA--C 1.566 3.256 0 N-CA-C 106.046 -2.822 . . . . 0.0 106.046 -170.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.404 ' CB ' ' OG1' ' A' ' 187' ' ' THR . 9.4 t -82.28 127.74 33.5 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -47.83 164.37 0.23 Allowed Glycine 0 N--CA 1.408 -3.226 0 CA-C-N 111.146 -2.752 . . . . 0.0 112.497 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -33.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -109.73 152.44 42.89 Favored Pre-proline 0 N--CA 1.415 -2.217 0 CA-C-N 112.544 -2.116 . . . . 0.0 109.288 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.08 -14.66 45.4 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.618 2.212 . . . . 0.0 111.686 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.39 -35.75 60.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.697 0.285 . . . . 0.0 110.498 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -41.16 72.94 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.336 0.589 . . . . 0.0 109.85 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -32.61 64.71 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.475 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.437 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 2.9 m-85 -72.27 -35.24 68.69 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.464 1.906 . . . . 0.0 113.948 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -44.44 93.9 Favored Glycine 0 C--N 1.318 -0.456 0 N-CA-C 106.971 -2.451 . . . . 0.0 106.971 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.53 -28.21 56.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.088 -1.056 . . . . 0.0 110.842 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.19 75.74 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.42 -31.96 51.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 121.598 1.999 . . . . 0.0 110.929 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.0 pt -87.18 45.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.639 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.13 140.32 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.364 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -49.73 -63.12 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.416 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.35 159.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -132.92 -157.74 0.84 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.021 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.0 -24.29 9.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.519 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -57.88 -35.07 70.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.801 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 -24.01 3.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.155 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.87 -38.11 73.09 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -35.18 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.788 0.804 . . . . 0.0 109.549 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -58.92 -37.5 76.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.027 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -84.28 -33.53 23.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.6 p -80.49 -40.06 19.19 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.517 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.0 -48.23 68.52 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.976 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.8 Cg_endo -71.96 -38.97 3.53 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.046 2.497 . . . . 0.0 113.675 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -63.25 -39.79 95.59 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.601 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.9 mm -70.31 -46.55 70.98 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.148 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.67 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -55.18 -45.64 81.71 Favored Glycine 0 C--N 1.364 2.128 0 O-C-N 128.529 3.643 . . . . 0.0 111.339 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.13 -41.41 80.58 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.19 -34.83 61.48 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.7 mt -67.69 -36.92 81.54 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.38 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.06 -39.58 82.53 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.277 -174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 88.4 t -58.38 -49.7 81.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.638 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.61 0.719 . . . . 0.0 110.155 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt -57.14 -34.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.119 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -141.26 72.11 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.437 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -174.36 57.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.566 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.66 83.83 7.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 11.5 pt -83.23 -176.88 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.571 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.98 126.05 55.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.638 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -76.3 -55.14 1.79 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.236 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -46.17 169.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.021 1.814 . . . . 0.0 112.465 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 58.14 91.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.632 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.43 137.07 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.576 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.64 -61.28 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.601 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 4.0 t70 64.59 158.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.489 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 56.56 97.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.665 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.84 162.28 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.667 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -71.95 -177.73 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.55 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -142.89 48.27 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 18.5 t 55.76 70.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.482 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.59 113.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.607 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.6 t 59.54 86.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.543 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -77.76 -176.28 4.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.541 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.4 m 70.11 -70.34 0.15 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.7 t -142.99 74.8 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -81.24 69.25 3.3 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 56.75 38.26 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.609 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.69 -44.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.593 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 61.33 87.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.59 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -67.76 -61.03 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.603 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -155.66 -41.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.569 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.19 164.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.594 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.89 -65.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.486 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 59.89 93.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.558 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -121.76 102.54 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.603 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -127.72 177.27 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.556 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.9 127.77 34.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.583 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 4.4 mt 57.19 99.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.618 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.01 103.5 7.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.594 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.8 t -126.13 31.64 5.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -113.64 59.0 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.563 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.07 31.27 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.612 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -132.3 148.64 52.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.572 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 6.9 mtp -71.32 -165.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -137.3 72.0 52.75 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.573 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -47.4 -42.33 28.24 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.745 2.297 . . . . 0.0 112.229 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -89.97 174.6 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.504 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 53.32 89.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.558 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.5 mt -76.99 175.31 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.559 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -85.78 136.21 33.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.466 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.68 -53.78 2.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.617 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -77.24 131.76 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.643 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.5 mp -52.87 -73.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 4.2 tt -154.49 21.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.766 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 3.3 m 49.41 81.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.733 0.301 . . . . 0.0 110.67 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -174.02 -178.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.557 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -96.78 128.24 43.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.544 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.25 112.32 10.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.569 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 3.1 mt -128.41 53.15 1.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.559 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -143.95 -59.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.527 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.0 m -77.6 118.23 19.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.602 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -102.79 -30.8 10.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.561 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.41 -34.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.571 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.13 121.1 8.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -114.05 121.38 43.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.581 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 1.7 t60 65.29 143.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.54 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -128.93 161.28 30.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.555 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.5 m80 49.97 83.1 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.619 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.76 178.14 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.579 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 7.4 t60 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.62 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.07 63.29 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -141.18 -54.16 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.558 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.27 -21.5 17.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.753 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 66.17 172.66 0.24 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.538 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -100.4 83.37 2.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.678 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -76.3 -37.74 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.428 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.51 171.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.646 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.83 140.6 49.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.466 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.56 105.63 17.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.63 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -114.63 -27.66 7.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.418 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -57.1 -15.93 6.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.332 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.54 -0.5 13.03 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.814 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.54 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.3 -35.77 72.33 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.762 0 CA-C-N 112.506 -2.134 . . . . 0.0 109.932 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.15 -35.02 69.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.99 -46.72 61.8 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -34.23 73.48 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.05 -38.08 78.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.174 -2.284 . . . . 0.0 108.748 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . . . -64.09 -46.82 82.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.355 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.431 ' HB ' ' N ' ' A' ' 105' ' ' ALA . 0.2 OUTLIER -75.91 -31.51 59.21 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.099 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -38.18 67.05 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.548 -0.72 . . . . 0.0 112.091 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -49.55 15.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 29' ' ' ILE . 97.7 t -65.33 -48.46 83.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.363 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 29' ' ' ILE . 50.1 t80 -53.95 -48.51 70.2 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.6 -29.21 20.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.387 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -36.2 67.41 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 25' ' ' VAL . 2.8 mm -63.06 -41.74 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.311 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.5 -38.83 71.89 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -37.97 84.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.96 -46.02 72.57 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.57 -30.64 23.19 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.82 -34.47 48.25 Favored Glycine 0 C--N 1.318 -0.468 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.391 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -19.51 45.03 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.69 -9.65 16.41 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.237 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -126.34 119.97 23.44 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 118.168 0.44 . . . . 0.0 110.14 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -68.3 139.93 52.91 Favored 'Cis proline' 0 N--CA 1.498 1.74 0 C-N-CA 124.714 -0.953 . . . . 0.0 111.774 -1.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.96 151.36 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.528 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.24 172.68 49.75 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -177.83 -41.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.858 0.361 . . . . 0.0 110.301 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -125.83 -25.62 3.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.558 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -60.79 179.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.604 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 -19.74 8.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.04 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.27 147.92 29.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.665 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.73 136.16 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.287 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -106.61 114.1 28.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.227 0.536 . . . . 0.0 111.418 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.23 163.04 15.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.393 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -49.87 -28.59 6.76 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.535 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -57.14 -39.02 64.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -64.7 -54.08 37.26 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.5 t -67.75 -45.65 84.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.724 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 m -69.29 -39.18 78.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.0 -31.68 72.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.38 94.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.231 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -65.88 -43.36 88.51 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.69 -43.02 96.94 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.275 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.2 -43.77 77.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.597 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -36.7 76.26 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.96 -34.13 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 113.228 -1.805 . . . . 0.0 108.13 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.76 85.96 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.174 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 p -70.12 -31.7 69.36 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.28 -40.78 71.44 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.96 -44.25 73.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.218 -1.81 . . . . 0.0 109.828 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -66.8 -39.0 87.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -12.21 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 119.978 1.263 . . . . 0.0 111.329 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.81 -37.12 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.765 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.25 154.52 6.87 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -53.29 -22.91 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.934 0.397 . . . . 0.0 111.065 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 tt -74.34 7.08 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -124.3 135.59 53.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.129 0.49 . . . . 0.0 111.57 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.48 -159.37 24.95 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.57 85.9 1.17 Allowed 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 118.254 -1.378 . . . . 0.0 108.589 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.545 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -82.41 8.44 11.46 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.122 -1.854 . . . . 0.0 112.235 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.95 140.09 30.59 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 119.333 0.97 . . . . 0.0 112.676 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.67 -30.62 0.74 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 123.27 2.647 . . . . 0.0 112.563 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.64 72.9 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.31 -36.69 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -30.89 70.71 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 tp -57.93 -38.0 75.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.242 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.32 -44.57 93.4 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -21.89 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.643 0.259 . . . . 0.0 111.326 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tp -52.11 -70.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.01 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.52 46.84 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.71 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.7 t -125.37 -26.16 3.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.518 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.81 111.42 13.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.562 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 70.56 0.93 3.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.791 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mp 45.92 57.86 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.658 0.265 . . . . 0.0 111.296 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 t 179.37 -84.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.012 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.2 mt 61.37 149.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 110.926 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -127.57 -40.82 1.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.891 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -54.26 -37.6 64.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.583 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.85 -35.0 77.79 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.212 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.58 -38.49 66.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.5 ttt -70.63 -38.76 73.92 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.542 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -62.59 -37.59 86.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.332 0.969 . . . . 0.0 109.67 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.09 -47.22 87.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.368 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 tp -70.35 -37.8 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.94 -47.43 77.68 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.529 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -35.18 70.58 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -35.88 71.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.76 -35.41 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.124 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.58 90.74 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 120.815 1.643 . . . . 0.0 113.437 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.431 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.85 -35.98 75.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.37 -42.7 87.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.689 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.86 -37.23 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.311 0.577 . . . . 0.0 109.567 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.38 84.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.105 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -37.03 74.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.394 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.76 -41.19 85.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.012 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.55 -48.22 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.26 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -24.43 61.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.0 t -62.03 -44.28 97.03 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.962 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.31 -36.28 62.4 Favored Glycine 0 CA--C 1.51 -0.234 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -32.39 36.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.366 -0.917 . . . . 0.0 110.742 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.1 m -70.53 -17.04 62.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.182 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.7 t -52.25 -33.88 43.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.202 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.0 p -92.2 -34.4 14.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.009 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mp -91.86 -174.01 3.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.023 0.44 . . . . 0.0 111.162 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.5 p -118.54 128.74 54.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.692 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.23 81.18 0.14 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -33.4 11.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.525 0.203 . . . . 0.0 111.316 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -176.82 78.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mp -89.23 7.98 32.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 72.35 18.49 78.26 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -112.63 122.78 48.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.061 0.458 . . . . 0.0 111.741 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.03 20.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.671 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -108.77 99.66 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.21 147.6 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.441 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.88 139.86 40.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.864 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -50.09 127.57 17.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 130.41 -105.11 0.63 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.68 HG13 ' HB2' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.01 131.0 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.447 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 3.7 t30 -71.74 -171.86 0.73 Allowed 'General case' 0 C--O 1.201 -1.482 0 N-CA-C 103.125 -2.917 . . . . 0.0 103.125 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -46.74 82.9 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 114.648 -2.821 . . . . 0.0 109.788 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.72 -41.51 95.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.976 -175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.68 ' HB2' HG13 ' A' ' 133' ' ' VAL . 1.8 mm100 -53.46 -23.24 9.55 Favored 'General case' 0 C--N 1.247 -3.863 0 CA-C-O 121.375 0.607 . . . . 0.0 110.715 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -68.78 -1.4 24.07 Favored Glycine 0 C--O 1.192 -2.521 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 tp -66.58 -50.04 64.4 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.29 1.045 . . . . 0.0 110.902 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.62 -36.15 75.63 Favored Glycine 0 N--CA 1.455 -0.064 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.473 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.0 OUTLIER -70.52 -36.29 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 113.407 -1.396 . . . . 0.0 111.633 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 138' ' ' GLY . 8.0 mt-10 -68.5 -36.46 78.94 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.06 0.933 . . . . 0.0 110.878 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 40.8 mt -68.82 -52.54 33.9 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 113.977 -1.465 . . . . 0.0 110.743 -174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.1 tp -68.17 -45.05 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 121.931 0.872 . . . . 0.0 111.472 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -60.7 -52.03 54.99 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.805 -1.543 . . . . 0.0 113.193 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.2 m -70.87 -40.51 72.23 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.93 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -40.01 69.03 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -176.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -57.84 -30.02 65.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.726 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.82 -51.18 43.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.255 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 70.1 t -60.09 -41.03 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.989 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.25 -35.52 80.63 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -34.42 77.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.08 -38.32 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.532 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -41.03 96.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 110.809 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.76 -31.61 72.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.172 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -54.76 -37.03 65.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.47 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.06 -8.98 41.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.277 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -77.23 107.67 9.79 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.778 0.323 . . . . 0.0 110.57 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -26.12 67.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.681 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -74.15 -176.25 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.64 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 65.73 27.7 11.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.626 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.65 -175.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.525 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -149.94 82.61 1.39 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.591 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.72 141.95 46.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.615 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 127.5 -139.83 11.43 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.55 -104.19 2.69 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.83 135.12 52.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.926 0.393 . . . . 0.0 110.702 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.429 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . -52.47 -44.85 95.28 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.248 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 23.2 Cg_exo -54.53 -46.5 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.377 1.385 . . . . 0.0 111.532 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.12 -35.91 74.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -44.12 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.947 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 172' ' ' ILE . 79.4 mt -58.26 -38.09 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.59 -37.45 93.64 Favored Glycine 0 C--O 1.196 -2.229 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.19 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mp -55.05 -35.66 64.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.65 77.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.3 175.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 27.0 t -73.08 -47.54 47.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.89 69.69 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.363 1.078 . . . . 0.0 109.859 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.268 1.8 tt -70.52 -49.73 45.15 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 124.503 2.097 . . . . 0.0 110.56 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.02 65.55 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 111.114 -2.767 . . . . 0.0 107.487 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.404 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.6 m-70 -70.18 -35.3 73.87 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.537 -1.831 . . . . 0.0 109.403 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.15 -48.11 81.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.112 -177.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.07 -52.55 10.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.453 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -70.41 -52.24 23.76 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.534 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 9.3 mt -55.34 -40.23 56.09 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.805 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -77.56 -35.7 52.89 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.194 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -59.91 -30.42 69.03 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.459 -1.296 . . . . 0.0 110.945 -171.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.272 0.1 OUTLIER -124.37 -26.61 3.89 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.083 -178.754 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.9 -6.11 83.94 Favored Glycine 0 CA--C 1.564 3.103 0 N-CA-C 106.208 -2.757 . . . . 0.0 106.208 -170.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 13.1 t -86.63 132.24 33.94 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.0 161.72 7.75 Favored Glycine 1 N--CA 1.392 -4.235 0 CA-C-N 111.285 -2.689 . . . . 0.0 111.031 178.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -72.29 -40.83 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -83.44 134.3 45.58 Favored Pre-proline 0 N--CA 1.416 -2.139 0 CA-C-N 112.693 -2.048 . . . . 0.0 108.038 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -58.37 -14.58 20.88 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.361 2.041 . . . . 0.0 111.642 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.04 -33.81 61.79 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 123.269 0.356 . . . . 0.0 111.653 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.553 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.49 -37.94 74.29 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.471 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -33.48 65.47 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.489 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.442 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 2.1 m-85 -72.4 -35.08 68.32 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 126.41 1.884 . . . . 0.0 114.452 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.79 -44.48 94.2 Favored Glycine 0 C--N 1.318 -0.453 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.1 p -76.44 -28.31 56.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.131 -1.035 . . . . 0.0 110.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.07 75.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.72 -33.41 59.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 121.268 1.849 . . . . 0.0 110.3 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 56.9 mt -57.8 -60.9 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.417 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.68 179.01 7.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.524 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -59.39 -170.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.572 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -144.07 116.3 8.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.435 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -131.13 -177.79 4.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.716 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.4 p -61.87 -33.95 75.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -57.03 -35.16 68.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.481 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -69.11 -15.96 63.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -70.49 -30.12 66.83 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.797 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 28.9 mm -52.63 -34.87 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 CA-C-O 121.778 0.799 . . . . 0.0 109.067 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.49 -35.29 72.0 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.016 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.35 -48.18 9.96 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 9.6 p -70.0 -47.87 66.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.321 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' A' ' 216' ' ' PRO . . . -55.68 -48.9 68.45 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 112.709 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 215' ' ' GLY . 49.5 Cg_endo -72.11 -31.1 12.59 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.757 1.638 . . . . 0.0 113.72 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -66.26 -37.37 85.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 0.0 111.29 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.584 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 13.2 mt -70.37 -46.68 70.11 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.084 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.449 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -55.42 -46.93 78.8 Favored Glycine 0 C--N 1.363 2.077 0 O-C-N 128.495 3.622 . . . . 0.0 110.996 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -68.41 -40.77 86.7 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.32 -34.8 61.79 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.4 mt -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.203 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -59.01 -39.74 82.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.251 -174.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.45 -49.73 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.885 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -39.53 94.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.709 0.766 . . . . 0.0 109.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mt -55.2 -34.69 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.426 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 33.78 5.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -111.52 -22.58 11.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.783 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.85 96.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.496 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 230' ' ' ILE . 87.5 mt -66.63 122.05 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.568 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 4.0 mt -141.51 82.74 1.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -170.74 165.66 5.0 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.479 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -51.26 127.49 22.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.85 2.367 . . . . 0.0 112.085 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.98 171.68 14.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.4 148.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.581 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.81 156.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.548 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.5 t70 62.6 54.27 2.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.76 134.23 35.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.563 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.3 t -85.73 152.71 22.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.39 151.81 46.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.493 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.38 27.06 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.591 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.84 -27.11 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.575 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -111.37 123.1 49.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.522 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 54.2 t -84.43 -62.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 50.74 -158.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.569 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.4 p -92.11 -54.66 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.555 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 18.3 m 52.76 71.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.636 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -50.38 100.27 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 55.04 -178.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.02 36.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.549 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -137.67 161.64 35.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.622 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -105.05 -45.64 4.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -98.7 31.5 2.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.508 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 59.82 179.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.525 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.53 -60.93 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.571 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.46 -73.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.709 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 50.83 64.74 1.71 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 110.574 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -61.06 2.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.564 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -141.21 129.85 22.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 10.5 mm -85.51 130.02 36.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.583 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.26 104.5 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.653 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.5 m -97.44 127.46 43.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.497 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -114.09 94.87 5.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.593 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 75.85 -7.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 O-C-N 123.692 0.62 . . . . 0.0 111.898 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -73.09 -179.39 3.25 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.586 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 11.0 mtp -100.11 163.54 12.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.64 66.07 0.9 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.601 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.89 -42.42 1.08 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.894 2.396 . . . . 0.0 112.065 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp 56.83 -175.72 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.56 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 62.94 172.99 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.563 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.6 mt -124.75 -26.55 3.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.569 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.14 123.86 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 60.45 166.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.571 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 54.95 85.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.501 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.28 -49.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.44 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 2.7 mp 56.82 86.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.596 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.52 106.27 15.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.582 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -58.6 101.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.601 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 50.34 35.32 10.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.507 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 53.21 73.47 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.641 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 8.7 tp -122.23 122.3 38.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.639 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -109.22 156.59 19.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.48 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.52 -46.12 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . 50.41 -168.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.9 t 59.33 101.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.477 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -104.09 54.25 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -103.5 -45.9 4.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.607 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -81.15 142.99 32.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.594 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -80.79 173.24 12.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -58.62 158.93 7.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.4 35.35 0.42 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.538 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 23.0 m80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.494 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.73 80.04 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.621 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.3 m -115.18 63.84 0.68 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.559 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 57.17 88.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.498 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.92 -33.36 14.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.613 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 108.18 20.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.587 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -84.68 -178.32 6.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.578 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -112.32 -57.61 2.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.536 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mp 61.98 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 56.35 174.42 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.912 0.387 . . . . 0.0 110.728 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -112.79 0.32 15.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.031 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -59.4 -15.97 20.14 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.749 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.1 1.35 17.28 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.502 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.51 -40.16 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.26 -35.91 73.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.629 0 CA-C-N 112.47 -2.15 . . . . 0.0 110.02 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.04 69.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -46.69 62.63 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -33.88 73.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 mt -58.71 -38.17 77.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.107 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 75' ' ' LEU . . . -65.44 -46.79 78.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 112.97 -1.923 . . . . 0.0 114.755 -176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.66 -31.42 59.77 Favored 'General case' 0 C--O 1.208 -1.128 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.525 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -34.98 72.13 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.995 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -45.34 82.63 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.13 -44.71 29.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 29' ' ' ILE . 76.3 t -65.03 -53.72 37.91 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.46 -175.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -53.7 -48.11 69.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -75.68 -29.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.504 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -36.51 69.11 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.6 mm -58.78 -44.49 90.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 113.661 -1.609 . . . . 0.0 109.223 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -36.76 65.7 Favored Glycine 0 C--O 1.226 -0.369 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -67.4 -44.37 79.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.49 -46.13 67.32 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 pp -85.84 -27.12 25.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.171 0.441 . . . . 0.0 111.823 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.72 -37.01 40.91 Favored Glycine 0 C--N 1.317 -0.494 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.445 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.98 -19.05 39.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -9.9 16.45 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.536 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -117.9 119.88 33.28 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 118.532 0.605 . . . . 0.0 110.099 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.92 145.13 78.92 Favored 'Cis proline' 0 N--CA 1.5 1.88 0 C-N-CA 124.699 -0.959 . . . . 0.0 112.09 -0.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 p -82.62 151.36 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.13 131.46 6.75 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -147.92 132.7 17.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 0.0 110.554 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -107.23 28.87 7.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.92 -164.22 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.526 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 t -100.66 10.51 41.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.72 145.21 48.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.78 0.324 . . . . 0.0 110.434 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.0 m -137.66 128.53 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.776 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -102.41 106.26 16.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.741 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.56 163.3 13.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.3 0.571 . . . . 0.0 111.56 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.72 -28.32 5.92 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.884 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.29 -32.29 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -53.96 37.65 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.6 t -68.15 -37.34 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.451 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 m -68.58 -41.15 80.08 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.985 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.55 -31.43 72.47 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.655 -1.612 . . . . 0.0 106.916 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.86 95.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.458 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 24' ' ' PHE . 3.6 t80 -66.03 -43.22 88.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.52 92.0 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.074 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.5 mp -68.6 -43.81 75.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.525 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 t -59.84 -36.69 77.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -34.37 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.663 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.66 -45.55 93.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.363 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 p -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.79 -42.91 72.35 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.33 72.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.97 -1.923 . . . . 0.0 110.914 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -67.02 -45.97 75.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.5 p -59.14 -12.37 5.01 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.932 1.242 . . . . 0.0 112.387 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.02 -42.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 0.0 111.29 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.24 159.16 8.08 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -57.41 -23.13 47.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.783 0.325 . . . . 0.0 111.43 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.76 7.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.46 135.66 53.41 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.618 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.12 -154.2 24.41 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.52 85.87 1.16 Allowed 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.183 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.97 -19.64 62.52 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.5 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 1.1 pp -80.46 -17.64 51.09 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.42 -1.718 . . . . 0.0 112.497 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -111.05 135.95 20.84 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.58 -22.87 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 123.441 2.761 . . . . 0.0 111.676 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.43 78.11 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -66.22 -36.84 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.753 0.311 . . . . 0.0 111.158 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 m -65.68 -28.63 69.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -43.82 82.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.92 0.39 . . . . 0.0 110.175 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.95 -39.64 97.82 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 tp -53.47 -57.54 10.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.088 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.47 -67.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.57 -31.75 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.633 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -91.58 179.19 5.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.2 m 54.31 -168.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.53 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -64.69 163.83 13.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.614 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pt -133.38 83.73 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.526 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.4 m -158.71 40.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.602 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pp -155.15 162.68 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.638 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -131.75 23.47 4.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.777 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -68.6 -35.95 78.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.14 78.2 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.09 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.69 -38.49 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -40.01 68.05 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.84 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -61.16 -37.63 83.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.357 0.98 . . . . 0.0 109.443 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.29 -44.38 88.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.903 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.3 mt -70.59 -37.78 71.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.2 72.81 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.56 -35.7 70.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -35.96 71.93 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.8 -35.47 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.153 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.68 -44.32 91.36 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 121.102 1.774 . . . . 0.0 113.38 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.74 -36.19 75.61 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.79 -42.59 86.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.821 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.9 -37.41 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.219 0.533 . . . . 0.0 110.068 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.78 75.29 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.318 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -67.75 -37.03 81.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.801 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.73 85.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.659 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.1 tt -69.18 -37.19 75.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.11 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.0 -24.09 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.87 0.367 . . . . 0.0 111.511 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 m -60.43 -44.21 96.01 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.503 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.37 61.26 Favored Glycine 0 CA--C 1.511 -0.215 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.95 32.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.849 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m -65.19 -21.48 66.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 97.1 p -52.27 -36.55 52.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.893 0.378 . . . . 0.0 110.249 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.15 -34.26 14.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.43 -174.17 4.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.818 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.44 126.88 52.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.62 81.48 0.11 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.01 -35.23 10.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.625 0.25 . . . . 0.0 111.173 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.9 t 177.92 86.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.759 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mp -88.43 8.03 29.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.283 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.4 16.51 80.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.62 124.34 52.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.608 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.6 m120 51.85 23.31 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.275 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.3 95.14 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.716 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.45 144.51 57.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.318 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.02 140.03 40.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.649 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -49.63 127.5 15.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.26 -105.48 0.6 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.641 HG12 ' HB2' ' A' ' 137' ' ' GLN . 1.1 t -85.94 126.82 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.45 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.58 -171.94 0.72 Allowed 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 176.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 m -62.39 -46.76 87.14 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 114.669 -2.812 . . . . 0.0 110.306 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.16 96.47 Favored Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.267 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.641 ' HB2' HG12 ' A' ' 133' ' ' VAL . 4.0 mt-30 -53.24 -23.42 8.73 Favored 'General case' 0 C--N 1.249 -3.778 0 CA-C-N 114.792 -0.704 . . . . 0.0 110.503 -176.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.482 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.87 -1.76 13.69 Favored Glycine 0 C--O 1.188 -2.736 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.9 -50.47 64.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 119.123 1.461 . . . . 0.0 110.743 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.87 -40.16 74.97 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.482 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.8 OUTLIER -68.85 -36.34 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 113.209 -1.495 . . . . 0.0 112.267 -177.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 77.1 mt-10 -68.54 -36.21 78.5 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-O 121.736 0.779 . . . . 0.0 110.569 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 38.3 mt -70.06 -41.9 79.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.437 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.2 mm -68.53 -48.84 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 122.389 1.09 . . . . 0.0 111.198 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.55 -46.9 93.21 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-N 112.841 -1.981 . . . . 0.0 112.966 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 76.2 m -70.93 -47.64 57.91 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 113.77 -1.215 . . . . 0.0 112.47 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.47 -40.45 68.46 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.252 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.6 pt20 -57.97 -31.28 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.82 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.8 tp -68.89 -52.21 31.92 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.596 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.14 -41.02 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -35.55 81.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 111.349 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -41.11 93.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.851 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 m -72.05 -38.37 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.52 -48.08 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.985 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.68 71.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.64 -36.93 82.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.464 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.7 t -92.82 -8.76 42.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.224 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -70.26 135.59 49.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.888 0.375 . . . . 0.0 110.517 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -63.3 -26.46 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.541 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.12 106.05 5.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.525 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 161.33 17.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.561 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -143.26 -37.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.17 133.78 47.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.499 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.56 141.7 28.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.393 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.69 -166.7 51.37 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 60.44 162.6 0.13 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.9 136.92 50.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.619 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.438 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . -52.37 -45.16 95.09 Favored Pre-proline 0 C--O 1.218 -0.571 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.808 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 35.3 Cg_exo -54.35 -44.3 50.69 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.738 1.625 . . . . 0.0 112.223 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 mp -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.302 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.33 56.59 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.006 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.5 pt -58.93 -35.96 59.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.61 93.6 Favored Glycine 0 C--O 1.198 -2.107 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.495 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.15 -36.37 65.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 -34.47 77.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.603 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.2 t -72.89 -47.24 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -175.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.82 94.97 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 122.054 0.93 . . . . 0.0 108.727 -176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.257 3.6 mt -58.29 -47.12 84.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.937 178.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.9 66.19 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.088 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.506 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 1.1 t60 -67.84 -34.79 77.39 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 112.926 -1.637 . . . . 0.0 109.789 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -64.66 -47.64 77.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.389 -176.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.96 -51.64 13.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.54 -51.24 37.39 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 188' ' ' GLY . 1.7 mp -66.78 -49.27 75.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.869 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -35.73 81.66 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 115.377 -2.529 . . . . 0.0 112.367 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.88 -31.28 69.64 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.524 -170.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.301 0.1 OUTLIER -124.32 -26.87 3.87 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.387 1.089 . . . . 0.0 113.332 -179.032 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 86.75 -5.78 84.17 Favored Glycine 0 CA--C 1.566 3.264 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 59.9 m -83.64 132.29 34.9 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -54.33 155.59 7.61 Favored Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.869 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -32.99 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 174.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -92.74 139.68 23.54 Favored Pre-proline 0 N--CA 1.42 -1.967 0 CA-C-N 113.321 -1.763 . . . . 0.0 107.234 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -64.47 -14.55 44.91 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.64 1.56 . . . . 0.0 111.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.14 -33.88 61.59 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.248 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.528 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.37 -39.11 78.24 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.0 t -73.18 -34.28 65.91 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.816 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.449 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 3.8 t80 -72.22 -35.4 68.87 Favored 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 126.315 1.846 . . . . 0.0 114.506 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.73 -46.19 92.54 Favored Glycine 0 C--N 1.319 -0.376 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.43 -28.29 56.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.281 -0.959 . . . . 0.0 110.379 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -64.65 -33.89 77.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.607 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.3 -31.17 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 120.939 1.699 . . . . 0.0 110.589 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.95 76.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.768 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.1 p 47.7 -163.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.784 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 60.37 41.82 15.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.611 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -94.76 97.66 10.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.518 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.16 174.78 10.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.506 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.4 p -65.01 -35.9 82.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -35.06 66.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -19.03 61.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.204 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -61.29 -20.16 62.58 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.256 0.348 . . . . 0.0 111.626 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 9.5 mm -52.63 -34.59 19.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -25.09 61.59 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.298 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -84.64 -42.35 15.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.02 -45.47 27.38 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.23 -44.87 84.27 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.531 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.3 Cg_endo -71.49 -28.68 17.46 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.491 2.128 . . . . 0.0 113.084 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -77.2 -31.99 55.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.195 0.521 . . . . 0.0 111.893 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.0 mm -70.7 -46.37 69.52 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.34 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.303 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.416 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -68.11 -46.78 63.25 Favored Glycine 0 C--N 1.357 1.733 0 O-C-N 128.5 3.625 . . . . 0.0 111.838 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.34 -48.91 35.05 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 118.067 -2.016 . . . . 0.0 109.835 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.78 68.45 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.554 0.692 . . . . 0.0 109.562 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -68.13 -30.98 70.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.292 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.8 82.83 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.8 t -58.06 -49.59 80.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.267 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -39.54 93.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.799 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -34.74 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -133.93 47.19 2.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.818 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -92.2 112.6 24.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.663 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -48.73 -42.14 34.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.655 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.29 118.69 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.629 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.76 -47.04 51.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.622 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . 177.81 -55.76 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.254 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.99 150.54 0.89 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.161 1.907 . . . . 0.0 112.248 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -29.22 18.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.526 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.8 t 58.33 100.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.54 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.48 -67.08 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.576 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.72 117.11 29.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.534 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.99 143.71 41.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.477 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.22 -30.54 5.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.552 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.91 46.65 13.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.597 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -60.74 -27.3 67.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.501 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.48 155.43 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.517 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.97 145.16 29.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.599 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.36 -27.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.594 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -139.62 121.88 15.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.93 128.62 15.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.1 p -107.81 98.92 8.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.595 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 128.35 145.39 6.03 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -119.72 33.66 5.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.382 . . . . 0.0 110.574 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.08 82.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -103.11 149.3 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.522 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.58 -66.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.573 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -161.34 80.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.475 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.2 161.04 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.5 pp -166.25 155.88 11.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.57 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.23 156.33 44.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.612 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -87.43 145.42 26.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.573 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 65.76 126.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.64 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.18 -61.24 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.37 137.24 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.508 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.43 -38.49 1.35 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.507 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.9 m -103.61 -168.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.514 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 70.26 -70.62 0.14 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.3 m -94.95 139.86 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.79 0.328 . . . . 0.0 110.608 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -66.21 162.6 19.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.512 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.91 145.88 48.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.669 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 164.96 14.04 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.533 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -52.03 104.76 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.688 2.259 . . . . 0.0 112.023 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -91.99 145.26 24.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.553 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -151.09 105.01 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.594 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.7 tp -119.53 119.56 34.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.589 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -155.4 152.72 29.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.462 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -96.01 152.93 18.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.2 85.49 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.593 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.27 149.39 25.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.521 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.97 -177.42 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.608 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 5.3 p 46.29 65.97 1.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.933 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -92.79 173.66 7.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 69.96 -70.95 0.13 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -166.11 -49.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.53 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 30.7 mt -129.98 -42.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.528 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.6 t30 70.1 -70.89 0.14 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.2 m -102.68 163.9 11.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.598 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -113.99 -62.35 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.603 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 32.4 m -64.76 157.54 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.83 79.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.46 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.46 -175.3 2.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.539 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -100.41 176.77 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.597 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.13 -73.35 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.565 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.0 176.37 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.526 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -122.34 -43.61 2.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.59 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 117.857 -1.068 . . . . 0.0 110.62 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mtt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.26 50.61 1.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -30.13 29.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.544 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -117.18 112.1 20.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.613 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -57.3 168.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -160.21 110.19 1.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.512 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -34.59 69.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.601 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 114.29 15.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.58 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.12 -54.24 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.678 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 54.31 24.08 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.495 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.71 -16.37 19.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -81.4 9.37 7.38 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.086 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.4 -14.31 5.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.452 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -39.89 87.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 5.9 p -68.66 -36.07 72.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.592 176.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.69 -35.35 70.49 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.95 -46.48 62.34 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -33.79 74.34 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 8.0 mt -58.77 -38.16 77.88 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.884 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 75' ' ' LEU . . . -65.68 -46.51 78.8 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.567 -2.106 . . . . 0.0 114.581 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.81 -31.63 61.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.208 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.2 -38.39 69.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.783 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -45.01 84.21 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -52.52 9.14 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 29' ' ' ILE . 1.5 m -65.64 -40.3 87.54 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 O-C-N 124.031 0.832 . . . . 0.0 112.802 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -54.18 -50.35 67.24 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.539 0.685 . . . . 0.0 111.908 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -29.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.531 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.24 -36.24 68.28 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -175.092 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 25' ' ' VAL . 4.1 mm -59.7 -40.05 81.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.086 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -36.88 64.69 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.8 m -67.5 -38.87 84.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.41 -46.21 67.37 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.78 -29.92 23.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -75.86 -36.05 43.22 Favored Glycine 0 C--N 1.319 -0.374 0 CA-C-O 119.54 -0.589 . . . . 0.0 112.962 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -18.56 35.83 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.319 -1.352 . . . . 0.0 107.511 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.57 -10.0 16.37 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.348 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' A' ' 34' ' ' GLY . 23.5 m-85 -129.83 123.64 21.17 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.241 0.473 . . . . 0.0 110.262 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.09 137.65 49.53 Favored 'Cis proline' 0 N--CA 1.497 1.685 0 C-N-CA 124.675 -0.969 . . . . 0.0 112.104 -0.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.94 149.64 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.553 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.79 150.44 22.52 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -27.85 14.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.757 0.313 . . . . 0.0 110.487 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.83 -162.25 0.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.525 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.19 148.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -94.08 -28.86 15.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.776 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.31 139.06 55.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.5 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.99 154.44 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.751 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -106.52 111.68 24.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.497 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -114.17 163.01 15.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.283 0.563 . . . . 0.0 110.94 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -49.73 -28.78 6.57 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.801 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.28 -38.37 61.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.726 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -64.8 -53.56 45.09 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.6 t -66.77 -50.06 68.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.416 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -66.53 -39.07 88.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.358 0.412 . . . . 0.0 110.004 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.85 -31.92 73.03 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.46 94.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.265 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -66.12 -42.44 89.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.42 -43.3 96.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.08 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.33 -43.66 81.03 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.547 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -36.58 74.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.98 -34.1 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.369 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.235 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.7 p -68.96 -31.7 70.75 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -40.58 71.78 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.94 -44.16 73.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.151 -1.841 . . . . 0.0 109.468 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -66.78 -38.47 86.62 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.8 m -59.61 -12.13 6.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 120.058 1.299 . . . . 0.0 111.415 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -42.83 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.697 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.06 168.4 12.83 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -66.0 -23.09 66.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -75.95 7.13 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.79 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 m -124.43 135.64 53.42 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.139 0.495 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -151.84 20.45 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.27 85.89 1.08 Allowed 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.441 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.39 61.91 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.555 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 2.1 pp -87.05 8.53 23.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.375 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.04 129.08 20.88 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.64 -20.49 4.66 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.773 2.315 . . . . 0.0 111.397 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.16 -50.94 62.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.7 -36.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.678 0.275 . . . . 0.0 111.57 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.0 m -64.91 -28.62 69.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -35.4 76.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.376 . . . . 0.0 110.55 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.53 -37.07 84.89 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.671 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -44.41 96.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.456 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 -43.03 77.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 100.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.5 p 177.16 99.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.488 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 65.51 -166.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.579 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.47 -69.34 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.524 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.0 mt 49.65 87.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.656 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.81 113.0 17.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 61.5 mt 62.22 153.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.515 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -176.69 177.66 1.35 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 110.903 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.73 -35.83 75.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.851 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.14 79.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.451 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.91 -38.53 67.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 ttt -73.27 -35.1 66.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.945 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -64.96 -37.53 87.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 119.523 1.056 . . . . 0.0 109.135 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -46.53 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.656 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.0 mm -67.7 -37.84 79.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.678 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.01 -47.06 86.49 Favored 'General case' 0 C--O 1.206 -1.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -71.24 -36.05 71.68 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.415 ' O ' HG13 ' A' ' 106' ' ' ILE . 3.8 t -57.87 -36.16 71.97 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.38 -35.19 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.645 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.51 -47.78 81.27 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.733 1.606 . . . . 0.0 112.586 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.452 ' HA ' HG23 ' A' ' 25' ' ' VAL . . . -69.88 -36.16 75.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 102' ' ' CYS . 79.3 mt -63.92 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.048 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.14 -37.42 71.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.425 0.631 . . . . 0.0 110.038 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.95 74.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.301 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 t -70.3 -36.94 74.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.2 -43.75 87.77 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.013 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.2 mm -69.24 -37.33 75.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.243 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.85 -24.49 66.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.512 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.2 t -62.76 -34.96 78.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.248 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.09 -36.16 60.81 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 4.2 mt -57.28 -40.83 76.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.624 -0.788 . . . . 0.0 110.538 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p -89.09 5.41 44.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.795 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.9 t -52.15 -30.17 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.292 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.3 m -92.2 -32.32 15.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.91 -174.44 3.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.1 p -118.39 135.65 54.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.621 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.74 83.2 0.09 OUTLIER Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.19 -20.58 17.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.749 -0.225 . . . . 0.0 111.544 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 p -161.7 49.37 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.062 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.9 7.77 32.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.081 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.09 15.62 81.01 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -112.6 120.11 40.46 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.925 0.393 . . . . 0.0 111.295 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 t30 51.83 23.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.25 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.88 84.7 2.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.419 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.65 144.9 56.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.489 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.91 139.65 40.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.136 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.77 127.67 18.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.3 -103.19 0.58 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.649 HG12 ' HB2' ' A' ' 137' ' ' GLN . 2.0 t -86.0 122.38 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.442 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.56 -171.8 0.69 Allowed 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -46.81 88.11 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 114.919 -2.712 . . . . 0.0 110.152 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.83 -41.67 96.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.157 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.649 ' HB2' HG12 ' A' ' 133' ' ' VAL . 24.0 mm100 -53.17 -23.43 8.36 Favored 'General case' 0 C--N 1.252 -3.661 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.232 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.05 -1.69 10.59 Favored Glycine 0 C--O 1.187 -2.796 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -50.5 65.54 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 119.17 1.485 . . . . 0.0 111.004 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.75 -40.13 76.21 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.505 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.7 OUTLIER -67.43 -38.19 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 113.051 -1.575 . . . . 0.0 112.13 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 138' ' ' GLY . 24.0 mt-10 -68.61 -36.53 78.8 Favored 'General case' 0 C--O 1.196 -1.728 0 CA-C-O 121.987 0.899 . . . . 0.0 110.872 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.5 mt -68.35 -43.62 84.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.421 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.154 -174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -68.4 -49.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 122.264 1.031 . . . . 0.0 111.671 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.26 -48.38 86.26 Favored Glycine 0 C--O 1.218 -0.866 0 CA-C-N 113.087 -1.869 . . . . 0.0 113.038 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.8 m -70.79 -45.29 64.93 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 113.97 -1.115 . . . . 0.0 112.175 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.0 tp -54.51 -40.59 68.73 Favored 'General case' 0 CA--C 1.487 -1.464 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.22 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.0 pt20 -59.33 -30.85 68.66 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.1 tp -68.88 -51.22 42.52 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.261 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.4 t -60.83 -41.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.976 . . . . 0.0 113.28 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.18 -35.65 81.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.563 0.22 . . . . 0.0 111.512 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.21 -35.04 78.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.038 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.19 -38.44 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.591 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tt -64.04 -43.57 95.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.78 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.69 -31.54 72.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.561 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -54.86 -36.71 65.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.402 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.91 -8.82 48.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.336 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -68.47 123.98 22.3 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.629 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -59.03 -26.4 64.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.601 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -65.8 111.35 3.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.476 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -65.09 158.0 27.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.609 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.72 -26.27 8.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.567 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.54 167.17 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.667 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.63 97.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.558 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 151.46 -124.58 1.71 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -167.88 -89.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.39 139.04 48.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.922 0.392 . . . . 0.0 110.691 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.431 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . -52.39 -45.37 95.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.017 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 23.0 Cg_exo -54.57 -46.48 33.11 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.57 1.514 . . . . 0.0 111.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.9 -36.14 78.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.271 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -45.02 63.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.275 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.26 -38.42 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.52 93.62 Favored Glycine 0 C--O 1.195 -2.293 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.164 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.21 -35.56 65.01 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -34.24 76.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.928 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 20.6 t -72.59 -47.31 51.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.26 -29.9 66.8 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.577 1.179 . . . . 0.0 110.182 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.267 9.3 mt -70.65 -49.18 50.19 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 124.711 2.196 . . . . 0.0 109.515 178.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.85 66.07 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 110.328 -3.124 . . . . 0.0 107.822 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.436 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -70.39 -35.22 73.34 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.041 -1.579 . . . . 0.0 109.727 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.72 -48.21 81.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.139 -177.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.54 -52.25 11.06 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.451 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.97 -51.68 30.56 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 188' ' ' GLY . 7.4 mt -60.58 -49.11 85.71 Favored 'Isoleucine or valine' 0 C--O 1.175 -2.862 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.538 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -35.67 76.59 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 116.741 -1.983 . . . . 0.0 113.502 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.02 -29.16 68.31 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.652 -171.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.285 0.1 OUTLIER -124.32 -26.65 3.91 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.181 0.991 . . . . 0.0 113.076 -179.167 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.56 -5.9 84.26 Favored Glycine 0 CA--C 1.565 3.163 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 -170.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.403 ' SG ' ' CE2' ' A' ' 212' ' ' PHE . 92.1 m -88.08 130.74 34.91 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -56.22 154.71 14.71 Favored Glycine 0 N--CA 1.397 -3.924 0 CA-C-N 111.174 -2.739 . . . . 0.0 112.538 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -27.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.49 135.11 29.79 Favored Pre-proline 0 N--CA 1.414 -2.25 0 CA-C-N 112.74 -2.027 . . . . 0.0 108.25 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -66.09 -17.36 54.86 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.986 1.791 . . . . 0.0 110.587 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.26 -35.37 61.39 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.431 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 29.3 tpt85 -70.62 -40.2 73.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.523 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.3 m -73.23 -38.19 66.13 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.442 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 12.4 t80 -72.25 -34.88 68.58 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 126.945 2.098 . . . . 0.0 114.596 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.62 -47.12 90.61 Favored Glycine 0 C--N 1.315 -0.592 0 N-CA-C 107.069 -2.412 . . . . 0.0 107.069 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -28.21 56.65 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.565 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -64.23 -34.1 77.32 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.412 -0.804 . . . . 0.0 112.843 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.66 -31.14 49.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 120.971 1.714 . . . . 0.0 110.803 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.0 mt -74.39 -32.32 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.927 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.9 m -146.75 66.7 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.55 156.7 38.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.502 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -131.0 -177.65 4.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.791 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -64.67 -147.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.252 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -21.04 4.51 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -55.15 -35.08 64.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.829 0.347 . . . . 0.0 110.382 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -22.32 60.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.275 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -69.79 -25.41 63.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.963 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.68 -34.61 19.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.728 0.775 . . . . 0.0 109.076 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . 0.444 ' N ' ' CD2' ' A' ' 212' ' ' PHE . 6.3 m-30 -58.27 -41.51 84.46 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.381 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.14 -33.64 24.22 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.8 -47.73 42.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.415 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.15 -48.52 67.76 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.111 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 17.3 Cg_endo -71.61 -28.67 17.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.145 1.896 . . . . 0.0 113.744 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -73.48 -30.65 63.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.304 0.574 . . . . 0.0 111.268 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.556 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 46.3 mt -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.483 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.376 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -66.57 -46.25 78.17 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 128.473 3.608 . . . . 0.0 111.896 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.42 -48.89 34.6 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 118.562 -1.78 . . . . 0.0 110.112 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -39.02 68.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.671 0.748 . . . . 0.0 109.513 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -68.03 -31.07 70.49 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.348 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.51 81.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.11 -49.59 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.962 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.06 -39.44 89.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.693 0.758 . . . . 0.0 109.532 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 mp -57.39 -34.61 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.703 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.19 80.82 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.77 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -174.73 61.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.526 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -62.11 162.34 9.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 mt -102.27 111.6 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.487 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.17 20.74 4.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . 49.15 72.62 1.2 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.617 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -71.13 114.61 3.97 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.801 2.334 . . . . 0.0 112.049 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -63.2 -77.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.23 133.58 34.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.606 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 71.7 m -73.54 146.19 44.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.468 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -54.48 159.79 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.51 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.32 161.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.1 p -108.69 93.22 4.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.614 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.34 -29.76 60.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.62 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -79.8 157.58 27.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.481 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.76 143.02 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.533 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.6 mttp 179.17 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.2 p -75.05 -27.14 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.499 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -94.58 -5.2 46.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.582 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.16 115.55 25.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.513 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.3 t -160.35 152.81 20.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.552 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 65.68 -172.52 23.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -128.4 -48.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.755 0.312 . . . . 0.0 110.532 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 53.7 t -114.88 -51.77 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.628 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -172.21 138.97 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.609 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.02 -58.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.55 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 65.6 138.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.595 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.65 -38.57 72.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.588 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -50.52 67.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.575 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.8 174.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.597 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.18 167.0 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.523 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -130.97 -179.31 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.541 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.53 138.21 44.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 7.5 tt -102.91 -26.6 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.517 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.79 -74.75 0.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.5 p -176.63 99.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.636 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -116.43 -50.95 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.568 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.34 135.11 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -125.57 104.89 8.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.586 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 3.1 mtm -106.68 31.8 4.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.543 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -130.14 165.03 36.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.465 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.38 -177.39 3.8 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.807 2.338 . . . . 0.0 112.154 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -87.3 -26.46 23.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.46 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -146.86 131.68 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.509 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 2.0 tp -69.87 111.97 5.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.611 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 58.15 95.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.44 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -90.22 134.8 34.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.597 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.98 174.96 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.588 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 59.02 167.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 12.4 pt -59.23 -25.83 31.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.621 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.4 100.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.551 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -61.33 113.77 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.639 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -131.05 85.82 2.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.566 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.14 167.08 22.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.565 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 131.02 43.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.594 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.79 -55.0 2.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.527 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.1 m -94.03 -50.94 5.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.686 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . 54.91 24.87 6.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.635 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.12 -22.8 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.85 -169.45 0.2 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.588 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 41.9 m170 60.55 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.01 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.44 -174.5 0.12 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.779 0.324 . . . . 0.0 110.57 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 60.81 27.63 17.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.566 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -135.52 33.51 3.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -112.99 105.1 13.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.584 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.586 179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.01 -177.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.657 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 t 54.04 87.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.593 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.18 92.06 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.477 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.05 29.52 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.623 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -127.53 88.22 2.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.538 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -116.6 102.62 9.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.611 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -64.75 169.11 5.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.642 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.66 88.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.612 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -174.29 155.24 2.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.431 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.8 m95 73.76 -58.96 0.57 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.695 0.622 . . . . 0.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -58.94 -13.31 6.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.308 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.72 -8.54 12.64 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.295 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.76 -40.31 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.55 -35.83 72.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 CA-C-N 112.807 -1.997 . . . . 0.0 110.696 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.51 -35.1 69.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -70.82 -46.6 62.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.17 -33.72 70.28 Favored 'General case' 0 C--O 1.212 -0.912 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.73 -38.29 78.03 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 112.284 -2.234 . . . . 0.0 109.461 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.01 -46.63 80.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.232 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.34 -31.14 62.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.61 -177.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -40.82 67.3 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.149 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.94 -45.04 83.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -52.59 9.1 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.66 -43.96 93.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.185 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.432 ' O ' HG12 ' A' ' 29' ' ' ILE . 53.0 t80 -54.13 -50.23 67.39 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.927 0.785 . . . . 0.0 112.135 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -29.16 20.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.705 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.4 -36.33 68.79 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -175.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 25' ' ' VAL . 4.2 mm -58.91 -39.94 79.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.544 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.68 63.74 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -67.35 -38.06 84.22 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.68 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.53 -46.42 66.53 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.72 -30.0 23.48 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.05 -36.49 40.77 Favored Glycine 0 C--N 1.317 -0.508 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.813 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.02 -19.53 44.66 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 118.507 -1.277 . . . . 0.0 107.669 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -10.01 16.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.148 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' A' ' 34' ' ' GLY . 19.3 t80 -123.64 119.92 26.96 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 118.216 0.462 . . . . 0.0 110.166 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.95 152.03 76.09 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 119.922 1.008 . . . . 0.0 111.469 -1.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -82.69 135.73 24.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.461 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.81 161.93 39.36 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -152.09 -40.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 110.504 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -126.41 -28.66 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.533 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -61.47 162.48 8.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.484 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 t -101.81 10.59 39.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.56 128.67 35.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.801 0.334 . . . . 0.0 110.55 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.7 p -125.67 136.53 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.512 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -104.35 128.76 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.495 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -114.14 162.95 15.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.126 0.488 . . . . 0.0 110.898 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.54 -28.73 14.61 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 p -61.04 -33.45 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -64.94 -54.12 35.68 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.601 1.091 . . . . 0.0 112.978 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.18 -40.56 83.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.599 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.6 m -69.31 -40.51 77.61 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -31.81 72.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.21 -39.52 94.14 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.969 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -66.01 -46.97 76.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.55 -45.84 93.74 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.278 -0.419 . . . . 0.0 114.005 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tp -66.32 -43.83 85.12 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.107 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -58.74 -36.74 74.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -34.0 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.496 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.7 -45.59 82.2 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.506 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -68.94 -32.07 71.42 Favored 'General case' 0 CA--C 1.469 -2.165 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.61 -40.44 72.11 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.87 -44.11 73.98 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.453 173.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -38.31 86.31 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -59.63 -12.29 6.5 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 119.889 1.222 . . . . 0.0 111.579 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -42.87 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 0.0 111.428 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.12 178.9 21.06 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -22.96 62.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.832 0.348 . . . . 0.0 111.133 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -72.69 7.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.306 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.6 m -124.32 135.51 53.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.279 0.561 . . . . 0.0 111.623 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.13 -140.62 8.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.53 85.88 1.16 Allowed 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.368 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -19.63 59.1 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.74 8.35 32.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.089 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -148.26 144.15 18.38 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 121.145 1.793 . . . . 0.0 114.222 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.51 -21.89 4.09 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 124.035 3.157 . . . . 0.0 112.943 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.22 -45.8 90.16 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.3 m -66.46 -38.16 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.4 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -29.96 70.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mt -60.23 -36.05 76.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.8 -48.92 31.75 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.737 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -14.79 62.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tt -62.22 -60.32 3.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.72 33.64 3.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.047 0.451 . . . . 0.0 110.878 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 t -83.17 -27.25 30.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.445 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.2 -42.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.47 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.26 -174.72 5.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.2 mm -133.88 -76.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.649 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.7 t -62.7 -77.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.732 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 66.57 140.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.492 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -127.44 -29.48 2.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -65.37 -35.81 82.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.612 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.41 -35.18 80.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.87 -38.73 67.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 tpp -73.33 -31.64 64.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.043 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -65.01 -44.24 89.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 118.777 0.717 . . . . 0.0 111.142 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -41.22 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.5 mt -70.38 -42.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.28 69.07 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -35.81 70.67 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.7 t -57.99 -36.14 72.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.3 -35.25 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.314 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.39 -47.54 82.2 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 120.908 1.685 . . . . 0.0 112.833 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.92 -35.98 74.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 mm -66.05 -50.34 70.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.32 -36.97 77.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.148 0.499 . . . . 0.0 109.757 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.68 75.26 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.556 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -64.68 -37.0 86.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.643 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.65 85.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.124 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.99 -37.33 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.681 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -24.61 67.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.645 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -38.98 88.06 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.423 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.0 -36.17 60.33 Favored Glycine 0 CA--C 1.511 -0.199 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 4.4 mt -54.14 -36.87 33.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.703 -0.749 . . . . 0.0 111.057 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.14 -14.91 54.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.555 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.2 m -52.33 -45.17 65.52 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.18 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -35.12 14.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 mp -81.48 -179.92 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.8 p -118.34 125.33 49.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.697 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.2 84.66 0.06 OUTLIER Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -98.09 -35.32 10.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.575 0.226 . . . . 0.0 111.175 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 t 179.27 83.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 0.0 111.03 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.09 7.9 32.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.887 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.05 78.27 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -112.6 124.38 52.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.024 0.44 . . . . 0.0 111.337 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 51.97 20.6 1.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.405 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -112.37 92.21 3.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.12 148.42 47.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.057 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.33 138.64 40.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.585 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -49.59 127.6 15.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.71 -105.18 0.66 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.682 HG11 ' HB2' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.16 131.92 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.451 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 -171.98 0.76 Allowed 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 176.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -46.73 81.39 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 114.52 -2.872 . . . . 0.0 109.883 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.93 -41.46 96.28 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.285 -0.96 . . . . 0.0 110.954 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.682 ' HB2' HG11 ' A' ' 133' ' ' VAL . 7.3 mm-40 -53.45 -23.41 9.98 Favored 'General case' 0 C--N 1.248 -3.838 0 CA-C-O 121.443 0.64 . . . . 0.0 110.61 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -69.61 -1.56 30.91 Favored Glycine 0 C--O 1.185 -2.913 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.54 -50.23 63.85 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 118.394 1.097 . . . . 0.0 111.146 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.53 -35.71 75.52 Favored Glycine 0 C--O 1.229 -0.163 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.461 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.1 OUTLIER -71.54 -36.04 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 113.239 -1.48 . . . . 0.0 111.845 -178.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' GLY . 7.9 mt-10 -68.42 -36.38 78.98 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 122.047 0.927 . . . . 0.0 110.863 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 41.2 mt -70.5 -50.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.923 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.25 -43.65 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.062 0.935 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.425 ' O ' ' CG ' ' A' ' 148' ' ' GLN . . . -62.35 -51.7 54.57 Favored Glycine 0 C--O 1.205 -1.663 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.237 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.1 m -70.01 -35.23 74.21 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.796 0.808 . . . . 0.0 110.363 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tp -54.87 -40.15 69.43 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -57.91 -33.35 68.67 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.949 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.477 ' N ' ' HG3' ' A' ' 148' ' ' GLN . 2.3 tp -68.89 -47.08 66.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.972 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.23 -41.02 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.76 -45.63 85.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 21.3 p -64.28 -28.44 69.72 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.704 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.01 -38.54 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.8 mt -65.89 -35.95 82.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.14 80.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.231 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.8 t -65.3 -36.83 85.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.677 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.8 m -83.35 -8.74 59.37 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.021 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 139.06 33.24 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.1 ttm-85 -85.79 -37.77 18.91 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.22 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 39.68 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.709 0.631 . . . . 0.0 111.197 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -102.51 138.03 39.96 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 65.78 -165.8 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.441 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.1 175.87 9.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.98 -165.64 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.54 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -120.51 -179.62 16.31 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 64.82 -174.88 13.86 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.81 123.69 46.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.547 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.438 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . -52.26 -45.62 94.36 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.621 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 28.0 Cg_exo -54.63 -38.27 90.89 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.557 1.505 . . . . 0.0 111.878 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 62.0 mt -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.035 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.63 -46.95 57.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.087 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.08 -42.05 82.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 121.546 0.688 . . . . 0.0 109.692 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.74 -37.63 93.65 Favored Glycine 0 C--O 1.195 -2.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.131 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.15 -35.53 64.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -34.43 77.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.821 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.5 t -72.01 -47.06 56.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.58 74.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.124 0.964 . . . . 0.0 110.131 -174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.276 4.3 mt -69.16 -52.94 23.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 125.293 2.473 . . . . 0.0 110.918 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.51 62.57 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 110.01 -3.268 . . . . 0.0 106.58 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.417 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 2.6 m80 -70.08 -34.88 73.71 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.756 -1.722 . . . . 0.0 110.081 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -56.84 -47.69 79.77 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.369 -178.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.66 -51.56 14.06 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.476 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.38 -52.07 30.56 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 188' ' ' GLY . 1.5 mp -56.65 -49.14 79.21 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.032 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.504 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -35.82 74.45 Favored 'General case' 0 C--N 1.277 -2.564 0 C-N-CA 115.998 -2.281 . . . . 0.0 113.067 -175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -60.18 -29.47 68.72 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.316 -171.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.276 0.1 OUTLIER -124.27 -26.95 3.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.199 1.0 . . . . 0.0 113.269 -178.744 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 88.48 -5.89 84.2 Favored Glycine 0 CA--C 1.564 3.102 0 N-CA-C 105.981 -2.848 . . . . 0.0 105.981 -170.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 17.4 t -84.45 129.47 34.86 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 123.601 1.667 . . . . 0.0 106.588 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.427 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -50.02 161.84 0.96 Allowed Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 110.659 -2.973 . . . . 0.0 112.465 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.53 -42.71 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -87.05 139.86 32.61 Favored Pre-proline 0 N--CA 1.418 -2.047 0 CA-C-N 111.85 -2.432 . . . . 0.0 107.695 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.01 -14.89 46.52 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.886 1.724 . . . . 0.0 111.674 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.31 -30.65 60.41 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.589 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.69 -39.61 73.39 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.288 0.566 . . . . 0.0 109.617 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -31.73 64.32 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.85 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.441 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 2.7 m-85 -72.04 -35.0 69.24 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.61 1.964 . . . . 0.0 113.911 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -46.6 91.99 Favored Glycine 0 C--N 1.319 -0.402 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 p -76.35 -28.24 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.688 -0.756 . . . . 0.0 110.297 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -64.81 -34.0 77.32 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.995 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.46 -31.18 27.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 121.186 1.812 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -48.68 147.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.651 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.28 170.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.673 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 66.41 96.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.678 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -129.14 166.79 18.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.405 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -160.22 -177.93 6.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.775 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -27.84 69.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.991 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.93 -35.09 66.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.344 . . . . 0.0 110.82 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.5 -26.35 30.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.431 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -70.55 -32.6 70.1 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.496 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 mm -52.6 -35.12 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.62 -36.61 74.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.112 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -84.33 -33.44 23.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 12.3 p -78.61 -47.08 24.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.15 -45.95 80.38 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.313 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 4.1 Cg_exo -71.69 -28.67 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.877 2.385 . . . . 0.0 113.29 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -33.75 58.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.569 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 49.8 mt -70.59 -46.12 71.25 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.295 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.436 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -67.34 -46.81 67.58 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 128.407 3.567 . . . . 0.0 111.886 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.32 -48.96 34.93 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 118.146 -1.978 . . . . 0.0 109.894 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.87 68.19 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.632 0.73 . . . . 0.0 109.789 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.84 -31.24 70.94 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.334 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.63 82.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.21 -49.64 81.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -39.34 91.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.7 0.762 . . . . 0.0 109.719 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -34.59 49.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.765 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -131.71 51.55 2.14 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.194 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -174.49 -31.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.732 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.94 -172.25 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.651 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 tt -137.85 98.19 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.933 0.397 . . . . 0.0 110.737 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 17.9 mt 48.24 92.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.069 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -131.64 158.6 74.93 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.35 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.39 -58.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.61 2.207 . . . . 0.0 112.287 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.15 93.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.507 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.17 124.77 5.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.587 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 11.1 t 179.1 -56.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.502 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -173.18 42.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.599 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.18 110.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.641 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.3 t -124.36 27.42 7.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.591 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.3 -26.58 19.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.533 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.4 77.71 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.625 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.11 95.46 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp 53.91 -175.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.498 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.89 -60.77 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.542 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 57.74 25.77 12.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.491 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 2.3 m 58.95 80.97 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.617 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.1 p -76.49 -65.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.81 -119.69 4.59 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -143.47 25.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 110.633 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.74 19.71 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 63.46 -83.92 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.956 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -159.98 135.71 8.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.545 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -104.94 167.46 9.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.642 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.1 -47.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.81 110.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.621 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.45 -52.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.616 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -155.31 -64.52 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.531 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.98 155.48 2.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.622 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -135.41 -67.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.566 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 10.0 mt 64.64 144.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.625 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.01 -73.52 0.09 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.81 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.59 -170.32 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.554 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 54.45 74.48 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.505 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 45.2 t -50.55 123.92 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.29 152.3 38.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.56 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 6.3 ttp -113.44 107.51 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.605 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.41 71.86 82.12 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.639 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -47.71 -39.0 30.33 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.823 2.349 . . . . 0.0 112.109 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.41 147.25 39.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 60.7 53.61 3.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.07 179.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.736 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -155.19 131.15 10.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.504 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.29 88.88 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 tttt 54.27 73.58 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.545 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.24 32.46 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.563 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.95 -26.38 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.55 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 8.1 t -99.22 83.81 2.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.548 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -56.06 124.34 17.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.595 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -139.95 176.58 8.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.621 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.32 96.81 7.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.529 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 2.7 mp -81.32 101.94 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.96 -73.64 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.8 p -57.08 124.06 17.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 0.0 110.554 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -159.76 -58.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.537 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.86 27.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.615 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.42 137.24 51.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.615 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 159.89 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.606 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -97.38 -65.21 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.536 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 13.8 m80 56.42 95.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.514 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -102.65 61.48 0.82 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.551 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -110.59 -43.98 3.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.543 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 3.5 p80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.59 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.92 78.23 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.59 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -99.16 142.45 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.55 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 53.74 32.01 13.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.433 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -120.97 -24.02 5.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.674 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.65 166.7 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.56 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -132.24 -178.72 5.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.631 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp 56.39 41.75 28.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.573 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.31 -28.54 42.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.698 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.32 96.46 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.683 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -115.84 -14.81 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -57.12 -16.47 7.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.095 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.16 -0.18 15.66 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.88 -40.09 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.3 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.775 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.584 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.82 69.42 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -46.74 62.79 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -33.82 73.26 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.3 mt -58.84 -38.35 78.48 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.68 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . . . -65.73 -47.07 76.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.742 -2.026 . . . . 0.0 115.077 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.429 ' HB ' ' N ' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -75.74 -31.5 59.61 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.493 -177.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.72 -39.0 67.28 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.737 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -45.06 83.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -47.2 21.19 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 29' ' ' ILE . 92.5 t -65.25 -50.57 72.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.477 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -53.86 -47.43 71.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -29.17 20.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.594 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -36.23 67.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.2 mm -62.97 -38.61 82.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.88 63.29 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.257 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -63.49 -45.02 92.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.726 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.52 -16.86 63.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.762 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.3 mt -78.42 -43.44 27.33 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 121.484 0.659 . . . . 0.0 110.003 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.46 -24.4 68.09 Favored Glycine 0 C--N 1.308 -1.01 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -26.98 63.56 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -106.78 -10.03 16.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.01 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.429 ' H ' ' C ' ' A' ' 34' ' ' GLY . 14.4 t80 -123.23 120.01 27.39 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 118.257 0.481 . . . . 0.0 110.479 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.56 142.12 65.42 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 119.825 0.973 . . . . 0.0 112.107 -0.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -77.18 151.31 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.688 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.06 -160.82 17.6 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.29 90.46 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.467 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -121.87 21.17 10.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.767 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -141.4 -168.81 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.339 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.1 p -88.42 -22.16 23.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.738 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.15 145.31 51.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.042 0.448 . . . . 0.0 110.964 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 t -141.54 132.43 26.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.117 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -105.58 106.01 16.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.023 0.44 . . . . 0.0 110.733 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -114.47 163.03 15.91 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.493 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -49.8 -28.04 5.79 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.407 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.0 t -56.81 -48.24 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.8 -44.12 90.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.2 -47.6 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.548 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.2 m -69.15 -36.49 77.48 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 49.4 tp -63.41 -31.88 73.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.2 90.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.374 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.401 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 8.4 m-30 -65.92 -43.33 88.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.875 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.56 -43.34 96.67 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.467 -0.396 . . . . 0.0 112.901 -178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.0 mt -66.76 -43.69 83.41 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.301 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -36.54 74.66 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.26 -34.08 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.645 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.39 -45.53 92.73 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.423 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.1 p -67.84 -31.42 71.24 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -41.96 72.1 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.96 -44.07 73.69 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.508 173.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -40.2 87.78 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.51 -12.13 5.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 119.802 1.183 . . . . 0.0 111.702 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -42.85 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.759 0.314 . . . . 0.0 111.395 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.6 170.65 11.91 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -23.08 62.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 pt -76.06 7.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 135.7 53.57 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.377 0.608 . . . . 0.0 111.697 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -149.55 18.45 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.34 85.35 1.09 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -20.01 62.34 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -89.84 3.43 52.97 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 112.26 -2.245 . . . . 0.0 113.636 178.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -126.46 133.85 25.41 Favored Pre-proline 0 N--CA 1.483 1.19 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.68 -32.25 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.171 2.58 . . . . 0.0 112.1 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.89 75.45 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.22 -36.81 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.825 0.345 . . . . 0.0 111.218 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -62.89 -28.63 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.71 -42.05 96.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.874 0.369 . . . . 0.0 110.409 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.68 -39.3 85.95 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -50.23 72.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.615 0.245 . . . . 0.0 111.294 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -66.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.837 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.14 -25.53 9.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.545 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 t -99.5 -162.71 0.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.434 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 65.58 -169.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.674 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -109.24 -69.46 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.705 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mt -77.7 -80.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.694 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.45 -161.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.475 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.3 mt 62.93 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.314 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 69.83 -73.62 0.09 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.805 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -63.11 -45.27 92.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.394 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.13 77.96 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.86 -38.44 67.47 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.4 ttt -71.71 -36.18 70.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.316 -1.765 . . . . 0.0 109.685 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -64.33 -37.52 87.81 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 119.177 0.899 . . . . 0.0 109.236 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.6 -48.12 88.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.532 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.2 pt -70.44 -37.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.22 -47.18 74.7 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.61 -35.84 70.59 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.96 71.74 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.7 t -70.81 -35.39 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.016 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.61 -42.21 90.33 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 121.152 1.797 . . . . 0.0 112.973 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.429 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.91 -36.05 75.08 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.03 -42.22 85.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.825 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.94 -37.23 72.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.269 0.557 . . . . 0.0 109.515 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.67 -44.67 85.92 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.14 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -70.32 -37.17 74.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.709 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -44.83 88.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.707 0.289 . . . . 0.0 111.113 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.8 mt -69.22 -37.51 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.39 . . . . 0.0 110.814 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.47 -24.5 67.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.023 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -36.89 81.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.969 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.95 -36.24 60.16 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.5 mm -55.33 -40.6 57.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.627 -0.787 . . . . 0.0 110.532 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -12.47 29.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.455 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -52.39 -44.45 65.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.745 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.08 -35.43 13.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.477 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 mp -87.66 -178.09 6.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 111.023 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.99 126.92 55.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.66 78.37 0.26 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.0 -35.42 10.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.575 0.226 . . . . 0.0 111.433 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 t -164.53 70.92 0.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.12 0.486 . . . . 0.0 110.559 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.09 8.1 25.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.113 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.13 15.43 78.76 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -112.71 117.47 32.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 111.71 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 52.0 29.44 6.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -108.79 89.61 3.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.01 143.79 57.47 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.055 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.03 139.99 40.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.887 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -49.62 127.63 16.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.28 -104.66 0.59 Allowed Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.662 HG12 ' HB2' ' A' ' 137' ' ' GLN . 1.3 t -86.09 127.76 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.434 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 9.4 t-20 -71.66 -172.03 0.74 Allowed 'General case' 0 C--O 1.203 -1.376 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.8 t -63.54 -46.97 83.56 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 114.499 -2.88 . . . . 0.0 109.893 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -40.13 94.79 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.13 -1.034 . . . . 0.0 111.323 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.662 ' HB2' HG12 ' A' ' 133' ' ' VAL . 2.4 mm100 -53.5 -23.54 10.65 Favored 'General case' 0 C--N 1.253 -3.618 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.676 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.435 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.34 -2.18 13.56 Favored Glycine 0 C--O 1.191 -2.56 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.05 -50.37 73.58 Favored 'General case' 0 C--O 1.206 -1.226 0 O-C-N 120.458 -1.613 . . . . 0.0 108.458 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.77 -46.52 53.12 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.435 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 2.1 mm -59.58 -42.83 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.186 -1.007 . . . . 0.0 111.352 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.19 -36.11 79.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.035 0.934 . . . . 0.0 112.59 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 19.6 mt -67.78 -50.48 59.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 O-C-N 121.718 -0.614 . . . . 0.0 110.474 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.29 -43.59 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.99 0.9 . . . . 0.0 111.948 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 148' ' ' GLN . . . -61.98 -51.05 59.69 Favored Glycine 0 C--O 1.2 -1.993 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.915 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.6 m -70.25 -37.61 74.98 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.838 0.828 . . . . 0.0 110.87 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 tp -55.03 -40.22 69.98 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 149' ' ' LEU . 1.1 pp0? -57.85 -31.42 66.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.778 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.438 ' N ' ' HG3' ' A' ' 148' ' ' GLN . 1.2 tp -68.72 -47.16 67.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.651 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 82.5 t -66.39 -40.98 88.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -45.65 82.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 24.6 p -65.68 -29.02 69.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.94 -39.0 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.167 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -38.21 88.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.554 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.7 72.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.71 -36.72 65.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.335 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.88 -8.83 42.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.167 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -64.89 101.0 0.45 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.852 0.358 . . . . 0.0 110.615 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.08 -27.84 65.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.32 153.06 44.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.455 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 51.78 83.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.506 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -102.24 61.21 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.568 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -146.12 40.48 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.3 mt -51.14 -63.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.589 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 151.29 -55.13 0.46 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -128.35 -111.73 1.62 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.56 129.92 56.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.172 0.51 . . . . 0.0 110.428 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.464 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . -52.62 -43.93 93.83 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 10.6 Cg_exo -62.32 -46.76 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.715 1.61 . . . . 0.0 113.842 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.37 -29.97 70.26 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.014 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.35 -45.16 63.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.777 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.16 -37.53 62.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.78 -37.56 93.54 Favored Glycine 0 C--O 1.196 -2.268 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.667 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.26 -35.86 65.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.54 -34.79 77.79 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.173 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.32 -46.92 69.43 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.66 -32.81 72.91 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.516 1.15 . . . . 0.0 110.527 -175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.279 2.7 tp -70.55 -50.64 35.36 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 124.739 2.209 . . . . 0.0 110.212 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.5 -37.12 65.72 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 109.896 -3.32 . . . . 0.0 107.042 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.418 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 0.3 OUTLIER -70.33 -35.24 73.49 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.959 -1.62 . . . . 0.0 109.648 178.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -57.16 -47.04 82.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.815 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -74.5 -52.11 12.86 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.494 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -69.98 -51.94 28.4 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 188' ' ' GLY . 3.7 mt -61.4 -49.21 85.44 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.681 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -35.55 76.29 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 116.226 -2.19 . . . . 0.0 112.645 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.538 -171.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.284 0.1 OUTLIER -124.54 -26.71 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.217 1.008 . . . . 0.0 113.2 -179.501 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.11 -5.67 84.72 Favored Glycine 0 CA--C 1.567 3.327 0 N-CA-C 106.332 -2.707 . . . . 0.0 106.332 -170.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.414 ' CB ' ' OG1' ' A' ' 187' ' ' THR . 37.5 t -84.25 126.04 32.79 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -46.53 162.61 0.17 Allowed Glycine 0 N--CA 1.411 -2.986 0 CA-C-N 111.307 -2.679 . . . . 0.0 112.647 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -41.55 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -94.35 146.31 31.31 Favored Pre-proline 0 N--CA 1.409 -2.488 0 CA-C-N 111.528 -2.578 . . . . 0.0 108.657 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.12 -14.69 45.5 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.524 2.15 . . . . 0.0 111.479 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.24 -34.33 61.41 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.76 0.314 . . . . 0.0 110.574 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.437 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 38.1 tpt85 -70.61 -40.53 73.13 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.906 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.2 -37.53 66.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.43 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 13.3 t80 -72.1 -35.06 69.08 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 126.718 2.007 . . . . 0.0 114.458 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.3 93.34 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 106.7 -2.56 . . . . 0.0 106.7 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 16.2 m -76.6 -28.3 56.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.992 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -67.53 -33.93 76.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.35 -31.29 14.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 121.152 1.796 . . . . 0.0 111.808 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 1.6 pt -64.02 -27.91 43.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.636 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.19 113.03 14.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.628 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -106.57 86.42 2.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.066 0.46 . . . . 0.0 110.472 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -178.89 -164.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.437 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 55.63 96.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.638 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.0 p -55.2 -26.68 40.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.457 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -59.27 -35.3 73.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.587 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -25.07 52.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.827 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -61.28 -20.06 62.44 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.494 0.496 . . . . 0.0 111.308 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.6 tp -52.39 -34.27 18.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -27.13 64.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -84.43 -44.68 13.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.18 -41.11 20.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -175.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.503 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.3 -45.07 84.35 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.434 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 3.4 Cg_exo -71.74 -28.66 16.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.624 2.216 . . . . 0.0 112.95 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -77.4 -31.0 53.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 111.993 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.4 mm -70.77 -46.44 68.81 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.296 0 C-N-CA 123.398 0.679 . . . . 0.0 112.457 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.429 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -68.95 -46.09 60.85 Favored Glycine 0 C--N 1.359 1.84 0 O-C-N 128.659 3.724 . . . . 0.0 111.535 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.27 -49.02 34.93 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.192 -1.956 . . . . 0.0 109.944 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.96 68.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.648 0.737 . . . . 0.0 109.626 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.73 -31.29 71.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.152 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.78 -39.47 81.16 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.5 t -58.15 -49.54 81.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.604 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -39.47 94.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.623 0.725 . . . . 0.0 109.817 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 21.4 mt -58.59 -34.42 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.346 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -71.78 0.67 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.386 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -72.23 73.65 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.755 0.312 . . . . 0.0 110.746 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -48.69 139.99 8.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.672 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.5 tt -130.59 -6.4 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.272 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -49.44 -71.0 0.07 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.861 0.362 . . . . 0.0 110.616 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -129.02 164.89 35.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.537 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.35 -42.8 53.0 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.706 2.271 . . . . 0.0 112.073 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -53.78 160.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.507 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.1 t -142.73 77.41 1.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.562 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.4 m 56.73 60.23 3.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.621 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.34 -179.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.3 mp -120.2 119.64 33.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.566 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 59.9 m 61.66 -84.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.002 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -145.87 -50.99 0.24 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.77 0.319 . . . . 0.0 110.537 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.13 55.21 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.7 t -127.1 -63.8 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.618 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -103.38 105.0 15.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.638 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 m -147.78 55.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.613 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -56.21 -46.47 79.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.557 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.7 141.85 26.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.9 t -168.13 30.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 133.38 -105.59 0.59 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -123.35 39.77 3.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.775 0.322 . . . . 0.0 110.548 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.7 146.37 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.683 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.34 43.05 26.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.546 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -155.06 109.08 2.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -98.15 -77.09 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.551 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.38 -168.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.593 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.86 -74.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.558 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.1 t0 57.05 -172.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.551 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -77.16 152.68 34.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.537 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.99 -49.75 59.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.525 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.37 -168.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.602 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 2.6 tt -143.02 137.13 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -115.69 69.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.514 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.04 -165.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.594 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -100.73 97.51 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.474 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.9 p -67.69 -29.83 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.539 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -128.25 173.97 9.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.519 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.19 70.71 4.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.551 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -55.26 39.21 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.342 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.07 138.82 8.86 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.05 1.833 . . . . 0.0 112.267 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -49.71 132.59 21.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.615 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -145.6 -47.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.594 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.11 102.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.523 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.69 -28.83 58.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.582 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 70.04 -70.9 0.14 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.96 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -72.95 95.83 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 0.0 110.587 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.1 tp 64.94 157.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.554 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 85.7 mt 50.9 89.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.599 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 17.6 m -91.06 -75.93 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.546 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -59.07 4.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.676 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -173.03 167.65 4.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.533 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.34 -65.22 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.563 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.57 65.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.539 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.15 -65.7 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.555 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.21 144.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.501 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -151.68 123.91 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.558 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.06 -43.48 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.603 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.99 -171.72 3.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.543 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.29 -76.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.585 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -174.28 85.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.629 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -126.13 19.74 7.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 48.7 57.96 5.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.681 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.02 -73.82 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.751 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 4.4 p80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.559 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.32 -172.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.586 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.1 m -154.03 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.515 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 55.4 179.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.77 34.08 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.6 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -77.15 -57.4 3.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.553 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt 49.55 87.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.472 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -132.6 -166.65 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.046 0.451 . . . . 0.0 110.723 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.42 -91.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.737 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 60.83 -87.13 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.37 0.129 . . . . 0.0 110.687 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.36 -18.69 25.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.738 0.304 . . . . 0.0 110.567 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -58.22 -16.15 12.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.017 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.4 1.99 17.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.683 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -40.25 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.36 -36.18 73.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.541 0 CA-C-N 112.605 -2.089 . . . . 0.0 109.833 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.09 70.16 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.18 -46.65 60.92 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -177.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -33.96 72.31 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.99 -38.06 78.29 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.508 -2.133 . . . . 0.0 108.912 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . . . -63.18 -46.81 85.39 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.313 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -31.23 59.45 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.699 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -38.16 67.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.781 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -44.92 84.37 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.96 -47.97 19.39 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 29' ' ' ILE . 91.8 t -65.44 -53.76 36.07 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.522 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -53.87 -44.36 70.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.264 0.484 . . . . 0.0 111.96 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.73 -29.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.903 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 25' ' ' VAL . 3.0 mm -61.82 -38.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.109 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.35 -36.95 64.08 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -67.14 -38.88 86.29 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.64 -16.88 63.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.506 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 26.9 mt -85.56 -37.37 19.68 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.606 0.717 . . . . 0.0 110.128 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.45 -31.54 54.11 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.046 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -23.29 57.15 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -106.91 -10.05 16.11 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.759 176.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' A' ' 34' ' ' GLY . 25.9 t80 -121.96 120.03 28.61 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 118.743 0.702 . . . . 0.0 110.392 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.31 143.94 71.74 Favored 'Cis proline' 0 N--CA 1.5 1.855 0 C-N-CA 124.773 -0.928 . . . . 0.0 112.174 -0.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 m -72.9 151.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.645 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.71 -128.67 45.49 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 70.18 -71.54 0.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.38 0.133 . . . . 0.0 110.718 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.1 t30 47.63 30.56 1.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 110.807 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -83.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.627 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.59 -26.71 6.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.347 . . . . 0.0 110.614 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.02 145.43 46.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.773 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.19 116.59 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.376 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.54 107.83 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -114.1 162.95 15.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.034 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.91 -28.83 53.79 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.659 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.94 -31.92 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -65.05 -54.18 34.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.5 m -68.36 -37.45 77.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.543 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -69.56 -43.19 73.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 55.8 tp -62.9 -31.72 72.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.535 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.68 93.85 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.504 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -66.28 -46.82 75.67 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.67 -41.65 97.62 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.737 -0.268 . . . . 0.0 113.38 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.39 -43.73 76.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.674 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -60.46 -36.48 78.36 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -33.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 113.077 -1.874 . . . . 0.0 107.987 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.08 -45.71 80.32 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.379 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 p -69.42 -31.55 69.97 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.42 -41.01 72.19 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.0 -44.43 72.8 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.155 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -36.74 82.91 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 t -59.68 -12.21 6.49 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 119.98 1.264 . . . . 0.0 111.367 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.59 -42.71 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.883 0.373 . . . . 0.0 110.957 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.14 156.41 6.79 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -23.01 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 tt -74.68 6.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.55 135.64 53.33 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.168 0.509 . . . . 0.0 111.26 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.12 -159.06 21.27 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.47 85.78 1.14 Allowed 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.064 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -19.64 61.08 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 2.1 pp -81.15 -10.26 59.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.856 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -112.73 131.24 22.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.69 -28.97 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.062 2.508 . . . . 0.0 112.557 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.68 74.35 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.39 -36.77 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.778 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.2 m -65.85 -28.52 69.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.78 -35.27 77.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.847 0.356 . . . . 0.0 110.715 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.72 98.27 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mt -58.96 -42.41 89.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 110.975 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.52 -53.94 26.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.45 -25.19 5.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.695 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -77.01 153.5 34.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.565 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 29.4 p -65.29 132.41 48.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.57 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -168.22 -64.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.609 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mt 53.58 93.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.627 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 m -139.76 84.97 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.841 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.5 pt 37.98 39.28 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.923 0.764 . . . . 0.0 111.732 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 49.21 50.98 17.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 110.545 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -68.36 -35.75 78.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.36 -35.06 79.83 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.228 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.79 -38.53 67.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtm -73.47 -31.7 63.91 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.738 -1.573 . . . . 0.0 110.132 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -67.66 -40.44 84.52 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 119.032 0.833 . . . . 0.0 111.447 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -41.29 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.48 -42.71 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.33 68.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -71.72 -35.83 70.32 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 t -58.03 -36.19 72.37 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.78 -35.41 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.857 175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.7 -44.76 91.37 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 120.897 1.681 . . . . 0.0 113.369 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.1 75.71 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 39.8 mt -67.26 -41.15 86.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.532 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.9 -37.3 77.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 0.0 109.53 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.99 83.39 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.382 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -67.73 -37.28 81.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.414 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.83 85.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.02 -39.17 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.774 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -24.32 67.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.352 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 m -60.62 -44.37 96.41 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.836 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.07 -36.26 60.87 Favored Glycine 0 CA--C 1.509 -0.297 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.21 -30.72 30.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.441 -0.879 . . . . 0.0 111.016 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.86 3.22 12.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.4 m -60.76 -42.02 96.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.225 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.96 -35.27 14.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 mt -88.58 -179.83 6.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.45 125.63 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.77 84.84 0.07 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.13 -35.02 10.53 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.7 t -163.1 69.94 0.24 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.923 0.392 . . . . 0.0 111.131 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 mp -81.33 7.94 10.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.311 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.02 25.39 71.51 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.6 ptt85 -112.59 118.52 35.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.957 0.408 . . . . 0.0 111.884 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 51.82 45.24 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -116.55 110.38 18.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.796 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -82.01 138.07 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.39 148.75 27.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.212 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -49.65 127.66 16.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.39 -97.6 0.87 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' A' ' 137' ' ' GLN . 2.6 t -86.09 119.15 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.44 ' N ' ' HB2' ' A' ' 137' ' ' GLN . 1.6 m-80 -71.8 -172.03 0.77 Allowed 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.78 -46.97 87.26 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 114.525 -2.87 . . . . 0.0 110.793 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.19 -39.35 94.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.519 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.632 ' HB2' HG11 ' A' ' 133' ' ' VAL . 85.4 mm-40 -52.95 -23.33 6.99 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-O 121.342 0.592 . . . . 0.0 110.196 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.532 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -63.5 -1.97 5.21 Favored Glycine 0 C--O 1.187 -2.787 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.23 -50.54 69.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 119.332 1.566 . . . . 0.0 110.951 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.84 -43.94 64.33 Favored Glycine 0 CA--C 1.51 -0.255 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.532 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.8 OUTLIER -63.56 -38.9 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 112.721 -1.739 . . . . 0.0 112.378 -178.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 138' ' ' GLY . 42.2 mt-10 -68.31 -36.3 79.11 Favored 'General case' 0 C--O 1.2 -1.541 0 CA-C-O 122.275 1.036 . . . . 0.0 110.48 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 40.2 mt -65.9 -46.46 88.43 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.645 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.48 -48.99 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 122.073 0.939 . . . . 0.0 111.769 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.77 56.8 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.008 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.8 m -70.65 -43.34 69.37 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.887 -1.156 . . . . 0.0 112.447 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.67 -40.18 68.83 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.705 -176.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt20 -57.86 -30.26 65.65 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.851 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.2 tp -68.82 -45.39 71.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.738 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.42 -40.95 87.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.18 -38.38 85.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 5.1 p -73.74 -28.3 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.393 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.98 -45.55 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -41.25 92.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.277 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.02 89.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.423 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.2 -36.84 74.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.543 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.79 -7.0 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.316 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.42 136.92 57.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.851 0.358 . . . . 0.0 110.525 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -26.15 65.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -77.89 111.09 13.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.59 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.18 -68.35 0.89 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.473 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 63.72 -83.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.033 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.94 -163.79 1.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.783 0.325 . . . . 0.0 110.495 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 65.84 125.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.492 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.66 -132.6 5.36 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.93 -175.26 0.2 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.47 132.45 42.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.545 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.432 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . -52.29 -45.67 94.52 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.818 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 23.6 Cg_exo -54.42 -41.08 79.98 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.485 1.456 . . . . 0.0 112.272 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.42 -42.42 91.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 -47.14 57.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.2 -37.11 60.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.44 93.49 Favored Glycine 0 C--O 1.2 -1.977 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.299 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -55.1 -36.23 65.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -34.6 77.41 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.562 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.06 -47.42 47.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.3 -31.75 69.22 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.966 1.365 . . . . 0.0 110.117 -175.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.273 11.3 tp -70.44 -48.67 54.88 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.547 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.72 -37.03 67.09 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 111.075 -2.784 . . . . 0.0 107.817 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.488 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 10.2 m-70 -68.59 -35.36 77.26 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.391 -1.405 . . . . 0.0 109.08 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -59.34 -47.73 84.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.672 -177.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -52.52 10.69 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -70.25 -51.96 26.66 Favored 'General case' 0 C--O 1.202 -1.404 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.488 ' HB ' ' O ' ' A' ' 180' ' ' HIS . 6.0 mt -59.43 -49.21 84.42 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.815 0 C-N-CA 118.984 -1.087 . . . . 0.0 113.14 -174.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -35.71 78.49 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 115.677 -2.409 . . . . 0.0 112.719 -176.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.84 -29.79 68.52 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.673 -171.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.28 0.1 OUTLIER -124.6 -26.85 3.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.292 1.044 . . . . 0.0 113.43 -179.317 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.54 -5.8 84.43 Favored Glycine 0 CA--C 1.566 3.277 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -170.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 11.4 t -84.1 129.0 34.92 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -49.82 159.2 1.31 Allowed Glycine 0 N--CA 1.405 -3.403 0 CA-C-N 111.496 -2.593 . . . . 0.0 112.056 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.433 HD11 HG21 ' A' ' 191' ' ' ILE . 20.3 pt -72.57 -33.07 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -97.69 143.62 26.53 Favored Pre-proline 0 N--CA 1.418 -2.038 0 CA-C-N 113.194 -1.821 . . . . 0.0 108.748 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.05 -14.44 33.31 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.395 2.063 . . . . 0.0 111.596 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.05 -37.38 61.7 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.623 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.533 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.41 -38.62 74.64 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.26 0.552 . . . . 0.0 109.839 -179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -33.74 65.43 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.502 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 2.8 m-85 -72.3 -35.25 68.62 Favored 'General case' 0 N--CA 1.512 2.663 0 C-N-CA 126.532 1.933 . . . . 0.0 114.469 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.69 91.91 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 107.274 -2.331 . . . . 0.0 107.274 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -76.35 -28.41 56.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.605 -0.798 . . . . 0.0 110.349 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -63.8 -34.05 77.05 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.704 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.45 -35.55 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 121.0 1.727 . . . . 0.0 110.418 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.9 mm -52.98 -47.89 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.97 -164.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.626 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -135.43 87.05 2.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.802 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -111.82 167.38 10.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.9 -76.13 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.012 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -43.04 93.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.342 . . . . 0.0 110.771 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.88 -35.09 74.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -26.36 67.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.448 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -70.62 -39.97 73.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.4 pp -52.7 -34.55 19.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -58.52 -38.54 77.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.706 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -84.21 -33.61 24.09 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 13.3 p -77.76 -45.16 28.55 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.477 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.18 -48.15 70.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.435 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 5.2 Cg_endo -72.16 -32.36 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.477 2.118 . . . . 0.0 114.015 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -39.88 75.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.569 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 5.8 mt -70.47 -46.52 70.14 Favored 'Isoleucine or valine' 0 C--O 1.173 -2.929 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.335 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -56.65 -48.46 77.08 Favored Glycine 0 C--N 1.365 2.156 0 O-C-N 128.624 3.703 . . . . 0.0 111.23 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.93 -39.44 89.35 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.47 -34.88 62.34 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 5.5 mt -67.55 -37.18 82.31 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.502 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.8 82.18 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.279 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.6 t -58.46 -49.72 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.08 -39.53 94.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.694 0.759 . . . . 0.0 110.344 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.92 -34.74 38.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.94 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -140.89 68.71 1.34 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.589 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -174.73 36.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.61 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -69.56 -43.51 72.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 tt -126.88 108.16 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.533 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.1 tt -169.38 -50.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.604 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -80.72 163.73 54.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.381 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -75.03 158.76 41.92 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.717 2.278 . . . . 0.0 112.105 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -137.55 154.9 49.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.604 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.9 m 52.88 48.42 22.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.563 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.65 -42.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.623 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.12 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.1 pp -116.93 146.06 43.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 110.532 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.16 161.45 15.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.515 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.21 92.29 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.555 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 54.92 69.36 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.53 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 77.7 t -133.93 -65.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.565 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -76.71 114.66 15.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.544 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.16 125.47 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.612 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -72.5 123.6 23.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.543 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.28 50.95 0.76 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.596 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.35 -60.07 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.497 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.57 119.22 5.74 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -54.58 97.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.362 . . . . 0.0 110.477 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.5 m -74.35 -171.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.528 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -158.16 -172.29 3.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.511 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -98.16 -31.14 12.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.566 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.86 -61.49 0.23 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.595 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 t0 65.22 143.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.58 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.5 mp -103.34 -176.73 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.473 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.97 -70.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -152.14 -59.67 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.578 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.46 -31.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.9 t0 64.12 106.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 1.1 pp -154.76 57.33 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.687 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -62.64 -41.34 98.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.542 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 25.0 p -165.37 -71.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.62 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 40.64 -160.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.874 0.734 . . . . 0.0 111.403 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.9 p -172.93 -32.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 110.643 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -105.6 130.98 53.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.502 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 2.0 ttt -103.23 -33.92 9.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.434 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -141.5 72.06 25.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.489 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.59 -54.9 4.49 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.75 2.3 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.48 164.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.581 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 70.17 -71.13 0.13 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.961 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 35.7 mt -86.18 -56.51 3.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.519 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 68.79 -74.5 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -139.27 148.89 43.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.49 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.88 -178.35 3.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.538 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.55 -179.3 7.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.619 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.66 -179.28 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.515 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.56 111.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.619 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -129.09 130.22 46.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.567 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 59.99 95.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.611 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -85.36 -37.1 20.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 1.8 tp -55.88 -46.13 78.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.577 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 57.3 t30 50.6 83.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.565 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 46.9 m -161.34 111.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.537 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.77 107.15 16.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.544 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.37 88.84 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.21 96.63 2.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.29 103.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.555 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.81 -34.3 69.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.51 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -96.39 92.91 6.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.591 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 147.56 30.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.599 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -74.99 137.63 41.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.566 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 4.1 t60 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.591 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.97 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.734 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 t -161.63 -56.88 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.901 0.381 . . . . 0.0 110.593 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 53.93 63.13 2.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.536 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.95 109.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.512 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -98.42 106.36 18.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.503 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp 59.45 -172.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.553 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.1 tttm 59.98 93.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.567 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.77 -64.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 49.42 66.88 0.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.668 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -130.52 -50.13 1.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.546 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -72.94 0.76 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.488 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.23 -12.03 11.23 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.383 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -60.24 -39.75 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -68.34 -35.92 72.85 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.301 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -35.09 69.52 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -70.93 -46.55 62.25 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -34.01 71.83 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -38.18 78.48 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.313 -2.222 . . . . 0.0 109.493 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB1' ' HA ' ' A' ' 75' ' ' LEU . . . -65.73 -46.67 78.01 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.021 -1.899 . . . . 0.0 114.572 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.46 -31.15 60.16 Favored 'General case' 0 C--O 1.204 -1.341 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.66 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.87 -38.05 67.15 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 111.678 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -44.97 84.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.04 -47.21 21.23 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 29' ' ' ILE . 87.8 t -65.41 -52.09 55.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.069 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -53.76 -47.35 70.76 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.094 0.473 . . . . 0.0 112.168 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.63 -29.86 21.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -36.19 69.41 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 25' ' ' VAL . 4.1 mm -59.3 -41.0 82.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.987 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.37 -36.85 64.04 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.9 m -67.38 -39.43 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.33 -46.22 67.59 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.73 -31.44 22.42 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.84 -36.16 42.95 Favored Glycine 0 CA--C 1.505 -0.566 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.365 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.97 -19.1 40.0 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.472 -1.291 . . . . 0.0 107.589 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 -10.06 16.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.667 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -123.25 122.31 26.83 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 118.393 0.542 . . . . 0.0 110.119 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.11 137.72 43.75 Favored 'Cis proline' 0 N--CA 1.497 1.711 0 CA-C-N 119.645 0.909 . . . . 0.0 112.381 0.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.82 151.25 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.651 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.79 46.81 59.71 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -127.79 29.07 5.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.559 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -132.23 161.57 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.663 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -107.06 -61.66 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.565 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -111.42 -26.6 9.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.405 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.33 144.69 50.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.94 147.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.133 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -106.63 106.19 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.417 . . . . 0.0 110.794 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.31 162.91 16.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.647 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -50.0 -28.52 7.07 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.116 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.2 t -57.15 -40.0 70.57 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -64.8 -53.76 41.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.4 t -67.9 -46.14 82.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.592 -176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.9 m -69.3 -38.67 78.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.77 -31.94 73.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.87 -39.37 94.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.569 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -65.94 -41.01 91.87 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.54 -41.75 99.11 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.848 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -43.61 80.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.59 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -58.65 -36.57 74.33 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.06 -34.04 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.436 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.66 -45.67 85.74 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.364 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.4 p -66.8 -31.59 72.32 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.7 -43.1 72.24 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.18 -44.41 72.24 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.382 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -66.83 -48.76 67.91 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 m -59.05 -12.13 4.41 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 119.708 1.14 . . . . 0.0 112.086 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.0 m -114.44 -42.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.95 0.405 . . . . 0.0 111.575 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 144.19 158.91 7.79 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -60.65 -23.02 64.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.642 0.258 . . . . 0.0 111.681 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.14 7.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.62 136.44 53.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.105 0.479 . . . . 0.0 111.599 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.37 -153.46 27.86 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.45 85.8 1.13 Allowed 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 118.439 -1.304 . . . . 0.0 107.802 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -19.65 65.15 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.402 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 1.1 pp -83.78 -11.95 56.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.64 -1.618 . . . . 0.0 113.031 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -115.37 135.7 22.62 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 119.846 1.203 . . . . 0.0 114.06 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.44 -21.6 4.29 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 123.14 2.56 . . . . 0.0 112.004 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.42 -48.67 74.48 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.14 -36.84 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.155 -0.341 . . . . 0.0 111.276 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -28.45 69.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -35.12 69.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.127 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.73 -48.79 47.26 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.76 -30.53 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.23 -69.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.9 tp 57.85 102.04 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.139 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.5 p -46.83 -87.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 27.3 t 58.34 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.43 0.157 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -108.69 -177.44 3.32 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.8 mm -114.95 100.11 9.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.789 0.328 . . . . 0.0 110.613 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.6 p -171.18 71.38 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.637 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.16 159.71 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.515 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -176.81 -44.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.848 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -63.61 -40.14 96.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.78 -35.02 77.93 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -38.64 67.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 176.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.93 -37.01 70.1 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.476 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -61.06 -37.69 83.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.923 0.868 . . . . 0.0 109.23 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.17 -48.51 87.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 113.784 -1.553 . . . . 0.0 113.367 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.8 mm -70.42 -38.12 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.31 74.48 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.201 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -35.61 70.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.402 ' O ' HG13 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -58.08 -36.09 72.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.22 -35.33 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.52 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.34 90.03 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 121.041 1.746 . . . . 0.0 113.105 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.02 75.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 102' ' ' CYS . 64.0 mt -65.39 -50.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.9 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.02 -37.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.29 0.567 . . . . 0.0 109.612 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.56 -45.11 85.57 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.619 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.42 -37.13 74.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.819 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -46.7 85.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 pt -67.09 -37.31 79.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.06 -24.4 65.98 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.233 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.3 m -60.89 -44.38 97.18 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.784 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.3 62.01 Favored Glycine 0 CA--C 1.512 -0.136 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.91 -31.62 36.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.258 -0.971 . . . . 0.0 111.009 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.17 5.52 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.723 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.3 t -52.13 -32.98 37.99 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.32 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.08 -34.47 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.599 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.61 -179.29 6.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.0 m -118.4 144.77 45.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.676 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.36 78.84 0.23 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -98.09 -24.75 15.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.596 0.236 . . . . 0.0 111.188 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.1 p -172.82 64.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.989 0.424 . . . . 0.0 110.557 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 40.8 mt -88.72 7.87 31.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.158 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 71.69 16.57 76.12 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 117.35 31.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.344 0.592 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 51.97 17.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.048 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.83 91.72 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.17 138.59 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.286 0.565 . . . . 0.0 110.749 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.94 135.61 48.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.405 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -49.81 127.57 16.41 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.05 -104.26 0.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.639 HG13 ' HB2' ' A' ' 137' ' ' GLN . 1.5 t -86.06 125.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.439 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.65 -171.87 0.72 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 102.956 -2.979 . . . . 0.0 102.956 176.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.1 m -62.67 -47.0 85.56 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 114.575 -2.85 . . . . 0.0 110.424 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.25 -39.85 95.12 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.46 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.639 ' HB2' HG13 ' A' ' 133' ' ' VAL . 37.9 mm-40 -53.5 -23.23 9.77 Favored 'General case' 0 C--N 1.25 -3.75 0 CA-C-O 121.29 0.567 . . . . 0.0 110.544 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.524 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.19 -1.65 21.48 Favored Glycine 0 C--O 1.186 -2.901 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -50.46 68.28 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-N 118.709 1.254 . . . . 0.0 110.836 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.48 -41.01 78.45 Favored Glycine 0 CA--C 1.51 -0.249 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.524 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.4 OUTLIER -65.04 -40.67 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 112.775 -1.713 . . . . 0.0 112.063 -178.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 138' ' ' GLY . 15.5 mt-10 -68.43 -36.42 79.03 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.834 0.825 . . . . 0.0 111.697 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 34.6 mt -66.63 -52.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.557 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.22 -44.83 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.935 0.874 . . . . 0.0 111.966 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.45 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.53 -51.88 56.44 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 113.542 -1.663 . . . . 0.0 112.036 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.5 m -70.58 -36.95 73.87 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.375 -0.912 . . . . 0.0 111.185 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tp -55.0 -40.45 70.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.008 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -58.87 -31.94 69.03 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.126 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.2 tp -68.77 -46.65 68.22 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.457 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.3 t -66.25 -40.98 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.7 -35.55 80.94 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.46 -33.51 74.31 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.05 -45.48 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -48.15 81.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.038 0.447 . . . . 0.0 109.928 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.78 -37.1 85.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.228 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.81 10.04 30.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.252 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.3 119.44 16.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.806 0.336 . . . . 0.0 110.599 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -59.28 -25.26 63.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.668 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -94.92 141.42 28.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 58.73 71.96 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.568 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.54 166.75 13.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.665 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 53.67 68.33 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.603 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.77 42.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.505 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.93 106.6 2.95 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.34 -127.06 38.51 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.97 138.66 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 110.52 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.43 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . -52.26 -46.19 94.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.828 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 21.1 Cg_exo -54.82 -46.27 34.6 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.17 -37.46 74.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.51 -45.95 61.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.782 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 49.3 mt -58.3 -39.37 73.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.591 0.71 . . . . 0.0 109.238 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.25 93.29 Favored Glycine 0 C--O 1.2 -2.015 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.929 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 tp -55.09 -35.8 64.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -34.47 76.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.395 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.09 -47.12 48.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.67 -30.85 68.63 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.485 1.135 . . . . 0.0 110.107 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.264 2.1 mp -70.56 -50.5 36.73 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 124.546 2.117 . . . . 0.0 110.323 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.45 -36.91 64.75 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 110.219 -3.173 . . . . 0.0 107.401 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.433 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 12.1 m170 -70.18 -35.34 73.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.096 -1.552 . . . . 0.0 109.645 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.88 -47.85 83.47 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.919 -178.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -75.04 -52.64 10.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -70.16 -52.04 26.61 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.497 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 10.8 mt -60.87 -40.67 86.0 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.901 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.61 -35.67 60.47 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 115.742 -2.383 . . . . 0.0 112.266 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.07 -29.94 68.89 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.802 -1.159 . . . . 0.0 111.179 -171.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.281 0.1 OUTLIER -124.44 -26.83 3.83 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.199 -179.109 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.2 -5.87 84.36 Favored Glycine 0 CA--C 1.569 3.423 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.419 ' CB ' ' OG1' ' A' ' 187' ' ' THR . 43.9 t -84.72 129.1 34.87 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.422 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -48.4 162.83 0.41 Allowed Glycine 0 N--CA 1.408 -3.187 0 CA-C-N 111.265 -2.698 . . . . 0.0 113.464 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.11 -42.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -92.38 144.73 29.34 Favored Pre-proline 0 N--CA 1.417 -2.096 0 CA-C-N 110.843 -2.889 . . . . 0.0 107.702 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.02 -14.71 45.72 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.907 1.738 . . . . 0.0 111.247 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.83 61.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.989 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.422 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.48 -39.25 74.33 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.376 0.607 . . . . 0.0 109.863 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -36.91 66.79 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.44 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 11.6 t80 -72.22 -35.24 68.82 Favored 'General case' 0 N--CA 1.511 2.575 0 C-N-CA 126.412 1.885 . . . . 0.0 114.442 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.26 93.51 Favored Glycine 0 C--N 1.318 -0.438 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.9 m -76.48 -28.42 56.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.265 -0.968 . . . . 0.0 110.647 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -66.26 -34.06 77.16 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.163 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.38 -30.85 44.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 121.013 1.733 . . . . 0.0 111.604 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 10.2 tt -34.51 -35.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.6 m -162.38 56.95 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.147 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 48.44 -160.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.287 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -177.06 176.54 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.38 . . . . 0.0 110.593 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -103.83 177.79 4.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.47 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -26.81 66.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.384 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -62.64 -35.17 78.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.637 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -18.55 64.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.476 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -20.11 62.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.892 0.377 . . . . 0.0 111.63 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 2.7 pp -52.44 -34.42 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -31.82 68.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.178 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -84.56 -33.91 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.79 -46.57 19.93 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.03 -44.73 83.26 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.177 -176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.9 Cg_exo -71.75 -28.6 16.76 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.842 2.362 . . . . 0.0 113.192 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.65 -35.02 60.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.244 0.545 . . . . 0.0 112.147 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.3 mm -70.55 -46.37 70.33 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.158 0 C-N-CA 124.165 0.986 . . . . 0.0 112.685 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.431 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -67.91 -46.74 64.76 Favored Glycine 0 C--N 1.359 1.858 0 O-C-N 128.713 3.758 . . . . 0.0 111.768 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.44 -49.04 33.69 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 118.158 -1.972 . . . . 0.0 109.762 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.94 68.6 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.57 0.7 . . . . 0.0 109.715 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.72 -31.2 70.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.274 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.69 82.41 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.129 0.966 . . . . 0.0 108.48 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.34 -49.64 81.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.587 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.84 -39.48 94.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.705 0.765 . . . . 0.0 109.829 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mm -57.84 -34.59 48.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.616 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -123.39 36.64 4.59 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.187 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.64 13.17 19.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.029 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -176.15 125.44 0.2 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.712 0.291 . . . . 0.0 110.423 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.05 109.71 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.454 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 11.7 tp -169.52 77.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.536 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . 57.15 72.31 0.96 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.593 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -46.18 165.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.894 2.396 . . . . 0.0 112.135 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.8 mtt180 -70.7 -49.66 44.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 p -71.78 -78.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.527 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.8 m 53.63 77.92 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.641 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.88 -168.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.524 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 58.29 93.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.499 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 41.1 p -111.86 -178.12 3.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.509 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.65 -49.53 56.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.581 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -176.08 -56.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.591 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.8 m -116.33 176.19 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.505 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.33 102.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.631 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.38 142.14 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.539 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.85 93.24 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.595 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 18.7 p -96.06 134.88 38.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.606 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.0 t -114.95 73.83 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.62 152.74 9.79 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.1 84.11 1.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.764 0.316 . . . . 0.0 110.614 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.6 -45.51 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.617 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 56.8 85.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.577 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -112.13 -56.21 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.494 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -139.88 25.49 2.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.529 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.91 93.37 4.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.56 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.6 98.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.553 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.25 -67.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -77.17 134.59 38.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.77 147.82 40.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.491 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -55.11 117.51 3.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.586 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -155.84 138.73 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.563 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.1 m120 50.0 83.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.578 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.9 m -122.93 -53.04 1.87 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.528 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 52.78 67.4 1.0 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.594 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.0 p -165.91 -35.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.575 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 51.17 -171.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.508 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.11 152.61 3.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.596 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -56.01 40.32 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.375 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.88 -30.55 4.53 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.994 1.796 . . . . 0.0 112.122 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -71.11 142.77 50.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.589 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 55.93 91.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.77 -78.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.556 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.92 -66.89 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.612 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -165.15 -69.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.549 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -103.54 -36.21 8.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.603 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.83 178.67 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 16.2 tt -162.94 148.21 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.589 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 23.0 t 51.15 66.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.596 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -98.5 -53.63 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.526 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 51.34 84.43 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.573 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -103.46 -40.87 6.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.538 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 9.2 tp -167.15 74.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.538 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 55.3 -179.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.52 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 29.0 t -152.21 118.42 5.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -89.63 -175.7 4.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.567 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.86 137.43 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.574 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -125.28 -176.76 3.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.598 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 30.6 p80 38.51 35.19 0.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.936 0.772 . . . . 0.0 111.678 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -78.94 74.34 5.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.645 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -131.51 32.52 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.513 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -172.22 -52.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.575 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 28.1 t60 49.87 84.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.512 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 35.3 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.521 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.81 108.69 2.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.46 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p -138.34 35.02 2.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.552 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -133.48 -61.83 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.51 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -100.93 89.22 3.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.445 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -160.37 45.48 0.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.529 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -121.57 -42.9 2.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.621 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -103.54 -34.52 8.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.578 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mt -54.78 -70.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.502 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.1 t80 70.25 -70.61 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.981 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -50.18 101.18 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.025 0.44 . . . . 0.0 110.802 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -67.56 -4.18 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.289 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.77 -1.45 12.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.276 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.98 -40.25 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.23 -35.67 72.12 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.641 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.786 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.8 69.33 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.73 -46.78 62.4 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -33.9 71.05 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.87 -38.17 78.19 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 112.293 -2.23 . . . . 0.0 109.482 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 75' ' ' LEU . . . -63.25 -46.59 86.15 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.006 -1.907 . . . . 0.0 113.73 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.454 ' HB ' ' N ' ' A' ' 105' ' ' ALA . 0.1 OUTLIER -75.58 -31.37 59.94 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.96 -177.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.86 -37.95 67.19 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.178 -0.951 . . . . 0.0 111.287 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.92 -45.25 82.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.715 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -77.13 -50.79 12.23 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 29' ' ' ILE . 43.2 t -64.59 -46.31 92.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.384 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.994 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -54.04 -48.67 70.3 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.189 0.519 . . . . 0.0 112.071 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.59 -29.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.519 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -36.19 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.505 HG12 ' O ' ' A' ' 25' ' ' VAL . 2.6 mm -64.02 -40.63 89.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.056 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.54 -41.32 81.05 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -67.57 -45.1 76.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.874 0.368 . . . . 0.0 111.876 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.1 -46.23 85.88 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.68 -27.94 25.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' C ' ' N ' ' A' ' 36' ' ' LYS . . . -75.92 -36.93 40.13 Favored Glycine 0 C--N 1.318 -0.434 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.482 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -58.77 -19.43 40.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' N ' ' C ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -106.56 -9.87 16.43 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.521 177.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -122.28 121.41 27.8 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.489 0.586 . . . . 0.0 110.283 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.96 141.3 70.01 Favored 'Cis proline' 0 N--CA 1.497 1.711 0 C-N-CA 124.681 -0.966 . . . . 0.0 112.178 -0.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.34 144.72 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.606 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.2 -79.11 1.93 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 63.59 172.35 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 0.0 110.459 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -93.09 -4.91 51.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.221 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -89.46 162.91 15.49 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.91 0.386 . . . . 0.0 110.645 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.11 10.45 41.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.58 142.82 50.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 110.655 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 m -116.5 143.32 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.396 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -106.24 123.39 47.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.583 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.23 162.52 16.45 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.817 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -49.89 -28.71 6.98 Favored 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.602 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.2 -34.59 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -64.94 -54.09 36.18 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.458 1.027 . . . . 0.0 113.443 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.15 -42.43 84.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.772 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.0 m -69.34 -41.36 76.73 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.52 0.512 . . . . 0.0 109.815 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.82 -31.94 73.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.07 -39.61 94.46 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.96 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -66.2 -46.83 75.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.44 -40.18 97.52 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.168 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.23 -43.49 77.8 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.093 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 p -58.69 -36.53 74.36 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -34.02 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.398 -1.728 . . . . 0.0 108.216 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.54 -45.63 82.68 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.326 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 p -69.08 -31.8 70.8 Favored 'General case' 0 CA--C 1.471 -2.067 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.31 -40.95 71.72 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.0 -44.07 73.55 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.827 173.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 t -59.65 -12.43 6.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 120.115 1.325 . . . . 0.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -32.69 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.809 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 168.58 12.21 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.54 -23.08 66.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 tt -73.62 7.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 p -124.42 135.56 53.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.215 0.531 . . . . 0.0 110.95 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.58 -159.82 22.95 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.41 85.89 1.12 Allowed 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.623 1.202 . . . . 0.0 108.468 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -73.2 -19.65 61.05 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.425 ' HA ' ' HB1' ' A' ' 20' ' ' ALA . 1.2 pp -84.87 8.67 16.63 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.787 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -134.55 127.63 18.74 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.33 -28.3 1.52 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.092 2.528 . . . . 0.0 112.275 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.35 -49.03 79.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -36.75 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 m -61.15 -28.62 69.25 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -44.34 96.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.38 . . . . 0.0 110.155 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.79 96.37 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.29 -46.18 65.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.657 0.265 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.97 -43.69 40.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.586 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 63.23 153.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.552 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.2 m -48.64 -81.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.788 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 48.6 -163.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.769 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -91.45 -44.08 9.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.542 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.1 tt -166.38 153.97 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.606 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -70.84 -163.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.442 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.57 -80.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.612 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 176.2 -43.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.594 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -54.66 -39.13 67.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.53 -35.26 78.75 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.681 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.42 67.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 176.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 tpp -73.39 -31.61 63.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.214 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.73 -39.19 76.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 119.267 0.939 . . . . 0.0 111.575 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.83 -41.19 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.695 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -70.65 -38.04 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.42 -47.0 74.63 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -35.71 70.81 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -36.11 72.44 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.35 -35.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.197 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.36 -46.72 86.39 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 120.899 1.681 . . . . 0.0 113.084 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.454 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.89 -36.04 75.13 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 77.6 mt -64.98 -50.31 75.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.305 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 m -65.42 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.27 -43.33 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.973 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -37.05 74.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.75 85.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.454 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt -66.76 -37.33 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.42 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.08 -24.44 65.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.4 p -61.4 -41.71 97.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.813 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.0 61.56 Favored Glycine 0 CA--C 1.51 -0.266 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -29.83 24.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.456 -0.872 . . . . 0.0 111.391 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -81.59 5.36 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.627 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m -58.01 -26.93 63.03 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.707 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 77.4 p -92.01 -35.5 13.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.111 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.2 135.46 49.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.882 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t -115.57 164.5 14.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.615 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 49.17 41.74 30.99 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -88.22 9.84 21.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.0 79.29 0.26 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.942 0.401 . . . . 0.0 110.699 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.62 7.96 30.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.13 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.91 23.5 74.57 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.54 117.11 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.2 0.524 . . . . 0.0 111.452 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 58.02 11.01 1.32 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.064 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -87.78 91.85 8.9 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.16 143.1 58.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.302 0.572 . . . . 0.0 111.101 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.95 134.71 49.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.636 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -49.79 127.58 16.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 128.94 -104.38 0.64 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.668 HG13 ' HB2' ' A' ' 137' ' ' GLN . 1.7 t -86.07 124.02 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.439 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 1.4 t30 -71.67 -171.78 0.71 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 102.823 -3.029 . . . . 0.0 102.823 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 p -62.2 -46.8 87.3 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 114.843 -2.743 . . . . 0.0 110.187 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.14 95.94 Favored Glycine 0 CA--C 1.498 -0.992 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.115 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.668 ' HB2' HG13 ' A' ' 133' ' ' VAL . 26.9 mm100 -53.46 -23.59 10.53 Favored 'General case' 0 C--N 1.248 -3.819 0 CA-C-O 121.496 0.665 . . . . 0.0 110.26 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -69.39 -1.54 29.21 Favored Glycine 0 C--O 1.188 -2.728 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.78 -50.32 65.14 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 118.556 1.178 . . . . 0.0 110.902 -176.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -38.23 76.36 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.531 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.7 OUTLIER -68.92 -38.32 78.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.18 -178.274 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 138' ' ' GLY . 20.4 mt-10 -68.54 -36.29 78.61 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-O 121.744 0.783 . . . . 0.0 111.123 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.7 mt -69.65 -45.46 77.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.395 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.496 -174.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.31 -48.78 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.463 1.125 . . . . 0.0 111.27 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.56 58.03 Favored Glycine 0 C--O 1.211 -1.299 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.718 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.8 m -70.62 -40.16 73.32 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.673 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tp -54.8 -40.55 69.59 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.277 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 1.1 pt20 -58.07 -31.1 66.76 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.241 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 tp -68.69 -47.17 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.49 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.33 -40.98 88.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -42.28 96.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 3.8 p -71.0 -27.18 63.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.457 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 t -72.09 -45.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.552 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.59 -41.98 92.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.372 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.56 87.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.519 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.92 -36.96 75.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.508 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.71 -1.98 58.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.476 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -67.2 108.65 2.77 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.64 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -60.91 -32.87 72.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.627 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -83.33 127.79 33.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.471 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.56 105.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.634 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -130.47 116.69 18.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.525 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.38 108.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.616 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.9 -58.06 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.487 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.48 142.29 9.2 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 75.65 -138.69 23.47 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 m -112.36 135.41 53.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 0.0 110.507 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.444 ' N ' ' CD ' ' A' ' 169' ' ' PRO . . . -52.34 -46.23 94.53 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.548 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 24.3 Cg_exo -54.67 -39.39 89.27 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.524 1.483 . . . . 0.0 111.972 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.54 -42.42 96.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.382 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.55 -47.06 57.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.703 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 41.6 mt -58.23 -37.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.62 -37.42 93.58 Favored Glycine 0 C--O 1.198 -2.125 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.306 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -35.98 65.27 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -34.56 77.24 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.52 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.0 t -73.15 -47.6 46.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.72 -34.89 78.85 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.261 1.029 . . . . 0.0 109.667 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.264 8.1 mt -67.06 -50.56 61.45 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 124.454 2.073 . . . . 0.0 110.863 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -36.97 65.38 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.117 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.425 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 5.4 m-70 -70.38 -35.12 73.31 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 112.669 -1.766 . . . . 0.0 109.504 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.2 -47.81 83.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.519 -177.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -52.33 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.463 ' O ' ' CG2' ' A' ' 187' ' ' THR . . . -70.15 -52.22 25.24 Favored 'General case' 0 C--O 1.206 -1.221 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 188' ' ' GLY . 7.4 mt -56.02 -49.03 77.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.914 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.644 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -69.02 -35.67 76.91 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 115.538 -2.465 . . . . 0.0 112.582 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 133' ' ' VAL . 2.4 m-85 -60.11 -30.35 69.2 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.721 -170.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.288 0.1 OUTLIER -124.54 -26.82 3.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.06 0.933 . . . . 0.0 113.101 -179.401 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 88.35 -5.99 84.09 Favored Glycine 0 CA--C 1.567 3.284 0 N-CA-C 106.165 -2.774 . . . . 0.0 106.165 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 17.1 t -85.36 130.68 34.54 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.47 160.65 10.04 Favored Glycine 0 N--CA 1.402 -3.625 0 CA-C-N 111.497 -2.592 . . . . 0.0 111.752 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.11 -38.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -85.88 139.19 34.99 Favored Pre-proline 0 N--CA 1.413 -2.32 0 CA-C-N 112.657 -2.065 . . . . 0.0 107.997 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -66.03 -14.46 44.53 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.49 2.127 . . . . 0.0 111.58 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -75.23 -33.23 61.33 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.411 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 15.6 tpt180 -70.74 -38.39 73.54 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.106 0.479 . . . . 0.0 110.158 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.4 t -73.44 -42.22 62.27 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.443 ' HA ' ' CB ' ' A' ' 200' ' ' ALA . 1.0 OUTLIER -71.96 -35.2 69.48 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 126.607 1.963 . . . . 0.0 114.777 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.41 93.12 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 m -76.38 -28.35 56.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.322 -0.939 . . . . 0.0 110.669 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 197' ' ' PHE . . . -66.31 -34.22 77.49 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.743 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 3.4 m -58.75 -31.11 43.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 121.79 2.086 . . . . 0.0 110.526 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.66 -54.71 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.506 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.27 -173.01 4.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.42 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -141.97 93.79 2.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 110.658 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -105.03 -178.49 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.24 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -124.98 -96.52 0.44 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.74 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.15 -42.63 93.58 Favored 'General case' 0 C--O 1.228 -0.063 0 CA-C-O 120.821 0.343 . . . . 0.0 110.993 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -55.17 -35.04 64.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.477 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -32.26 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.891 0.377 . . . . 0.0 111.077 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -70.44 -32.48 70.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.602 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.1 mp -52.82 -35.06 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.832 0.825 . . . . 0.0 109.005 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -58.8 -36.19 74.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.058 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.27 -33.41 24.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 12.0 p -77.74 -44.99 28.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.496 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.27 -47.73 73.13 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.682 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.1 Cg_endo -71.8 -28.62 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.936 2.424 . . . . 0.0 113.609 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -75.2 -33.81 61.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.051 0.453 . . . . 0.0 111.898 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.558 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 51.8 mt -70.58 -46.25 70.72 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.382 0 C-N-CA 123.892 0.877 . . . . 0.0 112.753 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.445 ' O ' ' CD1' ' A' ' 222' ' ' LEU . . . -68.29 -45.84 67.61 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 128.343 3.527 . . . . 0.0 111.752 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -70.39 -48.91 34.71 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 118.306 -1.902 . . . . 0.0 109.532 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.81 68.31 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.601 0.715 . . . . 0.0 109.674 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.0 OUTLIER -67.85 -31.33 71.08 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.225 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.432 ' O ' HG13 ' A' ' 226' ' ' ILE . . . -58.99 -40.03 83.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.51 -50.28 80.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.488 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -39.56 93.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 223' ' ' ALA . 1.1 pp -68.99 -34.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.325 -176.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -122.88 63.08 0.98 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -158.39 127.31 5.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -89.61 93.28 9.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.741 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 mm -143.55 122.38 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.425 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 70.73 -70.17 0.16 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.618 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . 61.78 72.67 0.63 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.578 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.64 73.8 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.724 2.282 . . . . 0.0 112.11 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -50.32 114.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.575 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.1 m -85.99 -32.04 21.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.543 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 4.4 t -86.44 -176.17 5.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.88 163.61 2.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.91 -60.41 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.552 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.65 93.41 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.574 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -112.4 27.06 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.52 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -119.01 -67.8 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.576 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.21 158.12 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.577 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -170.71 140.04 1.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.584 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.7 t 53.19 76.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.473 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -55.88 -48.81 74.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.49 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 10.5 p -70.05 179.29 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.596 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.96 142.43 41.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.604 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -60.19 108.8 1.93 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.82 166.81 13.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.545 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.5 t -101.29 -54.78 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.574 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -63.29 123.47 18.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.65 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -88.72 137.87 31.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.648 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -119.71 -34.58 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.6 -170.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.551 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.22 153.0 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.561 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.04 -82.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.18 107.32 1.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.567 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -159.62 37.07 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.499 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -127.38 31.92 5.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.564 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 22.9 mt 52.97 87.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.639 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -115.53 -31.05 6.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.608 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 1.1 p 55.85 -176.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.455 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 64.98 117.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.56 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.35 164.06 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.564 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 61.58 92.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.554 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 5.1 mtm -114.12 103.07 10.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.535 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 1.6 mttm 177.57 -55.64 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.06 -50.07 9.2 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.038 1.825 . . . . 0.0 112.309 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -109.81 145.41 36.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.581 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -120.97 -54.35 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.568 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.7 tp 57.05 28.55 15.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -137.45 134.9 36.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -103.7 135.73 44.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.41 102.01 7.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.644 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.2 tp -108.3 124.27 50.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.594 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 5.1 tt -118.59 -30.84 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.588 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 6.2 t -50.21 142.56 9.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.604 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -150.72 109.74 3.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.559 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -140.85 78.14 1.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.58 168.83 9.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.487 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.62 159.15 1.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.571 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -91.66 75.06 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.479 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.8 t -69.21 -40.21 78.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . 54.33 92.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.29 120.78 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.582 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.54 162.1 14.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.629 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -105.67 40.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.565 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -126.14 170.37 11.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.562 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -61.89 171.59 1.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -74.59 -30.08 61.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.66 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -94.61 -54.02 3.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.578 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 4.1 t60 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.453 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.63 -5.53 11.15 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.478 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -63.12 -40.26 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 9.0 p -68.23 -35.75 72.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.119 176.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.79 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -70.79 -46.54 62.69 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -176.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -33.53 71.66 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 19' ' ' LEU . 11.6 mt -58.43 -38.32 77.23 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.992 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.6 -46.64 78.58 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 112.899 -1.955 . . . . 0.0 114.865 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 105' ' ' ALA . 0.2 OUTLIER -75.63 -31.32 59.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.506 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.724 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -70.33 -39.05 74.97 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.736 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -44.73 84.01 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.636 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -76.83 -52.5 9.4 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.48 -44.72 94.13 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.604 -177.104 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.513 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 63.3 t80 -54.3 -48.97 70.71 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.424 0.631 . . . . 0.0 112.337 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 pt -75.65 -29.54 20.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.52 -36.42 69.18 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -175.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.803 HG21 HD22 ' A' ' 112' ' ' LEU . 3.8 mm -60.84 -38.59 79.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.065 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -36.8 64.65 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p -67.01 -41.28 86.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.469 179.579 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.806 0.336 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.52 -28.47 5.53 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG22 HD21 ' A' ' 181' ' ' LEU . 18.4 t -58.77 -42.5 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 O-C-N 121.821 -0.55 . . . . 0.0 112.264 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -65.01 -53.98 37.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.729 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 33.9 m -67.84 -42.17 85.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.225 -176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.456 ' N ' HG23 ' A' ' 52' ' ' VAL . 72.8 m -69.39 -41.23 76.74 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.933 0.771 . . . . 0.0 109.806 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.815 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.8 OUTLIER -62.74 -31.74 72.73 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.193 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -65.08 -39.49 93.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.508 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 60' ' ' ILE . 16.5 m-30 -66.15 -46.92 75.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.7 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -60.23 -36.96 92.2 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.277 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 27.1 mt -68.28 -43.06 78.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.8 m -57.61 -35.86 71.02 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 176' ' ' VAL . 0.6 OUTLIER -60.23 -33.81 54.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.675 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.745 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -60.64 -45.53 93.73 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.51 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -31.52 70.59 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.641 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -55.05 -42.59 72.9 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 104.199 -2.519 . . . . 0.0 104.199 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.98 -44.27 73.21 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.654 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -43.57 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -176.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -59.25 -12.26 5.2 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 119.936 1.243 . . . . 0.0 111.856 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 m -119.76 -38.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 154.16 6.34 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -52.94 -22.74 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 70' ' ' ILE . 2.1 mp -70.89 7.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.56 135.71 53.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.11 -159.61 31.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.48 85.99 1.15 Allowed 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 118.574 -1.25 . . . . 0.0 107.776 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -19.54 64.46 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 112.794 -2.003 . . . . 0.0 105.684 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 pp -84.84 0.18 51.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.398 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.26 128.81 25.53 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 119.371 0.987 . . . . 0.0 113.517 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 97.9 Cg_endo -83.35 -25.34 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.717 2.278 . . . . 0.0 111.86 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.56 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.27 -46.16 84.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.509 HG23 HD23 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -66.23 -36.8 78.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 110.802 177.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -64.68 -28.62 69.73 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -57.21 -44.47 83.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 110.285 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.24 95.89 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.8 tp -51.41 -41.26 60.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.576 0.227 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 tp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.432 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.854 0.359 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.724 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.7 -35.2 78.38 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.701 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 tp -54.78 -38.45 67.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -32.63 64.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.227 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -70.06 -38.65 75.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.287 0.949 . . . . 0.0 111.947 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.724 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -66.77 -41.25 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -178.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.49 -37.78 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.414 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.02 83.53 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.008 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.33 -35.89 71.37 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.438 ' O ' HG13 ' A' ' 106' ' ' ILE . 1.2 t -57.91 -36.14 72.03 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.57 -35.33 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.429 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.37 85.22 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 120.781 1.628 . . . . 0.0 113.221 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB2' ' CG2' ' A' ' 21' ' ' THR . . . -69.8 -35.9 75.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 102' ' ' CYS . 69.5 mt -65.03 -50.36 75.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.98 -37.12 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.434 0.635 . . . . 0.0 109.48 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.724 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.45 -49.83 74.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.407 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.71 -37.02 86.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.727 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -44.89 88.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.19 -37.28 76.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.087 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.803 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -65.81 -24.36 66.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.601 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 t -63.3 -44.38 95.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.901 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.25 -36.33 62.16 Favored Glycine 0 CA--C 1.509 -0.299 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -33.16 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.3 -0.95 . . . . 0.0 110.728 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.559 -179.508 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.54 117.2 31.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.281 0.563 . . . . 0.0 111.131 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.85 15.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.665 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.15 90.07 7.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 129' ' ' LEU . 1.2 mm? -63.1 142.8 58.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.317 0.58 . . . . 0.0 111.149 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.96 136.25 47.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.333 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 127.58 16.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.66 -105.05 0.65 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.8 t -86.09 124.13 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.48 ' O ' HG12 ' A' ' 133' ' ' VAL . 32.1 t30 -71.65 -171.95 0.73 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -62.01 -46.86 87.34 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 114.928 -2.709 . . . . 0.0 110.239 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.53 96.17 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.754 ' HB3' HG22 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -53.39 -23.53 9.9 Favored 'General case' 0 C--N 1.248 -3.809 0 CA-C-O 121.261 0.553 . . . . 0.0 110.796 -176.504 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -70.33 -1.95 38.53 Favored Glycine 0 C--O 1.187 -2.794 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.98 -50.64 71.26 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.521 -1.576 . . . . 0.0 110.168 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.71 -45.94 56.27 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.748 HD13 HG21 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -60.88 -42.08 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.184 -1.508 . . . . 0.0 112.084 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' A' ' 138' ' ' GLY . 8.3 tt0 -68.37 -36.32 79.02 Favored 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 123.687 0.795 . . . . 0.0 112.305 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.646 HG23 ' CA ' ' A' ' 219' ' ' GLY . 25.4 mt -67.65 -47.68 79.18 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.404 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 26.9 mt -68.33 -46.79 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.059 0.933 . . . . 0.0 111.695 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.536 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -60.18 -49.94 73.04 Favored Glycine 0 C--O 1.211 -1.335 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.323 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.5 ' HA ' HG23 ' A' ' 191' ' ' ILE . 28.1 m -70.58 -38.22 74.03 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.923 0.868 . . . . 0.0 111.13 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.612 ' O ' HD12 ' A' ' 147' ' ' LEU . 1.7 tp -54.98 -40.22 69.83 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.048 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.8 OUTLIER -58.77 -31.06 68.02 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.325 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.0 HD11 HG22 ' A' ' 176' ' ' VAL . 1.8 tp -68.91 -46.69 67.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.353 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.491 HG21 ' HA3' ' A' ' 220' ' ' GLY . 38.9 t -66.35 -45.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -31.87 72.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.089 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.09 -45.43 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 -48.1 80.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 111.119 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.84 -31.69 72.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.488 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.468 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.537 ' HB3' ' HD3' ' A' ' 169' ' ' PRO . . . . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 119.62 -0.229 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 39.5 Cg_exo -54.31 -44.24 51.24 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.795 1.663 . . . . 0.0 112.019 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 mp -66.1 -38.1 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.26 56.38 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 22.2 pt -60.26 -38.3 76.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.721 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.41 93.53 Favored Glycine 0 C--O 1.2 -1.994 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.681 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mt -55.04 -35.58 64.63 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.161 -2.162 . . . . 0.0 105.161 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -34.54 77.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.31 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 1.0 HG22 HD11 ' A' ' 149' ' ' LEU . 52.9 t -73.04 -47.24 48.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.907 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 -175.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.815 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -67.53 -33.61 75.41 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 122.665 1.222 . . . . 0.0 110.027 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.258 0.1 OUTLIER -70.61 -47.49 59.85 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.973 179.375 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.494 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.64 -36.84 65.94 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 111.564 -2.562 . . . . 0.0 107.664 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' HIS . . . . . 0.481 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 6.2 m170 -70.46 -34.99 73.06 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.933 -1.633 . . . . 0.0 109.54 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.02 -48.43 81.61 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.359 -177.678 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.536 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.41 -52.07 11.6 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 178.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -69.66 -51.96 30.04 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 180' ' ' HIS . 5.6 mt -62.11 -49.14 85.29 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.807 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.039 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -67.28 -35.51 79.64 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 116.119 -2.232 . . . . 0.0 112.818 -176.66 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.95 -30.4 69.05 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.909 -1.116 . . . . 0.0 111.699 -171.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.295 0.1 OUTLIER -124.31 -26.91 3.86 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.267 1.032 . . . . 0.0 113.182 -178.79 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.61 -5.74 84.51 Favored Glycine 0 CA--C 1.567 3.296 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -170.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.408 ' H ' HG23 ' A' ' 187' ' ' THR . 15.4 t -82.68 127.89 33.83 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.596 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -44.33 170.35 0.01 OUTLIER Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 111.358 -2.655 . . . . 0.0 113.363 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -79.76 -40.14 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 173.311 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -101.32 153.12 38.01 Favored Pre-proline 0 N--CA 1.407 -2.614 0 CA-C-N 111.432 -2.622 . . . . 0.0 108.361 177.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.46 -14.59 44.75 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 122.879 2.386 . . . . 0.0 111.661 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.622 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.11 -34.5 61.72 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.102 0.251 . . . . 0.0 111.094 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.596 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.52 -39.67 73.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.214 0.531 . . . . 0.0 109.928 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -36.49 66.39 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.008 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.814 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 6.1 t80 -72.26 -35.2 68.71 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 126.517 1.927 . . . . 0.0 114.268 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -46.77 91.73 Favored Glycine 0 C--N 1.319 -0.373 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.3 56.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.19 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -63.33 -34.07 76.89 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.514 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.429 HG23 ' CE2' ' A' ' 197' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 121.031 1.741 . . . . 0.0 110.425 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 CA--C 1.511 -0.545 0 CA-C-O 121.73 0.776 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.53 -36.57 74.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.049 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -84.21 -33.46 24.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 215' ' ' GLY . 15.0 p -79.09 -43.97 24.29 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.509 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.12 -44.15 83.6 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.417 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.6 Cg_exo -71.65 -28.72 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.258 . . . . 0.0 113.106 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.03 -32.14 50.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.146 0.498 . . . . 0.0 112.29 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.549 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.2 mm -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.255 0 C-N-CA 123.743 0.817 . . . . 0.0 112.164 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.646 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.71 -46.6 67.04 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 128.758 3.786 . . . . 0.0 111.731 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.31 -49.03 34.66 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 118.171 -1.966 . . . . 0.0 109.906 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -39.04 68.47 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.649 0.738 . . . . 0.0 109.713 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.86 -31.24 70.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.223 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.58 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.84 -39.68 81.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.17 -49.65 80.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.352 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.84 -39.42 91.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.754 0.788 . . . . 0.0 109.771 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 mt -58.27 -34.72 50.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.069 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--N 1.331 -0.229 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.563 -179.408 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.24 -14.4 11.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.027 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.01 -40.17 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 17.4 m -68.43 -35.81 72.24 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 112.83 -1.986 . . . . 0.0 110.521 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.18 70.07 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.683 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 11.1 mm-40 -70.81 -46.72 62.29 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -33.83 74.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 11.4 mt -58.63 -38.37 77.93 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.911 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.58 -46.99 77.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.781 -2.009 . . . . 0.0 114.749 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -75.65 -31.53 59.83 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.735 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.74 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.79 -36.88 67.69 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.507 -0.745 . . . . 0.0 111.607 -179.103 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -66.05 -45.22 82.15 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -77.18 -47.7 19.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 29' ' ' ILE . 90.2 t -65.28 -49.82 76.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.137 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.475 ' CE1' HD12 ' A' ' 112' ' ' LEU . 55.7 t80 -54.07 -48.07 71.01 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.5 -29.43 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.616 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -36.17 68.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.6 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -60.11 -43.74 93.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.76 63.87 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -67.33 -38.1 84.35 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.605 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 81.7 m-20 . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 121.08 0.466 . . . . 0.0 111.683 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.75 -28.02 5.64 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.403 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.566 HG12 HD21 ' A' ' 181' ' ' LEU . 24.5 m -56.74 -43.85 80.34 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.549 ' NZ ' HG23 ' A' ' 52' ' ' VAL . 1.7 pttp -64.77 -50.46 66.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 2.0 t -67.91 -47.65 78.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.647 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -69.31 -37.18 77.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.787 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 2.5 tm? -64.43 -32.01 73.46 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -62.35 -39.49 93.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.824 -1.534 . . . . 0.0 109.327 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -65.89 -44.27 85.78 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.76 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.48 -41.55 97.93 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -68.26 -43.92 76.73 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.749 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.467 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -61.04 -36.53 79.82 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.438 HD13 HD21 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -59.87 -33.89 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.006 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.752 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -68.61 -45.63 71.41 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.857 -1.519 . . . . 0.0 113.016 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 p -67.36 -31.88 72.43 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -55.35 -41.26 72.28 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.9 -44.14 73.81 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.788 173.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -38.03 85.96 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.8 m -59.54 -12.13 5.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 119.754 1.161 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.27 -42.91 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.936 0.398 . . . . 0.0 111.133 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 171.77 13.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -65.26 -23.05 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.767 0.318 . . . . 0.0 111.008 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.45 7.11 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.45 135.65 53.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.049 0.452 . . . . 0.0 111.051 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.92 -157.86 16.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.36 86.04 1.11 Allowed 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 122.507 1.146 . . . . 0.0 108.085 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -19.61 62.38 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.4 pp -84.53 4.58 31.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 113.669 -1.605 . . . . 0.0 111.625 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.447 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 14.5 t-20 -125.49 126.11 25.05 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.547 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 71.9 Cg_endo -83.23 -24.02 3.3 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.883 2.389 . . . . 0.0 111.632 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -66.16 -50.84 62.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -36.67 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.923 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 m -61.21 -32.23 72.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 217' ' ' PHE . 34.4 tp -57.27 -44.61 84.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.044 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.25 -45.87 63.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -44.29 66.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 111.008 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.862 0.363 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.91 -35.13 77.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.682 ' O ' HG13 ' A' ' 98' ' ' ILE . 3.1 mm? -54.54 -38.18 66.3 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mtm -73.71 -33.3 64.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.767 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -69.99 -37.84 75.84 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.096 -1.003 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.805 HG23 ' O ' ' A' ' 94' ' ' ALA . 1.8 pp -66.81 -42.55 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.384 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.12 -37.73 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.37 70.27 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -71.96 -35.97 69.72 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.669 0.668 . . . . 0.0 112.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 m -58.1 -35.88 72.07 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.52 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.8 t -70.4 -35.36 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.063 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.07 91.59 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 121.152 1.796 . . . . 0.0 112.519 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.469 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.95 -36.1 75.0 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 103' ' ' VAL . 37.0 mt -67.99 -42.41 85.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.575 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.4 t -69.93 -37.18 72.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.294 0.569 . . . . 0.0 110.107 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.63 -49.74 75.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.445 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 35.8 m -65.88 -37.1 85.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.457 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.53 88.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.735 0.303 . . . . 0.0 111.135 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.27 -50.5 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.28 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.6 HD22 HG21 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -58.85 -24.2 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.537 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -42.63 95.51 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.771 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.26 61.95 Favored Glycine 0 CA--C 1.511 -0.178 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.4 -31.95 44.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.779 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.582 -179.654 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.478 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.56 117.49 32.46 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.125 -0.538 . . . . 0.0 111.778 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 60.23 9.19 1.81 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.02 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -87.68 88.32 7.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.12 143.24 57.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.254 0.55 . . . . 0.0 110.88 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.05 135.7 48.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.679 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -49.64 127.45 15.76 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.6 -105.35 0.67 Allowed Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.86 HG21 HD13 ' A' ' 141' ' ' ILE . 1.6 t -85.83 123.93 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.461 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.5 m-20 -71.71 -171.85 0.73 Allowed 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -61.92 -46.74 88.05 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 114.807 -2.757 . . . . 0.0 110.409 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.04 -41.24 96.37 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.071 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.782 ' HB3' HG22 ' A' ' 133' ' ' VAL . 4.5 mt-30 -53.53 -23.42 10.48 Favored 'General case' 0 C--N 1.249 -3.789 0 CA-C-O 121.238 0.542 . . . . 0.0 110.237 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.565 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.65 -1.72 24.89 Favored Glycine 0 C--O 1.19 -2.597 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.43 -50.23 66.19 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 118.489 1.144 . . . . 0.0 110.322 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -40.96 75.16 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.86 HD13 HG21 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -66.17 -38.77 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 113.155 -1.523 . . . . 0.0 112.087 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 32.5 mt-10 -68.46 -36.24 78.71 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 121.948 0.88 . . . . 0.0 111.039 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.756 HG23 ' HA2' ' A' ' 219' ' ' GLY . 35.6 mt -67.29 -48.47 77.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.627 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.26 -48.47 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 122.088 0.947 . . . . 0.0 111.424 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.53 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -59.25 -51.97 56.02 Favored Glycine 0 C--O 1.211 -1.329 0 CA-C-N 113.466 -1.697 . . . . 0.0 113.138 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.401 ' HA ' HG23 ' A' ' 191' ' ' ILE . 24.2 m -70.39 -40.42 73.94 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.5 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 148' ' ' GLN . 0.5 OUTLIER -54.64 -40.11 68.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -176.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.46 ' N ' HD23 ' A' ' 147' ' ' LEU . 1.1 pt20 -58.0 -30.82 66.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.02 HD11 HG22 ' A' ' 176' ' ' VAL . 1.3 tp -68.75 -46.72 68.09 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.426 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.41 HG21 ' HA3' ' A' ' 220' ' ' GLY . 78.9 t -66.26 -41.03 88.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -35.65 81.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.442 0.297 . . . . 0.0 111.463 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -34.47 77.36 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.644 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.01 -38.53 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.847 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.4 mp -65.33 -48.02 74.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.81 0.338 . . . . 0.0 110.971 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.76 72.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.42 HG23 ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.193 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 169' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.479 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 17.9 Cg_endo -61.32 -36.78 77.3 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.007 1.138 . . . . 0.0 111.692 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mp -66.22 -44.95 82.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.87 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.4 -47.43 56.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.2 -37.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.515 0.674 . . . . 0.0 109.446 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.48 93.47 Favored Glycine 0 C--O 1.2 -2.013 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.755 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.3 OUTLIER -54.92 -35.65 64.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -34.49 77.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.421 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 1.02 HG22 HD11 ' A' ' 149' ' ' LEU . 16.7 t -73.16 -47.38 47.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.787 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.37 -30.73 67.73 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 122.528 1.156 . . . . 0.0 110.195 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.578 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.28 2.6 mm? -70.43 -50.88 33.87 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.874 2.274 . . . . 0.0 109.528 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.487 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.53 -36.92 65.36 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 110.559 -3.019 . . . . 0.0 107.114 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' HIS . . . . . 0.427 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.4 m-70 -69.08 -35.22 76.28 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.334 -1.433 . . . . 0.0 109.657 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.95 -48.34 81.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.234 -177.498 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.53 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.32 -52.07 11.69 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 178.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.567 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -69.79 -52.03 28.75 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.501 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 12.8 mt -60.16 -41.82 88.0 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.602 0 C-N-CA 118.731 -1.188 . . . . 0.0 113.244 -174.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -75.84 -35.68 59.87 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 115.911 -2.316 . . . . 0.0 112.564 -176.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.01 -29.68 68.65 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.385 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.283 0.1 OUTLIER -124.43 -26.8 3.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.063 -178.989 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.74 -5.97 84.15 Favored Glycine 0 CA--C 1.566 3.256 0 N-CA-C 106.046 -2.822 . . . . 0.0 106.046 -170.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.424 ' H ' HG23 ' A' ' 187' ' ' THR . 9.4 t -82.28 127.74 33.5 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 184' ' ' ILE . . . -47.83 164.37 0.23 Allowed Glycine 0 N--CA 1.408 -3.226 0 CA-C-N 111.146 -2.752 . . . . 0.0 112.497 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.567 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.6 OUTLIER -72.34 -33.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.2 p-10 -109.73 152.44 42.89 Favored Pre-proline 0 N--CA 1.415 -2.217 0 CA-C-N 112.544 -2.116 . . . . 0.0 109.288 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.08 -14.66 45.4 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.618 2.212 . . . . 0.0 111.686 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.547 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.39 -35.75 60.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.697 0.285 . . . . 0.0 110.498 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -41.16 72.94 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.336 0.589 . . . . 0.0 109.85 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -32.61 64.71 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.475 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.834 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.9 m-85 -72.27 -35.24 68.69 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.464 1.906 . . . . 0.0 113.948 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -44.44 93.9 Favored Glycine 0 C--N 1.318 -0.456 0 N-CA-C 106.971 -2.451 . . . . 0.0 106.971 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.53 -28.21 56.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.088 -1.056 . . . . 0.0 110.842 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.19 75.74 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 121.598 1.999 . . . . 0.0 110.929 -179.813 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.32 0 CA-C-O 121.788 0.804 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -58.92 -37.5 76.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.027 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -84.28 -33.53 23.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.6 p -80.49 -40.06 19.19 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.517 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.0 -48.23 68.52 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.976 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.8 Cg_endo -71.96 -38.97 3.53 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.046 2.497 . . . . 0.0 113.675 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.451 ' CD2' HD22 ' A' ' 81' ' ' LEU . 1.8 m-85 -63.25 -39.79 95.59 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.645 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.9 mm -70.31 -46.55 70.98 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.148 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.67 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.756 ' HA2' HG23 ' A' ' 143' ' ' ILE . . . -55.18 -45.64 81.71 Favored Glycine 0 C--N 1.364 2.128 0 O-C-N 128.529 3.643 . . . . 0.0 111.339 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -69.13 -41.41 80.58 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.19 -34.83 61.48 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.7 mt -67.69 -36.92 81.54 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.38 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -59.06 -39.58 82.53 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.277 -174.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 88.4 t -58.38 -49.7 81.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.638 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.61 0.719 . . . . 0.0 110.155 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt -57.14 -34.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.119 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--N 1.329 -0.292 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.437 -179.346 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.449 0.166 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.54 -0.5 13.03 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.814 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.54 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.3 -35.77 72.33 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.762 0 CA-C-N 112.506 -2.134 . . . . 0.0 109.932 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.15 -35.02 69.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.703 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -70.99 -46.72 61.8 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -177.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -34.23 73.48 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.05 -38.08 78.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.174 -2.284 . . . . 0.0 108.748 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -64.09 -46.82 82.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.355 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.91 -31.51 59.21 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.099 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.72 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.89 -38.18 67.05 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.548 -0.72 . . . . 0.0 112.091 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.515 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -76.9 -49.55 15.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.057 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 29' ' ' ILE . 97.7 t -65.33 -48.46 83.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.363 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' A' ' 112' ' ' LEU . 50.1 t80 -53.95 -48.51 70.2 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.6 -29.21 20.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.387 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -36.2 67.41 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.627 HG21 HD22 ' A' ' 112' ' ' LEU . 2.8 mm -63.06 -41.74 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.311 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.5 -38.83 71.89 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -37.97 84.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -176.819 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -49.87 -28.59 6.76 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.535 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG13 ' CE ' ' A' ' 51' ' ' LYS . 1.3 p -57.14 -39.02 64.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.53 ' CE ' HG13 ' A' ' 50' ' ' VAL . 4.6 mmtp -64.7 -54.08 37.26 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.728 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 94.5 t -67.75 -45.65 84.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.724 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 m -69.29 -39.18 78.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.785 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 62.5 tp -63.0 -31.68 72.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.45 -39.38 94.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.231 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -65.88 -43.36 88.51 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.745 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.69 -43.02 96.94 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.275 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 1.0 OUTLIER -68.2 -43.77 77.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.597 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -36.7 76.26 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.698 HD13 HD21 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -59.96 -34.13 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 113.228 -1.805 . . . . 0.0 108.13 -178.485 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.758 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -64.48 -45.76 85.96 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.174 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.41 ' H ' HG23 ' A' ' 62' ' ' THR . 8.3 p -70.12 -31.7 69.36 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.833 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -55.28 -40.78 71.44 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.96 -44.25 73.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.218 -1.81 . . . . 0.0 109.828 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 62' ' ' THR . 21.6 tp60 -66.8 -39.0 87.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -12.21 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 119.978 1.263 . . . . 0.0 111.329 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.81 -37.12 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.765 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.25 154.52 6.87 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -53.29 -22.91 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.934 0.397 . . . . 0.0 111.065 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 tt -74.34 7.08 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -124.3 135.59 53.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.129 0.49 . . . . 0.0 111.57 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.48 -159.37 24.95 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.57 85.9 1.17 Allowed 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 118.254 -1.378 . . . . 0.0 108.589 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.833 HD22 ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -82.41 8.44 11.46 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.122 -1.854 . . . . 0.0 112.235 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.522 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -136.95 140.09 30.59 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 119.333 0.97 . . . . 0.0 112.676 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 62.5 Cg_endo -83.67 -30.62 0.74 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 123.27 2.647 . . . . 0.0 112.563 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.713 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -60.12 -50.64 72.9 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.458 ' CG2' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -66.31 -36.69 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -30.89 70.71 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.478 HD22 ' CG ' ' A' ' 217' ' ' PHE . 13.7 tp -57.93 -38.0 75.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.242 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.32 -44.57 93.4 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -21.89 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.643 0.259 . . . . 0.0 111.326 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.01 -179.677 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 . . . . . 0 N--CA 1.46 0.054 0 CA-C-O 121.064 0.459 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.85 -35.0 77.79 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.212 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.58 -38.49 66.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.5 ttt -70.63 -38.76 73.92 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.542 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -62.59 -37.59 86.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.332 0.969 . . . . 0.0 109.67 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -58.09 -47.22 87.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.368 -178.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.434 ' N ' HG22 ' A' ' 98' ' ' ILE . 4.3 tp -70.35 -37.8 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . . . -64.94 -47.43 77.68 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.529 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 77' ' ' PRO . 5.0 pp0? -71.54 -35.18 70.58 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -35.88 71.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.76 -35.41 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.124 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.58 90.74 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 120.815 1.643 . . . . 0.0 113.437 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.464 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.85 -35.98 75.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.37 -42.7 87.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.689 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.86 -37.23 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.311 0.577 . . . . 0.0 109.567 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.72 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.59 -43.38 84.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.105 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -37.03 74.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.394 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.76 -41.19 85.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.012 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.55 -48.22 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.26 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.627 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -58.8 -24.43 61.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.0 t -62.03 -44.28 97.03 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.962 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.31 -36.28 62.4 Favored Glycine 0 CA--C 1.51 -0.234 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -32.39 36.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.366 -0.917 . . . . 0.0 110.742 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.1 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.182 -179.565 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -112.63 122.78 48.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.061 0.458 . . . . 0.0 111.741 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.03 20.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.671 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -108.77 99.66 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 135' ' ' SER . 3.4 mm? -63.21 147.6 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.441 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.88 139.86 40.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.864 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -50.09 127.57 17.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 130.41 -105.11 0.63 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.848 HG22 ' HB3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.01 131.0 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.447 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 3.7 t30 -71.74 -171.86 0.73 Allowed 'General case' 0 C--O 1.201 -1.482 0 N-CA-C 103.125 -2.917 . . . . 0.0 103.125 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.489 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -64.1 -46.74 82.9 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 114.648 -2.821 . . . . 0.0 109.788 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.704 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -58.72 -41.51 95.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.976 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.848 ' HB3' HG22 ' A' ' 133' ' ' VAL . 1.8 mm100 -53.46 -23.24 9.55 Favored 'General case' 0 C--N 1.247 -3.863 0 CA-C-O 121.375 0.607 . . . . 0.0 110.715 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -68.78 -1.4 24.07 Favored Glycine 0 C--O 1.192 -2.521 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 tp -66.58 -50.04 64.4 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.29 1.045 . . . . 0.0 110.902 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.415 ' HA2' HD12 ' A' ' 143' ' ' ILE . . . -69.62 -36.15 75.63 Favored Glycine 0 N--CA 1.455 -0.064 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.794 ' CD1' HG21 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -70.52 -36.29 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 113.407 -1.396 . . . . 0.0 111.633 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 138' ' ' GLY . 8.0 mt-10 -68.5 -36.46 78.94 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.06 0.933 . . . . 0.0 110.878 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 219' ' ' GLY . 40.8 mt -68.82 -52.54 33.9 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 113.977 -1.465 . . . . 0.0 110.743 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 145' ' ' GLY . 6.1 tp -68.17 -45.05 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 121.931 0.872 . . . . 0.0 111.472 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 144' ' ' ILE . . . -60.7 -52.03 54.99 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.805 -1.543 . . . . 0.0 113.193 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.505 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 20.2 m -70.87 -40.51 72.23 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.93 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.773 HD12 ' O ' ' A' ' 219' ' ' GLY . 0.7 OUTLIER -54.79 -40.01 69.03 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -176.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -57.84 -30.02 65.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.726 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.03 HD11 HG22 ' A' ' 176' ' ' VAL . 1.1 tp -68.82 -51.18 43.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.255 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.445 HG21 ' HA3' ' A' ' 220' ' ' GLY . 70.1 t -60.09 -41.03 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.989 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.25 -35.52 80.63 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -34.42 77.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.458 HG21 ' CG2' ' A' ' 79' ' ' VAL . 2.1 t -72.08 -38.32 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.532 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -41.03 96.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 110.809 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.76 -31.61 72.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.172 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.662 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.47 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.2 Cg_exo -54.53 -46.5 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.377 1.385 . . . . 0.0 111.532 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.12 -35.91 74.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -44.12 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.947 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.569 HD11 ' OG1' ' A' ' 156' ' ' THR . 79.4 mt -58.26 -38.09 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.59 -37.45 93.64 Favored Glycine 0 C--O 1.196 -2.229 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.19 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mp -55.05 -35.66 64.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.65 77.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.3 175.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 1.03 HG22 HD11 ' A' ' 149' ' ' LEU . 27.0 t -73.08 -47.54 47.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.785 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.08 -31.89 69.69 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.363 1.078 . . . . 0.0 109.859 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.268 1.8 tt -70.52 -49.73 45.15 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 124.503 2.097 . . . . 0.0 110.56 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.02 65.55 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 111.114 -2.767 . . . . 0.0 107.487 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' HIS . . . . . 0.433 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.6 m-70 -70.18 -35.3 73.87 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.537 -1.831 . . . . 0.0 109.403 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.15 -48.11 81.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.112 -177.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.07 -52.55 10.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.782 ' HB3' HG23 ' A' ' 191' ' ' ILE . . . -70.41 -52.24 23.76 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.557 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 9.3 mt -55.34 -40.23 56.09 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.805 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 35.0 t70 -77.56 -35.7 52.89 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.194 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -59.91 -30.42 69.03 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.459 -1.296 . . . . 0.0 110.945 -171.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 189' ' ' CYS 0.272 0.1 OUTLIER -124.37 -26.61 3.89 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.083 -178.754 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.9 -6.11 83.94 Favored Glycine 0 CA--C 1.564 3.103 0 N-CA-C 106.208 -2.757 . . . . 0.0 106.208 -170.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.465 ' H ' HG23 ' A' ' 187' ' ' THR . 13.1 t -86.63 132.24 33.94 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.658 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.0 161.72 7.75 Favored Glycine 1 N--CA 1.392 -4.235 0 CA-C-N 111.285 -2.689 . . . . 0.0 111.031 178.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.782 HG23 ' HB3' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -72.29 -40.83 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 174.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 17.0 p-10 -83.44 134.3 45.58 Favored Pre-proline 0 N--CA 1.416 -2.139 0 CA-C-N 112.693 -2.048 . . . . 0.0 108.038 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -58.37 -14.58 20.88 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.361 2.041 . . . . 0.0 111.642 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . . . -75.04 -33.81 61.79 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 123.269 0.356 . . . . 0.0 111.653 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.658 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.49 -37.94 74.29 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.471 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -33.48 65.47 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.489 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.841 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.1 m-85 -72.4 -35.08 68.32 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 126.41 1.884 . . . . 0.0 114.452 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.79 -44.48 94.2 Favored Glycine 0 C--N 1.318 -0.453 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.1 p -76.44 -28.31 56.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.131 -1.035 . . . . 0.0 110.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.07 75.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 121.268 1.849 . . . . 0.0 110.3 179.699 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.704 HG21 ' HA2' ' A' ' 136' ' ' GLY . 28.9 mm . . . . . 0 CA--C 1.512 -0.505 0 CA-C-O 121.778 0.799 . . . . 0.0 109.067 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.49 -35.29 72.0 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.016 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.35 -48.18 9.96 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 215' ' ' GLY . 9.6 p -70.0 -47.87 66.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.321 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.489 ' N ' HG13 ' A' ' 214' ' ' VAL . . . -55.68 -48.9 68.45 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 112.709 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 215' ' ' GLY . 49.5 Cg_endo -72.11 -31.1 12.59 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.757 1.638 . . . . 0.0 113.72 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.478 ' CG ' HD22 ' A' ' 81' ' ' LEU . 1.7 m-85 -66.26 -37.37 85.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 0.0 111.29 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.625 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 13.2 mt -70.37 -46.68 70.11 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.084 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.449 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.773 ' O ' HD12 ' A' ' 147' ' ' LEU . . . -55.42 -46.93 78.8 Favored Glycine 0 C--N 1.363 2.077 0 O-C-N 128.495 3.622 . . . . 0.0 110.996 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -68.41 -40.77 86.7 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.32 -34.8 61.79 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.4 mt -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.203 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -59.01 -39.74 82.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.251 -174.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.45 -49.73 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.885 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -39.53 94.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.709 0.766 . . . . 0.0 109.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mt -55.2 -34.69 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.426 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.546 0.213 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.1 1.35 17.28 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.502 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.51 -40.16 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 2.8 t -68.26 -35.91 73.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.629 0 CA-C-N 112.47 -2.15 . . . . 0.0 110.02 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.04 69.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.621 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -70.71 -46.69 62.63 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -177.002 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -33.88 73.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 11.1 mt -58.71 -38.17 77.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.107 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.44 -46.79 78.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 112.97 -1.923 . . . . 0.0 114.755 -176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.66 -31.42 59.77 Favored 'General case' 0 C--O 1.208 -1.128 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.525 -177.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -70.89 -34.98 72.13 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.995 -179.11 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -45.34 82.63 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.13 -44.71 29.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 29' ' ' ILE . 76.3 t -65.03 -53.72 37.91 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.46 -175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -53.7 -48.11 69.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -75.68 -29.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.504 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -36.51 69.11 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.835 HG21 HD22 ' A' ' 112' ' ' LEU . 3.6 mm -58.78 -44.49 90.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 113.661 -1.609 . . . . 0.0 109.223 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -36.76 65.7 Favored Glycine 0 C--O 1.226 -0.369 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -67.4 -44.37 79.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -176.35 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 121.3 0.571 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.72 -28.32 5.92 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.884 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.777 HG22 HD21 ' A' ' 181' ' ' LEU . 3.6 t -57.29 -32.29 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -53.96 37.65 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.703 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 12.6 t -68.15 -37.34 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.451 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 181' ' ' LEU . 3.2 m -68.58 -41.15 80.08 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.985 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.7 OUTLIER -65.55 -31.43 72.47 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.655 -1.612 . . . . 0.0 106.916 176.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -62.92 -39.86 95.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.458 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 24' ' ' PHE . 3.6 t80 -66.03 -43.22 88.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.763 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.62 -46.52 92.0 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.074 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.651 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 6.5 mp -68.6 -43.81 75.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.525 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 t -59.84 -36.69 77.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.587 ' CD1' HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -60.3 -34.37 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.663 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -61.66 -45.55 93.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.363 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.417 ' H ' HG23 ' A' ' 62' ' ' THR . 8.9 p -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -54.79 -42.91 72.35 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.04 -44.33 72.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.97 -1.923 . . . . 0.0 110.914 174.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -67.02 -45.97 75.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.5 p -59.14 -12.37 5.01 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.932 1.242 . . . . 0.0 112.387 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.02 -42.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 0.0 111.29 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.24 159.16 8.08 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -57.41 -23.13 47.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.783 0.325 . . . . 0.0 111.43 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.76 7.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.46 135.66 53.41 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.618 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.12 -154.2 24.41 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.52 85.87 1.16 Allowed 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.183 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.97 -19.64 62.52 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.687 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.1 pp -80.46 -17.64 51.09 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.42 -1.718 . . . . 0.0 112.497 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -111.05 135.95 20.84 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 97.0 Cg_endo -83.58 -22.87 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 123.441 2.761 . . . . 0.0 111.676 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.8 -47.43 78.11 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.622 HG23 HD23 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -66.22 -36.84 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.753 0.311 . . . . 0.0 111.158 177.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 m -65.68 -28.63 69.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -43.82 82.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.92 0.39 . . . . 0.0 110.175 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.95 -39.64 97.82 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 tp -53.47 -57.54 10.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.088 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 . . . . . 0 CA--C 1.526 0.026 0 CA-C-O 120.807 0.337 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.14 78.2 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.09 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.69 -38.49 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -40.01 68.05 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.84 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -61.16 -37.63 83.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.357 0.98 . . . . 0.0 109.443 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.29 -44.38 88.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.903 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.3 mt -70.59 -37.78 71.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . . . -66.81 -47.2 72.81 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.465 ' NE2' ' HD3' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -71.56 -35.7 70.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.234 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -35.96 71.93 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.8 -35.47 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.153 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.68 -44.32 91.36 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 121.102 1.774 . . . . 0.0 113.38 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.404 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.74 -36.19 75.61 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.79 -42.59 86.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.821 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.9 -37.41 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.219 0.533 . . . . 0.0 110.068 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.58 -49.78 75.29 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.318 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -67.75 -37.03 81.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.801 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.73 85.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.659 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.1 tt -69.18 -37.19 75.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.11 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.835 HD22 HG21 ' A' ' 29' ' ' ILE . 2.1 tt -66.0 -24.09 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.87 0.367 . . . . 0.0 111.511 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 m -60.43 -44.21 96.01 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.503 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.37 61.26 Favored Glycine 0 CA--C 1.511 -0.215 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.95 32.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.849 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 -179.465 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.62 124.34 52.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.608 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.6 m120 51.85 23.31 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.275 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.3 95.14 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.716 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 187' ' ' THR . 3.3 mm? -65.45 144.51 57.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.318 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.02 140.03 40.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.649 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -49.63 127.5 15.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.26 -105.48 0.6 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.1 t -85.94 126.82 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.45 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.58 -171.94 0.72 Allowed 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 176.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.48 ' N ' HD11 ' A' ' 129' ' ' LEU . 1.4 m -62.39 -46.76 87.14 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 114.669 -2.812 . . . . 0.0 110.306 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.16 96.47 Favored Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.267 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.799 ' HB3' HG22 ' A' ' 133' ' ' VAL . 4.0 mt-30 -53.24 -23.42 8.73 Favored 'General case' 0 C--N 1.249 -3.778 0 CA-C-N 114.792 -0.704 . . . . 0.0 110.503 -176.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.87 -1.76 13.69 Favored Glycine 0 C--O 1.188 -2.736 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.9 -50.47 64.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 119.123 1.461 . . . . 0.0 110.743 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.87 -40.16 74.97 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.682 HD13 HG21 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -68.85 -36.34 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 113.209 -1.495 . . . . 0.0 112.267 -177.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 77.1 mt-10 -68.54 -36.21 78.5 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-O 121.736 0.779 . . . . 0.0 110.569 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.71 HG23 ' CA ' ' A' ' 219' ' ' GLY . 38.3 mt -70.06 -41.9 79.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.437 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.2 mm -68.53 -48.84 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 122.389 1.09 . . . . 0.0 111.198 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.55 -46.9 93.21 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-N 112.841 -1.981 . . . . 0.0 112.966 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 191' ' ' ILE . 76.2 m -70.93 -47.64 57.91 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 113.77 -1.215 . . . . 0.0 112.47 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 8.2 tp -54.47 -40.45 68.46 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.252 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.6 pt20 -57.97 -31.28 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.82 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.82 HD11 HG22 ' A' ' 176' ' ' VAL . 2.8 tp -68.89 -52.21 31.92 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.451 HG21 ' HA3' ' A' ' 220' ' ' GLY . 54.3 t -60.14 -41.02 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -35.55 81.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 111.349 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -41.11 93.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.851 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 m -72.05 -38.37 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.52 -48.08 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.985 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.68 71.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.662 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.464 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . . . . . . 0 C--O 1.218 -0.571 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 35.3 Cg_exo -54.35 -44.3 50.69 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.738 1.625 . . . . 0.0 112.223 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 mp -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.302 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.33 56.59 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.006 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.5 pt -58.93 -35.96 59.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.61 93.6 Favored Glycine 0 C--O 1.198 -2.107 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.495 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.15 -36.37 65.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 -34.47 77.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.603 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.82 HG22 HD11 ' A' ' 149' ' ' LEU . 89.2 t -72.89 -47.24 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.763 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . . . -65.02 -41.82 94.97 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 122.054 0.93 . . . . 0.0 108.727 -176.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.257 3.6 mt -58.29 -47.12 84.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.937 178.041 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.9 66.19 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.088 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' HIS . . . . . 0.666 ' HA ' HD13 ' A' ' 184' ' ' ILE . 1.1 t60 -67.84 -34.79 77.39 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 112.926 -1.637 . . . . 0.0 109.789 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.777 HD21 HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -64.66 -47.64 77.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.389 -176.346 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.444 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -74.96 -51.64 13.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.955 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -69.54 -51.24 37.39 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 180' ' ' HIS . 1.7 mp -66.78 -49.27 75.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.869 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -65.63 -35.73 81.66 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 115.377 -2.529 . . . . 0.0 112.367 -176.327 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.88 -31.28 69.64 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.524 -170.542 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.524 ' O ' HD13 ' A' ' 129' ' ' LEU 0.301 0.1 OUTLIER -124.32 -26.87 3.87 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.387 1.089 . . . . 0.0 113.332 -179.032 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 86.75 -5.78 84.17 Favored Glycine 0 CA--C 1.566 3.264 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.4 ' H ' HG23 ' A' ' 187' ' ' THR . 59.9 m -83.64 132.29 34.9 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -54.33 155.59 7.61 Favored Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.869 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.955 HG22 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.62 -32.99 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 174.045 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.681 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 6.2 p-10 -92.74 139.68 23.54 Favored Pre-proline 0 N--CA 1.42 -1.967 0 CA-C-N 113.321 -1.763 . . . . 0.0 107.234 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -64.47 -14.55 44.91 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.64 1.56 . . . . 0.0 111.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.484 ' HB3' HD22 ' A' ' 192' ' ' ASN . . . -75.14 -33.88 61.59 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.248 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.645 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.37 -39.11 78.24 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.0 t -73.18 -34.28 65.91 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.816 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.818 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 3.8 t80 -72.22 -35.4 68.87 Favored 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 126.315 1.846 . . . . 0.0 114.506 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.73 -46.19 92.54 Favored Glycine 0 C--N 1.319 -0.376 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.43 -28.29 56.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.281 -0.959 . . . . 0.0 110.379 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.818 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.65 -33.89 77.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.607 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 120.939 1.699 . . . . 0.0 110.589 179.518 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 9.5 mm . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -25.09 61.59 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.298 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -84.64 -42.35 15.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.0 p -78.02 -45.47 27.38 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.23 -44.87 84.27 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.531 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.3 Cg_endo -71.49 -28.68 17.46 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.491 2.128 . . . . 0.0 113.084 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -77.2 -31.99 55.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.195 0.521 . . . . 0.0 111.893 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.0 mm -70.7 -46.37 69.52 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.34 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.303 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.71 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.11 -46.78 63.25 Favored Glycine 0 C--N 1.357 1.733 0 O-C-N 128.5 3.625 . . . . 0.0 111.838 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.34 -48.91 35.05 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 118.067 -2.016 . . . . 0.0 109.835 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.78 68.45 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.554 0.692 . . . . 0.0 109.562 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -68.13 -30.98 70.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.292 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.97 -39.8 82.83 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.8 t -58.06 -49.59 80.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.267 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -39.54 93.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.799 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -34.74 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.818 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.419 0.152 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.4 -14.31 5.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.452 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -39.89 87.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 5.9 p -68.66 -36.07 72.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.592 176.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.69 -35.35 70.49 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.694 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 3.6 mt-10 -70.95 -46.48 62.34 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -33.79 74.34 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 8.0 mt -58.77 -38.16 77.88 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.884 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.68 -46.51 78.8 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.567 -2.106 . . . . 0.0 114.581 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.612 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -74.81 -31.63 61.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.208 -177.557 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.2 -38.39 69.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.783 -178.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -45.01 84.21 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -77.11 -52.52 9.14 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.13 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 21' ' ' THR . 1.5 m -65.64 -40.3 87.54 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 O-C-N 124.031 0.832 . . . . 0.0 112.802 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.41 ' O ' HG12 ' A' ' 29' ' ' ILE . 49.3 t80 -54.18 -50.35 67.24 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.539 0.685 . . . . 0.0 111.908 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -29.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.531 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.24 -36.24 68.28 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -175.092 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.56 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -59.7 -40.05 81.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.086 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -36.88 64.69 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.8 m -67.5 -38.87 84.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -176.729 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB3' HG12 ' A' ' 50' ' ' VAL . 23.1 t0 . . . . . 0 C--O 1.224 -0.288 0 CA-C-O 121.283 0.563 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.73 -28.78 6.57 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.801 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.55 HG13 ' CE ' ' A' ' 51' ' ' LYS . 1.5 p -57.28 -38.37 61.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.726 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.55 ' CE ' HG13 ' A' ' 50' ' ' VAL . 4.5 mmtp -64.8 -53.56 45.09 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.699 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 70.6 t -66.77 -50.06 68.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.416 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -66.53 -39.07 88.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.358 0.412 . . . . 0.0 110.004 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.824 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 55.3 tp -62.85 -31.92 73.03 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.91 -39.46 94.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.265 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.521 ' O ' HD13 ' A' ' 60' ' ' ILE . 8.3 m-30 -66.12 -42.44 89.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.42 -43.3 96.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.08 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.664 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -67.33 -43.66 81.03 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.547 -178.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -36.58 74.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.633 HG13 HD21 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -59.98 -34.1 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.369 -178.395 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.757 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.235 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 65' ' ' GLN . 11.7 p -68.96 -31.7 70.75 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.607 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.46 -40.58 71.78 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.94 -44.16 73.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.151 -1.841 . . . . 0.0 109.468 173.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 62' ' ' THR . 26.0 tt0 -66.78 -38.47 86.62 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.8 m -59.61 -12.13 6.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 120.058 1.299 . . . . 0.0 111.415 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -42.83 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.697 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.06 168.4 12.83 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -66.0 -23.09 66.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 70' ' ' ILE . 2.1 mp -75.95 7.13 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.79 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 m -124.43 135.64 53.42 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.139 0.495 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -151.84 20.45 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.27 85.89 1.08 Allowed 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.441 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.39 61.91 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.633 HD21 HG13 ' A' ' 60' ' ' ILE . 2.1 pp -87.05 8.53 23.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.375 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.614 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -133.04 129.08 20.88 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -177.534 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.589 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 91.1 Cg_endo -83.64 -20.49 4.66 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.773 2.315 . . . . 0.0 111.397 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.627 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -66.16 -50.94 62.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.529 HG23 HD23 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -66.7 -36.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.678 0.275 . . . . 0.0 111.57 177.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.0 m -64.91 -28.62 69.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -35.4 76.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.376 . . . . 0.0 110.55 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.53 -37.07 84.89 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.671 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -44.41 96.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.456 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.405 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.227 -0.087 0 CA-C-O 120.726 0.298 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.405 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . . . -63.78 -35.14 79.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.451 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.91 -38.53 67.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 ttt -73.27 -35.1 66.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.945 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -64.96 -37.53 87.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 119.523 1.056 . . . . 0.0 109.135 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -58.12 -46.53 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.656 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.431 ' N ' HG22 ' A' ' 98' ' ' ILE . 2.0 mm -67.7 -37.84 79.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.678 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.01 -47.06 86.49 Favored 'General case' 0 C--O 1.206 -1.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -71.24 -36.05 71.68 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.424 ' O ' HG13 ' A' ' 106' ' ' ILE . 3.8 t -57.87 -36.16 71.97 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.38 -35.19 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.645 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.51 -47.78 81.27 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.733 1.606 . . . . 0.0 112.586 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.88 -36.16 75.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 102' ' ' CYS . 79.3 mt -63.92 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.048 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.14 -37.42 71.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.425 0.631 . . . . 0.0 110.038 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.53 -49.95 74.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.301 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.798 HG21 ' O ' ' A' ' 198' ' ' GLY . 1.8 t -70.3 -36.94 74.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.2 -43.75 87.77 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.013 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.2 mm -69.24 -37.33 75.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.243 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 29' ' ' ILE . 3.0 tt -66.85 -24.49 66.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.512 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.2 t -62.76 -34.96 78.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.248 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.09 -36.16 60.81 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.446 HD12 ' HG ' ' A' ' 112' ' ' LEU . 4.2 mt -57.28 -40.83 76.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.624 -0.788 . . . . 0.0 110.538 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.795 -179.03 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.86 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -112.6 120.11 40.46 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.925 0.393 . . . . 0.0 111.295 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 t30 51.83 23.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.25 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.88 84.7 2.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.419 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 187' ' ' THR . 3.4 mm? -66.65 144.9 56.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.489 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.91 139.65 40.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.136 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.77 127.67 18.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.3 -103.19 0.58 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 137' ' ' GLN . 2.0 t -86.0 122.38 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.56 -171.8 0.69 Allowed 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.466 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.68 -46.81 88.11 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 114.919 -2.712 . . . . 0.0 110.152 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.83 -41.67 96.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.157 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.726 ' HB3' HG22 ' A' ' 133' ' ' VAL . 24.0 mm100 -53.17 -23.43 8.36 Favored 'General case' 0 C--N 1.252 -3.661 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.232 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.55 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.05 -1.69 10.59 Favored Glycine 0 C--O 1.187 -2.796 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -50.5 65.54 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 119.17 1.485 . . . . 0.0 111.004 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.75 -40.13 76.21 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -67.43 -38.19 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 113.051 -1.575 . . . . 0.0 112.13 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 138' ' ' GLY . 24.0 mt-10 -68.61 -36.53 78.8 Favored 'General case' 0 C--O 1.196 -1.728 0 CA-C-O 121.987 0.899 . . . . 0.0 110.872 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.681 HG23 ' CA ' ' A' ' 219' ' ' GLY . 30.5 mt -68.35 -43.62 84.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.421 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.154 -174.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -68.4 -49.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 122.264 1.031 . . . . 0.0 111.671 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.51 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -59.26 -48.38 86.26 Favored Glycine 0 C--O 1.218 -0.866 0 CA-C-N 113.087 -1.869 . . . . 0.0 113.038 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.526 HG21 ' CB ' ' A' ' 216' ' ' PRO . 24.8 m -70.79 -45.29 64.93 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 113.97 -1.115 . . . . 0.0 112.175 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.636 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 6.0 tp -54.51 -40.59 68.73 Favored 'General case' 0 CA--C 1.487 -1.464 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.22 -175.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.0 pt20 -59.33 -30.85 68.66 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.03 HD11 HG22 ' A' ' 176' ' ' VAL . 2.1 tp -68.88 -51.22 42.52 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.261 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.483 HG21 ' HA3' ' A' ' 220' ' ' GLY . 20.4 t -60.83 -41.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.976 . . . . 0.0 113.28 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.18 -35.65 81.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.563 0.22 . . . . 0.0 111.512 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.21 -35.04 78.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.038 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.19 -38.44 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.591 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tt -64.04 -43.57 95.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.78 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.69 -31.54 72.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.561 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.699 ' OG1' HD11 ' A' ' 172' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.402 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.647 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.0 Cg_exo -54.57 -46.48 33.11 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.57 1.514 . . . . 0.0 111.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.9 -36.14 78.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.271 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -45.02 63.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.275 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.699 HD11 ' OG1' ' A' ' 156' ' ' THR . 21.9 mt -58.26 -38.42 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.52 93.62 Favored Glycine 0 C--O 1.195 -2.293 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.164 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.3 OUTLIER -55.21 -35.56 65.01 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -34.24 76.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.928 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 1.03 HG22 HD11 ' A' ' 149' ' ' LEU . 20.6 t -72.59 -47.31 51.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.824 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.26 -29.9 66.8 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.577 1.179 . . . . 0.0 110.182 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 174' ' ' LEU 0.267 9.3 mt -70.65 -49.18 50.19 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 124.711 2.196 . . . . 0.0 109.515 178.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.85 66.07 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 110.328 -3.124 . . . . 0.0 107.822 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' HIS . . . . . 0.529 ' HB3' HD12 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -70.39 -35.22 73.34 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.041 -1.579 . . . . 0.0 109.727 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.72 -48.21 81.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.139 -177.391 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.51 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.54 -52.25 11.06 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 1.068 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -69.97 -51.68 30.56 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.529 HD12 ' HB3' ' A' ' 180' ' ' HIS . 7.4 mt -60.58 -49.11 85.71 Favored 'Isoleucine or valine' 0 C--O 1.175 -2.862 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.538 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -69.15 -35.67 76.59 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 116.741 -1.983 . . . . 0.0 113.502 -176.132 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.02 -29.16 68.31 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.652 -171.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 129' ' ' LEU 0.285 0.1 OUTLIER -124.32 -26.65 3.91 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.181 0.991 . . . . 0.0 113.076 -179.167 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.56 -5.9 84.26 Favored Glycine 0 CA--C 1.565 3.163 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 -170.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.452 ' H ' HG23 ' A' ' 187' ' ' THR . 92.1 m -88.08 130.74 34.91 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.478 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -56.22 154.71 14.71 Favored Glycine 0 N--CA 1.397 -3.924 0 CA-C-N 111.174 -2.739 . . . . 0.0 112.538 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.068 HG22 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.35 -27.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.627 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -90.49 135.11 29.79 Favored Pre-proline 0 N--CA 1.414 -2.25 0 CA-C-N 112.74 -2.027 . . . . 0.0 108.25 177.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.534 ' CD ' ' HB2' ' A' ' 78' ' ' ALA . 6.3 Cg_exo -66.09 -17.36 54.86 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.986 1.791 . . . . 0.0 110.587 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.589 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.26 -35.37 61.39 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.478 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 29.3 tpt85 -70.62 -40.2 73.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.523 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.3 m -73.23 -38.19 66.13 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.82 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 12.4 t80 -72.25 -34.88 68.58 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 126.945 2.098 . . . . 0.0 114.596 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.798 ' O ' HG21 ' A' ' 109' ' ' THR . . . -57.62 -47.12 90.61 Favored Glycine 0 C--N 1.315 -0.592 0 N-CA-C 107.069 -2.412 . . . . 0.0 107.069 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -28.21 56.65 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.565 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.82 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.23 -34.1 77.32 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.412 -0.804 . . . . 0.0 112.843 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.318 -0.785 0 CA-C-N 120.971 1.714 . . . . 0.0 110.803 179.73 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 121.728 0.775 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' PHE . . . . . 0.444 ' N ' ' CD2' ' A' ' 212' ' ' PHE . 6.3 m-30 -58.27 -41.51 84.46 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.381 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.14 -33.64 24.22 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 215' ' ' GLY . 11.7 p -73.8 -47.73 42.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.486 ' N ' HG13 ' A' ' 214' ' ' VAL . . . -55.15 -48.52 67.76 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.111 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.526 ' CB ' HG21 ' A' ' 146' ' ' THR . 17.3 Cg_endo -71.61 -28.67 17.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.145 1.896 . . . . 0.0 113.744 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -73.48 -30.65 63.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.304 0.574 . . . . 0.0 111.268 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 46.3 mt -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.483 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.376 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.681 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -66.57 -46.25 78.17 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 128.473 3.608 . . . . 0.0 111.896 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.547 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.42 -48.89 34.6 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 118.562 -1.78 . . . . 0.0 110.112 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -39.02 68.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.671 0.748 . . . . 0.0 109.513 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -68.03 -31.07 70.49 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.348 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.636 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.89 -39.51 81.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.11 -49.59 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.962 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.06 -39.44 89.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.693 0.758 . . . . 0.0 109.532 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 222' ' ' LEU . 1.2 mp -57.39 -34.61 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.703 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.77 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.369 0.128 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.72 -8.54 12.64 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.295 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.76 -40.31 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.55 -35.83 72.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 CA-C-N 112.807 -1.997 . . . . 0.0 110.696 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.51 -35.1 69.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 14.9 mt-10 -70.82 -46.6 62.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.17 -33.72 70.28 Favored 'General case' 0 C--O 1.212 -0.912 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.73 -38.29 78.03 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 112.284 -2.234 . . . . 0.0 109.461 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.01 -46.63 80.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.232 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.707 ' CG2' ' HB2' ' A' ' 105' ' ' ALA . 0.7 OUTLIER -74.34 -31.14 62.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.61 -177.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.702 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.28 -40.82 67.3 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.149 -178.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 27' ' ' ILE . 1.8 mt -65.94 -45.04 83.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -52.59 9.1 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.66 -43.96 93.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.185 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.445 ' O ' HG12 ' A' ' 29' ' ' ILE . 53.0 t80 -54.13 -50.23 67.39 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.927 0.785 . . . . 0.0 112.135 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.73 -29.16 20.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.705 179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.4 -36.33 68.79 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -175.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.676 HG21 HD22 ' A' ' 112' ' ' LEU . 4.2 mm -58.91 -39.94 79.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.544 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.68 63.74 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -67.35 -38.06 84.22 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.68 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -176.868 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t70 . . . . . 0 C--O 1.225 -0.204 0 CA-C-O 121.126 0.488 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.54 -28.73 14.61 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' HD3' ' A' ' 51' ' ' LYS . 3.4 p -61.04 -33.45 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HD3' HG13 ' A' ' 50' ' ' VAL . 25.1 mmtt -64.94 -54.12 35.68 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.601 1.091 . . . . 0.0 112.978 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.735 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 8.8 p -68.18 -40.56 83.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.599 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.438 ' N ' HG13 ' A' ' 52' ' ' VAL . 72.6 m -69.31 -40.51 77.61 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.726 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.6 OUTLIER -62.85 -31.81 72.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.21 -39.52 94.14 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.969 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.542 ' O ' HD13 ' A' ' 60' ' ' ILE . 3.1 m-85 -66.01 -46.97 76.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.741 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.55 -45.84 93.74 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.278 -0.419 . . . . 0.0 114.005 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.652 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 1.4 tp -66.32 -43.83 85.12 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.107 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -58.74 -36.74 74.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -60.15 -34.0 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.496 -178.115 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.76 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.7 -45.59 82.2 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.506 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -68.94 -32.07 71.42 Favored 'General case' 0 CA--C 1.469 -2.165 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.998 HD13 HD12 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.61 -40.44 72.11 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.87 -44.11 73.98 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.453 173.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -38.31 86.31 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -59.63 -12.29 6.5 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 119.889 1.222 . . . . 0.0 111.579 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -42.87 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 0.0 111.428 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.12 178.9 21.06 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -22.96 62.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.832 0.348 . . . . 0.0 111.133 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -72.69 7.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.306 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.6 m -124.32 135.51 53.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.279 0.561 . . . . 0.0 111.623 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.13 -140.62 8.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HB3' HG21 ' A' ' 79' ' ' VAL . . . -72.53 85.88 1.16 Allowed 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.368 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -19.63 59.1 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.998 HD12 HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -89.74 8.35 32.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.089 179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 59.3 m-20 -148.26 144.15 18.38 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 121.145 1.793 . . . . 0.0 114.222 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 98.6 Cg_endo -83.51 -21.89 4.09 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 124.035 3.157 . . . . 0.0 112.943 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.732 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -59.22 -45.8 90.16 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 73' ' ' ALA . 26.3 m -66.46 -38.16 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.4 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.701 HG21 ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -61.66 -29.96 70.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mt -60.23 -36.05 76.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.8 -48.92 31.75 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.737 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -14.79 62.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.582 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.855 0.359 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -65.41 -35.18 80.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.87 -38.73 67.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 tpp -73.33 -31.64 64.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.043 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.701 ' CD2' HG21 ' A' ' 80' ' ' THR . 8.1 t80 -65.01 -44.24 89.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 118.777 0.717 . . . . 0.0 111.142 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -66.71 -41.22 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.191 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.5 mt -70.38 -42.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.28 69.07 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -35.81 70.67 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.7 t -57.99 -36.14 72.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 107' ' ' VAL . 2.8 t -71.3 -35.25 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.314 175.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.39 -47.54 82.2 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 120.908 1.685 . . . . 0.0 112.833 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.707 ' HB2' ' CG2' ' A' ' 21' ' ' THR . . . -69.92 -35.98 74.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 mm -66.05 -50.34 70.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 103' ' ' VAL . 34.5 m -62.32 -36.97 77.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.148 0.499 . . . . 0.0 109.757 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.24 -49.68 75.26 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.556 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -64.68 -37.0 86.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.643 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.65 85.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.124 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.99 -37.33 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.681 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -65.75 -24.61 67.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.645 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -61.04 -38.98 88.06 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.423 -178.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.0 -36.17 60.33 Favored Glycine 0 CA--C 1.511 -0.199 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 HD12 ' HG ' ' A' ' 112' ' ' LEU . 4.4 mt -54.14 -36.87 33.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.703 -0.749 . . . . 0.0 111.057 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 113' ' ' SER . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.555 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.604 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -112.6 124.38 52.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.024 0.44 . . . . 0.0 111.337 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 51.97 20.6 1.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.405 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -112.37 92.21 3.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 135' ' ' SER . 3.3 mm? -63.12 148.42 47.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.057 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -104.33 138.64 40.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.585 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -49.59 127.6 15.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.71 -105.18 0.66 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.829 HG22 ' HB3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.16 131.92 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.451 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 -171.98 0.76 Allowed 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 176.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.464 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -64.61 -46.73 81.39 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 114.52 -2.872 . . . . 0.0 109.883 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.656 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -58.93 -41.46 96.28 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.285 -0.96 . . . . 0.0 110.954 -175.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.829 ' HB3' HG22 ' A' ' 133' ' ' VAL . 7.3 mm-40 -53.45 -23.41 9.98 Favored 'General case' 0 C--N 1.248 -3.838 0 CA-C-O 121.443 0.64 . . . . 0.0 110.61 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -69.61 -1.56 30.91 Favored Glycine 0 C--O 1.185 -2.913 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.54 -50.23 63.85 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 118.394 1.097 . . . . 0.0 111.146 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.53 -35.71 75.52 Favored Glycine 0 C--O 1.229 -0.163 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.8 ' CD1' HG21 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -71.54 -36.04 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 113.239 -1.48 . . . . 0.0 111.845 -178.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' GLY . 7.9 mt-10 -68.42 -36.38 78.98 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 122.047 0.927 . . . . 0.0 110.863 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.657 HG23 ' CA ' ' A' ' 219' ' ' GLY . 41.2 mt -70.5 -50.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.923 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.25 -43.65 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.062 0.935 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.425 ' O ' ' CG ' ' A' ' 148' ' ' GLN . . . -62.35 -51.7 54.57 Favored Glycine 0 C--O 1.205 -1.663 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.237 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.416 ' HA ' HG23 ' A' ' 191' ' ' ILE . 45.1 m -70.01 -35.23 74.21 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.796 0.808 . . . . 0.0 110.363 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 147' ' ' LEU . 2.1 tp -54.87 -40.15 69.43 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -57.91 -33.35 68.67 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.949 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.986 HD11 HG22 ' A' ' 176' ' ' VAL . 2.3 tp -68.89 -47.08 66.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.972 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.655 HG21 ' HA3' ' A' ' 220' ' ' GLY . 54.3 t -66.23 -41.02 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.76 -45.63 85.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' A' ' 172' ' ' ILE . 21.3 p -64.28 -28.44 69.72 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.704 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.01 -38.54 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.8 mt -65.89 -35.95 82.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.14 80.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.231 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.691 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 1.8 t . . . . . 0 C--N 1.332 -0.192 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.677 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.691 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 28.0 Cg_exo -54.63 -38.27 90.89 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.557 1.505 . . . . 0.0 111.878 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 62.0 mt -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.035 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.63 -46.95 57.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.087 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.45 HG23 ' SG ' ' A' ' 152' ' ' CYS . 1.3 mp -58.08 -42.05 82.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 121.546 0.688 . . . . 0.0 109.692 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.74 -37.63 93.65 Favored Glycine 0 C--O 1.195 -2.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.131 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -55.15 -35.53 64.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 178.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -34.43 77.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.821 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.986 HG22 HD11 ' A' ' 149' ' ' LEU . 11.5 t -72.01 -47.06 56.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.741 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . . . -68.89 -33.58 74.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.124 0.964 . . . . 0.0 110.131 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.276 4.3 mt -69.16 -52.94 23.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 125.293 2.473 . . . . 0.0 110.918 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.51 62.57 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 110.01 -3.268 . . . . 0.0 106.58 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' HIS . . . . . 0.516 ' CD2' ' O ' ' A' ' 176' ' ' VAL . 1.6 m-70 -70.08 -34.88 73.71 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.756 -1.722 . . . . 0.0 110.081 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -56.84 -47.69 79.77 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.369 -178.352 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.66 -51.56 14.06 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 191' ' ' ILE . . . -69.38 -52.07 30.56 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 188' ' ' GLY . 1.5 mp -56.65 -49.14 79.21 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.032 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.504 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -70.09 -35.82 74.45 Favored 'General case' 0 C--N 1.277 -2.564 0 C-N-CA 115.998 -2.281 . . . . 0.0 113.067 -175.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -60.18 -29.47 68.72 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.316 -171.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.276 0.1 OUTLIER -124.27 -26.95 3.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.199 1.0 . . . . 0.0 113.269 -178.744 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 184' ' ' ILE . . . 88.48 -5.89 84.2 Favored Glycine 0 CA--C 1.564 3.102 0 N-CA-C 105.981 -2.848 . . . . 0.0 105.981 -170.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' ' 187' ' ' THR . 17.4 t -84.45 129.47 34.86 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 123.601 1.667 . . . . 0.0 106.588 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.477 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -50.02 161.84 0.96 Allowed Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 110.659 -2.973 . . . . 0.0 112.465 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.658 HG13 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.53 -42.71 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.189 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.732 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 7.9 p-10 -87.05 139.86 32.61 Favored Pre-proline 0 N--CA 1.418 -2.047 0 CA-C-N 111.85 -2.432 . . . . 0.0 107.695 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.01 -14.89 46.52 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.886 1.724 . . . . 0.0 111.674 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.463 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . . . -75.31 -30.65 60.41 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.589 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.438 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.4 OUTLIER -70.69 -39.61 73.39 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.288 0.566 . . . . 0.0 109.617 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -31.73 64.32 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.85 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.838 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.7 m-85 -72.04 -35.0 69.24 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.61 1.964 . . . . 0.0 113.911 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -46.6 91.99 Favored Glycine 0 C--N 1.319 -0.402 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 p -76.35 -28.24 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.688 -0.756 . . . . 0.0 110.297 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.838 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.81 -34.0 77.32 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.995 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 121.186 1.812 . . . . 0.0 111.019 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.656 HG21 ' HA2' ' A' ' 136' ' ' GLY . 31.9 mm . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.62 -36.61 74.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.112 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -84.33 -33.44 23.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 215' ' ' GLY . 12.3 p -78.61 -47.08 24.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.15 -45.95 80.38 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.313 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 4.1 Cg_exo -71.69 -28.67 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.877 2.385 . . . . 0.0 113.29 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -33.75 58.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 49.8 mt -70.59 -46.12 71.25 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.295 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.657 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.34 -46.81 67.58 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 128.407 3.567 . . . . 0.0 111.886 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.655 ' HA3' HG21 ' A' ' 150' ' ' VAL . . . -70.32 -48.96 34.93 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 118.146 -1.978 . . . . 0.0 109.894 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.87 68.19 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.632 0.73 . . . . 0.0 109.789 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.84 -31.24 70.94 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.334 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.565 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.99 -39.63 82.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.21 -49.64 81.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -39.34 91.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.7 0.762 . . . . 0.0 109.719 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -34.59 49.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.765 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--N 1.33 -0.265 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.194 -179.386 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.356 0.122 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.16 -0.18 15.66 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.88 -40.09 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.3 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.775 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.584 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.82 69.42 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.689 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -70.62 -46.74 62.79 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -176.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -33.82 73.26 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 19' ' ' LEU . 12.3 mt -58.84 -38.35 78.48 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.68 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.73 -47.07 76.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.742 -2.026 . . . . 0.0 115.077 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -75.74 -31.5 59.61 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.493 -177.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.767 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.72 -39.0 67.28 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.737 -178.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -45.06 83.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.63 ' CD2' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -77.07 -47.2 21.19 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 29' ' ' ILE . 92.5 t -65.25 -50.57 72.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.477 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.474 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 18.1 t80 -53.86 -47.43 71.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -29.17 20.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.594 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -36.23 67.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.728 HG21 HD22 ' A' ' 112' ' ' LEU . 3.2 mm -62.97 -38.61 82.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.88 63.29 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.257 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -63.49 -45.02 92.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.726 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.762 179.801 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 38.1 t0 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -49.8 -28.04 5.79 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.407 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG22 HD21 ' A' ' 181' ' ' LEU . 12.0 t -56.81 -48.24 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -64.8 -44.12 90.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.011 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.717 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 7.7 p -68.2 -47.6 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.548 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.454 ' N ' HG13 ' A' ' 52' ' ' VAL . 12.2 m -69.15 -36.49 77.48 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.78 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 49.4 tp -63.41 -31.88 73.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -65.79 -39.2 90.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.374 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 60' ' ' ILE . 8.4 m-30 -65.92 -43.33 88.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.875 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.771 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.56 -43.34 96.67 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.467 -0.396 . . . . 0.0 112.901 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 58.0 mt -66.76 -43.69 83.41 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.301 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -36.54 74.66 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -60.26 -34.08 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.645 -178.449 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.721 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -62.39 -45.53 92.73 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.423 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 62' ' ' THR . 8.1 p -67.84 -31.42 71.24 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -41.96 72.1 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.96 -44.07 73.69 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.508 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -40.2 87.78 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.51 -12.13 5.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 119.802 1.183 . . . . 0.0 111.702 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -42.85 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.759 0.314 . . . . 0.0 111.395 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.6 170.65 11.91 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -23.08 62.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 pt -76.06 7.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 135.7 53.57 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.377 0.608 . . . . 0.0 111.697 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -149.55 18.45 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.34 85.35 1.09 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -20.01 62.34 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.663 ' O ' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -89.84 3.43 52.97 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 112.26 -2.245 . . . . 0.0 113.636 178.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.624 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 3.6 t-20 -126.46 133.85 25.41 Favored Pre-proline 0 N--CA 1.483 1.19 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 83.6 Cg_endo -83.68 -32.25 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.171 2.58 . . . . 0.0 112.1 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.606 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -61.13 -49.89 75.45 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.454 ' CG2' HG21 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -66.22 -36.81 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.825 0.345 . . . . 0.0 111.218 177.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -62.89 -28.63 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.434 HD13 ' CG ' ' A' ' 217' ' ' PHE . 0.6 OUTLIER -60.71 -42.05 96.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.874 0.369 . . . . 0.0 110.409 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.68 -39.3 85.95 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -50.23 72.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.615 0.245 . . . . 0.0 111.294 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.837 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.898 0.38 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.13 77.96 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.86 -38.44 67.47 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.4 ttt -71.71 -36.18 70.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.316 -1.765 . . . . 0.0 109.685 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -64.33 -37.52 87.81 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 119.177 0.899 . . . . 0.0 109.236 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -59.6 -48.12 88.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.532 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.441 ' N ' HG22 ' A' ' 98' ' ' ILE . 26.2 pt -70.44 -37.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -66.22 -47.18 74.7 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.46 ' NE2' ' HD3' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -71.61 -35.84 70.59 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.96 71.74 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 100' ' ' ALA . 2.7 t -70.81 -35.39 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.016 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.61 -42.21 90.33 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 121.152 1.797 . . . . 0.0 112.973 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.465 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.91 -36.05 75.08 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.03 -42.22 85.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.825 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.94 -37.23 72.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.269 0.557 . . . . 0.0 109.515 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.67 -44.67 85.92 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.14 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -70.32 -37.17 74.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.709 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -44.83 88.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.707 0.289 . . . . 0.0 111.113 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.8 mt -69.22 -37.51 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.39 . . . . 0.0 110.814 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.728 HD22 HG21 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -64.47 -24.5 67.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.023 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -36.89 81.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.969 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.95 -36.24 60.16 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.5 mm -55.33 -40.6 57.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.627 -0.787 . . . . 0.0 110.532 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.455 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -112.71 117.47 32.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 111.71 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 52.0 29.44 6.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -108.79 89.61 3.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 187' ' ' THR . 3.3 mm? -63.01 143.79 57.47 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.055 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.03 139.99 40.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.887 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -49.62 127.63 16.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.28 -104.66 0.59 Allowed Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.834 HG21 HG13 ' A' ' 141' ' ' ILE . 1.3 t -86.09 127.76 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.459 ' O ' HG12 ' A' ' 133' ' ' VAL . 9.4 t-20 -71.66 -172.03 0.74 Allowed 'General case' 0 C--O 1.203 -1.376 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.505 ' N ' HD11 ' A' ' 129' ' ' LEU . 6.8 t -63.54 -46.97 83.56 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 114.499 -2.88 . . . . 0.0 109.893 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -40.13 94.79 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.13 -1.034 . . . . 0.0 111.323 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.795 ' HB3' HG22 ' A' ' 133' ' ' VAL . 2.4 mm100 -53.5 -23.54 10.65 Favored 'General case' 0 C--N 1.253 -3.618 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.676 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.532 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.34 -2.18 13.56 Favored Glycine 0 C--O 1.191 -2.56 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.693 HD13 HD11 ' A' ' 211' ' ' ILE . 7.3 tp -61.05 -50.37 73.58 Favored 'General case' 0 C--O 1.206 -1.226 0 O-C-N 120.458 -1.613 . . . . 0.0 108.458 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.77 -46.52 53.12 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.834 HG13 HG21 ' A' ' 133' ' ' VAL . 2.1 mm -59.58 -42.83 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.186 -1.007 . . . . 0.0 111.352 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.19 -36.11 79.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.035 0.934 . . . . 0.0 112.59 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.636 HG23 ' CA ' ' A' ' 219' ' ' GLY . 19.6 mt -67.78 -50.48 59.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 O-C-N 121.718 -0.614 . . . . 0.0 110.474 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.29 -43.59 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.99 0.9 . . . . 0.0 111.948 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 148' ' ' GLN . . . -61.98 -51.05 59.69 Favored Glycine 0 C--O 1.2 -1.993 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.915 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 216' ' ' PRO . 28.6 m -70.25 -37.61 74.98 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.838 0.828 . . . . 0.0 110.87 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 3.8 tp -55.03 -40.22 69.98 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.47 HE22 ' HB2' ' A' ' 175' ' ' SER . 1.1 pp0? -57.85 -31.42 66.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.778 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.887 HD11 HG22 ' A' ' 176' ' ' VAL . 1.2 tp -68.72 -47.16 67.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.651 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.616 HG21 ' HA3' ' A' ' 220' ' ' GLY . 82.5 t -66.39 -40.98 88.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -45.65 82.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' A' ' 172' ' ' ILE . 24.6 p -65.68 -29.02 69.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.454 HG21 ' CG2' ' A' ' 79' ' ' VAL . 2.5 t -71.94 -39.0 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.167 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -38.21 88.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.554 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.7 72.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.583 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.335 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.583 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 10.6 Cg_exo -62.32 -46.76 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.715 1.61 . . . . 0.0 113.842 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 171' ' ' ALA . 3.8 pp -66.37 -29.97 70.26 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.014 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.753 ' N ' HD12 ' A' ' 170' ' ' LEU . . . -71.35 -45.16 63.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.777 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.421 HG23 ' SG ' ' A' ' 152' ' ' CYS . 1.0 OUTLIER -58.16 -37.53 62.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.78 -37.56 93.54 Favored Glycine 0 C--O 1.196 -2.268 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.667 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.26 -35.86 65.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.47 ' HB2' HE22 ' A' ' 148' ' ' GLN . 0.7 OUTLIER -67.54 -34.79 77.79 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.173 176.004 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.887 HG22 HD11 ' A' ' 149' ' ' LEU . 10.5 t -70.32 -46.92 69.43 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.78 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -68.66 -32.81 72.91 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.516 1.15 . . . . 0.0 110.527 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.629 ' O ' HD22 ' A' ' 182' ' ' LEU 0.279 2.7 tp -70.55 -50.64 35.36 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 124.739 2.209 . . . . 0.0 110.212 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.5 -37.12 65.72 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 109.896 -3.32 . . . . 0.0 107.042 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' HIS . . . . . 0.443 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 0.3 OUTLIER -70.33 -35.24 73.49 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.959 -1.62 . . . . 0.0 109.648 178.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -57.16 -47.04 82.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.815 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.68 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -74.5 -52.11 12.86 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.71 ' HB3' HG13 ' A' ' 191' ' ' ILE . . . -69.98 -51.94 28.4 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 188' ' ' GLY . 3.7 mt -61.4 -49.21 85.44 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.681 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.536 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -69.23 -35.55 76.29 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 116.226 -2.19 . . . . 0.0 112.645 -176.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.538 -171.615 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.518 ' O ' HD13 ' A' ' 129' ' ' LEU 0.284 0.1 OUTLIER -124.54 -26.71 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.217 1.008 . . . . 0.0 113.2 -179.501 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.11 -5.67 84.72 Favored Glycine 0 CA--C 1.567 3.327 0 N-CA-C 106.332 -2.707 . . . . 0.0 106.332 -170.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.414 ' CB ' ' OG1' ' A' ' 187' ' ' THR . 37.5 t -84.25 126.04 32.79 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -46.53 162.61 0.17 Allowed Glycine 0 N--CA 1.411 -2.986 0 CA-C-N 111.307 -2.679 . . . . 0.0 112.647 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.71 HG13 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.39 -41.55 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.309 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.606 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.0 p30 -94.35 146.31 31.31 Favored Pre-proline 0 N--CA 1.409 -2.488 0 CA-C-N 111.528 -2.578 . . . . 0.0 108.657 179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.12 -14.69 45.5 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.524 2.15 . . . . 0.0 111.479 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.578 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.24 -34.33 61.41 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.76 0.314 . . . . 0.0 110.574 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.493 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 38.1 tpt85 -70.61 -40.53 73.13 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.906 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.2 -37.53 66.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.825 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 13.3 t80 -72.1 -35.06 69.08 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 126.718 2.007 . . . . 0.0 114.458 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.3 93.34 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 106.7 -2.56 . . . . 0.0 106.7 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 16.2 m -76.6 -28.3 56.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.992 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.825 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -67.53 -33.93 76.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 121.152 1.796 . . . . 0.0 111.808 -179.412 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 139' ' ' LEU . 2.6 tp . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -27.13 64.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -84.43 -44.68 13.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 214' ' ' VAL . 2.6 p -80.18 -41.11 20.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.503 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.3 -45.07 84.35 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.434 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.514 ' HB3' HG21 ' A' ' 146' ' ' THR . 3.4 Cg_exo -71.74 -28.66 16.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.624 2.216 . . . . 0.0 112.95 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.434 ' CG ' HD13 ' A' ' 81' ' ' LEU . 3.4 m-30 -77.4 -31.0 53.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 111.993 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.4 mm -70.77 -46.44 68.81 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.296 0 C-N-CA 123.398 0.679 . . . . 0.0 112.457 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.636 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.95 -46.09 60.85 Favored Glycine 0 C--N 1.359 1.84 0 O-C-N 128.659 3.724 . . . . 0.0 111.535 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.616 ' HA3' HG21 ' A' ' 150' ' ' VAL . . . -70.27 -49.02 34.93 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.192 -1.956 . . . . 0.0 109.944 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.96 68.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.648 0.737 . . . . 0.0 109.626 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.73 -31.29 71.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.152 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.78 -39.47 81.16 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.5 t -58.15 -49.54 81.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.604 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -39.47 94.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.623 0.725 . . . . 0.0 109.817 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 21.4 mt -58.59 -34.42 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.346 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.2 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.386 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.488 0.185 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.4 1.99 17.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.683 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -40.25 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.36 -36.18 73.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.541 0 CA-C-N 112.605 -2.089 . . . . 0.0 109.833 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.09 70.16 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.709 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -71.18 -46.65 60.92 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -177.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -33.96 72.31 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.99 -38.06 78.29 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.508 -2.133 . . . . 0.0 108.912 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -63.18 -46.81 85.39 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.313 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.76 -31.23 59.45 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.699 -177.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.82 -38.16 67.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.781 -178.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -44.92 84.37 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.494 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -76.96 -47.97 19.39 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 29' ' ' ILE . 91.8 t -65.44 -53.76 36.07 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.522 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.52 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 24.1 t80 -53.87 -44.36 70.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.264 0.484 . . . . 0.0 111.96 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.73 -29.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.903 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.798 HG21 HD22 ' A' ' 112' ' ' LEU . 3.0 mm -61.82 -38.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.109 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.35 -36.95 64.08 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -67.14 -38.88 86.29 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.506 179.625 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.7 t70 . . . . . 0 C--O 1.226 -0.169 0 CA-C-O 121.037 0.446 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.91 -28.83 53.79 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.659 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.469 HG23 HD11 ' A' ' 181' ' ' LEU . 4.9 p -61.94 -31.92 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 5.4 mmtp -65.05 -54.18 34.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.644 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 22.5 m -68.36 -37.45 77.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.543 -177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 52' ' ' VAL . 16.1 m -69.56 -43.19 73.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.765 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 55.8 tp -62.9 -31.72 72.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.535 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.98 -39.68 93.85 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.504 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -66.28 -46.82 75.67 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.741 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.67 -41.65 97.62 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.737 -0.268 . . . . 0.0 113.38 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 2.3 mt -68.39 -43.73 76.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.674 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -60.46 -36.48 78.36 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -33.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 113.077 -1.874 . . . . 0.0 107.987 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.759 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -66.08 -45.71 80.32 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.379 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 p -69.42 -31.55 69.97 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.42 -41.01 72.19 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.0 -44.43 72.8 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.155 173.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -36.74 82.91 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 t -59.68 -12.21 6.49 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 119.98 1.264 . . . . 0.0 111.367 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.59 -42.71 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.883 0.373 . . . . 0.0 110.957 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.14 156.41 6.79 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -23.01 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 tt -74.68 6.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.55 135.64 53.33 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.168 0.509 . . . . 0.0 111.26 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.12 -159.06 21.27 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.47 85.78 1.14 Allowed 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.064 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -19.64 61.08 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.691 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . 2.1 pp -81.15 -10.26 59.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.856 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 5.8 t-20 -112.73 131.24 22.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.55 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 92.7 Cg_endo -83.69 -28.97 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.062 2.508 . . . . 0.0 112.557 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -62.54 -49.68 74.35 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.513 HG21 HG21 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -66.39 -36.77 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.778 178.283 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.2 m -65.85 -28.52 69.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.451 HD23 ' HD1' ' A' ' 217' ' ' PHE . 1.3 mp -61.78 -35.27 77.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.847 0.356 . . . . 0.0 110.715 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.72 98.27 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mt -58.96 -42.41 89.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 110.975 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.794 0.33 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -65.36 -35.06 79.83 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.228 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.79 -38.53 67.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtm -73.47 -31.7 63.91 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.738 -1.573 . . . . 0.0 110.132 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -67.66 -40.44 84.52 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 119.032 0.833 . . . . 0.0 111.447 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -66.77 -41.29 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.48 -42.71 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.65 ' HB3' ' OE1' ' A' ' 17' ' ' GLU . . . -68.05 -47.33 68.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.448 ' NE2' ' HD3' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -71.72 -35.83 70.32 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.079 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 t -58.03 -36.19 72.37 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.457 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.9 t -69.78 -35.41 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.857 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.7 -44.76 91.37 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 120.897 1.681 . . . . 0.0 113.369 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.42 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.68 -36.1 75.71 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 103' ' ' VAL . 39.8 mt -67.26 -41.15 86.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.532 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.9 -37.3 77.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 0.0 109.53 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.61 -46.99 83.39 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.382 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -67.73 -37.28 81.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.414 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.83 85.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.02 -39.17 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.774 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.798 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -65.14 -24.32 67.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.352 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 m -60.62 -44.37 96.41 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.836 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.07 -36.26 60.87 Favored Glycine 0 CA--C 1.509 -0.297 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.21 -30.72 30.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.441 -0.879 . . . . 0.0 111.016 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.451 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.6 ptt85 -112.59 118.52 35.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.957 0.408 . . . . 0.0 111.884 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 51.82 45.24 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -116.55 110.38 18.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.796 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.59 ' H ' HD22 ' A' ' 129' ' ' LEU . 1.3 mm? -82.01 138.07 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.39 148.75 27.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.212 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -49.65 127.66 16.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.39 -97.6 0.87 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.657 HG21 HD13 ' A' ' 141' ' ' ILE . 2.6 t -86.09 119.15 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.6 m-80 -71.8 -172.03 0.77 Allowed 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.47 ' O ' HD13 ' A' ' 211' ' ' ILE . 1.0 OUTLIER -61.78 -46.97 87.26 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 114.525 -2.87 . . . . 0.0 110.793 -178.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.19 -39.35 94.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.519 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.656 ' CB ' HG13 ' A' ' 133' ' ' VAL . 85.4 mm-40 -52.95 -23.33 6.99 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-O 121.342 0.592 . . . . 0.0 110.196 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -63.5 -1.97 5.21 Favored Glycine 0 C--O 1.187 -2.787 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.23 -50.54 69.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 119.332 1.566 . . . . 0.0 110.951 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.84 -43.94 64.33 Favored Glycine 0 CA--C 1.51 -0.255 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.657 HD13 HG21 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -63.56 -38.9 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 112.721 -1.739 . . . . 0.0 112.378 -178.178 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 138' ' ' GLY . 42.2 mt-10 -68.31 -36.3 79.11 Favored 'General case' 0 C--O 1.2 -1.541 0 CA-C-O 122.275 1.036 . . . . 0.0 110.48 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.681 HG23 ' HA2' ' A' ' 219' ' ' GLY . 40.2 mt -65.9 -46.46 88.43 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.645 -174.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.48 -48.99 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 122.073 0.939 . . . . 0.0 111.769 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.77 56.8 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.008 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.486 HG21 ' HB3' ' A' ' 216' ' ' PRO . 17.8 m -70.65 -43.34 69.37 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.887 -1.156 . . . . 0.0 112.447 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 148' ' ' GLN . 0.8 OUTLIER -54.67 -40.18 68.83 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.705 -176.177 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt20 -57.86 -30.26 65.65 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.851 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 176' ' ' VAL . 2.2 tp -68.82 -45.39 71.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.738 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.433 HG21 ' HA3' ' A' ' 220' ' ' GLY . 82.9 t -66.42 -40.95 87.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.18 -38.38 85.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' A' ' 172' ' ' ILE . 5.1 p -73.74 -28.3 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.393 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.513 HG21 HG21 ' A' ' 79' ' ' VAL . 2.3 t -71.98 -45.55 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -41.25 92.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.277 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.02 89.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.423 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.622 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.543 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.622 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.6 Cg_exo -54.42 -41.08 79.98 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.485 1.456 . . . . 0.0 112.272 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.42 -42.42 91.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 -47.14 57.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.492 HD11 ' OG1' ' A' ' 156' ' ' THR . 41.6 mt -58.2 -37.11 60.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.44 93.49 Favored Glycine 0 C--O 1.2 -1.977 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.299 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -55.1 -36.23 65.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -34.6 77.41 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.562 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.988 HG22 HD11 ' A' ' 149' ' ' LEU . 48.4 t -73.06 -47.42 47.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.765 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.3 -31.75 69.22 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.966 1.365 . . . . 0.0 110.117 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.273 11.3 tp -70.44 -48.67 54.88 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.547 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.408 ' C ' HG21 ' A' ' 191' ' ' ILE . . . -55.72 -37.03 67.09 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 111.075 -2.784 . . . . 0.0 107.817 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' HIS . . . . . 0.531 ' HD2' HG23 ' A' ' 191' ' ' ILE . 25.2 m170 -68.59 -35.36 77.26 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.391 -1.405 . . . . 0.0 109.08 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -59.34 -47.73 84.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.672 -177.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.419 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.23 -52.52 10.69 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 1.035 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -70.25 -51.96 26.66 Favored 'General case' 0 C--O 1.202 -1.404 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 180' ' ' HIS . 6.0 mt -59.43 -49.21 84.42 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.815 0 C-N-CA 118.984 -1.087 . . . . 0.0 113.14 -174.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -35.71 78.49 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 115.677 -2.409 . . . . 0.0 112.719 -176.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.84 -29.79 68.52 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.673 -171.267 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.28 0.1 OUTLIER -124.6 -26.85 3.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.292 1.044 . . . . 0.0 113.43 -179.317 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.54 -5.8 84.43 Favored Glycine 0 CA--C 1.566 3.277 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -170.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.419 ' H ' HG23 ' A' ' 187' ' ' THR . 11.4 t -84.1 129.0 34.92 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -49.82 159.2 1.31 Allowed Glycine 0 N--CA 1.405 -3.403 0 CA-C-N 111.496 -2.593 . . . . 0.0 112.056 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 1.035 HG22 ' HB3' ' A' ' 183' ' ' ALA . 20.3 pt -72.57 -33.07 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.614 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.9 p30 -97.69 143.62 26.53 Favored Pre-proline 0 N--CA 1.418 -2.038 0 CA-C-N 113.194 -1.821 . . . . 0.0 108.748 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.05 -14.44 33.31 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.395 2.063 . . . . 0.0 111.596 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.55 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.05 -37.38 61.7 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.623 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.645 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.41 -38.62 74.64 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.26 0.552 . . . . 0.0 109.839 -179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -33.74 65.43 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.502 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.835 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.8 m-85 -72.3 -35.25 68.62 Favored 'General case' 0 N--CA 1.512 2.663 0 C-N-CA 126.532 1.933 . . . . 0.0 114.469 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.69 91.91 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 107.274 -2.331 . . . . 0.0 107.274 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -76.35 -28.41 56.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.605 -0.798 . . . . 0.0 110.349 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.835 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -63.8 -34.05 77.05 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.704 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.319 -0.736 0 CA-C-N 121.0 1.727 . . . . 0.0 110.418 179.739 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 135' ' ' SER . 1.4 pp . . . . . 0 CA--C 1.519 -0.214 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -58.52 -38.54 77.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.706 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -84.21 -33.61 24.09 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.587 HG22 HD12 ' A' ' 218' ' ' ILE . 13.3 p -77.76 -45.16 28.55 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.477 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.18 -48.15 70.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.435 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.486 ' HB3' HG21 ' A' ' 146' ' ' THR . 5.2 Cg_endo -72.16 -32.36 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.477 2.118 . . . . 0.0 114.015 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.451 ' HD1' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -70.13 -39.88 75.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.477 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 5.8 mt -70.47 -46.52 70.14 Favored 'Isoleucine or valine' 0 C--O 1.173 -2.929 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.335 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.681 ' HA2' HG23 ' A' ' 143' ' ' ILE . . . -56.65 -48.46 77.08 Favored Glycine 0 C--N 1.365 2.156 0 O-C-N 128.624 3.703 . . . . 0.0 111.23 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -67.93 -39.44 89.35 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.47 -34.88 62.34 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 5.5 mt -67.55 -37.18 82.31 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.502 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -58.8 -39.8 82.18 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.279 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.6 t -58.46 -49.72 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.08 -39.53 94.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.694 0.759 . . . . 0.0 110.344 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.92 -34.74 38.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.94 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.6 t80 . . . . . 0 C--N 1.331 -0.226 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.589 -179.469 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.23 -12.03 11.23 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.383 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -60.24 -39.75 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -68.34 -35.92 72.85 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.301 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -35.09 69.52 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 77.5 mt-10 -70.93 -46.55 62.25 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -34.01 71.83 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -38.18 78.48 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.313 -2.222 . . . . 0.0 109.493 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.73 -46.67 78.01 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.021 -1.899 . . . . 0.0 114.572 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.46 -31.15 60.16 Favored 'General case' 0 C--O 1.204 -1.341 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.66 -177.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.751 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.87 -38.05 67.15 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 111.678 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -44.97 84.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.643 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.04 -47.21 21.23 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 29' ' ' ILE . 87.8 t -65.41 -52.09 55.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.069 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 29' ' ' ILE . 31.7 t80 -53.76 -47.35 70.76 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.094 0.473 . . . . 0.0 112.168 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.63 -29.86 21.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -36.19 69.41 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.745 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -59.3 -41.0 82.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.987 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.37 -36.85 64.04 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.9 m -67.38 -39.43 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.615 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 121.044 0.449 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.0 -28.52 7.07 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.116 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.453 HG22 HD21 ' A' ' 181' ' ' LEU . 16.2 t -57.15 -40.0 70.57 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -64.8 -53.76 41.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.719 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 65.4 t -67.9 -46.14 82.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.592 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.9 m -69.3 -38.67 78.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.822 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 1.0 OUTLIER -62.77 -31.94 73.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 176.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.87 -39.37 94.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.569 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -65.94 -41.01 91.87 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.774 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.54 -41.75 99.11 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.848 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -67.57 -43.61 80.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.59 -178.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -58.65 -36.57 74.33 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.663 HG13 HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -60.06 -34.04 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.436 -178.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.722 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -64.66 -45.67 85.74 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.364 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.4 p -66.8 -31.59 72.32 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.706 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -54.7 -43.1 72.24 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.18 -44.41 72.24 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.382 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -66.83 -48.76 67.91 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 m -59.05 -12.13 4.41 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 119.708 1.14 . . . . 0.0 112.086 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 63' ' ' LEU . 13.0 m -114.44 -42.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.95 0.405 . . . . 0.0 111.575 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 144.19 158.91 7.79 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -60.65 -23.02 64.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.642 0.258 . . . . 0.0 111.681 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.14 7.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.62 136.44 53.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.105 0.479 . . . . 0.0 111.599 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.37 -153.46 27.86 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.45 85.8 1.13 Allowed 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 118.439 -1.304 . . . . 0.0 107.802 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -19.65 65.15 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.706 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.1 pp -83.78 -11.95 56.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.64 -1.618 . . . . 0.0 113.031 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -115.37 135.7 22.62 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 119.846 1.203 . . . . 0.0 114.06 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.483 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 96.6 Cg_endo -83.44 -21.6 4.29 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 123.14 2.56 . . . . 0.0 112.004 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.685 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.42 -48.67 74.48 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG23 HD23 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -66.14 -36.84 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.155 -0.341 . . . . 0.0 111.276 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -28.45 69.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.736 HD22 ' HA ' ' A' ' 217' ' ' PHE . 0.3 OUTLIER -57.08 -35.12 69.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.127 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.419 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -68.73 -48.79 47.26 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.76 -30.53 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.86 0.362 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.78 -35.02 77.93 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -38.64 67.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 176.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.93 -37.01 70.1 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.476 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -61.06 -37.69 83.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.923 0.868 . . . . 0.0 109.23 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -63.17 -48.51 87.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 113.784 -1.553 . . . . 0.0 113.367 -178.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.433 ' N ' HG22 ' A' ' 98' ' ' ILE . 2.8 mm -70.42 -38.12 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.31 74.48 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.201 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -35.61 70.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.411 ' O ' HG13 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -58.08 -36.09 72.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.22 -35.33 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.52 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.34 90.03 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 121.041 1.746 . . . . 0.0 113.105 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.02 75.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.493 HD11 ' CE2' ' A' ' 197' ' ' PHE . 64.0 mt -65.39 -50.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.9 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.02 -37.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.29 0.567 . . . . 0.0 109.612 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.56 -45.11 85.57 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.619 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.42 -37.13 74.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.819 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -46.7 85.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 pt -67.09 -37.31 79.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.745 HD22 HG21 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -67.06 -24.4 65.98 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.233 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.3 m -60.89 -44.38 97.18 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.784 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.3 62.01 Favored Glycine 0 CA--C 1.512 -0.136 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.91 -31.62 36.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.258 -0.971 . . . . 0.0 111.009 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.723 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.94 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 117.35 31.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.344 0.592 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 51.97 17.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.048 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.83 91.72 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.43 HD21 ' OG ' ' A' ' 135' ' ' SER . 0.9 OUTLIER -63.17 138.59 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.286 0.565 . . . . 0.0 110.749 -178.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.94 135.61 48.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.405 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -49.81 127.57 16.41 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.05 -104.26 0.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.846 HG21 HD13 ' A' ' 141' ' ' ILE . 1.5 t -86.06 125.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.456 ' O ' HG12 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.65 -171.87 0.72 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 102.956 -2.979 . . . . 0.0 102.956 176.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.488 ' O ' HD13 ' A' ' 211' ' ' ILE . 54.1 m -62.67 -47.0 85.56 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 114.575 -2.85 . . . . 0.0 110.424 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.556 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -59.25 -39.85 95.12 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.46 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.783 ' HB3' HG22 ' A' ' 133' ' ' VAL . 37.9 mm-40 -53.5 -23.23 9.77 Favored 'General case' 0 C--N 1.25 -3.75 0 CA-C-O 121.29 0.567 . . . . 0.0 110.544 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.19 -1.65 21.48 Favored Glycine 0 C--O 1.186 -2.901 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -50.46 68.28 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-N 118.709 1.254 . . . . 0.0 110.836 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.48 -41.01 78.45 Favored Glycine 0 CA--C 1.51 -0.249 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.846 HD13 HG21 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -65.04 -40.67 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 112.775 -1.713 . . . . 0.0 112.063 -178.369 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 138' ' ' GLY . 15.5 mt-10 -68.43 -36.42 79.03 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.834 0.825 . . . . 0.0 111.697 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.668 HG23 ' CA ' ' A' ' 219' ' ' GLY . 34.6 mt -66.63 -52.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.557 -174.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.22 -44.83 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.935 0.874 . . . . 0.0 111.966 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.53 -51.88 56.44 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 113.542 -1.663 . . . . 0.0 112.036 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.404 ' HA ' HG23 ' A' ' 191' ' ' ILE . 26.5 m -70.58 -36.95 73.87 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.375 -0.912 . . . . 0.0 111.185 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 1.5 tp -55.0 -40.45 70.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.008 -176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.6 OUTLIER -58.87 -31.94 69.03 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.126 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.987 HD11 HG22 ' A' ' 176' ' ' VAL . 1.2 tp -68.77 -46.65 68.22 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.457 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.491 HG21 ' HA3' ' A' ' 220' ' ' GLY . 52.3 t -66.25 -40.98 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.7 -35.55 80.94 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.46 -33.51 74.31 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.05 -45.48 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -48.15 81.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.038 0.447 . . . . 0.0 109.928 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.662 ' CB ' HD11 ' A' ' 172' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.228 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.639 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 21.1 Cg_exo -54.82 -46.27 34.6 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.17 -37.46 74.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.51 -45.95 61.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.782 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.662 HD11 ' CB ' ' A' ' 156' ' ' THR . 49.3 mt -58.3 -39.37 73.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.591 0.71 . . . . 0.0 109.238 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.25 93.29 Favored Glycine 0 C--O 1.2 -2.015 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.929 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.455 ' O ' HD13 ' A' ' 178' ' ' LEU . 2.0 tp -55.09 -35.8 64.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.422 ' O ' ' NE2' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -67.7 -34.47 76.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.395 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.987 HG22 HD11 ' A' ' 149' ' ' LEU . 24.8 t -73.09 -47.12 48.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -175.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.822 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -69.67 -30.85 68.63 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.485 1.135 . . . . 0.0 110.107 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.264 2.1 mp -70.56 -50.5 36.73 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 124.546 2.117 . . . . 0.0 110.323 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.458 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.45 -36.91 64.75 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 110.219 -3.173 . . . . 0.0 107.401 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' HIS . . . . . 0.46 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 12.1 m170 -70.18 -35.34 73.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.096 -1.552 . . . . 0.0 109.645 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 177' ' ' ALA . 0.1 OUTLIER -58.88 -47.85 83.47 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.919 -178.129 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -75.04 -52.64 10.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.745 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -70.16 -52.04 26.61 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.516 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 10.8 mt -60.87 -40.67 86.0 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.901 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -75.61 -35.67 60.47 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 115.742 -2.383 . . . . 0.0 112.266 -177.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.07 -29.94 68.89 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.802 -1.159 . . . . 0.0 111.179 -171.319 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.281 0.1 OUTLIER -124.44 -26.83 3.83 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.199 -179.109 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.2 -5.87 84.36 Favored Glycine 0 CA--C 1.569 3.423 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.431 ' H ' HG23 ' A' ' 187' ' ' THR . 43.9 t -84.72 129.1 34.87 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -48.4 162.83 0.41 Allowed Glycine 0 N--CA 1.408 -3.187 0 CA-C-N 111.265 -2.698 . . . . 0.0 113.464 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.745 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -73.11 -42.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.685 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.2 p-10 -92.38 144.73 29.34 Favored Pre-proline 0 N--CA 1.417 -2.096 0 CA-C-N 110.843 -2.889 . . . . 0.0 107.702 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.02 -14.71 45.72 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.907 1.738 . . . . 0.0 111.247 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.486 ' HB3' HD22 ' A' ' 192' ' ' ASN . . . -75.03 -31.83 61.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.989 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.525 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.48 -39.25 74.33 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.376 0.607 . . . . 0.0 109.863 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -36.91 66.79 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.828 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 11.6 t80 -72.22 -35.24 68.82 Favored 'General case' 0 N--CA 1.511 2.575 0 C-N-CA 126.412 1.885 . . . . 0.0 114.442 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.26 93.51 Favored Glycine 0 C--N 1.318 -0.438 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.9 m -76.48 -28.42 56.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.265 -0.968 . . . . 0.0 110.647 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.828 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -66.26 -34.06 77.16 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.163 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.318 -0.788 0 CA-C-N 121.013 1.733 . . . . 0.0 111.604 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.556 HG21 ' HA2' ' A' ' 136' ' ' GLY . 2.7 pp . . . . . 0 CA--C 1.515 -0.369 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' PHE . . . . . 0.526 ' N ' HD12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -58.46 -31.82 68.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.178 -179.196 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -84.56 -33.91 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.9 p -81.79 -46.57 19.93 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -175.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.03 -44.73 83.26 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.177 -176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.9 Cg_exo -71.75 -28.6 16.76 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.842 2.362 . . . . 0.0 113.192 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.736 ' HA ' HD22 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -75.65 -35.02 60.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.244 0.545 . . . . 0.0 112.147 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.553 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.3 mm -70.55 -46.37 70.33 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.158 0 C-N-CA 124.165 0.986 . . . . 0.0 112.685 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.668 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.91 -46.74 64.76 Favored Glycine 0 C--N 1.359 1.858 0 O-C-N 128.713 3.758 . . . . 0.0 111.768 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.561 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.44 -49.04 33.69 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 118.158 -1.972 . . . . 0.0 109.762 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.467 ' N ' HD11 ' A' ' 81' ' ' LEU . . . -55.03 -38.94 68.6 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.57 0.7 . . . . 0.0 109.715 -176.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.72 -31.2 70.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.274 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -58.95 -39.69 82.41 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.129 0.966 . . . . 0.0 108.48 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.34 -49.64 81.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.587 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.84 -39.48 94.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.705 0.765 . . . . 0.0 109.829 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mm -57.84 -34.59 48.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.616 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 t80 . . . . . 0 C--N 1.33 -0.262 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.187 -179.343 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 . . . . . 0 C--O 1.232 0.167 0 N-CA-C 111.289 0.107 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.77 -1.45 12.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.276 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.98 -40.25 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.23 -35.67 72.12 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.641 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.786 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.8 69.33 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 3.7 tp10 -70.73 -46.78 62.4 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -176.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -33.9 71.05 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.87 -38.17 78.19 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 112.293 -2.23 . . . . 0.0 109.482 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -63.25 -46.59 86.15 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.006 -1.907 . . . . 0.0 113.73 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -75.58 -31.37 59.94 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.96 -177.498 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.734 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.86 -37.95 67.19 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.178 -0.951 . . . . 0.0 111.287 -178.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.92 -45.25 82.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.715 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -77.13 -50.79 12.23 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 29' ' ' ILE . 43.2 t -64.59 -46.31 92.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.384 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.994 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.417 ' CE1' HD12 ' A' ' 112' ' ' LEU . 57.6 t80 -54.04 -48.67 70.3 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.189 0.519 . . . . 0.0 112.071 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.59 -29.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.519 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.05 -36.19 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.599 HG21 HD22 ' A' ' 112' ' ' LEU . 2.6 mm -64.02 -40.63 89.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.056 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.54 -41.32 81.05 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -67.57 -45.1 76.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.874 0.368 . . . . 0.0 111.876 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.94 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.224 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.438 ' ND2' ' OD1' ' A' ' 185' ' ' ASP . 1.7 t-20 -49.89 -28.71 6.98 Favored 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.602 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.2 -34.59 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -64.94 -54.09 36.18 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.458 1.027 . . . . 0.0 113.443 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.73 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 7.7 p -68.15 -42.43 84.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.772 -176.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.449 ' N ' HG13 ' A' ' 52' ' ' VAL . 57.0 m -69.34 -41.36 76.73 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.52 0.512 . . . . 0.0 109.815 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.81 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 2.5 tm? -62.82 -31.94 73.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.07 -39.61 94.46 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.96 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.408 ' O ' HD13 ' A' ' 60' ' ' ILE . 9.2 m-30 -66.2 -46.83 75.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.699 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.44 -40.18 97.52 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.168 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.663 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 3.7 mm? -68.23 -43.49 77.8 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.093 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 p -58.69 -36.53 74.36 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.482 HG13 HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -59.8 -34.02 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.398 -1.728 . . . . 0.0 108.216 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.76 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.54 -45.63 82.68 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.326 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 p -69.08 -31.8 70.8 Favored 'General case' 0 CA--C 1.471 -2.067 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.711 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.31 -40.95 71.72 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.0 -44.07 73.55 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.827 173.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 t -59.65 -12.43 6.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 120.115 1.325 . . . . 0.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -32.69 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.809 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 168.58 12.21 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.54 -23.08 66.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 tt -73.62 7.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 p -124.42 135.56 53.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.215 0.531 . . . . 0.0 110.95 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.58 -159.82 22.95 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.41 85.89 1.12 Allowed 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.623 1.202 . . . . 0.0 108.468 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -73.2 -19.65 61.05 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.711 HD22 ' HG ' ' A' ' 63' ' ' LEU . 1.2 pp -84.87 8.67 16.63 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.787 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 5.1 t-20 -134.55 127.63 18.74 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.559 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 88.5 Cg_endo -83.33 -28.3 1.52 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.092 2.528 . . . . 0.0 112.275 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -59.35 -49.03 79.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.571 HG23 HD23 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -66.42 -36.75 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 177.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 m -61.15 -28.62 69.25 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -44.34 96.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.38 . . . . 0.0 110.155 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.79 96.37 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.29 -46.18 65.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.657 0.265 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.586 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 . . . . . 0 N--CA 1.46 0.071 0 CA-C-O 120.816 0.341 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.53 -35.26 78.75 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.42 67.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 176.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 tpp -73.39 -31.61 63.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.214 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.73 -39.19 76.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 119.267 0.939 . . . . 0.0 111.575 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -66.83 -41.19 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.695 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -70.65 -38.04 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -66.42 -47.0 74.63 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -35.71 70.81 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.405 ' O ' HG13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -58.12 -36.11 72.44 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 100' ' ' ALA . 3.3 t -70.35 -35.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.197 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.36 -46.72 86.39 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 120.899 1.681 . . . . 0.0 113.084 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.485 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.89 -36.04 75.13 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.683 HG23 HG11 ' A' ' 201' ' ' VAL . 77.6 mt -64.98 -50.31 75.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.305 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 m -65.42 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.27 -43.33 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.973 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -37.05 74.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.75 85.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.454 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt -66.76 -37.33 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.42 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 29' ' ' ILE . 1.1 tt -67.08 -24.44 65.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.4 p -61.4 -41.71 97.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.813 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.0 61.56 Favored Glycine 0 CA--C 1.51 -0.266 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -29.83 24.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.456 -0.872 . . . . 0.0 111.391 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.627 -179.185 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.501 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.54 117.11 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.2 0.524 . . . . 0.0 111.452 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 58.02 11.01 1.32 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.064 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -87.78 91.85 8.9 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.16 143.1 58.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.302 0.572 . . . . 0.0 111.101 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.95 134.71 49.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.636 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -49.79 127.58 16.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 128.94 -104.38 0.64 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.7 t -86.07 124.02 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.469 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.4 t30 -71.67 -171.78 0.71 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 102.823 -3.029 . . . . 0.0 102.823 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 p -62.2 -46.8 87.3 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 114.843 -2.743 . . . . 0.0 110.187 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.14 95.94 Favored Glycine 0 CA--C 1.498 -0.992 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.115 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.762 ' HB3' HG22 ' A' ' 133' ' ' VAL . 26.9 mm100 -53.46 -23.59 10.53 Favored 'General case' 0 C--N 1.248 -3.819 0 CA-C-O 121.496 0.665 . . . . 0.0 110.26 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -69.39 -1.54 29.21 Favored Glycine 0 C--O 1.188 -2.728 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.78 -50.32 65.14 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 118.556 1.178 . . . . 0.0 110.902 -176.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -38.23 76.36 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.582 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.7 OUTLIER -68.92 -38.32 78.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.18 -178.274 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' GLY . 20.4 mt-10 -68.54 -36.29 78.61 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-O 121.744 0.783 . . . . 0.0 111.123 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.704 HG23 ' CA ' ' A' ' 219' ' ' GLY . 31.7 mt -69.65 -45.46 77.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.395 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.496 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.31 -48.78 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.463 1.125 . . . . 0.0 111.27 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.56 58.03 Favored Glycine 0 C--O 1.211 -1.299 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.718 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.427 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 44.8 m -70.62 -40.16 73.32 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.673 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.616 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 3.6 tp -54.8 -40.55 69.59 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.277 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 1.1 pt20 -58.07 -31.1 66.76 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.241 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.005 HD11 HG22 ' A' ' 176' ' ' VAL . 1.6 tp -68.69 -47.17 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.49 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.482 HG21 ' CA ' ' A' ' 220' ' ' GLY . 87.2 t -66.33 -40.98 88.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -42.28 96.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.492 ' SG ' HG23 ' A' ' 172' ' ' ILE . 3.8 p -71.0 -27.18 63.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.457 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.527 HG21 HG21 ' A' ' 79' ' ' VAL . 2.3 t -72.09 -45.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.552 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.59 -41.98 92.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.372 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.56 87.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.519 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.613 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.508 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.613 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 24.3 Cg_exo -54.67 -39.39 89.27 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.524 1.483 . . . . 0.0 111.972 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.54 -42.42 96.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.382 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.55 -47.06 57.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.703 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.492 HG23 ' SG ' ' A' ' 152' ' ' CYS . 41.6 mt -58.23 -37.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.62 -37.42 93.58 Favored Glycine 0 C--O 1.198 -2.125 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.306 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -55.13 -35.98 65.27 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -34.56 77.24 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.52 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 1.005 HG22 HD11 ' A' ' 149' ' ' LEU . 28.0 t -73.15 -47.6 46.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -66.72 -34.89 78.85 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.261 1.029 . . . . 0.0 109.667 -175.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 174' ' ' LEU 0.264 8.1 mt -67.06 -50.56 61.45 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 124.454 2.073 . . . . 0.0 110.863 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -36.97 65.38 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.117 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' HIS . . . . . 0.551 ' HD2' HD11 ' A' ' 191' ' ' ILE . 5.4 m-70 -70.38 -35.12 73.31 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 112.669 -1.766 . . . . 0.0 109.504 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.2 -47.81 83.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.519 -177.76 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.1 -52.33 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.757 ' HB3' HG23 ' A' ' 191' ' ' ILE . . . -70.15 -52.22 25.24 Favored 'General case' 0 C--O 1.206 -1.221 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 188' ' ' GLY . 7.4 mt -56.02 -49.03 77.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.914 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.644 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.438 ' OD1' ' ND2' ' A' ' 49' ' ' ASN . 1.3 t0 -69.02 -35.67 76.91 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 115.538 -2.465 . . . . 0.0 112.582 -176.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 133' ' ' VAL . 2.4 m-85 -60.11 -30.35 69.2 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.721 -170.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.288 0.1 OUTLIER -124.54 -26.82 3.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.06 0.933 . . . . 0.0 113.101 -179.401 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 88.35 -5.99 84.09 Favored Glycine 0 CA--C 1.567 3.284 0 N-CA-C 106.165 -2.774 . . . . 0.0 106.165 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.446 ' H ' HG23 ' A' ' 187' ' ' THR . 17.1 t -85.36 130.68 34.54 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.47 160.65 10.04 Favored Glycine 0 N--CA 1.402 -3.625 0 CA-C-N 111.497 -2.592 . . . . 0.0 111.752 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.757 HG23 ' HB3' ' A' ' 183' ' ' ALA . 1.2 pt -72.11 -38.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.727 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 10.2 p-10 -85.88 139.19 34.99 Favored Pre-proline 0 N--CA 1.413 -2.32 0 CA-C-N 112.657 -2.065 . . . . 0.0 107.997 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -66.03 -14.46 44.53 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.49 2.127 . . . . 0.0 111.58 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.23 -33.23 61.33 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.466 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 15.6 tpt180 -70.74 -38.39 73.54 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.106 0.479 . . . . 0.0 110.158 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.4 t -73.44 -42.22 62.27 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.837 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 1.0 OUTLIER -71.96 -35.2 69.48 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 126.607 1.963 . . . . 0.0 114.777 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.41 93.12 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 m -76.38 -28.35 56.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.322 -0.939 . . . . 0.0 110.669 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.837 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -66.31 -34.22 77.49 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.743 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.683 HG11 HG23 ' A' ' 106' ' ' ILE . 3.4 m . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 121.79 2.086 . . . . 0.0 110.526 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.832 0.825 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -58.8 -36.19 74.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.058 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.27 -33.41 24.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 215' ' ' GLY . 12.0 p -77.74 -44.99 28.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.496 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.27 -47.73 73.13 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.682 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.1 Cg_endo -71.8 -28.62 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.936 2.424 . . . . 0.0 113.609 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -75.2 -33.81 61.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.051 0.453 . . . . 0.0 111.898 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 51.8 mt -70.58 -46.25 70.72 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.382 0 C-N-CA 123.892 0.877 . . . . 0.0 112.753 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.704 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.29 -45.84 67.61 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 128.343 3.527 . . . . 0.0 111.752 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.39 -48.91 34.71 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 118.306 -1.902 . . . . 0.0 109.532 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.81 68.31 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.601 0.715 . . . . 0.0 109.674 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.769 ' O ' HG23 ' A' ' 226' ' ' ILE . 1.0 OUTLIER -67.85 -31.33 71.08 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.225 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.99 -40.03 83.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.51 -50.28 80.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.488 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -39.56 93.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 222' ' ' LEU . 1.1 pp -68.99 -34.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.325 -176.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.3 t80 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.5 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.09 141.07 43.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.553 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -139.76 98.64 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.606 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -135.67 -42.08 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.542 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -110.1 86.93 2.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.545 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -82.37 145.32 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? 72.62 -64.85 0.38 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.68 0.612 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttp 67.19 11.42 8.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.074 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 9' ' ' LEU . 8.8 mp 53.48 -179.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.848 0.356 . . . . 0.0 110.864 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -114.93 -44.69 3.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.522 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -141.13 156.38 45.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 -68.56 -0.23 4.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.926 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.63 -5.53 11.15 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.478 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -63.12 -40.26 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 9.0 p -68.23 -35.75 72.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.119 176.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.79 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -70.79 -46.54 62.69 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -176.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -33.53 71.66 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 19' ' ' LEU . 11.6 mt -58.43 -38.32 77.23 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.992 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.6 -46.64 78.58 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 112.899 -1.955 . . . . 0.0 114.865 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 105' ' ' ALA . 0.2 OUTLIER -75.63 -31.32 59.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.506 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.724 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -70.33 -39.05 74.97 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.736 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -44.73 84.01 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.636 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -76.83 -52.5 9.4 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.48 -44.72 94.13 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.604 -177.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.513 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 63.3 t80 -54.3 -48.97 70.71 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.424 0.631 . . . . 0.0 112.337 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 pt -75.65 -29.54 20.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.52 -36.42 69.18 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -175.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.803 HG21 HD22 ' A' ' 112' ' ' LEU . 3.8 mm -60.84 -38.59 79.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.065 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -36.8 64.65 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p -67.01 -41.28 86.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.54 -16.75 63.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.469 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.581 HD11 HD21 ' A' ' 112' ' ' LEU . 2.4 mt -83.69 -40.31 19.06 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.55 0.69 . . . . 0.0 110.232 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.64 -34.52 43.77 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.523 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -24.63 60.2 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.77 -9.85 16.28 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.663 176.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.468 ' H ' ' C ' ' A' ' 34' ' ' GLY . 35.6 t80 -121.42 121.74 28.34 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 118.753 0.706 . . . . 0.0 110.197 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.95 139.42 52.13 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 119.836 0.977 . . . . 0.0 112.215 0.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.65 151.31 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.866 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.54 154.07 14.06 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.02 103.55 2.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.513 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -124.33 -31.63 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -125.67 -164.86 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.577 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 p -98.61 -24.8 14.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.69 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.7 138.97 58.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.749 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.15 133.46 53.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.184 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -105.95 125.26 50.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.469 . . . . 0.0 111.046 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.12 163.22 15.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.789 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.52 -28.47 5.53 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG22 HD21 ' A' ' 181' ' ' LEU . 18.4 t -58.77 -42.5 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 O-C-N 121.821 -0.55 . . . . 0.0 112.264 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -65.01 -53.98 37.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.729 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 33.9 m -67.84 -42.17 85.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.225 -176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.456 ' N ' HG23 ' A' ' 52' ' ' VAL . 72.8 m -69.39 -41.23 76.74 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.933 0.771 . . . . 0.0 109.806 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.815 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.8 OUTLIER -62.74 -31.74 72.73 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -65.08 -39.49 93.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.508 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 60' ' ' ILE . 16.5 m-30 -66.15 -46.92 75.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.7 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -60.23 -36.96 92.2 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.277 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 27.1 mt -68.28 -43.06 78.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.8 m -57.61 -35.86 71.02 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 176' ' ' VAL . 0.6 OUTLIER -60.23 -33.81 54.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.675 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.745 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -60.64 -45.53 93.73 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.51 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -31.52 70.59 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.641 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -55.05 -42.59 72.9 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 104.199 -2.519 . . . . 0.0 104.199 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.98 -44.27 73.21 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.654 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -43.57 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -176.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -59.25 -12.26 5.2 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 119.936 1.243 . . . . 0.0 111.856 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 m -119.76 -38.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 154.16 6.34 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -52.94 -22.74 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 70' ' ' ILE . 2.1 mp -70.89 7.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.56 135.71 53.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.11 -159.61 31.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.48 85.99 1.15 Allowed 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 118.574 -1.25 . . . . 0.0 107.776 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -19.54 64.46 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 112.794 -2.003 . . . . 0.0 105.684 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 pp -84.84 0.18 51.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.398 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.26 128.81 25.53 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 119.371 0.987 . . . . 0.0 113.517 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 97.9 Cg_endo -83.35 -25.34 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.717 2.278 . . . . 0.0 111.86 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.56 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.27 -46.16 84.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.509 HG23 HD23 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -66.23 -36.8 78.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 110.802 177.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -64.68 -28.62 69.73 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -57.21 -44.47 83.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 110.285 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.24 95.89 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.8 tp -51.41 -41.26 60.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.576 0.227 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 tp -48.33 -51.18 27.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.432 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 70.05 -69.95 0.16 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.156 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 p -176.91 51.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.748 0.309 . . . . 0.0 110.556 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.8 m -135.98 114.24 11.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.645 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -171.71 86.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.656 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.93 -70.17 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.3 m -144.9 91.05 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.55 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.9 mt 65.15 134.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.723 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.41 161.96 38.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.496 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.3 -37.33 64.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.496 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.724 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.7 -35.2 78.38 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.701 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 tp -54.78 -38.45 67.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -32.63 64.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.227 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -70.06 -38.65 75.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.287 0.949 . . . . 0.0 111.947 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.724 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -66.77 -41.25 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -178.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.49 -37.78 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.414 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.02 83.53 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.008 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.33 -35.89 71.37 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.438 ' O ' HG13 ' A' ' 106' ' ' ILE . 1.2 t -57.91 -36.14 72.03 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.57 -35.33 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.429 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.37 85.22 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 120.781 1.628 . . . . 0.0 113.221 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB2' ' CG2' ' A' ' 21' ' ' THR . . . -69.8 -35.9 75.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 102' ' ' CYS . 69.5 mt -65.03 -50.36 75.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.98 -37.12 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.434 0.635 . . . . 0.0 109.48 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.724 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.45 -49.83 74.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.407 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.71 -37.02 86.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.727 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -44.89 88.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.19 -37.28 76.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.087 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.803 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -65.81 -24.36 66.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.601 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 t -63.3 -44.38 95.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.901 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.25 -36.33 62.16 Favored Glycine 0 CA--C 1.509 -0.299 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -33.16 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.3 -0.95 . . . . 0.0 110.728 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m -80.85 5.35 16.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.559 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.6 t -56.74 -35.02 68.12 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.524 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 t -92.16 -35.35 13.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.41 -177.49 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.43 124.91 48.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.72 78.4 0.26 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.07 -35.35 10.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.687 0.28 . . . . 0.0 111.006 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.49 58.27 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.075 0.464 . . . . 0.0 110.561 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.487 ' CD2' HD21 ' A' ' 33' ' ' LEU . 68.9 mt -81.74 7.95 11.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.284 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.79 81.85 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.54 117.2 31.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.281 0.563 . . . . 0.0 111.131 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.85 15.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.665 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.15 90.07 7.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 129' ' ' LEU . 1.2 mm? -63.1 142.8 58.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.317 0.58 . . . . 0.0 111.149 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.96 136.25 47.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.333 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 127.58 16.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.66 -105.05 0.65 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.8 t -86.09 124.13 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.48 ' O ' HG12 ' A' ' 133' ' ' VAL . 32.1 t30 -71.65 -171.95 0.73 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -62.01 -46.86 87.34 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 114.928 -2.709 . . . . 0.0 110.239 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.53 96.17 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.754 ' HB3' HG22 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -53.39 -23.53 9.9 Favored 'General case' 0 C--N 1.248 -3.809 0 CA-C-O 121.261 0.553 . . . . 0.0 110.796 -176.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -70.33 -1.95 38.53 Favored Glycine 0 C--O 1.187 -2.794 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.98 -50.64 71.26 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.521 -1.576 . . . . 0.0 110.168 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.71 -45.94 56.27 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.748 HD13 HG21 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -60.88 -42.08 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.184 -1.508 . . . . 0.0 112.084 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' A' ' 138' ' ' GLY . 8.3 tt0 -68.37 -36.32 79.02 Favored 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 123.687 0.795 . . . . 0.0 112.305 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.646 HG23 ' CA ' ' A' ' 219' ' ' GLY . 25.4 mt -67.65 -47.68 79.18 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.404 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 26.9 mt -68.33 -46.79 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.059 0.933 . . . . 0.0 111.695 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.536 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -60.18 -49.94 73.04 Favored Glycine 0 C--O 1.211 -1.335 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.323 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.5 ' HA ' HG23 ' A' ' 191' ' ' ILE . 28.1 m -70.58 -38.22 74.03 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.923 0.868 . . . . 0.0 111.13 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.612 ' O ' HD12 ' A' ' 147' ' ' LEU . 1.7 tp -54.98 -40.22 69.83 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.048 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.8 OUTLIER -58.77 -31.06 68.02 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.325 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.0 HD11 HG22 ' A' ' 176' ' ' VAL . 1.8 tp -68.91 -46.69 67.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.353 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.491 HG21 ' HA3' ' A' ' 220' ' ' GLY . 38.9 t -66.35 -45.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -31.87 72.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.089 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.09 -45.43 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 -48.1 80.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 111.119 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.84 -31.69 72.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.488 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.9 OUTLIER -63.8 -36.96 85.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.468 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.39 -8.83 52.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.358 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 135.69 53.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.785 0.326 . . . . 0.0 110.556 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -26.93 32.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -52.11 174.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.563 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.5 ttp85 -127.74 125.45 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.548 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.44 -58.18 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.59 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.87 107.93 9.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.588 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.16 133.2 38.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.41 83.95 0.11 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.89 -137.35 13.48 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.4 ' HB3' HD12 ' A' ' 170' ' ' LEU . 0.2 OUTLIER -110.72 141.57 43.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.59 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.537 ' HB3' ' HD3' ' A' ' 169' ' ' PRO . . . -52.37 -46.12 94.74 Favored Pre-proline 0 C--O 1.219 -0.505 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.433 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 39.5 Cg_exo -54.31 -44.24 51.24 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.795 1.663 . . . . 0.0 112.019 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.4 HD12 ' HB3' ' A' ' 167' ' ' SER . 1.8 mp -66.1 -38.1 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.26 56.38 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 22.2 pt -60.26 -38.3 76.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.721 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.41 93.53 Favored Glycine 0 C--O 1.2 -1.994 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.681 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mt -55.04 -35.58 64.63 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.161 -2.162 . . . . 0.0 105.161 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -34.54 77.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.31 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 1.0 HG22 HD11 ' A' ' 149' ' ' LEU . 52.9 t -73.04 -47.24 48.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.907 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 -175.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.815 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -67.53 -33.61 75.41 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 122.665 1.222 . . . . 0.0 110.027 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.258 0.1 OUTLIER -70.61 -47.49 59.85 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.973 179.375 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.494 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.64 -36.84 65.94 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 111.564 -2.562 . . . . 0.0 107.664 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.481 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 6.2 m170 -70.46 -34.99 73.06 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.933 -1.633 . . . . 0.0 109.54 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.02 -48.43 81.61 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.359 -177.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.536 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.41 -52.07 11.6 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 178.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -69.66 -51.96 30.04 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 180' ' ' HIS . 5.6 mt -62.11 -49.14 85.29 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.807 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.039 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -67.28 -35.51 79.64 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 116.119 -2.232 . . . . 0.0 112.818 -176.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.95 -30.4 69.05 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.909 -1.116 . . . . 0.0 111.699 -171.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.295 0.1 OUTLIER -124.31 -26.91 3.86 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.267 1.032 . . . . 0.0 113.182 -178.79 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.61 -5.74 84.51 Favored Glycine 0 CA--C 1.567 3.296 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -170.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.408 ' H ' HG23 ' A' ' 187' ' ' THR . 15.4 t -82.68 127.89 33.83 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.596 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -44.33 170.35 0.01 OUTLIER Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 111.358 -2.655 . . . . 0.0 113.363 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -79.76 -40.14 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 173.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -101.32 153.12 38.01 Favored Pre-proline 0 N--CA 1.407 -2.614 0 CA-C-N 111.432 -2.622 . . . . 0.0 108.361 177.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.46 -14.59 44.75 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 122.879 2.386 . . . . 0.0 111.661 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.622 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.11 -34.5 61.72 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.102 0.251 . . . . 0.0 111.094 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.596 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.52 -39.67 73.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.214 0.531 . . . . 0.0 109.928 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -36.49 66.39 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.008 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.814 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 6.1 t80 -72.26 -35.2 68.71 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 126.517 1.927 . . . . 0.0 114.268 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -46.77 91.73 Favored Glycine 0 C--N 1.319 -0.373 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.3 56.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.19 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -63.33 -34.07 76.89 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.514 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.429 HG23 ' CE2' ' A' ' 197' ' ' PHE . 0.9 OUTLIER -63.85 -31.74 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 121.031 1.741 . . . . 0.0 110.425 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.52 -63.22 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.64 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 71.5 m -116.56 110.47 18.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.622 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -79.74 158.64 26.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.454 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -143.88 -166.72 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.715 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -91.36 -143.75 0.19 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.347 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -53.16 -20.61 4.05 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.154 -0.341 . . . . 0.0 111.287 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -55.19 -35.23 64.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.895 0.379 . . . . 0.0 110.302 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -28.64 62.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -70.58 -37.55 73.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.463 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.6 mt -52.64 -35.11 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.73 0.776 . . . . 0.0 109.155 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.53 -36.57 74.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.049 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -84.21 -33.46 24.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 215' ' ' GLY . 15.0 p -79.09 -43.97 24.29 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.509 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.12 -44.15 83.6 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.417 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.6 Cg_exo -71.65 -28.72 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.258 . . . . 0.0 113.106 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.03 -32.14 50.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.146 0.498 . . . . 0.0 112.29 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.549 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.2 mm -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.255 0 C-N-CA 123.743 0.817 . . . . 0.0 112.164 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.646 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.71 -46.6 67.04 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 128.758 3.786 . . . . 0.0 111.731 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.31 -49.03 34.66 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 118.171 -1.966 . . . . 0.0 109.906 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -39.04 68.47 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.649 0.738 . . . . 0.0 109.713 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.86 -31.24 70.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.223 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.58 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.84 -39.68 81.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.17 -49.65 80.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.352 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.84 -39.42 91.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.754 0.788 . . . . 0.0 109.771 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 mt -58.27 -34.72 50.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.069 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -140.95 72.12 1.38 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.563 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -166.35 68.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.635 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -101.42 175.69 5.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.379 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 10.7 mm 58.25 98.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.404 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.94 143.66 26.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.565 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -159.83 68.67 3.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.535 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -47.52 106.39 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.811 2.341 . . . . 0.0 112.094 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 64.79 118.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.565 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.65 106.66 8.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.555 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.31 -28.06 15.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.615 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 38.0 t70 59.33 97.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.3 mt -50.48 -63.33 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.585 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.6 t -162.05 65.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.518 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 62.2 t0 55.13 95.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.58 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 55.64 -176.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.583 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 26.0 m -141.36 26.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.33 159.45 14.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.59 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 1.1 t -132.33 151.26 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.56 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -126.48 -26.71 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.541 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.7 m -151.69 104.79 3.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.544 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 28.0 t -57.82 164.36 2.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.553 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 114.97 -54.94 0.55 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -90.87 151.87 20.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.563 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 92.9 t -125.8 -40.13 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.62 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -97.79 -66.52 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.632 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -173.61 76.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.579 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -114.37 138.13 50.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.549 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.03 -27.63 14.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.568 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.51 172.03 7.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -141.49 54.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.571 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -53.85 173.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.57 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -132.87 38.97 3.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.559 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 56.72 78.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.596 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.63 -50.49 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.556 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -131.26 90.99 2.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.52 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 1.7 m -66.61 112.14 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.609 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -94.42 -58.88 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.545 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 85.1 t -115.36 105.17 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -129.12 -46.8 1.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 8.4 mmm -103.3 111.56 24.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.589 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -46.92 106.55 0.59 Allowed Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.727 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.4 -32.76 15.64 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.877 1.718 . . . . 0.0 112.087 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 270' ' ' ALA . 23.5 pttm -174.84 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 269' ' ' LYS . . . 64.8 105.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.587 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.5 tt 62.35 101.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.539 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -53.37 159.59 1.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -124.22 -50.9 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.568 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -157.52 -51.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.57 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 64.83 -82.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.818 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 276' ' ' ILE . 1.0 OUTLIER 75.36 -6.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.418 0.449 . . . . 0.0 111.838 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.15 138.22 7.67 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.612 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -99.97 173.66 6.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.622 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -60.13 -31.71 70.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.524 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.34 -75.75 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.73 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 49.44 30.02 3.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.337 . . . . 0.0 110.637 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 21.2 t30 63.66 163.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.536 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.8 m -130.03 59.32 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.615 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.16 -37.07 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.597 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.1 91.04 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.521 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -93.98 83.62 4.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.536 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -106.71 -28.65 10.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.552 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -82.41 162.53 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.591 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 13.0 m170 55.97 95.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -134.47 -76.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.591 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 37.6 m80 53.54 48.4 21.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.555 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtp . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.03 33.15 5.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.54 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.7 p -166.24 118.75 1.05 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.564 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.42 25.29 7.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 49.87 35.07 8.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.46 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -91.22 -43.27 9.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.643 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt 53.69 93.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.581 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -106.4 101.5 10.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.66 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.19 -79.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.446 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -141.79 -84.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.368 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 73.74 -54.93 0.68 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.441 0.463 . . . . 0.0 111.36 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.63 1.6 6.44 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.24 -14.4 11.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.027 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.01 -40.17 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 17.4 m -68.43 -35.81 72.24 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 112.83 -1.986 . . . . 0.0 110.521 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.18 70.07 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.683 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 11.1 mm-40 -70.81 -46.72 62.29 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -33.83 74.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 11.4 mt -58.63 -38.37 77.93 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.911 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.58 -46.99 77.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.781 -2.009 . . . . 0.0 114.749 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -75.65 -31.53 59.83 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.735 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.74 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.79 -36.88 67.69 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.507 -0.745 . . . . 0.0 111.607 -179.103 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -66.05 -45.22 82.15 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -77.18 -47.7 19.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 29' ' ' ILE . 90.2 t -65.28 -49.82 76.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.137 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.475 ' CE1' HD12 ' A' ' 112' ' ' LEU . 55.7 t80 -54.07 -48.07 71.01 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.5 -29.43 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.616 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -36.17 68.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.6 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -60.11 -43.74 93.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.76 63.87 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -67.33 -38.1 84.35 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.605 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . -69.45 -46.48 66.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.451 HD13 ' HA3' ' A' ' 121' ' ' GLY . 2.8 pp -85.94 -39.88 16.46 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' N ' HD12 ' A' ' 33' ' ' LEU . . . -69.81 -35.24 72.83 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.77 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.79 -20.04 46.37 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.326 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.71 -9.85 16.32 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.798 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' H ' ' C ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER -120.98 120.1 29.5 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 118.234 0.47 . . . . 0.0 110.312 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.24 141.92 69.09 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 C-N-CA 124.655 -0.977 . . . . 0.0 112.105 -0.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.75 150.97 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.686 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.73 88.73 0.34 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -77.24 155.54 32.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.321 . . . . 0.0 110.625 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -94.64 26.4 3.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.574 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 74.63 -7.89 1.62 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.952 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.56 -31.23 4.95 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.908 0.385 . . . . 0.0 110.488 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.61 143.38 57.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.565 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.55 115.68 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.758 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -100.51 105.9 17.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 81.7 m-20 -114.31 163.08 15.77 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 121.08 0.466 . . . . 0.0 111.683 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.75 -28.02 5.64 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.403 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.566 HG12 HD21 ' A' ' 181' ' ' LEU . 24.5 m -56.74 -43.85 80.34 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.549 ' NZ ' HG23 ' A' ' 52' ' ' VAL . 1.7 pttp -64.77 -50.46 66.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 2.0 t -67.91 -47.65 78.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.647 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -69.31 -37.18 77.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.787 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 2.5 tm? -64.43 -32.01 73.46 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -62.35 -39.49 93.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.824 -1.534 . . . . 0.0 109.327 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -65.89 -44.27 85.78 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.76 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.48 -41.55 97.93 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -68.26 -43.92 76.73 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.749 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.467 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -61.04 -36.53 79.82 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.438 HD13 HD21 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -59.87 -33.89 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.006 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.752 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -68.61 -45.63 71.41 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.857 -1.519 . . . . 0.0 113.016 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 p -67.36 -31.88 72.43 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -55.35 -41.26 72.28 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.9 -44.14 73.81 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.788 173.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -38.03 85.96 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.8 m -59.54 -12.13 5.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 119.754 1.161 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.27 -42.91 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.936 0.398 . . . . 0.0 111.133 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 171.77 13.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -65.26 -23.05 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.767 0.318 . . . . 0.0 111.008 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.45 7.11 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.45 135.65 53.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.049 0.452 . . . . 0.0 111.051 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.92 -157.86 16.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.36 86.04 1.11 Allowed 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 122.507 1.146 . . . . 0.0 108.085 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -19.61 62.38 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.4 pp -84.53 4.58 31.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 113.669 -1.605 . . . . 0.0 111.625 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.447 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 14.5 t-20 -125.49 126.11 25.05 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.547 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 71.9 Cg_endo -83.23 -24.02 3.3 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.883 2.389 . . . . 0.0 111.632 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -66.16 -50.84 62.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -36.67 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.923 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 m -61.21 -32.23 72.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 217' ' ' PHE . 34.4 tp -57.27 -44.61 84.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.044 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.25 -45.87 63.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -44.29 66.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 111.008 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.04 -32.0 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 55.9 57.64 5.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.537 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.92 116.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.6 t -169.65 -59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.442 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -174.74 55.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.516 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.1 tt -176.9 146.77 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.678 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 p -116.12 178.7 4.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.524 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -132.38 -31.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.7 t80 75.22 -53.72 0.66 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.695 0.622 . . . . 0.0 111.132 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -59.03 -36.02 74.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 0.0 110.792 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.91 -35.13 77.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.682 ' O ' HG13 ' A' ' 98' ' ' ILE . 3.1 mm? -54.54 -38.18 66.3 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mtm -73.71 -33.3 64.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.767 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -69.99 -37.84 75.84 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.096 -1.003 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.805 HG23 ' O ' ' A' ' 94' ' ' ALA . 1.8 pp -66.81 -42.55 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.384 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.12 -37.73 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.37 70.27 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -71.96 -35.97 69.72 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.669 0.668 . . . . 0.0 112.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 m -58.1 -35.88 72.07 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.52 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.8 t -70.4 -35.36 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.063 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.07 91.59 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 121.152 1.796 . . . . 0.0 112.519 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.469 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.95 -36.1 75.0 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 103' ' ' VAL . 37.0 mt -67.99 -42.41 85.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.575 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.4 t -69.93 -37.18 72.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.294 0.569 . . . . 0.0 110.107 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.63 -49.74 75.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.445 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 35.8 m -65.88 -37.1 85.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.457 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.53 88.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.735 0.303 . . . . 0.0 111.135 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.27 -50.5 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.28 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.6 HD22 HG21 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -58.85 -24.2 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.537 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -42.63 95.51 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.771 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.26 61.95 Favored Glycine 0 CA--C 1.511 -0.178 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.4 -31.95 44.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.779 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p -85.35 5.57 30.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.582 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 91.9 p -53.65 -26.08 20.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.702 0.286 . . . . 0.0 110.967 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.73 3.61 9.45 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.918 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.8 tp 67.71 20.2 9.55 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.589 0.233 . . . . 0.0 110.789 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 t -118.46 164.14 15.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.343 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.451 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 45.74 36.01 6.2 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -71.14 -6.38 38.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.447 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -79.71 76.23 6.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.955 0.407 . . . . 0.0 110.146 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt -85.26 7.93 20.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.479 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.32 31.33 57.27 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.56 117.49 32.46 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.125 -0.538 . . . . 0.0 111.778 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 60.23 9.19 1.81 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.02 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -87.68 88.32 7.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.12 143.24 57.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.254 0.55 . . . . 0.0 110.88 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.05 135.7 48.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.679 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -49.64 127.45 15.76 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.6 -105.35 0.67 Allowed Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.86 HG21 HD13 ' A' ' 141' ' ' ILE . 1.6 t -85.83 123.93 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.461 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.5 m-20 -71.71 -171.85 0.73 Allowed 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -61.92 -46.74 88.05 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 114.807 -2.757 . . . . 0.0 110.409 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.04 -41.24 96.37 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.071 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.782 ' HB3' HG22 ' A' ' 133' ' ' VAL . 4.5 mt-30 -53.53 -23.42 10.48 Favored 'General case' 0 C--N 1.249 -3.789 0 CA-C-O 121.238 0.542 . . . . 0.0 110.237 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.565 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.65 -1.72 24.89 Favored Glycine 0 C--O 1.19 -2.597 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.43 -50.23 66.19 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 118.489 1.144 . . . . 0.0 110.322 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -40.96 75.16 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.86 HD13 HG21 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -66.17 -38.77 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 113.155 -1.523 . . . . 0.0 112.087 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 32.5 mt-10 -68.46 -36.24 78.71 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 121.948 0.88 . . . . 0.0 111.039 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.756 HG23 ' HA2' ' A' ' 219' ' ' GLY . 35.6 mt -67.29 -48.47 77.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.627 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.26 -48.47 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 122.088 0.947 . . . . 0.0 111.424 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.53 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -59.25 -51.97 56.02 Favored Glycine 0 C--O 1.211 -1.329 0 CA-C-N 113.466 -1.697 . . . . 0.0 113.138 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.401 ' HA ' HG23 ' A' ' 191' ' ' ILE . 24.2 m -70.39 -40.42 73.94 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.5 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 148' ' ' GLN . 0.5 OUTLIER -54.64 -40.11 68.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -176.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.46 ' N ' HD23 ' A' ' 147' ' ' LEU . 1.1 pt20 -58.0 -30.82 66.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.02 HD11 HG22 ' A' ' 176' ' ' VAL . 1.3 tp -68.75 -46.72 68.09 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.426 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.41 HG21 ' HA3' ' A' ' 220' ' ' GLY . 78.9 t -66.26 -41.03 88.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -35.65 81.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.442 0.297 . . . . 0.0 111.463 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -34.47 77.36 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.644 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.01 -38.53 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.847 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.4 mp -65.33 -48.02 74.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.81 0.338 . . . . 0.0 110.971 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.76 72.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.42 HG23 ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -67.53 -37.23 82.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.193 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.401 HG23 HG22 ' A' ' 156' ' ' THR . 4.4 p -98.85 10.08 42.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -73.17 118.3 15.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.867 0.365 . . . . 0.0 110.568 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.86 -25.95 23.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -54.74 -62.01 1.94 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.659 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -83.78 117.95 23.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -84.6 -174.15 5.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.423 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.54 159.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.598 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.28 123.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.427 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -74.28 119.95 6.43 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.11 -157.22 38.76 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.429 ' CB ' HD13 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -111.49 142.24 44.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.087 0.47 . . . . 0.0 110.871 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 169' ' ' PRO . . . -52.63 -49.42 86.25 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.479 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 17.9 Cg_endo -61.32 -36.78 77.3 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.007 1.138 . . . . 0.0 111.692 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.429 HD13 ' CB ' ' A' ' 167' ' ' SER . 3.6 mp -66.22 -44.95 82.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.87 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.4 -47.43 56.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.2 -37.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.515 0.674 . . . . 0.0 109.446 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.48 93.47 Favored Glycine 0 C--O 1.2 -2.013 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.755 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.3 OUTLIER -54.92 -35.65 64.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -34.49 77.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.421 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 1.02 HG22 HD11 ' A' ' 149' ' ' LEU . 16.7 t -73.16 -47.38 47.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.787 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.37 -30.73 67.73 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 122.528 1.156 . . . . 0.0 110.195 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.578 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.28 2.6 mm? -70.43 -50.88 33.87 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.874 2.274 . . . . 0.0 109.528 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.487 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.53 -36.92 65.36 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 110.559 -3.019 . . . . 0.0 107.114 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.427 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.4 m-70 -69.08 -35.22 76.28 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.334 -1.433 . . . . 0.0 109.657 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.95 -48.34 81.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.234 -177.498 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.53 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.32 -52.07 11.69 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 178.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.567 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -69.79 -52.03 28.75 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.501 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 12.8 mt -60.16 -41.82 88.0 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.602 0 C-N-CA 118.731 -1.188 . . . . 0.0 113.244 -174.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -75.84 -35.68 59.87 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 115.911 -2.316 . . . . 0.0 112.564 -176.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.01 -29.68 68.65 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.385 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.283 0.1 OUTLIER -124.43 -26.8 3.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.063 -178.989 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.74 -5.97 84.15 Favored Glycine 0 CA--C 1.566 3.256 0 N-CA-C 106.046 -2.822 . . . . 0.0 106.046 -170.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.424 ' H ' HG23 ' A' ' 187' ' ' THR . 9.4 t -82.28 127.74 33.5 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 184' ' ' ILE . . . -47.83 164.37 0.23 Allowed Glycine 0 N--CA 1.408 -3.226 0 CA-C-N 111.146 -2.752 . . . . 0.0 112.497 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.567 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.6 OUTLIER -72.34 -33.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.2 p-10 -109.73 152.44 42.89 Favored Pre-proline 0 N--CA 1.415 -2.217 0 CA-C-N 112.544 -2.116 . . . . 0.0 109.288 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.08 -14.66 45.4 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.618 2.212 . . . . 0.0 111.686 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.547 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.39 -35.75 60.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.697 0.285 . . . . 0.0 110.498 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -41.16 72.94 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.336 0.589 . . . . 0.0 109.85 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -32.61 64.71 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.475 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.834 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.9 m-85 -72.27 -35.24 68.69 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.464 1.906 . . . . 0.0 113.948 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -44.44 93.9 Favored Glycine 0 C--N 1.318 -0.456 0 N-CA-C 106.971 -2.451 . . . . 0.0 106.971 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.53 -28.21 56.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.088 -1.056 . . . . 0.0 110.842 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.19 75.74 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.42 -31.96 51.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 121.598 1.999 . . . . 0.0 110.929 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.0 pt -87.18 45.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.639 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.13 140.32 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.364 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -49.73 -63.12 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.416 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.35 159.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -132.92 -157.74 0.84 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.021 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.0 -24.29 9.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.519 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -57.88 -35.07 70.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.801 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 -24.01 3.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.155 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.87 -38.11 73.09 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -35.18 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.788 0.804 . . . . 0.0 109.549 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -58.92 -37.5 76.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.027 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -84.28 -33.53 23.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.6 p -80.49 -40.06 19.19 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.517 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.0 -48.23 68.52 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.976 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.8 Cg_endo -71.96 -38.97 3.53 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.046 2.497 . . . . 0.0 113.675 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.451 ' CD2' HD22 ' A' ' 81' ' ' LEU . 1.8 m-85 -63.25 -39.79 95.59 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.645 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.9 mm -70.31 -46.55 70.98 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.148 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.67 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.756 ' HA2' HG23 ' A' ' 143' ' ' ILE . . . -55.18 -45.64 81.71 Favored Glycine 0 C--N 1.364 2.128 0 O-C-N 128.529 3.643 . . . . 0.0 111.339 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -69.13 -41.41 80.58 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.19 -34.83 61.48 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.7 mt -67.69 -36.92 81.54 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.38 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -59.06 -39.58 82.53 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.277 -174.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 88.4 t -58.38 -49.7 81.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.638 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.61 0.719 . . . . 0.0 110.155 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt -57.14 -34.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.119 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -141.26 72.11 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.437 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -174.36 57.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.566 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.66 83.83 7.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 11.5 pt -83.23 -176.88 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.571 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.98 126.05 55.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.638 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.691 ' HB3' ' HD3' ' A' ' 233' ' ' PRO . . . -76.3 -55.14 1.79 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.236 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' A' ' 232' ' ' ALA . 62.2 Cg_exo -46.17 169.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.021 1.814 . . . . 0.0 112.465 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 58.14 91.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.632 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.43 137.07 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.576 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.64 -61.28 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.601 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 4.0 t70 64.59 158.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.489 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 56.56 97.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.665 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.84 162.28 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.667 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -71.95 -177.73 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.55 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -142.89 48.27 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 18.5 t 55.76 70.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.482 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.59 113.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.607 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.6 t 59.54 86.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.543 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -77.76 -176.28 4.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.541 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.4 m 70.11 -70.34 0.15 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.7 t -142.99 74.8 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -81.24 69.25 3.3 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 56.75 38.26 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.609 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.69 -44.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.593 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 61.33 87.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.59 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -67.76 -61.03 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.603 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -155.66 -41.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.569 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.19 164.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.594 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.89 -65.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.486 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 59.89 93.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.558 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -121.76 102.54 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.603 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -127.72 177.27 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.556 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.9 127.77 34.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.583 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 4.4 mt 57.19 99.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.618 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.01 103.5 7.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.594 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.8 t -126.13 31.64 5.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -113.64 59.0 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.563 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.07 31.27 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.612 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -132.3 148.64 52.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.572 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 6.9 mtp -71.32 -165.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -137.3 72.0 52.75 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.573 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -47.4 -42.33 28.24 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.745 2.297 . . . . 0.0 112.229 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -89.97 174.6 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.504 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 53.32 89.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.558 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.5 mt -76.99 175.31 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.559 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -85.78 136.21 33.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.466 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.68 -53.78 2.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.617 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -77.24 131.76 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.643 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.5 mp -52.87 -73.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 4.2 tt -154.49 21.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.766 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 3.3 m 49.41 81.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.733 0.301 . . . . 0.0 110.67 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -174.02 -178.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.557 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -96.78 128.24 43.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.544 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.25 112.32 10.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.569 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 3.1 mt -128.41 53.15 1.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.559 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -143.95 -59.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.527 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.0 m -77.6 118.23 19.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.602 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -102.79 -30.8 10.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.561 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.41 -34.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.571 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.13 121.1 8.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -114.05 121.38 43.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.581 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 1.7 t60 65.29 143.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.54 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -128.93 161.28 30.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.555 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.5 m80 49.97 83.1 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.619 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.76 178.14 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.579 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 7.4 t60 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.62 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.07 63.29 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -141.18 -54.16 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.558 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.27 -21.5 17.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.753 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 66.17 172.66 0.24 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.538 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -100.4 83.37 2.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.678 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -76.3 -37.74 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.428 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.51 171.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.646 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.83 140.6 49.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.466 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.56 105.63 17.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.63 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -114.63 -27.66 7.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.418 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -57.1 -15.93 6.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.332 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.54 -0.5 13.03 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.814 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.54 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.3 -35.77 72.33 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.762 0 CA-C-N 112.506 -2.134 . . . . 0.0 109.932 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.15 -35.02 69.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.703 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -70.99 -46.72 61.8 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -177.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -34.23 73.48 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.05 -38.08 78.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.174 -2.284 . . . . 0.0 108.748 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -64.09 -46.82 82.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.355 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.91 -31.51 59.21 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.099 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.72 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.89 -38.18 67.05 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.548 -0.72 . . . . 0.0 112.091 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.515 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -76.9 -49.55 15.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.057 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 29' ' ' ILE . 97.7 t -65.33 -48.46 83.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.363 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' A' ' 112' ' ' LEU . 50.1 t80 -53.95 -48.51 70.2 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.6 -29.21 20.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.387 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -36.2 67.41 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.627 HG21 HD22 ' A' ' 112' ' ' LEU . 2.8 mm -63.06 -41.74 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.311 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.5 -38.83 71.89 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -37.97 84.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.96 -46.02 72.57 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.57 -30.64 23.19 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -75.82 -34.47 48.25 Favored Glycine 0 C--N 1.318 -0.468 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.391 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -19.51 45.03 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.476 ' O ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -106.69 -9.65 16.41 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.237 177.599 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.44 ' H ' ' C ' ' A' ' 34' ' ' GLY . 3.7 t80 -126.34 119.97 23.44 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 118.168 0.44 . . . . 0.0 110.14 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -68.3 139.93 52.91 Favored 'Cis proline' 0 N--CA 1.498 1.74 0 C-N-CA 124.714 -0.953 . . . . 0.0 111.774 -1.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 36' ' ' LYS . 15.6 m -63.96 151.36 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.528 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.24 172.68 49.75 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -177.83 -41.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.858 0.361 . . . . 0.0 110.301 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -125.83 -25.62 3.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.558 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -60.79 179.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.604 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 -19.74 8.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.04 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.27 147.92 29.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.665 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.73 136.16 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.287 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -106.61 114.1 28.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.227 0.536 . . . . 0.0 111.418 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.23 163.04 15.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.393 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -49.87 -28.59 6.76 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.535 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG13 ' CE ' ' A' ' 51' ' ' LYS . 1.3 p -57.14 -39.02 64.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' CE ' HG13 ' A' ' 50' ' ' VAL . 4.6 mmtp -64.7 -54.08 37.26 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.728 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 94.5 t -67.75 -45.65 84.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.724 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 m -69.29 -39.18 78.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.785 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 62.5 tp -63.0 -31.68 72.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.45 -39.38 94.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.231 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -65.88 -43.36 88.51 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.745 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.69 -43.02 96.94 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.275 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 1.0 OUTLIER -68.2 -43.77 77.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.597 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -36.7 76.26 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.698 HD13 HD21 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -59.96 -34.13 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 113.228 -1.805 . . . . 0.0 108.13 -178.485 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.758 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -64.48 -45.76 85.96 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.174 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.41 ' H ' HG23 ' A' ' 62' ' ' THR . 8.3 p -70.12 -31.7 69.36 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.833 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -55.28 -40.78 71.44 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.96 -44.25 73.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.218 -1.81 . . . . 0.0 109.828 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 62' ' ' THR . 21.6 tp60 -66.8 -39.0 87.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -12.21 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 119.978 1.263 . . . . 0.0 111.329 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.81 -37.12 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.765 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.25 154.52 6.87 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -53.29 -22.91 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.934 0.397 . . . . 0.0 111.065 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 tt -74.34 7.08 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -124.3 135.59 53.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.129 0.49 . . . . 0.0 111.57 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.48 -159.37 24.95 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.57 85.9 1.17 Allowed 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 118.254 -1.378 . . . . 0.0 108.589 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.833 HD22 ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -82.41 8.44 11.46 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.122 -1.854 . . . . 0.0 112.235 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.522 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -136.95 140.09 30.59 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 119.333 0.97 . . . . 0.0 112.676 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 62.5 Cg_endo -83.67 -30.62 0.74 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 123.27 2.647 . . . . 0.0 112.563 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.713 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -60.12 -50.64 72.9 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.458 ' CG2' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -66.31 -36.69 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -30.89 70.71 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.478 HD22 ' CG ' ' A' ' 217' ' ' PHE . 13.7 tp -57.93 -38.0 75.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.242 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.32 -44.57 93.4 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -21.89 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.643 0.259 . . . . 0.0 111.326 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tp -52.11 -70.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.01 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.52 46.84 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.71 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.7 t -125.37 -26.16 3.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.518 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.81 111.42 13.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.562 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 70.56 0.93 3.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.791 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mp 45.92 57.86 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.658 0.265 . . . . 0.0 111.296 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 t 179.37 -84.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.012 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.2 mt 61.37 149.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 110.926 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -127.57 -40.82 1.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.891 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -54.26 -37.6 64.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.583 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.85 -35.0 77.79 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.212 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.58 -38.49 66.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.5 ttt -70.63 -38.76 73.92 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.542 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -62.59 -37.59 86.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.332 0.969 . . . . 0.0 109.67 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -58.09 -47.22 87.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.368 -178.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.434 ' N ' HG22 ' A' ' 98' ' ' ILE . 4.3 tp -70.35 -37.8 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . . . -64.94 -47.43 77.68 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.529 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 77' ' ' PRO . 5.0 pp0? -71.54 -35.18 70.58 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -35.88 71.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.76 -35.41 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.124 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.58 90.74 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 120.815 1.643 . . . . 0.0 113.437 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.464 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.85 -35.98 75.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.37 -42.7 87.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.689 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.86 -37.23 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.311 0.577 . . . . 0.0 109.567 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.72 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.59 -43.38 84.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.105 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -37.03 74.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.394 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.76 -41.19 85.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.012 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.55 -48.22 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.26 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.627 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -58.8 -24.43 61.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.0 t -62.03 -44.28 97.03 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.962 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.31 -36.28 62.4 Favored Glycine 0 CA--C 1.51 -0.234 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -32.39 36.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.366 -0.917 . . . . 0.0 110.742 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.1 m -70.53 -17.04 62.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.182 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.7 t -52.25 -33.88 43.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.202 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.0 p -92.2 -34.4 14.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.009 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mp -91.86 -174.01 3.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.023 0.44 . . . . 0.0 111.162 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.5 p -118.54 128.74 54.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.692 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.23 81.18 0.14 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -33.4 11.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.525 0.203 . . . . 0.0 111.316 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -176.82 78.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mp -89.23 7.98 32.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 72.35 18.49 78.26 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -112.63 122.78 48.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.061 0.458 . . . . 0.0 111.741 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.03 20.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.671 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -108.77 99.66 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 135' ' ' SER . 3.4 mm? -63.21 147.6 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.441 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.88 139.86 40.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.864 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -50.09 127.57 17.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 130.41 -105.11 0.63 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.848 HG22 ' HB3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.01 131.0 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.447 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 3.7 t30 -71.74 -171.86 0.73 Allowed 'General case' 0 C--O 1.201 -1.482 0 N-CA-C 103.125 -2.917 . . . . 0.0 103.125 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.489 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -64.1 -46.74 82.9 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 114.648 -2.821 . . . . 0.0 109.788 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.704 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -58.72 -41.51 95.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.976 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.848 ' HB3' HG22 ' A' ' 133' ' ' VAL . 1.8 mm100 -53.46 -23.24 9.55 Favored 'General case' 0 C--N 1.247 -3.863 0 CA-C-O 121.375 0.607 . . . . 0.0 110.715 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -68.78 -1.4 24.07 Favored Glycine 0 C--O 1.192 -2.521 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 tp -66.58 -50.04 64.4 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.29 1.045 . . . . 0.0 110.902 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' HA2' HD12 ' A' ' 143' ' ' ILE . . . -69.62 -36.15 75.63 Favored Glycine 0 N--CA 1.455 -0.064 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.794 ' CD1' HG21 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -70.52 -36.29 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 113.407 -1.396 . . . . 0.0 111.633 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 138' ' ' GLY . 8.0 mt-10 -68.5 -36.46 78.94 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.06 0.933 . . . . 0.0 110.878 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 219' ' ' GLY . 40.8 mt -68.82 -52.54 33.9 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 113.977 -1.465 . . . . 0.0 110.743 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 145' ' ' GLY . 6.1 tp -68.17 -45.05 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 121.931 0.872 . . . . 0.0 111.472 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 144' ' ' ILE . . . -60.7 -52.03 54.99 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.805 -1.543 . . . . 0.0 113.193 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.505 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 20.2 m -70.87 -40.51 72.23 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.93 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.773 HD12 ' O ' ' A' ' 219' ' ' GLY . 0.7 OUTLIER -54.79 -40.01 69.03 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -176.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -57.84 -30.02 65.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.726 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.03 HD11 HG22 ' A' ' 176' ' ' VAL . 1.1 tp -68.82 -51.18 43.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.255 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.445 HG21 ' HA3' ' A' ' 220' ' ' GLY . 70.1 t -60.09 -41.03 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.989 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.25 -35.52 80.63 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -34.42 77.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.458 HG21 ' CG2' ' A' ' 79' ' ' VAL . 2.1 t -72.08 -38.32 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.532 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -41.03 96.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 110.809 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.76 -31.61 72.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.172 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.662 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -54.76 -37.03 65.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.47 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.06 -8.98 41.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.277 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -77.23 107.67 9.79 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.778 0.323 . . . . 0.0 110.57 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -26.12 67.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.681 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -74.15 -176.25 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.64 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 65.73 27.7 11.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.626 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.65 -175.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.525 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -149.94 82.61 1.39 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.591 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.72 141.95 46.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.615 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 127.5 -139.83 11.43 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.55 -104.19 2.69 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.83 135.12 52.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.926 0.393 . . . . 0.0 110.702 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . -52.47 -44.85 95.28 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.248 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.2 Cg_exo -54.53 -46.5 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.377 1.385 . . . . 0.0 111.532 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.12 -35.91 74.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -44.12 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.947 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.569 HD11 ' OG1' ' A' ' 156' ' ' THR . 79.4 mt -58.26 -38.09 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.59 -37.45 93.64 Favored Glycine 0 C--O 1.196 -2.229 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.19 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mp -55.05 -35.66 64.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.65 77.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.3 175.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 1.03 HG22 HD11 ' A' ' 149' ' ' LEU . 27.0 t -73.08 -47.54 47.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.785 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.08 -31.89 69.69 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.363 1.078 . . . . 0.0 109.859 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.268 1.8 tt -70.52 -49.73 45.15 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 124.503 2.097 . . . . 0.0 110.56 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.02 65.55 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 111.114 -2.767 . . . . 0.0 107.487 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.433 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.6 m-70 -70.18 -35.3 73.87 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.537 -1.831 . . . . 0.0 109.403 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.15 -48.11 81.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.112 -177.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.07 -52.55 10.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.782 ' HB3' HG23 ' A' ' 191' ' ' ILE . . . -70.41 -52.24 23.76 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.557 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 9.3 mt -55.34 -40.23 56.09 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.805 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 35.0 t70 -77.56 -35.7 52.89 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.194 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -59.91 -30.42 69.03 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.459 -1.296 . . . . 0.0 110.945 -171.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 189' ' ' CYS 0.272 0.1 OUTLIER -124.37 -26.61 3.89 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.083 -178.754 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.9 -6.11 83.94 Favored Glycine 0 CA--C 1.564 3.103 0 N-CA-C 106.208 -2.757 . . . . 0.0 106.208 -170.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.465 ' H ' HG23 ' A' ' 187' ' ' THR . 13.1 t -86.63 132.24 33.94 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.658 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.0 161.72 7.75 Favored Glycine 1 N--CA 1.392 -4.235 0 CA-C-N 111.285 -2.689 . . . . 0.0 111.031 178.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.782 HG23 ' HB3' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -72.29 -40.83 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 174.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 17.0 p-10 -83.44 134.3 45.58 Favored Pre-proline 0 N--CA 1.416 -2.139 0 CA-C-N 112.693 -2.048 . . . . 0.0 108.038 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -58.37 -14.58 20.88 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.361 2.041 . . . . 0.0 111.642 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . . . -75.04 -33.81 61.79 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 123.269 0.356 . . . . 0.0 111.653 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.658 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.49 -37.94 74.29 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.471 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -33.48 65.47 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.489 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.841 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.1 m-85 -72.4 -35.08 68.32 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 126.41 1.884 . . . . 0.0 114.452 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.79 -44.48 94.2 Favored Glycine 0 C--N 1.318 -0.453 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.1 p -76.44 -28.31 56.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.131 -1.035 . . . . 0.0 110.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.07 75.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.72 -33.41 59.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 121.268 1.849 . . . . 0.0 110.3 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 56.9 mt -57.8 -60.9 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.417 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.68 179.01 7.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.524 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -59.39 -170.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.572 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -144.07 116.3 8.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.435 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -131.13 -177.79 4.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.716 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.4 p -61.87 -33.95 75.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -57.03 -35.16 68.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.481 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -69.11 -15.96 63.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -70.49 -30.12 66.83 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.797 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.704 HG21 ' HA2' ' A' ' 136' ' ' GLY . 28.9 mm -52.63 -34.87 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 CA-C-O 121.778 0.799 . . . . 0.0 109.067 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.49 -35.29 72.0 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.016 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.35 -48.18 9.96 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 215' ' ' GLY . 9.6 p -70.0 -47.87 66.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.321 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.489 ' N ' HG13 ' A' ' 214' ' ' VAL . . . -55.68 -48.9 68.45 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 112.709 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 215' ' ' GLY . 49.5 Cg_endo -72.11 -31.1 12.59 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.757 1.638 . . . . 0.0 113.72 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.478 ' CG ' HD22 ' A' ' 81' ' ' LEU . 1.7 m-85 -66.26 -37.37 85.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 0.0 111.29 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.625 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 13.2 mt -70.37 -46.68 70.11 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.084 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.449 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.773 ' O ' HD12 ' A' ' 147' ' ' LEU . . . -55.42 -46.93 78.8 Favored Glycine 0 C--N 1.363 2.077 0 O-C-N 128.495 3.622 . . . . 0.0 110.996 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -68.41 -40.77 86.7 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.32 -34.8 61.79 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.4 mt -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.203 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -59.01 -39.74 82.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.251 -174.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.45 -49.73 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.885 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -39.53 94.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.709 0.766 . . . . 0.0 109.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mt -55.2 -34.69 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.426 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 33.78 5.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -111.52 -22.58 11.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.783 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.85 96.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.496 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 87.5 mt -66.63 122.05 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.568 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 4.0 mt -141.51 82.74 1.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 233' ' ' PRO . . . -170.74 165.66 5.0 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.479 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 232' ' ' ALA . 51.5 Cg_exo -51.26 127.49 22.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.85 2.367 . . . . 0.0 112.085 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.98 171.68 14.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.4 148.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.581 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.81 156.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.548 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.5 t70 62.6 54.27 2.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.76 134.23 35.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.563 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.3 t -85.73 152.71 22.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.39 151.81 46.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.493 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.38 27.06 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.591 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.84 -27.11 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.575 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -111.37 123.1 49.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.522 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 54.2 t -84.43 -62.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 50.74 -158.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.569 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.4 p -92.11 -54.66 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.555 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 18.3 m 52.76 71.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.636 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -50.38 100.27 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 55.04 -178.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.02 36.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.549 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -137.67 161.64 35.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.622 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -105.05 -45.64 4.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -98.7 31.5 2.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.508 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 59.82 179.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.525 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.53 -60.93 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.571 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.46 -73.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.709 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 50.83 64.74 1.71 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 110.574 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -61.06 2.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.564 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -141.21 129.85 22.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 10.5 mm -85.51 130.02 36.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.583 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.26 104.5 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.653 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.5 m -97.44 127.46 43.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.497 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -114.09 94.87 5.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.593 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 264' ' ' VAL . 0.5 OUTLIER 75.85 -7.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 O-C-N 123.692 0.62 . . . . 0.0 111.898 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -73.09 -179.39 3.25 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.586 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 11.0 mtp -100.11 163.54 12.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.64 66.07 0.9 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.601 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.89 -42.42 1.08 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.894 2.396 . . . . 0.0 112.065 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp 56.83 -175.72 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.56 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 62.94 172.99 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.563 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.6 mt -124.75 -26.55 3.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.569 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.14 123.86 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 60.45 166.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.571 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 54.95 85.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.501 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.28 -49.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.44 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 2.7 mp 56.82 86.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.596 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.52 106.27 15.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.582 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -58.6 101.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.601 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 50.34 35.32 10.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.507 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 53.21 73.47 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.641 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 8.7 tp -122.23 122.3 38.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.639 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -109.22 156.59 19.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.48 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.52 -46.12 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . 50.41 -168.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.9 t 59.33 101.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.477 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -104.09 54.25 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -103.5 -45.9 4.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.607 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -81.15 142.99 32.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.594 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -80.79 173.24 12.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -58.62 158.93 7.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.4 35.35 0.42 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.538 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 23.0 m80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.494 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.73 80.04 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.621 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.3 m -115.18 63.84 0.68 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.559 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 57.17 88.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.498 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.92 -33.36 14.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.613 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 108.18 20.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.587 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -84.68 -178.32 6.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.578 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -112.32 -57.61 2.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.536 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mp 61.98 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 56.35 174.42 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.912 0.387 . . . . 0.0 110.728 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -112.79 0.32 15.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.031 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -59.4 -15.97 20.14 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.749 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.1 1.35 17.28 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.502 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.51 -40.16 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 2.8 t -68.26 -35.91 73.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.629 0 CA-C-N 112.47 -2.15 . . . . 0.0 110.02 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.04 69.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.621 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -70.71 -46.69 62.63 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -177.002 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -33.88 73.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 11.1 mt -58.71 -38.17 77.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.107 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.44 -46.79 78.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 112.97 -1.923 . . . . 0.0 114.755 -176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.66 -31.42 59.77 Favored 'General case' 0 C--O 1.208 -1.128 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.525 -177.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -70.89 -34.98 72.13 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.995 -179.11 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -45.34 82.63 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.13 -44.71 29.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 29' ' ' ILE . 76.3 t -65.03 -53.72 37.91 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.46 -175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -53.7 -48.11 69.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -75.68 -29.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.504 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -36.51 69.11 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.835 HG21 HD22 ' A' ' 112' ' ' LEU . 3.6 mm -58.78 -44.49 90.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 113.661 -1.609 . . . . 0.0 109.223 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -36.76 65.7 Favored Glycine 0 C--O 1.226 -0.369 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -67.4 -44.37 79.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.49 -46.13 67.32 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.546 HD23 HG22 ' A' ' 29' ' ' ILE . 2.3 pp -85.84 -27.12 25.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.171 0.441 . . . . 0.0 111.823 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -75.72 -37.01 40.91 Favored Glycine 0 C--N 1.317 -0.494 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.445 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.98 -19.05 39.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -9.9 16.45 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.536 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.516 ' HE1' ' HG1' ' A' ' 120' ' ' THR . 39.8 t80 -117.9 119.88 33.28 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 118.532 0.605 . . . . 0.0 110.099 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.92 145.13 78.92 Favored 'Cis proline' 0 N--CA 1.5 1.88 0 C-N-CA 124.699 -0.959 . . . . 0.0 112.09 -0.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 p -82.62 151.36 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.13 131.46 6.75 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -147.92 132.7 17.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 0.0 110.554 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -107.23 28.87 7.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.92 -164.22 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.526 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 t -100.66 10.51 41.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.72 145.21 48.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.78 0.324 . . . . 0.0 110.434 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 46' ' ' VAL . 32.0 m -137.66 128.53 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.776 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -102.41 106.26 16.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.741 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.56 163.3 13.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.3 0.571 . . . . 0.0 111.56 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.72 -28.32 5.92 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.884 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.777 HG22 HD21 ' A' ' 181' ' ' LEU . 3.6 t -57.29 -32.29 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -53.96 37.65 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.703 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 12.6 t -68.15 -37.34 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.451 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 181' ' ' LEU . 3.2 m -68.58 -41.15 80.08 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.985 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.7 OUTLIER -65.55 -31.43 72.47 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.655 -1.612 . . . . 0.0 106.916 176.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -62.92 -39.86 95.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.458 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 24' ' ' PHE . 3.6 t80 -66.03 -43.22 88.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.763 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.62 -46.52 92.0 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.074 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.651 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 6.5 mp -68.6 -43.81 75.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.525 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 t -59.84 -36.69 77.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.587 ' CD1' HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -60.3 -34.37 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.663 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -61.66 -45.55 93.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.363 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.417 ' H ' HG23 ' A' ' 62' ' ' THR . 8.9 p -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -54.79 -42.91 72.35 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.04 -44.33 72.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.97 -1.923 . . . . 0.0 110.914 174.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -67.02 -45.97 75.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.5 p -59.14 -12.37 5.01 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.932 1.242 . . . . 0.0 112.387 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.02 -42.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 0.0 111.29 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.24 159.16 8.08 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -57.41 -23.13 47.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.783 0.325 . . . . 0.0 111.43 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.76 7.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.46 135.66 53.41 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.618 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.12 -154.2 24.41 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.52 85.87 1.16 Allowed 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.183 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.97 -19.64 62.52 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.687 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.1 pp -80.46 -17.64 51.09 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.42 -1.718 . . . . 0.0 112.497 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -111.05 135.95 20.84 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 97.0 Cg_endo -83.58 -22.87 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 123.441 2.761 . . . . 0.0 111.676 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.8 -47.43 78.11 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.622 HG23 HD23 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -66.22 -36.84 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.753 0.311 . . . . 0.0 111.158 177.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 m -65.68 -28.63 69.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -43.82 82.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.92 0.39 . . . . 0.0 110.175 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.95 -39.64 97.82 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 tp -53.47 -57.54 10.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.088 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.47 -67.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.57 -31.75 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.633 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -91.58 179.19 5.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.2 m 54.31 -168.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.53 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -64.69 163.83 13.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.614 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pt -133.38 83.73 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.526 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 91' ' ' ILE . 46.4 m -158.71 40.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.602 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 91' ' ' ILE . 1.1 pp -155.15 162.68 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.638 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -131.75 23.47 4.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.777 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -68.6 -35.95 78.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.14 78.2 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.09 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.69 -38.49 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -40.01 68.05 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.84 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -61.16 -37.63 83.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.357 0.98 . . . . 0.0 109.443 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.29 -44.38 88.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.903 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.3 mt -70.59 -37.78 71.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . . . -66.81 -47.2 72.81 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.465 ' NE2' ' HD3' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -71.56 -35.7 70.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -35.96 71.93 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.8 -35.47 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.153 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.68 -44.32 91.36 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 121.102 1.774 . . . . 0.0 113.38 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.404 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.74 -36.19 75.61 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.79 -42.59 86.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.821 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.9 -37.41 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.219 0.533 . . . . 0.0 110.068 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.58 -49.78 75.29 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.318 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -67.75 -37.03 81.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.801 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.73 85.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.659 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.1 tt -69.18 -37.19 75.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.11 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.835 HD22 HG21 ' A' ' 29' ' ' ILE . 2.1 tt -66.0 -24.09 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.87 0.367 . . . . 0.0 111.511 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 m -60.43 -44.21 96.01 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.503 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.37 61.26 Favored Glycine 0 CA--C 1.511 -0.215 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.95 32.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.849 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m -65.19 -21.48 66.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 97.1 p -52.27 -36.55 52.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.893 0.378 . . . . 0.0 110.249 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.15 -34.26 14.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.43 -174.17 4.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.818 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.516 ' HG1' ' HE1' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -118.44 126.88 52.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.62 81.48 0.11 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.01 -35.23 10.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.625 0.25 . . . . 0.0 111.173 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.9 t 177.92 86.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.759 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mp -88.43 8.03 29.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.283 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.4 16.51 80.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.62 124.34 52.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.608 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 51.85 23.31 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.275 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.3 95.14 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.716 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 187' ' ' THR . 3.3 mm? -65.45 144.51 57.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.318 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.02 140.03 40.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.649 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -49.63 127.5 15.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.26 -105.48 0.6 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.1 t -85.94 126.82 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.45 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.58 -171.94 0.72 Allowed 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 176.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.48 ' N ' HD11 ' A' ' 129' ' ' LEU . 1.4 m -62.39 -46.76 87.14 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 114.669 -2.812 . . . . 0.0 110.306 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.16 96.47 Favored Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.267 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.799 ' HB3' HG22 ' A' ' 133' ' ' VAL . 4.0 mt-30 -53.24 -23.42 8.73 Favored 'General case' 0 C--N 1.249 -3.778 0 CA-C-N 114.792 -0.704 . . . . 0.0 110.503 -176.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.87 -1.76 13.69 Favored Glycine 0 C--O 1.188 -2.736 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.9 -50.47 64.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 119.123 1.461 . . . . 0.0 110.743 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.87 -40.16 74.97 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.682 HD13 HG21 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -68.85 -36.34 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 113.209 -1.495 . . . . 0.0 112.267 -177.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 77.1 mt-10 -68.54 -36.21 78.5 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-O 121.736 0.779 . . . . 0.0 110.569 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.71 HG23 ' CA ' ' A' ' 219' ' ' GLY . 38.3 mt -70.06 -41.9 79.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.437 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.2 mm -68.53 -48.84 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 122.389 1.09 . . . . 0.0 111.198 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.55 -46.9 93.21 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-N 112.841 -1.981 . . . . 0.0 112.966 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 191' ' ' ILE . 76.2 m -70.93 -47.64 57.91 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 113.77 -1.215 . . . . 0.0 112.47 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 8.2 tp -54.47 -40.45 68.46 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.252 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.6 pt20 -57.97 -31.28 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.82 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.82 HD11 HG22 ' A' ' 176' ' ' VAL . 2.8 tp -68.89 -52.21 31.92 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.451 HG21 ' HA3' ' A' ' 220' ' ' GLY . 54.3 t -60.14 -41.02 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -35.55 81.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 111.349 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -41.11 93.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.851 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 m -72.05 -38.37 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.52 -48.08 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.985 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.68 71.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.662 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.9 OUTLIER -61.64 -36.93 82.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.464 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.7 t -92.82 -8.76 42.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.224 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -70.26 135.59 49.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.888 0.375 . . . . 0.0 110.517 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -63.3 -26.46 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.541 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.12 106.05 5.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.525 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 161.33 17.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.561 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -143.26 -37.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.17 133.78 47.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.499 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.56 141.7 28.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.393 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.69 -166.7 51.37 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 60.44 162.6 0.13 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -111.9 136.92 50.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.619 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . -52.37 -45.16 95.09 Favored Pre-proline 0 C--O 1.218 -0.571 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.808 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 35.3 Cg_exo -54.35 -44.3 50.69 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.738 1.625 . . . . 0.0 112.223 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 167' ' ' SER . 1.9 mp -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.302 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.33 56.59 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.006 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.5 pt -58.93 -35.96 59.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.61 93.6 Favored Glycine 0 C--O 1.198 -2.107 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.495 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.15 -36.37 65.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 -34.47 77.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.603 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.82 HG22 HD11 ' A' ' 149' ' ' LEU . 89.2 t -72.89 -47.24 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.763 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . . . -65.02 -41.82 94.97 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 122.054 0.93 . . . . 0.0 108.727 -176.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.257 3.6 mt -58.29 -47.12 84.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.937 178.041 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.9 66.19 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.088 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.666 ' HA ' HD13 ' A' ' 184' ' ' ILE . 1.1 t60 -67.84 -34.79 77.39 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 112.926 -1.637 . . . . 0.0 109.789 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.777 HD21 HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -64.66 -47.64 77.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.389 -176.346 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.444 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -74.96 -51.64 13.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.955 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -69.54 -51.24 37.39 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 180' ' ' HIS . 1.7 mp -66.78 -49.27 75.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.869 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -65.63 -35.73 81.66 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 115.377 -2.529 . . . . 0.0 112.367 -176.327 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.88 -31.28 69.64 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.524 -170.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.524 ' O ' HD13 ' A' ' 129' ' ' LEU 0.301 0.1 OUTLIER -124.32 -26.87 3.87 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.387 1.089 . . . . 0.0 113.332 -179.032 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 86.75 -5.78 84.17 Favored Glycine 0 CA--C 1.566 3.264 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.4 ' H ' HG23 ' A' ' 187' ' ' THR . 59.9 m -83.64 132.29 34.9 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -54.33 155.59 7.61 Favored Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.869 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.955 HG22 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.62 -32.99 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 174.045 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.681 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 6.2 p-10 -92.74 139.68 23.54 Favored Pre-proline 0 N--CA 1.42 -1.967 0 CA-C-N 113.321 -1.763 . . . . 0.0 107.234 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -64.47 -14.55 44.91 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.64 1.56 . . . . 0.0 111.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.484 ' HB3' HD22 ' A' ' 192' ' ' ASN . . . -75.14 -33.88 61.59 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.248 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.645 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.37 -39.11 78.24 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.0 t -73.18 -34.28 65.91 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.816 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.818 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 3.8 t80 -72.22 -35.4 68.87 Favored 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 126.315 1.846 . . . . 0.0 114.506 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.73 -46.19 92.54 Favored Glycine 0 C--N 1.319 -0.376 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.43 -28.29 56.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.281 -0.959 . . . . 0.0 110.379 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.818 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.65 -33.89 77.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.607 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.3 -31.17 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 120.939 1.699 . . . . 0.0 110.589 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.95 76.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.768 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.1 p 47.7 -163.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.784 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 60.37 41.82 15.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.611 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -94.76 97.66 10.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.518 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.16 174.78 10.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.506 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.4 p -65.01 -35.9 82.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -35.06 66.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -19.03 61.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.204 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -61.29 -20.16 62.58 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.256 0.348 . . . . 0.0 111.626 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 9.5 mm -52.63 -34.59 19.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -25.09 61.59 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.298 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -84.64 -42.35 15.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.0 p -78.02 -45.47 27.38 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.23 -44.87 84.27 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.531 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.3 Cg_endo -71.49 -28.68 17.46 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.491 2.128 . . . . 0.0 113.084 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -77.2 -31.99 55.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.195 0.521 . . . . 0.0 111.893 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.0 mm -70.7 -46.37 69.52 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.34 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.303 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.71 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.11 -46.78 63.25 Favored Glycine 0 C--N 1.357 1.733 0 O-C-N 128.5 3.625 . . . . 0.0 111.838 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.34 -48.91 35.05 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 118.067 -2.016 . . . . 0.0 109.835 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.78 68.45 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.554 0.692 . . . . 0.0 109.562 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -68.13 -30.98 70.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.292 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.97 -39.8 82.83 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.8 t -58.06 -49.59 80.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.267 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -39.54 93.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.799 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -34.74 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -133.93 47.19 2.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.818 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -92.2 112.6 24.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.663 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -48.73 -42.14 34.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.655 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.29 118.69 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.629 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 0.4 OUTLIER -49.76 -47.04 51.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.622 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.686 ' HB3' ' HD3' ' A' ' 233' ' ' PRO . . . 177.81 -55.76 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.254 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 232' ' ' ALA . 77.6 Cg_exo -44.99 150.54 0.89 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.161 1.907 . . . . 0.0 112.248 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -29.22 18.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.526 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.8 t 58.33 100.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.54 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.48 -67.08 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.576 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.72 117.11 29.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.534 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.99 143.71 41.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.477 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.22 -30.54 5.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.552 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.91 46.65 13.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.597 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -60.74 -27.3 67.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.501 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.48 155.43 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.517 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.97 145.16 29.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.599 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.36 -27.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.594 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -139.62 121.88 15.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.93 128.62 15.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.1 p -107.81 98.92 8.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.595 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 128.35 145.39 6.03 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -119.72 33.66 5.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.382 . . . . 0.0 110.574 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.08 82.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -103.11 149.3 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.522 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.58 -66.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.573 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -161.34 80.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.475 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.2 161.04 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.5 pp -166.25 155.88 11.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.57 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.23 156.33 44.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.612 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -87.43 145.42 26.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.573 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 65.76 126.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.64 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.18 -61.24 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.37 137.24 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.508 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.43 -38.49 1.35 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.507 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.9 m -103.61 -168.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.514 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 70.26 -70.62 0.14 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.3 m -94.95 139.86 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.79 0.328 . . . . 0.0 110.608 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -66.21 162.6 19.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.512 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.91 145.88 48.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.669 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 164.96 14.04 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.533 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -52.03 104.76 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.688 2.259 . . . . 0.0 112.023 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -91.99 145.26 24.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.553 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -151.09 105.01 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.594 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.7 tp -119.53 119.56 34.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.589 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -155.4 152.72 29.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.462 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -96.01 152.93 18.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.2 85.49 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.593 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.27 149.39 25.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.521 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.97 -177.42 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.608 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 5.3 p 46.29 65.97 1.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.933 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -92.79 173.66 7.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 69.96 -70.95 0.13 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -166.11 -49.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.53 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 30.7 mt -129.98 -42.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.528 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.6 t30 70.1 -70.89 0.14 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.2 m -102.68 163.9 11.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.598 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -113.99 -62.35 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.603 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 32.4 m -64.76 157.54 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.83 79.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.46 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.46 -175.3 2.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.539 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -100.41 176.77 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.597 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.13 -73.35 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.565 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.0 176.37 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.526 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -122.34 -43.61 2.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.59 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 117.857 -1.068 . . . . 0.0 110.62 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mtt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.26 50.61 1.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -30.13 29.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.544 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -117.18 112.1 20.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.613 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -57.3 168.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -160.21 110.19 1.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.512 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -34.59 69.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.601 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 114.29 15.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.58 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.12 -54.24 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.678 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 54.31 24.08 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.495 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.71 -16.37 19.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -81.4 9.37 7.38 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.086 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.4 -14.31 5.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.452 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -39.89 87.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 5.9 p -68.66 -36.07 72.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.592 176.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.69 -35.35 70.49 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.694 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 3.6 mt-10 -70.95 -46.48 62.34 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -33.79 74.34 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 8.0 mt -58.77 -38.16 77.88 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.884 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.68 -46.51 78.8 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.567 -2.106 . . . . 0.0 114.581 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.612 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -74.81 -31.63 61.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.208 -177.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.2 -38.39 69.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.783 -178.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -45.01 84.21 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -77.11 -52.52 9.14 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.13 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 21' ' ' THR . 1.5 m -65.64 -40.3 87.54 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 O-C-N 124.031 0.832 . . . . 0.0 112.802 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.41 ' O ' HG12 ' A' ' 29' ' ' ILE . 49.3 t80 -54.18 -50.35 67.24 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.539 0.685 . . . . 0.0 111.908 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -29.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.531 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.24 -36.24 68.28 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -175.092 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.56 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -59.7 -40.05 81.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.086 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -36.88 64.69 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.8 m -67.5 -38.87 84.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.41 -46.21 67.37 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.78 -29.92 23.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -75.86 -36.05 43.22 Favored Glycine 0 C--N 1.319 -0.374 0 CA-C-O 119.54 -0.589 . . . . 0.0 112.962 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -18.56 35.83 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.319 -1.352 . . . . 0.0 107.511 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -106.57 -10.0 16.37 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.348 177.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.45 ' H ' ' C ' ' A' ' 34' ' ' GLY . 23.5 m-85 -129.83 123.64 21.17 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.241 0.473 . . . . 0.0 110.262 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.09 137.65 49.53 Favored 'Cis proline' 0 N--CA 1.497 1.685 0 C-N-CA 124.675 -0.969 . . . . 0.0 112.104 -0.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.94 149.64 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.553 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.79 150.44 22.52 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -27.85 14.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.757 0.313 . . . . 0.0 110.487 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.83 -162.25 0.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.525 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.19 148.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -94.08 -28.86 15.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.776 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.31 139.06 55.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.5 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.99 154.44 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.751 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -106.52 111.68 24.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.497 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB3' HG12 ' A' ' 50' ' ' VAL . 23.1 t0 -114.17 163.01 15.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.283 0.563 . . . . 0.0 110.94 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.73 -28.78 6.57 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.801 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.55 HG13 ' CE ' ' A' ' 51' ' ' LYS . 1.5 p -57.28 -38.37 61.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.726 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.55 ' CE ' HG13 ' A' ' 50' ' ' VAL . 4.5 mmtp -64.8 -53.56 45.09 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.699 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 70.6 t -66.77 -50.06 68.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.416 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -66.53 -39.07 88.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.358 0.412 . . . . 0.0 110.004 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.824 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 55.3 tp -62.85 -31.92 73.03 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.91 -39.46 94.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.265 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.521 ' O ' HD13 ' A' ' 60' ' ' ILE . 8.3 m-30 -66.12 -42.44 89.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.42 -43.3 96.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.08 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.664 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -67.33 -43.66 81.03 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.547 -178.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -36.58 74.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.633 HG13 HD21 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -59.98 -34.1 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.369 -178.395 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.757 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.235 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 65' ' ' GLN . 11.7 p -68.96 -31.7 70.75 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.607 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.46 -40.58 71.78 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.94 -44.16 73.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.151 -1.841 . . . . 0.0 109.468 173.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 62' ' ' THR . 26.0 tt0 -66.78 -38.47 86.62 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.8 m -59.61 -12.13 6.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 120.058 1.299 . . . . 0.0 111.415 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -42.83 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.697 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.06 168.4 12.83 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -66.0 -23.09 66.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 70' ' ' ILE . 2.1 mp -75.95 7.13 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.79 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 m -124.43 135.64 53.42 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.139 0.495 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -151.84 20.45 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.27 85.89 1.08 Allowed 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.441 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.39 61.91 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.633 HD21 HG13 ' A' ' 60' ' ' ILE . 2.1 pp -87.05 8.53 23.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.375 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.614 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -133.04 129.08 20.88 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -177.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.589 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 91.1 Cg_endo -83.64 -20.49 4.66 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.773 2.315 . . . . 0.0 111.397 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.627 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -66.16 -50.94 62.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.529 HG23 HD23 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -66.7 -36.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.678 0.275 . . . . 0.0 111.57 177.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.0 m -64.91 -28.62 69.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -35.4 76.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.376 . . . . 0.0 110.55 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.53 -37.07 84.89 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.671 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -44.41 96.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.456 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.405 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -55.95 -43.03 77.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.372 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 100.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.5 p 177.16 99.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.488 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 65.51 -166.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.579 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.47 -69.34 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.524 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 86' ' ' SER . 88.0 mt 49.65 87.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.656 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.81 113.0 17.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 61.5 mt 62.22 153.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.515 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -176.69 177.66 1.35 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 110.903 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.73 -35.83 75.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.851 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.405 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . . . -63.78 -35.14 79.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.451 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.91 -38.53 67.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 ttt -73.27 -35.1 66.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.945 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -64.96 -37.53 87.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 119.523 1.056 . . . . 0.0 109.135 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -58.12 -46.53 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.656 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.431 ' N ' HG22 ' A' ' 98' ' ' ILE . 2.0 mm -67.7 -37.84 79.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.678 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.01 -47.06 86.49 Favored 'General case' 0 C--O 1.206 -1.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -71.24 -36.05 71.68 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.424 ' O ' HG13 ' A' ' 106' ' ' ILE . 3.8 t -57.87 -36.16 71.97 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.38 -35.19 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.645 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.51 -47.78 81.27 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.733 1.606 . . . . 0.0 112.586 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.88 -36.16 75.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 102' ' ' CYS . 79.3 mt -63.92 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.048 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.14 -37.42 71.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.425 0.631 . . . . 0.0 110.038 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.53 -49.95 74.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.301 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.798 HG21 ' O ' ' A' ' 198' ' ' GLY . 1.8 t -70.3 -36.94 74.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.2 -43.75 87.77 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.013 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.2 mm -69.24 -37.33 75.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.243 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 29' ' ' ILE . 3.0 tt -66.85 -24.49 66.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.512 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.2 t -62.76 -34.96 78.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.248 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.09 -36.16 60.81 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.446 HD12 ' HG ' ' A' ' 112' ' ' LEU . 4.2 mt -57.28 -40.83 76.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.624 -0.788 . . . . 0.0 110.538 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.42 HG21 HD11 ' A' ' 124' ' ' LEU . 2.2 p -89.09 5.41 44.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.795 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.9 t -52.15 -30.17 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.292 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.3 m -92.2 -32.32 15.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.91 -174.44 3.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.1 p -118.39 135.65 54.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.621 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.74 83.2 0.09 OUTLIER Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.19 -20.58 17.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.749 -0.225 . . . . 0.0 111.544 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 p -161.7 49.37 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.062 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.42 HD11 HG21 ' A' ' 116' ' ' THR . 1.1 mp -88.9 7.77 32.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.081 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.09 15.62 81.01 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -112.6 120.11 40.46 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.925 0.393 . . . . 0.0 111.295 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 t30 51.83 23.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.25 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.88 84.7 2.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.419 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 187' ' ' THR . 3.4 mm? -66.65 144.9 56.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.489 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.91 139.65 40.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.136 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.77 127.67 18.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.3 -103.19 0.58 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 137' ' ' GLN . 2.0 t -86.0 122.38 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.56 -171.8 0.69 Allowed 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.466 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.68 -46.81 88.11 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 114.919 -2.712 . . . . 0.0 110.152 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.83 -41.67 96.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.157 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.726 ' HB3' HG22 ' A' ' 133' ' ' VAL . 24.0 mm100 -53.17 -23.43 8.36 Favored 'General case' 0 C--N 1.252 -3.661 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.232 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.55 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.05 -1.69 10.59 Favored Glycine 0 C--O 1.187 -2.796 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -50.5 65.54 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 119.17 1.485 . . . . 0.0 111.004 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.75 -40.13 76.21 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -67.43 -38.19 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 113.051 -1.575 . . . . 0.0 112.13 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 138' ' ' GLY . 24.0 mt-10 -68.61 -36.53 78.8 Favored 'General case' 0 C--O 1.196 -1.728 0 CA-C-O 121.987 0.899 . . . . 0.0 110.872 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.681 HG23 ' CA ' ' A' ' 219' ' ' GLY . 30.5 mt -68.35 -43.62 84.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.421 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.154 -174.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -68.4 -49.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 122.264 1.031 . . . . 0.0 111.671 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.51 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -59.26 -48.38 86.26 Favored Glycine 0 C--O 1.218 -0.866 0 CA-C-N 113.087 -1.869 . . . . 0.0 113.038 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.526 HG21 ' CB ' ' A' ' 216' ' ' PRO . 24.8 m -70.79 -45.29 64.93 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 113.97 -1.115 . . . . 0.0 112.175 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.636 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 6.0 tp -54.51 -40.59 68.73 Favored 'General case' 0 CA--C 1.487 -1.464 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.22 -175.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.0 pt20 -59.33 -30.85 68.66 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.03 HD11 HG22 ' A' ' 176' ' ' VAL . 2.1 tp -68.88 -51.22 42.52 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.261 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.483 HG21 ' HA3' ' A' ' 220' ' ' GLY . 20.4 t -60.83 -41.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.976 . . . . 0.0 113.28 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.18 -35.65 81.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.563 0.22 . . . . 0.0 111.512 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.21 -35.04 78.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.038 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.19 -38.44 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.591 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tt -64.04 -43.57 95.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.78 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.69 -31.54 72.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.561 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.699 ' OG1' HD11 ' A' ' 172' ' ' ILE . 0.4 OUTLIER -54.86 -36.71 65.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.402 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.91 -8.82 48.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.336 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -68.47 123.98 22.3 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.629 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -59.03 -26.4 64.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.601 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -65.8 111.35 3.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.476 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -65.09 158.0 27.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.609 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.72 -26.27 8.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.567 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.54 167.17 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.667 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.63 97.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.558 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 151.46 -124.58 1.71 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -167.88 -89.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.39 139.04 48.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.922 0.392 . . . . 0.0 110.691 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.647 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . -52.39 -45.37 95.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.017 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.0 Cg_exo -54.57 -46.48 33.11 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.57 1.514 . . . . 0.0 111.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.9 -36.14 78.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.271 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -45.02 63.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.275 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.699 HD11 ' OG1' ' A' ' 156' ' ' THR . 21.9 mt -58.26 -38.42 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.52 93.62 Favored Glycine 0 C--O 1.195 -2.293 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.164 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.3 OUTLIER -55.21 -35.56 65.01 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -34.24 76.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.928 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 1.03 HG22 HD11 ' A' ' 149' ' ' LEU . 20.6 t -72.59 -47.31 51.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.824 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.26 -29.9 66.8 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.577 1.179 . . . . 0.0 110.182 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 174' ' ' LEU 0.267 9.3 mt -70.65 -49.18 50.19 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 124.711 2.196 . . . . 0.0 109.515 178.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.85 66.07 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 110.328 -3.124 . . . . 0.0 107.822 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.529 ' HB3' HD12 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -70.39 -35.22 73.34 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.041 -1.579 . . . . 0.0 109.727 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.72 -48.21 81.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.139 -177.391 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.51 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.54 -52.25 11.06 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 1.068 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -69.97 -51.68 30.56 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.529 HD12 ' HB3' ' A' ' 180' ' ' HIS . 7.4 mt -60.58 -49.11 85.71 Favored 'Isoleucine or valine' 0 C--O 1.175 -2.862 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.538 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -69.15 -35.67 76.59 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 116.741 -1.983 . . . . 0.0 113.502 -176.132 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.02 -29.16 68.31 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.652 -171.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 129' ' ' LEU 0.285 0.1 OUTLIER -124.32 -26.65 3.91 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.181 0.991 . . . . 0.0 113.076 -179.167 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.56 -5.9 84.26 Favored Glycine 0 CA--C 1.565 3.163 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 -170.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.452 ' H ' HG23 ' A' ' 187' ' ' THR . 92.1 m -88.08 130.74 34.91 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.478 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -56.22 154.71 14.71 Favored Glycine 0 N--CA 1.397 -3.924 0 CA-C-N 111.174 -2.739 . . . . 0.0 112.538 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.068 HG22 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.35 -27.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.627 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -90.49 135.11 29.79 Favored Pre-proline 0 N--CA 1.414 -2.25 0 CA-C-N 112.74 -2.027 . . . . 0.0 108.25 177.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.534 ' CD ' ' HB2' ' A' ' 78' ' ' ALA . 6.3 Cg_exo -66.09 -17.36 54.86 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.986 1.791 . . . . 0.0 110.587 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.589 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.26 -35.37 61.39 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.478 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 29.3 tpt85 -70.62 -40.2 73.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.523 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.3 m -73.23 -38.19 66.13 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.82 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 12.4 t80 -72.25 -34.88 68.58 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 126.945 2.098 . . . . 0.0 114.596 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.798 ' O ' HG21 ' A' ' 109' ' ' THR . . . -57.62 -47.12 90.61 Favored Glycine 0 C--N 1.315 -0.592 0 N-CA-C 107.069 -2.412 . . . . 0.0 107.069 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -28.21 56.65 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.565 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.82 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.23 -34.1 77.32 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.412 -0.804 . . . . 0.0 112.843 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.66 -31.14 49.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 120.971 1.714 . . . . 0.0 110.803 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.0 mt -74.39 -32.32 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.927 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.9 m -146.75 66.7 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.55 156.7 38.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.502 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -131.0 -177.65 4.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.791 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -64.67 -147.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.252 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -21.04 4.51 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -55.15 -35.08 64.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.829 0.347 . . . . 0.0 110.382 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -22.32 60.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.275 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -69.79 -25.41 63.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.963 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.68 -34.61 19.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.728 0.775 . . . . 0.0 109.076 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' PHE . . . . . 0.444 ' N ' ' CD2' ' A' ' 212' ' ' PHE . 6.3 m-30 -58.27 -41.51 84.46 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.381 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.14 -33.64 24.22 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 215' ' ' GLY . 11.7 p -73.8 -47.73 42.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.486 ' N ' HG13 ' A' ' 214' ' ' VAL . . . -55.15 -48.52 67.76 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.111 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.526 ' CB ' HG21 ' A' ' 146' ' ' THR . 17.3 Cg_endo -71.61 -28.67 17.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.145 1.896 . . . . 0.0 113.744 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -73.48 -30.65 63.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.304 0.574 . . . . 0.0 111.268 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 46.3 mt -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.483 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.376 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.681 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -66.57 -46.25 78.17 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 128.473 3.608 . . . . 0.0 111.896 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.547 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.42 -48.89 34.6 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 118.562 -1.78 . . . . 0.0 110.112 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -39.02 68.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.671 0.748 . . . . 0.0 109.513 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -68.03 -31.07 70.49 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.348 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.636 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.89 -39.51 81.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.11 -49.59 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.962 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.06 -39.44 89.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.693 0.758 . . . . 0.0 109.532 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 222' ' ' LEU . 1.2 mp -57.39 -34.61 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.703 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.19 80.82 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.77 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -174.73 61.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.526 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -62.11 162.34 9.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 mt -102.27 111.6 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.487 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.17 20.74 4.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . 49.15 72.62 1.2 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.617 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -71.13 114.61 3.97 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.801 2.334 . . . . 0.0 112.049 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -63.2 -77.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.23 133.58 34.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.606 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 71.7 m -73.54 146.19 44.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.468 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -54.48 159.79 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.51 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.32 161.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.1 p -108.69 93.22 4.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.614 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.34 -29.76 60.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.62 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -79.8 157.58 27.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.481 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.76 143.02 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.533 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.6 mttp 179.17 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.2 p -75.05 -27.14 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.499 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -94.58 -5.2 46.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.582 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.16 115.55 25.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.513 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.3 t -160.35 152.81 20.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.552 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 65.68 -172.52 23.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -128.4 -48.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.755 0.312 . . . . 0.0 110.532 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 53.7 t -114.88 -51.77 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.628 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -172.21 138.97 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.609 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.02 -58.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.55 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 65.6 138.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.595 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.65 -38.57 72.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.588 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -50.52 67.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.575 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.8 174.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.597 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.18 167.0 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.523 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -130.97 -179.31 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.541 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.53 138.21 44.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 7.5 tt -102.91 -26.6 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.517 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.79 -74.75 0.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.5 p -176.63 99.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.636 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -116.43 -50.95 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.568 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.34 135.11 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -125.57 104.89 8.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.586 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 3.1 mtm -106.68 31.8 4.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.543 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -130.14 165.03 36.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.465 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.38 -177.39 3.8 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.807 2.338 . . . . 0.0 112.154 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -87.3 -26.46 23.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.46 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -146.86 131.68 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.509 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 2.0 tp -69.87 111.97 5.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.611 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 58.15 95.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.44 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -90.22 134.8 34.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.597 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.98 174.96 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.588 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 59.02 167.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 12.4 pt -59.23 -25.83 31.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.621 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.4 100.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.551 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -61.33 113.77 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.639 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -131.05 85.82 2.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.566 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.14 167.08 22.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.565 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 131.02 43.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.594 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.79 -55.0 2.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.527 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.1 m -94.03 -50.94 5.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.686 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . 54.91 24.87 6.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.635 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.12 -22.8 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.85 -169.45 0.2 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.588 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 41.9 m170 60.55 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.01 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.44 -174.5 0.12 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.779 0.324 . . . . 0.0 110.57 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 60.81 27.63 17.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.566 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -135.52 33.51 3.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -112.99 105.1 13.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.584 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.586 179.979 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.01 -177.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.657 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 t 54.04 87.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.593 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.18 92.06 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.477 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.05 29.52 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.623 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -127.53 88.22 2.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.538 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -116.6 102.62 9.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.611 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -64.75 169.11 5.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.642 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.66 88.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.612 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -174.29 155.24 2.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.431 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.8 m95 73.76 -58.96 0.57 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.695 0.622 . . . . 0.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -58.94 -13.31 6.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.308 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.72 -8.54 12.64 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.295 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.76 -40.31 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.55 -35.83 72.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 CA-C-N 112.807 -1.997 . . . . 0.0 110.696 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.51 -35.1 69.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 14.9 mt-10 -70.82 -46.6 62.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.17 -33.72 70.28 Favored 'General case' 0 C--O 1.212 -0.912 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.73 -38.29 78.03 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 112.284 -2.234 . . . . 0.0 109.461 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.01 -46.63 80.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.232 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.707 ' CG2' ' HB2' ' A' ' 105' ' ' ALA . 0.7 OUTLIER -74.34 -31.14 62.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.61 -177.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.702 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.28 -40.82 67.3 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.149 -178.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 27' ' ' ILE . 1.8 mt -65.94 -45.04 83.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -52.59 9.1 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.66 -43.96 93.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.185 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.445 ' O ' HG12 ' A' ' 29' ' ' ILE . 53.0 t80 -54.13 -50.23 67.39 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.927 0.785 . . . . 0.0 112.135 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.73 -29.16 20.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.705 179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.4 -36.33 68.79 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -175.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.676 HG21 HD22 ' A' ' 112' ' ' LEU . 4.2 mm -58.91 -39.94 79.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.544 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.68 63.74 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -67.35 -38.06 84.22 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.68 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.53 -46.42 66.53 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.72 -30.0 23.48 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.05 -36.49 40.77 Favored Glycine 0 C--N 1.317 -0.508 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.813 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.02 -19.53 44.66 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 118.507 -1.277 . . . . 0.0 107.669 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -10.01 16.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.148 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.458 ' H ' ' C ' ' A' ' 34' ' ' GLY . 19.3 t80 -123.64 119.92 26.96 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 118.216 0.462 . . . . 0.0 110.166 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.95 152.03 76.09 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 119.922 1.008 . . . . 0.0 111.469 -1.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -82.69 135.73 24.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.461 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.81 161.93 39.36 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -152.09 -40.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 110.504 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -126.41 -28.66 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.533 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -61.47 162.48 8.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.484 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 t -101.81 10.59 39.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.56 128.67 35.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.801 0.334 . . . . 0.0 110.55 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.7 p -125.67 136.53 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.512 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -104.35 128.76 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.495 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -114.14 162.95 15.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.126 0.488 . . . . 0.0 110.898 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.54 -28.73 14.61 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' HD3' ' A' ' 51' ' ' LYS . 3.4 p -61.04 -33.45 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HD3' HG13 ' A' ' 50' ' ' VAL . 25.1 mmtt -64.94 -54.12 35.68 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.601 1.091 . . . . 0.0 112.978 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.735 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 8.8 p -68.18 -40.56 83.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.599 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.438 ' N ' HG13 ' A' ' 52' ' ' VAL . 72.6 m -69.31 -40.51 77.61 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.726 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.6 OUTLIER -62.85 -31.81 72.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.21 -39.52 94.14 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.969 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.542 ' O ' HD13 ' A' ' 60' ' ' ILE . 3.1 m-85 -66.01 -46.97 76.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.741 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.55 -45.84 93.74 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.278 -0.419 . . . . 0.0 114.005 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.652 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 1.4 tp -66.32 -43.83 85.12 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.107 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -58.74 -36.74 74.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -60.15 -34.0 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.496 -178.115 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.76 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.7 -45.59 82.2 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.506 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -68.94 -32.07 71.42 Favored 'General case' 0 CA--C 1.469 -2.165 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.998 HD13 HD12 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.61 -40.44 72.11 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.87 -44.11 73.98 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.453 173.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -38.31 86.31 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -59.63 -12.29 6.5 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 119.889 1.222 . . . . 0.0 111.579 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -42.87 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 0.0 111.428 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.12 178.9 21.06 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -22.96 62.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.832 0.348 . . . . 0.0 111.133 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -72.69 7.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.306 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.6 m -124.32 135.51 53.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.279 0.561 . . . . 0.0 111.623 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.13 -140.62 8.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HB3' HG21 ' A' ' 79' ' ' VAL . . . -72.53 85.88 1.16 Allowed 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.368 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -19.63 59.1 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.998 HD12 HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -89.74 8.35 32.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.089 179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 59.3 m-20 -148.26 144.15 18.38 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 121.145 1.793 . . . . 0.0 114.222 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 98.6 Cg_endo -83.51 -21.89 4.09 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 124.035 3.157 . . . . 0.0 112.943 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.732 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -59.22 -45.8 90.16 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 73' ' ' ALA . 26.3 m -66.46 -38.16 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.4 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.701 HG21 ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -61.66 -29.96 70.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mt -60.23 -36.05 76.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.8 -48.92 31.75 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.737 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -14.79 62.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tt -62.22 -60.32 3.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.72 33.64 3.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.047 0.451 . . . . 0.0 110.878 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 t -83.17 -27.25 30.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.445 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.2 -42.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.47 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.26 -174.72 5.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.2 mm -133.88 -76.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.649 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.7 t -62.7 -77.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.732 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER 66.57 140.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.492 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -127.44 -29.48 2.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -65.37 -35.81 82.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.612 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -65.41 -35.18 80.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.87 -38.73 67.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 tpp -73.33 -31.64 64.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.043 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.701 ' CD2' HG21 ' A' ' 80' ' ' THR . 8.1 t80 -65.01 -44.24 89.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 118.777 0.717 . . . . 0.0 111.142 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -66.71 -41.22 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.191 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.5 mt -70.38 -42.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.28 69.07 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -35.81 70.67 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.7 t -57.99 -36.14 72.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 107' ' ' VAL . 2.8 t -71.3 -35.25 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.314 175.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.39 -47.54 82.2 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 120.908 1.685 . . . . 0.0 112.833 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.707 ' HB2' ' CG2' ' A' ' 21' ' ' THR . . . -69.92 -35.98 74.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 mm -66.05 -50.34 70.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 103' ' ' VAL . 34.5 m -62.32 -36.97 77.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.148 0.499 . . . . 0.0 109.757 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.24 -49.68 75.26 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.556 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -64.68 -37.0 86.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.643 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.65 85.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.124 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.99 -37.33 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.681 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -65.75 -24.61 67.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.645 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -61.04 -38.98 88.06 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.423 -178.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.0 -36.17 60.33 Favored Glycine 0 CA--C 1.511 -0.199 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 HD12 ' HG ' ' A' ' 112' ' ' LEU . 4.4 mt -54.14 -36.87 33.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.703 -0.749 . . . . 0.0 111.057 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -63.14 -14.91 54.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.555 -178.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.2 m -52.33 -45.17 65.52 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.18 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -35.12 14.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 mp -81.48 -179.92 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.8 p -118.34 125.33 49.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.697 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.2 84.66 0.06 OUTLIER Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -98.09 -35.32 10.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.575 0.226 . . . . 0.0 111.175 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 t 179.27 83.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 0.0 111.03 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.09 7.9 32.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.887 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.05 78.27 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -112.6 124.38 52.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.024 0.44 . . . . 0.0 111.337 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 51.97 20.6 1.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.405 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -112.37 92.21 3.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 135' ' ' SER . 3.3 mm? -63.12 148.42 47.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.057 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -104.33 138.64 40.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.585 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -49.59 127.6 15.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.71 -105.18 0.66 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.829 HG22 ' HB3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.16 131.92 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.451 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 -171.98 0.76 Allowed 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 176.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.464 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -64.61 -46.73 81.39 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 114.52 -2.872 . . . . 0.0 109.883 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.656 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -58.93 -41.46 96.28 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.285 -0.96 . . . . 0.0 110.954 -175.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.829 ' HB3' HG22 ' A' ' 133' ' ' VAL . 7.3 mm-40 -53.45 -23.41 9.98 Favored 'General case' 0 C--N 1.248 -3.838 0 CA-C-O 121.443 0.64 . . . . 0.0 110.61 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -69.61 -1.56 30.91 Favored Glycine 0 C--O 1.185 -2.913 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.54 -50.23 63.85 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 118.394 1.097 . . . . 0.0 111.146 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.53 -35.71 75.52 Favored Glycine 0 C--O 1.229 -0.163 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.8 ' CD1' HG21 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -71.54 -36.04 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 113.239 -1.48 . . . . 0.0 111.845 -178.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' GLY . 7.9 mt-10 -68.42 -36.38 78.98 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 122.047 0.927 . . . . 0.0 110.863 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.657 HG23 ' CA ' ' A' ' 219' ' ' GLY . 41.2 mt -70.5 -50.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.923 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.25 -43.65 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.062 0.935 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.425 ' O ' ' CG ' ' A' ' 148' ' ' GLN . . . -62.35 -51.7 54.57 Favored Glycine 0 C--O 1.205 -1.663 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.237 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.416 ' HA ' HG23 ' A' ' 191' ' ' ILE . 45.1 m -70.01 -35.23 74.21 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.796 0.808 . . . . 0.0 110.363 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 147' ' ' LEU . 2.1 tp -54.87 -40.15 69.43 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -57.91 -33.35 68.67 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.949 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.986 HD11 HG22 ' A' ' 176' ' ' VAL . 2.3 tp -68.89 -47.08 66.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.972 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.655 HG21 ' HA3' ' A' ' 220' ' ' GLY . 54.3 t -66.23 -41.02 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.76 -45.63 85.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' A' ' 172' ' ' ILE . 21.3 p -64.28 -28.44 69.72 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.704 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.01 -38.54 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.8 mt -65.89 -35.95 82.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.14 80.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.231 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.691 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 1.8 t -65.3 -36.83 85.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.677 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.8 m -83.35 -8.74 59.37 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.021 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 139.06 33.24 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.1 ttm-85 -85.79 -37.77 18.91 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.22 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 39.68 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.709 0.631 . . . . 0.0 111.197 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -102.51 138.03 39.96 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 65.78 -165.8 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.441 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.1 175.87 9.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.98 -165.64 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.54 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -120.51 -179.62 16.31 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 64.82 -174.88 13.86 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.428 ' CB ' HD12 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -101.81 123.69 46.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.547 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.691 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . -52.26 -45.62 94.36 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.621 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 28.0 Cg_exo -54.63 -38.27 90.89 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.557 1.505 . . . . 0.0 111.878 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 167' ' ' SER . 62.0 mt -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.035 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.63 -46.95 57.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.087 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.45 HG23 ' SG ' ' A' ' 152' ' ' CYS . 1.3 mp -58.08 -42.05 82.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 121.546 0.688 . . . . 0.0 109.692 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.74 -37.63 93.65 Favored Glycine 0 C--O 1.195 -2.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.131 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -55.15 -35.53 64.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 178.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -34.43 77.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.821 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.986 HG22 HD11 ' A' ' 149' ' ' LEU . 11.5 t -72.01 -47.06 56.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.741 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . . . -68.89 -33.58 74.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.124 0.964 . . . . 0.0 110.131 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.276 4.3 mt -69.16 -52.94 23.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 125.293 2.473 . . . . 0.0 110.918 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.51 62.57 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 110.01 -3.268 . . . . 0.0 106.58 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.516 ' CD2' ' O ' ' A' ' 176' ' ' VAL . 1.6 m-70 -70.08 -34.88 73.71 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.756 -1.722 . . . . 0.0 110.081 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -56.84 -47.69 79.77 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.369 -178.352 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.66 -51.56 14.06 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 191' ' ' ILE . . . -69.38 -52.07 30.56 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 188' ' ' GLY . 1.5 mp -56.65 -49.14 79.21 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.032 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.504 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -70.09 -35.82 74.45 Favored 'General case' 0 C--N 1.277 -2.564 0 C-N-CA 115.998 -2.281 . . . . 0.0 113.067 -175.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -60.18 -29.47 68.72 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.316 -171.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.276 0.1 OUTLIER -124.27 -26.95 3.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.199 1.0 . . . . 0.0 113.269 -178.744 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 184' ' ' ILE . . . 88.48 -5.89 84.2 Favored Glycine 0 CA--C 1.564 3.102 0 N-CA-C 105.981 -2.848 . . . . 0.0 105.981 -170.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' ' 187' ' ' THR . 17.4 t -84.45 129.47 34.86 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 123.601 1.667 . . . . 0.0 106.588 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.477 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -50.02 161.84 0.96 Allowed Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 110.659 -2.973 . . . . 0.0 112.465 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.658 HG13 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.53 -42.71 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.189 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.732 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 7.9 p-10 -87.05 139.86 32.61 Favored Pre-proline 0 N--CA 1.418 -2.047 0 CA-C-N 111.85 -2.432 . . . . 0.0 107.695 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.01 -14.89 46.52 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.886 1.724 . . . . 0.0 111.674 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.463 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . . . -75.31 -30.65 60.41 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.589 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.438 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.4 OUTLIER -70.69 -39.61 73.39 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.288 0.566 . . . . 0.0 109.617 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -31.73 64.32 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.85 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.838 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.7 m-85 -72.04 -35.0 69.24 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.61 1.964 . . . . 0.0 113.911 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -46.6 91.99 Favored Glycine 0 C--N 1.319 -0.402 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 202' ' ' ILE . 1.3 p -76.35 -28.24 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.688 -0.756 . . . . 0.0 110.297 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.838 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.81 -34.0 77.32 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.995 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.46 -31.18 27.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 121.186 1.812 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 199' ' ' SER . 0.7 OUTLIER -48.68 147.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.651 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.28 170.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.673 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 66.41 96.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.678 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -129.14 166.79 18.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.405 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -160.22 -177.93 6.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.775 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -27.84 69.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.991 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.93 -35.09 66.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.344 . . . . 0.0 110.82 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.5 -26.35 30.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.431 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -70.55 -32.6 70.1 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.496 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.656 HG21 ' HA2' ' A' ' 136' ' ' GLY . 31.9 mm -52.6 -35.12 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.62 -36.61 74.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.112 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -84.33 -33.44 23.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 215' ' ' GLY . 12.3 p -78.61 -47.08 24.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.15 -45.95 80.38 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.313 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 4.1 Cg_exo -71.69 -28.67 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.877 2.385 . . . . 0.0 113.29 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -33.75 58.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 49.8 mt -70.59 -46.12 71.25 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.295 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.657 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.34 -46.81 67.58 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 128.407 3.567 . . . . 0.0 111.886 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.655 ' HA3' HG21 ' A' ' 150' ' ' VAL . . . -70.32 -48.96 34.93 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 118.146 -1.978 . . . . 0.0 109.894 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.87 68.19 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.632 0.73 . . . . 0.0 109.789 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.84 -31.24 70.94 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.334 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.565 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.99 -39.63 82.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.21 -49.64 81.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -39.34 91.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.7 0.762 . . . . 0.0 109.719 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -34.59 49.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.765 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -131.71 51.55 2.14 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.194 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -174.49 -31.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.732 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.94 -172.25 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.651 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 tt -137.85 98.19 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.933 0.397 . . . . 0.0 110.737 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 17.9 mt 48.24 92.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.069 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -131.64 158.6 74.93 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.35 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.39 -58.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.61 2.207 . . . . 0.0 112.287 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.15 93.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.507 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.17 124.77 5.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.587 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 11.1 t 179.1 -56.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.502 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -173.18 42.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.599 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.18 110.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.641 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.3 t -124.36 27.42 7.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.591 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.3 -26.58 19.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.533 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.4 77.71 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.625 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.11 95.46 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp 53.91 -175.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.498 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 246' ' ' THR . 38.5 t -63.89 -60.77 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.542 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 57.74 25.77 12.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.491 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.442 ' H ' HG12 ' A' ' 244' ' ' VAL . 2.3 m 58.95 80.97 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.617 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.1 p -76.49 -65.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.81 -119.69 4.59 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -143.47 25.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 110.633 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.74 19.71 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 63.46 -83.92 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.956 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -159.98 135.71 8.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.545 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -104.94 167.46 9.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.642 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.1 -47.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.81 110.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.621 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.45 -52.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.616 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -155.31 -64.52 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.531 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.98 155.48 2.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.622 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -135.41 -67.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.566 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 10.0 mt 64.64 144.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.625 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.01 -73.52 0.09 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.81 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.59 -170.32 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.554 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 54.45 74.48 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.505 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 45.2 t -50.55 123.92 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.29 152.3 38.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.56 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 6.3 ttp -113.44 107.51 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.605 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.41 71.86 82.12 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.639 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -47.71 -39.0 30.33 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.823 2.349 . . . . 0.0 112.109 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.41 147.25 39.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 60.7 53.61 3.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.07 179.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.736 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -155.19 131.15 10.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.504 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.29 88.88 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 tttt 54.27 73.58 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.545 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.24 32.46 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.563 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.95 -26.38 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.55 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 8.1 t -99.22 83.81 2.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.548 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -56.06 124.34 17.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.595 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -139.95 176.58 8.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.621 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.32 96.81 7.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.529 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 2.7 mp -81.32 101.94 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.96 -73.64 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.8 p -57.08 124.06 17.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 0.0 110.554 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -159.76 -58.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.537 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.86 27.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.615 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.42 137.24 51.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.615 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 159.89 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.606 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -97.38 -65.21 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.536 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 13.8 m80 56.42 95.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.514 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -102.65 61.48 0.82 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.551 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -110.59 -43.98 3.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.543 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 3.5 p80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.59 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.92 78.23 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.59 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -99.16 142.45 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.55 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 53.74 32.01 13.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.433 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -120.97 -24.02 5.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.674 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.65 166.7 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.56 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -132.24 -178.72 5.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.631 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp 56.39 41.75 28.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.573 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.31 -28.54 42.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.698 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.32 96.46 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.683 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -115.84 -14.81 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -57.12 -16.47 7.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.095 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.16 -0.18 15.66 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.88 -40.09 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.3 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.775 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.584 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.82 69.42 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.689 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -70.62 -46.74 62.79 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -176.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -33.82 73.26 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 19' ' ' LEU . 12.3 mt -58.84 -38.35 78.48 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.68 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.73 -47.07 76.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.742 -2.026 . . . . 0.0 115.077 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -75.74 -31.5 59.61 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.493 -177.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.767 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.72 -39.0 67.28 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.737 -178.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -45.06 83.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.63 ' CD2' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -77.07 -47.2 21.19 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 29' ' ' ILE . 92.5 t -65.25 -50.57 72.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.477 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.474 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 18.1 t80 -53.86 -47.43 71.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -29.17 20.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.594 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -36.23 67.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.728 HG21 HD22 ' A' ' 112' ' ' LEU . 3.2 mm -62.97 -38.61 82.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' A' ' 33' ' ' LEU . . . -55.26 -36.88 63.29 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.257 -177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -63.49 -45.02 92.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.726 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.52 -16.86 63.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.762 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.512 HD11 HD21 ' A' ' 112' ' ' LEU . 14.3 mt -78.42 -43.44 27.33 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 121.484 0.659 . . . . 0.0 110.003 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.46 -24.4 68.09 Favored Glycine 0 C--N 1.308 -1.01 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -26.98 63.56 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -106.78 -10.03 16.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.01 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 34' ' ' GLY . 14.4 t80 -123.23 120.01 27.39 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 118.257 0.481 . . . . 0.0 110.479 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.56 142.12 65.42 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 119.825 0.973 . . . . 0.0 112.107 -0.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -77.18 151.31 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.688 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.06 -160.82 17.6 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.29 90.46 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.467 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -121.87 21.17 10.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.767 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -141.4 -168.81 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.339 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.1 p -88.42 -22.16 23.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.738 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.15 145.31 51.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.042 0.448 . . . . 0.0 110.964 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 t -141.54 132.43 26.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.117 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -105.58 106.01 16.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.023 0.44 . . . . 0.0 110.733 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 38.1 t0 -114.47 163.03 15.91 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.493 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -49.8 -28.04 5.79 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.407 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG22 HD21 ' A' ' 181' ' ' LEU . 12.0 t -56.81 -48.24 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -64.8 -44.12 90.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.011 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.717 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 7.7 p -68.2 -47.6 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.548 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.454 ' N ' HG13 ' A' ' 52' ' ' VAL . 12.2 m -69.15 -36.49 77.48 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.78 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 49.4 tp -63.41 -31.88 73.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -65.79 -39.2 90.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.374 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 60' ' ' ILE . 8.4 m-30 -65.92 -43.33 88.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.875 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.771 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.56 -43.34 96.67 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.467 -0.396 . . . . 0.0 112.901 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 58.0 mt -66.76 -43.69 83.41 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.301 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -36.54 74.66 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -60.26 -34.08 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.645 -178.449 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.721 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -62.39 -45.53 92.73 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.423 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 62' ' ' THR . 8.1 p -67.84 -31.42 71.24 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -41.96 72.1 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.96 -44.07 73.69 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.508 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -40.2 87.78 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.51 -12.13 5.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 119.802 1.183 . . . . 0.0 111.702 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -42.85 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.759 0.314 . . . . 0.0 111.395 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.6 170.65 11.91 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -23.08 62.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 pt -76.06 7.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 135.7 53.57 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.377 0.608 . . . . 0.0 111.697 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -149.55 18.45 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.34 85.35 1.09 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -20.01 62.34 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.663 ' O ' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -89.84 3.43 52.97 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 112.26 -2.245 . . . . 0.0 113.636 178.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.624 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 3.6 t-20 -126.46 133.85 25.41 Favored Pre-proline 0 N--CA 1.483 1.19 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 83.6 Cg_endo -83.68 -32.25 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.171 2.58 . . . . 0.0 112.1 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.606 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -61.13 -49.89 75.45 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.454 ' CG2' HG21 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -66.22 -36.81 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.825 0.345 . . . . 0.0 111.218 177.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -62.89 -28.63 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.434 HD13 ' CG ' ' A' ' 217' ' ' PHE . 0.6 OUTLIER -60.71 -42.05 96.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.874 0.369 . . . . 0.0 110.409 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.68 -39.3 85.95 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -50.23 72.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.615 0.245 . . . . 0.0 111.294 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -66.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.837 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.14 -25.53 9.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.545 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 t -99.5 -162.71 0.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.434 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 65.58 -169.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.674 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -109.24 -69.46 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.705 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mt -77.7 -80.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.694 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.45 -161.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.475 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 92' ' ' PHE . 42.3 mt 62.93 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.314 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.472 ' N ' HG22 ' A' ' 91' ' ' ILE . 0.2 OUTLIER 69.83 -73.62 0.09 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.805 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -63.11 -45.27 92.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.394 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.13 77.96 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.86 -38.44 67.47 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.4 ttt -71.71 -36.18 70.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.316 -1.765 . . . . 0.0 109.685 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -64.33 -37.52 87.81 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 119.177 0.899 . . . . 0.0 109.236 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -59.6 -48.12 88.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.532 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.441 ' N ' HG22 ' A' ' 98' ' ' ILE . 26.2 pt -70.44 -37.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -66.22 -47.18 74.7 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.46 ' NE2' ' HD3' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -71.61 -35.84 70.59 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.96 71.74 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 100' ' ' ALA . 2.7 t -70.81 -35.39 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.016 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.61 -42.21 90.33 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 121.152 1.797 . . . . 0.0 112.973 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.465 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.91 -36.05 75.08 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.03 -42.22 85.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.825 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.94 -37.23 72.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.269 0.557 . . . . 0.0 109.515 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.67 -44.67 85.92 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.14 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -70.32 -37.17 74.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.709 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -44.83 88.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.707 0.289 . . . . 0.0 111.113 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.8 mt -69.22 -37.51 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.39 . . . . 0.0 110.814 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.728 HD22 HG21 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -64.47 -24.5 67.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.023 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -36.89 81.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.969 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.95 -36.24 60.16 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.5 mm -55.33 -40.6 57.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.627 -0.787 . . . . 0.0 110.532 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -12.47 29.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.455 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -52.39 -44.45 65.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.745 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.08 -35.43 13.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.477 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 mp -87.66 -178.09 6.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 111.023 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.99 126.92 55.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.612 ' CA ' HD11 ' A' ' 124' ' ' LEU . . . -68.66 78.37 0.26 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.0 -35.42 10.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.575 0.226 . . . . 0.0 111.433 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 t -164.53 70.92 0.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.12 0.486 . . . . 0.0 110.559 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.612 HD11 ' CA ' ' A' ' 121' ' ' GLY . 0.9 OUTLIER -87.09 8.1 25.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.113 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.13 15.43 78.76 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -112.71 117.47 32.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 111.71 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 52.0 29.44 6.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -108.79 89.61 3.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 187' ' ' THR . 3.3 mm? -63.01 143.79 57.47 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.055 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.03 139.99 40.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.887 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -49.62 127.63 16.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.28 -104.66 0.59 Allowed Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.834 HG21 HG13 ' A' ' 141' ' ' ILE . 1.3 t -86.09 127.76 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.459 ' O ' HG12 ' A' ' 133' ' ' VAL . 9.4 t-20 -71.66 -172.03 0.74 Allowed 'General case' 0 C--O 1.203 -1.376 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.505 ' N ' HD11 ' A' ' 129' ' ' LEU . 6.8 t -63.54 -46.97 83.56 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 114.499 -2.88 . . . . 0.0 109.893 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -40.13 94.79 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.13 -1.034 . . . . 0.0 111.323 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.795 ' HB3' HG22 ' A' ' 133' ' ' VAL . 2.4 mm100 -53.5 -23.54 10.65 Favored 'General case' 0 C--N 1.253 -3.618 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.676 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.532 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.34 -2.18 13.56 Favored Glycine 0 C--O 1.191 -2.56 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.693 HD13 HD11 ' A' ' 211' ' ' ILE . 7.3 tp -61.05 -50.37 73.58 Favored 'General case' 0 C--O 1.206 -1.226 0 O-C-N 120.458 -1.613 . . . . 0.0 108.458 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.77 -46.52 53.12 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.834 HG13 HG21 ' A' ' 133' ' ' VAL . 2.1 mm -59.58 -42.83 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.186 -1.007 . . . . 0.0 111.352 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.19 -36.11 79.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.035 0.934 . . . . 0.0 112.59 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.636 HG23 ' CA ' ' A' ' 219' ' ' GLY . 19.6 mt -67.78 -50.48 59.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 O-C-N 121.718 -0.614 . . . . 0.0 110.474 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.29 -43.59 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.99 0.9 . . . . 0.0 111.948 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 148' ' ' GLN . . . -61.98 -51.05 59.69 Favored Glycine 0 C--O 1.2 -1.993 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.915 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 216' ' ' PRO . 28.6 m -70.25 -37.61 74.98 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.838 0.828 . . . . 0.0 110.87 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 3.8 tp -55.03 -40.22 69.98 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.47 HE22 ' HB2' ' A' ' 175' ' ' SER . 1.1 pp0? -57.85 -31.42 66.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.778 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.887 HD11 HG22 ' A' ' 176' ' ' VAL . 1.2 tp -68.72 -47.16 67.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.651 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.616 HG21 ' HA3' ' A' ' 220' ' ' GLY . 82.5 t -66.39 -40.98 88.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -45.65 82.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' A' ' 172' ' ' ILE . 24.6 p -65.68 -29.02 69.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.454 HG21 ' CG2' ' A' ' 79' ' ' VAL . 2.5 t -71.94 -39.0 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.167 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -38.21 88.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.554 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.7 72.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.583 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -54.71 -36.72 65.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.335 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.88 -8.83 42.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.167 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -64.89 101.0 0.45 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.852 0.358 . . . . 0.0 110.615 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.08 -27.84 65.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.32 153.06 44.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.455 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 51.78 83.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.506 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -102.24 61.21 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.568 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -146.12 40.48 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.3 mt -51.14 -63.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.589 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 151.29 -55.13 0.46 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -128.35 -111.73 1.62 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.56 129.92 56.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.172 0.51 . . . . 0.0 110.428 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.583 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . -52.62 -43.93 93.83 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 10.6 Cg_exo -62.32 -46.76 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.715 1.61 . . . . 0.0 113.842 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 171' ' ' ALA . 3.8 pp -66.37 -29.97 70.26 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.014 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.753 ' N ' HD12 ' A' ' 170' ' ' LEU . . . -71.35 -45.16 63.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.777 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.421 HG23 ' SG ' ' A' ' 152' ' ' CYS . 1.0 OUTLIER -58.16 -37.53 62.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.78 -37.56 93.54 Favored Glycine 0 C--O 1.196 -2.268 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.667 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.26 -35.86 65.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.47 ' HB2' HE22 ' A' ' 148' ' ' GLN . 0.7 OUTLIER -67.54 -34.79 77.79 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.173 176.004 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.887 HG22 HD11 ' A' ' 149' ' ' LEU . 10.5 t -70.32 -46.92 69.43 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.78 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -68.66 -32.81 72.91 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.516 1.15 . . . . 0.0 110.527 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.629 ' O ' HD22 ' A' ' 182' ' ' LEU 0.279 2.7 tp -70.55 -50.64 35.36 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 124.739 2.209 . . . . 0.0 110.212 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.5 -37.12 65.72 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 109.896 -3.32 . . . . 0.0 107.042 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.443 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 0.3 OUTLIER -70.33 -35.24 73.49 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.959 -1.62 . . . . 0.0 109.648 178.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -57.16 -47.04 82.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.815 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.68 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -74.5 -52.11 12.86 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.71 ' HB3' HG13 ' A' ' 191' ' ' ILE . . . -69.98 -51.94 28.4 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 188' ' ' GLY . 3.7 mt -61.4 -49.21 85.44 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.681 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.536 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -69.23 -35.55 76.29 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 116.226 -2.19 . . . . 0.0 112.645 -176.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.538 -171.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.518 ' O ' HD13 ' A' ' 129' ' ' LEU 0.284 0.1 OUTLIER -124.54 -26.71 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.217 1.008 . . . . 0.0 113.2 -179.501 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.11 -5.67 84.72 Favored Glycine 0 CA--C 1.567 3.327 0 N-CA-C 106.332 -2.707 . . . . 0.0 106.332 -170.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.414 ' CB ' ' OG1' ' A' ' 187' ' ' THR . 37.5 t -84.25 126.04 32.79 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -46.53 162.61 0.17 Allowed Glycine 0 N--CA 1.411 -2.986 0 CA-C-N 111.307 -2.679 . . . . 0.0 112.647 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.71 HG13 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.39 -41.55 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.606 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.0 p30 -94.35 146.31 31.31 Favored Pre-proline 0 N--CA 1.409 -2.488 0 CA-C-N 111.528 -2.578 . . . . 0.0 108.657 179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.12 -14.69 45.5 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.524 2.15 . . . . 0.0 111.479 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.578 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.24 -34.33 61.41 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.76 0.314 . . . . 0.0 110.574 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.493 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 38.1 tpt85 -70.61 -40.53 73.13 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.906 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.2 -37.53 66.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.825 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 13.3 t80 -72.1 -35.06 69.08 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 126.718 2.007 . . . . 0.0 114.458 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.3 93.34 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 106.7 -2.56 . . . . 0.0 106.7 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 16.2 m -76.6 -28.3 56.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.992 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.825 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -67.53 -33.93 76.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.35 -31.29 14.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 121.152 1.796 . . . . 0.0 111.808 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 1.6 pt -64.02 -27.91 43.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.636 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.19 113.03 14.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.628 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -106.57 86.42 2.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.066 0.46 . . . . 0.0 110.472 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -178.89 -164.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.437 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 55.63 96.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.638 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.0 p -55.2 -26.68 40.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.457 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -59.27 -35.3 73.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.587 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -25.07 52.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.827 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -61.28 -20.06 62.44 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.494 0.496 . . . . 0.0 111.308 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 139' ' ' LEU . 2.6 tp -52.39 -34.27 18.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -27.13 64.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -84.43 -44.68 13.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 214' ' ' VAL . 2.6 p -80.18 -41.11 20.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.503 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.3 -45.07 84.35 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.434 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.514 ' HB3' HG21 ' A' ' 146' ' ' THR . 3.4 Cg_exo -71.74 -28.66 16.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.624 2.216 . . . . 0.0 112.95 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.434 ' CG ' HD13 ' A' ' 81' ' ' LEU . 3.4 m-30 -77.4 -31.0 53.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 111.993 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.4 mm -70.77 -46.44 68.81 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.296 0 C-N-CA 123.398 0.679 . . . . 0.0 112.457 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.636 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.95 -46.09 60.85 Favored Glycine 0 C--N 1.359 1.84 0 O-C-N 128.659 3.724 . . . . 0.0 111.535 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.616 ' HA3' HG21 ' A' ' 150' ' ' VAL . . . -70.27 -49.02 34.93 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.192 -1.956 . . . . 0.0 109.944 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.96 68.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.648 0.737 . . . . 0.0 109.626 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.73 -31.29 71.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.152 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.78 -39.47 81.16 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.5 t -58.15 -49.54 81.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.604 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -39.47 94.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.623 0.725 . . . . 0.0 109.817 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 21.4 mt -58.59 -34.42 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.346 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -71.78 0.67 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.386 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -72.23 73.65 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.755 0.312 . . . . 0.0 110.746 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -48.69 139.99 8.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.672 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.5 tt -130.59 -6.4 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.272 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -49.44 -71.0 0.07 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.861 0.362 . . . . 0.0 110.616 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.519 ' HB1' ' HD2' ' A' ' 233' ' ' PRO . . . -129.02 164.89 35.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.537 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 232' ' ' ALA . 51.2 Cg_exo -51.35 -42.8 53.0 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.706 2.271 . . . . 0.0 112.073 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -53.78 160.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.507 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.1 t -142.73 77.41 1.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.562 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.4 m 56.73 60.23 3.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.621 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.34 -179.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.3 mp -120.2 119.64 33.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.566 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 59.9 m 61.66 -84.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.002 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -145.87 -50.99 0.24 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.77 0.319 . . . . 0.0 110.537 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.13 55.21 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.7 t -127.1 -63.8 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.618 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -103.38 105.0 15.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.638 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 m -147.78 55.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.613 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -56.21 -46.47 79.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.557 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.7 141.85 26.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.9 t -168.13 30.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 133.38 -105.59 0.59 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -123.35 39.77 3.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.775 0.322 . . . . 0.0 110.548 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.7 146.37 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.683 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.34 43.05 26.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.546 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -155.06 109.08 2.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -98.15 -77.09 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.551 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.38 -168.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.593 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.86 -74.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.558 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.1 t0 57.05 -172.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.551 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -77.16 152.68 34.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.537 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.99 -49.75 59.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.525 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.37 -168.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.602 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 2.6 tt -143.02 137.13 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -115.69 69.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.514 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.04 -165.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.594 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -100.73 97.51 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.474 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.9 p -67.69 -29.83 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.539 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -128.25 173.97 9.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.519 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.19 70.71 4.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.551 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -55.26 39.21 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.342 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.07 138.82 8.86 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.05 1.833 . . . . 0.0 112.267 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -49.71 132.59 21.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.615 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -145.6 -47.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.594 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.11 102.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.523 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.69 -28.83 58.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.582 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 70.04 -70.9 0.14 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.96 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -72.95 95.83 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 0.0 110.587 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.1 tp 64.94 157.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.554 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 85.7 mt 50.9 89.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.599 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 17.6 m -91.06 -75.93 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.546 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -59.07 4.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.676 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -173.03 167.65 4.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.533 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.34 -65.22 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.563 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.57 65.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.539 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -106.15 -65.7 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.555 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.21 144.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.501 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -151.68 123.91 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.558 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.06 -43.48 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.603 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.99 -171.72 3.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.543 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.29 -76.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.585 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -174.28 85.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.629 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -126.13 19.74 7.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 48.7 57.96 5.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.681 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.02 -73.82 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.751 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 4.4 p80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.559 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.32 -172.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.586 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.1 m -154.03 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.515 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 55.4 179.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.77 34.08 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.6 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -77.15 -57.4 3.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.553 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt 49.55 87.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.472 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -132.6 -166.65 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.046 0.451 . . . . 0.0 110.723 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.42 -91.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.737 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 60.83 -87.13 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.37 0.129 . . . . 0.0 110.687 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.36 -18.69 25.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.738 0.304 . . . . 0.0 110.567 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -58.22 -16.15 12.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.017 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.4 1.99 17.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.683 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -40.25 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.36 -36.18 73.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.541 0 CA-C-N 112.605 -2.089 . . . . 0.0 109.833 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.09 70.16 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.709 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -71.18 -46.65 60.92 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -177.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -33.96 72.31 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.99 -38.06 78.29 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.508 -2.133 . . . . 0.0 108.912 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -63.18 -46.81 85.39 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.313 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.76 -31.23 59.45 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.699 -177.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.82 -38.16 67.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.781 -178.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -44.92 84.37 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.494 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -76.96 -47.97 19.39 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 29' ' ' ILE . 91.8 t -65.44 -53.76 36.07 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.522 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.52 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 24.1 t80 -53.87 -44.36 70.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.264 0.484 . . . . 0.0 111.96 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.73 -29.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.903 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.798 HG21 HD22 ' A' ' 112' ' ' LEU . 3.0 mm -61.82 -38.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.109 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.35 -36.95 64.08 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -67.14 -38.88 86.29 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.64 -16.88 63.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.506 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.573 HD11 HD21 ' A' ' 112' ' ' LEU . 26.9 mt -85.56 -37.37 19.68 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.606 0.717 . . . . 0.0 110.128 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.45 -31.54 54.11 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.046 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -23.29 57.15 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -106.91 -10.05 16.11 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.759 176.103 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 34' ' ' GLY . 25.9 t80 -121.96 120.03 28.61 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 118.743 0.702 . . . . 0.0 110.392 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.31 143.94 71.74 Favored 'Cis proline' 0 N--CA 1.5 1.855 0 C-N-CA 124.773 -0.928 . . . . 0.0 112.174 -0.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 36' ' ' LYS . 11.0 m -72.9 151.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.645 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.71 -128.67 45.49 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 70.18 -71.54 0.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.38 0.133 . . . . 0.0 110.718 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.1 t30 47.63 30.56 1.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 110.807 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -83.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.627 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.59 -26.71 6.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.347 . . . . 0.0 110.614 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.02 145.43 46.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.773 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.19 116.59 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.376 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.54 107.83 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.7 t70 -114.1 162.95 15.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.034 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.91 -28.83 53.79 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.659 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.469 HG23 HD11 ' A' ' 181' ' ' LEU . 4.9 p -61.94 -31.92 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 5.4 mmtp -65.05 -54.18 34.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.644 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 22.5 m -68.36 -37.45 77.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.543 -177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 52' ' ' VAL . 16.1 m -69.56 -43.19 73.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.765 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 55.8 tp -62.9 -31.72 72.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.535 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.98 -39.68 93.85 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.504 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -66.28 -46.82 75.67 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.741 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.67 -41.65 97.62 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.737 -0.268 . . . . 0.0 113.38 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 2.3 mt -68.39 -43.73 76.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.674 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -60.46 -36.48 78.36 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -33.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 113.077 -1.874 . . . . 0.0 107.987 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.759 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -66.08 -45.71 80.32 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.379 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 p -69.42 -31.55 69.97 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.42 -41.01 72.19 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.0 -44.43 72.8 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.155 173.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -36.74 82.91 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 t -59.68 -12.21 6.49 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 119.98 1.264 . . . . 0.0 111.367 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.59 -42.71 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.883 0.373 . . . . 0.0 110.957 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.14 156.41 6.79 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -23.01 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 tt -74.68 6.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.55 135.64 53.33 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.168 0.509 . . . . 0.0 111.26 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.12 -159.06 21.27 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.47 85.78 1.14 Allowed 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.064 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -19.64 61.08 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.691 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . 2.1 pp -81.15 -10.26 59.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.856 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 5.8 t-20 -112.73 131.24 22.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.55 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 92.7 Cg_endo -83.69 -28.97 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.062 2.508 . . . . 0.0 112.557 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -62.54 -49.68 74.35 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.513 HG21 HG21 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -66.39 -36.77 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.778 178.283 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.2 m -65.85 -28.52 69.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.451 HD23 ' HD1' ' A' ' 217' ' ' PHE . 1.3 mp -61.78 -35.27 77.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.847 0.356 . . . . 0.0 110.715 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.72 98.27 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mt -58.96 -42.41 89.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 110.975 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.52 -53.94 26.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.45 -25.19 5.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.695 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -77.01 153.5 34.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.565 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 29.4 p -65.29 132.41 48.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.57 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -168.22 -64.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.609 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mt 53.58 93.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.627 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 m -139.76 84.97 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.841 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.5 pt 37.98 39.28 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.923 0.764 . . . . 0.0 111.732 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 49.21 50.98 17.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 110.545 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -68.36 -35.75 78.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -65.36 -35.06 79.83 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.228 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.79 -38.53 67.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtm -73.47 -31.7 63.91 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.738 -1.573 . . . . 0.0 110.132 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -67.66 -40.44 84.52 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 119.032 0.833 . . . . 0.0 111.447 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -66.77 -41.29 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.48 -42.71 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.65 ' HB3' ' OE1' ' A' ' 17' ' ' GLU . . . -68.05 -47.33 68.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.448 ' NE2' ' HD3' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -71.72 -35.83 70.32 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.079 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 t -58.03 -36.19 72.37 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.457 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.9 t -69.78 -35.41 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.857 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.7 -44.76 91.37 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 120.897 1.681 . . . . 0.0 113.369 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.42 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.68 -36.1 75.71 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 103' ' ' VAL . 39.8 mt -67.26 -41.15 86.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.532 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.9 -37.3 77.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 0.0 109.53 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.61 -46.99 83.39 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.382 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -67.73 -37.28 81.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.414 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.83 85.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.02 -39.17 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.774 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.798 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -65.14 -24.32 67.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.352 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 m -60.62 -44.37 96.41 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.836 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.07 -36.26 60.87 Favored Glycine 0 CA--C 1.509 -0.297 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.21 -30.72 30.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.441 -0.879 . . . . 0.0 111.016 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.86 3.22 12.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.4 m -60.76 -42.02 96.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.225 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.96 -35.27 14.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 mt -88.58 -179.83 6.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.45 125.63 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.77 84.84 0.07 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.13 -35.02 10.53 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.7 t -163.1 69.94 0.24 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.923 0.392 . . . . 0.0 111.131 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 mp -81.33 7.94 10.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.311 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.02 25.39 71.51 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.6 ptt85 -112.59 118.52 35.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.957 0.408 . . . . 0.0 111.884 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 t30 51.82 45.24 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -116.55 110.38 18.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.796 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.59 ' H ' HD22 ' A' ' 129' ' ' LEU . 1.3 mm? -82.01 138.07 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.39 148.75 27.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.212 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -49.65 127.66 16.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.39 -97.6 0.87 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.657 HG21 HD13 ' A' ' 141' ' ' ILE . 2.6 t -86.09 119.15 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.6 m-80 -71.8 -172.03 0.77 Allowed 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.47 ' O ' HD13 ' A' ' 211' ' ' ILE . 1.0 OUTLIER -61.78 -46.97 87.26 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 114.525 -2.87 . . . . 0.0 110.793 -178.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.19 -39.35 94.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.519 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.656 ' CB ' HG13 ' A' ' 133' ' ' VAL . 85.4 mm-40 -52.95 -23.33 6.99 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-O 121.342 0.592 . . . . 0.0 110.196 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -63.5 -1.97 5.21 Favored Glycine 0 C--O 1.187 -2.787 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.23 -50.54 69.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 119.332 1.566 . . . . 0.0 110.951 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.84 -43.94 64.33 Favored Glycine 0 CA--C 1.51 -0.255 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.657 HD13 HG21 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -63.56 -38.9 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 112.721 -1.739 . . . . 0.0 112.378 -178.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 138' ' ' GLY . 42.2 mt-10 -68.31 -36.3 79.11 Favored 'General case' 0 C--O 1.2 -1.541 0 CA-C-O 122.275 1.036 . . . . 0.0 110.48 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.681 HG23 ' HA2' ' A' ' 219' ' ' GLY . 40.2 mt -65.9 -46.46 88.43 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.645 -174.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.48 -48.99 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 122.073 0.939 . . . . 0.0 111.769 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.77 56.8 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.008 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.486 HG21 ' HB3' ' A' ' 216' ' ' PRO . 17.8 m -70.65 -43.34 69.37 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.887 -1.156 . . . . 0.0 112.447 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 148' ' ' GLN . 0.8 OUTLIER -54.67 -40.18 68.83 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.705 -176.177 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt20 -57.86 -30.26 65.65 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.851 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 176' ' ' VAL . 2.2 tp -68.82 -45.39 71.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.738 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.433 HG21 ' HA3' ' A' ' 220' ' ' GLY . 82.9 t -66.42 -40.95 87.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.18 -38.38 85.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' A' ' 172' ' ' ILE . 5.1 p -73.74 -28.3 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.393 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.513 HG21 HG21 ' A' ' 79' ' ' VAL . 2.3 t -71.98 -45.55 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -41.25 92.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.277 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.02 89.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.423 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.622 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 0.7 OUTLIER -70.2 -36.84 74.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.543 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.79 -7.0 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.316 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.42 136.92 57.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.851 0.358 . . . . 0.0 110.525 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -26.15 65.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -77.89 111.09 13.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.59 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.18 -68.35 0.89 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.473 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 63.72 -83.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.033 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.94 -163.79 1.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.783 0.325 . . . . 0.0 110.495 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 65.84 125.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.492 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.66 -132.6 5.36 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.93 -175.26 0.2 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.443 ' HB3' HD12 ' A' ' 170' ' ' LEU . 0.3 OUTLIER -96.47 132.45 42.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.545 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.622 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . -52.29 -45.67 94.52 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.818 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.6 Cg_exo -54.42 -41.08 79.98 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.485 1.456 . . . . 0.0 112.272 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 167' ' ' SER . 0.3 OUTLIER -59.42 -42.42 91.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 -47.14 57.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.492 HD11 ' OG1' ' A' ' 156' ' ' THR . 41.6 mt -58.2 -37.11 60.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.44 93.49 Favored Glycine 0 C--O 1.2 -1.977 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.299 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -55.1 -36.23 65.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -34.6 77.41 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.562 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.988 HG22 HD11 ' A' ' 149' ' ' LEU . 48.4 t -73.06 -47.42 47.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.765 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.3 -31.75 69.22 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.966 1.365 . . . . 0.0 110.117 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.273 11.3 tp -70.44 -48.67 54.88 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.547 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.408 ' C ' HG21 ' A' ' 191' ' ' ILE . . . -55.72 -37.03 67.09 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 111.075 -2.784 . . . . 0.0 107.817 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.531 ' HD2' HG23 ' A' ' 191' ' ' ILE . 25.2 m170 -68.59 -35.36 77.26 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.391 -1.405 . . . . 0.0 109.08 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -59.34 -47.73 84.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.672 -177.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.419 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.23 -52.52 10.69 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 1.035 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -70.25 -51.96 26.66 Favored 'General case' 0 C--O 1.202 -1.404 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 180' ' ' HIS . 6.0 mt -59.43 -49.21 84.42 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.815 0 C-N-CA 118.984 -1.087 . . . . 0.0 113.14 -174.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -35.71 78.49 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 115.677 -2.409 . . . . 0.0 112.719 -176.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.84 -29.79 68.52 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.673 -171.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.28 0.1 OUTLIER -124.6 -26.85 3.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.292 1.044 . . . . 0.0 113.43 -179.317 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.54 -5.8 84.43 Favored Glycine 0 CA--C 1.566 3.277 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -170.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.419 ' H ' HG23 ' A' ' 187' ' ' THR . 11.4 t -84.1 129.0 34.92 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -49.82 159.2 1.31 Allowed Glycine 0 N--CA 1.405 -3.403 0 CA-C-N 111.496 -2.593 . . . . 0.0 112.056 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 1.035 HG22 ' HB3' ' A' ' 183' ' ' ALA . 20.3 pt -72.57 -33.07 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.614 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.9 p30 -97.69 143.62 26.53 Favored Pre-proline 0 N--CA 1.418 -2.038 0 CA-C-N 113.194 -1.821 . . . . 0.0 108.748 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.05 -14.44 33.31 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.395 2.063 . . . . 0.0 111.596 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.55 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.05 -37.38 61.7 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.623 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.645 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.41 -38.62 74.64 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.26 0.552 . . . . 0.0 109.839 -179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -33.74 65.43 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.502 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.835 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.8 m-85 -72.3 -35.25 68.62 Favored 'General case' 0 N--CA 1.512 2.663 0 C-N-CA 126.532 1.933 . . . . 0.0 114.469 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.69 91.91 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 107.274 -2.331 . . . . 0.0 107.274 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -76.35 -28.41 56.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.605 -0.798 . . . . 0.0 110.349 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.835 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -63.8 -34.05 77.05 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.704 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.45 -35.55 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 121.0 1.727 . . . . 0.0 110.418 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.9 mm -52.98 -47.89 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.97 -164.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.626 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -135.43 87.05 2.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.802 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -111.82 167.38 10.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.9 -76.13 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.012 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -43.04 93.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.342 . . . . 0.0 110.771 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.88 -35.09 74.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -26.36 67.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.448 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -70.62 -39.97 73.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 135' ' ' SER . 1.4 pp -52.7 -34.55 19.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -58.52 -38.54 77.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.706 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -84.21 -33.61 24.09 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.587 HG22 HD12 ' A' ' 218' ' ' ILE . 13.3 p -77.76 -45.16 28.55 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.477 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.18 -48.15 70.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.435 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.486 ' HB3' HG21 ' A' ' 146' ' ' THR . 5.2 Cg_endo -72.16 -32.36 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.477 2.118 . . . . 0.0 114.015 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.451 ' HD1' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -70.13 -39.88 75.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 5.8 mt -70.47 -46.52 70.14 Favored 'Isoleucine or valine' 0 C--O 1.173 -2.929 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.335 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.681 ' HA2' HG23 ' A' ' 143' ' ' ILE . . . -56.65 -48.46 77.08 Favored Glycine 0 C--N 1.365 2.156 0 O-C-N 128.624 3.703 . . . . 0.0 111.23 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -67.93 -39.44 89.35 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.47 -34.88 62.34 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 5.5 mt -67.55 -37.18 82.31 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.502 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -58.8 -39.8 82.18 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.279 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.6 t -58.46 -49.72 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.08 -39.53 94.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.694 0.759 . . . . 0.0 110.344 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.92 -34.74 38.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.94 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -140.89 68.71 1.34 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.589 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -174.73 36.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.61 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -69.56 -43.51 72.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 tt -126.88 108.16 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.533 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.1 tt -169.38 -50.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.604 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 233' ' ' PRO . . . -80.72 163.73 54.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.381 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 232' ' ' ALA . 57.1 Cg_endo -75.03 158.76 41.92 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.717 2.278 . . . . 0.0 112.105 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -137.55 154.9 49.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.604 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.9 m 52.88 48.42 22.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.563 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.65 -42.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.623 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.12 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.1 pp -116.93 146.06 43.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 110.532 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.16 161.45 15.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.515 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.21 92.29 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.555 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 54.92 69.36 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.53 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 77.7 t -133.93 -65.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.565 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -76.71 114.66 15.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.544 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.16 125.47 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.612 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -72.5 123.6 23.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.543 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.28 50.95 0.76 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.596 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.35 -60.07 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.497 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.57 119.22 5.74 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -54.58 97.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.362 . . . . 0.0 110.477 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.5 m -74.35 -171.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.528 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -158.16 -172.29 3.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.511 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -98.16 -31.14 12.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.566 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.86 -61.49 0.23 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.595 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 t0 65.22 143.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.58 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.5 mp -103.34 -176.73 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.473 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.97 -70.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -152.14 -59.67 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.578 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.46 -31.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.444 ' O ' HG23 ' A' ' 260' ' ' ILE . 3.9 t0 64.12 106.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 259' ' ' ASP . 1.1 pp -154.76 57.33 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.687 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -62.64 -41.34 98.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.542 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 25.0 p -165.37 -71.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.62 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 40.64 -160.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.874 0.734 . . . . 0.0 111.403 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.9 p -172.93 -32.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 110.643 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -105.6 130.98 53.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.502 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 2.0 ttt -103.23 -33.92 9.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.434 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -141.5 72.06 25.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.489 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.59 -54.9 4.49 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.75 2.3 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 270' ' ' ALA . 0.0 OUTLIER 60.48 164.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.581 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 269' ' ' LYS . . . 70.17 -71.13 0.13 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.961 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 35.7 mt -86.18 -56.51 3.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.519 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 68.79 -74.5 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -139.27 148.89 43.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.49 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.88 -178.35 3.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.538 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.55 -179.3 7.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.619 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.66 -179.28 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.515 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.56 111.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.619 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -129.09 130.22 46.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.567 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 59.99 95.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.611 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -85.36 -37.1 20.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 1.8 tp -55.88 -46.13 78.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.577 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 57.3 t30 50.6 83.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.565 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 46.9 m -161.34 111.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.537 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.77 107.15 16.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.544 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.37 88.84 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.21 96.63 2.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.29 103.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.555 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.81 -34.3 69.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.51 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -96.39 92.91 6.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.591 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 147.56 30.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.599 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -74.99 137.63 41.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.566 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 4.1 t60 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.591 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.97 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.734 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 t -161.63 -56.88 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.901 0.381 . . . . 0.0 110.593 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 53.93 63.13 2.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.536 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.95 109.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.512 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -98.42 106.36 18.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.503 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp 59.45 -172.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.553 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.1 tttm 59.98 93.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.567 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.77 -64.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 49.42 66.88 0.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.668 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -130.52 -50.13 1.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.546 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -72.94 0.76 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.488 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.23 -12.03 11.23 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.383 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -60.24 -39.75 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -68.34 -35.92 72.85 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.301 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -35.09 69.52 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 77.5 mt-10 -70.93 -46.55 62.25 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -34.01 71.83 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -38.18 78.48 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.313 -2.222 . . . . 0.0 109.493 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.73 -46.67 78.01 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.021 -1.899 . . . . 0.0 114.572 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.46 -31.15 60.16 Favored 'General case' 0 C--O 1.204 -1.341 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.66 -177.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.751 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.87 -38.05 67.15 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 111.678 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -44.97 84.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.643 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.04 -47.21 21.23 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 29' ' ' ILE . 87.8 t -65.41 -52.09 55.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.069 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 29' ' ' ILE . 31.7 t80 -53.76 -47.35 70.76 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.094 0.473 . . . . 0.0 112.168 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.63 -29.86 21.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -36.19 69.41 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.745 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -59.3 -41.0 82.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.987 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.37 -36.85 64.04 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.9 m -67.38 -39.43 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.33 -46.22 67.59 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.505 HD22 HD23 ' A' ' 124' ' ' LEU . 2.4 pp -85.73 -31.44 22.42 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -75.84 -36.16 42.95 Favored Glycine 0 CA--C 1.505 -0.566 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.365 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.97 -19.1 40.0 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.472 -1.291 . . . . 0.0 107.589 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -106.59 -10.06 16.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.667 177.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.43 ' H ' ' C ' ' A' ' 34' ' ' GLY . 8.0 t80 -123.25 122.31 26.83 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 118.393 0.542 . . . . 0.0 110.119 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.11 137.72 43.75 Favored 'Cis proline' 0 N--CA 1.497 1.711 0 CA-C-N 119.645 0.909 . . . . 0.0 112.381 0.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.82 151.25 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.651 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.79 46.81 59.71 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -127.79 29.07 5.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.559 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -132.23 161.57 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.663 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -107.06 -61.66 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.565 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -111.42 -26.6 9.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.405 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.33 144.69 50.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.94 147.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.133 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -106.63 106.19 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.417 . . . . 0.0 110.794 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.31 162.91 16.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.647 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.0 -28.52 7.07 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.116 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.453 HG22 HD21 ' A' ' 181' ' ' LEU . 16.2 t -57.15 -40.0 70.57 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -64.8 -53.76 41.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.719 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 65.4 t -67.9 -46.14 82.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.592 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.9 m -69.3 -38.67 78.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.822 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 1.0 OUTLIER -62.77 -31.94 73.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 176.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.87 -39.37 94.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.569 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -65.94 -41.01 91.87 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.774 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.54 -41.75 99.11 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.848 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -67.57 -43.61 80.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.59 -178.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -58.65 -36.57 74.33 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.663 HG13 HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -60.06 -34.04 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.436 -178.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.722 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -64.66 -45.67 85.74 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.364 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.4 p -66.8 -31.59 72.32 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.706 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -54.7 -43.1 72.24 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.18 -44.41 72.24 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.382 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -66.83 -48.76 67.91 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 m -59.05 -12.13 4.41 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 119.708 1.14 . . . . 0.0 112.086 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 63' ' ' LEU . 13.0 m -114.44 -42.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.95 0.405 . . . . 0.0 111.575 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 144.19 158.91 7.79 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -60.65 -23.02 64.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.642 0.258 . . . . 0.0 111.681 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.14 7.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.62 136.44 53.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.105 0.479 . . . . 0.0 111.599 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.37 -153.46 27.86 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.45 85.8 1.13 Allowed 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 118.439 -1.304 . . . . 0.0 107.802 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -19.65 65.15 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.706 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.1 pp -83.78 -11.95 56.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.64 -1.618 . . . . 0.0 113.031 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -115.37 135.7 22.62 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 119.846 1.203 . . . . 0.0 114.06 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.483 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 96.6 Cg_endo -83.44 -21.6 4.29 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 123.14 2.56 . . . . 0.0 112.004 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.685 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.42 -48.67 74.48 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG23 HD23 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -66.14 -36.84 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.155 -0.341 . . . . 0.0 111.276 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -28.45 69.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.736 HD22 ' HA ' ' A' ' 217' ' ' PHE . 0.3 OUTLIER -57.08 -35.12 69.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.127 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.419 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -68.73 -48.79 47.26 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.76 -30.53 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.23 -69.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.9 tp 57.85 102.04 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.139 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.5 p -46.83 -87.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 27.3 t 58.34 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.43 0.157 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -108.69 -177.44 3.32 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.8 mm -114.95 100.11 9.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.789 0.328 . . . . 0.0 110.613 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.6 p -171.18 71.38 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.637 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.16 159.71 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.515 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -176.81 -44.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.848 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -63.61 -40.14 96.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.78 -35.02 77.93 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -38.64 67.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 176.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.93 -37.01 70.1 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.476 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -61.06 -37.69 83.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.923 0.868 . . . . 0.0 109.23 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -63.17 -48.51 87.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 113.784 -1.553 . . . . 0.0 113.367 -178.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.433 ' N ' HG22 ' A' ' 98' ' ' ILE . 2.8 mm -70.42 -38.12 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.31 74.48 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.201 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -35.61 70.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.411 ' O ' HG13 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -58.08 -36.09 72.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.22 -35.33 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.52 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.34 90.03 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 121.041 1.746 . . . . 0.0 113.105 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.02 75.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.493 HD11 ' CE2' ' A' ' 197' ' ' PHE . 64.0 mt -65.39 -50.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.9 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.02 -37.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.29 0.567 . . . . 0.0 109.612 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.56 -45.11 85.57 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.619 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.42 -37.13 74.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.819 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -46.7 85.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 pt -67.09 -37.31 79.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.745 HD22 HG21 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -67.06 -24.4 65.98 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.233 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.3 m -60.89 -44.38 97.18 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.784 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.3 62.01 Favored Glycine 0 CA--C 1.512 -0.136 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.91 -31.62 36.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.258 -0.971 . . . . 0.0 111.009 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.17 5.52 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.723 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.3 t -52.13 -32.98 37.99 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.32 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.08 -34.47 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.599 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.61 -179.29 6.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.0 m -118.4 144.77 45.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.676 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.36 78.84 0.23 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -98.09 -24.75 15.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.596 0.236 . . . . 0.0 111.188 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.1 p -172.82 64.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.989 0.424 . . . . 0.0 110.557 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.505 HD23 HD22 ' A' ' 33' ' ' LEU . 40.8 mt -88.72 7.87 31.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.158 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 71.69 16.57 76.12 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 117.35 31.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.344 0.592 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 51.97 17.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.048 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.83 91.72 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.43 HD21 ' OG ' ' A' ' 135' ' ' SER . 0.9 OUTLIER -63.17 138.59 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.286 0.565 . . . . 0.0 110.749 -178.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.94 135.61 48.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.405 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -49.81 127.57 16.41 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.05 -104.26 0.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.846 HG21 HD13 ' A' ' 141' ' ' ILE . 1.5 t -86.06 125.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.456 ' O ' HG12 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.65 -171.87 0.72 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 102.956 -2.979 . . . . 0.0 102.956 176.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.488 ' O ' HD13 ' A' ' 211' ' ' ILE . 54.1 m -62.67 -47.0 85.56 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 114.575 -2.85 . . . . 0.0 110.424 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.556 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -59.25 -39.85 95.12 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.46 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.783 ' HB3' HG22 ' A' ' 133' ' ' VAL . 37.9 mm-40 -53.5 -23.23 9.77 Favored 'General case' 0 C--N 1.25 -3.75 0 CA-C-O 121.29 0.567 . . . . 0.0 110.544 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.19 -1.65 21.48 Favored Glycine 0 C--O 1.186 -2.901 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -50.46 68.28 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-N 118.709 1.254 . . . . 0.0 110.836 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.48 -41.01 78.45 Favored Glycine 0 CA--C 1.51 -0.249 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.846 HD13 HG21 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -65.04 -40.67 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 112.775 -1.713 . . . . 0.0 112.063 -178.369 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 138' ' ' GLY . 15.5 mt-10 -68.43 -36.42 79.03 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.834 0.825 . . . . 0.0 111.697 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.668 HG23 ' CA ' ' A' ' 219' ' ' GLY . 34.6 mt -66.63 -52.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.557 -174.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.22 -44.83 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.935 0.874 . . . . 0.0 111.966 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.53 -51.88 56.44 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 113.542 -1.663 . . . . 0.0 112.036 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.404 ' HA ' HG23 ' A' ' 191' ' ' ILE . 26.5 m -70.58 -36.95 73.87 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.375 -0.912 . . . . 0.0 111.185 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 1.5 tp -55.0 -40.45 70.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.008 -176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.6 OUTLIER -58.87 -31.94 69.03 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.126 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.987 HD11 HG22 ' A' ' 176' ' ' VAL . 1.2 tp -68.77 -46.65 68.22 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.457 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.491 HG21 ' HA3' ' A' ' 220' ' ' GLY . 52.3 t -66.25 -40.98 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.7 -35.55 80.94 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.46 -33.51 74.31 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.05 -45.48 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -48.15 81.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.038 0.447 . . . . 0.0 109.928 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.662 ' CB ' HD11 ' A' ' 172' ' ' ILE . 0.9 OUTLIER -65.78 -37.1 85.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.228 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.81 10.04 30.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.252 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.3 119.44 16.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.806 0.336 . . . . 0.0 110.599 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -59.28 -25.26 63.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.668 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -94.92 141.42 28.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 58.73 71.96 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.568 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.54 166.75 13.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.665 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 53.67 68.33 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.603 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.77 42.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.505 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.93 106.6 2.95 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.34 -127.06 38.51 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.97 138.66 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 110.52 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.639 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . -52.26 -46.19 94.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.828 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 21.1 Cg_exo -54.82 -46.27 34.6 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.17 -37.46 74.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.51 -45.95 61.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.782 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.662 HD11 ' CB ' ' A' ' 156' ' ' THR . 49.3 mt -58.3 -39.37 73.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.591 0.71 . . . . 0.0 109.238 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.25 93.29 Favored Glycine 0 C--O 1.2 -2.015 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.929 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.455 ' O ' HD13 ' A' ' 178' ' ' LEU . 2.0 tp -55.09 -35.8 64.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.422 ' O ' ' NE2' ' A' ' 148' ' ' GLN . 0.0 OUTLIER -67.7 -34.47 76.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.395 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.987 HG22 HD11 ' A' ' 149' ' ' LEU . 24.8 t -73.09 -47.12 48.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -175.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.822 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -69.67 -30.85 68.63 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.485 1.135 . . . . 0.0 110.107 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.264 2.1 mp -70.56 -50.5 36.73 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 124.546 2.117 . . . . 0.0 110.323 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.458 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.45 -36.91 64.75 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 110.219 -3.173 . . . . 0.0 107.401 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.46 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 12.1 m170 -70.18 -35.34 73.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.096 -1.552 . . . . 0.0 109.645 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 177' ' ' ALA . 0.1 OUTLIER -58.88 -47.85 83.47 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.919 -178.129 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -75.04 -52.64 10.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.745 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -70.16 -52.04 26.61 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.516 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 10.8 mt -60.87 -40.67 86.0 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.901 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -75.61 -35.67 60.47 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 115.742 -2.383 . . . . 0.0 112.266 -177.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.07 -29.94 68.89 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.802 -1.159 . . . . 0.0 111.179 -171.319 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.281 0.1 OUTLIER -124.44 -26.83 3.83 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.199 -179.109 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.2 -5.87 84.36 Favored Glycine 0 CA--C 1.569 3.423 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.431 ' H ' HG23 ' A' ' 187' ' ' THR . 43.9 t -84.72 129.1 34.87 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -48.4 162.83 0.41 Allowed Glycine 0 N--CA 1.408 -3.187 0 CA-C-N 111.265 -2.698 . . . . 0.0 113.464 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.745 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -73.11 -42.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.685 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.2 p-10 -92.38 144.73 29.34 Favored Pre-proline 0 N--CA 1.417 -2.096 0 CA-C-N 110.843 -2.889 . . . . 0.0 107.702 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.02 -14.71 45.72 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.907 1.738 . . . . 0.0 111.247 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.486 ' HB3' HD22 ' A' ' 192' ' ' ASN . . . -75.03 -31.83 61.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.989 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.525 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.48 -39.25 74.33 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.376 0.607 . . . . 0.0 109.863 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -36.91 66.79 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.828 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 11.6 t80 -72.22 -35.24 68.82 Favored 'General case' 0 N--CA 1.511 2.575 0 C-N-CA 126.412 1.885 . . . . 0.0 114.442 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.26 93.51 Favored Glycine 0 C--N 1.318 -0.438 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 202' ' ' ILE . 4.9 m -76.48 -28.42 56.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.265 -0.968 . . . . 0.0 110.647 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.828 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -66.26 -34.06 77.16 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.163 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.38 -30.85 44.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 121.013 1.733 . . . . 0.0 111.604 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 199' ' ' SER . 10.2 tt -34.51 -35.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.6 m -162.38 56.95 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.147 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 48.44 -160.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.287 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -177.06 176.54 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.38 . . . . 0.0 110.593 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -103.83 177.79 4.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.47 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -26.81 66.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.384 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 211' ' ' ILE . 4.7 m120 -62.64 -35.17 78.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.637 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -18.55 64.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.476 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -20.11 62.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.892 0.377 . . . . 0.0 111.63 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 208' ' ' ASN . 2.7 pp -52.44 -34.42 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' PHE . . . . . 0.526 ' N ' HD12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -58.46 -31.82 68.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.178 -179.196 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -84.56 -33.91 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.9 p -81.79 -46.57 19.93 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -175.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.03 -44.73 83.26 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.177 -176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.9 Cg_exo -71.75 -28.6 16.76 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.842 2.362 . . . . 0.0 113.192 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.736 ' HA ' HD22 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -75.65 -35.02 60.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.244 0.545 . . . . 0.0 112.147 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.553 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.3 mm -70.55 -46.37 70.33 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.158 0 C-N-CA 124.165 0.986 . . . . 0.0 112.685 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.668 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.91 -46.74 64.76 Favored Glycine 0 C--N 1.359 1.858 0 O-C-N 128.713 3.758 . . . . 0.0 111.768 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.561 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.44 -49.04 33.69 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 118.158 -1.972 . . . . 0.0 109.762 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.467 ' N ' HD11 ' A' ' 81' ' ' LEU . . . -55.03 -38.94 68.6 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.57 0.7 . . . . 0.0 109.715 -176.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.72 -31.2 70.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.274 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -58.95 -39.69 82.41 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.129 0.966 . . . . 0.0 108.48 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.34 -49.64 81.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.587 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.84 -39.48 94.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.705 0.765 . . . . 0.0 109.829 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mm -57.84 -34.59 48.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.616 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -123.39 36.64 4.59 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.187 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.64 13.17 19.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.029 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -176.15 125.44 0.2 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.712 0.291 . . . . 0.0 110.423 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.05 109.71 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.454 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 11.7 tp -169.52 77.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.536 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . 57.15 72.31 0.96 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.593 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -46.18 165.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.894 2.396 . . . . 0.0 112.135 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.8 mtt180 -70.7 -49.66 44.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 p -71.78 -78.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.527 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.8 m 53.63 77.92 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.641 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.88 -168.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.524 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 58.29 93.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.499 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 41.1 p -111.86 -178.12 3.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.509 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.65 -49.53 56.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.581 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -176.08 -56.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.591 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.8 m -116.33 176.19 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.505 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.33 102.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.631 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.38 142.14 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.539 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.85 93.24 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.595 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 18.7 p -96.06 134.88 38.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.606 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.0 t -114.95 73.83 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.62 152.74 9.79 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.1 84.11 1.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.764 0.316 . . . . 0.0 110.614 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.6 -45.51 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.617 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 56.8 85.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.577 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -112.13 -56.21 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.494 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -139.88 25.49 2.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.529 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.91 93.37 4.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.56 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.6 98.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.553 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.25 -67.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -77.17 134.59 38.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.77 147.82 40.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.491 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -55.11 117.51 3.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.586 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -155.84 138.73 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.563 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.1 m120 50.0 83.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.578 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.9 m -122.93 -53.04 1.87 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.528 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 52.78 67.4 1.0 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.594 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.0 p -165.91 -35.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.575 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 51.17 -171.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.508 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.11 152.61 3.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.596 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -56.01 40.32 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.375 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.88 -30.55 4.53 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.994 1.796 . . . . 0.0 112.122 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -71.11 142.77 50.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.589 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 55.93 91.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.77 -78.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.556 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.92 -66.89 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.612 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -165.15 -69.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.549 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -103.54 -36.21 8.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.603 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.83 178.67 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 16.2 tt -162.94 148.21 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.589 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 23.0 t 51.15 66.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.596 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -98.5 -53.63 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.526 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 51.34 84.43 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.573 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -103.46 -40.87 6.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.538 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 9.2 tp -167.15 74.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.538 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 55.3 -179.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.52 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 29.0 t -152.21 118.42 5.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -89.63 -175.7 4.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.567 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.86 137.43 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.574 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -125.28 -176.76 3.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.598 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 30.6 p80 38.51 35.19 0.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.936 0.772 . . . . 0.0 111.678 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -78.94 74.34 5.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.645 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -131.51 32.52 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.513 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -172.22 -52.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.575 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 28.1 t60 49.87 84.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.512 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 35.3 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.521 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.81 108.69 2.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.46 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p -138.34 35.02 2.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.552 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -133.48 -61.83 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.51 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -100.93 89.22 3.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.445 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -160.37 45.48 0.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.529 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -121.57 -42.9 2.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.621 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -103.54 -34.52 8.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.578 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mt -54.78 -70.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.502 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.1 t80 70.25 -70.61 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.981 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -50.18 101.18 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.025 0.44 . . . . 0.0 110.802 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -67.56 -4.18 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.289 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.77 -1.45 12.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.276 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.98 -40.25 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.23 -35.67 72.12 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.641 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.786 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.8 69.33 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 3.7 tp10 -70.73 -46.78 62.4 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -176.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -33.9 71.05 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.87 -38.17 78.19 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 112.293 -2.23 . . . . 0.0 109.482 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -63.25 -46.59 86.15 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.006 -1.907 . . . . 0.0 113.73 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -75.58 -31.37 59.94 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.96 -177.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.734 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.86 -37.95 67.19 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.178 -0.951 . . . . 0.0 111.287 -178.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.92 -45.25 82.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.715 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -77.13 -50.79 12.23 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 29' ' ' ILE . 43.2 t -64.59 -46.31 92.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.384 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.994 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.417 ' CE1' HD12 ' A' ' 112' ' ' LEU . 57.6 t80 -54.04 -48.67 70.3 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.189 0.519 . . . . 0.0 112.071 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.59 -29.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.519 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.05 -36.19 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.599 HG21 HD22 ' A' ' 112' ' ' LEU . 2.6 mm -64.02 -40.63 89.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.056 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.54 -41.32 81.05 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -67.57 -45.1 76.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.874 0.368 . . . . 0.0 111.876 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.1 -46.23 85.88 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.68 -27.94 25.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -75.92 -36.93 40.13 Favored Glycine 0 C--N 1.318 -0.434 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.482 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -58.77 -19.43 40.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' N ' ' C ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -106.56 -9.87 16.43 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.521 177.47 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 34' ' ' GLY . 7.7 t80 -122.28 121.41 27.8 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.489 0.586 . . . . 0.0 110.283 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.96 141.3 70.01 Favored 'Cis proline' 0 N--CA 1.497 1.711 0 C-N-CA 124.681 -0.966 . . . . 0.0 112.178 -0.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.34 144.72 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.606 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.2 -79.11 1.93 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 63.59 172.35 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 0.0 110.459 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -93.09 -4.91 51.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.221 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -89.46 162.91 15.49 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.91 0.386 . . . . 0.0 110.645 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.11 10.45 41.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.58 142.82 50.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 110.655 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 m -116.5 143.32 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.396 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -106.24 123.39 47.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.583 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.23 162.52 16.45 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.817 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.438 ' ND2' ' OD1' ' A' ' 185' ' ' ASP . 1.7 t-20 -49.89 -28.71 6.98 Favored 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.602 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.2 -34.59 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -64.94 -54.09 36.18 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.458 1.027 . . . . 0.0 113.443 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.73 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 7.7 p -68.15 -42.43 84.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.772 -176.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.449 ' N ' HG13 ' A' ' 52' ' ' VAL . 57.0 m -69.34 -41.36 76.73 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.52 0.512 . . . . 0.0 109.815 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.81 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 2.5 tm? -62.82 -31.94 73.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.07 -39.61 94.46 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.96 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.408 ' O ' HD13 ' A' ' 60' ' ' ILE . 9.2 m-30 -66.2 -46.83 75.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.699 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.44 -40.18 97.52 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.168 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.663 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 3.7 mm? -68.23 -43.49 77.8 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.093 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 p -58.69 -36.53 74.36 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.482 HG13 HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -59.8 -34.02 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.398 -1.728 . . . . 0.0 108.216 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.76 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.54 -45.63 82.68 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.326 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 p -69.08 -31.8 70.8 Favored 'General case' 0 CA--C 1.471 -2.067 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.711 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.31 -40.95 71.72 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.0 -44.07 73.55 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.827 173.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 t -59.65 -12.43 6.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 120.115 1.325 . . . . 0.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -32.69 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.809 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 168.58 12.21 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.54 -23.08 66.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 tt -73.62 7.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 p -124.42 135.56 53.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.215 0.531 . . . . 0.0 110.95 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.58 -159.82 22.95 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.41 85.89 1.12 Allowed 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.623 1.202 . . . . 0.0 108.468 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -73.2 -19.65 61.05 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.711 HD22 ' HG ' ' A' ' 63' ' ' LEU . 1.2 pp -84.87 8.67 16.63 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.787 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 5.1 t-20 -134.55 127.63 18.74 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.559 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 88.5 Cg_endo -83.33 -28.3 1.52 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.092 2.528 . . . . 0.0 112.275 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -59.35 -49.03 79.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.571 HG23 HD23 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -66.42 -36.75 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 177.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 m -61.15 -28.62 69.25 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -44.34 96.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.38 . . . . 0.0 110.155 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.79 96.37 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.29 -46.18 65.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.657 0.265 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.97 -43.69 40.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.586 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 63.23 153.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.552 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.2 m -48.64 -81.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.788 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 48.6 -163.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.769 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -91.45 -44.08 9.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.542 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.1 tt -166.38 153.97 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.606 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -70.84 -163.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.442 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.57 -80.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.612 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 176.2 -43.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.594 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -54.66 -39.13 67.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.53 -35.26 78.75 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.42 67.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 176.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 tpp -73.39 -31.61 63.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.214 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.73 -39.19 76.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 119.267 0.939 . . . . 0.0 111.575 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -66.83 -41.19 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.695 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -70.65 -38.04 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -66.42 -47.0 74.63 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -35.71 70.81 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.405 ' O ' HG13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -58.12 -36.11 72.44 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 100' ' ' ALA . 3.3 t -70.35 -35.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.197 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.36 -46.72 86.39 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 120.899 1.681 . . . . 0.0 113.084 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.485 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.89 -36.04 75.13 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.683 HG23 HG11 ' A' ' 201' ' ' VAL . 77.6 mt -64.98 -50.31 75.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.305 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 m -65.42 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.27 -43.33 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.973 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -37.05 74.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.75 85.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.454 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt -66.76 -37.33 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.42 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 29' ' ' ILE . 1.1 tt -67.08 -24.44 65.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.4 p -61.4 -41.71 97.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.813 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.0 61.56 Favored Glycine 0 CA--C 1.51 -0.266 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -29.83 24.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.456 -0.872 . . . . 0.0 111.391 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -81.59 5.36 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.627 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m -58.01 -26.93 63.03 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.707 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 77.4 p -92.01 -35.5 13.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.111 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.2 135.46 49.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.882 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t -115.57 164.5 14.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.615 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 49.17 41.74 30.99 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -88.22 9.84 21.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.0 79.29 0.26 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.942 0.401 . . . . 0.0 110.699 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 124' ' ' LEU . 8.2 mp -88.62 7.96 30.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.91 23.5 74.57 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.54 117.11 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.2 0.524 . . . . 0.0 111.452 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 t30 58.02 11.01 1.32 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.064 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -87.78 91.85 8.9 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.16 143.1 58.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.302 0.572 . . . . 0.0 111.101 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.95 134.71 49.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.636 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -49.79 127.58 16.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 128.94 -104.38 0.64 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.7 t -86.07 124.02 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.469 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.4 t30 -71.67 -171.78 0.71 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 102.823 -3.029 . . . . 0.0 102.823 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 p -62.2 -46.8 87.3 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 114.843 -2.743 . . . . 0.0 110.187 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.14 95.94 Favored Glycine 0 CA--C 1.498 -0.992 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.115 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.762 ' HB3' HG22 ' A' ' 133' ' ' VAL . 26.9 mm100 -53.46 -23.59 10.53 Favored 'General case' 0 C--N 1.248 -3.819 0 CA-C-O 121.496 0.665 . . . . 0.0 110.26 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -69.39 -1.54 29.21 Favored Glycine 0 C--O 1.188 -2.728 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.78 -50.32 65.14 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 118.556 1.178 . . . . 0.0 110.902 -176.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -38.23 76.36 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.582 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.7 OUTLIER -68.92 -38.32 78.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.18 -178.274 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' GLY . 20.4 mt-10 -68.54 -36.29 78.61 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-O 121.744 0.783 . . . . 0.0 111.123 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.704 HG23 ' CA ' ' A' ' 219' ' ' GLY . 31.7 mt -69.65 -45.46 77.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.395 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.496 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.31 -48.78 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.463 1.125 . . . . 0.0 111.27 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.56 58.03 Favored Glycine 0 C--O 1.211 -1.299 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.718 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.427 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 44.8 m -70.62 -40.16 73.32 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.673 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.616 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 3.6 tp -54.8 -40.55 69.59 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.277 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 1.1 pt20 -58.07 -31.1 66.76 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.241 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.005 HD11 HG22 ' A' ' 176' ' ' VAL . 1.6 tp -68.69 -47.17 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.49 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.482 HG21 ' CA ' ' A' ' 220' ' ' GLY . 87.2 t -66.33 -40.98 88.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -42.28 96.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.492 ' SG ' HG23 ' A' ' 172' ' ' ILE . 3.8 p -71.0 -27.18 63.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.457 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.527 HG21 HG21 ' A' ' 79' ' ' VAL . 2.3 t -72.09 -45.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.552 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.59 -41.98 92.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.372 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.56 87.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.519 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.613 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 0.7 OUTLIER -69.92 -36.96 75.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.508 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 157' ' ' THR . 0.6 OUTLIER -88.71 -1.98 58.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.476 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -67.2 108.65 2.77 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.64 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -60.91 -32.87 72.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.627 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -83.33 127.79 33.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.471 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.56 105.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.634 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -130.47 116.69 18.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.525 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.38 108.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.616 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.9 -58.06 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.487 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.48 142.29 9.2 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 75.65 -138.69 23.47 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.402 ' CB ' HD12 ' A' ' 170' ' ' LEU . 1.4 m -112.36 135.41 53.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 0.0 110.507 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.613 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . -52.34 -46.23 94.53 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.548 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 24.3 Cg_exo -54.67 -39.39 89.27 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.524 1.483 . . . . 0.0 111.972 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.402 HD12 ' CB ' ' A' ' 167' ' ' SER . 32.5 mt -60.54 -42.42 96.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.382 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.55 -47.06 57.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.703 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.492 HG23 ' SG ' ' A' ' 152' ' ' CYS . 41.6 mt -58.23 -37.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.62 -37.42 93.58 Favored Glycine 0 C--O 1.198 -2.125 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.306 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -55.13 -35.98 65.27 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -34.56 77.24 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.52 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 1.005 HG22 HD11 ' A' ' 149' ' ' LEU . 28.0 t -73.15 -47.6 46.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -66.72 -34.89 78.85 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.261 1.029 . . . . 0.0 109.667 -175.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 174' ' ' LEU 0.264 8.1 mt -67.06 -50.56 61.45 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 124.454 2.073 . . . . 0.0 110.863 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -36.97 65.38 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.117 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.551 ' HD2' HD11 ' A' ' 191' ' ' ILE . 5.4 m-70 -70.38 -35.12 73.31 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 112.669 -1.766 . . . . 0.0 109.504 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.2 -47.81 83.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.519 -177.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.1 -52.33 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.757 ' HB3' HG23 ' A' ' 191' ' ' ILE . . . -70.15 -52.22 25.24 Favored 'General case' 0 C--O 1.206 -1.221 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 188' ' ' GLY . 7.4 mt -56.02 -49.03 77.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.914 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.644 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.438 ' OD1' ' ND2' ' A' ' 49' ' ' ASN . 1.3 t0 -69.02 -35.67 76.91 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 115.538 -2.465 . . . . 0.0 112.582 -176.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 133' ' ' VAL . 2.4 m-85 -60.11 -30.35 69.2 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.721 -170.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.288 0.1 OUTLIER -124.54 -26.82 3.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.06 0.933 . . . . 0.0 113.101 -179.401 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 88.35 -5.99 84.09 Favored Glycine 0 CA--C 1.567 3.284 0 N-CA-C 106.165 -2.774 . . . . 0.0 106.165 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.446 ' H ' HG23 ' A' ' 187' ' ' THR . 17.1 t -85.36 130.68 34.54 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.47 160.65 10.04 Favored Glycine 0 N--CA 1.402 -3.625 0 CA-C-N 111.497 -2.592 . . . . 0.0 111.752 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.757 HG23 ' HB3' ' A' ' 183' ' ' ALA . 1.2 pt -72.11 -38.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.727 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 10.2 p-10 -85.88 139.19 34.99 Favored Pre-proline 0 N--CA 1.413 -2.32 0 CA-C-N 112.657 -2.065 . . . . 0.0 107.997 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -66.03 -14.46 44.53 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.49 2.127 . . . . 0.0 111.58 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.23 -33.23 61.33 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.466 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 15.6 tpt180 -70.74 -38.39 73.54 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.106 0.479 . . . . 0.0 110.158 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.4 t -73.44 -42.22 62.27 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.837 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 1.0 OUTLIER -71.96 -35.2 69.48 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 126.607 1.963 . . . . 0.0 114.777 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.41 93.12 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 m -76.38 -28.35 56.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.322 -0.939 . . . . 0.0 110.669 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.837 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -66.31 -34.22 77.49 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.743 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.683 HG11 HG23 ' A' ' 106' ' ' ILE . 3.4 m -58.75 -31.11 43.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 121.79 2.086 . . . . 0.0 110.526 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.66 -54.71 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.506 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.27 -173.01 4.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.42 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -141.97 93.79 2.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 110.658 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -105.03 -178.49 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.24 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -124.98 -96.52 0.44 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.74 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.15 -42.63 93.58 Favored 'General case' 0 C--O 1.228 -0.063 0 CA-C-O 120.821 0.343 . . . . 0.0 110.993 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -55.17 -35.04 64.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.477 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -32.26 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.891 0.377 . . . . 0.0 111.077 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -70.44 -32.48 70.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.602 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.1 mp -52.82 -35.06 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.832 0.825 . . . . 0.0 109.005 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -58.8 -36.19 74.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.058 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.27 -33.41 24.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 215' ' ' GLY . 12.0 p -77.74 -44.99 28.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.496 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.27 -47.73 73.13 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.682 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.1 Cg_endo -71.8 -28.62 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.936 2.424 . . . . 0.0 113.609 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -75.2 -33.81 61.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.051 0.453 . . . . 0.0 111.898 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 51.8 mt -70.58 -46.25 70.72 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.382 0 C-N-CA 123.892 0.877 . . . . 0.0 112.753 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.704 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.29 -45.84 67.61 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 128.343 3.527 . . . . 0.0 111.752 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.39 -48.91 34.71 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 118.306 -1.902 . . . . 0.0 109.532 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.81 68.31 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.601 0.715 . . . . 0.0 109.674 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.769 ' O ' HG23 ' A' ' 226' ' ' ILE . 1.0 OUTLIER -67.85 -31.33 71.08 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.225 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.99 -40.03 83.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.51 -50.28 80.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.488 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -39.56 93.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 222' ' ' LEU . 1.1 pp -68.99 -34.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.325 -176.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -122.88 63.08 0.98 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -158.39 127.31 5.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -89.61 93.28 9.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.741 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 mm -143.55 122.38 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.425 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 70.73 -70.17 0.16 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.618 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . 61.78 72.67 0.63 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.578 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.64 73.8 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.724 2.282 . . . . 0.0 112.11 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -50.32 114.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.575 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.1 m -85.99 -32.04 21.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.543 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 4.4 t -86.44 -176.17 5.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.88 163.61 2.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.91 -60.41 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.552 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.65 93.41 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.574 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -112.4 27.06 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.52 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -119.01 -67.8 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.576 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.21 158.12 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.577 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -170.71 140.04 1.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.584 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.7 t 53.19 76.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.473 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -55.88 -48.81 74.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.49 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 10.5 p -70.05 179.29 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.596 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.96 142.43 41.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.604 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -60.19 108.8 1.93 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.82 166.81 13.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.545 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.5 t -101.29 -54.78 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.574 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -63.29 123.47 18.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.65 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -88.72 137.87 31.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.648 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -119.71 -34.58 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.6 -170.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.551 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.22 153.0 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.561 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.04 -82.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.18 107.32 1.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.567 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -159.62 37.07 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.499 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -127.38 31.92 5.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.564 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 22.9 mt 52.97 87.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.639 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -115.53 -31.05 6.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.608 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 1.1 p 55.85 -176.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.455 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 64.98 117.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.56 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.35 164.06 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.564 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 61.58 92.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.554 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 5.1 mtm -114.12 103.07 10.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.535 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 1.6 mttm 177.57 -55.64 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.06 -50.07 9.2 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.038 1.825 . . . . 0.0 112.309 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -109.81 145.41 36.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.581 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -120.97 -54.35 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.568 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.7 tp 57.05 28.55 15.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -137.45 134.9 36.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -103.7 135.73 44.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.41 102.01 7.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.644 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.2 tp -108.3 124.27 50.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.594 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 5.1 tt -118.59 -30.84 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.588 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 6.2 t -50.21 142.56 9.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.604 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -150.72 109.74 3.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.559 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -140.85 78.14 1.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.58 168.83 9.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.487 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.62 159.15 1.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.571 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -91.66 75.06 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.479 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.8 t -69.21 -40.21 78.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . 54.33 92.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.29 120.78 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.582 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.54 162.1 14.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.629 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -105.67 40.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.565 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -126.14 170.37 11.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.562 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -61.89 171.59 1.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -74.59 -30.08 61.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.66 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -94.61 -54.02 3.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.578 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 4.1 t60 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.453 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.63 -5.53 11.15 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.478 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -63.12 -40.26 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 9.0 p -68.23 -35.75 72.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.119 176.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.79 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -70.79 -46.54 62.69 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -176.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -33.53 71.66 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 19' ' ' LEU . 11.6 mt -58.43 -38.32 77.23 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.992 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.6 -46.64 78.58 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 112.899 -1.955 . . . . 0.0 114.865 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 105' ' ' ALA . 0.2 OUTLIER -75.63 -31.32 59.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.506 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.724 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -70.33 -39.05 74.97 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.736 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -44.73 84.01 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.636 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -76.83 -52.5 9.4 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.48 -44.72 94.13 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.604 -177.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.513 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 63.3 t80 -54.3 -48.97 70.71 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.424 0.631 . . . . 0.0 112.337 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 pt -75.65 -29.54 20.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.52 -36.42 69.18 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -175.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.803 HG21 HD22 ' A' ' 112' ' ' LEU . 3.8 mm -60.84 -38.59 79.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.065 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -36.8 64.65 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p -67.01 -41.28 86.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.469 179.579 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.806 0.336 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -49.52 -28.47 5.53 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG22 HD21 ' A' ' 181' ' ' LEU . 18.4 t -58.77 -42.5 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 O-C-N 121.821 -0.55 . . . . 0.0 112.264 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -65.01 -53.98 37.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.729 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 33.9 m -67.84 -42.17 85.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.225 -176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.456 ' N ' HG23 ' A' ' 52' ' ' VAL . 72.8 m -69.39 -41.23 76.74 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.933 0.771 . . . . 0.0 109.806 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.815 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.8 OUTLIER -62.74 -31.74 72.73 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -65.08 -39.49 93.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.508 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 60' ' ' ILE . 16.5 m-30 -66.15 -46.92 75.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.7 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -60.23 -36.96 92.2 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.277 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 27.1 mt -68.28 -43.06 78.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.8 m -57.61 -35.86 71.02 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 176' ' ' VAL . 0.6 OUTLIER -60.23 -33.81 54.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.675 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.745 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -60.64 -45.53 93.73 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.51 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -31.52 70.59 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.641 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -55.05 -42.59 72.9 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 104.199 -2.519 . . . . 0.0 104.199 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.98 -44.27 73.21 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.654 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -43.57 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -176.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -59.25 -12.26 5.2 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 119.936 1.243 . . . . 0.0 111.856 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 m -119.76 -38.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 154.16 6.34 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -52.94 -22.74 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 70' ' ' ILE . 2.1 mp -70.89 7.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.56 135.71 53.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.11 -159.61 31.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.48 85.99 1.15 Allowed 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 118.574 -1.25 . . . . 0.0 107.776 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -19.54 64.46 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 112.794 -2.003 . . . . 0.0 105.684 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 pp -84.84 0.18 51.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.398 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.26 128.81 25.53 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 119.371 0.987 . . . . 0.0 113.517 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 97.9 Cg_endo -83.35 -25.34 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.717 2.278 . . . . 0.0 111.86 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.56 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.27 -46.16 84.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.509 HG23 HD23 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -66.23 -36.8 78.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 110.802 177.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -64.68 -28.62 69.73 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -57.21 -44.47 83.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 110.285 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.24 95.89 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.8 tp -51.41 -41.26 60.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.576 0.227 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 tp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.432 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.854 0.359 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.724 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.7 -35.2 78.38 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.701 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 tp -54.78 -38.45 67.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -32.63 64.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.227 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -70.06 -38.65 75.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.287 0.949 . . . . 0.0 111.947 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.724 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -66.77 -41.25 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -178.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.49 -37.78 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.414 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.02 83.53 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.008 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.33 -35.89 71.37 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.438 ' O ' HG13 ' A' ' 106' ' ' ILE . 1.2 t -57.91 -36.14 72.03 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.57 -35.33 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.429 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.37 85.22 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 120.781 1.628 . . . . 0.0 113.221 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB2' ' CG2' ' A' ' 21' ' ' THR . . . -69.8 -35.9 75.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 102' ' ' CYS . 69.5 mt -65.03 -50.36 75.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.98 -37.12 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.434 0.635 . . . . 0.0 109.48 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.724 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.45 -49.83 74.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.407 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.71 -37.02 86.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.727 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -44.89 88.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.19 -37.28 76.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.087 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.803 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -65.81 -24.36 66.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.601 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 t -63.3 -44.38 95.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.901 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.25 -36.33 62.16 Favored Glycine 0 CA--C 1.509 -0.299 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -33.16 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.3 -0.95 . . . . 0.0 110.728 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.559 -179.508 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.54 117.2 31.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.281 0.563 . . . . 0.0 111.131 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.85 15.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.665 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.15 90.07 7.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 129' ' ' LEU . 1.2 mm? -63.1 142.8 58.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.317 0.58 . . . . 0.0 111.149 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.96 136.25 47.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.333 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 127.58 16.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.66 -105.05 0.65 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.8 t -86.09 124.13 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.48 ' O ' HG12 ' A' ' 133' ' ' VAL . 32.1 t30 -71.65 -171.95 0.73 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -62.01 -46.86 87.34 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 114.928 -2.709 . . . . 0.0 110.239 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.53 96.17 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.754 ' HB3' HG22 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -53.39 -23.53 9.9 Favored 'General case' 0 C--N 1.248 -3.809 0 CA-C-O 121.261 0.553 . . . . 0.0 110.796 -176.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -70.33 -1.95 38.53 Favored Glycine 0 C--O 1.187 -2.794 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.98 -50.64 71.26 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.521 -1.576 . . . . 0.0 110.168 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.71 -45.94 56.27 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.748 HD13 HG21 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -60.88 -42.08 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.184 -1.508 . . . . 0.0 112.084 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' A' ' 138' ' ' GLY . 8.3 tt0 -68.37 -36.32 79.02 Favored 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 123.687 0.795 . . . . 0.0 112.305 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.646 HG23 ' CA ' ' A' ' 219' ' ' GLY . 25.4 mt -67.65 -47.68 79.18 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.404 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 26.9 mt -68.33 -46.79 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.059 0.933 . . . . 0.0 111.695 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.536 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -60.18 -49.94 73.04 Favored Glycine 0 C--O 1.211 -1.335 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.323 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.5 ' HA ' HG23 ' A' ' 191' ' ' ILE . 28.1 m -70.58 -38.22 74.03 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.923 0.868 . . . . 0.0 111.13 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.612 ' O ' HD12 ' A' ' 147' ' ' LEU . 1.7 tp -54.98 -40.22 69.83 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.048 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.8 OUTLIER -58.77 -31.06 68.02 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.325 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.0 HD11 HG22 ' A' ' 176' ' ' VAL . 1.8 tp -68.91 -46.69 67.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.353 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.491 HG21 ' HA3' ' A' ' 220' ' ' GLY . 38.9 t -66.35 -45.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -31.87 72.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.089 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.09 -45.43 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 -48.1 80.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 111.119 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.84 -31.69 72.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.488 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.468 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.537 ' HB3' ' HD3' ' A' ' 169' ' ' PRO . . . . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 119.62 -0.229 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 39.5 Cg_exo -54.31 -44.24 51.24 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.795 1.663 . . . . 0.0 112.019 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 mp -66.1 -38.1 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.26 56.38 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 22.2 pt -60.26 -38.3 76.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.721 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.41 93.53 Favored Glycine 0 C--O 1.2 -1.994 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.681 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mt -55.04 -35.58 64.63 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.161 -2.162 . . . . 0.0 105.161 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -34.54 77.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.31 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 1.0 HG22 HD11 ' A' ' 149' ' ' LEU . 52.9 t -73.04 -47.24 48.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.907 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 -175.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.815 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -67.53 -33.61 75.41 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 122.665 1.222 . . . . 0.0 110.027 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.258 0.1 OUTLIER -70.61 -47.49 59.85 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.973 179.375 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.494 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.64 -36.84 65.94 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 111.564 -2.562 . . . . 0.0 107.664 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' HIS . . . . . 0.481 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 6.2 m170 -70.46 -34.99 73.06 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.933 -1.633 . . . . 0.0 109.54 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.02 -48.43 81.61 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.359 -177.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.536 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.41 -52.07 11.6 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 178.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -69.66 -51.96 30.04 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 180' ' ' HIS . 5.6 mt -62.11 -49.14 85.29 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.807 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.039 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -67.28 -35.51 79.64 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 116.119 -2.232 . . . . 0.0 112.818 -176.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.95 -30.4 69.05 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.909 -1.116 . . . . 0.0 111.699 -171.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.295 0.1 OUTLIER -124.31 -26.91 3.86 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.267 1.032 . . . . 0.0 113.182 -178.79 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.61 -5.74 84.51 Favored Glycine 0 CA--C 1.567 3.296 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -170.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.408 ' H ' HG23 ' A' ' 187' ' ' THR . 15.4 t -82.68 127.89 33.83 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.596 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -44.33 170.35 0.01 OUTLIER Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 111.358 -2.655 . . . . 0.0 113.363 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -79.76 -40.14 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 173.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.2 p-10 -101.32 153.12 38.01 Favored Pre-proline 0 N--CA 1.407 -2.614 0 CA-C-N 111.432 -2.622 . . . . 0.0 108.361 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.46 -14.59 44.75 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 122.879 2.386 . . . . 0.0 111.661 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.622 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.11 -34.5 61.72 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.102 0.251 . . . . 0.0 111.094 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.596 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.52 -39.67 73.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.214 0.531 . . . . 0.0 109.928 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -36.49 66.39 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.008 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.814 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 6.1 t80 -72.26 -35.2 68.71 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 126.517 1.927 . . . . 0.0 114.268 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -46.77 91.73 Favored Glycine 0 C--N 1.319 -0.373 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.3 56.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.19 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -63.33 -34.07 76.89 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.514 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.429 HG23 ' CE2' ' A' ' 197' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 121.031 1.741 . . . . 0.0 110.425 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.6 mt . . . . . 0 CA--C 1.511 -0.545 0 CA-C-O 121.73 0.776 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.53 -36.57 74.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.049 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -84.21 -33.46 24.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 215' ' ' GLY . 15.0 p -79.09 -43.97 24.29 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.509 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.12 -44.15 83.6 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.417 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.6 Cg_exo -71.65 -28.72 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.258 . . . . 0.0 113.106 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.03 -32.14 50.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.146 0.498 . . . . 0.0 112.29 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.549 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.2 mm -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.255 0 C-N-CA 123.743 0.817 . . . . 0.0 112.164 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.646 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.71 -46.6 67.04 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 128.758 3.786 . . . . 0.0 111.731 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.31 -49.03 34.66 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 118.171 -1.966 . . . . 0.0 109.906 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -39.04 68.47 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.649 0.738 . . . . 0.0 109.713 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.86 -31.24 70.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.223 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.58 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.84 -39.68 81.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.17 -49.65 80.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.352 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.84 -39.42 91.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.754 0.788 . . . . 0.0 109.771 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 mt -58.27 -34.72 50.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.069 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--N 1.331 -0.229 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.563 -179.408 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.24 -14.4 11.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.027 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.01 -40.17 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 17.4 m -68.43 -35.81 72.24 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 112.83 -1.986 . . . . 0.0 110.521 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.18 70.07 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.683 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 11.1 mm-40 -70.81 -46.72 62.29 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -33.83 74.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 11.4 mt -58.63 -38.37 77.93 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.911 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.58 -46.99 77.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.781 -2.009 . . . . 0.0 114.749 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -75.65 -31.53 59.83 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.735 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.74 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.79 -36.88 67.69 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.507 -0.745 . . . . 0.0 111.607 -179.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -66.05 -45.22 82.15 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -77.18 -47.7 19.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 29' ' ' ILE . 90.2 t -65.28 -49.82 76.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.137 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.475 ' CE1' HD12 ' A' ' 112' ' ' LEU . 55.7 t80 -54.07 -48.07 71.01 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.5 -29.43 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.616 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -36.17 68.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.6 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -60.11 -43.74 93.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.76 63.87 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -67.33 -38.1 84.35 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.605 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 81.7 m-20 . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 121.08 0.466 . . . . 0.0 111.683 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.75 -28.02 5.64 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.403 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.566 HG12 HD21 ' A' ' 181' ' ' LEU . 24.5 m -56.74 -43.85 80.34 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.549 ' NZ ' HG23 ' A' ' 52' ' ' VAL . 1.7 pttp -64.77 -50.46 66.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 2.0 t -67.91 -47.65 78.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.647 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -69.31 -37.18 77.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.787 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 2.5 tm? -64.43 -32.01 73.46 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -62.35 -39.49 93.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.824 -1.534 . . . . 0.0 109.327 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -65.89 -44.27 85.78 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.76 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.48 -41.55 97.93 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -68.26 -43.92 76.73 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.749 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.467 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -61.04 -36.53 79.82 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.438 HD13 HD21 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -59.87 -33.89 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.006 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.752 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -68.61 -45.63 71.41 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.857 -1.519 . . . . 0.0 113.016 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 p -67.36 -31.88 72.43 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -55.35 -41.26 72.28 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.9 -44.14 73.81 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.788 173.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -38.03 85.96 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.8 m -59.54 -12.13 5.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 119.754 1.161 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.27 -42.91 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.936 0.398 . . . . 0.0 111.133 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 171.77 13.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -65.26 -23.05 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.767 0.318 . . . . 0.0 111.008 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.45 7.11 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.45 135.65 53.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.049 0.452 . . . . 0.0 111.051 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.92 -157.86 16.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.36 86.04 1.11 Allowed 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 122.507 1.146 . . . . 0.0 108.085 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -19.61 62.38 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.4 pp -84.53 4.58 31.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 113.669 -1.605 . . . . 0.0 111.625 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.447 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 14.5 t-20 -125.49 126.11 25.05 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.547 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 71.9 Cg_endo -83.23 -24.02 3.3 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.883 2.389 . . . . 0.0 111.632 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -66.16 -50.84 62.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -36.67 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.923 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 m -61.21 -32.23 72.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 217' ' ' PHE . 34.4 tp -57.27 -44.61 84.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.044 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.25 -45.87 63.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -44.29 66.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 111.008 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.862 0.363 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.91 -35.13 77.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.682 ' O ' HG13 ' A' ' 98' ' ' ILE . 3.1 mm? -54.54 -38.18 66.3 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mtm -73.71 -33.3 64.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.767 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -69.99 -37.84 75.84 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.096 -1.003 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.805 HG23 ' O ' ' A' ' 94' ' ' ALA . 1.8 pp -66.81 -42.55 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.384 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.12 -37.73 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.37 70.27 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -71.96 -35.97 69.72 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.669 0.668 . . . . 0.0 112.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 m -58.1 -35.88 72.07 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.52 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.8 t -70.4 -35.36 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.063 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.07 91.59 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 121.152 1.796 . . . . 0.0 112.519 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.469 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.95 -36.1 75.0 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 103' ' ' VAL . 37.0 mt -67.99 -42.41 85.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.575 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.4 t -69.93 -37.18 72.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.294 0.569 . . . . 0.0 110.107 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.63 -49.74 75.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.445 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 35.8 m -65.88 -37.1 85.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.457 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.53 88.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.735 0.303 . . . . 0.0 111.135 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.27 -50.5 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.28 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.6 HD22 HG21 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -58.85 -24.2 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.537 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -42.63 95.51 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.771 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.26 61.95 Favored Glycine 0 CA--C 1.511 -0.178 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.4 -31.95 44.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.779 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.582 -179.654 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.478 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.56 117.49 32.46 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.125 -0.538 . . . . 0.0 111.778 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 60.23 9.19 1.81 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.02 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -87.68 88.32 7.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.12 143.24 57.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.254 0.55 . . . . 0.0 110.88 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.05 135.7 48.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.679 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -49.64 127.45 15.76 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.6 -105.35 0.67 Allowed Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.86 HG21 HD13 ' A' ' 141' ' ' ILE . 1.6 t -85.83 123.93 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.461 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.5 m-20 -71.71 -171.85 0.73 Allowed 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -61.92 -46.74 88.05 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 114.807 -2.757 . . . . 0.0 110.409 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.04 -41.24 96.37 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.071 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.782 ' HB3' HG22 ' A' ' 133' ' ' VAL . 4.5 mt-30 -53.53 -23.42 10.48 Favored 'General case' 0 C--N 1.249 -3.789 0 CA-C-O 121.238 0.542 . . . . 0.0 110.237 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.565 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.65 -1.72 24.89 Favored Glycine 0 C--O 1.19 -2.597 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.43 -50.23 66.19 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 118.489 1.144 . . . . 0.0 110.322 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -40.96 75.16 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.86 HD13 HG21 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -66.17 -38.77 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 113.155 -1.523 . . . . 0.0 112.087 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 32.5 mt-10 -68.46 -36.24 78.71 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 121.948 0.88 . . . . 0.0 111.039 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.756 HG23 ' HA2' ' A' ' 219' ' ' GLY . 35.6 mt -67.29 -48.47 77.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.627 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.26 -48.47 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 122.088 0.947 . . . . 0.0 111.424 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.53 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -59.25 -51.97 56.02 Favored Glycine 0 C--O 1.211 -1.329 0 CA-C-N 113.466 -1.697 . . . . 0.0 113.138 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.401 ' HA ' HG23 ' A' ' 191' ' ' ILE . 24.2 m -70.39 -40.42 73.94 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.5 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 148' ' ' GLN . 0.5 OUTLIER -54.64 -40.11 68.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -176.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.46 ' N ' HD23 ' A' ' 147' ' ' LEU . 1.1 pt20 -58.0 -30.82 66.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.02 HD11 HG22 ' A' ' 176' ' ' VAL . 1.3 tp -68.75 -46.72 68.09 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.426 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.41 HG21 ' HA3' ' A' ' 220' ' ' GLY . 78.9 t -66.26 -41.03 88.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -35.65 81.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.442 0.297 . . . . 0.0 111.463 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -34.47 77.36 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.644 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.01 -38.53 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.847 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.4 mp -65.33 -48.02 74.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.81 0.338 . . . . 0.0 110.971 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.76 72.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.42 HG23 ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.193 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 169' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.479 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 17.9 Cg_endo -61.32 -36.78 77.3 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.007 1.138 . . . . 0.0 111.692 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mp -66.22 -44.95 82.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.87 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.4 -47.43 56.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.2 -37.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.515 0.674 . . . . 0.0 109.446 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.48 93.47 Favored Glycine 0 C--O 1.2 -2.013 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.755 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.3 OUTLIER -54.92 -35.65 64.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -34.49 77.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.421 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 1.02 HG22 HD11 ' A' ' 149' ' ' LEU . 16.7 t -73.16 -47.38 47.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.787 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.37 -30.73 67.73 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 122.528 1.156 . . . . 0.0 110.195 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.578 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.28 2.6 mm? -70.43 -50.88 33.87 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.874 2.274 . . . . 0.0 109.528 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.487 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.53 -36.92 65.36 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 110.559 -3.019 . . . . 0.0 107.114 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' HIS . . . . . 0.427 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.4 m-70 -69.08 -35.22 76.28 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.334 -1.433 . . . . 0.0 109.657 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.95 -48.34 81.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.234 -177.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.53 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.32 -52.07 11.69 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 178.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.567 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -69.79 -52.03 28.75 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.501 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 12.8 mt -60.16 -41.82 88.0 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.602 0 C-N-CA 118.731 -1.188 . . . . 0.0 113.244 -174.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -75.84 -35.68 59.87 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 115.911 -2.316 . . . . 0.0 112.564 -176.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.01 -29.68 68.65 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.385 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.283 0.1 OUTLIER -124.43 -26.8 3.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.063 -178.989 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.74 -5.97 84.15 Favored Glycine 0 CA--C 1.566 3.256 0 N-CA-C 106.046 -2.822 . . . . 0.0 106.046 -170.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.424 ' H ' HG23 ' A' ' 187' ' ' THR . 9.4 t -82.28 127.74 33.5 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 184' ' ' ILE . . . -47.83 164.37 0.23 Allowed Glycine 0 N--CA 1.408 -3.226 0 CA-C-N 111.146 -2.752 . . . . 0.0 112.497 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.567 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.6 OUTLIER -72.34 -33.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.2 p-10 -109.73 152.44 42.89 Favored Pre-proline 0 N--CA 1.415 -2.217 0 CA-C-N 112.544 -2.116 . . . . 0.0 109.288 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.08 -14.66 45.4 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.618 2.212 . . . . 0.0 111.686 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.547 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.39 -35.75 60.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.697 0.285 . . . . 0.0 110.498 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -41.16 72.94 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.336 0.589 . . . . 0.0 109.85 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -32.61 64.71 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.475 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.834 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.9 m-85 -72.27 -35.24 68.69 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.464 1.906 . . . . 0.0 113.948 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -44.44 93.9 Favored Glycine 0 C--N 1.318 -0.456 0 N-CA-C 106.971 -2.451 . . . . 0.0 106.971 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.53 -28.21 56.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.088 -1.056 . . . . 0.0 110.842 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.19 75.74 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 121.598 1.999 . . . . 0.0 110.929 -179.813 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.32 0 CA-C-O 121.788 0.804 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -58.92 -37.5 76.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.027 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -84.28 -33.53 23.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.6 p -80.49 -40.06 19.19 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.517 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.0 -48.23 68.52 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.976 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.8 Cg_endo -71.96 -38.97 3.53 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.046 2.497 . . . . 0.0 113.675 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.451 ' CD2' HD22 ' A' ' 81' ' ' LEU . 1.8 m-85 -63.25 -39.79 95.59 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.645 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.9 mm -70.31 -46.55 70.98 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.148 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.67 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.756 ' HA2' HG23 ' A' ' 143' ' ' ILE . . . -55.18 -45.64 81.71 Favored Glycine 0 C--N 1.364 2.128 0 O-C-N 128.529 3.643 . . . . 0.0 111.339 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -69.13 -41.41 80.58 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.19 -34.83 61.48 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.7 mt -67.69 -36.92 81.54 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.38 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -59.06 -39.58 82.53 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.277 -174.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 88.4 t -58.38 -49.7 81.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.638 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.61 0.719 . . . . 0.0 110.155 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt -57.14 -34.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.119 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 C--N 1.329 -0.292 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.437 -179.346 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.449 0.166 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.54 -0.5 13.03 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.814 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.54 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.3 -35.77 72.33 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.762 0 CA-C-N 112.506 -2.134 . . . . 0.0 109.932 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.15 -35.02 69.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.703 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -70.99 -46.72 61.8 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -177.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -34.23 73.48 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.05 -38.08 78.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.174 -2.284 . . . . 0.0 108.748 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -64.09 -46.82 82.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.355 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.91 -31.51 59.21 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.099 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.72 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.89 -38.18 67.05 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.548 -0.72 . . . . 0.0 112.091 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.515 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -76.9 -49.55 15.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 29' ' ' ILE . 97.7 t -65.33 -48.46 83.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.363 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' A' ' 112' ' ' LEU . 50.1 t80 -53.95 -48.51 70.2 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.6 -29.21 20.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.387 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -36.2 67.41 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.627 HG21 HD22 ' A' ' 112' ' ' LEU . 2.8 mm -63.06 -41.74 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.311 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.5 -38.83 71.89 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -37.97 84.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -176.819 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 C--O 1.226 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -49.87 -28.59 6.76 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.535 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG13 ' CE ' ' A' ' 51' ' ' LYS . 1.3 p -57.14 -39.02 64.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.53 ' CE ' HG13 ' A' ' 50' ' ' VAL . 4.6 mmtp -64.7 -54.08 37.26 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.728 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 94.5 t -67.75 -45.65 84.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.724 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 m -69.29 -39.18 78.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.785 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 62.5 tp -63.0 -31.68 72.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.45 -39.38 94.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.231 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -65.88 -43.36 88.51 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.745 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.69 -43.02 96.94 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.275 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 1.0 OUTLIER -68.2 -43.77 77.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.597 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -36.7 76.26 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.698 HD13 HD21 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -59.96 -34.13 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 113.228 -1.805 . . . . 0.0 108.13 -178.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.758 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -64.48 -45.76 85.96 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.174 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.41 ' H ' HG23 ' A' ' 62' ' ' THR . 8.3 p -70.12 -31.7 69.36 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.833 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -55.28 -40.78 71.44 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.96 -44.25 73.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.218 -1.81 . . . . 0.0 109.828 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 62' ' ' THR . 21.6 tp60 -66.8 -39.0 87.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -12.21 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 119.978 1.263 . . . . 0.0 111.329 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.81 -37.12 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.765 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.25 154.52 6.87 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -53.29 -22.91 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.934 0.397 . . . . 0.0 111.065 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 tt -74.34 7.08 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -124.3 135.59 53.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.129 0.49 . . . . 0.0 111.57 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.48 -159.37 24.95 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.57 85.9 1.17 Allowed 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 118.254 -1.378 . . . . 0.0 108.589 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.833 HD22 ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -82.41 8.44 11.46 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.122 -1.854 . . . . 0.0 112.235 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.522 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -136.95 140.09 30.59 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 119.333 0.97 . . . . 0.0 112.676 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 62.5 Cg_endo -83.67 -30.62 0.74 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 123.27 2.647 . . . . 0.0 112.563 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.713 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -60.12 -50.64 72.9 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.458 ' CG2' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -66.31 -36.69 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -30.89 70.71 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.478 HD22 ' CG ' ' A' ' 217' ' ' PHE . 13.7 tp -57.93 -38.0 75.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.242 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.32 -44.57 93.4 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -21.89 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.643 0.259 . . . . 0.0 111.326 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.01 -179.677 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 . . . . . 0 N--CA 1.46 0.054 0 CA-C-O 121.064 0.459 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.85 -35.0 77.79 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.212 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.58 -38.49 66.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.5 ttt -70.63 -38.76 73.92 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.542 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -62.59 -37.59 86.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.332 0.969 . . . . 0.0 109.67 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -58.09 -47.22 87.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.368 -178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.434 ' N ' HG22 ' A' ' 98' ' ' ILE . 4.3 tp -70.35 -37.8 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . . . -64.94 -47.43 77.68 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.529 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -35.18 70.58 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -35.88 71.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.76 -35.41 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.124 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.58 90.74 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 120.815 1.643 . . . . 0.0 113.437 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.464 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.85 -35.98 75.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.37 -42.7 87.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.689 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.86 -37.23 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.311 0.577 . . . . 0.0 109.567 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.72 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.59 -43.38 84.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.105 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -37.03 74.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.394 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.76 -41.19 85.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.012 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.55 -48.22 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.26 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.627 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -58.8 -24.43 61.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.0 t -62.03 -44.28 97.03 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.962 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.31 -36.28 62.4 Favored Glycine 0 CA--C 1.51 -0.234 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -32.39 36.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.366 -0.917 . . . . 0.0 110.742 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.1 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.182 -179.565 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -112.63 122.78 48.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.061 0.458 . . . . 0.0 111.741 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.03 20.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.671 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -108.77 99.66 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 135' ' ' SER . 3.4 mm? -63.21 147.6 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.441 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.88 139.86 40.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.864 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -50.09 127.57 17.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 130.41 -105.11 0.63 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.848 HG22 ' HB3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.01 131.0 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.447 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 3.7 t30 -71.74 -171.86 0.73 Allowed 'General case' 0 C--O 1.201 -1.482 0 N-CA-C 103.125 -2.917 . . . . 0.0 103.125 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.489 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -64.1 -46.74 82.9 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 114.648 -2.821 . . . . 0.0 109.788 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.704 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -58.72 -41.51 95.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.976 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.848 ' HB3' HG22 ' A' ' 133' ' ' VAL . 1.8 mm100 -53.46 -23.24 9.55 Favored 'General case' 0 C--N 1.247 -3.863 0 CA-C-O 121.375 0.607 . . . . 0.0 110.715 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -68.78 -1.4 24.07 Favored Glycine 0 C--O 1.192 -2.521 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 tp -66.58 -50.04 64.4 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.29 1.045 . . . . 0.0 110.902 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.415 ' HA2' HD12 ' A' ' 143' ' ' ILE . . . -69.62 -36.15 75.63 Favored Glycine 0 N--CA 1.455 -0.064 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.794 ' CD1' HG21 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -70.52 -36.29 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 113.407 -1.396 . . . . 0.0 111.633 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 138' ' ' GLY . 8.0 mt-10 -68.5 -36.46 78.94 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.06 0.933 . . . . 0.0 110.878 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 219' ' ' GLY . 40.8 mt -68.82 -52.54 33.9 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 113.977 -1.465 . . . . 0.0 110.743 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 145' ' ' GLY . 6.1 tp -68.17 -45.05 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 121.931 0.872 . . . . 0.0 111.472 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 144' ' ' ILE . . . -60.7 -52.03 54.99 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.805 -1.543 . . . . 0.0 113.193 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.505 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 20.2 m -70.87 -40.51 72.23 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.93 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.773 HD12 ' O ' ' A' ' 219' ' ' GLY . 0.7 OUTLIER -54.79 -40.01 69.03 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -176.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -57.84 -30.02 65.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.726 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.03 HD11 HG22 ' A' ' 176' ' ' VAL . 1.1 tp -68.82 -51.18 43.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.255 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.445 HG21 ' HA3' ' A' ' 220' ' ' GLY . 70.1 t -60.09 -41.03 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.989 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.25 -35.52 80.63 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -34.42 77.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.458 HG21 ' CG2' ' A' ' 79' ' ' VAL . 2.1 t -72.08 -38.32 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.532 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -41.03 96.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 110.809 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.76 -31.61 72.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.172 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.662 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.47 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.2 Cg_exo -54.53 -46.5 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.377 1.385 . . . . 0.0 111.532 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.12 -35.91 74.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -44.12 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.947 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.569 HD11 ' OG1' ' A' ' 156' ' ' THR . 79.4 mt -58.26 -38.09 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.59 -37.45 93.64 Favored Glycine 0 C--O 1.196 -2.229 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.19 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mp -55.05 -35.66 64.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.65 77.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.3 175.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 1.03 HG22 HD11 ' A' ' 149' ' ' LEU . 27.0 t -73.08 -47.54 47.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.785 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.08 -31.89 69.69 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.363 1.078 . . . . 0.0 109.859 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.268 1.8 tt -70.52 -49.73 45.15 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 124.503 2.097 . . . . 0.0 110.56 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.02 65.55 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 111.114 -2.767 . . . . 0.0 107.487 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' HIS . . . . . 0.433 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.6 m-70 -70.18 -35.3 73.87 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.537 -1.831 . . . . 0.0 109.403 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.15 -48.11 81.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.112 -177.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.07 -52.55 10.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.782 ' HB3' HG23 ' A' ' 191' ' ' ILE . . . -70.41 -52.24 23.76 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.557 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 9.3 mt -55.34 -40.23 56.09 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.805 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 35.0 t70 -77.56 -35.7 52.89 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.194 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -59.91 -30.42 69.03 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.459 -1.296 . . . . 0.0 110.945 -171.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 189' ' ' CYS 0.272 0.1 OUTLIER -124.37 -26.61 3.89 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.083 -178.754 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.9 -6.11 83.94 Favored Glycine 0 CA--C 1.564 3.103 0 N-CA-C 106.208 -2.757 . . . . 0.0 106.208 -170.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.465 ' H ' HG23 ' A' ' 187' ' ' THR . 13.1 t -86.63 132.24 33.94 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.658 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.0 161.72 7.75 Favored Glycine 1 N--CA 1.392 -4.235 0 CA-C-N 111.285 -2.689 . . . . 0.0 111.031 178.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.782 HG23 ' HB3' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -72.29 -40.83 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 174.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 17.0 p-10 -83.44 134.3 45.58 Favored Pre-proline 0 N--CA 1.416 -2.139 0 CA-C-N 112.693 -2.048 . . . . 0.0 108.038 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -58.37 -14.58 20.88 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.361 2.041 . . . . 0.0 111.642 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . . . -75.04 -33.81 61.79 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 123.269 0.356 . . . . 0.0 111.653 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.658 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.49 -37.94 74.29 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.471 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -33.48 65.47 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.489 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.841 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.1 m-85 -72.4 -35.08 68.32 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 126.41 1.884 . . . . 0.0 114.452 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.79 -44.48 94.2 Favored Glycine 0 C--N 1.318 -0.453 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.1 p -76.44 -28.31 56.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.131 -1.035 . . . . 0.0 110.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.07 75.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 121.268 1.849 . . . . 0.0 110.3 179.699 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.704 HG21 ' HA2' ' A' ' 136' ' ' GLY . 28.9 mm . . . . . 0 CA--C 1.512 -0.505 0 CA-C-O 121.778 0.799 . . . . 0.0 109.067 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.49 -35.29 72.0 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.016 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.35 -48.18 9.96 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 215' ' ' GLY . 9.6 p -70.0 -47.87 66.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.321 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.489 ' N ' HG13 ' A' ' 214' ' ' VAL . . . -55.68 -48.9 68.45 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 112.709 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 215' ' ' GLY . 49.5 Cg_endo -72.11 -31.1 12.59 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.757 1.638 . . . . 0.0 113.72 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.478 ' CG ' HD22 ' A' ' 81' ' ' LEU . 1.7 m-85 -66.26 -37.37 85.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 0.0 111.29 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.625 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 13.2 mt -70.37 -46.68 70.11 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.084 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.449 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.773 ' O ' HD12 ' A' ' 147' ' ' LEU . . . -55.42 -46.93 78.8 Favored Glycine 0 C--N 1.363 2.077 0 O-C-N 128.495 3.622 . . . . 0.0 110.996 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -68.41 -40.77 86.7 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.32 -34.8 61.79 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.4 mt -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.203 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -59.01 -39.74 82.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.251 -174.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.45 -49.73 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.885 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -39.53 94.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.709 0.766 . . . . 0.0 109.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mt -55.2 -34.69 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.426 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.546 0.213 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.1 1.35 17.28 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.502 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.51 -40.16 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 2.8 t -68.26 -35.91 73.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.629 0 CA-C-N 112.47 -2.15 . . . . 0.0 110.02 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.04 69.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.621 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -70.71 -46.69 62.63 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -177.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -33.88 73.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 11.1 mt -58.71 -38.17 77.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.107 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.44 -46.79 78.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 112.97 -1.923 . . . . 0.0 114.755 -176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.66 -31.42 59.77 Favored 'General case' 0 C--O 1.208 -1.128 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.525 -177.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -70.89 -34.98 72.13 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.995 -179.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -45.34 82.63 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.13 -44.71 29.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 29' ' ' ILE . 76.3 t -65.03 -53.72 37.91 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.46 -175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -53.7 -48.11 69.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -75.68 -29.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.504 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -36.51 69.11 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.835 HG21 HD22 ' A' ' 112' ' ' LEU . 3.6 mm -58.78 -44.49 90.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 113.661 -1.609 . . . . 0.0 109.223 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -36.76 65.7 Favored Glycine 0 C--O 1.226 -0.369 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -67.4 -44.37 79.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -176.35 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.225 -0.186 0 CA-C-O 121.3 0.571 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.72 -28.32 5.92 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.884 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.777 HG22 HD21 ' A' ' 181' ' ' LEU . 3.6 t -57.29 -32.29 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -53.96 37.65 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.703 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 12.6 t -68.15 -37.34 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.451 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 181' ' ' LEU . 3.2 m -68.58 -41.15 80.08 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.985 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.7 OUTLIER -65.55 -31.43 72.47 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.655 -1.612 . . . . 0.0 106.916 176.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -62.92 -39.86 95.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.458 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 24' ' ' PHE . 3.6 t80 -66.03 -43.22 88.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.763 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.62 -46.52 92.0 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.074 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.651 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 6.5 mp -68.6 -43.81 75.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.525 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 t -59.84 -36.69 77.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.587 ' CD1' HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -60.3 -34.37 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.663 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -61.66 -45.55 93.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.363 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.417 ' H ' HG23 ' A' ' 62' ' ' THR . 8.9 p -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -54.79 -42.91 72.35 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.04 -44.33 72.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.97 -1.923 . . . . 0.0 110.914 174.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -67.02 -45.97 75.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.5 p -59.14 -12.37 5.01 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.932 1.242 . . . . 0.0 112.387 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.02 -42.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 0.0 111.29 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.24 159.16 8.08 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -57.41 -23.13 47.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.783 0.325 . . . . 0.0 111.43 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.76 7.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.46 135.66 53.41 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.618 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.12 -154.2 24.41 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.52 85.87 1.16 Allowed 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.183 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.97 -19.64 62.52 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.687 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.1 pp -80.46 -17.64 51.09 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.42 -1.718 . . . . 0.0 112.497 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -111.05 135.95 20.84 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 97.0 Cg_endo -83.58 -22.87 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 123.441 2.761 . . . . 0.0 111.676 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.8 -47.43 78.11 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.622 HG23 HD23 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -66.22 -36.84 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.753 0.311 . . . . 0.0 111.158 177.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 m -65.68 -28.63 69.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -43.82 82.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.92 0.39 . . . . 0.0 110.175 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.95 -39.64 97.82 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 tp -53.47 -57.54 10.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.088 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 . . . . . 0 CA--C 1.526 0.026 0 CA-C-O 120.807 0.337 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.14 78.2 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.09 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.69 -38.49 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -40.01 68.05 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.84 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -61.16 -37.63 83.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.357 0.98 . . . . 0.0 109.443 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.29 -44.38 88.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.903 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.3 mt -70.59 -37.78 71.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . . . -66.81 -47.2 72.81 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.56 -35.7 70.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -35.96 71.93 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.8 -35.47 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.153 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.68 -44.32 91.36 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 121.102 1.774 . . . . 0.0 113.38 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.404 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.74 -36.19 75.61 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.79 -42.59 86.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.821 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.9 -37.41 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.219 0.533 . . . . 0.0 110.068 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.58 -49.78 75.29 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.318 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -67.75 -37.03 81.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.801 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.73 85.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.659 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.1 tt -69.18 -37.19 75.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.11 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.835 HD22 HG21 ' A' ' 29' ' ' ILE . 2.1 tt -66.0 -24.09 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.87 0.367 . . . . 0.0 111.511 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 m -60.43 -44.21 96.01 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.503 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.37 61.26 Favored Glycine 0 CA--C 1.511 -0.215 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.95 32.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.849 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 -179.465 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.62 124.34 52.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.608 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.6 m120 51.85 23.31 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.275 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.3 95.14 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.716 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 187' ' ' THR . 3.3 mm? -65.45 144.51 57.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.318 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.02 140.03 40.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.649 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -49.63 127.5 15.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.26 -105.48 0.6 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.1 t -85.94 126.82 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.45 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.58 -171.94 0.72 Allowed 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 176.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.48 ' N ' HD11 ' A' ' 129' ' ' LEU . 1.4 m -62.39 -46.76 87.14 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 114.669 -2.812 . . . . 0.0 110.306 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.16 96.47 Favored Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.267 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.799 ' HB3' HG22 ' A' ' 133' ' ' VAL . 4.0 mt-30 -53.24 -23.42 8.73 Favored 'General case' 0 C--N 1.249 -3.778 0 CA-C-N 114.792 -0.704 . . . . 0.0 110.503 -176.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.87 -1.76 13.69 Favored Glycine 0 C--O 1.188 -2.736 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.9 -50.47 64.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 119.123 1.461 . . . . 0.0 110.743 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.87 -40.16 74.97 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.682 HD13 HG21 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -68.85 -36.34 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 113.209 -1.495 . . . . 0.0 112.267 -177.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 77.1 mt-10 -68.54 -36.21 78.5 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-O 121.736 0.779 . . . . 0.0 110.569 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.71 HG23 ' CA ' ' A' ' 219' ' ' GLY . 38.3 mt -70.06 -41.9 79.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.437 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.2 mm -68.53 -48.84 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 122.389 1.09 . . . . 0.0 111.198 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.55 -46.9 93.21 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-N 112.841 -1.981 . . . . 0.0 112.966 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 191' ' ' ILE . 76.2 m -70.93 -47.64 57.91 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 113.77 -1.215 . . . . 0.0 112.47 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 8.2 tp -54.47 -40.45 68.46 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.252 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.6 pt20 -57.97 -31.28 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.82 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.82 HD11 HG22 ' A' ' 176' ' ' VAL . 2.8 tp -68.89 -52.21 31.92 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.451 HG21 ' HA3' ' A' ' 220' ' ' GLY . 54.3 t -60.14 -41.02 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -35.55 81.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 111.349 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -41.11 93.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.851 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 m -72.05 -38.37 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.52 -48.08 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.985 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.68 71.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.662 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.464 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . . . . . . 0 C--O 1.218 -0.571 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 35.3 Cg_exo -54.35 -44.3 50.69 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.738 1.625 . . . . 0.0 112.223 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 mp -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.302 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.33 56.59 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.006 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.5 pt -58.93 -35.96 59.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.61 93.6 Favored Glycine 0 C--O 1.198 -2.107 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.495 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.15 -36.37 65.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 -34.47 77.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.603 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.82 HG22 HD11 ' A' ' 149' ' ' LEU . 89.2 t -72.89 -47.24 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.763 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . . . -65.02 -41.82 94.97 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 122.054 0.93 . . . . 0.0 108.727 -176.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.257 3.6 mt -58.29 -47.12 84.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.937 178.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.9 66.19 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.088 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' HIS . . . . . 0.666 ' HA ' HD13 ' A' ' 184' ' ' ILE . 1.1 t60 -67.84 -34.79 77.39 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 112.926 -1.637 . . . . 0.0 109.789 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.777 HD21 HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -64.66 -47.64 77.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.389 -176.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.444 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -74.96 -51.64 13.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.955 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -69.54 -51.24 37.39 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 180' ' ' HIS . 1.7 mp -66.78 -49.27 75.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.869 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -65.63 -35.73 81.66 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 115.377 -2.529 . . . . 0.0 112.367 -176.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.88 -31.28 69.64 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.524 -170.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.524 ' O ' HD13 ' A' ' 129' ' ' LEU 0.301 0.1 OUTLIER -124.32 -26.87 3.87 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.387 1.089 . . . . 0.0 113.332 -179.032 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 86.75 -5.78 84.17 Favored Glycine 0 CA--C 1.566 3.264 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.4 ' H ' HG23 ' A' ' 187' ' ' THR . 59.9 m -83.64 132.29 34.9 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -54.33 155.59 7.61 Favored Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.869 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.955 HG22 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.62 -32.99 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 174.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.681 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 6.2 p-10 -92.74 139.68 23.54 Favored Pre-proline 0 N--CA 1.42 -1.967 0 CA-C-N 113.321 -1.763 . . . . 0.0 107.234 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -64.47 -14.55 44.91 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.64 1.56 . . . . 0.0 111.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.484 ' HB3' HD22 ' A' ' 192' ' ' ASN . . . -75.14 -33.88 61.59 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.248 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.645 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.37 -39.11 78.24 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.0 t -73.18 -34.28 65.91 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.816 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.818 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 3.8 t80 -72.22 -35.4 68.87 Favored 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 126.315 1.846 . . . . 0.0 114.506 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.73 -46.19 92.54 Favored Glycine 0 C--N 1.319 -0.376 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.43 -28.29 56.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.281 -0.959 . . . . 0.0 110.379 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.818 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.65 -33.89 77.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.607 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 120.939 1.699 . . . . 0.0 110.589 179.518 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 9.5 mm . . . . . 0 CA--C 1.512 -0.485 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -25.09 61.59 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.298 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -84.64 -42.35 15.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.0 p -78.02 -45.47 27.38 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.23 -44.87 84.27 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.531 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.3 Cg_endo -71.49 -28.68 17.46 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.491 2.128 . . . . 0.0 113.084 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -77.2 -31.99 55.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.195 0.521 . . . . 0.0 111.893 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.0 mm -70.7 -46.37 69.52 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.34 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.303 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.71 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.11 -46.78 63.25 Favored Glycine 0 C--N 1.357 1.733 0 O-C-N 128.5 3.625 . . . . 0.0 111.838 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.34 -48.91 35.05 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 118.067 -2.016 . . . . 0.0 109.835 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.78 68.45 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.554 0.692 . . . . 0.0 109.562 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -68.13 -30.98 70.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.292 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.97 -39.8 82.83 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.8 t -58.06 -49.59 80.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.267 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -39.54 93.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.799 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -34.74 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.818 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.419 0.152 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.4 -14.31 5.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.452 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -39.89 87.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 5.9 p -68.66 -36.07 72.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.592 176.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.69 -35.35 70.49 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.694 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 3.6 mt-10 -70.95 -46.48 62.34 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -33.79 74.34 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 8.0 mt -58.77 -38.16 77.88 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.884 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.68 -46.51 78.8 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.567 -2.106 . . . . 0.0 114.581 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.612 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -74.81 -31.63 61.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.208 -177.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.2 -38.39 69.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.783 -178.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -45.01 84.21 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -77.11 -52.52 9.14 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 21' ' ' THR . 1.5 m -65.64 -40.3 87.54 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 O-C-N 124.031 0.832 . . . . 0.0 112.802 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.41 ' O ' HG12 ' A' ' 29' ' ' ILE . 49.3 t80 -54.18 -50.35 67.24 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.539 0.685 . . . . 0.0 111.908 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -29.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.531 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.24 -36.24 68.28 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -175.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.56 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -59.7 -40.05 81.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.086 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -36.88 64.69 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.8 m -67.5 -38.87 84.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -176.729 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB3' HG12 ' A' ' 50' ' ' VAL . 23.1 t0 . . . . . 0 C--O 1.224 -0.288 0 CA-C-O 121.283 0.563 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -49.73 -28.78 6.57 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.801 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.55 HG13 ' CE ' ' A' ' 51' ' ' LYS . 1.5 p -57.28 -38.37 61.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.726 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.55 ' CE ' HG13 ' A' ' 50' ' ' VAL . 4.5 mmtp -64.8 -53.56 45.09 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.699 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 70.6 t -66.77 -50.06 68.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.416 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -66.53 -39.07 88.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.358 0.412 . . . . 0.0 110.004 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.824 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 55.3 tp -62.85 -31.92 73.03 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.91 -39.46 94.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.265 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.521 ' O ' HD13 ' A' ' 60' ' ' ILE . 8.3 m-30 -66.12 -42.44 89.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.42 -43.3 96.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.08 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.664 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -67.33 -43.66 81.03 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.547 -178.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -36.58 74.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.633 HG13 HD21 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -59.98 -34.1 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.369 -178.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.757 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.235 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 65' ' ' GLN . 11.7 p -68.96 -31.7 70.75 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.607 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.46 -40.58 71.78 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.94 -44.16 73.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.151 -1.841 . . . . 0.0 109.468 173.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 62' ' ' THR . 26.0 tt0 -66.78 -38.47 86.62 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.8 m -59.61 -12.13 6.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 120.058 1.299 . . . . 0.0 111.415 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -42.83 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.697 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.06 168.4 12.83 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -66.0 -23.09 66.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 70' ' ' ILE . 2.1 mp -75.95 7.13 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.79 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 m -124.43 135.64 53.42 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.139 0.495 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -151.84 20.45 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.27 85.89 1.08 Allowed 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.441 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.39 61.91 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.633 HD21 HG13 ' A' ' 60' ' ' ILE . 2.1 pp -87.05 8.53 23.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.375 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.614 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -133.04 129.08 20.88 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -177.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.589 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 91.1 Cg_endo -83.64 -20.49 4.66 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.773 2.315 . . . . 0.0 111.397 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.627 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -66.16 -50.94 62.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.529 HG23 HD23 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -66.7 -36.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.678 0.275 . . . . 0.0 111.57 177.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.0 m -64.91 -28.62 69.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -35.4 76.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.376 . . . . 0.0 110.55 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.53 -37.07 84.89 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.671 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -44.41 96.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.456 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.405 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.227 -0.087 0 CA-C-O 120.726 0.298 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.405 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . . . -63.78 -35.14 79.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.451 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.91 -38.53 67.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 ttt -73.27 -35.1 66.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.945 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -64.96 -37.53 87.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 119.523 1.056 . . . . 0.0 109.135 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -58.12 -46.53 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.656 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.431 ' N ' HG22 ' A' ' 98' ' ' ILE . 2.0 mm -67.7 -37.84 79.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.678 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.01 -47.06 86.49 Favored 'General case' 0 C--O 1.206 -1.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -71.24 -36.05 71.68 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.424 ' O ' HG13 ' A' ' 106' ' ' ILE . 3.8 t -57.87 -36.16 71.97 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.38 -35.19 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.645 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.51 -47.78 81.27 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.733 1.606 . . . . 0.0 112.586 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.88 -36.16 75.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 102' ' ' CYS . 79.3 mt -63.92 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.048 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.14 -37.42 71.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.425 0.631 . . . . 0.0 110.038 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.53 -49.95 74.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.301 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.798 HG21 ' O ' ' A' ' 198' ' ' GLY . 1.8 t -70.3 -36.94 74.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.2 -43.75 87.77 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.013 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.2 mm -69.24 -37.33 75.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.243 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 29' ' ' ILE . 3.0 tt -66.85 -24.49 66.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.512 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.2 t -62.76 -34.96 78.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.248 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.09 -36.16 60.81 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.446 HD12 ' HG ' ' A' ' 112' ' ' LEU . 4.2 mt -57.28 -40.83 76.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.624 -0.788 . . . . 0.0 110.538 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.795 -179.03 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.86 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -112.6 120.11 40.46 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.925 0.393 . . . . 0.0 111.295 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 t30 51.83 23.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.25 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.88 84.7 2.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.419 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 187' ' ' THR . 3.4 mm? -66.65 144.9 56.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.489 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.91 139.65 40.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.136 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.77 127.67 18.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.3 -103.19 0.58 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 137' ' ' GLN . 2.0 t -86.0 122.38 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.56 -171.8 0.69 Allowed 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.466 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.68 -46.81 88.11 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 114.919 -2.712 . . . . 0.0 110.152 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.83 -41.67 96.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.157 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.726 ' HB3' HG22 ' A' ' 133' ' ' VAL . 24.0 mm100 -53.17 -23.43 8.36 Favored 'General case' 0 C--N 1.252 -3.661 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.232 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.55 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.05 -1.69 10.59 Favored Glycine 0 C--O 1.187 -2.796 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -50.5 65.54 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 119.17 1.485 . . . . 0.0 111.004 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.75 -40.13 76.21 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -67.43 -38.19 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 113.051 -1.575 . . . . 0.0 112.13 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 138' ' ' GLY . 24.0 mt-10 -68.61 -36.53 78.8 Favored 'General case' 0 C--O 1.196 -1.728 0 CA-C-O 121.987 0.899 . . . . 0.0 110.872 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.681 HG23 ' CA ' ' A' ' 219' ' ' GLY . 30.5 mt -68.35 -43.62 84.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.421 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.154 -174.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -68.4 -49.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 122.264 1.031 . . . . 0.0 111.671 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.51 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -59.26 -48.38 86.26 Favored Glycine 0 C--O 1.218 -0.866 0 CA-C-N 113.087 -1.869 . . . . 0.0 113.038 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.526 HG21 ' CB ' ' A' ' 216' ' ' PRO . 24.8 m -70.79 -45.29 64.93 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 113.97 -1.115 . . . . 0.0 112.175 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.636 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 6.0 tp -54.51 -40.59 68.73 Favored 'General case' 0 CA--C 1.487 -1.464 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.22 -175.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.0 pt20 -59.33 -30.85 68.66 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.03 HD11 HG22 ' A' ' 176' ' ' VAL . 2.1 tp -68.88 -51.22 42.52 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.261 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.483 HG21 ' HA3' ' A' ' 220' ' ' GLY . 20.4 t -60.83 -41.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.976 . . . . 0.0 113.28 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.18 -35.65 81.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.563 0.22 . . . . 0.0 111.512 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.21 -35.04 78.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.038 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.19 -38.44 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.591 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tt -64.04 -43.57 95.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.78 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.69 -31.54 72.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.561 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.699 ' OG1' HD11 ' A' ' 172' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.402 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.647 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.0 Cg_exo -54.57 -46.48 33.11 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.57 1.514 . . . . 0.0 111.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.9 -36.14 78.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.271 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -45.02 63.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.275 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.699 HD11 ' OG1' ' A' ' 156' ' ' THR . 21.9 mt -58.26 -38.42 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.52 93.62 Favored Glycine 0 C--O 1.195 -2.293 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.164 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.3 OUTLIER -55.21 -35.56 65.01 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -34.24 76.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.928 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 1.03 HG22 HD11 ' A' ' 149' ' ' LEU . 20.6 t -72.59 -47.31 51.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.824 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.26 -29.9 66.8 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.577 1.179 . . . . 0.0 110.182 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 174' ' ' LEU 0.267 9.3 mt -70.65 -49.18 50.19 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 124.711 2.196 . . . . 0.0 109.515 178.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.85 66.07 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 110.328 -3.124 . . . . 0.0 107.822 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' HIS . . . . . 0.529 ' HB3' HD12 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -70.39 -35.22 73.34 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.041 -1.579 . . . . 0.0 109.727 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.72 -48.21 81.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.139 -177.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.51 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.54 -52.25 11.06 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 1.068 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -69.97 -51.68 30.56 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.529 HD12 ' HB3' ' A' ' 180' ' ' HIS . 7.4 mt -60.58 -49.11 85.71 Favored 'Isoleucine or valine' 0 C--O 1.175 -2.862 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.538 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -69.15 -35.67 76.59 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 116.741 -1.983 . . . . 0.0 113.502 -176.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.02 -29.16 68.31 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.652 -171.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 129' ' ' LEU 0.285 0.1 OUTLIER -124.32 -26.65 3.91 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.181 0.991 . . . . 0.0 113.076 -179.167 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.56 -5.9 84.26 Favored Glycine 0 CA--C 1.565 3.163 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 -170.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.452 ' H ' HG23 ' A' ' 187' ' ' THR . 92.1 m -88.08 130.74 34.91 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.478 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -56.22 154.71 14.71 Favored Glycine 0 N--CA 1.397 -3.924 0 CA-C-N 111.174 -2.739 . . . . 0.0 112.538 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.068 HG22 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.35 -27.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.627 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -90.49 135.11 29.79 Favored Pre-proline 0 N--CA 1.414 -2.25 0 CA-C-N 112.74 -2.027 . . . . 0.0 108.25 177.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.534 ' CD ' ' HB2' ' A' ' 78' ' ' ALA . 6.3 Cg_exo -66.09 -17.36 54.86 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.986 1.791 . . . . 0.0 110.587 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.589 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.26 -35.37 61.39 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.478 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 29.3 tpt85 -70.62 -40.2 73.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.523 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.3 m -73.23 -38.19 66.13 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.82 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 12.4 t80 -72.25 -34.88 68.58 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 126.945 2.098 . . . . 0.0 114.596 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.798 ' O ' HG21 ' A' ' 109' ' ' THR . . . -57.62 -47.12 90.61 Favored Glycine 0 C--N 1.315 -0.592 0 N-CA-C 107.069 -2.412 . . . . 0.0 107.069 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -28.21 56.65 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.565 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.82 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.23 -34.1 77.32 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.412 -0.804 . . . . 0.0 112.843 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.318 -0.785 0 CA-C-N 120.971 1.714 . . . . 0.0 110.803 179.73 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 121.728 0.775 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . 0.444 ' N ' ' CD2' ' A' ' 212' ' ' PHE . 6.3 m-30 -58.27 -41.51 84.46 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.381 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.14 -33.64 24.22 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 215' ' ' GLY . 11.7 p -73.8 -47.73 42.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.486 ' N ' HG13 ' A' ' 214' ' ' VAL . . . -55.15 -48.52 67.76 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.111 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.526 ' CB ' HG21 ' A' ' 146' ' ' THR . 17.3 Cg_endo -71.61 -28.67 17.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.145 1.896 . . . . 0.0 113.744 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -73.48 -30.65 63.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.304 0.574 . . . . 0.0 111.268 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 46.3 mt -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.483 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.376 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.681 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -66.57 -46.25 78.17 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 128.473 3.608 . . . . 0.0 111.896 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.547 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.42 -48.89 34.6 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 118.562 -1.78 . . . . 0.0 110.112 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -39.02 68.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.671 0.748 . . . . 0.0 109.513 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -68.03 -31.07 70.49 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.348 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.636 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.89 -39.51 81.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.11 -49.59 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.962 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.06 -39.44 89.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.693 0.758 . . . . 0.0 109.532 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 222' ' ' LEU . 1.2 mp -57.39 -34.61 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.703 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.77 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.369 0.128 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.72 -8.54 12.64 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.295 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.76 -40.31 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.55 -35.83 72.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 CA-C-N 112.807 -1.997 . . . . 0.0 110.696 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.51 -35.1 69.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 14.9 mt-10 -70.82 -46.6 62.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.17 -33.72 70.28 Favored 'General case' 0 C--O 1.212 -0.912 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.73 -38.29 78.03 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 112.284 -2.234 . . . . 0.0 109.461 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.01 -46.63 80.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.232 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.707 ' CG2' ' HB2' ' A' ' 105' ' ' ALA . 0.7 OUTLIER -74.34 -31.14 62.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.61 -177.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.702 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.28 -40.82 67.3 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.149 -178.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 27' ' ' ILE . 1.8 mt -65.94 -45.04 83.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -52.59 9.1 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.66 -43.96 93.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.185 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.445 ' O ' HG12 ' A' ' 29' ' ' ILE . 53.0 t80 -54.13 -50.23 67.39 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.927 0.785 . . . . 0.0 112.135 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.73 -29.16 20.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.705 179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.4 -36.33 68.79 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -175.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.676 HG21 HD22 ' A' ' 112' ' ' LEU . 4.2 mm -58.91 -39.94 79.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.544 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.68 63.74 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -67.35 -38.06 84.22 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.68 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -176.868 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t70 . . . . . 0 C--O 1.225 -0.204 0 CA-C-O 121.126 0.488 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.54 -28.73 14.61 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' HD3' ' A' ' 51' ' ' LYS . 3.4 p -61.04 -33.45 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HD3' HG13 ' A' ' 50' ' ' VAL . 25.1 mmtt -64.94 -54.12 35.68 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.601 1.091 . . . . 0.0 112.978 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.735 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 8.8 p -68.18 -40.56 83.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.599 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.438 ' N ' HG13 ' A' ' 52' ' ' VAL . 72.6 m -69.31 -40.51 77.61 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.726 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.6 OUTLIER -62.85 -31.81 72.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.21 -39.52 94.14 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.969 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.542 ' O ' HD13 ' A' ' 60' ' ' ILE . 3.1 m-85 -66.01 -46.97 76.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.741 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.55 -45.84 93.74 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.278 -0.419 . . . . 0.0 114.005 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.652 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 1.4 tp -66.32 -43.83 85.12 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.107 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -58.74 -36.74 74.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -60.15 -34.0 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.496 -178.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.76 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.7 -45.59 82.2 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.506 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -68.94 -32.07 71.42 Favored 'General case' 0 CA--C 1.469 -2.165 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.998 HD13 HD12 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.61 -40.44 72.11 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.87 -44.11 73.98 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.453 173.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -38.31 86.31 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -59.63 -12.29 6.5 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 119.889 1.222 . . . . 0.0 111.579 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -42.87 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 0.0 111.428 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.12 178.9 21.06 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -22.96 62.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.832 0.348 . . . . 0.0 111.133 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -72.69 7.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.306 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.6 m -124.32 135.51 53.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.279 0.561 . . . . 0.0 111.623 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.13 -140.62 8.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HB3' HG21 ' A' ' 79' ' ' VAL . . . -72.53 85.88 1.16 Allowed 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.368 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -19.63 59.1 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.998 HD12 HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -89.74 8.35 32.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.089 179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 59.3 m-20 -148.26 144.15 18.38 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 121.145 1.793 . . . . 0.0 114.222 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 98.6 Cg_endo -83.51 -21.89 4.09 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 124.035 3.157 . . . . 0.0 112.943 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.732 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -59.22 -45.8 90.16 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 73' ' ' ALA . 26.3 m -66.46 -38.16 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.4 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.701 HG21 ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -61.66 -29.96 70.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mt -60.23 -36.05 76.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.8 -48.92 31.75 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.737 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -14.79 62.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.582 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.855 0.359 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -65.41 -35.18 80.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.87 -38.73 67.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 tpp -73.33 -31.64 64.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.043 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.701 ' CD2' HG21 ' A' ' 80' ' ' THR . 8.1 t80 -65.01 -44.24 89.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 118.777 0.717 . . . . 0.0 111.142 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -66.71 -41.22 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.5 mt -70.38 -42.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.28 69.07 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -35.81 70.67 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.7 t -57.99 -36.14 72.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 107' ' ' VAL . 2.8 t -71.3 -35.25 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.314 175.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.39 -47.54 82.2 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 120.908 1.685 . . . . 0.0 112.833 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.707 ' HB2' ' CG2' ' A' ' 21' ' ' THR . . . -69.92 -35.98 74.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 mm -66.05 -50.34 70.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 103' ' ' VAL . 34.5 m -62.32 -36.97 77.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.148 0.499 . . . . 0.0 109.757 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.24 -49.68 75.26 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.556 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -64.68 -37.0 86.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.643 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.65 85.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.124 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.99 -37.33 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.681 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -65.75 -24.61 67.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.645 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -61.04 -38.98 88.06 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.423 -178.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.0 -36.17 60.33 Favored Glycine 0 CA--C 1.511 -0.199 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 HD12 ' HG ' ' A' ' 112' ' ' LEU . 4.4 mt -54.14 -36.87 33.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.703 -0.749 . . . . 0.0 111.057 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 113' ' ' SER . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.555 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.604 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -112.6 124.38 52.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.024 0.44 . . . . 0.0 111.337 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 51.97 20.6 1.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.405 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -112.37 92.21 3.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 135' ' ' SER . 3.3 mm? -63.12 148.42 47.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.057 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -104.33 138.64 40.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.585 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -49.59 127.6 15.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.71 -105.18 0.66 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.829 HG22 ' HB3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.16 131.92 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.451 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 -171.98 0.76 Allowed 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 176.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.464 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -64.61 -46.73 81.39 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 114.52 -2.872 . . . . 0.0 109.883 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.656 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -58.93 -41.46 96.28 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.285 -0.96 . . . . 0.0 110.954 -175.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.829 ' HB3' HG22 ' A' ' 133' ' ' VAL . 7.3 mm-40 -53.45 -23.41 9.98 Favored 'General case' 0 C--N 1.248 -3.838 0 CA-C-O 121.443 0.64 . . . . 0.0 110.61 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -69.61 -1.56 30.91 Favored Glycine 0 C--O 1.185 -2.913 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.54 -50.23 63.85 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 118.394 1.097 . . . . 0.0 111.146 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.53 -35.71 75.52 Favored Glycine 0 C--O 1.229 -0.163 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.8 ' CD1' HG21 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -71.54 -36.04 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 113.239 -1.48 . . . . 0.0 111.845 -178.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' GLY . 7.9 mt-10 -68.42 -36.38 78.98 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 122.047 0.927 . . . . 0.0 110.863 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.657 HG23 ' CA ' ' A' ' 219' ' ' GLY . 41.2 mt -70.5 -50.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.923 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.25 -43.65 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.062 0.935 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.425 ' O ' ' CG ' ' A' ' 148' ' ' GLN . . . -62.35 -51.7 54.57 Favored Glycine 0 C--O 1.205 -1.663 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.237 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.416 ' HA ' HG23 ' A' ' 191' ' ' ILE . 45.1 m -70.01 -35.23 74.21 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.796 0.808 . . . . 0.0 110.363 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 147' ' ' LEU . 2.1 tp -54.87 -40.15 69.43 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -57.91 -33.35 68.67 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.949 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.986 HD11 HG22 ' A' ' 176' ' ' VAL . 2.3 tp -68.89 -47.08 66.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.972 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.655 HG21 ' HA3' ' A' ' 220' ' ' GLY . 54.3 t -66.23 -41.02 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.76 -45.63 85.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' A' ' 172' ' ' ILE . 21.3 p -64.28 -28.44 69.72 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.704 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.01 -38.54 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.8 mt -65.89 -35.95 82.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.14 80.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.231 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.691 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 1.8 t . . . . . 0 C--N 1.332 -0.192 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.677 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.691 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 28.0 Cg_exo -54.63 -38.27 90.89 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.557 1.505 . . . . 0.0 111.878 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 62.0 mt -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.035 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.63 -46.95 57.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.087 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.45 HG23 ' SG ' ' A' ' 152' ' ' CYS . 1.3 mp -58.08 -42.05 82.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 121.546 0.688 . . . . 0.0 109.692 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.74 -37.63 93.65 Favored Glycine 0 C--O 1.195 -2.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.131 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -55.15 -35.53 64.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 178.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -34.43 77.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.821 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.986 HG22 HD11 ' A' ' 149' ' ' LEU . 11.5 t -72.01 -47.06 56.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.741 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . . . -68.89 -33.58 74.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.124 0.964 . . . . 0.0 110.131 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.276 4.3 mt -69.16 -52.94 23.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 125.293 2.473 . . . . 0.0 110.918 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.51 62.57 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 110.01 -3.268 . . . . 0.0 106.58 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' HIS . . . . . 0.448 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 2.6 m80 -70.08 -34.88 73.71 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.756 -1.722 . . . . 0.0 110.081 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -56.84 -47.69 79.77 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.369 -178.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.66 -51.56 14.06 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 191' ' ' ILE . . . -69.38 -52.07 30.56 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 188' ' ' GLY . 1.5 mp -56.65 -49.14 79.21 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.032 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.504 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -70.09 -35.82 74.45 Favored 'General case' 0 C--N 1.277 -2.564 0 C-N-CA 115.998 -2.281 . . . . 0.0 113.067 -175.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -60.18 -29.47 68.72 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.316 -171.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.276 0.1 OUTLIER -124.27 -26.95 3.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.199 1.0 . . . . 0.0 113.269 -178.744 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 184' ' ' ILE . . . 88.48 -5.89 84.2 Favored Glycine 0 CA--C 1.564 3.102 0 N-CA-C 105.981 -2.848 . . . . 0.0 105.981 -170.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' ' 187' ' ' THR . 17.4 t -84.45 129.47 34.86 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 123.601 1.667 . . . . 0.0 106.588 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.477 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -50.02 161.84 0.96 Allowed Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 110.659 -2.973 . . . . 0.0 112.465 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.658 HG13 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.53 -42.71 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.189 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.732 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 7.9 p-10 -87.05 139.86 32.61 Favored Pre-proline 0 N--CA 1.418 -2.047 0 CA-C-N 111.85 -2.432 . . . . 0.0 107.695 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.01 -14.89 46.52 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.886 1.724 . . . . 0.0 111.674 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.463 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . . . -75.31 -30.65 60.41 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.589 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.438 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.4 OUTLIER -70.69 -39.61 73.39 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.288 0.566 . . . . 0.0 109.617 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -31.73 64.32 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.85 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.838 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.7 m-85 -72.04 -35.0 69.24 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.61 1.964 . . . . 0.0 113.911 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -46.6 91.99 Favored Glycine 0 C--N 1.319 -0.402 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 p -76.35 -28.24 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.688 -0.756 . . . . 0.0 110.297 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.838 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.81 -34.0 77.32 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.995 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 121.186 1.812 . . . . 0.0 111.019 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.656 HG21 ' HA2' ' A' ' 136' ' ' GLY . 31.9 mm . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.62 -36.61 74.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.112 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -84.33 -33.44 23.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 215' ' ' GLY . 12.3 p -78.61 -47.08 24.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.15 -45.95 80.38 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.313 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 4.1 Cg_exo -71.69 -28.67 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.877 2.385 . . . . 0.0 113.29 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -33.75 58.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 49.8 mt -70.59 -46.12 71.25 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.295 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.657 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.34 -46.81 67.58 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 128.407 3.567 . . . . 0.0 111.886 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.655 ' HA3' HG21 ' A' ' 150' ' ' VAL . . . -70.32 -48.96 34.93 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 118.146 -1.978 . . . . 0.0 109.894 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.87 68.19 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.632 0.73 . . . . 0.0 109.789 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.84 -31.24 70.94 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.334 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.565 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.99 -39.63 82.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.21 -49.64 81.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -39.34 91.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.7 0.762 . . . . 0.0 109.719 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -34.59 49.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.765 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--N 1.33 -0.265 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.194 -179.386 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.356 0.122 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.16 -0.18 15.66 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.88 -40.09 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.3 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.775 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.584 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.82 69.42 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.689 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -70.62 -46.74 62.79 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -176.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -33.82 73.26 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 19' ' ' LEU . 12.3 mt -58.84 -38.35 78.48 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.68 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.73 -47.07 76.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.742 -2.026 . . . . 0.0 115.077 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -75.74 -31.5 59.61 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.493 -177.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.767 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.72 -39.0 67.28 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.737 -178.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -45.06 83.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.63 ' CD2' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -77.07 -47.2 21.19 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 29' ' ' ILE . 92.5 t -65.25 -50.57 72.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.477 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.474 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 18.1 t80 -53.86 -47.43 71.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -29.17 20.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.594 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -36.23 67.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.728 HG21 HD22 ' A' ' 112' ' ' LEU . 3.2 mm -62.97 -38.61 82.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.88 63.29 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.257 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -63.49 -45.02 92.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.726 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.762 179.801 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 38.1 t0 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 121.181 0.515 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -49.8 -28.04 5.79 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.407 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG22 HD21 ' A' ' 181' ' ' LEU . 12.0 t -56.81 -48.24 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -64.8 -44.12 90.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.717 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 7.7 p -68.2 -47.6 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.548 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.454 ' N ' HG13 ' A' ' 52' ' ' VAL . 12.2 m -69.15 -36.49 77.48 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.78 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 49.4 tp -63.41 -31.88 73.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -65.79 -39.2 90.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.374 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 60' ' ' ILE . 8.4 m-30 -65.92 -43.33 88.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.875 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.771 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.56 -43.34 96.67 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.467 -0.396 . . . . 0.0 112.901 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 58.0 mt -66.76 -43.69 83.41 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.301 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -36.54 74.66 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -60.26 -34.08 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.645 -178.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.721 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -62.39 -45.53 92.73 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.423 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 62' ' ' THR . 8.1 p -67.84 -31.42 71.24 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -41.96 72.1 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.96 -44.07 73.69 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.508 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -40.2 87.78 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.51 -12.13 5.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 119.802 1.183 . . . . 0.0 111.702 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -42.85 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.759 0.314 . . . . 0.0 111.395 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.6 170.65 11.91 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -23.08 62.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 pt -76.06 7.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 135.7 53.57 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.377 0.608 . . . . 0.0 111.697 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -149.55 18.45 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.34 85.35 1.09 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -20.01 62.34 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.663 ' O ' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -89.84 3.43 52.97 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 112.26 -2.245 . . . . 0.0 113.636 178.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.624 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 3.6 t-20 -126.46 133.85 25.41 Favored Pre-proline 0 N--CA 1.483 1.19 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 83.6 Cg_endo -83.68 -32.25 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.171 2.58 . . . . 0.0 112.1 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.606 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -61.13 -49.89 75.45 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.454 ' CG2' HG21 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -66.22 -36.81 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.825 0.345 . . . . 0.0 111.218 177.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -62.89 -28.63 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.434 HD13 ' CG ' ' A' ' 217' ' ' PHE . 0.6 OUTLIER -60.71 -42.05 96.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.874 0.369 . . . . 0.0 110.409 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.68 -39.3 85.95 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -50.23 72.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.615 0.245 . . . . 0.0 111.294 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.837 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.898 0.38 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.13 77.96 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.86 -38.44 67.47 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.4 ttt -71.71 -36.18 70.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.316 -1.765 . . . . 0.0 109.685 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -64.33 -37.52 87.81 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 119.177 0.899 . . . . 0.0 109.236 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -59.6 -48.12 88.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.532 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.441 ' N ' HG22 ' A' ' 98' ' ' ILE . 26.2 pt -70.44 -37.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -66.22 -47.18 74.7 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.61 -35.84 70.59 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.96 71.74 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 100' ' ' ALA . 2.7 t -70.81 -35.39 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.016 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.61 -42.21 90.33 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 121.152 1.797 . . . . 0.0 112.973 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.465 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.91 -36.05 75.08 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.03 -42.22 85.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.825 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.94 -37.23 72.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.269 0.557 . . . . 0.0 109.515 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.67 -44.67 85.92 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.14 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -70.32 -37.17 74.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.709 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -44.83 88.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.707 0.289 . . . . 0.0 111.113 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.8 mt -69.22 -37.51 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.39 . . . . 0.0 110.814 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.728 HD22 HG21 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -64.47 -24.5 67.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.023 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -36.89 81.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.969 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.95 -36.24 60.16 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.5 mm -55.33 -40.6 57.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.627 -0.787 . . . . 0.0 110.532 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.455 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -112.71 117.47 32.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 111.71 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 52.0 29.44 6.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -108.79 89.61 3.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 187' ' ' THR . 3.3 mm? -63.01 143.79 57.47 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.055 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.03 139.99 40.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.887 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -49.62 127.63 16.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.28 -104.66 0.59 Allowed Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.834 HG21 HG13 ' A' ' 141' ' ' ILE . 1.3 t -86.09 127.76 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.459 ' O ' HG12 ' A' ' 133' ' ' VAL . 9.4 t-20 -71.66 -172.03 0.74 Allowed 'General case' 0 C--O 1.203 -1.376 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.505 ' N ' HD11 ' A' ' 129' ' ' LEU . 6.8 t -63.54 -46.97 83.56 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 114.499 -2.88 . . . . 0.0 109.893 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -40.13 94.79 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.13 -1.034 . . . . 0.0 111.323 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.795 ' HB3' HG22 ' A' ' 133' ' ' VAL . 2.4 mm100 -53.5 -23.54 10.65 Favored 'General case' 0 C--N 1.253 -3.618 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.676 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.532 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.34 -2.18 13.56 Favored Glycine 0 C--O 1.191 -2.56 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.693 HD13 HD11 ' A' ' 211' ' ' ILE . 7.3 tp -61.05 -50.37 73.58 Favored 'General case' 0 C--O 1.206 -1.226 0 O-C-N 120.458 -1.613 . . . . 0.0 108.458 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.77 -46.52 53.12 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.834 HG13 HG21 ' A' ' 133' ' ' VAL . 2.1 mm -59.58 -42.83 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.186 -1.007 . . . . 0.0 111.352 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.19 -36.11 79.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.035 0.934 . . . . 0.0 112.59 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.636 HG23 ' CA ' ' A' ' 219' ' ' GLY . 19.6 mt -67.78 -50.48 59.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 O-C-N 121.718 -0.614 . . . . 0.0 110.474 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.29 -43.59 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.99 0.9 . . . . 0.0 111.948 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 148' ' ' GLN . . . -61.98 -51.05 59.69 Favored Glycine 0 C--O 1.2 -1.993 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.915 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 216' ' ' PRO . 28.6 m -70.25 -37.61 74.98 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.838 0.828 . . . . 0.0 110.87 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 3.8 tp -55.03 -40.22 69.98 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.47 HE22 ' HB2' ' A' ' 175' ' ' SER . 1.1 pp0? -57.85 -31.42 66.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.778 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.887 HD11 HG22 ' A' ' 176' ' ' VAL . 1.2 tp -68.72 -47.16 67.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.651 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.616 HG21 ' HA3' ' A' ' 220' ' ' GLY . 82.5 t -66.39 -40.98 88.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -45.65 82.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' A' ' 172' ' ' ILE . 24.6 p -65.68 -29.02 69.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.454 HG21 ' CG2' ' A' ' 79' ' ' VAL . 2.5 t -71.94 -39.0 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.167 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -38.21 88.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.554 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.7 72.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.583 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.335 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.583 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 10.6 Cg_exo -62.32 -46.76 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.715 1.61 . . . . 0.0 113.842 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 171' ' ' ALA . 3.8 pp -66.37 -29.97 70.26 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.014 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.753 ' N ' HD12 ' A' ' 170' ' ' LEU . . . -71.35 -45.16 63.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.777 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.421 HG23 ' SG ' ' A' ' 152' ' ' CYS . 1.0 OUTLIER -58.16 -37.53 62.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.78 -37.56 93.54 Favored Glycine 0 C--O 1.196 -2.268 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.667 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.26 -35.86 65.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.47 ' HB2' HE22 ' A' ' 148' ' ' GLN . 0.7 OUTLIER -67.54 -34.79 77.79 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.173 176.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.887 HG22 HD11 ' A' ' 149' ' ' LEU . 10.5 t -70.32 -46.92 69.43 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.78 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -68.66 -32.81 72.91 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.516 1.15 . . . . 0.0 110.527 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.629 ' O ' HD22 ' A' ' 182' ' ' LEU 0.279 2.7 tp -70.55 -50.64 35.36 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 124.739 2.209 . . . . 0.0 110.212 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.5 -37.12 65.72 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 109.896 -3.32 . . . . 0.0 107.042 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' HIS . . . . . 0.443 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 0.3 OUTLIER -70.33 -35.24 73.49 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.959 -1.62 . . . . 0.0 109.648 178.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -57.16 -47.04 82.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.815 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.68 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -74.5 -52.11 12.86 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.71 ' HB3' HG13 ' A' ' 191' ' ' ILE . . . -69.98 -51.94 28.4 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 188' ' ' GLY . 3.7 mt -61.4 -49.21 85.44 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.681 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.536 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -69.23 -35.55 76.29 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 116.226 -2.19 . . . . 0.0 112.645 -176.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.538 -171.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.518 ' O ' HD13 ' A' ' 129' ' ' LEU 0.284 0.1 OUTLIER -124.54 -26.71 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.217 1.008 . . . . 0.0 113.2 -179.501 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.11 -5.67 84.72 Favored Glycine 0 CA--C 1.567 3.327 0 N-CA-C 106.332 -2.707 . . . . 0.0 106.332 -170.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.414 ' CB ' ' OG1' ' A' ' 187' ' ' THR . 37.5 t -84.25 126.04 32.79 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -46.53 162.61 0.17 Allowed Glycine 0 N--CA 1.411 -2.986 0 CA-C-N 111.307 -2.679 . . . . 0.0 112.647 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.71 HG13 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.39 -41.55 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.606 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.0 p30 -94.35 146.31 31.31 Favored Pre-proline 0 N--CA 1.409 -2.488 0 CA-C-N 111.528 -2.578 . . . . 0.0 108.657 179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.12 -14.69 45.5 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.524 2.15 . . . . 0.0 111.479 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.578 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.24 -34.33 61.41 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.76 0.314 . . . . 0.0 110.574 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.493 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 38.1 tpt85 -70.61 -40.53 73.13 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.906 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.2 -37.53 66.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.825 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 13.3 t80 -72.1 -35.06 69.08 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 126.718 2.007 . . . . 0.0 114.458 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.3 93.34 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 106.7 -2.56 . . . . 0.0 106.7 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 16.2 m -76.6 -28.3 56.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.992 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.825 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -67.53 -33.93 76.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 121.152 1.796 . . . . 0.0 111.808 -179.412 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 139' ' ' LEU . 2.6 tp . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -27.13 64.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -84.43 -44.68 13.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 214' ' ' VAL . 2.6 p -80.18 -41.11 20.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.503 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.3 -45.07 84.35 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.434 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.514 ' HB3' HG21 ' A' ' 146' ' ' THR . 3.4 Cg_exo -71.74 -28.66 16.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.624 2.216 . . . . 0.0 112.95 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.434 ' CG ' HD13 ' A' ' 81' ' ' LEU . 3.4 m-30 -77.4 -31.0 53.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 111.993 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.4 mm -70.77 -46.44 68.81 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.296 0 C-N-CA 123.398 0.679 . . . . 0.0 112.457 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.636 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.95 -46.09 60.85 Favored Glycine 0 C--N 1.359 1.84 0 O-C-N 128.659 3.724 . . . . 0.0 111.535 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.616 ' HA3' HG21 ' A' ' 150' ' ' VAL . . . -70.27 -49.02 34.93 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.192 -1.956 . . . . 0.0 109.944 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.96 68.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.648 0.737 . . . . 0.0 109.626 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.73 -31.29 71.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.152 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.78 -39.47 81.16 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.5 t -58.15 -49.54 81.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.604 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -39.47 94.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.623 0.725 . . . . 0.0 109.817 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 21.4 mt -58.59 -34.42 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.346 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.2 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.386 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.488 0.185 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.4 1.99 17.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.683 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -40.25 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.36 -36.18 73.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.541 0 CA-C-N 112.605 -2.089 . . . . 0.0 109.833 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.09 70.16 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.709 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -71.18 -46.65 60.92 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -177.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -33.96 72.31 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.99 -38.06 78.29 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.508 -2.133 . . . . 0.0 108.912 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -63.18 -46.81 85.39 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.313 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.76 -31.23 59.45 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.699 -177.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.82 -38.16 67.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.781 -178.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -44.92 84.37 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.494 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -76.96 -47.97 19.39 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 29' ' ' ILE . 91.8 t -65.44 -53.76 36.07 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.522 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.52 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 24.1 t80 -53.87 -44.36 70.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.264 0.484 . . . . 0.0 111.96 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.73 -29.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.903 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.798 HG21 HD22 ' A' ' 112' ' ' LEU . 3.0 mm -61.82 -38.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.109 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.35 -36.95 64.08 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -67.14 -38.88 86.29 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.506 179.625 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.7 t70 . . . . . 0 C--O 1.226 -0.169 0 CA-C-O 121.037 0.446 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.91 -28.83 53.79 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.659 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.469 HG23 HD11 ' A' ' 181' ' ' LEU . 4.9 p -61.94 -31.92 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 5.4 mmtp -65.05 -54.18 34.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.644 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 22.5 m -68.36 -37.45 77.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.543 -177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 52' ' ' VAL . 16.1 m -69.56 -43.19 73.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.765 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 55.8 tp -62.9 -31.72 72.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.535 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.98 -39.68 93.85 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.504 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -66.28 -46.82 75.67 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.741 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.67 -41.65 97.62 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.737 -0.268 . . . . 0.0 113.38 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 2.3 mt -68.39 -43.73 76.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.674 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -60.46 -36.48 78.36 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -33.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 113.077 -1.874 . . . . 0.0 107.987 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.759 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -66.08 -45.71 80.32 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.379 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 p -69.42 -31.55 69.97 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.42 -41.01 72.19 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.0 -44.43 72.8 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.155 173.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -36.74 82.91 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 t -59.68 -12.21 6.49 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 119.98 1.264 . . . . 0.0 111.367 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.59 -42.71 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.883 0.373 . . . . 0.0 110.957 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.14 156.41 6.79 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -23.01 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 tt -74.68 6.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.55 135.64 53.33 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.168 0.509 . . . . 0.0 111.26 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.12 -159.06 21.27 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.47 85.78 1.14 Allowed 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.064 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -19.64 61.08 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.691 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . 2.1 pp -81.15 -10.26 59.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.856 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 5.8 t-20 -112.73 131.24 22.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.55 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 92.7 Cg_endo -83.69 -28.97 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.062 2.508 . . . . 0.0 112.557 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -62.54 -49.68 74.35 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.513 HG21 HG21 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -66.39 -36.77 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.778 178.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.2 m -65.85 -28.52 69.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.451 HD23 ' HD1' ' A' ' 217' ' ' PHE . 1.3 mp -61.78 -35.27 77.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.847 0.356 . . . . 0.0 110.715 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.72 98.27 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mt -58.96 -42.41 89.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 110.975 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.794 0.33 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -65.36 -35.06 79.83 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.228 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.79 -38.53 67.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtm -73.47 -31.7 63.91 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.738 -1.573 . . . . 0.0 110.132 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -67.66 -40.44 84.52 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 119.032 0.833 . . . . 0.0 111.447 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -66.77 -41.29 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.48 -42.71 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.65 ' HB3' ' OE1' ' A' ' 17' ' ' GLU . . . -68.05 -47.33 68.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -71.72 -35.83 70.32 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 t -58.03 -36.19 72.37 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.457 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.9 t -69.78 -35.41 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.857 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.7 -44.76 91.37 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 120.897 1.681 . . . . 0.0 113.369 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.42 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.68 -36.1 75.71 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 103' ' ' VAL . 39.8 mt -67.26 -41.15 86.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.532 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.9 -37.3 77.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 0.0 109.53 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.61 -46.99 83.39 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.382 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -67.73 -37.28 81.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.414 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.83 85.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.02 -39.17 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.774 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.798 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -65.14 -24.32 67.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.352 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 m -60.62 -44.37 96.41 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.836 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.07 -36.26 60.87 Favored Glycine 0 CA--C 1.509 -0.297 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.21 -30.72 30.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.441 -0.879 . . . . 0.0 111.016 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.451 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.6 ptt85 -112.59 118.52 35.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.957 0.408 . . . . 0.0 111.884 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 51.82 45.24 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -116.55 110.38 18.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.796 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.59 ' H ' HD22 ' A' ' 129' ' ' LEU . 1.3 mm? -82.01 138.07 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.39 148.75 27.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.212 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -49.65 127.66 16.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.39 -97.6 0.87 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.657 HG21 HD13 ' A' ' 141' ' ' ILE . 2.6 t -86.09 119.15 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.6 m-80 -71.8 -172.03 0.77 Allowed 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.47 ' O ' HD13 ' A' ' 211' ' ' ILE . 1.0 OUTLIER -61.78 -46.97 87.26 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 114.525 -2.87 . . . . 0.0 110.793 -178.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.19 -39.35 94.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.519 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.656 ' CB ' HG13 ' A' ' 133' ' ' VAL . 85.4 mm-40 -52.95 -23.33 6.99 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-O 121.342 0.592 . . . . 0.0 110.196 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -63.5 -1.97 5.21 Favored Glycine 0 C--O 1.187 -2.787 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.23 -50.54 69.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 119.332 1.566 . . . . 0.0 110.951 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.84 -43.94 64.33 Favored Glycine 0 CA--C 1.51 -0.255 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.657 HD13 HG21 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -63.56 -38.9 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 112.721 -1.739 . . . . 0.0 112.378 -178.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 138' ' ' GLY . 42.2 mt-10 -68.31 -36.3 79.11 Favored 'General case' 0 C--O 1.2 -1.541 0 CA-C-O 122.275 1.036 . . . . 0.0 110.48 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.681 HG23 ' HA2' ' A' ' 219' ' ' GLY . 40.2 mt -65.9 -46.46 88.43 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.645 -174.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.48 -48.99 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 122.073 0.939 . . . . 0.0 111.769 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.77 56.8 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.008 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.486 HG21 ' HB3' ' A' ' 216' ' ' PRO . 17.8 m -70.65 -43.34 69.37 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.887 -1.156 . . . . 0.0 112.447 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 148' ' ' GLN . 0.8 OUTLIER -54.67 -40.18 68.83 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.705 -176.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt20 -57.86 -30.26 65.65 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.851 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 176' ' ' VAL . 2.2 tp -68.82 -45.39 71.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.738 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.433 HG21 ' HA3' ' A' ' 220' ' ' GLY . 82.9 t -66.42 -40.95 87.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.18 -38.38 85.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' A' ' 172' ' ' ILE . 5.1 p -73.74 -28.3 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.393 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.513 HG21 HG21 ' A' ' 79' ' ' VAL . 2.3 t -71.98 -45.55 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -41.25 92.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.277 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.02 89.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.423 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.622 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.543 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.622 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.6 Cg_exo -54.42 -41.08 79.98 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.485 1.456 . . . . 0.0 112.272 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.42 -42.42 91.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 -47.14 57.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.492 HD11 ' OG1' ' A' ' 156' ' ' THR . 41.6 mt -58.2 -37.11 60.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.44 93.49 Favored Glycine 0 C--O 1.2 -1.977 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.299 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -55.1 -36.23 65.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -34.6 77.41 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.562 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.988 HG22 HD11 ' A' ' 149' ' ' LEU . 48.4 t -73.06 -47.42 47.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.765 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.3 -31.75 69.22 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.966 1.365 . . . . 0.0 110.117 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.273 11.3 tp -70.44 -48.67 54.88 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.547 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.408 ' C ' HG21 ' A' ' 191' ' ' ILE . . . -55.72 -37.03 67.09 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 111.075 -2.784 . . . . 0.0 107.817 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' HIS . . . . . 0.516 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 10.2 m-70 -68.59 -35.36 77.26 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.391 -1.405 . . . . 0.0 109.08 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -59.34 -47.73 84.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.672 -177.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.419 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.23 -52.52 10.69 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 1.035 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -70.25 -51.96 26.66 Favored 'General case' 0 C--O 1.202 -1.404 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 180' ' ' HIS . 6.0 mt -59.43 -49.21 84.42 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.815 0 C-N-CA 118.984 -1.087 . . . . 0.0 113.14 -174.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -35.71 78.49 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 115.677 -2.409 . . . . 0.0 112.719 -176.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.84 -29.79 68.52 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.673 -171.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.28 0.1 OUTLIER -124.6 -26.85 3.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.292 1.044 . . . . 0.0 113.43 -179.317 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.54 -5.8 84.43 Favored Glycine 0 CA--C 1.566 3.277 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -170.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.419 ' H ' HG23 ' A' ' 187' ' ' THR . 11.4 t -84.1 129.0 34.92 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -49.82 159.2 1.31 Allowed Glycine 0 N--CA 1.405 -3.403 0 CA-C-N 111.496 -2.593 . . . . 0.0 112.056 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 1.035 HG22 ' HB3' ' A' ' 183' ' ' ALA . 20.3 pt -72.57 -33.07 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.614 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.9 p30 -97.69 143.62 26.53 Favored Pre-proline 0 N--CA 1.418 -2.038 0 CA-C-N 113.194 -1.821 . . . . 0.0 108.748 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.05 -14.44 33.31 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.395 2.063 . . . . 0.0 111.596 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.55 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.05 -37.38 61.7 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.623 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.645 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.41 -38.62 74.64 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.26 0.552 . . . . 0.0 109.839 -179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -33.74 65.43 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.502 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.835 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.8 m-85 -72.3 -35.25 68.62 Favored 'General case' 0 N--CA 1.512 2.663 0 C-N-CA 126.532 1.933 . . . . 0.0 114.469 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.69 91.91 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 107.274 -2.331 . . . . 0.0 107.274 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -76.35 -28.41 56.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.605 -0.798 . . . . 0.0 110.349 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.835 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -63.8 -34.05 77.05 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.704 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.319 -0.736 0 CA-C-N 121.0 1.727 . . . . 0.0 110.418 179.739 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 135' ' ' SER . 1.4 pp . . . . . 0 CA--C 1.519 -0.214 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -58.52 -38.54 77.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.706 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -84.21 -33.61 24.09 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.587 HG22 HD12 ' A' ' 218' ' ' ILE . 13.3 p -77.76 -45.16 28.55 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.477 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.18 -48.15 70.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.435 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.486 ' HB3' HG21 ' A' ' 146' ' ' THR . 5.2 Cg_endo -72.16 -32.36 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.477 2.118 . . . . 0.0 114.015 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.451 ' HD1' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -70.13 -39.88 75.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 5.8 mt -70.47 -46.52 70.14 Favored 'Isoleucine or valine' 0 C--O 1.173 -2.929 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.335 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.681 ' HA2' HG23 ' A' ' 143' ' ' ILE . . . -56.65 -48.46 77.08 Favored Glycine 0 C--N 1.365 2.156 0 O-C-N 128.624 3.703 . . . . 0.0 111.23 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -67.93 -39.44 89.35 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.47 -34.88 62.34 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 5.5 mt -67.55 -37.18 82.31 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.502 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -58.8 -39.8 82.18 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.279 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.6 t -58.46 -49.72 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.08 -39.53 94.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.694 0.759 . . . . 0.0 110.344 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.92 -34.74 38.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.94 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.6 t80 . . . . . 0 C--N 1.331 -0.226 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.589 -179.469 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.23 -12.03 11.23 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.383 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -60.24 -39.75 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -68.34 -35.92 72.85 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.301 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -35.09 69.52 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 77.5 mt-10 -70.93 -46.55 62.25 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -34.01 71.83 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -38.18 78.48 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.313 -2.222 . . . . 0.0 109.493 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.73 -46.67 78.01 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.021 -1.899 . . . . 0.0 114.572 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.46 -31.15 60.16 Favored 'General case' 0 C--O 1.204 -1.341 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.66 -177.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.751 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.87 -38.05 67.15 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 111.678 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -44.97 84.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.643 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.04 -47.21 21.23 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 29' ' ' ILE . 87.8 t -65.41 -52.09 55.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.069 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 29' ' ' ILE . 31.7 t80 -53.76 -47.35 70.76 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.094 0.473 . . . . 0.0 112.168 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.63 -29.86 21.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -36.19 69.41 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.745 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -59.3 -41.0 82.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.987 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.37 -36.85 64.04 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.9 m -67.38 -39.43 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.615 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 121.044 0.449 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -50.0 -28.52 7.07 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.116 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.453 HG22 HD21 ' A' ' 181' ' ' LEU . 16.2 t -57.15 -40.0 70.57 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -64.8 -53.76 41.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.719 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 65.4 t -67.9 -46.14 82.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.592 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.9 m -69.3 -38.67 78.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.822 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 1.0 OUTLIER -62.77 -31.94 73.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 176.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.87 -39.37 94.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.569 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -65.94 -41.01 91.87 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.774 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.54 -41.75 99.11 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.848 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -67.57 -43.61 80.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.59 -178.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -58.65 -36.57 74.33 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.663 HG13 HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -60.06 -34.04 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.436 -178.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.722 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -64.66 -45.67 85.74 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.364 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.4 p -66.8 -31.59 72.32 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.706 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -54.7 -43.1 72.24 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.18 -44.41 72.24 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.382 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -66.83 -48.76 67.91 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 m -59.05 -12.13 4.41 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 119.708 1.14 . . . . 0.0 112.086 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 63' ' ' LEU . 13.0 m -114.44 -42.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.95 0.405 . . . . 0.0 111.575 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 144.19 158.91 7.79 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -60.65 -23.02 64.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.642 0.258 . . . . 0.0 111.681 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.14 7.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.62 136.44 53.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.105 0.479 . . . . 0.0 111.599 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.37 -153.46 27.86 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.45 85.8 1.13 Allowed 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 118.439 -1.304 . . . . 0.0 107.802 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -19.65 65.15 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.706 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.1 pp -83.78 -11.95 56.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.64 -1.618 . . . . 0.0 113.031 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -115.37 135.7 22.62 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 119.846 1.203 . . . . 0.0 114.06 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.483 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 96.6 Cg_endo -83.44 -21.6 4.29 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 123.14 2.56 . . . . 0.0 112.004 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.685 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.42 -48.67 74.48 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG23 HD23 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -66.14 -36.84 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.155 -0.341 . . . . 0.0 111.276 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -28.45 69.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.736 HD22 ' HA ' ' A' ' 217' ' ' PHE . 0.3 OUTLIER -57.08 -35.12 69.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.127 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.419 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -68.73 -48.79 47.26 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.76 -30.53 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.86 0.362 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.78 -35.02 77.93 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -38.64 67.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 176.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.93 -37.01 70.1 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.476 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -61.06 -37.69 83.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.923 0.868 . . . . 0.0 109.23 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -63.17 -48.51 87.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 113.784 -1.553 . . . . 0.0 113.367 -178.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.433 ' N ' HG22 ' A' ' 98' ' ' ILE . 2.8 mm -70.42 -38.12 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.31 74.48 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.201 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -35.61 70.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.411 ' O ' HG13 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -58.08 -36.09 72.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.22 -35.33 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.52 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.34 90.03 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 121.041 1.746 . . . . 0.0 113.105 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.02 75.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.493 HD11 ' CE2' ' A' ' 197' ' ' PHE . 64.0 mt -65.39 -50.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.9 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.02 -37.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.29 0.567 . . . . 0.0 109.612 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.56 -45.11 85.57 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.619 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.42 -37.13 74.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.819 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -46.7 85.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 pt -67.09 -37.31 79.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.745 HD22 HG21 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -67.06 -24.4 65.98 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.233 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.3 m -60.89 -44.38 97.18 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.784 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.3 62.01 Favored Glycine 0 CA--C 1.512 -0.136 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.91 -31.62 36.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.258 -0.971 . . . . 0.0 111.009 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.723 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.94 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 117.35 31.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.344 0.592 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 51.97 17.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.048 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.83 91.72 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.43 HD21 ' OG ' ' A' ' 135' ' ' SER . 0.9 OUTLIER -63.17 138.59 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.286 0.565 . . . . 0.0 110.749 -178.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.94 135.61 48.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.405 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -49.81 127.57 16.41 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.05 -104.26 0.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.846 HG21 HD13 ' A' ' 141' ' ' ILE . 1.5 t -86.06 125.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.456 ' O ' HG12 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.65 -171.87 0.72 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 102.956 -2.979 . . . . 0.0 102.956 176.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.488 ' O ' HD13 ' A' ' 211' ' ' ILE . 54.1 m -62.67 -47.0 85.56 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 114.575 -2.85 . . . . 0.0 110.424 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.556 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -59.25 -39.85 95.12 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.46 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.783 ' HB3' HG22 ' A' ' 133' ' ' VAL . 37.9 mm-40 -53.5 -23.23 9.77 Favored 'General case' 0 C--N 1.25 -3.75 0 CA-C-O 121.29 0.567 . . . . 0.0 110.544 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.19 -1.65 21.48 Favored Glycine 0 C--O 1.186 -2.901 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -50.46 68.28 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-N 118.709 1.254 . . . . 0.0 110.836 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.48 -41.01 78.45 Favored Glycine 0 CA--C 1.51 -0.249 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.846 HD13 HG21 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -65.04 -40.67 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 112.775 -1.713 . . . . 0.0 112.063 -178.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 138' ' ' GLY . 15.5 mt-10 -68.43 -36.42 79.03 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.834 0.825 . . . . 0.0 111.697 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.668 HG23 ' CA ' ' A' ' 219' ' ' GLY . 34.6 mt -66.63 -52.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.557 -174.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.22 -44.83 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.935 0.874 . . . . 0.0 111.966 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.53 -51.88 56.44 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 113.542 -1.663 . . . . 0.0 112.036 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.404 ' HA ' HG23 ' A' ' 191' ' ' ILE . 26.5 m -70.58 -36.95 73.87 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.375 -0.912 . . . . 0.0 111.185 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 1.5 tp -55.0 -40.45 70.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.008 -176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -58.87 -31.94 69.03 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.126 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.987 HD11 HG22 ' A' ' 176' ' ' VAL . 1.2 tp -68.77 -46.65 68.22 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.457 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.491 HG21 ' HA3' ' A' ' 220' ' ' GLY . 52.3 t -66.25 -40.98 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.7 -35.55 80.94 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.46 -33.51 74.31 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.05 -45.48 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -48.15 81.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.038 0.447 . . . . 0.0 109.928 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.662 ' CB ' HD11 ' A' ' 172' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.228 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.639 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 21.1 Cg_exo -54.82 -46.27 34.6 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.17 -37.46 74.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.51 -45.95 61.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.782 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.662 HD11 ' CB ' ' A' ' 156' ' ' THR . 49.3 mt -58.3 -39.37 73.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.591 0.71 . . . . 0.0 109.238 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.25 93.29 Favored Glycine 0 C--O 1.2 -2.015 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.929 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.455 ' O ' HD13 ' A' ' 178' ' ' LEU . 2.0 tp -55.09 -35.8 64.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -34.47 76.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.395 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.987 HG22 HD11 ' A' ' 149' ' ' LEU . 24.8 t -73.09 -47.12 48.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -175.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.822 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -69.67 -30.85 68.63 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.485 1.135 . . . . 0.0 110.107 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.264 2.1 mp -70.56 -50.5 36.73 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 124.546 2.117 . . . . 0.0 110.323 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.458 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.45 -36.91 64.75 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 110.219 -3.173 . . . . 0.0 107.401 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' HIS . . . . . 0.46 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 12.1 m170 -70.18 -35.34 73.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.096 -1.552 . . . . 0.0 109.645 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 177' ' ' ALA . 0.1 OUTLIER -58.88 -47.85 83.47 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.919 -178.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -75.04 -52.64 10.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.745 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -70.16 -52.04 26.61 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.516 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 10.8 mt -60.87 -40.67 86.0 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.901 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -75.61 -35.67 60.47 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 115.742 -2.383 . . . . 0.0 112.266 -177.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.07 -29.94 68.89 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.802 -1.159 . . . . 0.0 111.179 -171.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.281 0.1 OUTLIER -124.44 -26.83 3.83 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.199 -179.109 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.2 -5.87 84.36 Favored Glycine 0 CA--C 1.569 3.423 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.431 ' H ' HG23 ' A' ' 187' ' ' THR . 43.9 t -84.72 129.1 34.87 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -48.4 162.83 0.41 Allowed Glycine 0 N--CA 1.408 -3.187 0 CA-C-N 111.265 -2.698 . . . . 0.0 113.464 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.745 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -73.11 -42.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.685 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.2 p-10 -92.38 144.73 29.34 Favored Pre-proline 0 N--CA 1.417 -2.096 0 CA-C-N 110.843 -2.889 . . . . 0.0 107.702 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.02 -14.71 45.72 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.907 1.738 . . . . 0.0 111.247 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.486 ' HB3' HD22 ' A' ' 192' ' ' ASN . . . -75.03 -31.83 61.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.989 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.525 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.48 -39.25 74.33 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.376 0.607 . . . . 0.0 109.863 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -36.91 66.79 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.828 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 11.6 t80 -72.22 -35.24 68.82 Favored 'General case' 0 N--CA 1.511 2.575 0 C-N-CA 126.412 1.885 . . . . 0.0 114.442 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.26 93.51 Favored Glycine 0 C--N 1.318 -0.438 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.9 m -76.48 -28.42 56.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.265 -0.968 . . . . 0.0 110.647 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.828 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -66.26 -34.06 77.16 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.163 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.318 -0.788 0 CA-C-N 121.013 1.733 . . . . 0.0 111.604 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.556 HG21 ' HA2' ' A' ' 136' ' ' GLY . 2.7 pp . . . . . 0 CA--C 1.515 -0.369 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . 0.526 ' N ' HD12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -58.46 -31.82 68.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.178 -179.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -84.56 -33.91 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.9 p -81.79 -46.57 19.93 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -175.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.03 -44.73 83.26 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.177 -176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.9 Cg_exo -71.75 -28.6 16.76 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.842 2.362 . . . . 0.0 113.192 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.736 ' HA ' HD22 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -75.65 -35.02 60.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.244 0.545 . . . . 0.0 112.147 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.553 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.3 mm -70.55 -46.37 70.33 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.158 0 C-N-CA 124.165 0.986 . . . . 0.0 112.685 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.668 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.91 -46.74 64.76 Favored Glycine 0 C--N 1.359 1.858 0 O-C-N 128.713 3.758 . . . . 0.0 111.768 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.561 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.44 -49.04 33.69 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 118.158 -1.972 . . . . 0.0 109.762 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.467 ' N ' HD11 ' A' ' 81' ' ' LEU . . . -55.03 -38.94 68.6 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.57 0.7 . . . . 0.0 109.715 -176.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.72 -31.2 70.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.274 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -58.95 -39.69 82.41 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.129 0.966 . . . . 0.0 108.48 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.34 -49.64 81.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.587 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.84 -39.48 94.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.705 0.765 . . . . 0.0 109.829 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mm -57.84 -34.59 48.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.616 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 t80 . . . . . 0 C--N 1.33 -0.262 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.187 -179.343 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 . . . . . 0 C--O 1.232 0.167 0 N-CA-C 111.289 0.107 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.77 -1.45 12.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.276 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.98 -40.25 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.23 -35.67 72.12 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.641 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.786 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.8 69.33 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 3.7 tp10 -70.73 -46.78 62.4 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -176.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -33.9 71.05 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.87 -38.17 78.19 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 112.293 -2.23 . . . . 0.0 109.482 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -63.25 -46.59 86.15 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.006 -1.907 . . . . 0.0 113.73 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -75.58 -31.37 59.94 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.96 -177.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.734 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.86 -37.95 67.19 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.178 -0.951 . . . . 0.0 111.287 -178.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.92 -45.25 82.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.715 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -77.13 -50.79 12.23 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 29' ' ' ILE . 43.2 t -64.59 -46.31 92.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.384 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.994 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.417 ' CE1' HD12 ' A' ' 112' ' ' LEU . 57.6 t80 -54.04 -48.67 70.3 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.189 0.519 . . . . 0.0 112.071 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.59 -29.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.519 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.05 -36.19 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.599 HG21 HD22 ' A' ' 112' ' ' LEU . 2.6 mm -64.02 -40.63 89.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.056 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.54 -41.32 81.05 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -67.57 -45.1 76.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.874 0.368 . . . . 0.0 111.876 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.5 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.224 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -49.89 -28.71 6.98 Favored 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.602 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.2 -34.59 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -64.94 -54.09 36.18 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.458 1.027 . . . . 0.0 113.443 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.73 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 7.7 p -68.15 -42.43 84.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.772 -176.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.449 ' N ' HG13 ' A' ' 52' ' ' VAL . 57.0 m -69.34 -41.36 76.73 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.52 0.512 . . . . 0.0 109.815 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.81 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 2.5 tm? -62.82 -31.94 73.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.07 -39.61 94.46 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.96 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.408 ' O ' HD13 ' A' ' 60' ' ' ILE . 9.2 m-30 -66.2 -46.83 75.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.699 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.44 -40.18 97.52 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.168 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.663 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 3.7 mm? -68.23 -43.49 77.8 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.093 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 p -58.69 -36.53 74.36 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.482 HG13 HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -59.8 -34.02 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.398 -1.728 . . . . 0.0 108.216 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.76 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.54 -45.63 82.68 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.326 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 p -69.08 -31.8 70.8 Favored 'General case' 0 CA--C 1.471 -2.067 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.711 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.31 -40.95 71.72 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.0 -44.07 73.55 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.827 173.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 t -59.65 -12.43 6.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 120.115 1.325 . . . . 0.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -32.69 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.809 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 168.58 12.21 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.54 -23.08 66.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 tt -73.62 7.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 p -124.42 135.56 53.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.215 0.531 . . . . 0.0 110.95 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.58 -159.82 22.95 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.41 85.89 1.12 Allowed 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.623 1.202 . . . . 0.0 108.468 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -73.2 -19.65 61.05 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.711 HD22 ' HG ' ' A' ' 63' ' ' LEU . 1.2 pp -84.87 8.67 16.63 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.787 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 5.1 t-20 -134.55 127.63 18.74 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.559 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 88.5 Cg_endo -83.33 -28.3 1.52 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.092 2.528 . . . . 0.0 112.275 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -59.35 -49.03 79.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.571 HG23 HD23 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -66.42 -36.75 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 177.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 m -61.15 -28.62 69.25 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -44.34 96.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.38 . . . . 0.0 110.155 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.79 96.37 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.29 -46.18 65.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.657 0.265 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.586 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 . . . . . 0 N--CA 1.46 0.071 0 CA-C-O 120.816 0.341 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.53 -35.26 78.75 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.42 67.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 176.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 tpp -73.39 -31.61 63.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.214 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.73 -39.19 76.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 119.267 0.939 . . . . 0.0 111.575 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -66.83 -41.19 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.695 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -70.65 -38.04 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -66.42 -47.0 74.63 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -35.71 70.81 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.405 ' O ' HG13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -58.12 -36.11 72.44 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 100' ' ' ALA . 3.3 t -70.35 -35.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.197 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.36 -46.72 86.39 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 120.899 1.681 . . . . 0.0 113.084 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.485 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.89 -36.04 75.13 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.683 HG23 HG11 ' A' ' 201' ' ' VAL . 77.6 mt -64.98 -50.31 75.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.305 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 m -65.42 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.27 -43.33 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.973 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -37.05 74.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.75 85.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.454 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt -66.76 -37.33 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.42 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 29' ' ' ILE . 1.1 tt -67.08 -24.44 65.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.4 p -61.4 -41.71 97.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.813 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.0 61.56 Favored Glycine 0 CA--C 1.51 -0.266 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -29.83 24.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.456 -0.872 . . . . 0.0 111.391 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.627 -179.185 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.501 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.54 117.11 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.2 0.524 . . . . 0.0 111.452 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 58.02 11.01 1.32 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.064 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -87.78 91.85 8.9 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.16 143.1 58.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.302 0.572 . . . . 0.0 111.101 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.95 134.71 49.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.636 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -49.79 127.58 16.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 128.94 -104.38 0.64 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.7 t -86.07 124.02 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.469 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.4 t30 -71.67 -171.78 0.71 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 102.823 -3.029 . . . . 0.0 102.823 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 p -62.2 -46.8 87.3 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 114.843 -2.743 . . . . 0.0 110.187 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.14 95.94 Favored Glycine 0 CA--C 1.498 -0.992 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.115 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.762 ' HB3' HG22 ' A' ' 133' ' ' VAL . 26.9 mm100 -53.46 -23.59 10.53 Favored 'General case' 0 C--N 1.248 -3.819 0 CA-C-O 121.496 0.665 . . . . 0.0 110.26 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -69.39 -1.54 29.21 Favored Glycine 0 C--O 1.188 -2.728 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.78 -50.32 65.14 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 118.556 1.178 . . . . 0.0 110.902 -176.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -38.23 76.36 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.582 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.7 OUTLIER -68.92 -38.32 78.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.18 -178.274 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' GLY . 20.4 mt-10 -68.54 -36.29 78.61 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-O 121.744 0.783 . . . . 0.0 111.123 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.704 HG23 ' CA ' ' A' ' 219' ' ' GLY . 31.7 mt -69.65 -45.46 77.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.395 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.496 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.31 -48.78 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.463 1.125 . . . . 0.0 111.27 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.56 58.03 Favored Glycine 0 C--O 1.211 -1.299 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.718 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.427 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 44.8 m -70.62 -40.16 73.32 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.673 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.616 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 3.6 tp -54.8 -40.55 69.59 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.277 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 1.1 pt20 -58.07 -31.1 66.76 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.241 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.005 HD11 HG22 ' A' ' 176' ' ' VAL . 1.6 tp -68.69 -47.17 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.49 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.482 HG21 ' CA ' ' A' ' 220' ' ' GLY . 87.2 t -66.33 -40.98 88.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -42.28 96.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.492 ' SG ' HG23 ' A' ' 172' ' ' ILE . 3.8 p -71.0 -27.18 63.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.457 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.527 HG21 HG21 ' A' ' 79' ' ' VAL . 2.3 t -72.09 -45.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.552 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.59 -41.98 92.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.372 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.56 87.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.519 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.613 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.508 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.613 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 24.3 Cg_exo -54.67 -39.39 89.27 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.524 1.483 . . . . 0.0 111.972 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 32.5 mt -60.54 -42.42 96.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.382 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.55 -47.06 57.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.703 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.492 HG23 ' SG ' ' A' ' 152' ' ' CYS . 41.6 mt -58.23 -37.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.62 -37.42 93.58 Favored Glycine 0 C--O 1.198 -2.125 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.306 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -55.13 -35.98 65.27 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -34.56 77.24 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.52 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 1.005 HG22 HD11 ' A' ' 149' ' ' LEU . 28.0 t -73.15 -47.6 46.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -66.72 -34.89 78.85 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.261 1.029 . . . . 0.0 109.667 -175.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 174' ' ' LEU 0.264 8.1 mt -67.06 -50.56 61.45 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 124.454 2.073 . . . . 0.0 110.863 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -36.97 65.38 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.117 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' HIS . . . . . 0.551 ' HD2' HD11 ' A' ' 191' ' ' ILE . 5.4 m-70 -70.38 -35.12 73.31 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 112.669 -1.766 . . . . 0.0 109.504 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.2 -47.81 83.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.519 -177.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.1 -52.33 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.757 ' HB3' HG23 ' A' ' 191' ' ' ILE . . . -70.15 -52.22 25.24 Favored 'General case' 0 C--O 1.206 -1.221 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 188' ' ' GLY . 7.4 mt -56.02 -49.03 77.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.914 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.644 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -69.02 -35.67 76.91 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 115.538 -2.465 . . . . 0.0 112.582 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 133' ' ' VAL . 2.4 m-85 -60.11 -30.35 69.2 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.721 -170.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.288 0.1 OUTLIER -124.54 -26.82 3.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.06 0.933 . . . . 0.0 113.101 -179.401 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 88.35 -5.99 84.09 Favored Glycine 0 CA--C 1.567 3.284 0 N-CA-C 106.165 -2.774 . . . . 0.0 106.165 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.446 ' H ' HG23 ' A' ' 187' ' ' THR . 17.1 t -85.36 130.68 34.54 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.47 160.65 10.04 Favored Glycine 0 N--CA 1.402 -3.625 0 CA-C-N 111.497 -2.592 . . . . 0.0 111.752 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.757 HG23 ' HB3' ' A' ' 183' ' ' ALA . 1.2 pt -72.11 -38.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.727 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 10.2 p-10 -85.88 139.19 34.99 Favored Pre-proline 0 N--CA 1.413 -2.32 0 CA-C-N 112.657 -2.065 . . . . 0.0 107.997 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -66.03 -14.46 44.53 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.49 2.127 . . . . 0.0 111.58 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.23 -33.23 61.33 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.466 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 15.6 tpt180 -70.74 -38.39 73.54 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.106 0.479 . . . . 0.0 110.158 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.4 t -73.44 -42.22 62.27 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.837 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 1.0 OUTLIER -71.96 -35.2 69.48 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 126.607 1.963 . . . . 0.0 114.777 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.41 93.12 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 m -76.38 -28.35 56.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.322 -0.939 . . . . 0.0 110.669 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.837 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -66.31 -34.22 77.49 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.743 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.683 HG11 HG23 ' A' ' 106' ' ' ILE . 3.4 m . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 121.79 2.086 . . . . 0.0 110.526 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.832 0.825 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -58.8 -36.19 74.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.058 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.27 -33.41 24.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 215' ' ' GLY . 12.0 p -77.74 -44.99 28.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.496 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.27 -47.73 73.13 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.682 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.1 Cg_endo -71.8 -28.62 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.936 2.424 . . . . 0.0 113.609 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -75.2 -33.81 61.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.051 0.453 . . . . 0.0 111.898 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 51.8 mt -70.58 -46.25 70.72 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.382 0 C-N-CA 123.892 0.877 . . . . 0.0 112.753 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.704 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.29 -45.84 67.61 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 128.343 3.527 . . . . 0.0 111.752 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.39 -48.91 34.71 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 118.306 -1.902 . . . . 0.0 109.532 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.81 68.31 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.601 0.715 . . . . 0.0 109.674 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.769 ' O ' HG23 ' A' ' 226' ' ' ILE . 1.0 OUTLIER -67.85 -31.33 71.08 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.225 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.99 -40.03 83.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.51 -50.28 80.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.488 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -39.56 93.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 222' ' ' LEU . 1.1 pp -68.99 -34.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.325 -176.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.3 t80 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.5 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.09 141.07 43.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.553 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -139.76 98.64 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.606 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -135.67 -42.08 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.542 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -110.1 86.93 2.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.545 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -82.37 145.32 29.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? 72.62 -64.85 0.38 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.68 0.612 . . . . 0.0 110.979 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttp 67.19 11.42 8.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.074 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 9' ' ' LEU . 8.8 mp 53.48 -179.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.848 0.356 . . . . 0.0 110.864 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -114.93 -44.69 3.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.522 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -141.13 156.38 45.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.3 mtt-85 -68.56 -0.23 4.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.926 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.63 -5.53 11.15 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.478 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 t -63.12 -40.26 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 9.0 p -68.23 -35.75 72.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 112.751 -2.022 . . . . 0.0 110.119 176.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.79 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -70.79 -46.54 62.69 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -176.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.3 -33.53 71.66 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 19' ' ' LEU . 11.6 mt -58.43 -38.32 77.23 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.992 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.6 -46.64 78.58 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 112.899 -1.955 . . . . 0.0 114.865 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 105' ' ' ALA . 0.2 OUTLIER -75.63 -31.32 59.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.506 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.724 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -70.33 -39.05 74.97 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 121.372 -0.83 . . . . 0.0 110.736 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -44.73 84.01 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.636 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -76.83 -52.5 9.4 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -177.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.48 -44.72 94.13 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.341 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.604 -177.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.513 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 63.3 t80 -54.3 -48.97 70.71 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.424 0.631 . . . . 0.0 112.337 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 pt -75.65 -29.54 20.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.52 -36.42 69.18 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -175.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.803 HG21 HD22 ' A' ' 112' ' ' LEU . 3.8 mm -60.84 -38.59 79.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 113.472 -1.694 . . . . 0.0 110.065 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.47 -36.8 64.65 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p -67.01 -41.28 86.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.54 -16.75 63.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.469 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.581 HD11 HD21 ' A' ' 112' ' ' LEU . 2.4 mt -83.69 -40.31 19.06 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.55 0.69 . . . . 0.0 110.232 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.64 -34.52 43.77 Favored Glycine 0 C--N 1.309 -0.954 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.523 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -24.63 60.2 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -106.77 -9.85 16.28 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.663 176.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.468 ' H ' ' C ' ' A' ' 34' ' ' GLY . 35.6 t80 -121.42 121.74 28.34 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 118.753 0.706 . . . . 0.0 110.197 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.95 139.42 52.13 Favored 'Cis proline' 0 N--CA 1.499 1.8 0 CA-C-N 119.836 0.977 . . . . 0.0 112.215 0.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -82.65 151.31 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.866 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.54 154.07 14.06 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.02 103.55 2.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.513 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -124.33 -31.63 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -125.67 -164.86 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.577 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 p -98.61 -24.8 14.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.69 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.7 138.97 58.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.749 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.3 p -135.15 133.46 53.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.184 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -105.95 125.26 50.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.084 0.469 . . . . 0.0 111.046 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.12 163.22 15.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.789 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -49.52 -28.47 5.53 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG22 HD21 ' A' ' 181' ' ' LEU . 18.4 t -58.77 -42.5 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 O-C-N 121.821 -0.55 . . . . 0.0 112.264 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -65.01 -53.98 37.49 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.729 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 33.9 m -67.84 -42.17 85.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-N 114.629 -1.168 . . . . 0.0 112.225 -176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.456 ' N ' HG23 ' A' ' 52' ' ' VAL . 72.8 m -69.39 -41.23 76.74 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.933 0.771 . . . . 0.0 109.806 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.815 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.8 OUTLIER -62.74 -31.74 72.73 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -65.08 -39.49 93.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 113.326 -1.761 . . . . 0.0 109.508 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 60' ' ' ILE . 16.5 m-30 -66.15 -46.92 75.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.7 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -60.23 -36.96 92.2 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 121.573 -0.346 . . . . 0.0 113.277 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.619 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 27.1 mt -68.28 -43.06 78.57 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.8 m -57.61 -35.86 71.02 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -175.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 176' ' ' VAL . 0.6 OUTLIER -60.23 -33.81 54.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.675 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.745 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -60.64 -45.53 93.73 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.51 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -68.8 -31.52 70.59 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.641 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -55.05 -42.59 72.9 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 104.199 -2.519 . . . . 0.0 104.199 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.98 -44.27 73.21 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 112.681 -2.054 . . . . 0.0 110.654 174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -43.57 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -176.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -59.25 -12.26 5.2 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 119.936 1.243 . . . . 0.0 111.856 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 m -119.76 -38.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 154.16 6.34 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -52.94 -22.74 5.96 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 70' ' ' ILE . 2.1 mp -70.89 7.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.56 135.71 53.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.11 -159.61 31.37 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.48 85.99 1.15 Allowed 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 118.574 -1.25 . . . . 0.0 107.776 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -19.54 64.46 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 112.794 -2.003 . . . . 0.0 105.684 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 pp -84.84 0.18 51.81 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.398 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -121.26 128.81 25.53 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-N 119.371 0.987 . . . . 0.0 113.517 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 97.9 Cg_endo -83.35 -25.34 2.66 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 122.717 2.278 . . . . 0.0 111.86 177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.56 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.27 -46.16 84.88 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.509 HG23 HD23 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -66.23 -36.8 78.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 110.802 177.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -64.68 -28.62 69.73 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.2 mt -57.21 -44.47 83.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 110.285 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.74 -38.24 95.89 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.8 tp -51.41 -41.26 60.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.576 0.227 . . . . 0.0 110.905 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 tp -48.33 -51.18 27.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.432 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 70.05 -69.95 0.16 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.156 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.0 p -176.91 51.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.748 0.309 . . . . 0.0 110.556 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.8 m -135.98 114.24 11.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.645 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -171.71 86.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.656 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.93 -70.17 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.505 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.3 m -144.9 91.05 2.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.55 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.9 mt 65.15 134.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.723 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.41 161.96 38.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.496 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.3 -37.33 64.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.496 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.724 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.7 -35.2 78.38 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.701 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 tp -54.78 -38.45 67.27 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -32.63 64.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.227 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -70.06 -38.65 75.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 119.287 0.949 . . . . 0.0 111.947 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.724 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -66.77 -41.25 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -178.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.49 -37.78 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.414 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.02 83.53 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.008 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -71.33 -35.89 71.37 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.438 ' O ' HG13 ' A' ' 106' ' ' ILE . 1.2 t -57.91 -36.14 72.03 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.57 -35.33 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.429 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.63 -47.37 85.22 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 120.781 1.628 . . . . 0.0 113.221 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB2' ' CG2' ' A' ' 21' ' ' THR . . . -69.8 -35.9 75.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 102' ' ' CYS . 69.5 mt -65.03 -50.36 75.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.98 -37.12 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.434 0.635 . . . . 0.0 109.48 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.724 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.45 -49.83 74.98 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.407 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.71 -37.02 86.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.727 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -44.89 88.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.942 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.19 -37.28 76.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.087 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.803 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -65.81 -24.36 66.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.601 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 t -63.3 -44.38 95.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.901 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.25 -36.33 62.16 Favored Glycine 0 CA--C 1.509 -0.299 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.4 -33.16 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 114.3 -0.95 . . . . 0.0 110.728 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.7 m -80.85 5.35 16.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.559 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.6 t -56.74 -35.02 68.12 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.524 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 t -92.16 -35.35 13.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.41 -177.49 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.43 124.91 48.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.72 78.4 0.26 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -98.07 -35.35 10.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.687 0.28 . . . . 0.0 111.006 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.49 58.27 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.075 0.464 . . . . 0.0 110.561 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.487 ' CD2' HD21 ' A' ' 33' ' ' LEU . 68.9 mt -81.74 7.95 11.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.284 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.79 81.85 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.54 117.2 31.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.281 0.563 . . . . 0.0 111.131 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.85 15.61 1.19 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.665 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.15 90.07 7.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 129' ' ' LEU . 1.2 mm? -63.1 142.8 58.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.317 0.58 . . . . 0.0 111.149 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.96 136.25 47.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.333 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 127.58 16.11 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.66 -105.05 0.65 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.8 t -86.09 124.13 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.48 ' O ' HG12 ' A' ' 133' ' ' VAL . 32.1 t30 -71.65 -171.95 0.73 Allowed 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 102.874 -3.01 . . . . 0.0 102.874 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -62.01 -46.86 87.34 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 114.928 -2.709 . . . . 0.0 110.239 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.53 96.17 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.18 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.754 ' HB3' HG22 ' A' ' 133' ' ' VAL . 0.3 OUTLIER -53.39 -23.53 9.9 Favored 'General case' 0 C--N 1.248 -3.809 0 CA-C-O 121.261 0.553 . . . . 0.0 110.796 -176.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -70.33 -1.95 38.53 Favored Glycine 0 C--O 1.187 -2.794 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.98 -50.64 71.26 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.521 -1.576 . . . . 0.0 110.168 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.71 -45.94 56.27 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.748 HD13 HG21 ' A' ' 133' ' ' VAL . 0.5 OUTLIER -60.88 -42.08 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.184 -1.508 . . . . 0.0 112.084 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' A' ' 138' ' ' GLY . 8.3 tt0 -68.37 -36.32 79.02 Favored 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 123.687 0.795 . . . . 0.0 112.305 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.646 HG23 ' CA ' ' A' ' 219' ' ' GLY . 25.4 mt -67.65 -47.68 79.18 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.404 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 26.9 mt -68.33 -46.79 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 122.059 0.933 . . . . 0.0 111.695 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.536 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -60.18 -49.94 73.04 Favored Glycine 0 C--O 1.211 -1.335 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.323 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.5 ' HA ' HG23 ' A' ' 191' ' ' ILE . 28.1 m -70.58 -38.22 74.03 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.923 0.868 . . . . 0.0 111.13 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.612 ' O ' HD12 ' A' ' 147' ' ' LEU . 1.7 tp -54.98 -40.22 69.83 Favored 'General case' 0 CA--C 1.488 -1.44 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.048 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.8 OUTLIER -58.77 -31.06 68.02 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.051 -1.886 . . . . 0.0 110.325 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.0 HD11 HG22 ' A' ' 176' ' ' VAL . 1.8 tp -68.91 -46.69 67.67 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.353 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.491 HG21 ' HA3' ' A' ' 220' ' ' GLY . 38.9 t -66.35 -45.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.451 0.167 . . . . 0.0 111.451 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -31.87 72.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.089 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.09 -45.43 62.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 -48.1 80.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 111.119 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.84 -31.69 72.95 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.488 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.9 OUTLIER -63.8 -36.96 85.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.468 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.39 -8.83 52.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.358 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.61 135.69 53.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.785 0.326 . . . . 0.0 110.556 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -26.93 32.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -52.11 174.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.563 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.5 ttp85 -127.74 125.45 39.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.548 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.44 -58.18 0.11 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.59 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.87 107.93 9.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.588 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.16 133.2 38.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.41 83.95 0.11 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.89 -137.35 13.48 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.4 ' HB3' HD12 ' A' ' 170' ' ' LEU . 0.2 OUTLIER -110.72 141.57 43.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 0.0 110.59 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.537 ' HB3' ' HD3' ' A' ' 169' ' ' PRO . . . -52.37 -46.12 94.74 Favored Pre-proline 0 C--O 1.219 -0.505 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.433 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 39.5 Cg_exo -54.31 -44.24 51.24 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.795 1.663 . . . . 0.0 112.019 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.4 HD12 ' HB3' ' A' ' 167' ' ' SER . 1.8 mp -66.1 -38.1 87.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.362 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.52 -47.26 56.38 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 22.2 pt -60.26 -38.3 76.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 109.721 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.41 93.53 Favored Glycine 0 C--O 1.2 -1.994 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.681 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.8 mt -55.04 -35.58 64.63 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 105.161 -2.162 . . . . 0.0 105.161 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -34.54 77.18 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.31 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 1.0 HG22 HD11 ' A' ' 149' ' ' LEU . 52.9 t -73.04 -47.24 48.73 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.907 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 -175.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.815 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -67.53 -33.61 75.41 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 122.665 1.222 . . . . 0.0 110.027 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.258 0.1 OUTLIER -70.61 -47.49 59.85 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.973 179.375 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.494 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.64 -36.84 65.94 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 111.564 -2.562 . . . . 0.0 107.664 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.481 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 6.2 m170 -70.46 -34.99 73.06 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.933 -1.633 . . . . 0.0 109.54 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.02 -48.43 81.61 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.359 -177.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.536 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.41 -52.07 11.6 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 178.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -69.66 -51.96 30.04 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -176.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 180' ' ' HIS . 5.6 mt -62.11 -49.14 85.29 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.807 0 C-N-CA 118.927 -1.109 . . . . 0.0 113.039 -174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -67.28 -35.51 79.64 Favored 'General case' 0 C--N 1.277 -2.586 0 C-N-CA 116.119 -2.232 . . . . 0.0 112.818 -176.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.95 -30.4 69.05 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.909 -1.116 . . . . 0.0 111.699 -171.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.295 0.1 OUTLIER -124.31 -26.91 3.86 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.267 1.032 . . . . 0.0 113.182 -178.79 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.61 -5.74 84.51 Favored Glycine 0 CA--C 1.567 3.296 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -170.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.408 ' H ' HG23 ' A' ' 187' ' ' THR . 15.4 t -82.68 127.89 33.83 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.596 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -44.33 170.35 0.01 OUTLIER Glycine 0 N--CA 1.412 -2.935 0 CA-C-N 111.358 -2.655 . . . . 0.0 113.363 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -79.76 -40.14 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 173.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.2 p-10 -101.32 153.12 38.01 Favored Pre-proline 0 N--CA 1.407 -2.614 0 CA-C-N 111.432 -2.622 . . . . 0.0 108.361 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.46 -14.59 44.75 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 122.879 2.386 . . . . 0.0 111.661 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.622 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.11 -34.5 61.72 Favored 'General case' 0 C--O 1.224 -0.249 0 O-C-N 123.102 0.251 . . . . 0.0 111.094 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.596 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.52 -39.67 73.93 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.214 0.531 . . . . 0.0 109.928 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -36.49 66.39 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.008 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.814 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 6.1 t80 -72.26 -35.2 68.71 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 126.517 1.927 . . . . 0.0 114.268 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -46.77 91.73 Favored Glycine 0 C--N 1.319 -0.373 0 N-CA-C 107.403 -2.279 . . . . 0.0 107.403 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.3 56.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.569 -0.816 . . . . 0.0 110.19 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.814 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -63.33 -34.07 76.89 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.514 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.429 HG23 ' CE2' ' A' ' 197' ' ' PHE . 0.9 OUTLIER -63.85 -31.74 54.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 121.031 1.741 . . . . 0.0 110.425 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.9 mt -63.52 -63.22 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.64 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 71.5 m -116.56 110.47 18.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.622 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -79.74 158.64 26.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.454 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -143.88 -166.72 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.715 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -91.36 -143.75 0.19 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.347 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -53.16 -20.61 4.05 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.154 -0.341 . . . . 0.0 111.287 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -55.19 -35.23 64.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.895 0.379 . . . . 0.0 110.302 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.52 -28.64 62.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -70.58 -37.55 73.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.463 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.6 mt -52.64 -35.11 20.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.73 0.776 . . . . 0.0 109.155 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.53 -36.57 74.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.049 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -84.21 -33.46 24.14 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 215' ' ' GLY . 15.0 p -79.09 -43.97 24.29 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.509 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.12 -44.15 83.6 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.417 -176.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.6 Cg_exo -71.65 -28.72 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.258 . . . . 0.0 113.106 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -78.03 -32.14 50.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.146 0.498 . . . . 0.0 112.29 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.549 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.2 mm -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.255 0 C-N-CA 123.743 0.817 . . . . 0.0 112.164 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.646 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.71 -46.6 67.04 Favored Glycine 0 C--N 1.361 1.95 0 O-C-N 128.758 3.786 . . . . 0.0 111.731 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.31 -49.03 34.66 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 118.171 -1.966 . . . . 0.0 109.906 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -39.04 68.47 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.649 0.738 . . . . 0.0 109.713 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.86 -31.24 70.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.223 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.58 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.84 -39.68 81.98 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 55.0 t -58.17 -49.65 80.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.832 -1.531 . . . . 0.0 112.352 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.84 -39.42 91.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.754 0.788 . . . . 0.0 109.771 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.2 mt -58.27 -34.72 50.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.069 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -140.95 72.12 1.38 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.563 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -166.35 68.71 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.635 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -101.42 175.69 5.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.379 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 10.7 mm 58.25 98.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.404 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.94 143.66 26.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.565 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -159.83 68.67 3.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.535 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -47.52 106.39 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.811 2.341 . . . . 0.0 112.094 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 64.79 118.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.565 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.65 106.66 8.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.555 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.31 -28.06 15.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.615 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 38.0 t70 59.33 97.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.628 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.3 mt -50.48 -63.33 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.585 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.6 t -162.05 65.51 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.518 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 62.2 t0 55.13 95.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.58 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 55.64 -176.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.583 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 26.0 m -141.36 26.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -166.33 159.45 14.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.59 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 1.1 t -132.33 151.26 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.56 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -126.48 -26.71 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.541 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 1.7 m -151.69 104.79 3.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.544 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 28.0 t -57.82 164.36 2.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.553 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 114.97 -54.94 0.55 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -90.87 151.87 20.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 110.563 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 92.9 t -125.8 -40.13 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.62 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -97.79 -66.52 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.632 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -173.61 76.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.579 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -114.37 138.13 50.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.549 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.03 -27.63 14.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.568 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.51 172.03 7.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -141.49 54.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.571 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -53.85 173.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.57 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -132.87 38.97 3.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.559 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 56.72 78.6 0.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.596 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.63 -50.49 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.556 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -131.26 90.99 2.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.52 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 1.7 m -66.61 112.14 4.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.609 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -94.42 -58.88 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.545 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 85.1 t -115.36 105.17 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -129.12 -46.8 1.22 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.613 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 8.4 mmm -103.3 111.56 24.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.589 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -46.92 106.55 0.59 Allowed Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.727 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -47.4 -32.76 15.64 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.877 1.718 . . . . 0.0 112.087 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 270' ' ' ALA . 23.5 pttm -174.84 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.549 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 269' ' ' LYS . . . 64.8 105.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.587 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.5 tt 62.35 101.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.539 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -53.37 159.59 1.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -124.22 -50.9 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.568 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -157.52 -51.27 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.57 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 64.83 -82.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.818 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 276' ' ' ILE . 1.0 OUTLIER 75.36 -6.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.418 0.449 . . . . 0.0 111.838 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.15 138.22 7.67 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.612 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -99.97 173.66 6.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.622 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -60.13 -31.71 70.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.524 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.34 -75.75 0.06 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.73 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 49.44 30.02 3.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.807 0.337 . . . . 0.0 110.637 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 21.2 t30 63.66 163.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.536 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.8 m -130.03 59.32 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.615 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.16 -37.07 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.597 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.1 91.04 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.521 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -93.98 83.62 4.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.536 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -106.71 -28.65 10.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.552 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -82.41 162.53 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.591 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 13.0 m170 55.97 95.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -134.47 -76.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.591 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 37.6 m80 53.54 48.4 21.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.568 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.555 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtp . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.03 33.15 5.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.54 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.7 p -166.24 118.75 1.05 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.564 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.42 25.29 7.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 49.87 35.07 8.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.46 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -91.22 -43.27 9.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.643 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt 53.69 93.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.581 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -106.4 101.5 10.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.66 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.19 -79.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.446 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -141.79 -84.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.368 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 73.74 -54.93 0.68 Allowed 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.441 0.463 . . . . 0.0 111.36 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.63 1.6 6.44 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.24 -14.4 11.08 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.027 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.01 -40.17 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 17.4 m -68.43 -35.81 72.24 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 CA-C-N 112.83 -1.986 . . . . 0.0 110.521 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.18 70.07 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -175.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.683 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 11.1 mm-40 -70.81 -46.72 62.29 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.11 -33.83 74.1 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 11.4 mt -58.63 -38.37 77.93 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.911 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.58 -46.99 77.27 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 112.781 -2.009 . . . . 0.0 114.749 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -75.65 -31.53 59.83 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.735 -177.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.74 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.79 -36.88 67.69 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.507 -0.745 . . . . 0.0 111.607 -179.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -66.05 -45.22 82.15 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -77.18 -47.7 19.59 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 29' ' ' ILE . 90.2 t -65.28 -49.82 76.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.457 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.137 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.475 ' CE1' HD12 ' A' ' 112' ' ' LEU . 55.7 t80 -54.07 -48.07 71.01 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.5 -29.43 20.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.743 -0.783 . . . . 0.0 109.616 178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -36.17 68.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.6 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -60.11 -43.74 93.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 113.764 -1.562 . . . . 0.0 110.192 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.76 63.87 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -67.33 -38.1 84.35 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.605 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' A' ' 52' ' ' VAL . . . -69.45 -46.48 66.62 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.451 HD13 ' HA3' ' A' ' 121' ' ' GLY . 2.8 pp -85.94 -39.88 16.46 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' N ' HD12 ' A' ' 33' ' ' LEU . . . -69.81 -35.24 72.83 Favored Glycine 0 CA--C 1.506 -0.488 0 CA-C-O 119.284 -0.731 . . . . 0.0 113.77 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.79 -20.04 46.37 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.326 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.71 -9.85 16.32 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.798 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' H ' ' C ' ' A' ' 34' ' ' GLY . 0.5 OUTLIER -120.98 120.1 29.5 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 118.234 0.47 . . . . 0.0 110.312 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.24 141.92 69.09 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 C-N-CA 124.655 -0.977 . . . . 0.0 112.105 -0.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.75 150.97 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.686 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.73 88.73 0.34 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -77.24 155.54 32.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.321 . . . . 0.0 110.625 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -94.64 26.4 3.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.574 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 74.63 -7.89 1.62 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.952 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.56 -31.23 4.95 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-O 120.908 0.385 . . . . 0.0 110.488 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.61 143.38 57.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.565 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.55 115.68 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.758 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -100.51 105.9 17.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.408 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 81.7 m-20 -114.31 163.08 15.77 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-O 121.08 0.466 . . . . 0.0 111.683 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.75 -28.02 5.64 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.403 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.566 HG12 HD21 ' A' ' 181' ' ' LEU . 24.5 m -56.74 -43.85 80.34 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.549 ' NZ ' HG23 ' A' ' 52' ' ' VAL . 1.7 pttp -64.77 -50.46 66.71 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 2.0 t -67.91 -47.65 78.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.647 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.8 m -69.31 -37.18 77.64 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.907 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.787 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 2.5 tm? -64.43 -32.01 73.46 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -62.35 -39.49 93.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 113.824 -1.534 . . . . 0.0 109.327 178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -65.89 -44.27 85.78 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.76 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.48 -41.55 97.93 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -68.26 -43.92 76.73 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.749 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.467 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -61.04 -36.53 79.82 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.438 HD13 HD21 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -59.87 -33.89 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.006 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.752 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -68.61 -45.63 71.41 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 113.857 -1.519 . . . . 0.0 113.016 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.0 p -67.36 -31.88 72.43 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.586 HD13 HD22 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -55.35 -41.26 72.28 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 -179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.9 -44.14 73.81 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 112.845 -1.98 . . . . 0.0 109.788 173.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.68 -38.03 85.96 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.8 m -59.54 -12.13 5.91 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 119.754 1.161 . . . . 0.0 111.503 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.27 -42.91 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.936 0.398 . . . . 0.0 111.133 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.44 171.77 13.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -65.26 -23.05 66.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.767 0.318 . . . . 0.0 111.008 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.45 7.11 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.45 135.65 53.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.049 0.452 . . . . 0.0 111.051 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.92 -157.86 16.89 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.36 86.04 1.11 Allowed 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 122.507 1.146 . . . . 0.0 108.085 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -19.61 62.38 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.4 pp -84.53 4.58 31.3 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 113.669 -1.605 . . . . 0.0 111.625 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.447 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 14.5 t-20 -125.49 126.11 25.05 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -177.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.547 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 71.9 Cg_endo -83.23 -24.02 3.3 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.883 2.389 . . . . 0.0 111.632 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -66.16 -50.84 62.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -36.67 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 120.896 -0.321 . . . . 0.0 110.923 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 m -61.21 -32.23 72.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 217' ' ' PHE . 34.4 tp -57.27 -44.61 84.13 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.044 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -53.25 -45.87 63.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.9 -44.29 66.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 111.008 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -49.04 -32.0 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.512 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 55.9 57.64 5.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.537 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.92 116.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.6 t -169.65 -59.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.442 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -174.74 55.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.516 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.1 tt -176.9 146.77 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.678 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 p -116.12 178.7 4.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.524 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.8 mt -132.38 -31.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.7 t80 75.22 -53.72 0.66 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.695 0.622 . . . . 0.0 111.132 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 -59.03 -36.02 74.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.862 0.363 . . . . 0.0 110.792 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.91 -35.13 77.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.543 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.682 ' O ' HG13 ' A' ' 98' ' ' ILE . 3.1 mm? -54.54 -38.18 66.3 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.2 mtm -73.71 -33.3 64.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.767 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -69.99 -37.84 75.84 Favored 'General case' 0 C--N 1.318 -0.772 0 O-C-N 121.096 -1.003 . . . . 0.0 111.044 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.805 HG23 ' O ' ' A' ' 94' ' ' ALA . 1.8 pp -66.81 -42.55 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.384 -177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.3 pp -71.12 -37.73 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.48 -47.37 70.27 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -71.96 -35.97 69.72 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.669 0.668 . . . . 0.0 112.399 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 m -58.1 -35.88 72.07 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.52 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.8 t -70.4 -35.36 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.063 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.82 -42.07 91.59 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 121.152 1.796 . . . . 0.0 112.519 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.469 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.95 -36.1 75.0 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 103' ' ' VAL . 37.0 mt -67.99 -42.41 85.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.575 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.4 t -69.93 -37.18 72.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.294 0.569 . . . . 0.0 110.107 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.63 -49.74 75.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.445 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 35.8 m -65.88 -37.1 85.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.457 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -43.53 88.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.735 0.303 . . . . 0.0 111.135 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.27 -50.5 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.28 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.6 HD22 HG21 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -58.85 -24.2 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.537 -179.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -42.63 95.51 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.771 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.26 61.95 Favored Glycine 0 CA--C 1.511 -0.178 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.4 -31.95 44.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.307 -0.947 . . . . 0.0 110.779 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p -85.35 5.57 30.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.582 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 91.9 p -53.65 -26.08 20.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.702 0.286 . . . . 0.0 110.967 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.73 3.61 9.45 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.918 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.8 tp 67.71 20.2 9.55 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.589 0.233 . . . . 0.0 110.789 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 t -118.46 164.14 15.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.343 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.451 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 45.74 36.01 6.2 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -71.14 -6.38 38.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.447 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -79.71 76.23 6.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.955 0.407 . . . . 0.0 110.146 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt -85.26 7.93 20.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.479 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.32 31.33 57.27 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.56 117.49 32.46 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.125 -0.538 . . . . 0.0 111.778 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 60.23 9.19 1.81 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.02 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -87.68 88.32 7.63 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.12 143.24 57.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.254 0.55 . . . . 0.0 110.88 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.05 135.7 48.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.679 -178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -49.64 127.45 15.76 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.6 -105.35 0.67 Allowed Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.86 HG21 HD13 ' A' ' 141' ' ' ILE . 1.6 t -85.83 123.93 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.461 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.5 m-20 -71.71 -171.85 0.73 Allowed 'General case' 0 C--O 1.202 -1.422 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -61.92 -46.74 88.05 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 114.807 -2.757 . . . . 0.0 110.409 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.04 -41.24 96.37 Favored Glycine 0 CA--C 1.499 -0.934 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.071 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.782 ' HB3' HG22 ' A' ' 133' ' ' VAL . 4.5 mt-30 -53.53 -23.42 10.48 Favored 'General case' 0 C--N 1.249 -3.789 0 CA-C-O 121.238 0.542 . . . . 0.0 110.237 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.565 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.65 -1.72 24.89 Favored Glycine 0 C--O 1.19 -2.597 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.43 -50.23 66.19 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 118.489 1.144 . . . . 0.0 110.322 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -40.96 75.16 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.86 HD13 HG21 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -66.17 -38.77 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 113.155 -1.523 . . . . 0.0 112.087 -178.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 32.5 mt-10 -68.46 -36.24 78.71 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 121.948 0.88 . . . . 0.0 111.039 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.756 HG23 ' HA2' ' A' ' 219' ' ' GLY . 35.6 mt -67.29 -48.47 77.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.199 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.627 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.26 -48.47 73.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 122.088 0.947 . . . . 0.0 111.424 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.53 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -59.25 -51.97 56.02 Favored Glycine 0 C--O 1.211 -1.329 0 CA-C-N 113.466 -1.697 . . . . 0.0 113.138 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.401 ' HA ' HG23 ' A' ' 191' ' ' ILE . 24.2 m -70.39 -40.42 73.94 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.5 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 148' ' ' GLN . 0.5 OUTLIER -54.64 -40.11 68.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -176.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.46 ' N ' HD23 ' A' ' 147' ' ' LEU . 1.1 pt20 -58.0 -30.82 66.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.02 HD11 HG22 ' A' ' 176' ' ' VAL . 1.3 tp -68.75 -46.72 68.09 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.426 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.41 HG21 ' HA3' ' A' ' 220' ' ' GLY . 78.9 t -66.26 -41.03 88.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -35.65 81.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.442 0.297 . . . . 0.0 111.463 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 -34.47 77.36 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.644 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.01 -38.53 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.847 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.4 mp -65.33 -48.02 74.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.81 0.338 . . . . 0.0 110.971 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.6 -31.76 72.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.42 HG23 ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -67.53 -37.23 82.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.193 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.401 HG23 HG22 ' A' ' 156' ' ' THR . 4.4 p -98.85 10.08 42.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -73.17 118.3 15.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.867 0.365 . . . . 0.0 110.568 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.86 -25.95 23.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -54.74 -62.01 1.94 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.659 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -83.78 117.95 23.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -84.6 -174.15 5.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.423 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.54 159.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.598 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.28 123.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.427 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -74.28 119.95 6.43 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.11 -157.22 38.76 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.429 ' CB ' HD13 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -111.49 142.24 44.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.087 0.47 . . . . 0.0 110.871 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 169' ' ' PRO . . . -52.63 -49.42 86.25 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.479 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 17.9 Cg_endo -61.32 -36.78 77.3 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.007 1.138 . . . . 0.0 111.692 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.429 HD13 ' CB ' ' A' ' 167' ' ' SER . 3.6 mp -66.22 -44.95 82.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.87 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.4 -47.43 56.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.2 -37.21 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.515 0.674 . . . . 0.0 109.446 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.48 93.47 Favored Glycine 0 C--O 1.2 -2.013 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.755 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.3 OUTLIER -54.92 -35.65 64.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -34.49 77.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.421 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 1.02 HG22 HD11 ' A' ' 149' ' ' LEU . 16.7 t -73.16 -47.38 47.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.787 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.37 -30.73 67.73 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 122.528 1.156 . . . . 0.0 110.195 -175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.578 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.28 2.6 mm? -70.43 -50.88 33.87 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 124.874 2.274 . . . . 0.0 109.528 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.487 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.53 -36.92 65.36 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 110.559 -3.019 . . . . 0.0 107.114 -177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.427 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.4 m-70 -69.08 -35.22 76.28 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.334 -1.433 . . . . 0.0 109.657 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.95 -48.34 81.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.234 -177.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.53 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.32 -52.07 11.69 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 178.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.567 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -69.79 -52.03 28.75 Favored 'General case' 0 C--O 1.201 -1.456 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -176.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.501 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 12.8 mt -60.16 -41.82 88.0 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.602 0 C-N-CA 118.731 -1.188 . . . . 0.0 113.244 -174.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.6 OUTLIER -75.84 -35.68 59.87 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 115.911 -2.316 . . . . 0.0 112.564 -176.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.01 -29.68 68.65 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.385 -171.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.283 0.1 OUTLIER -124.43 -26.8 3.84 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.063 -178.989 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.74 -5.97 84.15 Favored Glycine 0 CA--C 1.566 3.256 0 N-CA-C 106.046 -2.822 . . . . 0.0 106.046 -170.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.424 ' H ' HG23 ' A' ' 187' ' ' THR . 9.4 t -82.28 127.74 33.5 Favored 'General case' 0 N--CA 1.406 -2.627 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.447 ' HA2' HG12 ' A' ' 184' ' ' ILE . . . -47.83 164.37 0.23 Allowed Glycine 0 N--CA 1.408 -3.226 0 CA-C-N 111.146 -2.752 . . . . 0.0 112.497 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.567 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.6 OUTLIER -72.34 -33.6 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 174.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.2 p-10 -109.73 152.44 42.89 Favored Pre-proline 0 N--CA 1.415 -2.217 0 CA-C-N 112.544 -2.116 . . . . 0.0 109.288 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.08 -14.66 45.4 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.618 2.212 . . . . 0.0 111.686 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.547 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.39 -35.75 60.99 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.697 0.285 . . . . 0.0 110.498 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -41.16 72.94 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.336 0.589 . . . . 0.0 109.85 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.31 -32.61 64.71 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.475 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.834 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.9 m-85 -72.27 -35.24 68.69 Favored 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 126.464 1.906 . . . . 0.0 113.948 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.6 -44.44 93.9 Favored Glycine 0 C--N 1.318 -0.456 0 N-CA-C 106.971 -2.451 . . . . 0.0 106.971 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.53 -28.21 56.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.088 -1.056 . . . . 0.0 110.842 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.19 75.74 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.42 -31.96 51.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 121.598 1.999 . . . . 0.0 110.929 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.0 pt -87.18 45.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.639 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.13 140.32 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.364 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -49.73 -63.12 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.416 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.35 159.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.912 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -132.92 -157.74 0.84 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.021 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.0 -24.29 9.21 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.519 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -57.88 -35.07 70.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.801 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 -24.01 3.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.155 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.87 -38.11 73.09 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.62 -35.18 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.788 0.804 . . . . 0.0 109.549 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -58.92 -37.5 76.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.027 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -84.28 -33.53 23.97 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.6 p -80.49 -40.06 19.19 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -176.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.517 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.0 -48.23 68.52 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.976 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.8 Cg_endo -71.96 -38.97 3.53 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 123.046 2.497 . . . . 0.0 113.675 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.451 ' CD2' HD22 ' A' ' 81' ' ' LEU . 1.8 m-85 -63.25 -39.79 95.59 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.645 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 7.9 mm -70.31 -46.55 70.98 Favored 'Isoleucine or valine' 0 C--O 1.169 -3.148 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.67 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.756 ' HA2' HG23 ' A' ' 143' ' ' ILE . . . -55.18 -45.64 81.71 Favored Glycine 0 C--N 1.364 2.128 0 O-C-N 128.529 3.643 . . . . 0.0 111.339 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -69.13 -41.41 80.58 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.19 -34.83 61.48 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.7 mt -67.69 -36.92 81.54 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.38 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -59.06 -39.58 82.53 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.277 -174.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 88.4 t -58.38 -49.7 81.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.638 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.19 -39.46 94.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.61 0.719 . . . . 0.0 110.155 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt -57.14 -34.81 46.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.119 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -141.26 72.11 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.437 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -174.36 57.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.566 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.66 83.83 7.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 11.5 pt -83.23 -176.88 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.571 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.98 126.05 55.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.638 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.691 ' HB3' ' HD3' ' A' ' 233' ' ' PRO . . . -76.3 -55.14 1.79 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.236 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.691 ' HD3' ' HB3' ' A' ' 232' ' ' ALA . 62.2 Cg_exo -46.17 169.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.021 1.814 . . . . 0.0 112.465 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 58.14 91.78 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.632 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.43 137.07 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.576 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.64 -61.28 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.601 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 4.0 t70 64.59 158.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.489 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 56.56 97.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.665 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.84 162.28 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.667 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -71.95 -177.73 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.55 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -142.89 48.27 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 18.5 t 55.76 70.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.482 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.59 113.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.607 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.6 t 59.54 86.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.543 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -77.76 -176.28 4.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.541 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 4.4 m 70.11 -70.34 0.15 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.844 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.7 t -142.99 74.8 1.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.568 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -81.24 69.25 3.3 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 56.75 38.26 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.609 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.69 -44.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.593 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 61.33 87.18 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.59 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -67.76 -61.03 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.603 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -155.66 -41.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.569 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.19 164.55 0.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.594 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.89 -65.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.486 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 59.89 93.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.558 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -121.76 102.54 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.603 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -127.72 177.27 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.556 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.9 127.77 34.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.583 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 4.4 mt 57.19 99.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.618 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.01 103.5 7.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.594 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.8 t -126.13 31.64 5.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -113.64 59.0 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.563 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.07 31.27 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.612 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -132.3 148.64 52.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.572 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 6.9 mtp -71.32 -165.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.491 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -137.3 72.0 52.75 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.573 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -47.4 -42.33 28.24 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.745 2.297 . . . . 0.0 112.229 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -89.97 174.6 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.504 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 53.32 89.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.558 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.5 mt -76.99 175.31 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.559 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -85.78 136.21 33.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.466 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.68 -53.78 2.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.617 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -77.24 131.76 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.643 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.5 mp -52.87 -73.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.581 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 4.2 tt -154.49 21.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.766 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 3.3 m 49.41 81.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.733 0.301 . . . . 0.0 110.67 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -174.02 -178.12 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.557 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -96.78 128.24 43.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.544 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.25 112.32 10.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.569 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 3.1 mt -128.41 53.15 1.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.559 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -143.95 -59.08 0.39 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.527 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.0 m -77.6 118.23 19.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.602 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -102.79 -30.8 10.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.561 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.41 -34.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.571 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.13 121.1 8.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -114.05 121.38 43.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.581 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 1.7 t60 65.29 143.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.54 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -128.93 161.28 30.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.555 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.5 m80 49.97 83.1 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.619 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.76 178.14 0.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.579 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 7.4 t60 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.62 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.07 63.29 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.635 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -141.18 -54.16 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.558 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.27 -21.5 17.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.753 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 66.17 172.66 0.24 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.538 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -100.4 83.37 2.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.678 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -76.3 -37.74 57.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.428 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.51 171.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.646 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.83 140.6 49.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.466 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.56 105.63 17.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.63 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -114.63 -27.66 7.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.418 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -57.1 -15.93 6.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.332 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.54 -0.5 13.03 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.814 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.54 -40.34 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 103.493 -2.78 . . . . 0.0 103.493 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.3 m -68.3 -35.77 72.33 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.762 0 CA-C-N 112.506 -2.134 . . . . 0.0 109.932 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.15 -35.02 69.01 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.703 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -70.99 -46.72 61.8 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -177.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -34.23 73.48 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.6 tp -59.05 -38.08 78.51 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 112.174 -2.284 . . . . 0.0 108.748 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -64.09 -46.82 82.55 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 112.909 -1.951 . . . . 0.0 114.355 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.91 -31.51 59.21 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.099 -177.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.72 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.89 -38.18 67.05 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.548 -0.72 . . . . 0.0 112.091 -178.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.409 ' O ' HG12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.515 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -76.9 -49.55 15.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -178.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 29' ' ' ILE . 97.7 t -65.33 -48.46 83.17 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.358 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.363 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.432 ' CE1' HD12 ' A' ' 112' ' ' LEU . 50.1 t80 -53.95 -48.51 70.2 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.6 -29.21 20.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.387 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -36.2 67.41 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -175.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.627 HG21 HD22 ' A' ' 112' ' ' LEU . 2.8 mm -63.06 -41.74 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.311 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.5 -38.83 71.89 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -37.97 84.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.96 -46.02 72.57 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.57 -30.64 23.19 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -75.82 -34.47 48.25 Favored Glycine 0 C--N 1.318 -0.468 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.391 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -19.51 45.03 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.476 ' O ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -106.69 -9.65 16.41 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.237 177.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.44 ' H ' ' C ' ' A' ' 34' ' ' GLY . 3.7 t80 -126.34 119.97 23.44 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 118.168 0.44 . . . . 0.0 110.14 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -68.3 139.93 52.91 Favored 'Cis proline' 0 N--CA 1.498 1.74 0 C-N-CA 124.714 -0.953 . . . . 0.0 111.774 -1.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 36' ' ' LYS . 15.6 m -63.96 151.36 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.528 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.24 172.68 49.75 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -177.83 -41.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.858 0.361 . . . . 0.0 110.301 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -125.83 -25.62 3.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.558 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -60.79 179.96 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.604 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 -19.74 8.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.04 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.27 147.92 29.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.665 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.73 136.16 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.287 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -106.61 114.1 28.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.227 0.536 . . . . 0.0 111.418 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.23 163.04 15.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.393 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -49.87 -28.59 6.76 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.535 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG13 ' CE ' ' A' ' 51' ' ' LYS . 1.3 p -57.14 -39.02 64.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' CE ' HG13 ' A' ' 50' ' ' VAL . 4.6 mmtp -64.7 -54.08 37.26 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.728 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 94.5 t -67.75 -45.65 84.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.724 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 m -69.29 -39.18 78.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.785 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 62.5 tp -63.0 -31.68 72.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.45 -39.38 94.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.231 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -65.88 -43.36 88.51 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.745 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.69 -43.02 96.94 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.275 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 1.0 OUTLIER -68.2 -43.77 77.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.597 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -36.7 76.26 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.698 HD13 HD21 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -59.96 -34.13 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 CA-C-N 113.228 -1.805 . . . . 0.0 108.13 -178.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.758 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -64.48 -45.76 85.96 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.174 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.41 ' H ' HG23 ' A' ' 62' ' ' THR . 8.3 p -70.12 -31.7 69.36 Favored 'General case' 0 CA--C 1.472 -2.021 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.833 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -55.28 -40.78 71.44 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.96 -44.25 73.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.218 -1.81 . . . . 0.0 109.828 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.4 ' CB ' ' HA ' ' A' ' 62' ' ' THR . 21.6 tp60 -66.8 -39.0 87.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -12.21 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 119.978 1.263 . . . . 0.0 111.329 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.81 -37.12 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.765 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.25 154.52 6.87 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -53.29 -22.91 7.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.934 0.397 . . . . 0.0 111.065 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 tt -74.34 7.08 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.1 m -124.3 135.59 53.48 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.129 0.49 . . . . 0.0 111.57 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.48 -159.37 24.95 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.57 85.9 1.17 Allowed 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 118.254 -1.378 . . . . 0.0 108.589 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.833 HD22 ' HG ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -82.41 8.44 11.46 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.122 -1.854 . . . . 0.0 112.235 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.522 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -136.95 140.09 30.59 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 119.333 0.97 . . . . 0.0 112.676 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 62.5 Cg_endo -83.67 -30.62 0.74 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 123.27 2.647 . . . . 0.0 112.563 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.713 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -60.12 -50.64 72.9 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.391 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.458 ' CG2' HG21 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -66.31 -36.69 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -30.89 70.71 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.478 HD22 ' CG ' ' A' ' 217' ' ' PHE . 13.7 tp -57.93 -38.0 75.14 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.242 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -57.32 -44.57 93.4 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.4 -21.89 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.643 0.259 . . . . 0.0 111.326 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tp -52.11 -70.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.01 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.52 46.84 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.903 0.382 . . . . 0.0 110.71 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.7 t -125.37 -26.16 3.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.518 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.81 111.42 13.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.562 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 70.56 0.93 3.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.791 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mp 45.92 57.86 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 120.658 0.265 . . . . 0.0 111.296 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 t 179.37 -84.9 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.012 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.2 mt 61.37 149.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 110.926 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -127.57 -40.82 1.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.891 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -54.26 -37.6 64.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.064 0.459 . . . . 0.0 110.583 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.85 -35.0 77.79 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.212 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.58 -38.49 66.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.5 ttt -70.63 -38.76 73.92 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.542 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -62.59 -37.59 86.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 119.332 0.969 . . . . 0.0 109.67 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -58.09 -47.22 87.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.368 -178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.434 ' N ' HG22 ' A' ' 98' ' ' ILE . 4.3 tp -70.35 -37.8 72.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . . . -64.94 -47.43 77.68 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.529 -177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -35.18 70.58 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -35.88 71.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.2 t -70.76 -35.41 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.124 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.56 -44.58 90.74 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 120.815 1.643 . . . . 0.0 113.437 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.464 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.85 -35.98 75.17 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.37 -42.7 87.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.689 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.86 -37.23 72.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.311 0.577 . . . . 0.0 109.567 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.72 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.59 -43.38 84.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.105 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -37.03 74.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.394 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.76 -41.19 85.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.012 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.6 mm -69.55 -48.22 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.26 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.627 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -58.8 -24.43 61.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.275 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.0 t -62.03 -44.28 97.03 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.361 -0.535 . . . . 0.0 110.962 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.31 -36.28 62.4 Favored Glycine 0 CA--C 1.51 -0.234 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -32.39 36.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.366 -0.917 . . . . 0.0 110.742 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.1 m -70.53 -17.04 62.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.182 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.7 t -52.25 -33.88 43.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.202 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.0 p -92.2 -34.4 14.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.009 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.2 mp -91.86 -174.01 3.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.023 0.44 . . . . 0.0 111.162 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.5 p -118.54 128.74 54.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.692 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.23 81.18 0.14 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -33.4 11.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.525 0.203 . . . . 0.0 111.316 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -176.82 78.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mp -89.23 7.98 32.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.081 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 72.35 18.49 78.26 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -112.63 122.78 48.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.061 0.458 . . . . 0.0 111.741 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.03 20.4 1.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.671 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -108.77 99.66 8.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.176 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 135' ' ' SER . 3.4 mm? -63.21 147.6 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.441 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.88 139.86 40.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.864 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -50.09 127.57 17.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 130.41 -105.11 0.63 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.848 HG22 ' HB3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.01 131.0 35.57 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.447 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 3.7 t30 -71.74 -171.86 0.73 Allowed 'General case' 0 C--O 1.201 -1.482 0 N-CA-C 103.125 -2.917 . . . . 0.0 103.125 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.489 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -64.1 -46.74 82.9 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 114.648 -2.821 . . . . 0.0 109.788 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.704 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -58.72 -41.51 95.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.248 -0.977 . . . . 0.0 110.976 -175.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.848 ' HB3' HG22 ' A' ' 133' ' ' VAL . 1.8 mm100 -53.46 -23.24 9.55 Favored 'General case' 0 C--N 1.247 -3.863 0 CA-C-O 121.375 0.607 . . . . 0.0 110.715 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -68.78 -1.4 24.07 Favored Glycine 0 C--O 1.192 -2.521 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 tp -66.58 -50.04 64.4 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 118.29 1.045 . . . . 0.0 110.902 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' HA2' HD12 ' A' ' 143' ' ' ILE . . . -69.62 -36.15 75.63 Favored Glycine 0 N--CA 1.455 -0.064 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.794 ' CD1' HG21 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -70.52 -36.29 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 113.407 -1.396 . . . . 0.0 111.633 -178.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 138' ' ' GLY . 8.0 mt-10 -68.5 -36.46 78.94 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 122.06 0.933 . . . . 0.0 110.878 177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 219' ' ' GLY . 40.8 mt -68.82 -52.54 33.9 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 113.977 -1.465 . . . . 0.0 110.743 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 145' ' ' GLY . 6.1 tp -68.17 -45.05 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 121.931 0.872 . . . . 0.0 111.472 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 144' ' ' ILE . . . -60.7 -52.03 54.99 Favored Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.805 -1.543 . . . . 0.0 113.193 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.505 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 20.2 m -70.87 -40.51 72.23 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 114.613 -0.793 . . . . 0.0 111.93 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.773 HD12 ' O ' ' A' ' 219' ' ' GLY . 0.7 OUTLIER -54.79 -40.01 69.03 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -176.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -57.84 -30.02 65.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.726 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.03 HD11 HG22 ' A' ' 176' ' ' VAL . 1.1 tp -68.82 -51.18 43.48 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.255 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.445 HG21 ' HA3' ' A' ' 220' ' ' GLY . 70.1 t -60.09 -41.03 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.989 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.25 -35.52 80.63 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -34.42 77.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.686 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.458 HG21 ' CG2' ' A' ' 79' ' ' VAL . 2.1 t -72.08 -38.32 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.532 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -41.03 96.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 0.0 110.809 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.76 -31.61 72.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.172 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.662 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -54.76 -37.03 65.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.47 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.06 -8.98 41.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.277 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -77.23 107.67 9.79 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.778 0.323 . . . . 0.0 110.57 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.92 -26.12 67.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.681 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -74.15 -176.25 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.64 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 65.73 27.7 11.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.626 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.65 -175.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.525 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -149.94 82.61 1.39 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.591 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.72 141.95 46.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.615 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 127.5 -139.83 11.43 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.55 -104.19 2.69 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.83 135.12 52.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.926 0.393 . . . . 0.0 110.702 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . -52.47 -44.85 95.28 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.248 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.2 Cg_exo -54.53 -46.5 32.96 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.377 1.385 . . . . 0.0 111.532 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 mp -59.12 -35.91 74.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.853 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -44.12 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.947 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.569 HD11 ' OG1' ' A' ' 156' ' ' THR . 79.4 mt -58.26 -38.09 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.59 -37.45 93.64 Favored Glycine 0 C--O 1.196 -2.229 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.19 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.7 mp -55.05 -35.66 64.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.65 77.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.3 175.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 1.03 HG22 HD11 ' A' ' 149' ' ' LEU . 27.0 t -73.08 -47.54 47.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -175.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.785 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.08 -31.89 69.69 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 122.363 1.078 . . . . 0.0 109.859 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.268 1.8 tt -70.52 -49.73 45.15 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 124.503 2.097 . . . . 0.0 110.56 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.02 65.55 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 111.114 -2.767 . . . . 0.0 107.487 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.433 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 7.6 m-70 -70.18 -35.3 73.87 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.537 -1.831 . . . . 0.0 109.403 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.15 -48.11 81.27 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.112 -177.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.07 -52.55 10.77 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.782 ' HB3' HG23 ' A' ' 191' ' ' ILE . . . -70.41 -52.24 23.76 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.557 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 9.3 mt -55.34 -40.23 56.09 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.805 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.216 -174.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 35.0 t70 -77.56 -35.7 52.89 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 115.652 -2.419 . . . . 0.0 112.194 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.3 OUTLIER -59.91 -30.42 69.03 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.459 -1.296 . . . . 0.0 110.945 -171.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 189' ' ' CYS 0.272 0.1 OUTLIER -124.37 -26.61 3.89 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.083 -178.754 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.9 -6.11 83.94 Favored Glycine 0 CA--C 1.564 3.103 0 N-CA-C 106.208 -2.757 . . . . 0.0 106.208 -170.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.465 ' H ' HG23 ' A' ' 187' ' ' THR . 13.1 t -86.63 132.24 33.94 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.658 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.0 161.72 7.75 Favored Glycine 1 N--CA 1.392 -4.235 0 CA-C-N 111.285 -2.689 . . . . 0.0 111.031 178.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.782 HG23 ' HB3' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -72.29 -40.83 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 174.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 17.0 p-10 -83.44 134.3 45.58 Favored Pre-proline 0 N--CA 1.416 -2.139 0 CA-C-N 112.693 -2.048 . . . . 0.0 108.038 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -58.37 -14.58 20.88 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 122.361 2.041 . . . . 0.0 111.642 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.54 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . . . -75.04 -33.81 61.79 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 123.269 0.356 . . . . 0.0 111.653 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.658 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.49 -37.94 74.29 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.471 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.17 -33.48 65.47 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.489 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.841 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.1 m-85 -72.4 -35.08 68.32 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 126.41 1.884 . . . . 0.0 114.452 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.79 -44.48 94.2 Favored Glycine 0 C--N 1.318 -0.453 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.1 p -76.44 -28.31 56.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.131 -1.035 . . . . 0.0 110.981 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -68.26 -34.07 75.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.72 -33.41 59.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 121.268 1.849 . . . . 0.0 110.3 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 56.9 mt -57.8 -60.9 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.417 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.68 179.01 7.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.524 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -59.39 -170.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.572 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -144.07 116.3 8.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.435 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -131.13 -177.79 4.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.716 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.4 p -61.87 -33.95 75.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -57.03 -35.16 68.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.481 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -69.11 -15.96 63.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -70.49 -30.12 66.83 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.797 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.704 HG21 ' HA2' ' A' ' 136' ' ' GLY . 28.9 mm -52.63 -34.87 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 CA-C-O 121.778 0.799 . . . . 0.0 109.067 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -58.49 -35.29 72.0 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.016 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -84.35 -48.18 9.96 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 215' ' ' GLY . 9.6 p -70.0 -47.87 66.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.321 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.489 ' N ' HG13 ' A' ' 214' ' ' VAL . . . -55.68 -48.9 68.45 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 119.342 -1.409 . . . . 0.0 112.709 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 215' ' ' GLY . 49.5 Cg_endo -72.11 -31.1 12.59 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.757 1.638 . . . . 0.0 113.72 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.478 ' CG ' HD22 ' A' ' 81' ' ' LEU . 1.7 m-85 -66.26 -37.37 85.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 0.0 111.29 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.625 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 13.2 mt -70.37 -46.68 70.11 Favored 'Isoleucine or valine' 0 C--O 1.17 -3.084 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.449 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.773 ' O ' HD12 ' A' ' 147' ' ' LEU . . . -55.42 -46.93 78.8 Favored Glycine 0 C--N 1.363 2.077 0 O-C-N 128.495 3.622 . . . . 0.0 110.996 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -68.41 -40.77 86.7 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.32 -34.8 61.79 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 4.4 mt -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.411 -2.418 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.203 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -59.01 -39.74 82.77 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.251 -174.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.45 -49.73 81.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.885 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -39.53 94.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.709 0.766 . . . . 0.0 109.965 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.4 mt -55.2 -34.69 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.426 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.59 33.78 5.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -111.52 -22.58 11.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.783 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 57.85 96.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.496 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 87.5 mt -66.63 122.05 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.568 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 4.0 mt -141.51 82.74 1.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 233' ' ' PRO . . . -170.74 165.66 5.0 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.479 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 232' ' ' ALA . 51.5 Cg_exo -51.26 127.49 22.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.85 2.367 . . . . 0.0 112.085 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.98 171.68 14.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 64.4 148.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.581 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.81 156.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.548 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.5 t70 62.6 54.27 2.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.76 134.23 35.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.563 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.3 t -85.73 152.71 22.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.56 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.39 151.81 46.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.493 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.38 27.06 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.591 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.84 -27.11 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.575 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -111.37 123.1 49.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.522 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 54.2 t -84.43 -62.1 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.618 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 50.74 -158.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.569 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.4 p -92.11 -54.66 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.555 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 18.3 m 52.76 71.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.636 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -50.38 100.27 0.04 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 55.04 -178.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.02 36.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.549 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -137.67 161.64 35.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.622 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -105.05 -45.64 4.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.454 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -98.7 31.5 2.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.508 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 59.82 179.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.525 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.53 -60.93 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.571 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.46 -73.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.709 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . 50.83 64.74 1.71 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 110.574 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.43 -61.06 2.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.564 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -141.21 129.85 22.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 10.5 mm -85.51 130.02 36.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.583 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.26 104.5 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.653 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 10.5 m -97.44 127.46 43.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.497 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -114.09 94.87 5.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.593 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 264' ' ' VAL . 0.5 OUTLIER 75.85 -7.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 O-C-N 123.692 0.62 . . . . 0.0 111.898 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -73.09 -179.39 3.25 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.586 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 11.0 mtp -100.11 163.54 12.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.64 66.07 0.9 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.601 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -72.89 -42.42 1.08 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.894 2.396 . . . . 0.0 112.065 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp 56.83 -175.72 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.56 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 62.94 172.99 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.563 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.6 mt -124.75 -26.55 3.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.569 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.14 123.86 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 60.45 166.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.571 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 54.95 85.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.501 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -158.28 -49.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.44 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 2.7 mp 56.82 86.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.596 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.52 106.27 15.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.582 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -58.6 101.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.601 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 50.34 35.32 10.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.507 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 53.21 73.47 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.641 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 8.7 tp -122.23 122.3 38.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.639 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -109.22 156.59 19.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.48 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.52 -46.12 0.89 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.605 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . 50.41 -168.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.578 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.9 t 59.33 101.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.477 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -104.09 54.25 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -103.5 -45.9 4.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.607 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -81.15 142.99 32.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.594 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -80.79 173.24 12.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -58.62 158.93 7.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.4 35.35 0.42 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.538 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 23.0 m80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.494 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.73 80.04 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.621 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.3 m -115.18 63.84 0.68 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.559 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 57.17 88.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.498 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.92 -33.36 14.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.613 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.26 108.18 20.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.587 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -84.68 -178.32 6.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.578 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -112.32 -57.61 2.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.536 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mp 61.98 -85.79 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 56.35 174.42 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.912 0.387 . . . . 0.0 110.728 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -112.79 0.32 15.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.031 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -59.4 -15.97 20.14 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.749 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.1 1.35 17.28 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.502 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.51 -40.16 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 2.8 t -68.26 -35.91 73.0 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.629 0 CA-C-N 112.47 -2.15 . . . . 0.0 110.02 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.04 69.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.621 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -70.71 -46.69 62.63 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -177.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -33.88 73.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 11.1 mt -58.71 -38.17 77.71 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 112.47 -2.15 . . . . 0.0 109.107 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.44 -46.79 78.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 112.97 -1.923 . . . . 0.0 114.755 -176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.66 -31.42 59.77 Favored 'General case' 0 C--O 1.208 -1.128 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.525 -177.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -70.89 -34.98 72.13 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.879 -0.729 . . . . 0.0 110.995 -179.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -45.34 82.63 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CE1' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.13 -44.71 29.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 29' ' ' ILE . 76.3 t -65.03 -53.72 37.91 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.46 -175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -53.7 -48.11 69.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -176.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -75.68 -29.67 20.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.504 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.45 -36.51 69.11 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.835 HG21 HD22 ' A' ' 112' ' ' LEU . 3.6 mm -58.78 -44.49 90.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 113.661 -1.609 . . . . 0.0 109.223 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.63 -36.76 65.7 Favored Glycine 0 C--O 1.226 -0.369 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -67.4 -44.37 79.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.49 -46.13 67.32 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.546 HD23 HG22 ' A' ' 29' ' ' ILE . 2.3 pp -85.84 -27.12 25.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.171 0.441 . . . . 0.0 111.823 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -75.72 -37.01 40.91 Favored Glycine 0 C--N 1.317 -0.494 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.445 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.98 -19.05 39.63 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -9.9 16.45 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.536 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.516 ' HE1' ' HG1' ' A' ' 120' ' ' THR . 39.8 t80 -117.9 119.88 33.28 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 118.532 0.605 . . . . 0.0 110.099 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.92 145.13 78.92 Favored 'Cis proline' 0 N--CA 1.5 1.88 0 C-N-CA 124.699 -0.959 . . . . 0.0 112.09 -0.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 p -82.62 151.36 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.807 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.13 131.46 6.75 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -147.92 132.7 17.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 0.0 110.554 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -107.23 28.87 7.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.651 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.92 -164.22 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.526 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 t -100.66 10.51 41.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.72 145.21 48.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.78 0.324 . . . . 0.0 110.434 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 46' ' ' VAL . 32.0 m -137.66 128.53 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.776 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -102.41 106.26 16.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.741 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.56 163.3 13.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.3 0.571 . . . . 0.0 111.56 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.72 -28.32 5.92 Favored 'General case' 0 C--O 1.206 -1.231 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.884 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.777 HG22 HD21 ' A' ' 181' ' ' LEU . 3.6 t -57.29 -32.29 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -53.96 37.65 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.703 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 12.6 t -68.15 -37.34 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 113.957 -1.474 . . . . 0.0 111.451 -177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 181' ' ' LEU . 3.2 m -68.58 -41.15 80.08 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.985 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.609 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.7 OUTLIER -65.55 -31.43 72.47 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.655 -1.612 . . . . 0.0 106.916 176.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -62.92 -39.86 95.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.458 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 24' ' ' PHE . 3.6 t80 -66.03 -43.22 88.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.763 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.62 -46.52 92.0 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.149 -0.548 . . . . 0.0 113.074 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.651 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 6.5 mp -68.6 -43.81 75.64 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.525 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 t -59.84 -36.69 77.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.587 ' CD1' HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -60.3 -34.37 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.663 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -61.66 -45.55 93.54 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.363 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.417 ' H ' HG23 ' A' ' 62' ' ' THR . 8.9 p -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -54.79 -42.91 72.35 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.04 -44.33 72.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 112.97 -1.923 . . . . 0.0 110.914 174.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -67.02 -45.97 75.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.5 p -59.14 -12.37 5.01 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 119.932 1.242 . . . . 0.0 112.387 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.02 -42.91 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 0.0 111.29 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.24 159.16 8.08 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -57.41 -23.13 47.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.783 0.325 . . . . 0.0 111.43 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.6 pt -71.76 7.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.46 135.66 53.41 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.618 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.12 -154.2 24.41 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.52 85.87 1.16 Allowed 'General case' 0 CA--C 1.482 -1.642 0 C-N-CA 118.361 -1.335 . . . . 0.0 108.183 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -70.97 -19.64 62.52 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.687 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.1 pp -80.46 -17.64 51.09 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.42 -1.718 . . . . 0.0 112.497 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -111.05 135.95 20.84 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 97.0 Cg_endo -83.58 -22.87 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 123.441 2.761 . . . . 0.0 111.676 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.8 -47.43 78.11 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.622 HG23 HD23 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -66.22 -36.84 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.753 0.311 . . . . 0.0 111.158 177.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 m -65.68 -28.63 69.22 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -43.82 82.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.92 0.39 . . . . 0.0 110.175 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.95 -39.64 97.82 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 tp -53.47 -57.54 10.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.088 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -48.47 -67.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.57 -31.75 11.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.633 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.9 t -91.58 179.19 5.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.2 m 54.31 -168.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.53 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -64.69 163.83 13.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.614 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pt -133.38 83.73 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.526 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 91' ' ' ILE . 46.4 m -158.71 40.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.602 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 91' ' ' ILE . 1.1 pp -155.15 162.68 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.638 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -131.75 23.47 4.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.777 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -68.6 -35.95 78.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.399 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.14 78.2 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.09 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.69 -38.49 67.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -40.01 68.05 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.84 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -61.16 -37.63 83.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 119.357 0.98 . . . . 0.0 109.443 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.29 -44.38 88.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.903 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.3 mt -70.59 -37.78 71.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . . . -66.81 -47.2 72.81 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.56 -35.7 70.7 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -35.96 71.93 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.8 -35.47 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.153 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.68 -44.32 91.36 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 121.102 1.774 . . . . 0.0 113.38 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.404 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.74 -36.19 75.61 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.79 -42.59 86.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.821 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.9 -37.41 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.219 0.533 . . . . 0.0 110.068 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.58 -49.78 75.29 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.318 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 89.5 m -67.75 -37.03 81.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.801 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.73 85.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.659 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.1 tt -69.18 -37.19 75.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.11 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.835 HD22 HG21 ' A' ' 29' ' ' ILE . 2.1 tt -66.0 -24.09 66.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.87 0.367 . . . . 0.0 111.511 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.7 m -60.43 -44.21 96.01 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.503 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.1 -36.37 61.26 Favored Glycine 0 CA--C 1.511 -0.215 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.95 32.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.849 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 m -65.19 -21.48 66.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 97.1 p -52.27 -36.55 52.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.893 0.378 . . . . 0.0 110.249 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.15 -34.26 14.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.7 mt -88.43 -174.17 4.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.818 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.516 ' HG1' ' HE1' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -118.44 126.88 52.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.62 81.48 0.11 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.01 -35.23 10.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.625 0.25 . . . . 0.0 111.173 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.9 t 177.92 86.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.759 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mp -88.43 8.03 29.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.283 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.4 16.51 80.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.62 124.34 52.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.972 0.415 . . . . 0.0 111.608 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.6 m120 51.85 23.31 2.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.275 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.3 95.14 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.716 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 187' ' ' THR . 3.3 mm? -65.45 144.51 57.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.318 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.02 140.03 40.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.649 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -49.63 127.5 15.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.26 -105.48 0.6 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.799 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.1 t -85.94 126.82 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.45 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.58 -171.94 0.72 Allowed 'General case' 0 C--O 1.2 -1.505 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 176.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.48 ' N ' HD11 ' A' ' 129' ' ' LEU . 1.4 m -62.39 -46.76 87.14 Favored 'General case' 0 C--N 1.286 -2.187 0 C-N-CA 114.669 -2.812 . . . . 0.0 110.306 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -42.16 96.47 Favored Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.09 -1.053 . . . . 0.0 111.267 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.799 ' HB3' HG22 ' A' ' 133' ' ' VAL . 4.0 mt-30 -53.24 -23.42 8.73 Favored 'General case' 0 C--N 1.249 -3.778 0 CA-C-N 114.792 -0.704 . . . . 0.0 110.503 -176.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.87 -1.76 13.69 Favored Glycine 0 C--O 1.188 -2.736 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.9 -50.47 64.34 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 119.123 1.461 . . . . 0.0 110.743 -176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.87 -40.16 74.97 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.682 HD13 HG21 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -68.85 -36.34 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 113.209 -1.495 . . . . 0.0 112.267 -177.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' GLY . 77.1 mt-10 -68.54 -36.21 78.5 Favored 'General case' 0 C--O 1.197 -1.677 0 CA-C-O 121.736 0.779 . . . . 0.0 110.569 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.71 HG23 ' CA ' ' A' ' 219' ' ' GLY . 38.3 mt -70.06 -41.9 79.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.437 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.2 mm -68.53 -48.84 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 122.389 1.09 . . . . 0.0 111.198 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.55 -46.9 93.21 Favored Glycine 0 C--O 1.221 -0.715 0 CA-C-N 112.841 -1.981 . . . . 0.0 112.966 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.409 ' HA ' HD12 ' A' ' 191' ' ' ILE . 76.2 m -70.93 -47.64 57.91 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 113.77 -1.215 . . . . 0.0 112.47 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 8.2 tp -54.47 -40.45 68.46 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.252 -175.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.6 pt20 -57.97 -31.28 66.74 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.82 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.82 HD11 HG22 ' A' ' 176' ' ' VAL . 2.8 tp -68.89 -52.21 31.92 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.451 HG21 ' HA3' ' A' ' 220' ' ' GLY . 54.3 t -60.14 -41.02 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.64 -35.55 81.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 111.349 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -41.11 93.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.851 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 16.1 m -72.05 -38.37 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.52 -48.08 82.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.803 0.335 . . . . 0.0 110.985 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.56 -31.68 71.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.662 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.9 OUTLIER -61.64 -36.93 82.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.464 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.7 t -92.82 -8.76 42.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.224 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -70.26 135.59 49.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.888 0.375 . . . . 0.0 110.517 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -63.3 -26.46 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.541 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.12 106.05 5.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.525 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 161.33 17.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.561 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -143.26 -37.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.17 133.78 47.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.499 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.56 141.7 28.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.393 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.69 -166.7 51.37 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 60.44 162.6 0.13 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' ' 170' ' ' LEU . 0.1 OUTLIER -111.9 136.92 50.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.619 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.662 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . -52.37 -45.16 95.09 Favored Pre-proline 0 C--O 1.218 -0.571 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.808 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 35.3 Cg_exo -54.35 -44.3 50.69 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.738 1.625 . . . . 0.0 112.223 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 167' ' ' SER . 1.9 mp -66.23 -38.24 87.45 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.302 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.33 56.59 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.006 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 26.5 pt -58.93 -35.96 59.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.77 -37.61 93.6 Favored Glycine 0 C--O 1.198 -2.107 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.495 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.15 -36.37 65.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 -34.47 77.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.751 -1.568 . . . . 0.0 111.603 175.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.82 HG22 HD11 ' A' ' 149' ' ' LEU . 89.2 t -72.89 -47.24 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.763 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . . . -65.02 -41.82 94.97 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 122.054 0.93 . . . . 0.0 108.727 -176.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.257 3.6 mt -58.29 -47.12 84.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 112.448 -2.16 . . . . 0.0 109.937 178.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.9 66.19 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.088 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.666 ' HA ' HD13 ' A' ' 184' ' ' ILE . 1.1 t60 -67.84 -34.79 77.39 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 112.926 -1.637 . . . . 0.0 109.789 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.777 HD21 HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -64.66 -47.64 77.71 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.389 -176.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.444 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -74.96 -51.64 13.18 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.955 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -69.54 -51.24 37.39 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 180' ' ' HIS . 1.7 mp -66.78 -49.27 75.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.869 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -65.63 -35.73 81.66 Favored 'General case' 0 C--N 1.271 -2.811 0 C-N-CA 115.377 -2.529 . . . . 0.0 112.367 -176.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.88 -31.28 69.64 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.524 -170.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.524 ' O ' HD13 ' A' ' 129' ' ' LEU 0.301 0.1 OUTLIER -124.32 -26.87 3.87 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 122.387 1.089 . . . . 0.0 113.332 -179.032 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 86.75 -5.78 84.17 Favored Glycine 0 CA--C 1.566 3.264 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 -170.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.4 ' H ' HG23 ' A' ' 187' ' ' THR . 59.9 m -83.64 132.29 34.9 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -54.33 155.59 7.61 Favored Glycine 0 N--CA 1.406 -3.342 0 CA-C-N 111.224 -2.716 . . . . 0.0 111.869 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.955 HG22 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.62 -32.99 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 174.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.681 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 6.2 p-10 -92.74 139.68 23.54 Favored Pre-proline 0 N--CA 1.42 -1.967 0 CA-C-N 113.321 -1.763 . . . . 0.0 107.234 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -64.47 -14.55 44.91 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.64 1.56 . . . . 0.0 111.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.484 ' HB3' HD22 ' A' ' 192' ' ' ASN . . . -75.14 -33.88 61.59 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.248 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.645 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -69.37 -39.11 78.24 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.0 t -73.18 -34.28 65.91 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.816 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.818 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 3.8 t80 -72.22 -35.4 68.87 Favored 'General case' 0 N--CA 1.514 2.746 0 C-N-CA 126.315 1.846 . . . . 0.0 114.506 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.73 -46.19 92.54 Favored Glycine 0 C--N 1.319 -0.376 0 N-CA-C 107.19 -2.364 . . . . 0.0 107.19 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.43 -28.29 56.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.281 -0.959 . . . . 0.0 110.379 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.818 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.65 -33.89 77.0 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.607 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.3 -31.17 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 120.939 1.699 . . . . 0.0 110.589 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.95 76.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.768 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.1 p 47.7 -163.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.784 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 60.37 41.82 15.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.611 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -94.76 97.66 10.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.518 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.16 174.78 10.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.506 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.4 p -65.01 -35.9 82.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.702 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -35.06 66.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -19.03 61.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.204 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -61.29 -20.16 62.58 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.256 0.348 . . . . 0.0 111.626 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 9.5 mm -52.63 -34.59 19.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -25.09 61.59 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.298 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -84.64 -42.35 15.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.0 p -78.02 -45.47 27.38 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.507 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.23 -44.87 84.27 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.531 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.3 Cg_endo -71.49 -28.68 17.46 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.491 2.128 . . . . 0.0 113.084 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -77.2 -31.99 55.7 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.195 0.521 . . . . 0.0 111.893 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.0 mm -70.7 -46.37 69.52 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.34 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.303 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.71 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.11 -46.78 63.25 Favored Glycine 0 C--N 1.357 1.733 0 O-C-N 128.5 3.625 . . . . 0.0 111.838 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.34 -48.91 35.05 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 118.067 -2.016 . . . . 0.0 109.835 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -38.78 68.45 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 121.554 0.692 . . . . 0.0 109.562 -176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -68.13 -30.98 70.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.292 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.627 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.97 -39.8 82.83 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 60.8 t -58.06 -49.59 80.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.686 -1.597 . . . . 0.0 112.267 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -39.54 93.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.799 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -34.74 43.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.406 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -133.93 47.19 2.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.818 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -92.2 112.6 24.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.663 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -48.73 -42.14 34.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.655 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.29 118.69 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.629 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 232' ' ' ALA . 0.4 OUTLIER -49.76 -47.04 51.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.622 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.686 ' HB3' ' HD3' ' A' ' 233' ' ' PRO . . . 177.81 -55.76 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.254 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 232' ' ' ALA . 77.6 Cg_exo -44.99 150.54 0.89 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.161 1.907 . . . . 0.0 112.248 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -29.22 18.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.526 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.8 t 58.33 100.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.54 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.48 -67.08 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.576 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.72 117.11 29.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.534 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.99 143.71 41.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.477 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.22 -30.54 5.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.552 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.91 46.65 13.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.597 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -60.74 -27.3 67.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.501 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.48 155.43 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.517 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.97 145.16 29.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.599 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.36 -27.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.594 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -139.62 121.88 15.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.57 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.93 128.62 15.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.1 p -107.81 98.92 8.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.595 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 128.35 145.39 6.03 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -119.72 33.66 5.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.382 . . . . 0.0 110.574 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.08 82.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.513 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -103.11 149.3 24.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.522 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.58 -66.15 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.573 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -161.34 80.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.475 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.2 161.04 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.5 pp -166.25 155.88 11.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.57 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.23 156.33 44.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.612 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -87.43 145.42 26.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.573 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 65.76 126.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.64 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.18 -61.24 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 2.4 mp -113.37 137.24 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.508 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.43 -38.49 1.35 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.507 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 15.9 m -103.61 -168.91 1.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.514 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 70.26 -70.62 0.14 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.3 m -94.95 139.86 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.79 0.328 . . . . 0.0 110.608 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -66.21 162.6 19.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.512 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.91 145.88 48.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.669 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 164.96 14.04 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.533 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -52.03 104.76 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.688 2.259 . . . . 0.0 112.023 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -91.99 145.26 24.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.553 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -151.09 105.01 3.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.594 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.7 tp -119.53 119.56 34.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.589 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -155.4 152.72 29.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.462 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -96.01 152.93 18.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.524 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.2 85.49 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.593 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.27 149.39 25.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.521 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 1.6 pt -119.97 -177.42 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.608 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 5.3 p 46.29 65.97 1.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.933 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -92.79 173.66 7.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 69.96 -70.95 0.13 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -166.11 -49.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.53 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 30.7 mt -129.98 -42.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.528 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.6 t30 70.1 -70.89 0.14 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.2 m -102.68 163.9 11.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.598 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -113.99 -62.35 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.603 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 32.4 m -64.76 157.54 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.83 79.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.46 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.46 -175.3 2.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.539 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -100.41 176.77 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.597 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.13 -73.35 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.565 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.0 176.37 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.526 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -122.34 -43.61 2.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.59 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 117.857 -1.068 . . . . 0.0 110.62 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mtt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.26 50.61 1.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -30.13 29.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.544 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -117.18 112.1 20.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.613 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -57.3 168.24 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -160.21 110.19 1.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.512 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -34.59 69.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.601 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 114.29 15.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.58 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.12 -54.24 4.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.678 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 54.31 24.08 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.495 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.71 -16.37 19.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -81.4 9.37 7.38 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.086 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.4 -14.31 5.88 Favored 'General case' 0 CA--C 1.502 -0.879 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.452 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -39.89 87.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 175.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 5.9 p -68.66 -36.07 72.83 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.439 0 CA-C-N 113.243 -1.799 . . . . 0.0 110.592 176.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.69 -35.35 70.49 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.694 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 3.6 mt-10 -70.95 -46.48 62.34 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -33.79 74.34 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 8.0 mt -58.77 -38.16 77.88 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.884 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.68 -46.51 78.8 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.567 -2.106 . . . . 0.0 114.581 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.612 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -74.81 -31.63 61.77 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.208 -177.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.2 -38.39 69.05 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.783 -178.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -45.01 84.21 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -77.11 -52.52 9.14 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 21' ' ' THR . 1.5 m -65.64 -40.3 87.54 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.635 0 O-C-N 124.031 0.832 . . . . 0.0 112.802 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.41 ' O ' HG12 ' A' ' 29' ' ' ILE . 49.3 t80 -54.18 -50.35 67.24 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.539 0.685 . . . . 0.0 111.908 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -29.25 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.531 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.24 -36.24 68.28 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -175.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.56 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -59.7 -40.05 81.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.086 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.45 -36.88 64.69 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.8 m -67.5 -38.87 84.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.41 -46.21 67.37 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.78 -29.92 23.45 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -75.86 -36.05 43.22 Favored Glycine 0 C--N 1.319 -0.374 0 CA-C-O 119.54 -0.589 . . . . 0.0 112.962 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -18.56 35.83 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.319 -1.352 . . . . 0.0 107.511 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -106.57 -10.0 16.37 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.348 177.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.45 ' H ' ' C ' ' A' ' 34' ' ' GLY . 23.5 m-85 -129.83 123.64 21.17 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.241 0.473 . . . . 0.0 110.262 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.09 137.65 49.53 Favored 'Cis proline' 0 N--CA 1.497 1.685 0 C-N-CA 124.675 -0.969 . . . . 0.0 112.104 -0.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.94 149.64 5.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.553 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.79 150.44 22.52 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -27.85 14.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.757 0.313 . . . . 0.0 110.487 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.83 -162.25 0.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.525 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.19 148.2 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.461 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -94.08 -28.86 15.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.776 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.31 139.06 55.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.5 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.99 154.44 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.751 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -106.52 111.68 24.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.497 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB3' HG12 ' A' ' 50' ' ' VAL . 23.1 t0 -114.17 163.01 15.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.283 0.563 . . . . 0.0 110.94 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -49.73 -28.78 6.57 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.801 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.55 HG13 ' CE ' ' A' ' 51' ' ' LYS . 1.5 p -57.28 -38.37 61.61 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.726 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.55 ' CE ' HG13 ' A' ' 50' ' ' VAL . 4.5 mmtp -64.8 -53.56 45.09 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.699 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 70.6 t -66.77 -50.06 68.89 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 CA-C-N 114.409 -1.268 . . . . 0.0 112.416 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.2 m -66.53 -39.07 88.41 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.358 0.412 . . . . 0.0 110.004 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.824 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 55.3 tp -62.85 -31.92 73.03 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.91 -39.46 94.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.874 -1.512 . . . . 0.0 109.265 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.521 ' O ' HD13 ' A' ' 60' ' ' ILE . 8.3 m-30 -66.12 -42.44 89.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.737 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.42 -43.3 96.96 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.08 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.664 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -67.33 -43.66 81.03 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.547 -178.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.68 -36.58 74.42 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.633 HG13 HD21 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -59.98 -34.1 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.369 -178.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.757 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.12 -45.71 83.97 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.235 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 65' ' ' GLN . 11.7 p -68.96 -31.7 70.75 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.607 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.46 -40.58 71.78 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.94 -44.16 73.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.151 -1.841 . . . . 0.0 109.468 173.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 62' ' ' THR . 26.0 tt0 -66.78 -38.47 86.62 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.8 m -59.61 -12.13 6.12 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 120.058 1.299 . . . . 0.0 111.415 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -42.83 3.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.997 0.427 . . . . 0.0 110.697 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.06 168.4 12.83 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -66.0 -23.09 66.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 70' ' ' ILE . 2.1 mp -75.95 7.13 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.79 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 m -124.43 135.64 53.42 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.139 0.495 . . . . 0.0 111.155 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -151.84 20.45 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.27 85.89 1.08 Allowed 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.441 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -19.39 61.91 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 175.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.633 HD21 HG13 ' A' ' 60' ' ' ILE . 2.1 pp -87.05 8.53 23.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.375 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.614 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -133.04 129.08 20.88 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -177.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.589 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 91.1 Cg_endo -83.64 -20.49 4.66 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.773 2.315 . . . . 0.0 111.397 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.627 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -66.16 -50.94 62.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.529 HG23 HD23 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -66.7 -36.68 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.678 0.275 . . . . 0.0 111.57 177.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.0 m -64.91 -28.62 69.66 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -35.4 76.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.891 0.376 . . . . 0.0 110.55 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.53 -37.07 84.89 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.671 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.84 -44.41 96.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.33 . . . . 0.0 111.456 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.405 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -55.95 -43.03 77.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 100.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.5 p 177.16 99.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.488 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER 65.51 -166.34 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.579 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.47 -69.34 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.524 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.438 HD12 ' O ' ' A' ' 86' ' ' SER . 88.0 mt 49.65 87.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.656 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.81 113.0 17.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 61.5 mt 62.22 153.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.515 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -176.69 177.66 1.35 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 0.0 110.903 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.73 -35.83 75.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.851 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.405 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . . . -63.78 -35.14 79.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.451 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.91 -38.53 67.72 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.1 ttt -73.27 -35.1 66.13 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.392 -1.731 . . . . 0.0 109.945 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -64.96 -37.53 87.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 119.523 1.056 . . . . 0.0 109.135 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.3 OUTLIER -58.12 -46.53 88.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.656 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.431 ' N ' HG22 ' A' ' 98' ' ' ILE . 2.0 mm -67.7 -37.84 79.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.678 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.01 -47.06 86.49 Favored 'General case' 0 C--O 1.206 -1.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -71.24 -36.05 71.68 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.424 ' O ' HG13 ' A' ' 106' ' ' ILE . 3.8 t -57.87 -36.16 71.97 Favored 'General case' 0 CA--C 1.497 -1.092 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.38 -35.19 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.646 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.645 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.51 -47.78 81.27 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 120.733 1.606 . . . . 0.0 112.586 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.88 -36.16 75.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 102' ' ' CYS . 79.3 mt -63.92 -41.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.048 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -70.14 -37.42 71.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.425 0.631 . . . . 0.0 110.038 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.53 -49.95 74.67 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.842 -1.072 . . . . 0.0 113.301 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.798 HG21 ' O ' ' A' ' 198' ' ' GLY . 1.8 t -70.3 -36.94 74.64 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.2 -43.75 87.77 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.013 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.2 mm -69.24 -37.33 75.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.243 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.56 HD22 HG21 ' A' ' 29' ' ' ILE . 3.0 tt -66.85 -24.49 66.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.512 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.2 t -62.76 -34.96 78.29 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.248 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.09 -36.16 60.81 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.446 HD12 ' HG ' ' A' ' 112' ' ' LEU . 4.2 mt -57.28 -40.83 76.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.624 -0.788 . . . . 0.0 110.538 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.42 HG21 HD11 ' A' ' 124' ' ' LEU . 2.2 p -89.09 5.41 44.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.795 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.9 t -52.15 -30.17 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.292 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.3 m -92.2 -32.32 15.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.91 -174.44 3.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.1 p -118.39 135.65 54.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.621 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.74 83.2 0.09 OUTLIER Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.19 -20.58 17.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.749 -0.225 . . . . 0.0 111.544 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 p -161.7 49.37 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.062 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.42 HD11 HG21 ' A' ' 116' ' ' THR . 1.1 mp -88.9 7.77 32.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.081 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 75.09 15.62 81.01 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -112.6 120.11 40.46 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.925 0.393 . . . . 0.0 111.295 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 t30 51.83 23.12 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.25 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.88 84.7 2.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.419 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 187' ' ' THR . 3.4 mm? -66.65 144.9 56.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.489 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.91 139.65 40.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.136 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.77 127.67 18.91 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.3 -103.19 0.58 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 137' ' ' GLN . 2.0 t -86.0 122.38 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.56 -171.8 0.69 Allowed 'General case' 0 C--O 1.201 -1.477 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.466 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.68 -46.81 88.11 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 114.919 -2.712 . . . . 0.0 110.152 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.83 -41.67 96.18 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.157 -175.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.726 ' HB3' HG22 ' A' ' 133' ' ' VAL . 24.0 mm100 -53.17 -23.43 8.36 Favored 'General case' 0 C--N 1.252 -3.661 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.232 -176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.55 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.05 -1.69 10.59 Favored Glycine 0 C--O 1.187 -2.796 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -50.5 65.54 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 119.17 1.485 . . . . 0.0 111.004 -176.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.75 -40.13 76.21 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.714 HD13 HG21 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -67.43 -38.19 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 113.051 -1.575 . . . . 0.0 112.13 -178.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 138' ' ' GLY . 24.0 mt-10 -68.61 -36.53 78.8 Favored 'General case' 0 C--O 1.196 -1.728 0 CA-C-O 121.987 0.899 . . . . 0.0 110.872 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.681 HG23 ' CA ' ' A' ' 219' ' ' GLY . 30.5 mt -68.35 -43.62 84.19 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.421 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.154 -174.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -68.4 -49.04 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 122.264 1.031 . . . . 0.0 111.671 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.51 ' HA2' HD11 ' A' ' 182' ' ' LEU . . . -59.26 -48.38 86.26 Favored Glycine 0 C--O 1.218 -0.866 0 CA-C-N 113.087 -1.869 . . . . 0.0 113.038 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.526 HG21 ' CB ' ' A' ' 216' ' ' PRO . 24.8 m -70.79 -45.29 64.93 Favored 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 113.97 -1.115 . . . . 0.0 112.175 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.636 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 6.0 tp -54.51 -40.59 68.73 Favored 'General case' 0 CA--C 1.487 -1.464 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.22 -175.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 3.0 pt20 -59.33 -30.85 68.66 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.015 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.03 HD11 HG22 ' A' ' 176' ' ' VAL . 2.1 tp -68.88 -51.22 42.52 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.261 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.483 HG21 ' HA3' ' A' ' 220' ' ' GLY . 20.4 t -60.83 -41.08 87.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.054 -0.976 . . . . 0.0 113.28 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.18 -35.65 81.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.563 0.22 . . . . 0.0 111.512 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.21 -35.04 78.77 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.038 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.19 -38.44 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.591 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.7 tt -64.04 -43.57 95.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.78 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.69 -31.54 72.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.561 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.699 ' OG1' HD11 ' A' ' 172' ' ' ILE . 0.4 OUTLIER -54.86 -36.71 65.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.402 -179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.91 -8.82 48.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.336 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -68.47 123.98 22.3 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.629 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -59.03 -26.4 64.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.601 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -65.8 111.35 3.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.476 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -65.09 158.0 27.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.609 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.72 -26.27 8.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.567 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.54 167.17 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.667 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.0 mp 56.63 97.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.558 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 151.46 -124.58 1.71 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -167.88 -89.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.39 139.04 48.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.922 0.392 . . . . 0.0 110.691 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.647 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . -52.39 -45.37 95.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.017 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.0 Cg_exo -54.57 -46.48 33.11 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.57 1.514 . . . . 0.0 111.696 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.9 -36.14 78.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.271 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.45 -45.02 63.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.275 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.699 HD11 ' OG1' ' A' ' 156' ' ' THR . 21.9 mt -58.26 -38.42 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.67 -37.52 93.62 Favored Glycine 0 C--O 1.195 -2.293 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.164 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.3 OUTLIER -55.21 -35.56 65.01 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -34.24 76.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.928 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 1.03 HG22 HD11 ' A' ' 149' ' ' LEU . 20.6 t -72.59 -47.31 51.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.824 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.26 -29.9 66.8 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.577 1.179 . . . . 0.0 110.182 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 174' ' ' LEU 0.267 9.3 mt -70.65 -49.18 50.19 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-O 124.711 2.196 . . . . 0.0 109.515 178.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.65 -36.85 66.07 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 110.328 -3.124 . . . . 0.0 107.822 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.529 ' HB3' HD12 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -70.39 -35.22 73.34 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 113.041 -1.579 . . . . 0.0 109.727 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -58.72 -48.21 81.95 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.139 -177.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.51 HD11 ' HA2' ' A' ' 145' ' ' GLY . 0.1 OUTLIER -75.54 -52.25 11.06 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 177.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 1.068 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -69.97 -51.68 30.56 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.529 HD12 ' HB3' ' A' ' 180' ' ' HIS . 7.4 mt -60.58 -49.11 85.71 Favored 'Isoleucine or valine' 0 C--O 1.175 -2.862 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.538 -175.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -69.15 -35.67 76.59 Favored 'General case' 0 C--N 1.283 -2.314 0 C-N-CA 116.741 -1.983 . . . . 0.0 113.502 -176.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.02 -29.16 68.31 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.652 -171.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 129' ' ' LEU 0.285 0.1 OUTLIER -124.32 -26.65 3.91 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 122.181 0.991 . . . . 0.0 113.076 -179.167 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.56 -5.9 84.26 Favored Glycine 0 CA--C 1.565 3.163 0 N-CA-C 106.535 -2.626 . . . . 0.0 106.535 -170.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.452 ' H ' HG23 ' A' ' 187' ' ' THR . 92.1 m -88.08 130.74 34.91 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.478 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -56.22 154.71 14.71 Favored Glycine 0 N--CA 1.397 -3.924 0 CA-C-N 111.174 -2.739 . . . . 0.0 112.538 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.068 HG22 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.35 -27.21 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 174.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.627 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -90.49 135.11 29.79 Favored Pre-proline 0 N--CA 1.414 -2.25 0 CA-C-N 112.74 -2.027 . . . . 0.0 108.25 177.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.534 ' CD ' ' HB2' ' A' ' 78' ' ' ALA . 6.3 Cg_exo -66.09 -17.36 54.86 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.986 1.791 . . . . 0.0 110.587 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.589 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.26 -35.37 61.39 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.478 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 29.3 tpt85 -70.62 -40.2 73.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.523 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.3 m -73.23 -38.19 66.13 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.82 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 12.4 t80 -72.25 -34.88 68.58 Favored 'General case' 0 N--CA 1.511 2.598 0 C-N-CA 126.945 2.098 . . . . 0.0 114.596 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.798 ' O ' HG21 ' A' ' 109' ' ' THR . . . -57.62 -47.12 90.61 Favored Glycine 0 C--N 1.315 -0.592 0 N-CA-C 107.069 -2.412 . . . . 0.0 107.069 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -28.21 56.65 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.726 -0.737 . . . . 0.0 110.565 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.82 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.23 -34.1 77.32 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 118.412 -0.804 . . . . 0.0 112.843 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.9 p -61.66 -31.14 49.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 120.971 1.714 . . . . 0.0 110.803 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.0 mt -74.39 -32.32 30.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.927 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.9 m -146.75 66.7 1.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -72.55 156.7 38.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.502 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -131.0 -177.65 4.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.791 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -64.67 -147.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.252 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.17 -21.04 4.51 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -55.15 -35.08 64.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.829 0.347 . . . . 0.0 110.382 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -22.32 60.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.275 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -69.79 -25.41 63.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.963 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -52.68 -34.61 19.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.728 0.775 . . . . 0.0 109.076 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . 0.444 ' N ' ' CD2' ' A' ' 212' ' ' PHE . 6.3 m-30 -58.27 -41.51 84.46 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.381 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.14 -33.64 24.22 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 215' ' ' GLY . 11.7 p -73.8 -47.73 42.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.486 ' N ' HG13 ' A' ' 214' ' ' VAL . . . -55.15 -48.52 67.76 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.111 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.526 ' CB ' HG21 ' A' ' 146' ' ' THR . 17.3 Cg_endo -71.61 -28.67 17.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.145 1.896 . . . . 0.0 113.744 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -73.48 -30.65 63.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.304 0.574 . . . . 0.0 111.268 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 46.3 mt -70.56 -46.31 70.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.483 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.376 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.681 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -66.57 -46.25 78.17 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 128.473 3.608 . . . . 0.0 111.896 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.547 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.42 -48.89 34.6 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 118.562 -1.78 . . . . 0.0 110.112 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.06 -39.02 68.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.671 0.748 . . . . 0.0 109.513 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -68.03 -31.07 70.49 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.348 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.636 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.89 -39.51 81.68 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.11 -49.59 81.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.962 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.06 -39.44 89.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.693 0.758 . . . . 0.0 109.532 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.435 HD13 ' O ' ' A' ' 222' ' ' LEU . 1.2 mp -57.39 -34.61 46.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.703 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.19 80.82 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.77 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -174.73 61.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.526 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -62.11 162.34 9.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.458 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 mt -102.27 111.6 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.487 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.17 20.74 4.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . 49.15 72.62 1.2 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.617 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -71.13 114.61 3.97 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.801 2.334 . . . . 0.0 112.049 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -63.2 -77.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.622 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.23 133.58 34.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.606 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 71.7 m -73.54 146.19 44.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.468 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -54.48 159.79 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.51 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.32 161.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 1.1 p -108.69 93.22 4.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.614 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.34 -29.76 60.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.62 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -79.8 157.58 27.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.481 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.76 143.02 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.533 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.6 mttp 179.17 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.636 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.2 p -75.05 -27.14 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.499 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -94.58 -5.2 46.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.582 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.16 115.55 25.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.513 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 15.3 t -160.35 152.81 20.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.552 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 65.68 -172.52 23.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -128.4 -48.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.755 0.312 . . . . 0.0 110.532 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 53.7 t -114.88 -51.77 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.628 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -172.21 138.97 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.609 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.02 -58.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.55 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 65.6 138.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.595 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.65 -38.57 72.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.588 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -50.52 67.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.575 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.8 174.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.597 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -137.18 167.0 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.523 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -130.97 -179.31 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.541 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.53 138.21 44.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 7.5 tt -102.91 -26.6 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.517 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.79 -74.75 0.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.5 p -176.63 99.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.636 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -116.43 -50.95 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.568 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.34 135.11 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.596 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -125.57 104.89 8.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.586 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 3.1 mtm -106.68 31.8 4.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.543 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -130.14 165.03 36.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.465 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.38 -177.39 3.8 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.807 2.338 . . . . 0.0 112.154 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -87.3 -26.46 23.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.46 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -146.86 131.68 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.509 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 2.0 tp -69.87 111.97 5.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.611 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 58.15 95.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.44 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -90.22 134.8 34.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.597 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.98 174.96 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.588 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 59.02 167.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 12.4 pt -59.23 -25.83 31.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.621 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.4 100.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.551 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -61.33 113.77 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.639 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -131.05 85.82 2.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.566 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -140.14 167.08 22.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.565 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.03 131.02 43.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.594 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.79 -55.0 2.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.527 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.1 m -94.03 -50.94 5.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.686 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . 54.91 24.87 6.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.635 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.12 -22.8 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.85 -169.45 0.2 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.588 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 41.9 m170 60.55 -85.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.01 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.44 -174.5 0.12 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.779 0.324 . . . . 0.0 110.57 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 60.81 27.63 17.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.566 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -135.52 33.51 3.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -112.99 105.1 13.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.584 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.586 179.979 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.01 -177.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.657 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 t 54.04 87.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.593 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.18 92.06 0.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.477 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.05 29.52 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.623 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -127.53 88.22 2.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.538 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -116.6 102.62 9.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.611 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -64.75 169.11 5.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.642 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.66 88.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.612 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -174.29 155.24 2.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.431 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.8 m95 73.76 -58.96 0.57 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.695 0.622 . . . . 0.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -58.94 -13.31 6.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.308 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.72 -8.54 12.64 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.295 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.76 -40.31 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.55 -35.83 72.03 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.715 0 CA-C-N 112.807 -1.997 . . . . 0.0 110.696 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.51 -35.1 69.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 14.9 mt-10 -70.82 -46.6 62.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.17 -33.72 70.28 Favored 'General case' 0 C--O 1.212 -0.912 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 tt -58.73 -38.29 78.03 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 112.284 -2.234 . . . . 0.0 109.461 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.01 -46.63 80.55 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.14 -1.845 . . . . 0.0 114.232 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.707 ' CG2' ' HB2' ' A' ' 105' ' ' ALA . 0.7 OUTLIER -74.34 -31.14 62.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.61 -177.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.702 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.28 -40.82 67.3 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.149 -178.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 27' ' ' ILE . 1.8 mt -65.94 -45.04 83.26 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -52.59 9.1 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -65.66 -43.96 93.66 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.314 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.185 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.445 ' O ' HG12 ' A' ' 29' ' ' ILE . 53.0 t80 -54.13 -50.23 67.39 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.927 0.785 . . . . 0.0 112.135 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -75.73 -29.16 20.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.705 179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 25' ' ' VAL . 0.5 OUTLIER -56.4 -36.33 68.79 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -175.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.676 HG21 HD22 ' A' ' 112' ' ' LEU . 4.2 mm -58.91 -39.94 79.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.544 177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.38 -36.68 63.74 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -67.35 -38.06 84.22 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.68 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.53 -46.42 66.53 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.72 -30.0 23.48 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.05 -36.49 40.77 Favored Glycine 0 C--N 1.317 -0.508 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.813 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.02 -19.53 44.66 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 118.507 -1.277 . . . . 0.0 107.669 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -10.01 16.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.148 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.458 ' H ' ' C ' ' A' ' 34' ' ' GLY . 19.3 t80 -123.64 119.92 26.96 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 118.216 0.462 . . . . 0.0 110.166 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.95 152.03 76.09 Favored 'Cis proline' 0 N--CA 1.498 1.773 0 CA-C-N 119.922 1.008 . . . . 0.0 111.469 -1.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -82.69 135.73 24.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.461 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.81 161.93 39.36 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -152.09 -40.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 110.504 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -126.41 -28.66 3.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.533 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -61.47 162.48 8.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.484 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 t -101.81 10.59 39.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.56 128.67 35.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.801 0.334 . . . . 0.0 110.55 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.7 p -125.67 136.53 60.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.512 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -104.35 128.76 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.495 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -114.14 162.95 15.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.126 0.488 . . . . 0.0 110.898 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -51.54 -28.73 14.61 Favored 'General case' 0 C--O 1.209 -1.073 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.276 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.488 HG13 ' HD3' ' A' ' 51' ' ' LYS . 3.4 p -61.04 -33.45 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HD3' HG13 ' A' ' 50' ' ' VAL . 25.1 mmtt -64.94 -54.12 35.68 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.601 1.091 . . . . 0.0 112.978 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.735 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 8.8 p -68.18 -40.56 83.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.599 -176.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.438 ' N ' HG13 ' A' ' 52' ' ' VAL . 72.6 m -69.31 -40.51 77.61 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.726 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 0.6 OUTLIER -62.85 -31.81 72.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.21 -39.52 94.14 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.969 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.542 ' O ' HD13 ' A' ' 60' ' ' ILE . 3.1 m-85 -66.01 -46.97 76.04 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.741 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.55 -45.84 93.74 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.278 -0.419 . . . . 0.0 114.005 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.652 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 1.4 tp -66.32 -43.83 85.12 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.107 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.7 m -58.74 -36.74 74.82 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -60.15 -34.0 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.496 -178.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.76 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.7 -45.59 82.2 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.506 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.8 p -68.94 -32.07 71.42 Favored 'General case' 0 CA--C 1.469 -2.165 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.998 HD13 HD12 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.61 -40.44 72.11 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.87 -44.11 73.98 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 112.931 -1.94 . . . . 0.0 109.453 173.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -38.31 86.31 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.0 m -59.63 -12.29 6.5 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 119.889 1.222 . . . . 0.0 111.579 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.8 -42.87 2.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 0.0 111.428 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.12 178.9 21.06 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -22.96 62.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.832 0.348 . . . . 0.0 111.133 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -72.69 7.05 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.306 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.6 m -124.32 135.51 53.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.279 0.561 . . . . 0.0 111.623 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.13 -140.62 8.7 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.672 ' HB3' HG21 ' A' ' 79' ' ' VAL . . . -72.53 85.88 1.16 Allowed 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 118.347 -1.341 . . . . 0.0 108.368 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.61 -19.63 59.1 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.998 HD12 HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -89.74 8.35 32.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.089 179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 59.3 m-20 -148.26 144.15 18.38 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 121.145 1.793 . . . . 0.0 114.222 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 194' ' ' ALA . 98.6 Cg_endo -83.51 -21.89 4.09 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 124.035 3.157 . . . . 0.0 112.943 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.732 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -59.22 -45.8 90.16 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 73' ' ' ALA . 26.3 m -66.46 -38.16 81.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.4 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.701 HG21 ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -61.66 -29.96 70.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mt -60.23 -36.05 76.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.15 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.8 -48.92 31.75 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.737 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.59 -14.79 62.85 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 tt -62.22 -60.32 3.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.72 33.64 3.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.047 0.451 . . . . 0.0 110.878 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 t -83.17 -27.25 30.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.445 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.2 -42.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.47 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.26 -174.72 5.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.578 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.2 mm -133.88 -76.37 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.649 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.7 t -62.7 -77.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.732 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER 66.57 140.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.492 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -127.44 -29.48 2.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.547 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -65.37 -35.81 82.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.612 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -65.41 -35.18 80.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.095 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.87 -38.73 67.86 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 2.2 tpp -73.33 -31.64 64.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.043 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.701 ' CD2' HG21 ' A' ' 80' ' ' THR . 8.1 t80 -65.01 -44.24 89.84 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 118.777 0.717 . . . . 0.0 111.142 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -66.71 -41.22 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.5 mt -70.38 -42.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.28 69.07 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -35.81 70.67 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.7 t -57.99 -36.14 72.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 107' ' ' VAL . 2.8 t -71.3 -35.25 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.314 175.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.39 -47.54 82.2 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 120.908 1.685 . . . . 0.0 112.833 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.707 ' HB2' ' CG2' ' A' ' 21' ' ' THR . . . -69.92 -35.98 74.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.0 mm -66.05 -50.34 70.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 103' ' ' VAL . 34.5 m -62.32 -36.97 77.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.148 0.499 . . . . 0.0 109.757 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.24 -49.68 75.26 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.556 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 30.3 m -64.68 -37.0 86.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.643 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.65 85.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.124 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.99 -37.33 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.801 0.334 . . . . 0.0 110.681 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -65.75 -24.61 67.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.645 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -61.04 -38.98 88.06 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.423 -178.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.0 -36.17 60.33 Favored Glycine 0 CA--C 1.511 -0.199 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 HD12 ' HG ' ' A' ' 112' ' ' LEU . 4.4 mt -54.14 -36.87 33.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.703 -0.749 . . . . 0.0 111.057 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -63.14 -14.91 54.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.555 -178.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.2 m -52.33 -45.17 65.52 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.18 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -35.12 14.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 mp -81.48 -179.92 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 42.8 p -118.34 125.33 49.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.697 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.2 84.66 0.06 OUTLIER Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -98.09 -35.32 10.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.575 0.226 . . . . 0.0 111.175 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.9 t 179.27 83.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.914 0.387 . . . . 0.0 111.03 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.09 7.9 32.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.887 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.05 78.27 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -112.6 124.38 52.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.024 0.44 . . . . 0.0 111.337 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 51.97 20.6 1.27 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.405 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -112.37 92.21 3.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.755 0.312 . . . . 0.0 110.432 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 135' ' ' SER . 3.3 mm? -63.12 148.42 47.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.057 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -104.33 138.64 40.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.585 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -49.59 127.6 15.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.71 -105.18 0.66 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.829 HG22 ' HB3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -86.16 131.92 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.451 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 0.6 OUTLIER -71.77 -171.98 0.76 Allowed 'General case' 0 C--O 1.201 -1.489 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 176.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.464 ' N ' HD11 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -64.61 -46.73 81.39 Favored 'General case' 0 C--N 1.285 -2.231 0 C-N-CA 114.52 -2.872 . . . . 0.0 109.883 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.656 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -58.93 -41.46 96.28 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.285 -0.96 . . . . 0.0 110.954 -175.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.829 ' HB3' HG22 ' A' ' 133' ' ' VAL . 7.3 mm-40 -53.45 -23.41 9.98 Favored 'General case' 0 C--N 1.248 -3.838 0 CA-C-O 121.443 0.64 . . . . 0.0 110.61 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLU . . . -69.61 -1.56 30.91 Favored Glycine 0 C--O 1.185 -2.913 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.54 -50.23 63.85 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 118.394 1.097 . . . . 0.0 111.146 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.53 -35.71 75.52 Favored Glycine 0 C--O 1.229 -0.163 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.8 ' CD1' HG21 ' A' ' 133' ' ' VAL . 0.1 OUTLIER -71.54 -36.04 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 113.239 -1.48 . . . . 0.0 111.845 -178.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 138' ' ' GLY . 7.9 mt-10 -68.42 -36.38 78.98 Favored 'General case' 0 C--O 1.207 -1.142 0 CA-C-O 122.047 0.927 . . . . 0.0 110.863 177.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.657 HG23 ' CA ' ' A' ' 219' ' ' GLY . 41.2 mt -70.5 -50.24 46.91 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.233 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.923 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.25 -43.65 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 122.062 0.935 . . . . 0.0 111.383 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.425 ' O ' ' CG ' ' A' ' 148' ' ' GLN . . . -62.35 -51.7 54.57 Favored Glycine 0 C--O 1.205 -1.663 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.237 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.416 ' HA ' HG23 ' A' ' 191' ' ' ILE . 45.1 m -70.01 -35.23 74.21 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.796 0.808 . . . . 0.0 110.363 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 147' ' ' LEU . 2.1 tp -54.87 -40.15 69.43 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -57.91 -33.35 68.67 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.949 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.986 HD11 HG22 ' A' ' 176' ' ' VAL . 2.3 tp -68.89 -47.08 66.73 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.972 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.655 HG21 ' HA3' ' A' ' 220' ' ' GLY . 54.3 t -66.23 -41.02 88.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.76 -45.63 85.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' A' ' 172' ' ' ILE . 21.3 p -64.28 -28.44 69.72 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.704 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.01 -38.54 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.8 mt -65.89 -35.95 82.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.14 80.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.231 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.691 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 1.8 t -65.3 -36.83 85.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.677 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.8 m -83.35 -8.74 59.37 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.021 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 139.06 33.24 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 41.1 ttm-85 -85.79 -37.77 18.91 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.22 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 39.68 -158.02 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.709 0.631 . . . . 0.0 111.197 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -102.51 138.03 39.96 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 65.78 -165.8 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.441 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -141.1 175.87 9.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.98 -165.64 1.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.54 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -120.51 -179.62 16.31 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 64.82 -174.88 13.86 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.428 ' CB ' HD12 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -101.81 123.69 46.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.547 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.691 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . -52.26 -45.62 94.36 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.621 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 28.0 Cg_exo -54.63 -38.27 90.89 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.557 1.505 . . . . 0.0 111.878 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 167' ' ' SER . 62.0 mt -60.72 -43.2 98.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.035 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.63 -46.95 57.54 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.087 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.45 HG23 ' SG ' ' A' ' 152' ' ' CYS . 1.3 mp -58.08 -42.05 82.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 CA-C-O 121.546 0.688 . . . . 0.0 109.692 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.74 -37.63 93.65 Favored Glycine 0 C--O 1.195 -2.316 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.131 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -55.15 -35.53 64.83 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 178.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -34.43 77.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.821 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.986 HG22 HD11 ' A' ' 149' ' ' LEU . 11.5 t -72.01 -47.06 56.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.741 ' HB2' ' HA3' ' A' ' 57' ' ' GLY . . . -68.89 -33.58 74.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 122.124 0.964 . . . . 0.0 110.131 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.276 4.3 mt -69.16 -52.94 23.02 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 125.293 2.473 . . . . 0.0 110.918 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.51 62.57 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 110.01 -3.268 . . . . 0.0 106.58 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.448 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 2.6 m80 -70.08 -34.88 73.71 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.756 -1.722 . . . . 0.0 110.081 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.567 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -56.84 -47.69 79.77 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.369 -178.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.66 -51.56 14.06 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 191' ' ' ILE . . . -69.38 -52.07 30.56 Favored 'General case' 0 C--O 1.205 -1.28 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 188' ' ' GLY . 1.5 mp -56.65 -49.14 79.21 Favored 'Isoleucine or valine' 0 C--O 1.171 -3.032 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.504 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -70.09 -35.82 74.45 Favored 'General case' 0 C--N 1.277 -2.564 0 C-N-CA 115.998 -2.281 . . . . 0.0 113.067 -175.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -60.18 -29.47 68.72 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.316 -171.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.276 0.1 OUTLIER -124.27 -26.95 3.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 122.199 1.0 . . . . 0.0 113.269 -178.744 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 184' ' ' ILE . . . 88.48 -5.89 84.2 Favored Glycine 0 CA--C 1.564 3.102 0 N-CA-C 105.981 -2.848 . . . . 0.0 105.981 -170.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.438 ' H ' HG23 ' A' ' 187' ' ' THR . 17.4 t -84.45 129.47 34.86 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 123.601 1.667 . . . . 0.0 106.588 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.477 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -50.02 161.84 0.96 Allowed Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 110.659 -2.973 . . . . 0.0 112.465 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.658 HG13 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.53 -42.71 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.189 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.732 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 7.9 p-10 -87.05 139.86 32.61 Favored Pre-proline 0 N--CA 1.418 -2.047 0 CA-C-N 111.85 -2.432 . . . . 0.0 107.695 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -66.01 -14.89 46.52 Favored 'Trans proline' 0 C--N 1.321 -0.92 0 C-N-CA 121.886 1.724 . . . . 0.0 111.674 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.463 ' HB2' ' HD3' ' A' ' 77' ' ' PRO . . . -75.31 -30.65 60.41 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.589 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.438 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.4 OUTLIER -70.69 -39.61 73.39 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.288 0.566 . . . . 0.0 109.617 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -31.73 64.32 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.85 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.838 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.7 m-85 -72.04 -35.0 69.24 Favored 'General case' 0 N--CA 1.505 2.306 0 C-N-CA 126.61 1.964 . . . . 0.0 113.911 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -46.6 91.99 Favored Glycine 0 C--N 1.319 -0.402 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 202' ' ' ILE . 1.3 p -76.35 -28.24 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.688 -0.756 . . . . 0.0 110.297 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.838 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -64.81 -34.0 77.32 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.995 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 7.3 p -55.46 -31.18 27.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 121.186 1.812 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 199' ' ' SER . 0.7 OUTLIER -48.68 147.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.651 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.28 170.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.673 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 66.41 96.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.678 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -129.14 166.79 18.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.405 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -160.22 -177.93 6.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.775 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -27.84 69.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.991 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -55.93 -35.09 66.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.821 0.344 . . . . 0.0 110.82 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.5 -26.35 30.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.431 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -70.55 -32.6 70.1 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.496 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.656 HG21 ' HA2' ' A' ' 136' ' ' GLY . 31.9 mm -52.6 -35.12 20.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -58.62 -36.61 74.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.112 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -84.33 -33.44 23.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 215' ' ' GLY . 12.3 p -78.61 -47.08 24.2 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.15 -45.95 80.38 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.313 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 4.1 Cg_exo -71.69 -28.67 16.85 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.877 2.385 . . . . 0.0 113.29 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -33.75 58.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.255 0.55 . . . . 0.0 112.113 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 49.8 mt -70.59 -46.12 71.25 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.44 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.295 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.657 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.34 -46.81 67.58 Favored Glycine 0 C--N 1.356 1.657 0 O-C-N 128.407 3.567 . . . . 0.0 111.886 -178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.655 ' HA3' HG21 ' A' ' 150' ' ' VAL . . . -70.32 -48.96 34.93 Favored Glycine 0 N--CA 1.434 -1.496 0 C-N-CA 118.146 -1.978 . . . . 0.0 109.894 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.92 -38.87 68.19 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.632 0.73 . . . . 0.0 109.789 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.4 pp -67.84 -31.24 70.94 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.334 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.565 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.99 -39.63 82.39 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.21 -49.64 81.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 113.852 -1.522 . . . . 0.0 112.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -39.34 91.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.7 0.762 . . . . 0.0 109.719 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -34.59 49.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.765 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -131.71 51.55 2.14 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.194 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -174.49 -31.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.732 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.94 -172.25 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.651 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 tt -137.85 98.19 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.933 0.397 . . . . 0.0 110.737 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 17.9 mt 48.24 92.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.069 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -131.64 158.6 74.93 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.35 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.39 -58.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.61 2.207 . . . . 0.0 112.287 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.15 93.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.507 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.17 124.77 5.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.587 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 11.1 t 179.1 -56.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.502 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -173.18 42.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.599 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.18 110.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.641 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.3 t -124.36 27.42 7.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.591 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.3 -26.58 19.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.533 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.4 77.71 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.625 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.11 95.46 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp 53.91 -175.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.498 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 246' ' ' THR . 38.5 t -63.89 -60.77 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.542 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 57.74 25.77 12.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.491 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.442 ' H ' HG12 ' A' ' 244' ' ' VAL . 2.3 m 58.95 80.97 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.617 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.1 p -76.49 -65.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -105.81 -119.69 4.59 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -143.47 25.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.735 0.302 . . . . 0.0 110.633 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.74 19.71 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 63.46 -83.92 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.956 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -159.98 135.71 8.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.545 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -104.94 167.46 9.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.642 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.1 -47.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.597 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 62.81 110.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.621 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.45 -52.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.616 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -155.31 -64.52 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.531 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.98 155.48 2.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.622 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -135.41 -67.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.566 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 10.0 mt 64.64 144.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.625 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.01 -73.52 0.09 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.81 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.59 -170.32 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.369 . . . . 0.0 110.554 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? 54.45 74.48 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.505 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 45.2 t -50.55 123.92 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.569 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.29 152.3 38.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.56 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 6.3 ttp -113.44 107.51 15.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.605 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.41 71.86 82.12 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.639 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -47.71 -39.0 30.33 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.823 2.349 . . . . 0.0 112.109 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.41 147.25 39.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.551 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 60.7 53.61 3.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.07 179.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.736 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -155.19 131.15 10.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.504 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -145.29 88.88 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.472 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 15.9 tttt 54.27 73.58 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.545 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.24 32.46 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.563 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.95 -26.38 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.55 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 8.1 t -99.22 83.81 2.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.548 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -56.06 124.34 17.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.595 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -139.95 176.58 8.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.621 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.32 96.81 7.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.529 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 2.7 mp -81.32 101.94 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.598 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.96 -73.64 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 1.8 p -57.08 124.06 17.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 0.0 110.554 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -159.76 -58.52 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.537 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.86 27.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.615 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.42 137.24 51.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.615 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 159.89 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.606 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -97.38 -65.21 0.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.536 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 13.8 m80 56.42 95.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.514 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -102.65 61.48 0.82 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.551 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -110.59 -43.98 3.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.543 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 3.5 p80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.59 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.92 78.23 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.59 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -99.16 142.45 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.55 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 53.74 32.01 13.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.433 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -120.97 -24.02 5.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.674 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.65 166.7 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.56 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -132.24 -178.72 5.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.631 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 ttpp 56.39 41.75 28.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.573 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.31 -28.54 42.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.698 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.32 96.46 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.683 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -115.84 -14.81 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -57.12 -16.47 7.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.095 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.16 -0.18 15.66 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.88 -40.09 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 175.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.3 -35.73 72.19 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.775 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.584 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.48 -34.82 69.42 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.689 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -70.62 -46.74 62.79 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -176.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -33.82 73.26 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 19' ' ' LEU . 12.3 mt -58.84 -38.35 78.48 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.68 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.73 -47.07 76.54 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 112.742 -2.026 . . . . 0.0 115.077 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -75.74 -31.5 59.61 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.493 -177.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.767 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.72 -39.0 67.28 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.737 -178.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.89 -45.06 83.4 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.63 ' CD2' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -77.07 -47.2 21.19 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 29' ' ' ILE . 92.5 t -65.25 -50.57 72.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.334 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.477 -177.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.474 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 18.1 t80 -53.86 -47.43 71.03 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.52 -29.17 20.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.594 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -36.23 67.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.728 HG21 HD22 ' A' ' 112' ' ' LEU . 3.2 mm -62.97 -38.61 82.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.142 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' A' ' 33' ' ' LEU . . . -55.26 -36.88 63.29 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.257 -177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -63.49 -45.02 92.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.726 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.52 -16.86 63.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.762 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.512 HD11 HD21 ' A' ' 112' ' ' LEU . 14.3 mt -78.42 -43.44 27.33 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 121.484 0.659 . . . . 0.0 110.003 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.46 -24.4 68.09 Favored Glycine 0 C--N 1.308 -1.01 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.25 -26.98 63.56 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -106.78 -10.03 16.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.01 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.478 ' H ' ' C ' ' A' ' 34' ' ' GLY . 14.4 t80 -123.23 120.01 27.39 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 118.257 0.481 . . . . 0.0 110.479 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.56 142.12 65.42 Favored 'Cis proline' 0 N--CA 1.499 1.845 0 CA-C-N 119.825 0.973 . . . . 0.0 112.107 -0.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 p -77.18 151.31 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.688 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.06 -160.82 17.6 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.29 90.46 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.467 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -121.87 21.17 10.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.767 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -141.4 -168.81 2.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.339 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.1 p -88.42 -22.16 23.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.738 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.15 145.31 51.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.042 0.448 . . . . 0.0 110.964 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 t -141.54 132.43 26.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.117 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -105.58 106.01 16.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.023 0.44 . . . . 0.0 110.733 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 38.1 t0 -114.47 163.03 15.91 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.493 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -49.8 -28.04 5.79 Favored 'General case' 0 C--O 1.206 -1.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.407 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG22 HD21 ' A' ' 181' ' ' LEU . 12.0 t -56.81 -48.24 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -64.8 -44.12 90.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.717 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 7.7 p -68.2 -47.6 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.548 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.454 ' N ' HG13 ' A' ' 52' ' ' VAL . 12.2 m -69.15 -36.49 77.48 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.78 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 49.4 tp -63.41 -31.88 73.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -65.79 -39.2 90.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.494 -1.685 . . . . 0.0 109.374 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 60' ' ' ILE . 8.4 m-30 -65.92 -43.33 88.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.875 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.771 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.56 -43.34 96.67 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.467 -0.396 . . . . 0.0 112.901 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 58.0 mt -66.76 -43.69 83.41 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.301 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -36.54 74.66 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -60.26 -34.08 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-N 113.368 -1.742 . . . . 0.0 108.645 -178.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.721 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -62.39 -45.53 92.73 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.423 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 62' ' ' THR . 8.1 p -67.84 -31.42 71.24 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -41.96 72.1 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -68.96 -44.07 73.69 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 112.919 -1.946 . . . . 0.0 110.508 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -40.2 87.78 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.51 -12.13 5.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 119.802 1.183 . . . . 0.0 111.702 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.98 -42.85 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.759 0.314 . . . . 0.0 111.395 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.6 170.65 11.91 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -23.08 62.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 9.2 pt -76.06 7.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 135.7 53.57 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.377 0.608 . . . . 0.0 111.697 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.48 -149.55 18.45 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.34 85.35 1.09 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -20.01 62.34 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.663 ' O ' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -89.84 3.43 52.97 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 112.26 -2.245 . . . . 0.0 113.636 178.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.624 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 3.6 t-20 -126.46 133.85 25.41 Favored Pre-proline 0 N--CA 1.483 1.19 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 83.6 Cg_endo -83.68 -32.25 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 123.171 2.58 . . . . 0.0 112.1 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.606 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -61.13 -49.89 75.45 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.454 ' CG2' HG21 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -66.22 -36.81 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.825 0.345 . . . . 0.0 111.218 177.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 m -62.89 -28.63 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.434 HD13 ' CG ' ' A' ' 217' ' ' PHE . 0.6 OUTLIER -60.71 -42.05 96.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.874 0.369 . . . . 0.0 110.409 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -56.68 -39.3 85.95 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.36 -50.23 72.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.615 0.245 . . . . 0.0 111.294 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -66.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.837 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.14 -25.53 9.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.545 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 t -99.5 -162.71 0.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.434 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 65.58 -169.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.674 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -109.24 -69.46 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.705 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.7 mt -77.7 -80.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.694 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.45 -161.28 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.475 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 92' ' ' PHE . 42.3 mt 62.93 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.314 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.472 ' N ' HG22 ' A' ' 91' ' ' ILE . 0.2 OUTLIER 69.83 -73.62 0.09 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.805 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -63.11 -45.27 92.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.394 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.89 -35.13 77.96 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.86 -38.44 67.47 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.4 ttt -71.71 -36.18 70.44 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.316 -1.765 . . . . 0.0 109.685 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -64.33 -37.52 87.81 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 119.177 0.899 . . . . 0.0 109.236 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.4 OUTLIER -59.6 -48.12 88.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.532 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.441 ' N ' HG22 ' A' ' 98' ' ' ILE . 26.2 pt -70.44 -37.75 71.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -66.22 -47.18 74.7 Favored 'General case' 0 C--O 1.213 -0.864 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.61 -35.84 70.59 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.96 71.74 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 100' ' ' ALA . 2.7 t -70.81 -35.39 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.016 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.61 -42.21 90.33 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 121.152 1.797 . . . . 0.0 112.973 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.465 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.91 -36.05 75.08 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 53.7 mt -68.03 -42.22 85.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.825 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.94 -37.23 72.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.269 0.557 . . . . 0.0 109.515 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.67 -44.67 85.92 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.14 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -70.32 -37.17 74.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.709 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.28 -44.83 88.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.707 0.289 . . . . 0.0 111.113 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 57.8 mt -69.22 -37.51 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.39 . . . . 0.0 110.814 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.728 HD22 HG21 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -64.47 -24.5 67.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.023 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.48 -36.89 81.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.969 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -54.95 -36.24 60.16 Favored Glycine 0 CA--C 1.51 -0.269 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 19.5 mm -55.33 -40.6 57.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.627 -0.787 . . . . 0.0 110.532 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.29 -12.47 29.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.455 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -52.39 -44.45 65.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.745 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.08 -35.43 13.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.477 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 mp -87.66 -178.09 6.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.848 0.356 . . . . 0.0 111.023 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.99 126.92 55.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.612 ' CA ' HD11 ' A' ' 124' ' ' LEU . . . -68.66 78.37 0.26 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.0 -35.42 10.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.575 0.226 . . . . 0.0 111.433 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 t -164.53 70.92 0.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.12 0.486 . . . . 0.0 110.559 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.612 HD11 ' CA ' ' A' ' 121' ' ' GLY . 0.9 OUTLIER -87.09 8.1 25.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.113 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.13 15.43 78.76 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -112.71 117.47 32.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 120.761 0.315 . . . . 0.0 111.71 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 52.0 29.44 6.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.101 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -108.79 89.61 3.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.52 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 187' ' ' THR . 3.3 mm? -63.01 143.79 57.47 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.055 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -107.03 139.99 40.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.887 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -49.62 127.63 16.06 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.28 -104.66 0.59 Allowed Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.834 HG21 HG13 ' A' ' 141' ' ' ILE . 1.3 t -86.09 127.76 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.459 ' O ' HG12 ' A' ' 133' ' ' VAL . 9.4 t-20 -71.66 -172.03 0.74 Allowed 'General case' 0 C--O 1.203 -1.376 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.505 ' N ' HD11 ' A' ' 129' ' ' LEU . 6.8 t -63.54 -46.97 83.56 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 114.499 -2.88 . . . . 0.0 109.893 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.85 -40.13 94.79 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.13 -1.034 . . . . 0.0 111.323 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.795 ' HB3' HG22 ' A' ' 133' ' ' VAL . 2.4 mm100 -53.5 -23.54 10.65 Favored 'General case' 0 C--N 1.253 -3.618 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.676 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.532 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -66.34 -2.18 13.56 Favored Glycine 0 C--O 1.191 -2.56 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 176.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.693 HD13 HD11 ' A' ' 211' ' ' ILE . 7.3 tp -61.05 -50.37 73.58 Favored 'General case' 0 C--O 1.206 -1.226 0 O-C-N 120.458 -1.613 . . . . 0.0 108.458 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.77 -46.52 53.12 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.834 HG13 HG21 ' A' ' 133' ' ' VAL . 2.1 mm -59.58 -42.83 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 114.186 -1.007 . . . . 0.0 111.352 -177.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.19 -36.11 79.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 124.035 0.934 . . . . 0.0 112.59 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.636 HG23 ' CA ' ' A' ' 219' ' ' GLY . 19.6 mt -67.78 -50.48 59.85 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.374 0 O-C-N 121.718 -0.614 . . . . 0.0 110.474 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.3 mt -68.29 -43.59 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.99 0.9 . . . . 0.0 111.948 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 148' ' ' GLN . . . -61.98 -51.05 59.69 Favored Glycine 0 C--O 1.2 -1.993 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.915 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 216' ' ' PRO . 28.6 m -70.25 -37.61 74.98 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.838 0.828 . . . . 0.0 110.87 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 3.8 tp -55.03 -40.22 69.98 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.572 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.47 HE22 ' HB2' ' A' ' 175' ' ' SER . 1.1 pp0? -57.85 -31.42 66.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 113.658 -1.61 . . . . 0.0 109.778 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.887 HD11 HG22 ' A' ' 176' ' ' VAL . 1.2 tp -68.72 -47.16 67.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.651 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.616 HG21 ' HA3' ' A' ' 220' ' ' GLY . 82.5 t -66.39 -40.98 88.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -45.65 82.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' A' ' 172' ' ' ILE . 24.6 p -65.68 -29.02 69.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.925 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.454 HG21 ' CG2' ' A' ' 79' ' ' VAL . 2.5 t -71.94 -39.0 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.167 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.59 -38.21 88.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.554 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.75 -31.7 72.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.977 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.583 ' OG1' ' HB1' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -54.71 -36.72 65.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.335 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.88 -8.83 42.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.167 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -64.89 101.0 0.45 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.852 0.358 . . . . 0.0 110.615 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.08 -27.84 65.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.581 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.32 153.06 44.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.455 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 51.78 83.9 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.506 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -102.24 61.21 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.568 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -146.12 40.48 1.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.602 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.3 mt -51.14 -63.6 1.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.589 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 151.29 -55.13 0.46 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -128.35 -111.73 1.62 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.56 129.92 56.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.172 0.51 . . . . 0.0 110.428 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.583 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . -52.62 -43.93 93.83 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 168' ' ' ALA . 10.6 Cg_exo -62.32 -46.76 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.715 1.61 . . . . 0.0 113.842 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 171' ' ' ALA . 3.8 pp -66.37 -29.97 70.26 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.014 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.753 ' N ' HD12 ' A' ' 170' ' ' LEU . . . -71.35 -45.16 63.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.777 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.421 HG23 ' SG ' ' A' ' 152' ' ' CYS . 1.0 OUTLIER -58.16 -37.53 62.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.402 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.78 -37.56 93.54 Favored Glycine 0 C--O 1.196 -2.268 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.667 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.26 -35.86 65.47 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.47 ' HB2' HE22 ' A' ' 148' ' ' GLN . 0.7 OUTLIER -67.54 -34.79 77.79 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.173 176.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.887 HG22 HD11 ' A' ' 149' ' ' LEU . 10.5 t -70.32 -46.92 69.43 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.78 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -68.66 -32.81 72.91 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.516 1.15 . . . . 0.0 110.527 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.629 ' O ' HD22 ' A' ' 182' ' ' LEU 0.279 2.7 tp -70.55 -50.64 35.36 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 124.739 2.209 . . . . 0.0 110.212 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.5 -37.12 65.72 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 109.896 -3.32 . . . . 0.0 107.042 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.443 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 0.3 OUTLIER -70.33 -35.24 73.49 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.959 -1.62 . . . . 0.0 109.648 178.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -57.16 -47.04 82.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.815 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.68 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -74.5 -52.11 12.86 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.71 ' HB3' HG13 ' A' ' 191' ' ' ILE . . . -69.98 -51.94 28.4 Favored 'General case' 0 C--O 1.2 -1.506 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 188' ' ' GLY . 3.7 mt -61.4 -49.21 85.44 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.681 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -174.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.536 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -69.23 -35.55 76.29 Favored 'General case' 0 C--N 1.28 -2.45 0 C-N-CA 116.226 -2.19 . . . . 0.0 112.645 -176.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.09 -28.86 68.17 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.538 -171.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.518 ' O ' HD13 ' A' ' 129' ' ' LEU 0.284 0.1 OUTLIER -124.54 -26.71 3.82 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.217 1.008 . . . . 0.0 113.2 -179.501 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.11 -5.67 84.72 Favored Glycine 0 CA--C 1.567 3.327 0 N-CA-C 106.332 -2.707 . . . . 0.0 106.332 -170.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.414 ' CB ' ' OG1' ' A' ' 187' ' ' THR . 37.5 t -84.25 126.04 32.79 Favored 'General case' 0 N--CA 1.407 -2.597 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -46.53 162.61 0.17 Allowed Glycine 0 N--CA 1.411 -2.986 0 CA-C-N 111.307 -2.679 . . . . 0.0 112.647 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.71 HG13 ' HB3' ' A' ' 183' ' ' ALA . 0.1 OUTLIER -72.39 -41.55 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 174.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.606 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.0 p30 -94.35 146.31 31.31 Favored Pre-proline 0 N--CA 1.409 -2.488 0 CA-C-N 111.528 -2.578 . . . . 0.0 108.657 179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.12 -14.69 45.5 Favored 'Trans proline' 0 N--CA 1.483 0.863 0 C-N-CA 122.524 2.15 . . . . 0.0 111.479 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.578 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.24 -34.33 61.41 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-O 120.76 0.314 . . . . 0.0 110.574 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.493 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 38.1 tpt85 -70.61 -40.53 73.13 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.906 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.2 -37.53 66.44 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.825 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 13.3 t80 -72.1 -35.06 69.08 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 126.718 2.007 . . . . 0.0 114.458 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.3 93.34 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 106.7 -2.56 . . . . 0.0 106.7 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 16.2 m -76.6 -28.3 56.1 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.361 -0.919 . . . . 0.0 110.992 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.825 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -67.53 -33.93 76.05 Favored 'General case' 0 CA--C 1.501 -0.912 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.35 -31.29 14.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 121.152 1.796 . . . . 0.0 111.808 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 1.6 pt -64.02 -27.91 43.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.636 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.19 113.03 14.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.628 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -106.57 86.42 2.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.066 0.46 . . . . 0.0 110.472 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -178.89 -164.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.437 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 55.63 96.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.638 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 25.0 p -55.2 -26.68 40.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.457 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -59.27 -35.3 73.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.587 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -25.07 52.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.827 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -61.28 -20.06 62.44 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.494 0.496 . . . . 0.0 111.308 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 139' ' ' LEU . 2.6 tp -52.39 -34.27 18.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -27.13 64.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.803 -178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -84.43 -44.68 13.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 214' ' ' VAL . 2.6 p -80.18 -41.11 20.72 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.415 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.503 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.3 -45.07 84.35 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.434 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.514 ' HB3' HG21 ' A' ' 146' ' ' THR . 3.4 Cg_exo -71.74 -28.66 16.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.624 2.216 . . . . 0.0 112.95 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.434 ' CG ' HD13 ' A' ' 81' ' ' LEU . 3.4 m-30 -77.4 -31.0 53.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.983 0.42 . . . . 0.0 111.993 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.4 mm -70.77 -46.44 68.81 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.296 0 C-N-CA 123.398 0.679 . . . . 0.0 112.457 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.636 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.95 -46.09 60.85 Favored Glycine 0 C--N 1.359 1.84 0 O-C-N 128.659 3.724 . . . . 0.0 111.535 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.616 ' HA3' HG21 ' A' ' 150' ' ' VAL . . . -70.27 -49.02 34.93 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 118.192 -1.956 . . . . 0.0 109.944 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.96 68.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.648 0.737 . . . . 0.0 109.626 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.73 -31.29 71.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.152 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.78 -39.47 81.16 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 61.5 t -58.15 -49.54 81.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.604 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -39.47 94.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.623 0.725 . . . . 0.0 109.817 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 21.4 mt -58.59 -34.42 51.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.346 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -71.78 0.67 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.386 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -72.23 73.65 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.755 0.312 . . . . 0.0 110.746 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -48.69 139.99 8.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.672 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.5 tt -130.59 -6.4 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.272 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -49.44 -71.0 0.07 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.861 0.362 . . . . 0.0 110.616 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.519 ' HB1' ' HD2' ' A' ' 233' ' ' PRO . . . -129.02 164.89 35.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.537 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 232' ' ' ALA . 51.2 Cg_exo -51.35 -42.8 53.0 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.706 2.271 . . . . 0.0 112.073 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -53.78 160.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.507 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 14.1 t -142.73 77.41 1.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.562 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.4 m 56.73 60.23 3.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.621 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.34 -179.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.583 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.3 mp -120.2 119.64 33.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.566 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 59.9 m 61.66 -84.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.002 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -145.87 -50.99 0.24 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.77 0.319 . . . . 0.0 110.537 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.13 55.21 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.7 t -127.1 -63.8 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.618 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -103.38 105.0 15.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.638 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 m -147.78 55.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.613 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -56.21 -46.47 79.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.557 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.7 141.85 26.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.573 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.9 t -168.13 30.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 133.38 -105.59 0.59 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -123.35 39.77 3.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.775 0.322 . . . . 0.0 110.548 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 9.7 p -124.7 146.37 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.683 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.34 43.05 26.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.546 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -155.06 109.08 2.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -98.15 -77.09 0.51 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.551 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.38 -168.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.593 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.86 -74.51 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.558 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.1 t0 57.05 -172.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.551 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -77.16 152.68 34.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.537 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.99 -49.75 59.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.525 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.37 -168.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.602 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 2.6 tt -143.02 137.13 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -115.69 69.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.514 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.04 -165.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.594 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -100.73 97.51 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.474 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.9 p -67.69 -29.83 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.539 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -128.25 173.97 9.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.519 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.19 70.71 4.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.551 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -55.26 39.21 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.342 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -45.07 138.82 8.86 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.05 1.833 . . . . 0.0 112.267 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -49.71 132.59 21.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.615 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -145.6 -47.91 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.594 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.11 102.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.523 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.69 -28.83 58.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.582 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 70.04 -70.9 0.14 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.96 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -72.95 95.83 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 0.0 110.587 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.1 tp 64.94 157.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.554 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 85.7 mt 50.9 89.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.599 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 17.6 m -91.06 -75.93 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.546 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -59.07 4.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.676 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -173.03 167.65 4.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.533 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -94.34 -65.22 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.563 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.57 65.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.539 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.15 -65.7 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.555 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.21 144.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.501 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -151.68 123.91 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.558 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.06 -43.48 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.603 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.99 -171.72 3.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.543 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.29 -76.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.585 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -174.28 85.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.629 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -126.13 19.74 7.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 48.7 57.96 5.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.681 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.02 -73.82 0.09 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.751 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 4.4 p80 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.559 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.32 -172.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.586 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.1 m -154.03 -73.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.515 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 55.4 179.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.77 34.08 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.6 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -77.15 -57.4 3.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.553 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt 49.55 87.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.472 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -132.6 -166.65 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.046 0.451 . . . . 0.0 110.723 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.42 -91.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.737 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 60.83 -87.13 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.37 0.129 . . . . 0.0 110.687 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.36 -18.69 25.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.738 0.304 . . . . 0.0 110.567 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -58.22 -16.15 12.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.017 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.4 1.99 17.32 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.683 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -40.25 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.36 -36.18 73.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.541 0 CA-C-N 112.605 -2.089 . . . . 0.0 109.833 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.09 70.16 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.709 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -71.18 -46.65 60.92 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -177.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -33.96 72.31 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.99 -38.06 78.29 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.508 -2.133 . . . . 0.0 108.912 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -63.18 -46.81 85.39 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.041 -1.89 . . . . 0.0 114.313 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.76 -31.23 59.45 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.699 -177.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.742 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.82 -38.16 67.25 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.781 -178.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.77 -44.92 84.37 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.494 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -76.96 -47.97 19.39 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 29' ' ' ILE . 91.8 t -65.44 -53.76 36.07 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.522 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.52 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . 24.1 t80 -53.87 -44.36 70.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.264 0.484 . . . . 0.0 111.96 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 pt -75.73 -29.91 20.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.903 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -36.42 69.41 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.798 HG21 HD22 ' A' ' 112' ' ' LEU . 3.0 mm -61.82 -38.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.109 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.35 -36.95 64.08 Favored Glycine 0 C--N 1.33 0.216 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -67.14 -38.88 86.29 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.64 -16.88 63.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.506 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.573 HD11 HD21 ' A' ' 112' ' ' LEU . 26.9 mt -85.56 -37.37 19.68 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.606 0.717 . . . . 0.0 110.128 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -76.45 -31.54 54.11 Favored Glycine 0 C--N 1.315 -0.591 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.046 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -23.29 57.15 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -106.91 -10.05 16.11 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.759 176.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 34' ' ' GLY . 25.9 t80 -121.96 120.03 28.61 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 118.743 0.702 . . . . 0.0 110.392 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.31 143.94 71.74 Favored 'Cis proline' 0 N--CA 1.5 1.855 0 C-N-CA 124.773 -0.928 . . . . 0.0 112.174 -0.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 36' ' ' LYS . 11.0 m -72.9 151.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.645 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.71 -128.67 45.49 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 70.18 -71.54 0.12 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.38 0.133 . . . . 0.0 110.718 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.1 t30 47.63 30.56 1.78 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 110.807 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -83.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.627 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.59 -26.71 6.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.347 . . . . 0.0 110.614 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.02 145.43 46.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.773 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.19 116.59 29.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.376 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.54 107.83 19.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.896 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.7 t70 -114.1 162.95 15.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.034 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.91 -28.83 53.79 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.659 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.469 HG23 HD11 ' A' ' 181' ' ' LEU . 4.9 p -61.94 -31.92 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 48' ' ' ASP . 5.4 mmtp -65.05 -54.18 34.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.644 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 22.5 m -68.36 -37.45 77.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.543 -177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 52' ' ' VAL . 16.1 m -69.56 -43.19 73.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.765 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 55.8 tp -62.9 -31.72 72.84 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.535 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.98 -39.68 93.85 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.504 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -66.28 -46.82 75.67 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.741 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.67 -41.65 97.62 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.737 -0.268 . . . . 0.0 113.38 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 2.3 mt -68.39 -43.73 76.66 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.674 -177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -60.46 -36.48 78.36 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -33.99 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 113.077 -1.874 . . . . 0.0 107.987 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.759 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -66.08 -45.71 80.32 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.379 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.1 p -69.42 -31.55 69.97 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.42 -41.01 72.19 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.0 -44.43 72.8 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.25 -1.795 . . . . 0.0 110.155 173.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -36.74 82.91 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.9 t -59.68 -12.21 6.49 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 119.98 1.264 . . . . 0.0 111.367 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.59 -42.71 2.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.883 0.373 . . . . 0.0 110.957 -178.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.14 156.41 6.79 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -23.01 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.743 0.306 . . . . 0.0 110.956 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 tt -74.68 6.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.55 135.64 53.33 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.168 0.509 . . . . 0.0 111.26 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.12 -159.06 21.27 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.47 85.78 1.14 Allowed 'General case' 0 CA--C 1.489 -1.366 0 C-N-CA 118.319 -1.352 . . . . 0.0 108.064 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -19.64 61.08 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.691 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . 2.1 pp -81.15 -10.26 59.67 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.32 -1.764 . . . . 0.0 111.856 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 5.8 t-20 -112.73 131.24 22.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.55 ' CD ' ' HB2' ' A' ' 194' ' ' ALA . 92.7 Cg_endo -83.69 -28.97 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.062 2.508 . . . . 0.0 112.557 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -62.54 -49.68 74.35 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.513 HG21 HG21 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -66.39 -36.77 78.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.778 178.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.2 m -65.85 -28.52 69.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.451 HD23 ' HD1' ' A' ' 217' ' ' PHE . 1.3 mp -61.78 -35.27 77.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.847 0.356 . . . . 0.0 110.715 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -63.9 -42.72 98.27 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mt -58.96 -42.41 89.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 110.975 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.52 -53.94 26.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.805 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -51.45 -25.19 5.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.695 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -77.01 153.5 34.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.565 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 29.4 p -65.29 132.41 48.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.57 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -168.22 -64.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.609 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mt 53.58 93.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.627 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 m -139.76 84.97 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.841 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 47.5 pt 37.98 39.28 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 123.923 0.764 . . . . 0.0 111.732 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 49.21 50.98 17.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 110.545 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -68.36 -35.75 78.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -65.36 -35.06 79.83 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.228 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.79 -38.53 67.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtm -73.47 -31.7 63.91 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.738 -1.573 . . . . 0.0 110.132 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -67.66 -40.44 84.52 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 119.032 0.833 . . . . 0.0 111.447 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -66.77 -41.29 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -70.48 -42.71 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.65 ' HB3' ' OE1' ' A' ' 17' ' ' GLU . . . -68.05 -47.33 68.64 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -71.72 -35.83 70.32 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.8 t -58.03 -36.19 72.37 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.457 ' HA ' HD12 ' A' ' 106' ' ' ILE . 2.9 t -69.78 -35.41 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.857 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.7 -44.76 91.37 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 120.897 1.681 . . . . 0.0 113.369 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.42 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.68 -36.1 75.71 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 103' ' ' VAL . 39.8 mt -67.26 -41.15 86.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.532 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -68.9 -37.3 77.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.41 0.624 . . . . 0.0 109.53 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.61 -46.99 83.39 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.382 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 p -67.73 -37.28 81.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.414 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.83 85.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.02 -39.17 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.774 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.798 HD22 HG21 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -65.14 -24.32 67.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.352 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.2 m -60.62 -44.37 96.41 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.836 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.07 -36.26 60.87 Favored Glycine 0 CA--C 1.509 -0.297 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.21 -30.72 30.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 114.441 -0.879 . . . . 0.0 111.016 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.86 3.22 12.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.4 m -60.76 -42.02 96.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.856 0.36 . . . . 0.0 110.225 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.96 -35.27 14.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.706 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.4 mt -88.58 -179.83 6.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.45 125.63 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.77 84.84 0.07 OUTLIER Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.13 -35.02 10.53 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.7 t -163.1 69.94 0.24 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.923 0.392 . . . . 0.0 111.131 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 mp -81.33 7.94 10.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.311 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.02 25.39 71.51 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 17.6 ptt85 -112.59 118.52 35.3 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.957 0.408 . . . . 0.0 111.884 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 51.82 45.24 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.038 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -116.55 110.38 18.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.796 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.59 ' H ' HD22 ' A' ' 129' ' ' LEU . 1.3 mm? -82.01 138.07 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.39 148.75 27.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.212 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -49.65 127.66 16.21 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.39 -97.6 0.87 Allowed Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.657 HG21 HD13 ' A' ' 141' ' ' ILE . 2.6 t -86.09 119.15 33.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.6 m-80 -71.8 -172.03 0.77 Allowed 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.47 ' O ' HD13 ' A' ' 211' ' ' ILE . 1.0 OUTLIER -61.78 -46.97 87.26 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 114.525 -2.87 . . . . 0.0 110.793 -178.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -59.19 -39.35 94.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.519 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.656 ' CB ' HG13 ' A' ' 133' ' ' VAL . 85.4 mm-40 -52.95 -23.33 6.99 Favored 'General case' 0 C--N 1.255 -3.524 0 CA-C-O 121.342 0.592 . . . . 0.0 110.196 -176.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -63.5 -1.97 5.21 Favored Glycine 0 C--O 1.187 -2.787 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.23 -50.54 69.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 119.332 1.566 . . . . 0.0 110.951 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.84 -43.94 64.33 Favored Glycine 0 CA--C 1.51 -0.255 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.657 HD13 HG21 ' A' ' 133' ' ' VAL . 0.8 OUTLIER -63.56 -38.9 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 112.721 -1.739 . . . . 0.0 112.378 -178.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 138' ' ' GLY . 42.2 mt-10 -68.31 -36.3 79.11 Favored 'General case' 0 C--O 1.2 -1.541 0 CA-C-O 122.275 1.036 . . . . 0.0 110.48 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.681 HG23 ' HA2' ' A' ' 219' ' ' GLY . 40.2 mt -65.9 -46.46 88.43 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.645 -174.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.48 -48.99 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 122.073 0.939 . . . . 0.0 111.769 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.77 56.8 Favored Glycine 0 C--O 1.216 -0.992 0 CA-C-N 113.408 -1.724 . . . . 0.0 113.008 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.486 HG21 ' HB3' ' A' ' 216' ' ' PRO . 17.8 m -70.65 -43.34 69.37 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.887 -1.156 . . . . 0.0 112.447 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 148' ' ' GLN . 0.8 OUTLIER -54.67 -40.18 68.83 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.705 -176.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt20 -57.86 -30.26 65.65 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.851 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 176' ' ' VAL . 2.2 tp -68.82 -45.39 71.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.738 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.433 HG21 ' HA3' ' A' ' 220' ' ' GLY . 82.9 t -66.42 -40.95 87.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.18 -38.38 85.31 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' A' ' 172' ' ' ILE . 5.1 p -73.74 -28.3 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.393 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.513 HG21 HG21 ' A' ' 79' ' ' VAL . 2.3 t -71.98 -45.55 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -41.25 92.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.277 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.02 89.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.423 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.622 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 0.7 OUTLIER -70.2 -36.84 74.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.543 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.79 -7.0 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.316 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.42 136.92 57.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.851 0.358 . . . . 0.0 110.525 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -26.15 65.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -77.89 111.09 13.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.59 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.18 -68.35 0.89 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.473 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 63.72 -83.07 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.033 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.94 -163.79 1.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.783 0.325 . . . . 0.0 110.495 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 65.84 125.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.492 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.66 -132.6 5.36 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 52.93 -175.26 0.2 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.443 ' HB3' HD12 ' A' ' 170' ' ' LEU . 0.3 OUTLIER -96.47 132.45 42.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.545 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.622 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . -52.29 -45.67 94.52 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.818 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 23.6 Cg_exo -54.42 -41.08 79.98 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.485 1.456 . . . . 0.0 112.272 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 167' ' ' SER . 0.3 OUTLIER -59.42 -42.42 91.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.404 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 -47.14 57.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.492 HD11 ' OG1' ' A' ' 156' ' ' THR . 41.6 mt -58.2 -37.11 60.68 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.44 93.49 Favored Glycine 0 C--O 1.2 -1.977 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.299 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 mt -55.1 -36.23 65.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -34.6 77.41 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.562 175.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.988 HG22 HD11 ' A' ' 149' ' ' LEU . 48.4 t -73.06 -47.42 47.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.765 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -70.3 -31.75 69.22 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.966 1.365 . . . . 0.0 110.117 -175.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.273 11.3 tp -70.44 -48.67 54.88 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.446 -2.161 . . . . 0.0 109.547 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.408 ' C ' HG21 ' A' ' 191' ' ' ILE . . . -55.72 -37.03 67.09 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 111.075 -2.784 . . . . 0.0 107.817 -177.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.516 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 10.2 m-70 -68.59 -35.36 77.26 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 113.391 -1.405 . . . . 0.0 109.08 178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -59.34 -47.73 84.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.672 -177.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.419 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.23 -52.52 10.69 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 1.035 ' HB3' HG22 ' A' ' 191' ' ' ILE . . . -70.25 -51.96 26.66 Favored 'General case' 0 C--O 1.202 -1.404 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 180' ' ' HIS . 6.0 mt -59.43 -49.21 84.42 Favored 'Isoleucine or valine' 0 C--O 1.176 -2.815 0 C-N-CA 118.984 -1.087 . . . . 0.0 113.14 -174.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -35.71 78.49 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 115.677 -2.409 . . . . 0.0 112.719 -176.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -59.84 -29.79 68.52 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.673 -171.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.28 0.1 OUTLIER -124.6 -26.85 3.78 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 122.292 1.044 . . . . 0.0 113.43 -179.317 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 87.54 -5.8 84.43 Favored Glycine 0 CA--C 1.566 3.277 0 N-CA-C 106.135 -2.786 . . . . 0.0 106.135 -170.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.419 ' H ' HG23 ' A' ' 187' ' ' THR . 11.4 t -84.1 129.0 34.92 Favored 'General case' 0 N--CA 1.404 -2.746 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -49.82 159.2 1.31 Allowed Glycine 0 N--CA 1.405 -3.403 0 CA-C-N 111.496 -2.593 . . . . 0.0 112.056 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 1.035 HG22 ' HB3' ' A' ' 183' ' ' ALA . 20.3 pt -72.57 -33.07 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.614 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.9 p30 -97.69 143.62 26.53 Favored Pre-proline 0 N--CA 1.418 -2.038 0 CA-C-N 113.194 -1.821 . . . . 0.0 108.748 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.05 -14.44 33.31 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.395 2.063 . . . . 0.0 111.596 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.55 ' HB2' ' CD ' ' A' ' 77' ' ' PRO . . . -75.05 -37.38 61.7 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.623 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.645 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.41 -38.62 74.64 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.26 0.552 . . . . 0.0 109.839 -179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -33.74 65.43 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.502 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.835 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 2.8 m-85 -72.3 -35.25 68.62 Favored 'General case' 0 N--CA 1.512 2.663 0 C-N-CA 126.532 1.933 . . . . 0.0 114.469 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.69 91.91 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 107.274 -2.331 . . . . 0.0 107.274 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -76.35 -28.41 56.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.605 -0.798 . . . . 0.0 110.349 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.835 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -63.8 -34.05 77.05 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.704 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.45 -35.55 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 121.0 1.727 . . . . 0.0 110.418 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 4.9 mm -52.98 -47.89 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.97 -164.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.626 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -135.43 87.05 2.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.802 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -111.82 167.38 10.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.9 -76.13 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.012 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -43.04 93.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.342 . . . . 0.0 110.771 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -69.88 -35.09 74.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -26.36 67.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.448 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 25.4 t-105 -70.62 -39.97 73.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 135' ' ' SER . 1.4 pp -52.7 -34.55 19.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -58.52 -38.54 77.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.706 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -84.21 -33.61 24.09 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.587 HG22 HD12 ' A' ' 218' ' ' ILE . 13.3 p -77.76 -45.16 28.55 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.495 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.477 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.18 -48.15 70.09 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 119.536 -1.316 . . . . 0.0 111.435 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.486 ' HB3' HG21 ' A' ' 146' ' ' THR . 5.2 Cg_endo -72.16 -32.36 10.79 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.477 2.118 . . . . 0.0 114.015 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.451 ' HD1' HD23 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -70.13 -39.88 75.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 5.8 mt -70.47 -46.52 70.14 Favored 'Isoleucine or valine' 0 C--O 1.173 -2.929 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.335 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.681 ' HA2' HG23 ' A' ' 143' ' ' ILE . . . -56.65 -48.46 77.08 Favored Glycine 0 C--N 1.365 2.156 0 O-C-N 128.624 3.703 . . . . 0.0 111.23 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -67.93 -39.44 89.35 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 218' ' ' ILE . . . -54.47 -34.88 62.34 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 5.5 mt -67.55 -37.18 82.31 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 113.487 -1.688 . . . . 0.0 110.502 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -58.8 -39.8 82.18 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.279 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 95.6 t -58.46 -49.72 81.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.794 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.08 -39.53 94.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.694 0.759 . . . . 0.0 110.344 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.92 -34.74 38.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.94 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -140.89 68.71 1.34 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.589 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -174.73 36.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.61 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -69.56 -43.51 72.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.1 tt -126.88 108.16 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.533 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 3.1 tt -169.38 -50.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.604 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 233' ' ' PRO . . . -80.72 163.73 54.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.381 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 232' ' ' ALA . 57.1 Cg_endo -75.03 158.76 41.92 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.717 2.278 . . . . 0.0 112.105 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -137.55 154.9 49.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.604 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 44.9 m 52.88 48.42 22.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.563 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.65 -42.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.623 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.12 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 2.1 pp -116.93 146.06 43.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 110.532 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.16 161.45 15.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.515 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.21 92.29 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.555 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 54.92 69.36 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.53 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 77.7 t -133.93 -65.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.565 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -76.71 114.66 15.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.544 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.16 125.47 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.612 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -72.5 123.6 23.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.543 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.28 50.95 0.76 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.596 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.35 -60.07 1.98 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.497 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -107.57 119.22 5.74 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -54.58 97.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.362 . . . . 0.0 110.477 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.5 m -74.35 -171.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.528 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -158.16 -172.29 3.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.511 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -98.16 -31.14 12.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.566 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.86 -61.49 0.23 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.595 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 t0 65.22 143.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.58 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.5 mp -103.34 -176.73 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.473 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.97 -70.05 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -152.14 -59.67 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.578 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.46 -31.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.444 ' O ' HG23 ' A' ' 260' ' ' ILE . 3.9 t0 64.12 106.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.535 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 259' ' ' ASP . 1.1 pp -154.76 57.33 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.687 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -62.64 -41.34 98.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.542 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 25.0 p -165.37 -71.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.62 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 40.64 -160.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.874 0.734 . . . . 0.0 111.403 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.9 p -172.93 -32.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 110.643 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -105.6 130.98 53.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.502 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 2.0 ttt -103.23 -33.92 9.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.434 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -141.5 72.06 25.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.489 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.59 -54.9 4.49 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.75 2.3 . . . . 0.0 112.094 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 270' ' ' ALA . 0.0 OUTLIER 60.48 164.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.581 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 269' ' ' LYS . . . 70.17 -71.13 0.13 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.961 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 35.7 mt -86.18 -56.51 3.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.519 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 68.79 -74.5 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -139.27 148.89 43.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.49 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.88 -178.35 3.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.538 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.55 -179.3 7.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.619 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.66 -179.28 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.515 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.56 111.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.619 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -129.09 130.22 46.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.567 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 59.99 95.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.611 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -85.36 -37.1 20.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.593 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 1.8 tp -55.88 -46.13 78.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.577 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 57.3 t30 50.6 83.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.565 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 46.9 m -161.34 111.01 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.537 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.77 107.15 16.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.544 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.37 88.84 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.21 96.63 2.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.588 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.29 103.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.555 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.81 -34.3 69.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.51 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -96.39 92.91 6.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.591 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.72 147.56 30.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.599 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -74.99 137.63 41.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.566 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 4.1 t60 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.591 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.97 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.734 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 t -161.63 -56.88 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.901 0.381 . . . . 0.0 110.593 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 53.93 63.13 2.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.536 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.95 109.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.512 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -98.42 106.36 18.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.503 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp 59.45 -172.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.553 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.1 tttm 59.98 93.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.567 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.77 -64.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.453 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 49.42 66.88 0.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.668 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -130.52 -50.13 1.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.546 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -72.94 0.76 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.488 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.23 -12.03 11.23 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.383 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -60.24 -39.75 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 m -68.34 -35.92 72.85 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.301 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -35.09 69.52 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 77.5 mt-10 -70.93 -46.55 62.25 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -34.01 71.83 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -38.18 78.48 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.313 -2.222 . . . . 0.0 109.493 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -65.73 -46.67 78.01 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.021 -1.899 . . . . 0.0 114.572 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -75.46 -31.15 60.16 Favored 'General case' 0 C--O 1.204 -1.341 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.66 -177.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.751 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.87 -38.05 67.15 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 111.678 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -44.97 84.01 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.643 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.04 -47.21 21.23 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 29' ' ' ILE . 87.8 t -65.41 -52.09 55.97 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.493 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.069 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 29' ' ' ILE . 31.7 t80 -53.76 -47.35 70.76 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.094 0.473 . . . . 0.0 112.168 -176.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -75.63 -29.86 21.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.962 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.71 -36.19 69.41 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.745 HG21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm -59.3 -41.0 82.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 113.474 -1.694 . . . . 0.0 109.987 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.37 -36.85 64.04 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.9 m -67.38 -39.43 85.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.33 -46.22 67.59 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.505 HD22 HD23 ' A' ' 124' ' ' LEU . 2.4 pp -85.73 -31.44 22.42 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -75.84 -36.16 42.95 Favored Glycine 0 CA--C 1.505 -0.566 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.365 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.97 -19.1 40.0 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.472 -1.291 . . . . 0.0 107.589 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -106.59 -10.06 16.34 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.667 177.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.43 ' H ' ' C ' ' A' ' 34' ' ' GLY . 8.0 t80 -123.25 122.31 26.83 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 118.393 0.542 . . . . 0.0 110.119 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.11 137.72 43.75 Favored 'Cis proline' 0 N--CA 1.497 1.711 0 CA-C-N 119.645 0.909 . . . . 0.0 112.381 0.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.82 151.25 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.651 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.79 46.81 59.71 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -127.79 29.07 5.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.762 0.315 . . . . 0.0 110.559 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -132.23 161.57 33.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.663 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -107.06 -61.66 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.565 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -111.42 -26.6 9.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.405 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.33 144.69 50.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.94 147.38 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.133 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -106.63 106.19 16.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.975 0.417 . . . . 0.0 110.794 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.31 162.91 16.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.647 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -50.0 -28.52 7.07 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.116 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.453 HG22 HD21 ' A' ' 181' ' ' LEU . 16.2 t -57.15 -40.0 70.57 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -64.8 -53.76 41.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.719 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 65.4 t -67.9 -46.14 82.63 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.592 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.9 m -69.3 -38.67 78.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.822 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 1.0 OUTLIER -62.77 -31.94 73.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 176.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -63.87 -39.37 94.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.569 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -65.94 -41.01 91.87 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.774 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -63.54 -41.75 99.11 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.848 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 0.5 OUTLIER -67.57 -43.61 80.2 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.59 -178.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -58.65 -36.57 74.33 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.663 HG13 HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -60.06 -34.04 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.436 -178.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.722 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -64.66 -45.67 85.74 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.134 -1.394 . . . . 0.0 112.364 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.4 p -66.8 -31.59 72.32 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.706 ' HG ' HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -54.7 -43.1 72.24 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.18 -44.41 72.24 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.382 173.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -66.83 -48.76 67.91 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 m -59.05 -12.13 4.41 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 119.708 1.14 . . . . 0.0 112.086 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 63' ' ' LEU . 13.0 m -114.44 -42.11 3.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.95 0.405 . . . . 0.0 111.575 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 67' ' ' VAL . . . 144.19 158.91 7.79 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -60.65 -23.02 64.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.642 0.258 . . . . 0.0 111.681 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.14 7.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.62 136.44 53.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.105 0.479 . . . . 0.0 111.599 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -99.37 -153.46 27.86 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.45 85.8 1.13 Allowed 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 118.439 -1.304 . . . . 0.0 107.802 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -19.65 65.15 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.706 HD23 ' HG ' ' A' ' 63' ' ' LEU . 1.1 pp -83.78 -11.95 56.37 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.64 -1.618 . . . . 0.0 113.031 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -115.37 135.7 22.62 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 119.846 1.203 . . . . 0.0 114.06 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.483 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 96.6 Cg_endo -83.44 -21.6 4.29 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 123.14 2.56 . . . . 0.0 112.004 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.685 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -64.42 -48.67 74.48 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG23 HD23 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -66.14 -36.84 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.155 -0.341 . . . . 0.0 111.276 178.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.98 -28.45 69.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.736 HD22 ' HA ' ' A' ' 217' ' ' PHE . 0.3 OUTLIER -57.08 -35.12 69.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.795 0.331 . . . . 0.0 110.127 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.419 ' N ' ' HG ' ' A' ' 81' ' ' LEU . . . -68.73 -48.79 47.26 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.76 -30.53 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 110.885 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.23 -69.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.9 tp 57.85 102.04 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.139 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.5 p -46.83 -87.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 27.3 t 58.34 -88.83 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.43 0.157 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -108.69 -177.44 3.32 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.8 mm -114.95 100.11 9.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.789 0.328 . . . . 0.0 110.613 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.6 p -171.18 71.38 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.637 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.16 159.71 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.515 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -176.81 -44.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.848 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -63.61 -40.14 96.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.706 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.78 -35.02 77.93 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.932 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.69 -38.64 67.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 176.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.93 -37.01 70.1 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.476 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -61.06 -37.69 83.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.923 0.868 . . . . 0.0 109.23 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -63.17 -48.51 87.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 113.784 -1.553 . . . . 0.0 113.367 -178.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.433 ' N ' HG22 ' A' ' 98' ' ' ILE . 2.8 mm -70.42 -38.12 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.15 -47.31 74.48 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.201 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -35.61 70.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.411 ' O ' HG13 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -58.08 -36.09 72.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.22 -35.33 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-N 114.141 -1.391 . . . . 0.0 110.52 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.34 90.03 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-N 121.041 1.746 . . . . 0.0 113.105 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.02 75.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.493 HD11 ' CE2' ' A' ' 197' ' ' PHE . 64.0 mt -65.39 -50.15 74.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.9 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.02 -37.13 77.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.29 0.567 . . . . 0.0 109.612 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.56 -45.11 85.57 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.619 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.42 -37.13 74.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.819 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.32 -46.7 85.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.7 pt -67.09 -37.31 79.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.258 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.745 HD22 HG21 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -67.06 -24.4 65.98 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.233 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 70.3 m -60.89 -44.38 97.18 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.784 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.24 -36.3 62.01 Favored Glycine 0 CA--C 1.512 -0.136 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.91 -31.62 36.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.258 -0.971 . . . . 0.0 111.009 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.17 5.52 51.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.723 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.3 t -52.13 -32.98 37.99 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.32 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.08 -34.47 14.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.599 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.61 -179.29 6.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.0 m -118.4 144.77 45.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.676 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.36 78.84 0.23 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -98.09 -24.75 15.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.596 0.236 . . . . 0.0 111.188 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.1 p -172.82 64.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.989 0.424 . . . . 0.0 110.557 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.505 HD23 HD22 ' A' ' 33' ' ' LEU . 40.8 mt -88.72 7.87 31.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.158 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 71.69 16.57 76.12 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 117.35 31.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.344 0.592 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 51.97 17.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.048 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -84.83 91.72 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.43 HD21 ' OG ' ' A' ' 135' ' ' SER . 0.9 OUTLIER -63.17 138.59 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.286 0.565 . . . . 0.0 110.749 -178.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 185' ' ' ASP . . . -106.94 135.61 48.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.405 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -49.81 127.57 16.41 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 131.05 -104.26 0.58 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.846 HG21 HD13 ' A' ' 141' ' ' ILE . 1.5 t -86.06 125.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.456 ' O ' HG12 ' A' ' 133' ' ' VAL . 0.9 OUTLIER -71.65 -171.87 0.72 Allowed 'General case' 0 C--O 1.203 -1.37 0 N-CA-C 102.956 -2.979 . . . . 0.0 102.956 176.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.488 ' O ' HD13 ' A' ' 211' ' ' ILE . 54.1 m -62.67 -47.0 85.56 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 114.575 -2.85 . . . . 0.0 110.424 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.556 ' HA2' HG21 ' A' ' 211' ' ' ILE . . . -59.25 -39.85 95.12 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.46 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.783 ' HB3' HG22 ' A' ' 133' ' ' VAL . 37.9 mm-40 -53.5 -23.23 9.77 Favored 'General case' 0 C--N 1.25 -3.75 0 CA-C-O 121.29 0.567 . . . . 0.0 110.544 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -68.19 -1.65 21.48 Favored Glycine 0 C--O 1.186 -2.901 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -50.46 68.28 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-N 118.709 1.254 . . . . 0.0 110.836 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.48 -41.01 78.45 Favored Glycine 0 CA--C 1.51 -0.249 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.846 HD13 HG21 ' A' ' 133' ' ' VAL . 0.4 OUTLIER -65.04 -40.67 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 112.775 -1.713 . . . . 0.0 112.063 -178.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 138' ' ' GLY . 15.5 mt-10 -68.43 -36.42 79.03 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.834 0.825 . . . . 0.0 111.697 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.668 HG23 ' CA ' ' A' ' 219' ' ' GLY . 34.6 mt -66.63 -52.35 46.71 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.557 -174.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.22 -44.83 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.935 0.874 . . . . 0.0 111.966 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -59.53 -51.88 56.44 Favored Glycine 0 C--O 1.211 -1.327 0 CA-C-N 113.542 -1.663 . . . . 0.0 112.036 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.404 ' HA ' HG23 ' A' ' 191' ' ' ILE . 26.5 m -70.58 -36.95 73.87 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.375 -0.912 . . . . 0.0 111.185 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 1.5 tp -55.0 -40.45 70.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.008 -176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -58.87 -31.94 69.03 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 112.951 -1.931 . . . . 0.0 110.126 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.987 HD11 HG22 ' A' ' 176' ' ' VAL . 1.2 tp -68.77 -46.65 68.22 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.457 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.491 HG21 ' HA3' ' A' ' 220' ' ' GLY . 52.3 t -66.25 -40.98 88.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.7 -35.55 80.94 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.46 -33.51 74.31 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.431 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.05 -45.48 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -48.15 81.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.77 0.319 . . . . 0.0 111.272 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.68 72.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.038 0.447 . . . . 0.0 109.928 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.662 ' CB ' HD11 ' A' ' 172' ' ' ILE . 0.9 OUTLIER -65.78 -37.1 85.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.228 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.81 10.04 30.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.252 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.3 119.44 16.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.806 0.336 . . . . 0.0 110.599 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -59.28 -25.26 63.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.668 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -94.92 141.42 28.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.505 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 58.73 71.96 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.568 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.54 166.75 13.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.665 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 53.67 68.33 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.603 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.77 42.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.505 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.93 106.6 2.95 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.34 -127.06 38.51 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.97 138.66 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 110.52 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.639 ' HB1' ' OG1' ' A' ' 156' ' ' THR . . . -52.26 -46.19 94.17 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.828 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 21.1 Cg_exo -54.82 -46.27 34.6 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.459 1.439 . . . . 0.0 112.028 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.17 -37.46 74.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.965 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.51 -45.95 61.02 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.782 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.662 HD11 ' CB ' ' A' ' 156' ' ' THR . 49.3 mt -58.3 -39.37 73.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 121.591 0.71 . . . . 0.0 109.238 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.25 93.29 Favored Glycine 0 C--O 1.2 -2.015 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.929 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.455 ' O ' HD13 ' A' ' 178' ' ' LEU . 2.0 tp -55.09 -35.8 64.98 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -34.47 76.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.395 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.987 HG22 HD11 ' A' ' 149' ' ' LEU . 24.8 t -73.09 -47.12 48.93 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -175.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.822 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -69.67 -30.85 68.63 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 122.485 1.135 . . . . 0.0 110.107 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 181' ' ' LEU 0.264 2.1 mp -70.56 -50.5 36.73 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 124.546 2.117 . . . . 0.0 110.323 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.458 ' O ' HD11 ' A' ' 191' ' ' ILE . . . -55.45 -36.91 64.75 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 110.219 -3.173 . . . . 0.0 107.401 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.46 ' O ' ' HB ' ' A' ' 184' ' ' ILE . 12.1 m170 -70.18 -35.34 73.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.096 -1.552 . . . . 0.0 109.645 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 177' ' ' ALA . 0.1 OUTLIER -58.88 -47.85 83.47 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.919 -178.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.734 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -75.04 -52.64 10.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.745 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -70.16 -52.04 26.61 Favored 'General case' 0 C--O 1.201 -1.471 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.516 ' O ' ' HA2' ' A' ' 188' ' ' GLY . 10.8 mt -60.87 -40.67 86.0 Favored 'Isoleucine or valine' 0 C--O 1.178 -2.683 0 C-N-CA 118.94 -1.104 . . . . 0.0 112.901 -174.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -75.61 -35.67 60.47 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 115.742 -2.383 . . . . 0.0 112.266 -177.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 133' ' ' VAL . 0.2 OUTLIER -60.07 -29.94 68.89 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.802 -1.159 . . . . 0.0 111.179 -171.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.281 0.1 OUTLIER -124.44 -26.83 3.83 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.199 -179.109 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 184' ' ' ILE . . . 87.2 -5.87 84.36 Favored Glycine 0 CA--C 1.569 3.423 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.431 ' H ' HG23 ' A' ' 187' ' ' THR . 43.9 t -84.72 129.1 34.87 Favored 'General case' 0 N--CA 1.403 -2.778 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -48.4 162.83 0.41 Allowed Glycine 0 N--CA 1.408 -3.187 0 CA-C-N 111.265 -2.698 . . . . 0.0 113.464 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.745 HG12 ' HB3' ' A' ' 183' ' ' ALA . 0.5 OUTLIER -73.11 -42.62 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.685 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 3.2 p-10 -92.38 144.73 29.34 Favored Pre-proline 0 N--CA 1.417 -2.096 0 CA-C-N 110.843 -2.889 . . . . 0.0 107.702 177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.02 -14.71 45.72 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.907 1.738 . . . . 0.0 111.247 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.486 ' HB3' HD22 ' A' ' 192' ' ' ASN . . . -75.03 -31.83 61.43 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 121.243 -0.183 . . . . 0.0 110.989 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.525 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -70.48 -39.25 74.33 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.376 0.607 . . . . 0.0 109.863 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -36.91 66.79 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.828 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 11.6 t80 -72.22 -35.24 68.82 Favored 'General case' 0 N--CA 1.511 2.575 0 C-N-CA 126.412 1.885 . . . . 0.0 114.442 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.26 93.51 Favored Glycine 0 C--N 1.318 -0.438 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 202' ' ' ILE . 4.9 m -76.48 -28.42 56.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.265 -0.968 . . . . 0.0 110.647 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.828 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -66.26 -34.06 77.16 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.163 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -70.38 -30.85 44.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 121.013 1.733 . . . . 0.0 111.604 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 199' ' ' SER . 10.2 tt -34.51 -35.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.6 m -162.38 56.95 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.147 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 48.44 -160.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.287 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -177.06 176.54 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.38 . . . . 0.0 110.593 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -103.83 177.79 4.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.47 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -26.81 66.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.384 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 211' ' ' ILE . 4.7 m120 -62.64 -35.17 78.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.637 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -18.55 64.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.476 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -20.11 62.55 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.892 0.377 . . . . 0.0 111.63 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 208' ' ' ASN . 2.7 pp -52.44 -34.42 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . 0.526 ' N ' HD12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -58.46 -31.82 68.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.178 -179.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -84.56 -33.91 23.34 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 215' ' ' GLY . 14.9 p -81.79 -46.57 19.93 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.509 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -175.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.03 -44.73 83.26 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.177 -176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.9 Cg_exo -71.75 -28.6 16.76 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.842 2.362 . . . . 0.0 113.192 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.736 ' HA ' HD22 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -75.65 -35.02 60.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.244 0.545 . . . . 0.0 112.147 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.553 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 6.3 mm -70.55 -46.37 70.33 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.158 0 C-N-CA 124.165 0.986 . . . . 0.0 112.685 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.668 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -67.91 -46.74 64.76 Favored Glycine 0 C--N 1.359 1.858 0 O-C-N 128.713 3.758 . . . . 0.0 111.768 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.561 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.44 -49.04 33.69 Favored Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 118.158 -1.972 . . . . 0.0 109.762 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.467 ' N ' HD11 ' A' ' 81' ' ' LEU . . . -55.03 -38.94 68.6 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.57 0.7 . . . . 0.0 109.715 -176.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 218' ' ' ILE . 1.3 pp -67.72 -31.2 70.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.274 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 220' ' ' GLY . . . -58.95 -39.69 82.41 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.129 0.966 . . . . 0.0 108.48 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.0 t -58.34 -49.64 81.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.587 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.84 -39.48 94.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.705 0.765 . . . . 0.0 109.829 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 1.1 mm -57.84 -34.59 48.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.405 -1.27 . . . . 0.0 111.616 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -123.39 36.64 4.59 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.187 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.64 13.17 19.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.029 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -176.15 125.44 0.2 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.712 0.291 . . . . 0.0 110.423 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.05 109.71 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.454 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 11.7 tp -169.52 77.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.536 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . 57.15 72.31 0.96 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.593 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -46.18 165.18 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.894 2.396 . . . . 0.0 112.135 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.8 mtt180 -70.7 -49.66 44.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.565 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 1.4 p -71.78 -78.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.527 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.8 m 53.63 77.92 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.641 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 58.88 -168.59 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.524 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 58.29 93.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.499 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 41.1 p -111.86 -178.12 3.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.509 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.65 -49.53 56.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.581 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -176.08 -56.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.591 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.8 m -116.33 176.19 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.505 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.33 102.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.631 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.38 142.14 16.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.539 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -112.85 93.24 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.595 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 18.7 p -96.06 134.88 38.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.606 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 5.0 t -114.95 73.83 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.537 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.62 152.74 9.79 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.1 84.11 1.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.764 0.316 . . . . 0.0 110.614 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.6 -45.51 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.617 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 56.8 85.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.577 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -112.13 -56.21 2.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.494 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -139.88 25.49 2.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.529 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.91 93.37 4.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.56 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.6 98.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.553 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.25 -67.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.524 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -77.17 134.59 38.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.77 147.82 40.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.491 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -55.11 117.51 3.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.586 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -155.84 138.73 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.563 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 2.1 m120 50.0 83.17 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.578 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.9 m -122.93 -53.04 1.87 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.528 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 52.78 67.4 1.0 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.594 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.0 p -165.91 -35.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.575 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 51.17 -171.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.508 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.11 152.61 3.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.596 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -56.01 40.32 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.375 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.88 -30.55 4.53 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.994 1.796 . . . . 0.0 112.122 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -71.11 142.77 50.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.589 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . 55.93 91.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.601 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.77 -78.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.556 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -74.92 -66.89 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.612 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -165.15 -69.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.549 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -103.54 -36.21 8.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.603 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.2 mp -91.83 178.67 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 16.2 tt -162.94 148.21 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.589 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 23.0 t 51.15 66.1 1.28 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.596 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -98.5 -53.63 3.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.526 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 51.34 84.43 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.573 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -103.46 -40.87 6.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.538 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 9.2 tp -167.15 74.19 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.538 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 55.3 -179.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.52 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 29.0 t -152.21 118.42 5.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.555 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -89.63 -175.7 4.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.567 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.86 137.43 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.574 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -125.28 -176.76 3.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.598 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 30.6 p80 38.51 35.19 0.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.936 0.772 . . . . 0.0 111.678 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -78.94 74.34 5.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.645 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -131.51 32.52 4.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.513 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -172.22 -52.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.575 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 28.1 t60 49.87 84.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.512 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 35.3 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.521 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.81 108.69 2.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.46 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p -138.34 35.02 2.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.552 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -133.48 -61.83 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.51 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -100.93 89.22 3.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.445 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -160.37 45.48 0.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.529 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -121.57 -42.9 2.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.621 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -103.54 -34.52 8.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.578 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mt -54.78 -70.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.502 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.1 t80 70.25 -70.61 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.981 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -50.18 101.18 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.025 0.44 . . . . 0.0 110.802 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -67.56 -4.18 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.289 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.77 -1.45 12.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.276 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.1 t -63.98 -40.25 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.23 -35.67 72.12 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.641 0 CA-C-N 112.49 -2.141 . . . . 0.0 109.786 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.44 -34.8 69.33 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 3.7 tp10 -70.73 -46.78 62.4 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 -176.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -33.9 71.05 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tt -58.87 -38.17 78.19 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 112.293 -2.23 . . . . 0.0 109.482 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -63.25 -46.59 86.15 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.006 -1.907 . . . . 0.0 113.73 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -75.58 -31.37 59.94 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 113.855 -1.52 . . . . 0.0 111.96 -177.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.734 ' HA ' ' HB2' ' A' ' 108' ' ' ALA . 0.2 OUTLIER -72.86 -37.95 67.19 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.178 -0.951 . . . . 0.0 111.287 -178.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.92 -45.25 82.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.715 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -77.13 -50.79 12.23 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 29' ' ' ILE . 43.2 t -64.59 -46.31 92.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.384 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.994 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.417 ' CE1' HD12 ' A' ' 112' ' ' LEU . 57.6 t80 -54.04 -48.67 70.3 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.189 0.519 . . . . 0.0 112.071 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.59 -29.03 20.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.519 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -56.05 -36.19 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 -174.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.599 HG21 HD22 ' A' ' 112' ' ' LEU . 2.6 mm -64.02 -40.63 89.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.056 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.54 -41.32 81.05 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -67.57 -45.1 76.55 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.874 0.368 . . . . 0.0 111.876 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.1 -46.23 85.88 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -85.68 -27.94 25.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 37' ' ' TYR . . . -75.92 -36.93 40.13 Favored Glycine 0 C--N 1.318 -0.434 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.482 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -58.77 -19.43 40.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' N ' ' C ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -106.56 -9.87 16.43 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.521 177.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 34' ' ' GLY . 7.7 t80 -122.28 121.41 27.8 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.489 0.586 . . . . 0.0 110.283 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.96 141.3 70.01 Favored 'Cis proline' 0 N--CA 1.497 1.711 0 C-N-CA 124.681 -0.966 . . . . 0.0 112.178 -0.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -82.34 144.72 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.606 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.2 -79.11 1.93 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 63.59 172.35 0.17 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 0.0 110.459 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -93.09 -4.91 51.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.221 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -89.46 162.91 15.49 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.91 0.386 . . . . 0.0 110.645 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.11 10.45 41.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.58 142.82 50.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 110.655 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 m -116.5 143.32 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.396 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -106.24 123.39 47.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.583 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.23 162.52 16.45 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 121.058 0.456 . . . . 0.0 110.817 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -49.89 -28.71 6.98 Favored 'General case' 0 C--O 1.205 -1.253 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.602 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.2 -34.59 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -64.94 -54.09 36.18 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.458 1.027 . . . . 0.0 113.443 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.73 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 7.7 p -68.15 -42.43 84.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.772 -176.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.449 ' N ' HG13 ' A' ' 52' ' ' VAL . 57.0 m -69.34 -41.36 76.73 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.52 0.512 . . . . 0.0 109.815 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.81 ' HA ' ' HB1' ' A' ' 177' ' ' ALA . 2.5 tm? -62.82 -31.94 73.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 52' ' ' VAL . . . -64.07 -39.61 94.46 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.96 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.408 ' O ' HD13 ' A' ' 60' ' ' ILE . 9.2 m-30 -66.2 -46.83 75.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.699 ' HA3' ' HB2' ' A' ' 177' ' ' ALA . . . -64.44 -40.18 97.52 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.168 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.663 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 3.7 mm? -68.23 -43.49 77.8 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.093 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 p -58.69 -36.53 74.36 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.482 HG13 HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -59.8 -34.02 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.398 -1.728 . . . . 0.0 108.216 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.76 ' O ' ' HB3' ' A' ' 64' ' ' ALA . . . -65.54 -45.63 82.68 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.326 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 p -69.08 -31.8 70.8 Favored 'General case' 0 CA--C 1.471 -2.067 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.711 ' HG ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -55.31 -40.95 71.72 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 61' ' ' ALA . . . -69.0 -44.07 73.55 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 112.907 -1.951 . . . . 0.0 109.827 173.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 t -59.65 -12.43 6.83 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 120.115 1.325 . . . . 0.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.91 -32.69 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.809 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 168.58 12.21 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.54 -23.08 66.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 tt -73.62 7.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 p -124.42 135.56 53.36 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.215 0.531 . . . . 0.0 110.95 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.58 -159.82 22.95 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 76' ' ' ASN . . . -72.41 85.89 1.12 Allowed 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 122.623 1.202 . . . . 0.0 108.468 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -73.2 -19.65 61.05 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.711 HD22 ' HG ' ' A' ' 63' ' ' LEU . 1.2 pp -84.87 8.67 16.63 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 112.866 -1.97 . . . . 0.0 110.787 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 5.1 t-20 -134.55 127.63 18.74 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -177.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.559 ' HG3' ' HB2' ' A' ' 194' ' ' ALA . 88.5 Cg_endo -83.33 -28.3 1.52 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.092 2.528 . . . . 0.0 112.275 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 192' ' ' ASN . . . -59.35 -49.03 79.37 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.571 HG23 HD23 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -66.42 -36.75 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 177.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 m -61.15 -28.62 69.25 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.54 -44.34 96.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.38 . . . . 0.0 110.155 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -61.49 -38.79 96.37 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.29 -46.18 65.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.657 0.265 . . . . 0.0 110.941 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.97 -43.69 40.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.586 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 63.23 153.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.552 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.2 m -48.64 -81.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.788 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 48.6 -163.24 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.769 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -91.45 -44.08 9.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.542 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.1 tt -166.38 153.97 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.606 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.2 p -70.84 -163.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.442 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.6 mp -107.57 -80.47 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.612 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 176.2 -43.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.594 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -54.66 -39.13 67.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.704 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.672 ' O ' HG23 ' A' ' 98' ' ' ILE . . . -67.53 -35.26 78.75 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.42 67.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 176.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 tpp -73.39 -31.61 63.98 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.214 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -69.73 -39.19 76.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 119.267 0.939 . . . . 0.0 111.575 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -66.83 -41.19 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.695 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -70.65 -38.04 71.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 103' ' ' VAL . . . -66.42 -47.0 74.63 Favored 'General case' 0 C--O 1.212 -0.904 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -35.71 70.81 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.405 ' O ' HG13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -58.12 -36.11 72.44 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 100' ' ' ALA . 3.3 t -70.35 -35.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.197 175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.36 -46.72 86.39 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 120.899 1.681 . . . . 0.0 113.084 -177.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.485 ' N ' ' HB ' ' A' ' 21' ' ' THR . . . -69.89 -36.04 75.13 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.683 HG23 HG11 ' A' ' 201' ' ' VAL . 77.6 mt -64.98 -50.31 75.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.305 -177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.2 m -65.42 -36.92 78.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 22' ' ' THR . . . -57.27 -43.33 82.99 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.973 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -37.05 74.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.75 85.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.454 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt -66.76 -37.33 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.42 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 29' ' ' ILE . 1.1 tt -67.08 -24.44 65.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.4 p -61.4 -41.71 97.56 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.813 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.26 -36.0 61.56 Favored Glycine 0 CA--C 1.51 -0.266 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -55.38 -29.83 24.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.456 -0.872 . . . . 0.0 111.391 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -81.59 5.36 18.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.627 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m -58.01 -26.93 63.03 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.707 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 77.4 p -92.01 -35.5 13.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.111 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.2 135.46 49.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.882 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t -115.57 164.5 14.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.615 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 49.17 41.74 30.99 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -88.22 9.84 21.6 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.0 79.29 0.26 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.942 0.401 . . . . 0.0 110.699 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 124' ' ' LEU . 8.2 mp -88.62 7.96 30.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.91 23.5 74.57 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.54 117.11 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.2 0.524 . . . . 0.0 111.452 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 58.02 11.01 1.32 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.064 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -87.78 91.85 8.9 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.16 143.1 58.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.302 0.572 . . . . 0.0 111.101 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.95 134.71 49.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.636 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -49.79 127.58 16.38 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 128.94 -104.38 0.64 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 137' ' ' GLN . 1.7 t -86.07 124.02 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.469 ' O ' HG12 ' A' ' 133' ' ' VAL . 1.4 t30 -71.67 -171.78 0.71 Allowed 'General case' 0 C--O 1.203 -1.365 0 N-CA-C 102.823 -3.029 . . . . 0.0 102.823 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.1 p -62.2 -46.8 87.3 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 114.843 -2.743 . . . . 0.0 110.187 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -58.84 -41.14 95.94 Favored Glycine 0 CA--C 1.498 -0.992 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.115 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.762 ' HB3' HG22 ' A' ' 133' ' ' VAL . 26.9 mm100 -53.46 -23.59 10.53 Favored 'General case' 0 C--N 1.248 -3.819 0 CA-C-O 121.496 0.665 . . . . 0.0 110.26 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 141' ' ' ILE . . . -69.39 -1.54 29.21 Favored Glycine 0 C--O 1.188 -2.728 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.78 -50.32 65.14 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 118.556 1.178 . . . . 0.0 110.902 -176.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.78 -38.23 76.36 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.582 ' HB ' ' HA2' ' A' ' 138' ' ' GLY . 0.7 OUTLIER -68.92 -38.32 78.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 113.228 -1.486 . . . . 0.0 112.18 -178.274 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' GLY . 20.4 mt-10 -68.54 -36.29 78.61 Favored 'General case' 0 C--O 1.203 -1.346 0 CA-C-O 121.744 0.783 . . . . 0.0 111.123 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.704 HG23 ' CA ' ' A' ' 219' ' ' GLY . 31.7 mt -69.65 -45.46 77.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.395 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.496 -174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.31 -48.78 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.463 1.125 . . . . 0.0 111.27 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 148' ' ' GLN . . . -58.48 -51.56 58.03 Favored Glycine 0 C--O 1.211 -1.299 0 CA-C-N 112.748 -2.024 . . . . 0.0 112.718 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.427 ' CG2' ' HB1' ' A' ' 78' ' ' ALA . 44.8 m -70.62 -40.16 73.32 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.234 -0.983 . . . . 0.0 111.673 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.616 ' CD1' ' HB2' ' A' ' 223' ' ' ALA . 3.6 tp -54.8 -40.55 69.59 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.277 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 1.1 pt20 -58.07 -31.1 66.76 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.241 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.005 HD11 HG22 ' A' ' 176' ' ' VAL . 1.6 tp -68.69 -47.17 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.49 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.482 HG21 ' CA ' ' A' ' 220' ' ' GLY . 87.2 t -66.33 -40.98 88.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -42.28 96.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.492 ' SG ' HG23 ' A' ' 172' ' ' ILE . 3.8 p -71.0 -27.18 63.51 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.457 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.527 HG21 HG21 ' A' ' 79' ' ' VAL . 2.3 t -72.09 -45.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.552 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.59 -41.98 92.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.372 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.56 87.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.519 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.613 ' HB ' ' HB1' ' A' ' 168' ' ' ALA . 0.7 OUTLIER -69.92 -36.96 75.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.508 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 157' ' ' THR . 0.6 OUTLIER -88.71 -1.98 58.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.476 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -67.2 108.65 2.77 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.64 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -60.91 -32.87 72.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.627 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -83.33 127.79 33.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.471 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.56 105.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.634 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -130.47 116.69 18.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.525 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.38 108.63 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.616 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.9 -58.06 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.487 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.48 142.29 9.2 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 75.65 -138.69 23.47 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.402 ' CB ' HD12 ' A' ' 170' ' ' LEU . 1.4 m -112.36 135.41 53.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 0.0 110.507 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.613 ' HB1' ' HB ' ' A' ' 156' ' ' THR . . . -52.34 -46.23 94.53 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.548 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 168' ' ' ALA . 24.3 Cg_exo -54.67 -39.39 89.27 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.524 1.483 . . . . 0.0 111.972 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.402 HD12 ' CB ' ' A' ' 167' ' ' SER . 32.5 mt -60.54 -42.42 96.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.382 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.55 -47.06 57.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.703 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.492 HG23 ' SG ' ' A' ' 152' ' ' CYS . 41.6 mt -58.23 -37.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -65.62 -37.42 93.58 Favored Glycine 0 C--O 1.198 -2.125 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.306 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -55.13 -35.98 65.27 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -34.56 77.24 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.52 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 1.005 HG22 HD11 ' A' ' 149' ' ' LEU . 28.0 t -73.15 -47.6 46.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 54' ' ' LEU . . . -66.72 -34.89 78.85 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-O 122.261 1.029 . . . . 0.0 109.667 -175.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 174' ' ' LEU 0.264 8.1 mt -67.06 -50.56 61.45 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 124.454 2.073 . . . . 0.0 110.863 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -55.52 -36.97 65.38 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.117 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.551 ' HD2' HD11 ' A' ' 191' ' ' ILE . 5.4 m-70 -70.38 -35.12 73.31 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 112.669 -1.766 . . . . 0.0 109.504 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -59.2 -47.81 83.95 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.519 -177.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -75.1 -52.33 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.757 ' HB3' HG23 ' A' ' 191' ' ' ILE . . . -70.15 -52.22 25.24 Favored 'General case' 0 C--O 1.206 -1.221 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 188' ' ' GLY . 7.4 mt -56.02 -49.03 77.85 Favored 'Isoleucine or valine' 0 C--O 1.174 -2.914 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.644 -174.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -69.02 -35.67 76.91 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 115.538 -2.465 . . . . 0.0 112.582 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 133' ' ' VAL . 2.4 m-85 -60.11 -30.35 69.2 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.721 -170.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 183' ' ' ALA 0.288 0.1 OUTLIER -124.54 -26.82 3.8 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 122.06 0.933 . . . . 0.0 113.101 -179.401 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 184' ' ' ILE . . . 88.35 -5.99 84.09 Favored Glycine 0 CA--C 1.567 3.284 0 N-CA-C 106.165 -2.774 . . . . 0.0 106.165 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.446 ' H ' HG23 ' A' ' 187' ' ' THR . 17.1 t -85.36 130.68 34.54 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 195' ' ' ARG . . . -57.47 160.65 10.04 Favored Glycine 0 N--CA 1.402 -3.625 0 CA-C-N 111.497 -2.592 . . . . 0.0 111.752 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.757 HG23 ' HB3' ' A' ' 183' ' ' ALA . 1.2 pt -72.11 -38.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.727 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 10.2 p-10 -85.88 139.19 34.99 Favored Pre-proline 0 N--CA 1.413 -2.32 0 CA-C-N 112.657 -2.065 . . . . 0.0 107.997 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -66.03 -14.46 44.53 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.49 2.127 . . . . 0.0 111.58 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' A' ' 77' ' ' PRO . . . -75.23 -33.23 61.33 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.466 ' HB3' ' HA3' ' A' ' 190' ' ' GLY . 15.6 tpt180 -70.74 -38.39 73.54 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.106 0.479 . . . . 0.0 110.158 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.4 t -73.44 -42.22 62.27 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.837 ' HA ' ' HB3' ' A' ' 200' ' ' ALA . 1.0 OUTLIER -71.96 -35.2 69.48 Favored 'General case' 0 N--CA 1.512 2.661 0 C-N-CA 126.607 1.963 . . . . 0.0 114.777 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.51 -45.41 93.12 Favored Glycine 0 C--N 1.315 -0.606 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 m -76.38 -28.35 56.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.322 -0.939 . . . . 0.0 110.669 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.837 ' HB3' ' HA ' ' A' ' 197' ' ' PHE . . . -66.31 -34.22 77.49 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.743 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.683 HG11 HG23 ' A' ' 106' ' ' ILE . 3.4 m -58.75 -31.11 43.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 121.79 2.086 . . . . 0.0 110.526 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.66 -54.71 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.506 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.27 -173.01 4.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.42 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -141.97 93.79 2.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 110.658 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -105.03 -178.49 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.24 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -124.98 -96.52 0.44 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.74 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.15 -42.63 93.58 Favored 'General case' 0 C--O 1.228 -0.063 0 CA-C-O 120.821 0.343 . . . . 0.0 110.993 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -55.17 -35.04 64.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.477 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -32.26 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.891 0.377 . . . . 0.0 111.077 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -70.44 -32.48 70.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.602 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 1.1 mp -52.82 -35.06 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.832 0.825 . . . . 0.0 109.005 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -58.8 -36.19 74.06 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.058 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.27 -33.41 24.02 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 215' ' ' GLY . 12.0 p -77.74 -44.99 28.81 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.496 ' N ' ' CD ' ' A' ' 216' ' ' PRO . . . -55.27 -47.73 73.13 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.682 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 215' ' ' GLY . 2.1 Cg_endo -71.8 -28.62 16.56 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.936 2.424 . . . . 0.0 113.609 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -75.2 -33.81 61.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.051 0.453 . . . . 0.0 111.898 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 51.8 mt -70.58 -46.25 70.72 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.382 0 C-N-CA 123.892 0.877 . . . . 0.0 112.753 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.704 ' CA ' HG23 ' A' ' 143' ' ' ILE . . . -68.29 -45.84 67.61 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 128.343 3.527 . . . . 0.0 111.752 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 223' ' ' ALA . . . -70.39 -48.91 34.71 Favored Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 118.306 -1.902 . . . . 0.0 109.532 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.81 68.31 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.601 0.715 . . . . 0.0 109.674 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.769 ' O ' HG23 ' A' ' 226' ' ' ILE . 1.0 OUTLIER -67.85 -31.33 71.08 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.225 178.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -58.99 -40.03 83.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 52.7 t -59.51 -50.28 80.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.488 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -39.56 93.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 222' ' ' LEU . 1.1 pp -68.99 -34.22 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.325 -176.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -122.88 63.08 0.98 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -158.39 127.31 5.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.368 . . . . 0.0 110.748 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -89.61 93.28 9.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.741 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.5 mm -143.55 122.38 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.425 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 70.73 -70.17 0.16 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.618 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . 61.78 72.67 0.63 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.905 0.383 . . . . 0.0 110.578 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -72.64 73.8 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.724 2.282 . . . . 0.0 112.11 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -50.32 114.11 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.575 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 6.1 m -85.99 -32.04 21.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.543 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 4.4 t -86.44 -176.17 5.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.494 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.88 163.61 2.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.91 -60.41 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.552 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.65 93.41 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.574 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -112.4 27.06 9.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.52 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -119.01 -67.8 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.576 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -157.21 158.12 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.577 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -170.71 140.04 1.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.584 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 9.7 t 53.19 76.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.473 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -55.88 -48.81 74.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.49 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 10.5 p -70.05 179.29 2.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.596 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.96 142.43 41.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.604 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -60.19 108.8 1.93 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.82 166.81 13.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.545 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.5 t -101.29 -54.78 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.574 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -63.29 123.47 18.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.65 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -88.72 137.87 31.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.648 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -119.71 -34.58 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.57 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.6 -170.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.551 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.22 153.0 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.561 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.04 -82.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -64.18 107.32 1.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.567 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -159.62 37.07 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.499 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -127.38 31.92 5.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.564 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 22.9 mt 52.97 87.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.639 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -115.53 -31.05 6.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.608 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 1.1 p 55.85 -176.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.455 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 64.98 117.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.56 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.35 164.06 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.564 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 61.58 92.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.554 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' MET . . . . . . . . . . . . . 5.1 mtm -114.12 103.07 10.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.535 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 1.6 mttm 177.57 -55.64 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -45.06 -50.07 9.2 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.038 1.825 . . . . 0.0 112.309 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -109.81 145.41 36.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.581 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -120.97 -54.35 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.568 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 1.7 tp 57.05 28.55 15.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.488 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -137.45 134.9 36.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.581 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -103.7 135.73 44.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.446 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.41 102.01 7.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.644 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.2 tp -108.3 124.27 50.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.594 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 5.1 tt -118.59 -30.84 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.588 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 6.2 t -50.21 142.56 9.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.604 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -150.72 109.74 3.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.559 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -140.85 78.14 1.63 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.58 168.83 9.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.487 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 1.1 mt -53.62 159.15 1.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.571 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -91.66 75.06 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.479 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 22.8 t -69.21 -40.21 78.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.579 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . 54.33 92.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.466 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.29 120.78 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.582 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.54 162.1 14.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.629 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -105.67 40.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.565 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -126.14 170.37 11.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.562 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -61.89 171.59 1.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -74.59 -30.08 61.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.66 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -94.61 -54.02 3.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.578 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 4.1 t60 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.453 -179.898 . . . . . . . . 0 0 . 1 stop_ save_